1	The	the	DT	_	2	det
2	effects	effect	NNS	_	0	ROOT
3	of	of	IN	_	6	case
4	concomitant	concomitant	JJ	_	6	amod
5	drug1	drug1	NN	_	6	compound
6	administration	administration	NN	_	2	nmod
7	on	on	IN	_	10	case
8	the	the	DT	_	10	det
9	steady-state	steady-state	JJ	_	10	amod
10	pharmacokinetics	pharmacokinetic	NNS	_	2	nmod
11	of	of	IN	_	12	case
12	drug2	drug2	NN	_	10	nmod
13	.	.	.	_	2	punct

1	drug1	drug1	NN	_	11	nsubj
2	-LRB-	-lrb-	-LRB-	_	4	punct
3	'	'	''	_	4	punct
4	drug2	drug2	NN	_	1	appos
5	'	'	''	_	4	punct
6	-RRB-	-rrb-	-RRB-	_	4	punct
7	is	be	VBZ	_	11	cop
8	a	a	DT	_	11	det
9	newly	newly	RB	_	10	advmod
10	introduced	introduce	VBN	_	11	amod
11	drug3	drug3	NN	_	0	ROOT
12	with	with	IN	_	14	case
13	demonstrated	demonstrate	VBN	_	14	amod
14	efficacy	efficacy	NN	_	11	nmod
15	in	in	IN	_	17	case
16	the	the	DT	_	17	det
17	treatment	treatment	NN	_	14	nmod
18	of	of	IN	_	22	case
19	positive	positive	JJ	_	22	amod
20	and	and	CC	_	19	cc
21	negative	negative	JJ	_	19	conj
22	symptoms	symptom	NNS	_	17	nmod
23	of	of	IN	_	24	case
24	schizophrenia	schizophrenia	NN	_	22	nmod
25	.	.	.	_	11	punct

1	It	it	PRP	_	4	nsubjpass
2	is	be	VBZ	_	4	auxpass
3	extensively	extensively	RB	_	4	advmod
4	metabolized	metabolize	VBN	_	0	ROOT
5	,	,	,	_	4	punct
6	predominantly	predominantly	RB	_	10	advmod
7	by	by	IN	_	10	case
8	cytochrome	cytochrome	NN	_	10	compound
9	P450	p450	NN	_	10	compound
10	3A4	3a4	NN	_	4	nmod
11	.	.	.	_	4	punct

1	Therefore	therefore	RB	_	14	advmod
2	,	,	,	_	14	punct
3	concurrent	concurrent	JJ	_	4	amod
4	administration	administration	NN	_	14	nsubj
5	of	of	IN	_	6	case
6	drugs	drug	NNS	_	4	nmod
7	that	that	WDT	_	8	nsubj
8	induce	induce	VBP	_	6	acl:relcl
9	or	or	CC	_	8	cc
10	inhibit	inhibit	VBP	_	8	conj
11	this	this	DT	_	12	det
12	enzyme	enzyme	NN	_	8	dobj
13	may	may	MD	_	14	aux
14	affect	affect	VB	_	0	ROOT
15	drug1	drug1	NN	_	16	compound
16	pharmacokinetics	pharmacokinetic	NNS	_	14	dobj
17	.	.	.	_	14	punct

1	This	this	DT	_	2	det
2	study	study	NN	_	3	nsubj
3	demonstrated	demonstrate	VBD	_	0	ROOT
4	that	that	IN	_	13	mark
5	the	the	DT	_	10	det
6	potent	potent	JJ	_	10	amod
7	cytochrome	cytochrome	NN	_	10	compound
8	P450	p450	NN	_	10	compound
9	enzyme-inducer	enzyme-inducer	JJ	_	10	amod
10	drug1	drug1	NN	_	13	nsubj
11	did	do	VBD	_	13	aux
12	indeed	indeed	RB	_	13	advmod
13	have	have	VB	_	3	ccomp
14	a	a	DT	_	16	det
15	marked	marked	JJ	_	16	amod
16	effect	effect	NN	_	13	dobj
17	on	on	IN	_	19	case
18	the	the	DT	_	19	det
19	metabolism	metabolism	NN	_	16	nmod
20	of	of	IN	_	21	case
21	drug2	drug2	NN	_	19	nmod
22	,	,	,	_	13	punct
23	resulting	result	VBG	_	13	advcl
24	in	in	IN	_	27	case
25	a	a	DT	_	27	det
26	5-fold	5-fold	JJ	_	27	amod
27	increase	increase	NN	_	23	nmod
28	in	in	IN	_	29	case
29	clearance	clearance	NN	_	27	nmod
30	when	when	WRB	_	31	advmod
31	administered	administer	VBN	_	23	advcl
32	concomitantly	concomitantly	RB	_	31	advmod
33	to	to	TO	_	34	case
34	patients	patient	NNS	_	31	nmod
35	with	with	IN	_	37	case
36	DSM-IV-diagnosed	dsm-iv-diagnosed	JJ	_	37	amod
37	schizophrenia	schizophrenia	NN	_	34	nmod
38	,	,	,	_	13	punct
39	schizoaffective	schizoaffective	JJ	_	40	amod
40	disorder	disorder	NN	_	13	dobj
41	,	,	,	_	40	punct
42	or	or	CC	_	40	cc
43	bipolar	bipolar	JJ	_	44	amod
44	disorder	disorder	NN	_	40	conj
45	.	.	.	_	3	punct

1	These	these	DT	_	2	det
2	results	result	NNS	_	3	nsubj
3	indicate	indicate	VBP	_	0	ROOT
4	that	that	IN	_	11	mark
5	dosage	dosage	NN	_	6	compound
6	adjustment	adjustment	NN	_	11	nsubj
7	of	of	IN	_	8	case
8	drug1	drug1	NN	_	6	nmod
9	may	may	MD	_	11	aux
10	be	be	VB	_	11	cop
11	necessary	necessary	JJ	_	3	ccomp
12	when	when	WRB	_	17	advmod
13	the	the	DT	_	15	det
14	two	two	CD	_	15	nummod
15	drugs	drug	NNS	_	17	nsubjpass
16	are	be	VBP	_	17	auxpass
17	given	give	VBN	_	11	dep
18	concurrently	concurrently	RB	_	17	advmod
19	and	and	CC	_	17	cc
20	that	that	IN	_	24	mark
21	caution	caution	NN	_	24	nsubjpass
22	may	may	MD	_	24	aux
23	be	be	VB	_	24	auxpass
24	required	require	VBN	_	17	conj
25	when	when	WRB	_	26	advmod
26	administering	administer	VBG	_	24	advcl
27	other	other	JJ	_	28	amod
28	drugs	drug	NNS	_	26	dobj
29	that	that	WDT	_	30	nsubj
30	inhibit	inhibit	VBP	_	28	acl:relcl
31	or	or	CC	_	30	cc
32	induce	induce	VBP	_	30	conj
33	cytochromes	cytochrome	NNS	_	30	dobj
34	,	,	,	_	11	punct
35	particularly	particularly	RB	_	37	advmod
36	P450	p450	NN	_	37	compound
37	3A4	3a4	NN	_	11	dep
38	.	.	.	_	3	punct

1	-LSB-	-lsb-	-LRB-	_	3	punct
2	Drug	drug	NN	_	3	compound
3	treatment	treatment	NN	_	18	nsubj
4	of	of	IN	_	6	case
5	erection	erection	NN	_	6	compound
6	disorders	disorder	NNS	_	3	nmod
7	in	in	IN	_	8	case
8	patients	patient	NNS	_	6	nmod
9	with	with	IN	_	11	case
10	cardiovascular	cardiovascular	JJ	_	11	amod
11	disease	disease	NN	_	8	nmod
12	-RSB-	-rsb-	-RRB-	_	11	punct
13	Erectile	erectile	NN	_	14	compound
14	dysfunction	dysfunction	NN	_	11	dep
15	is	be	VBZ	_	18	cop
16	a	a	DT	_	18	det
17	frequent	frequent	JJ	_	18	amod
18	condition	condition	NN	_	0	ROOT
19	in	in	IN	_	21	case
20	cardiovascular	cardiovascular	JJ	_	21	amod
21	patients	patient	NNS	_	18	nmod
22	.	.	.	_	18	punct

1	Since	since	IN	_	9	mark
2	the	the	DT	_	3	det
3	arrival	arrival	NN	_	9	nsubj
4	of	of	IN	_	6	case
5	oral	oral	JJ	_	6	amod
6	drug1	drug1	NN	_	3	nmod
7	,	,	,	_	9	punct
8	patients	patient	NNS	_	9	nsubj
9	want	want	VBP	_	0	ROOT
10	to	to	TO	_	11	mark
11	know	know	VB	_	9	xcomp
12	how	how	WRB	_	13	advmod
13	safe	safe	JJ	_	19	dep
14	sexual	sexual	JJ	_	15	amod
15	activity	activity	NN	_	19	nsubj
16	is	be	VBZ	_	19	cop
17	in	in	IN	_	19	case
18	cardiovascular	cardiovascular	JJ	_	19	amod
19	disease	disease	NN	_	11	ccomp
20	in	in	IN	_	21	case
21	general	general	JJ	_	19	nmod
22	and	and	CC	_	19	cc
23	during	during	IN	_	24	case
24	use	use	NN	_	19	conj
25	of	of	IN	_	26	case
26	drug2	drug2	NN	_	24	nmod
27	in	in	IN	_	28	case
28	particular	particular	JJ	_	24	nmod
29	.	.	.	_	9	punct

1	Sexual	sexual	JJ	_	2	amod
2	intercourse	intercourse	NN	_	7	nsubj
3	with	with	IN	_	6	case
4	a	a	DT	_	6	det
5	steady	steady	JJ	_	6	amod
6	partner	partner	NN	_	2	nmod
7	causes	cause	VBZ	_	0	ROOT
8	no	no	RB	_	11	neg
9	more	more	RBR	_	10	advmod
10	cardiovascular	cardiovascular	JJ	_	11	amod
11	risk	risk	NN	_	7	dobj
12	than	than	IN	_	15	case
13	normal	normal	JJ	_	15	amod
14	daily	daily	JJ	_	15	amod
15	activities	activity	NNS	_	11	nmod
16	such	such	JJ	_	18	case
17	as	as	IN	_	16	mwe
18	ironing	ironing	NN	_	15	nmod
19	,	,	,	_	18	punct
20	2	2	CD	_	21	nummod
21	kilometers	kilometer	NNS	_	18	appos
22	of	of	IN	_	23	mark
23	walking	walk	VBG	_	21	acl
24	without	without	IN	_	25	mark
25	climbing	climb	VBG	_	23	advcl
26	,	,	,	_	25	punct
27	paperhanging	paperhanging	NN	_	25	conj
28	,	,	,	_	25	punct
29	playing	play	VBG	_	25	advcl
30	golf	golf	NN	_	29	dobj
31	or	or	CC	_	30	cc
32	gardening	gardening	NN	_	30	conj
33	.	.	.	_	7	punct

1	The	the	DT	_	3	det
2	relative	relative	JJ	_	3	amod
3	risk	risk	NN	_	13	nsubj
4	of	of	IN	_	6	case
5	myocardial	myocardial	JJ	_	6	amod
6	infarction	infarction	NN	_	3	nmod
7	during	during	IN	_	9	case
8	sexual	sexual	JJ	_	9	amod
9	activity	activity	NN	_	3	nmod
10	is	be	VBZ	_	13	cop
11	not	not	RB	_	13	neg
12	significantly	significantly	RB	_	13	advmod
13	higher	higher	JJR	_	0	ROOT
14	than	than	IN	_	17	case
15	for	for	IN	_	17	case
16	healthy	healthy	JJ	_	17	amod
17	persons	person	NNS	_	13	nmod
18	.	.	.	_	13	punct

1	The	the	DT	_	2	det
2	incidence	incidence	NN	_	10	nsubj
3	of	of	IN	_	5	case
4	cardiovascular	cardiovascular	JJ	_	5	amod
5	morbidity	morbidity	NN	_	2	nmod
6	and	and	CC	_	5	cc
7	mortality	mortality	NN	_	5	conj
8	is	be	VBZ	_	10	cop
9	not	not	RB	_	10	neg
10	higher	higher	JJR	_	0	ROOT
11	among	among	IN	_	12	case
12	users	user	NNS	_	10	nmod
13	of	of	IN	_	14	case
14	drug1	drug1	NN	_	12	nmod
15	.	.	.	_	10	punct

1	drug1	drug1	NN	_	3	nsubjpass
2	is	be	VBZ	_	3	auxpass
3	contraindicated	contraindicate	VBN	_	0	ROOT
4	in	in	IN	_	5	case
5	patients	patient	NNS	_	3	nmod
6	using	use	VBG	_	5	acl
7	drug2	drug2	NN	_	6	dobj
8	or	or	CC	_	7	cc
9	who	who	WP	_	11	nsubj
10	may	may	MD	_	11	aux
11	need	need	VB	_	7	conj
12	to	to	TO	_	13	mark
13	use	use	VB	_	11	xcomp
14	drug3	drug3	NN	_	13	dobj
15	,	,	,	_	3	punct
16	because	because	IN	_	20	mark
17	the	the	DT	_	18	det
18	combination	combination	NN	_	20	nsubj
19	may	may	MD	_	20	aux
20	cause	cause	VB	_	3	advcl
21	a	a	DT	_	23	det
22	sharp	sharp	JJ	_	23	amod
23	fall	fall	NN	_	20	dobj
24	of	of	IN	_	27	case
25	the	the	DT	_	27	det
26	blood	blood	NN	_	27	compound
27	pressure	pressure	NN	_	23	nmod
28	.	.	.	_	3	punct

1	No	no	DT	_	2	neg
2	interactions	interaction	NNS	_	5	nsubjpass
3	have	have	VBP	_	5	aux
4	been	be	VBN	_	5	auxpass
5	observed	observe	VBN	_	0	ROOT
6	with	with	IN	_	7	case
7	drug1	drug1	NN	_	5	nmod
8	,	,	,	_	7	punct
9	drug2	drug2	NN	_	7	conj
10	,	,	,	_	7	punct
11	drug3	drug3	NN	_	7	conj
12	and	and	CC	_	7	cc
13	drug4	drug4	NN	_	7	conj
14	and	and	CC	_	13	cc
15	drug5	drug5	NN	_	13	conj
16	.	.	.	_	5	punct

1	Before	before	IN	_	2	mark
2	prescribing	prescribe	VBG	_	19	advcl
3	a	a	DT	_	8	det
4	symptomatic	symptomatic	JJ	_	8	amod
5	-LRB-	-lrb-	-LRB-	_	6	punct
6	pharmaceutical	pharmaceutical	JJ	_	4	dep
7	-RRB-	-rrb-	-RRB-	_	6	punct
8	treatment	treatment	NN	_	2	dobj
9	for	for	IN	_	10	case
10	patients	patient	NNS	_	8	nmod
11	with	with	IN	_	14	case
12	an	a	DT	_	14	det
13	erection	erection	NN	_	14	compound
14	disorder	disorder	NN	_	10	nmod
15	,	,	,	_	19	punct
16	attention	attention	NN	_	19	nsubjpass
17	should	should	MD	_	19	aux
18	be	be	VB	_	19	auxpass
19	given	give	VBN	_	0	ROOT
20	tot	tot	NN	_	19	iobj
21	the	the	DT	_	27	det
22	sexological	sexological	JJ	_	27	amod
23	,	,	,	_	22	punct
24	psychological	psychological	JJ	_	22	conj
25	and	and	CC	_	22	cc
26	medical	medical	JJ	_	22	conj
27	backgrounds	background	NNS	_	19	dobj
28	of	of	IN	_	30	case
29	the	the	DT	_	30	det
30	disorder	disorder	NN	_	27	nmod
31	.	.	.	_	19	punct

1	Secondary	secondary	JJ	_	2	amod
2	prevention	prevention	NN	_	9	nsubj
3	of	of	IN	_	6	case
4	atherosclerotic	atherosclerotic	JJ	_	6	amod
5	risk	risk	NN	_	6	compound
6	factors	factor	NNS	_	2	nmod
7	is	be	VBZ	_	9	cop
8	also	also	RB	_	9	advmod
9	important	important	JJ	_	0	ROOT
10	:	:	:	_	9	punct
11	regulation	regulation	NN	_	9	dep
12	of	of	IN	_	14	case
13	blood	blood	NN	_	14	compound
14	pressure	pressure	NN	_	11	nmod
15	and	and	CC	_	14	cc
16	blood	blood	NN	_	18	compound
17	sugar	sugar	NN	_	18	compound
18	level	level	NN	_	14	conj
19	,	,	,	_	11	punct
20	hyperlipidaemia	hyperlipidaemia	NN	_	11	conj
21	and	and	CC	_	11	cc
22	obesity	obesity	NN	_	11	conj
23	,	,	,	_	11	punct
24	as	as	RB	_	11	cc
25	well	well	RB	_	24	mwe
26	as	as	IN	_	24	mwe
27	a	a	DT	_	28	det
28	change	change	NN	_	11	conj
29	of	of	IN	_	30	case
30	lifestyle	lifestyle	NN	_	28	nmod
31	-LRB-	-lrb-	-LRB-	_	32	punct
32	giving	give	VBG	_	28	dep
33	up	up	RP	_	32	compound:prt
34	smoking	smoking	NN	_	32	dobj
35	,	,	,	_	32	punct
36	adapting	adapting	NN	_	32	conj
37	of	of	IN	_	38	case
38	diet	diet	NN	_	36	nmod
39	and	and	CC	_	32	cc
40	more	more	JJR	_	42	amod
41	physical	physical	JJ	_	42	amod
42	exertion	exertion	NN	_	32	conj
43	-RRB-	-rrb-	-RRB-	_	32	punct
44	.	.	.	_	9	punct

1	Patients	patient	NNS	_	10	nsubjpass
2	with	with	IN	_	7	case
3	a	a	DT	_	7	det
4	very	very	RB	_	5	advmod
5	low	low	JJ	_	7	amod
6	cardiac	cardiac	JJ	_	7	amod
7	capacity	capacity	NN	_	1	nmod
8	should	should	MD	_	10	aux
9	be	be	VB	_	10	auxpass
10	advised	advise	VBN	_	0	ROOT
11	to	to	TO	_	12	mark
12	refrain	refrain	VB	_	10	xcomp
13	from	from	IN	_	14	case
14	treatment	treatment	NN	_	12	nmod
15	of	of	IN	_	18	case
16	the	the	DT	_	18	det
17	erection	erection	NN	_	18	compound
18	disorder	disorder	NN	_	14	nmod
19	.	.	.	_	10	punct

1	Failure	failure	NN	_	0	ROOT
2	of	of	IN	_	3	case
3	drug1	drug1	NN	_	1	nmod
4	to	to	TO	_	5	mark
5	modify	modify	VB	_	1	acl
6	drug2	drug2	NN	_	8	compound
7	induced	induce	VBN	_	8	amod
8	hypertension	hypertension	NN	_	5	dobj
9	in	in	IN	_	10	case
10	sheep	sheep	NN	_	8	nmod
11	.	.	.	_	1	punct

1	Studies	study	NNS	_	5	nsubj
2	in	in	IN	_	3	case
3	rats	rat	NNS	_	1	nmod
4	have	have	VBP	_	5	aux
5	shown	show	VBN	_	0	ROOT
6	that	that	IN	_	9	mark
7	drug1	drug1	NN	_	8	compound
8	administration	administration	NN	_	9	nsubj
9	attenuates	attenuate	VBZ	_	5	ccomp
10	certain	certain	JJ	_	11	amod
11	types	type	NNS	_	9	dobj
12	of	of	IN	_	15	case
13	drug2	drug2	NN	_	15	compound
14	dependent	dependent	JJ	_	15	amod
15	hypertension	hypertension	NN	_	11	nmod
16	,	,	,	_	11	punct
17	including	include	VBG	_	19	case
18	drug3	drug3	NN	_	19	compound
19	hypertension	hypertension	NN	_	11	nmod
20	.	.	.	_	5	punct

1	The	the	DT	_	2	det
2	effects	effect	NNS	_	8	nsubj
3	of	of	IN	_	5	case
4	oral	oral	JJ	_	5	amod
5	drug1	drug1	NN	_	2	nmod
6	on	on	IN	_	7	case
7	drug2	drug2	NN	_	2	nmod
8	induced	induce	VBD	_	0	ROOT
9	hypertension	hypertension	NN	_	8	dobj
10	were	be	VBD	_	11	auxpass
11	examined	examine	VBN	_	8	dep
12	in	in	IN	_	14	case
13	conscious	conscious	JJ	_	14	amod
14	sheep	sheep	NN	_	11	nmod
15	.	.	.	_	8	punct

1	drug1	drug1	NN	_	2	nsubj
2	has	have	VBZ	_	0	ROOT
3	no	no	DT	_	4	neg
4	effect	effect	NN	_	2	dobj
5	on	on	IN	_	8	case
6	the	the	DT	_	8	det
7	blood	blood	NN	_	8	compound
8	pressure	pressure	NN	_	2	nmod
9	or	or	CC	_	8	cc
10	metabolic	metabolic	JJ	_	11	amod
11	responses	response	NNS	_	8	conj
12	to	to	TO	_	13	mark
13	drug2	drug2	VB	_	8	acl
14	in	in	IN	_	15	case
15	sheep	sheep	NN	_	13	nmod
16	.	.	.	_	2	punct

1	Pharmacokinetic	pharmacokinetic	JJ	_	2	amod
2	Interaction	interaction	NN	_	0	ROOT
3	between	between	IN	_	4	case
4	drug1	drug1	NN	_	2	nmod
5	and	and	CC	_	4	cc
6	drug2	drug2	NN	_	4	conj
7	or	or	CC	_	6	cc
8	drug3	drug3	NN	_	6	conj
9	in	in	IN	_	11	case
10	healthy	healthy	JJ	_	11	amod
11	males	male	NNS	_	2	nmod
12	.	.	.	_	2	punct

1	The	the	DT	_	2	det
2	objective	objective	NN	_	6	nsubj
3	of	of	IN	_	5	case
4	this	this	DT	_	5	det
5	study	study	NN	_	2	nmod
6	was	be	VBD	_	0	ROOT
7	to	to	TO	_	8	mark
8	determine	determine	VB	_	6	xcomp
9	if	if	IN	_	11	mark
10	there	there	EX	_	11	expl
11	is	be	VBZ	_	8	advcl
12	a	a	DT	_	14	det
13	pharmacokinetic	pharmacokinetic	JJ	_	14	amod
14	interaction	interaction	NN	_	11	nsubj
15	when	when	WRB	_	18	advmod
16	drug1	drug1	NN	_	18	nsubjpass
17	is	be	VBZ	_	18	auxpass
18	given	give	VBN	_	11	advcl
19	with	with	IN	_	20	case
20	drug2	drug2	NN	_	18	nmod
21	or	or	CC	_	20	cc
22	drug3	drug3	NN	_	20	conj
23	and	and	CC	_	18	cc
24	to	to	TO	_	25	mark
25	determine	determine	VB	_	18	conj
26	the	the	DT	_	27	det
27	effects	effect	NNS	_	25	dobj
28	of	of	IN	_	30	case
29	these	these	DT	_	30	det
30	drugs	drug	NNS	_	27	nmod
31	on	on	IN	_	35	case
32	the	the	DT	_	35	det
33	erythromycin	erythromycin	NN	_	35	compound
34	breath	breath	NN	_	35	compound
35	test	test	NN	_	27	nmod
36	-LRB-	-lrb-	-LRB-	_	37	punct
37	ERMBT	ermbt	NN	_	35	appos
38	-RRB-	-rrb-	-RRB-	_	37	punct
39	.	.	.	_	6	punct

1	Twenty-four	twenty-four	CD	_	4	nummod
2	healthy	healthy	JJ	_	4	amod
3	male	male	JJ	_	4	amod
4	subjects	subject	NNS	_	6	nsubjpass
5	were	be	VBD	_	6	auxpass
6	randomized	randomize	VBN	_	0	ROOT
7	to	to	TO	_	8	case
8	one	one	CD	_	6	nmod
9	of	of	IN	_	11	case
10	two	two	CD	_	11	nummod
11	cohorts	cohort	NNS	_	8	nmod
12	.	.	.	_	6	punct

1	All	all	DT	_	2	det
2	subjects	subject	NNS	_	3	nsubj
3	received	receive	VBD	_	0	ROOT
4	drug1	drug1	NN	_	3	dobj
5	-LRB-	-lrb-	-LRB-	_	7	punct
6	1,200	1,200	CD	_	7	nummod
7	mg	mg	NN	_	4	dep
8	twice	twice	RB	_	10	advmod
9	a	a	DT	_	10	det
10	day	day	NN	_	7	nmod:tmod
11	-RRB-	-rrb-	-RRB-	_	7	punct
12	for	for	IN	_	14	case
13	4	4	CD	_	14	nummod
14	days	day	NNS	_	3	nmod
15	,	,	,	_	3	punct
16	followed	follow	VBN	_	3	dep
17	by	by	IN	_	21	case
18	a	a	DT	_	21	det
19	7-day	7-day	JJ	_	21	amod
20	washout	washout	NN	_	21	compound
21	period	period	NN	_	16	nmod
22	,	,	,	_	16	punct
23	followed	follow	VBN	_	16	dep
24	by	by	IN	_	26	case
25	either	either	CC	_	26	cc:preconj
26	drug2	drug2	NN	_	23	nmod
27	-LRB-	-lrb-	-LRB-	_	29	punct
28	300	300	CD	_	29	nummod
29	mg	mg	NN	_	26	dep
30	once	once	RB	_	32	advmod
31	a	a	DT	_	32	det
32	day	day	NN	_	29	dep
33	-LSB-	-lsb-	-LRB-	_	34	punct
34	QD	qd	NN	_	32	appos
35	-RSB-	-rsb-	-RRB-	_	34	punct
36	-RRB-	-rrb-	-RRB-	_	29	punct
37	-LRB-	-lrb-	-LRB-	_	38	punct
38	cohort	cohort	NN	_	26	appos
39	1	1	CD	_	38	nummod
40	-RRB-	-rrb-	-RRB-	_	38	punct
41	or	or	CC	_	26	cc
42	drug3	drug3	NN	_	26	conj
43	-LRB-	-lrb-	-LRB-	_	46	punct
44	600	600	CD	_	45	compound
45	mg	mg	NN	_	46	amod
46	QD	qd	NN	_	42	appos
47	-RRB-	-rrb-	-RRB-	_	46	punct
48	-LRB-	-lrb-	-LRB-	_	49	punct
49	cohort	cohort	NN	_	42	appos
50	2	2	CD	_	49	nummod
51	-RRB-	-rrb-	-RRB-	_	49	punct
52	for	for	IN	_	54	case
53	14	14	CD	_	54	nummod
54	days	day	NNS	_	23	nmod
55	.	.	.	_	3	punct

1	Cohort	cohort	NN	_	4	nsubj
2	1	1	CD	_	1	nummod
3	then	then	RB	_	4	advmod
4	received	receive	VBD	_	0	ROOT
5	drug1	drug1	NN	_	4	dobj
6	plus	plus	CC	_	5	cc
7	drug2	drug2	NN	_	5	conj
8	for	for	IN	_	10	case
9	10	10	CD	_	10	nummod
10	days	day	NNS	_	4	nmod
11	,	,	,	_	4	punct
12	and	and	CC	_	4	cc
13	cohort	cohort	NN	_	15	nsubj
14	2	2	CD	_	13	nummod
15	received	receive	VBD	_	4	conj
16	drug3	drug3	NN	_	15	dobj
17	plus	plus	CC	_	16	cc
18	drug4	drug4	NN	_	16	conj
19	for	for	IN	_	21	case
20	4	4	CD	_	21	nummod
21	days	day	NNS	_	15	nmod
22	.	.	.	_	4	punct

1	Serial	serial	JJ	_	2	amod
2	plasma	plasma	NN	_	20	nsubjpass
3	and	and	CC	_	2	cc
4	urine	urine	NN	_	2	conj
5	samples	sample	NNS	_	2	dep
6	for	for	IN	_	7	case
7	measurement	measurement	NN	_	2	nmod
8	of	of	IN	_	9	case
9	drug1	drug1	NN	_	7	nmod
10	,	,	,	_	9	punct
11	drug2	drug2	NN	_	9	conj
12	,	,	,	_	9	punct
13	and	and	CC	_	9	cc
14	drug3	drug3	NN	_	9	conj
15	and	and	CC	_	7	cc
16	their	they	PRP$	_	17	nmod:poss
17	drug4	drug4	NN	_	7	conj
18	,	,	,	_	2	punct
19	were	be	VBD	_	20	auxpass
20	measured	measure	VBN	_	0	ROOT
21	by	by	IN	_	24	case
22	high-performance	high-performance	JJ	_	24	amod
23	liquid	liquid	JJ	_	24	amod
24	chromatography	chromatography	NN	_	20	nmod
25	.	.	.	_	20	punct

1	drug1	drug1	NN	_	5	nsubj
2	did	do	VBD	_	5	aux
3	not	not	RB	_	5	neg
4	significantly	significantly	RB	_	5	advmod
5	affect	affect	VB	_	0	ROOT
6	drug2	drug2	NN	_	8	nmod:poss
7	's	's	POS	_	6	case
8	pharmacokinetics	pharmacokinetic	NNS	_	5	dobj
9	.	.	.	_	5	punct

1	drug1	drug1	NN	_	3	nsubj
2	significantly	significantly	RB	_	3	advmod
3	increased	increase	VBD	_	0	ROOT
4	the	the	DT	_	5	det
5	area	area	NN	_	3	dobj
6	under	under	IN	_	8	case
7	the	the	DT	_	8	det
8	curve	curve	NN	_	3	nmod
9	at	at	IN	_	11	case
10	steady	steady	JJ	_	11	amod
11	state	state	NN	_	8	nmod
12	-LRB-	-lrb-	-LRB-	_	13	punct
13	AUC	auc	NN	_	8	dep
14	-LRB-	-lrb-	-LRB-	_	15	punct
15	ss	ss	NN	_	13	appos
16	-RRB-	-rrb-	-RRB-	_	15	punct
17	-RRB-	-rrb-	-RRB-	_	13	punct
18	of	of	IN	_	19	case
19	drug2	drug2	NN	_	8	nmod
20	by	by	IN	_	21	case
21	2.93-fold	2.93-fold	JJ	_	3	nmod
22	and	and	CC	_	21	cc
23	the	the	DT	_	24	det
24	AUC	auc	NN	_	21	conj
25	-LRB-	-lrb-	-LRB-	_	26	punct
26	ss	ss	NN	_	24	appos
27	-RRB-	-rrb-	-RRB-	_	26	punct
28	of	of	IN	_	29	case
29	drug3	drug3	NN	_	24	nmod
30	by	by	IN	_	31	case
31	13.3-fold	13.3-fold	RB	_	3	nmod
32	.	.	.	_	3	punct

1	drug1	drug1	NN	_	3	nsubj
2	significantly	significantly	RB	_	3	advmod
3	decreased	decrease	VBD	_	0	ROOT
4	the	the	DT	_	5	det
5	AUC	auc	NN	_	3	dobj
6	-LRB-	-lrb-	-LRB-	_	7	punct
7	ss	ss	NN	_	5	appos
8	-RRB-	-rrb-	-RRB-	_	7	punct
9	of	of	IN	_	10	case
10	drug2	drug2	NN	_	5	nmod
11	by	by	IN	_	13	case
12	82	82	CD	_	13	nummod
13	%	%	NN	_	3	nmod
14	,	,	,	_	3	punct
15	but	but	CC	_	3	cc
16	drug3	drug3	NN	_	17	nsubj
17	had	have	VBD	_	3	conj
18	no	no	DT	_	19	neg
19	effect	effect	NN	_	17	dobj
20	on	on	IN	_	22	case
21	drug4	drug4	NN	_	22	compound
22	pharmacokinetics	pharmacokinetic	NNS	_	17	nmod
23	.	.	.	_	3	punct

1	drug1	drug1	NN	_	2	nsubj
2	decreased	decrease	VBD	_	0	ROOT
3	the	the	DT	_	4	det
4	results	result	NNS	_	2	dobj
5	of	of	IN	_	7	case
6	the	the	DT	_	7	det
7	ERMBT	ermbt	NN	_	4	nmod
8	by	by	IN	_	10	case
9	83	83	CD	_	10	nummod
10	%	%	NN	_	2	nmod
11	.	.	.	_	2	punct

1	The	the	DT	_	2	det
2	results	result	NNS	_	15	nsubjpass
3	of	of	IN	_	5	case
4	the	the	DT	_	5	det
5	ERMBT	ERMBT	NNP	_	2	nmod
6	after	after	IN	_	8	case
7	2	2	CD	_	8	nummod
8	weeks	week	NNS	_	2	nmod
9	of	of	IN	_	10	case
10	drug1	drug1	NN	_	8	nmod
11	and	and	CC	_	10	cc
12	drug2	drug2	NN	_	13	compound
13	therapy	therapy	NN	_	10	conj
14	were	be	VBD	_	15	auxpass
15	increased	increase	VBN	_	0	ROOT
16	187	187	CD	_	19	nummod
17	and	and	CC	_	16	cc
18	156	156	CD	_	16	conj
19	%	%	NN	_	15	dobj
20	,	,	,	_	15	punct
21	respectively	respectively	RB	_	15	advmod
22	.	.	.	_	15	punct

1	drug1	drug1	NN	_	6	nsubjpass
2	plus	plus	CC	_	1	cc
3	drug2	drug2	NN	_	1	conj
4	was	be	VBD	_	6	auxpass
5	well	well	RB	_	6	advmod
6	tolerated	tolerate	VBN	_	0	ROOT
7	.	.	.	_	6	punct

1	drug1	drug1	NN	_	6	nsubjpass
2	plus	plus	CC	_	1	cc
3	drug2	drug2	NN	_	1	conj
4	was	be	VBD	_	6	auxpass
5	poorly	poorly	RB	_	6	advmod
6	tolerated	tolerate	VBN	_	0	ROOT
7	,	,	,	_	6	punct
8	and	and	CC	_	6	cc
9	5	5	CD	_	6	conj
10	of	of	IN	_	12	case
11	11	11	CD	_	12	nummod
12	subjects	subject	NNS	_	9	nmod
13	discontinued	discontinued	JJ	_	14	amod
14	therapy	therapy	NN	_	12	dep
15	.	.	.	_	6	punct

1	drug1	drug1	NN	_	3	nsubj
2	markedly	markedly	RB	_	3	advmod
3	increases	increase	VBZ	_	0	ROOT
4	the	the	DT	_	6	det
5	metabolic	metabolic	JJ	_	6	amod
6	clearance	clearance	NN	_	3	dobj
7	of	of	IN	_	8	case
8	drug2	drug2	NN	_	6	nmod
9	,	,	,	_	3	punct
10	and	and	CC	_	3	cc
11	coadministration	coadministration	NN	_	13	nsubjpass
12	is	be	VBZ	_	13	auxpass
13	contraindicated	contraindicate	VBN	_	3	conj
14	.	.	.	_	3	punct

1	drug1	drug1	NN	_	3	nsubj
2	significantly	significantly	RB	_	3	advmod
3	decreases	decrease	VBZ	_	0	ROOT
4	clearance	clearance	NN	_	3	dobj
5	of	of	IN	_	6	case
6	drug2	drug2	NN	_	4	nmod
7	and	and	CC	_	6	cc
8	drug3	drug3	NN	_	6	conj
9	,	,	,	_	3	punct
10	and	and	CC	_	3	cc
11	the	the	DT	_	12	det
12	combination	combination	NN	_	15	nsubjpass
13	is	be	VBZ	_	15	auxpass
14	poorly	poorly	RB	_	15	advmod
15	tolerated	tolerate	VBN	_	3	conj
16	.	.	.	_	3	punct

1	drug1	drug1	NN	_	2	nsubj
2	inhibits	inhibit	VBZ	_	0	ROOT
3	the	the	DT	_	4	det
4	ERMBT	ERMBT	NNP	_	2	dobj
5	,	,	,	_	2	punct
6	and	and	CC	_	2	cc
7	drug2	drug2	NN	_	12	nsubj
8	and	and	CC	_	7	cc
9	drug3	drug3	NN	_	7	conj
10	are	be	VBP	_	12	cop
11	equipotent	equipotent	JJ	_	12	amod
12	inducers	inducer	NNS	_	2	conj
13	of	of	IN	_	15	case
14	the	the	DT	_	15	det
15	ERMBT	ERMBT	NNP	_	12	nmod
16	.	.	.	_	2	punct

1	-LSB-	-lsb-	-LRB-	_	3	punct
2	The	the	DT	_	3	det
3	effect	effect	NN	_	33	dep
4	of	of	IN	_	5	case
5	drug1	drug1	NN	_	3	nmod
6	on	on	IN	_	8	case
7	the	the	DT	_	8	det
8	activity	activity	NN	_	3	nmod
9	of	of	IN	_	11	case
10	mixed-function	mixed-function	JJ	_	11	amod
11	mono-oxidases	mono-oxidase	NNS	_	8	nmod
12	in	in	IN	_	15	case
13	the	the	DT	_	15	det
14	liver	liver	NN	_	15	compound
15	microsomes	microsome	NNS	_	8	nmod
16	-RSB-	-rsb-	-RRB-	_	3	punct
17	The	the	DT	_	18	det
18	effects	effect	NNS	_	33	nsubjpass
19	of	of	IN	_	21	case
20	the	the	DT	_	21	det
21	drug2	drug2	NN	_	18	nmod
22	--	--	:	_	21	punct
23	the	the	DT	_	25	det
24	drug	drug	NN	_	25	compound
25	drug3	drug3	NN	_	21	dep
26	--	--	:	_	21	punct
27	on	on	IN	_	31	case
28	hepatic	hepatic	JJ	_	31	amod
29	microsomal	microsomal	JJ	_	31	amod
30	monooxygenase	monooxygenase	NN	_	31	compound
31	activities	activity	NNS	_	18	nmod
32	were	be	VBD	_	33	auxpass
33	studied	study	VBN	_	0	ROOT
34	.	.	.	_	33	punct

1	The	the	DT	_	2	det
2	agent	agent	NN	_	4	nsubjpass
3	was	be	VBD	_	4	auxpass
4	found	find	VBN	_	0	ROOT
5	to	to	TO	_	6	mark
6	produce	produce	VB	_	4	xcomp
7	some	some	DT	_	9	det
8	inhibiting	inhibiting	NN	_	9	compound
9	activity	activity	NN	_	6	dobj
10	against	against	IN	_	14	case
11	hepatic	hepatic	JJ	_	14	amod
12	microsomal	microsomal	JJ	_	14	amod
13	7-ethoxycoumarine	7-ethoxycoumarine	JJ	_	14	amod
14	deethylase	deethylase	NN	_	9	nmod
15	in	in	IN	_	18	case
16	male	male	JJ	_	18	amod
17	Wistar	Wistar	NNP	_	18	compound
18	rats	rat	NNS	_	9	nmod
19	in	in	FW	_	20	compound
20	vitro	vitro	FW	_	21	advmod
21	and	and	CC	_	6	advmod
22	in	in	FW	_	24	amod
23	vivo	vivo	FW	_	22	dep
24	experiments	experiment	NNS	_	21	advmod
25	.	.	.	_	4	punct

1	When	when	WRB	_	2	advmod
2	given	give	VBN	_	11	advcl
3	in	in	IN	_	5	case
4	a	a	DT	_	5	det
5	dose	dose	NN	_	2	nmod
6	of	of	IN	_	8	case
7	50	50	CD	_	8	nummod
8	mg/kg	mg/kg	NN	_	5	nmod
9	,	,	,	_	11	punct
10	drug1	drug1	NN	_	11	nsubj
11	produced	produce	VBD	_	0	ROOT
12	no	no	DT	_	15	neg
13	statistically	statistically	RB	_	14	advmod
14	significant	significant	JJ	_	15	amod
15	effect	effect	NN	_	11	dobj
16	on	on	IN	_	18	case
17	the	the	DT	_	18	det
18	duration	duration	NN	_	11	nmod
19	of	of	IN	_	21	case
20	hexanal-induced	hexanal-induced	JJ	_	21	amod
21	sleep	sleep	NN	_	18	nmod
22	in	in	IN	_	23	case
23	mice	mouse	NNS	_	21	nmod
24	.	.	.	_	11	punct

1	The	the	DT	_	2	det
2	findings	finding	NNS	_	3	nsubj
3	suggest	suggest	VBP	_	0	ROOT
4	that	that	IN	_	7	mark
5	the	the	DT	_	6	det
6	agent	agent	NN	_	7	nsubj
7	has	have	VBZ	_	3	ccomp
8	slight	slight	JJ	_	9	amod
9	effects	effect	NNS	_	7	dobj
10	on	on	IN	_	13	case
11	the	the	DT	_	13	det
12	tested	test	VBN	_	13	amod
13	activities	activity	NNS	_	7	nmod
14	.	.	.	_	3	punct

1	Repeated	repeat	VBN	_	3	amod
2	oral	oral	JJ	_	3	amod
3	administration	administration	NN	_	0	ROOT
4	of	of	IN	_	5	case
5	drug1	drug1	NN	_	3	nmod
6	in	in	IN	_	7	case
7	sheep	sheep	NN	_	3	nmod
8	:	:	:	_	3	punct
9	interactions	interaction	NNS	_	3	dep
10	of	of	IN	_	11	case
11	drug2	drug2	NN	_	9	nmod
12	with	with	IN	_	13	case
13	drug3	drug3	NN	_	9	nmod
14	,	,	,	_	13	punct
15	drug4	drug4	NN	_	13	conj
16	,	,	,	_	13	punct
17	and	and	CC	_	13	cc
18	drug5	drug5	NN	_	13	conj
19	.	.	.	_	3	punct

1	Interactions	interaction	NNS	_	29	nsubjpass
2	between	between	IN	_	3	case
3	treatments	treatment	NNS	_	1	nmod
4	with	with	IN	_	5	case
5	drug1	drug1	NN	_	3	nmod
6	,	,	,	_	5	punct
7	drug2	drug2	NN	_	5	conj
8	-LRB-	-lrb-	-LRB-	_	10	punct
9	an	a	DT	_	10	det
10	drug3	drug3	NN	_	7	appos
11	-RRB-	-rrb-	-RRB-	_	10	punct
12	,	,	,	_	5	punct
13	drug4	drug4	NN	_	5	conj
14	-LRB-	-lrb-	-LRB-	_	16	punct
15	an	a	DT	_	16	det
16	drug5	drug5	NN	_	13	appos
17	-RRB-	-rrb-	-RRB-	_	16	punct
18	,	,	,	_	5	punct
19	and	and	CC	_	5	cc
20	drug6	drug6	NN	_	5	conj
21	-LRB-	-lrb-	-LRB-	_	23	punct
22	an	a	DT	_	23	det
23	inducer	inducer	NN	_	20	dep
24	of	of	IN	_	26	case
25	microsomal	microsomal	JJ	_	26	amod
26	enzymes	enzyme	NNS	_	23	nmod
27	-RRB-	-rrb-	-RRB-	_	23	punct
28	were	be	VBD	_	29	auxpass
29	investigated	investigate	VBN	_	0	ROOT
30	in	in	IN	_	31	case
31	sheep	sheep	NN	_	29	nmod
32	.	.	.	_	29	punct

1	A	a	DT	_	3	det
2	daily	daily	JJ	_	3	amod
3	dose	dose	NN	_	19	nsubj
4	of	of	IN	_	6	case
5	2	2	CD	_	6	nummod
6	mg	mg	NN	_	3	nmod
7	of	of	IN	_	8	case
8	drug1	drug1	NN	_	6	nmod
9	/	/	:	_	3	punct
10	kg	kg	NN	_	3	dep
11	of	of	IN	_	13	case
12	body	body	NN	_	13	compound
13	weight	weight	NN	_	10	nmod
14	for	for	IN	_	16	case
15	6	6	CD	_	16	nummod
16	days	day	NNS	_	10	nmod
17	did	do	VBD	_	19	aux
18	not	not	RB	_	19	neg
19	affect	affect	VB	_	0	ROOT
20	the	the	DT	_	22	det
21	plasma	plasma	NN	_	22	compound
22	enzymes	enzyme	NNS	_	19	dobj
23	or	or	CC	_	22	cc
24	the	the	DT	_	26	det
25	antiprothrombinemic	antiprothrombinemic	JJ	_	26	amod
26	effect	effect	NN	_	22	conj
27	of	of	IN	_	28	case
28	drug2	drug2	NN	_	26	nmod
29	in	in	IN	_	30	case
30	wethers	wether	NNS	_	19	nmod
31	.	.	.	_	19	punct

1	The	the	DT	_	2	det
2	treatment	treatment	NN	_	28	nsubj
3	of	of	IN	_	4	case
4	ewes	ewe	NNS	_	2	nmod
5	with	with	IN	_	11	case
6	an	a	DT	_	11	det
7	intravenous	intravenous	JJ	_	11	amod
8	-LRB-	-lrb-	-LRB-	_	9	punct
9	IV	iv	CD	_	7	dep
10	-RRB-	-rrb-	-RRB-	_	9	punct
11	injection	injection	NN	_	2	nmod
12	of	of	IN	_	13	case
13	drug1	drug1	NN	_	11	nmod
14	,	,	,	_	2	punct
15	insufficient	insufficient	JJ	_	2	amod
16	to	to	TO	_	17	mark
17	produce	produce	VB	_	15	xcomp
18	significant	significant	JJ	_	19	amod
19	inhibition	inhibition	NN	_	17	dobj
20	of	of	IN	_	22	case
21	erythrocyte	erythrocyte	NN	_	22	compound
22	acetylcholinesterase	acetylcholinesterase	NN	_	19	nmod
23	-LRB-	-lrb-	-LRB-	_	24	punct
24	AChE	ache	NN	_	22	appos
25	-RRB-	-rrb-	-RRB-	_	24	punct
26	activity	activity	NN	_	22	dep
27	,	,	,	_	2	punct
28	appeared	appear	VBD	_	0	ROOT
29	to	to	TO	_	30	mark
30	produce	produce	VB	_	28	xcomp
31	additive	additive	JJ	_	32	amod
32	effects	effect	NNS	_	30	dobj
33	with	with	IN	_	34	case
34	those	those	DT	_	32	nmod
35	produced	produce	VBN	_	34	acl
36	by	by	IN	_	38	case
37	subsequent	subsequent	JJ	_	38	amod
38	treatment	treatment	NN	_	35	nmod
39	with	with	IN	_	41	case
40	4	4	CD	_	41	nummod
41	mg	mg	NN	_	38	nmod
42	of	of	IN	_	43	case
43	drug2	drug2	NN	_	41	nmod
44	/	/	:	_	41	punct
45	kg/day	kg/day	NN	_	41	dep
46	.	.	.	_	28	punct

1	In	in	IN	_	2	case
2	ewes	ewe	NNS	_	30	nmod
3	given	give	VBN	_	5	case
4	40	40	CD	_	5	nummod
5	mg	mg	NN	_	2	nmod
6	of	of	IN	_	7	case
7	drug1	drug1	NN	_	5	nmod
8	/	/	:	_	9	punct
9	kg	kg	NN	_	30	nsubjpass
10	for	for	IN	_	12	case
11	5	5	CD	_	12	nummod
12	days	day	NNS	_	9	nmod
13	intraperitoneally	intraperitoneally	RB	_	12	dep
14	-LRB-	-lrb-	-LRB-	_	15	punct
15	IP	IP	NNP	_	13	appos
16	-RRB-	-rrb-	-RRB-	_	15	punct
17	,	,	,	_	9	punct
18	the	the	DT	_	20	det
19	anticholinesterase	anticholinesterase	JJ	_	20	amod
20	effect	effect	NN	_	9	appos
21	of	of	IN	_	23	case
22	4	4	CD	_	23	nummod
23	mg	mg	NN	_	20	nmod
24	of	of	IN	_	25	case
25	drug2	drug2	NN	_	23	nmod
26	/	/	:	_	9	punct
27	kg	kg	NN	_	9	dep
28	was	be	VBD	_	30	auxpass
29	significantly	significantly	RB	_	30	advmod
30	reduced	reduce	VBN	_	0	ROOT
31	and	and	CC	_	30	cc
32	signs	sign	NNS	_	37	nsubj
33	of	of	IN	_	34	case
34	toxicity	toxicity	NN	_	32	nmod
35	were	be	VBD	_	37	cop
36	not	not	RB	_	37	neg
37	present	present	JJ	_	30	conj
38	.	.	.	_	30	punct

1	Treatment	treatment	NN	_	11	nsubj
2	with	with	IN	_	4	case
3	daily	daily	JJ	_	4	amod
4	doses	dose	NNS	_	1	nmod
5	of	of	IN	_	7	case
6	2	2	CD	_	7	nummod
7	mg	mg	NN	_	4	nmod
8	of	of	IN	_	9	case
9	drug1	drug1	NN	_	7	nmod
10	/	/	:	_	11	punct
11	kg	kg	NN	_	0	ROOT
12	for	for	IN	_	14	case
13	6	6	CD	_	14	nummod
14	days	day	NNS	_	11	nmod
15	did	do	VBD	_	17	aux
16	not	not	RB	_	17	neg
17	modify	modify	VB	_	11	dep
18	the	the	DT	_	20	det
19	anticholinesterase	anticholinesterase	NN	_	20	compound
20	effect	effect	NN	_	17	dobj
21	of	of	IN	_	24	case
22	a	a	DT	_	24	det
23	2nd	2nd	JJ	_	24	amod
24	series	series	NN	_	20	nmod
25	of	of	IN	_	26	case
26	treatments	treatment	NNS	_	24	nmod
27	given	give	VBN	_	24	acl
28	6	6	CD	_	29	nummod
29	weeks	week	NNS	_	30	nmod:npmod
30	later	later	RB	_	27	advmod
31	.	.	.	_	11	punct

1	Pharmacokinetic	pharmacokinetic	JJ	_	2	amod
2	profile	profile	NN	_	0	ROOT
3	of	of	IN	_	4	case
4	drug1	drug1	NN	_	2	nmod
5	in	in	IN	_	7	case
6	special	special	JJ	_	7	amod
7	populations	population	NNS	_	2	nmod
8	.	.	.	_	2	punct

1	The	the	DT	_	2	det
2	pharmacokinetics	pharmacokinetic	NNS	_	12	nsubjpass
3	of	of	IN	_	4	case
4	drug1	drug1	NN	_	2	nmod
5	in	in	IN	_	8	case
6	healthy	healthy	JJ	_	8	amod
7	normal	normal	JJ	_	8	amod
8	volunteers	volunteer	NNS	_	2	nmod
9	has	have	VBZ	_	12	aux
10	been	be	VBN	_	12	auxpass
11	extensively	extensively	RB	_	12	advmod
12	studied	study	VBN	_	0	ROOT
13	and	and	CC	_	12	cc
14	is	be	VBZ	_	16	auxpass
15	well	well	RB	_	16	advmod
16	described	describe	VBN	_	12	conj
17	.	.	.	_	12	punct

1	drug1	drug1	NN	_	3	nsubjpass
2	is	be	VBZ	_	3	auxpass
3	characterised	characterise	VBN	_	0	ROOT
4	by	by	IN	_	8	case
5	a	a	DT	_	8	det
6	high	high	JJ	_	8	amod
7	oral	oral	JJ	_	8	amod
8	bioavailability	bioavailability	NN	_	3	nmod
9	,	,	,	_	8	punct
10	low	low	JJ	_	11	amod
11	clearance	clearance	NN	_	8	conj
12	,	,	,	_	8	punct
13	a	a	DT	_	15	det
14	small	small	JJ	_	15	amod
15	volume	volume	NN	_	8	conj
16	of	of	IN	_	17	case
17	distribution	distribution	NN	_	15	nmod
18	,	,	,	_	8	punct
19	and	and	CC	_	8	cc
20	a	a	DT	_	22	det
21	7-hour	7-hour	JJ	_	22	amod
22	half-life	half-life	NN	_	8	conj
23	.	.	.	_	3	punct

1	It	it	PRP	_	5	nsubjpass
2	is	be	VBZ	_	5	auxpass
3	essentially	essentially	RB	_	5	advmod
4	completely	completely	RB	_	5	advmod
5	metabolised	metabolise	VBN	_	0	ROOT
6	,	,	,	_	5	punct
7	therefore	therefore	RB	_	8	advmod
8	little	little	JJ	_	10	nsubjpass
9	is	be	VBZ	_	10	auxpass
10	excreted	excrete	VBN	_	5	ccomp
11	unchanged	unchanged	JJ	_	10	xcomp
12	.	.	.	_	5	punct

1	drug1	drug1	NN	_	4	nsubj
2	is	be	VBZ	_	4	cop
3	highly	highly	RB	_	4	advmod
4	protein	protein	NN	_	0	ROOT
5	bound	bind	VBD	_	4	acl
6	.	.	.	_	4	punct

1	To	to	TO	_	2	mark
2	investigate	investigate	VB	_	0	ROOT
3	the	the	DT	_	4	det
4	effect	effect	NN	_	2	dobj
5	of	of	IN	_	7	case
6	disease	disease	NN	_	7	compound
7	states	state	NNS	_	4	nmod
8	or	or	CC	_	7	cc
9	concomitant	concomitant	JJ	_	11	amod
10	drug	drug	NN	_	11	compound
11	administration	administration	NN	_	7	conj
12	on	on	IN	_	16	case
13	a	a	DT	_	14	det
14	patient	patient	NN	_	16	nmod:poss
15	's	's	POS	_	14	case
16	response	response	NN	_	4	nmod
17	to	to	TO	_	18	case
18	drug1	drug1	NN	_	16	nmod
19	,	,	,	_	2	punct
20	additional	additional	JJ	_	22	amod
21	pharmacokinetic	pharmacokinetic	JJ	_	22	amod
22	studies	study	NNS	_	24	nsubjpass
23	were	be	VBD	_	24	auxpass
24	carried	carry	VBN	_	2	parataxis
25	out	out	RP	_	24	compound:prt
26	in	in	IN	_	28	case
27	special	special	JJ	_	28	amod
28	populations	population	NNS	_	24	nmod
29	.	.	.	_	2	punct

1	Since	since	IN	_	3	mark
2	drug1	drug1	NN	_	3	nsubj
3	has	have	VBZ	_	15	advcl
4	a	a	DT	_	7	det
5	well-defined	well-defined	JJ	_	7	amod
6	pharmacokinetic-pharmacodynamic	pharmacokinetic-pharmacodynamic	JJ	_	7	amod
7	relationship	relationship	NN	_	3	dobj
8	,	,	,	_	15	punct
9	measurement	measurement	NN	_	15	nsubj
10	of	of	IN	_	12	case
11	pharmacokinetic	pharmacokinetic	JJ	_	12	amod
12	parameters	parameter	NNS	_	9	nmod
13	is	be	VBZ	_	15	cop
14	clinically	clinically	RB	_	15	advmod
15	relevant	relevant	JJ	_	0	ROOT
16	.	.	.	_	15	punct

1	Data	datum	NNS	_	6	nsubj
2	from	from	IN	_	3	case
3	studies	study	NNS	_	1	nmod
4	to	to	TO	_	5	case
5	date	date	NN	_	3	nmod
6	show	show	VBP	_	0	ROOT
7	that	that	IN	_	20	mark
8	disease	disease	NN	_	9	compound
9	states	state	NNS	_	20	nsubj
10	,	,	,	_	9	punct
11	underlying	underlie	VBG	_	12	amod
12	conditions	condition	NNS	_	9	conj
13	,	,	,	_	9	punct
14	and	and	CC	_	9	cc
15	concomitantly	concomitantly	RB	_	16	advmod
16	administered	administer	VBN	_	19	amod
17	highly	highly	RB	_	18	advmod
18	protein-bound	protein-bound	JJ	_	19	amod
19	drugs	drug	NNS	_	9	conj
20	have	have	VBP	_	6	ccomp
21	essentially	essentially	RB	_	23	advmod
22	no	no	DT	_	23	neg
23	effect	effect	NN	_	20	dobj
24	on	on	IN	_	26	case
25	drug1	drug1	NN	_	26	compound
26	pharmacokinetics	pharmacokinetic	NNS	_	23	nmod
27	.	.	.	_	6	punct

1	Therefore	therefore	RB	_	7	advmod
2	,	,	,	_	7	punct
3	drug1	drug1	NN	_	7	nsubjpass
4	can	can	MD	_	7	aux
5	generally	generally	RB	_	7	advmod
6	be	be	VB	_	7	auxpass
7	given	give	VBN	_	0	ROOT
8	without	without	IN	_	10	case
9	the	the	DT	_	10	det
10	need	need	NN	_	7	nmod
11	for	for	IN	_	13	case
12	dosage	dosage	NN	_	13	compound
13	modifications	modification	NNS	_	10	nmod
14	in	in	IN	_	16	case
15	special	special	JJ	_	16	amod
16	populations	population	NNS	_	13	nmod
17	such	such	JJ	_	21	case
18	as	as	IN	_	17	mwe
19	uncompromised	uncompromised	JJ	_	21	amod
20	elderly	elderly	JJ	_	21	amod
21	patients	patient	NNS	_	16	nmod
22	,	,	,	_	7	punct
23	those	those	DT	_	7	conj
24	with	with	IN	_	27	case
25	moderate	moderate	JJ	_	27	amod
26	renal	renal	JJ	_	27	amod
27	impairment	impairment	NN	_	23	nmod
28	,	,	,	_	7	punct
29	and	and	CC	_	7	cc
30	patients	patient	NNS	_	7	conj
31	with	with	IN	_	34	case
32	stable	stable	JJ	_	34	amod
33	hepatic	hepatic	JJ	_	34	amod
34	disease	disease	NN	_	30	nmod
35	.	.	.	_	7	punct

1	Enhanced	enhance	VBN	_	3	amod
2	drug1	drug1	NN	_	3	compound
3	clearance	clearance	NN	_	0	ROOT
4	secondary	secondary	JJ	_	3	amod
5	to	to	TO	_	7	case
6	drug2	drug2	NN	_	7	compound
7	therapy	therapy	NN	_	4	nmod
8	.	.	.	_	3	punct

1	This	this	DT	_	2	det
2	report	report	NN	_	3	nsubj
3	describes	describe	VBZ	_	0	ROOT
4	two	two	CD	_	5	nummod
5	cases	case	NNS	_	3	dobj
6	in	in	IN	_	7	case
7	which	which	WDT	_	10	nmod
8	drug1	drug1	NN	_	9	compound
9	clearance	clearance	NN	_	10	nsubj
10	accelerated	accelerate	VBD	_	5	acl:relcl
11	markedly	markedly	RB	_	10	advmod
12	with	with	IN	_	15	case
13	concomitant	concomitant	JJ	_	15	amod
14	drug2	drug2	NN	_	15	compound
15	administration	administration	NN	_	10	nmod
16	.	.	.	_	3	punct

1	Maximum	Maximum	NNP	_	2	nsubj
2	calculated	calculate	VBN	_	0	ROOT
3	drug1	drug1	NN	_	4	compound
4	clearance	clearance	NN	_	5	nsubj
5	ranged	range	VBD	_	2	ccomp
6	from	from	IN	_	11	case
7	2 1/2	2 1/2	CD	_	9	compound
8	to	to	TO	_	9	dep
9	3 1/2	3 1/2	CD	_	10	dep
10	times	time	NNS	_	11	dep
11	baseline	baseline	NN	_	5	nmod
12	.	.	.	_	2	punct

1	Onset	onset	NN	_	5	nsubj
2	of	of	IN	_	4	case
3	the	the	DT	_	4	det
4	interaction	interaction	NN	_	1	nmod
5	began	begin	VBD	_	0	ROOT
6	within	within	IN	_	8	case
7	five	five	CD	_	8	nummod
8	days	day	NNS	_	5	nmod
9	of	of	IN	_	10	mark
10	beginning	begin	VBG	_	8	acl
11	concurrent	concurrent	JJ	_	12	amod
12	therapy	therapy	NN	_	10	dobj
13	.	.	.	_	5	punct

1	With	with	IN	_	3	case
2	combined	combine	VBN	_	3	amod
3	use	use	NN	_	8	nmod
4	,	,	,	_	8	punct
5	clinicians	clinician	NNS	_	8	nsubj
6	should	should	MD	_	8	aux
7	be	be	VB	_	8	cop
8	aware	aware	JJ	_	0	ROOT
9	,	,	,	_	8	punct
10	when	when	WRB	_	13	advmod
11	drug1	drug1	NN	_	13	nsubjpass
12	is	be	VBZ	_	13	auxpass
13	added	add	VBN	_	8	advcl
14	,	,	,	_	13	punct
15	of	of	IN	_	17	case
16	the	the	DT	_	17	det
17	potential	potential	NN	_	13	nmod
18	for	for	IN	_	19	case
19	reexacerbation	reexacerbation	NN	_	17	nmod
20	of	of	IN	_	22	case
21	pulmonary	pulmonary	JJ	_	22	amod
22	symptomatology	symptomatology	NN	_	19	nmod
23	due	due	JJ	_	28	case
24	to	to	TO	_	23	mwe
25	lowered	lowered	JJ	_	28	amod
26	serum	serum	NN	_	28	compound
27	drug2	drug2	NN	_	28	compound
28	concentrations	concentration	NNS	_	17	nmod
29	.	.	.	_	8	punct

1	In	in	FW	_	3	amod
2	vitro	vitro	FW	_	1	dep
3	activity	activity	NN	_	0	ROOT
4	of	of	IN	_	5	case
5	drug1	drug1	NN	_	3	nmod
6	,	,	,	_	3	punct
7	either	either	CC	_	3	dep
8	singly	singly	RB	_	7	dep
9	or	or	CC	_	7	cc
10	in	in	IN	_	11	case
11	combination	combination	NN	_	7	conj
12	with	with	IN	_	13	case
13	drug2	drug2	NN	_	11	nmod
14	,	,	,	_	3	punct
15	against	against	IN	_	17	case
16	Mycobacterium	mycobacterium	NN	_	17	compound
17	ulcerans	ulceran	NNS	_	3	nmod
18	.	.	.	_	3	punct

1	The	the	DT	_	3	det
2	antimicrobial	antimicrobial	JJ	_	3	amod
3	effect	effect	NN	_	0	ROOT
4	of	of	IN	_	3	dep
5	a	a	DT	_	4	dep
6	drug1	drug1	NN	_	19	nsubjpass
7	,	,	,	_	6	punct
8	drug2	drug2	NN	_	6	conj
9	,	,	,	_	6	punct
10	either	either	CC	_	6	dep
11	alone	alone	RB	_	10	dep
12	or	or	CC	_	10	cc
13	in	in	IN	_	14	case
14	combination	combination	NN	_	10	conj
15	with	with	IN	_	16	case
16	drug3	drug3	NN	_	14	nmod
17	,	,	,	_	6	punct
18	was	be	VBD	_	19	auxpass
19	evaluated	evaluate	VBN	_	5	acl:relcl
20	in	in	FW	_	21	compound
21	vitro	vitro	FW	_	19	advmod
22	against	against	IN	_	25	case
23	two	two	CD	_	25	nummod
24	type	type	NN	_	25	compound
25	strains	strain	NNS	_	19	nmod
26	and	and	CC	_	25	cc
27	six	six	CD	_	29	nummod
28	clinical	clinical	JJ	_	29	amod
29	isolates	isolate	NNS	_	25	conj
30	of	of	IN	_	32	case
31	Mycobacterium	mycobacterium	NN	_	32	compound
32	ulcerans	ulceran	NNS	_	29	nmod
33	.	.	.	_	3	punct

1	Growth	growth	NN	_	0	ROOT
2	of	of	IN	_	3	case
3	M.	m.	NN	_	1	nmod

1	ulcerans	ulceran	NNS	_	3	nsubjpass
2	was	be	VBD	_	3	auxpass
3	measured	measure	VBN	_	0	ROOT
4	by	by	IN	_	6	case
5	plate	plate	NN	_	6	compound
6	counts	count	NNS	_	3	nmod
7	and	and	CC	_	6	cc
8	the	the	DT	_	11	det
9	BACTEC	bactec	NN	_	11	compound
10	radiometric	radiometric	JJ	_	11	amod
11	method	method	NN	_	6	conj
12	.	.	.	_	3	punct

1	The	the	DT	_	4	det
2	minimal	minimal	JJ	_	4	amod
3	inhibitory	inhibitory	JJ	_	4	amod
4	concentration	concentration	NN	_	0	ROOT
5	as	as	RB	_	4	cc
6	well	well	RB	_	5	mwe
7	as	as	IN	_	5	mwe
8	minimal	minimal	JJ	_	10	amod
9	bactericidal	bactericidal	JJ	_	10	amod
10	concentration	concentration	NN	_	4	conj
11	of	of	IN	_	12	case
12	drug1	drug1	NN	_	10	nmod
13	against	against	IN	_	14	case
14	M.	m.	NN	_	4	nmod

1	ulcerans	ulceran	NNS	_	4	nsubj
2	was	be	VBD	_	4	cop
3	between	between	IN	_	4	case
4	0.012	0.012	CD	_	0	ROOT
5	and	and	CC	_	4	cc
6	0.025	0.025	CD	_	4	conj
7	mg/l	mg/l	NN	_	4	dep
8	,	,	,	_	4	punct
9	while	while	IN	_	19	mark
10	corresponding	correspond	VBG	_	11	amod
11	values	value	NNS	_	19	nsubj
12	for	for	IN	_	13	case
13	drug1	drug1	NN	_	11	nmod
14	and	and	CC	_	13	cc
15	drug2	drug2	NN	_	13	conj
16	were	be	VBD	_	19	cop
17	in	in	IN	_	19	case
18	the	the	DT	_	19	det
19	range	range	NN	_	4	advcl
20	of	of	IN	_	23	case
21	0.1-0	0.1-0	CD	_	22	compound
22	.8	.8	CD	_	23	nummod
23	mg/l	mg/l	NN	_	19	nmod
24	and	and	CC	_	23	cc
25	0.1-0	0.1-0	CD	_	26	compound
26	.4	.4	CD	_	27	nummod
27	mg/l	mg/l	NN	_	23	conj
28	respectively	respectively	RB	_	19	advmod
29	.	.	.	_	4	punct

1	When	when	WRB	_	2	advmod
2	combined	combine	VBN	_	7	advcl
3	with	with	IN	_	4	case
4	drug1	drug1	NN	_	2	nmod
5	,	,	,	_	7	punct
6	drug2	drug2	NN	_	7	nsubj
7	exhibited	exhibit	VBD	_	0	ROOT
8	strong	strong	JJ	_	10	amod
9	synergistic	synergistic	JJ	_	10	amod
10	activity	activity	NN	_	7	dobj
11	while	while	IN	_	16	mark
12	only	only	RB	_	14	advmod
13	additive	additive	JJ	_	14	amod
14	effects	effect	NNS	_	16	nsubjpass
15	were	be	VBD	_	16	auxpass
16	observed	observe	VBN	_	7	advcl
17	with	with	IN	_	19	case
18	the	the	DT	_	19	det
19	combination	combination	NN	_	16	nmod
20	of	of	IN	_	21	case
21	drug3	drug3	NN	_	19	nmod
22	-LRB-	-lrb-	-LRB-	_	24	punct
23	or	or	CC	_	24	cc
24	drug4	drug4	NN	_	21	appos
25	-RRB-	-rrb-	-RRB-	_	24	punct
26	and	and	CC	_	21	cc
27	drug5	drug5	NN	_	21	conj
28	.	.	.	_	7	punct

1	These	these	DT	_	2	det
2	results	result	NNS	_	3	nsubj
3	suggest	suggest	VBP	_	0	ROOT
4	that	that	IN	_	6	mark
5	drug1	drug1	NN	_	6	nsubj
6	has	have	VBZ	_	3	ccomp
7	a	a	DT	_	9	det
8	great	great	JJ	_	9	amod
9	potential	potential	JJ	_	6	dobj
10	in	in	IN	_	12	case
11	the	the	DT	_	12	det
12	treatment	treatment	NN	_	6	nmod
13	of	of	IN	_	14	case
14	M.	m.	NN	_	12	nmod

1	ulcerans	ulcerans	JJ	_	2	amod
2	infection	infection	NN	_	0	ROOT
3	.	.	.	_	2	punct

1	Pharmacokinetics	pharmacokinetic	NNS	_	0	ROOT
2	of	of	IN	_	3	case
3	drug1	drug1	NN	_	1	nmod
4	.	.	.	_	1	punct

1	Effective	effective	JJ	_	2	amod
2	use	use	NN	_	7	nsubj
3	of	of	IN	_	4	case
4	drugs	drug	NNS	_	2	nmod
5	in	in	IN	_	6	case
6	therapy	therapy	NN	_	2	nmod
7	depends	depend	VBZ	_	0	ROOT
8	not	not	RB	_	9	neg
9	only	only	RB	_	12	cc:preconj
10	on	on	IN	_	12	case
11	clinical	clinical	JJ	_	12	amod
12	acumen	acumen	NNS	_	7	nmod
13	but	but	CC	_	12	cc
14	also	also	RB	_	17	advmod
15	on	on	IN	_	17	case
16	the	the	DT	_	17	det
17	availability	availability	NN	_	12	conj
18	of	of	IN	_	23	case
19	relevant	relevant	JJ	_	23	amod
20	pharmacokinetic	pharmacokinetic	JJ	_	23	amod
21	and	and	CC	_	20	cc
22	pharmacodynamic	pharmacodynamic	JJ	_	20	conj
23	data	datum	NNS	_	17	nmod
24	.	.	.	_	7	punct

1	Such	such	JJ	_	2	amod
2	information	information	NN	_	3	nsubj
3	assists	assist	VBZ	_	0	ROOT
4	in	in	IN	_	5	case
5	development	development	NN	_	3	nmod
6	of	of	IN	_	9	case
7	safe	safe	JJ	_	9	amod
8	dosing	dosing	NN	_	9	compound
9	regimens	regimen	NNS	_	5	nmod
10	,	,	,	_	3	punct
11	prediction	prediction	NN	_	3	dobj
12	of	of	IN	_	14	case
13	abnormal	abnormal	JJ	_	14	amod
14	handling	handling	NN	_	11	nmod
15	of	of	IN	_	16	case
16	drugs	drug	NNS	_	14	nmod
17	in	in	IN	_	18	case
18	states	state	NNS	_	11	nmod
19	of	of	IN	_	20	case
20	disease	disease	NN	_	18	nmod
21	and	and	CC	_	20	cc
22	disorder	disorder	NN	_	20	conj
23	and	and	CC	_	11	cc
24	anticipation	anticipation	NN	_	11	conj
25	of	of	IN	_	27	case
26	drug	drug	NN	_	27	compound
27	interactions	interaction	NNS	_	24	nmod
28	.	.	.	_	3	punct

1	For	for	IN	_	3	case
2	the	the	DT	_	3	det
3	drug1	drug1	NN	_	20	nmod
4	now	now	RB	_	5	advmod
5	available	available	JJ	_	3	amod
6	in	in	IN	_	9	case
7	the	the	DT	_	9	det
8	United	United	NNP	_	9	compound
9	States	States	NNPS	_	5	nmod
10	-LRB-	-lrb-	-LRB-	_	11	punct
11	drug2	drug2	NN	_	9	dep
12	,	,	,	_	11	punct
13	drug3	drug3	NN	_	11	conj
14	and	and	CC	_	11	cc
15	drug4	drug4	NN	_	11	conj
16	-RRB-	-rrb-	-RRB-	_	11	punct
17	,	,	,	_	20	punct
18	these	these	DT	_	19	det
19	data	datum	NNS	_	20	nsubj
20	appeared	appear	VBD	_	0	ROOT
21	well	well	RB	_	20	advmod
22	after	after	IN	_	24	case
23	clinical	clinical	JJ	_	24	amod
24	patterns	pattern	NNS	_	20	nmod
25	of	of	IN	_	26	case
26	use	use	NN	_	24	nmod
27	evolved	evolve	VBD	_	20	dep
28	.	.	.	_	20	punct

1	Nonetheless	nonetheless	RB	_	5	advmod
2	,	,	,	_	5	punct
3	their	they	PRP$	_	4	nmod:poss
4	relevance	relevance	NN	_	5	nsubj
5	continues	continue	VBZ	_	0	ROOT
6	to	to	TO	_	8	mark
7	be	be	VB	_	8	auxpass
8	demonstrated	demonstrate	VBN	_	5	xcomp
9	by	by	IN	_	11	case
10	the	the	DT	_	11	det
11	dependence	dependence	NN	_	8	nmod
12	of	of	IN	_	14	case
13	each	each	DT	_	14	det
14	agent	agent	NN	_	11	nmod
15	on	on	IN	_	19	case
16	intact	intact	JJ	_	19	amod
17	liver	liver	NN	_	19	compound
18	blood	blood	NN	_	19	compound
19	flow	flow	NN	_	11	nmod
20	and	and	CC	_	19	cc
21	function	function	NN	_	19	conj
22	for	for	IN	_	24	case
23	normal	normal	JJ	_	24	amod
24	rates	rate	NNS	_	19	nmod
25	of	of	IN	_	26	case
26	elimination	elimination	NN	_	24	nmod
27	;	;	:	_	5	punct

1	by	by	IN	_	5	case
2	the	the	DT	_	5	det
3	nonlinear	nonlinear	JJ	_	5	amod
4	kinetic	kinetic	JJ	_	5	amod
5	characteristics	characteristic	NNS	_	0	ROOT
6	for	for	IN	_	7	case
7	drug1	drug1	NN	_	5	nmod
8	and	and	CC	_	7	cc
9	drug2	drug2	NN	_	7	conj
10	-LRB-	-lrb-	-LRB-	_	14	punct
11	and	and	CC	_	14	cc
12	probably	probably	RB	_	14	advmod
13	for	for	IN	_	14	case
14	drug3	drug3	NN	_	5	dep
15	,	,	,	_	14	punct
16	as	as	RB	_	14	advmod
17	well	well	RB	_	16	mwe
18	-RRB-	-rrb-	-RRB-	_	14	punct
19	and	and	CC	_	5	cc
20	the	the	DT	_	22	det
21	derivative	derivative	JJ	_	22	amod
22	implications	implication	NNS	_	5	conj
23	for	for	IN	_	27	case
24	decreased	decrease	VBN	_	27	amod
25	dosing	dosing	NN	_	27	compound
26	frequency	frequency	NN	_	27	compound
27	requirements	requirement	NNS	_	22	nmod
28	;	;	:	_	5	punct

1	and	and	CC	_	0	ROOT
2	by	by	IN	_	3	case
3	observations	observation	NNS	_	1	nmod
4	now	now	RB	_	5	advmod
5	appearing	appear	VBG	_	3	acl
6	on	on	IN	_	8	case
7	the	the	DT	_	8	det
8	relation	relation	NN	_	5	nmod
9	between	between	IN	_	12	case
10	plasma	plasma	NN	_	12	compound
11	drug	drug	NN	_	12	compound
12	levels	level	NNS	_	8	nmod
13	and	and	CC	_	12	cc
14	drug	drug	NN	_	15	compound
15	effects	effect	NNS	_	12	conj
16	,	,	,	_	3	punct
17	both	both	DT	_	18	cc:preconj
18	therapeutic	therapeutic	JJ	_	16	root
19	and	and	CC	_	18	cc
20	toxic	toxic	JJ	_	18	conj
21	.	.	.	_	18	punct

1	Such	such	JJ	_	2	amod
2	data	datum	NNS	_	4	nsubjpass
3	are	be	VBP	_	4	auxpass
4	discussed	discuss	VBN	_	0	ROOT
5	herein	herein	RB	_	4	advmod
6	,	,	,	_	4	punct
7	with	with	IN	_	8	case
8	emphasis	emphasis	NN	_	4	nmod
9	on	on	IN	_	11	case
10	those	those	DT	_	11	det
11	aspects	aspect	NNS	_	8	nmod
12	that	that	WDT	_	13	nsubj
13	impact	impact	VBP	_	11	acl:relcl
14	on	on	IN	_	17	case
15	the	the	DT	_	17	det
16	clinical	clinical	JJ	_	17	amod
17	use	use	NN	_	13	nmod
18	of	of	IN	_	20	case
19	the	the	DT	_	20	det
20	drug1	drug1	NN	_	17	nmod
21	.	.	.	_	4	punct

1	Herbal	herbal	JJ	_	2	amod
2	remedies	remedy	NNS	_	0	ROOT
3	,	,	,	_	2	punct
4	nephropathies	nephropathy	NNS	_	2	conj
5	,	,	,	_	2	punct
6	and	and	CC	_	2	cc
7	renal	renal	JJ	_	8	amod
8	disease	disease	NN	_	2	conj
9	.	.	.	_	2	punct

1	The	the	DT	_	2	det
2	use	use	NN	_	7	nsubj
3	of	of	IN	_	5	case
4	herbal	herbal	JJ	_	5	amod
5	remedies	remedy	NNS	_	2	nmod
6	is	be	VBZ	_	7	aux
7	becoming	become	VBG	_	0	ROOT
8	increasingly	increasingly	RB	_	9	advmod
9	popular	popular	JJ	_	7	xcomp
10	in	in	IN	_	13	case
11	the	the	DT	_	13	det
12	United	United	NNP	_	13	compound
13	States	States	NNPS	_	7	nmod
14	.	.	.	_	7	punct

1	Research	Research	NNP	_	3	nsubj
2	has	have	VBZ	_	3	aux
3	shown	show	VBN	_	0	ROOT
4	that	that	IN	_	10	mark
5	herbal	herbal	JJ	_	7	amod
6	remedy	remedy	NN	_	7	compound
7	use	use	NN	_	10	nsubjpass
8	may	may	MD	_	10	aux
9	be	be	VB	_	10	auxpass
10	associated	associate	VBN	_	3	ccomp
11	with	with	IN	_	14	case
12	acute	acute	JJ	_	14	amod
13	renal	renal	JJ	_	14	amod
14	failure	failure	NN	_	10	nmod
15	.	.	.	_	3	punct

1	In	in	IN	_	2	case
2	addition	addition	NN	_	11	nmod
3	,	,	,	_	11	punct
4	the	the	DT	_	5	det
5	use	use	NN	_	11	nsubj
6	of	of	IN	_	8	case
7	herbal	herbal	JJ	_	8	amod
8	remedies	remedy	NNS	_	5	nmod
9	may	may	MD	_	11	aux
10	be	be	VB	_	11	cop
11	detrimental	detrimental	JJ	_	0	ROOT
12	for	for	IN	_	14	case
13	the	the	DT	_	14	det
14	patient	patient	NN	_	11	nmod
15	with	with	IN	_	18	case
16	compromised	compromise	VBN	_	18	amod
17	renal	renal	JJ	_	18	amod
18	function	function	NN	_	14	nmod
19	.	.	.	_	11	punct

1	Patients	patient	NNS	_	11	nsubj
2	with	with	IN	_	4	case
3	renal	renal	JJ	_	4	amod
4	insufficiency	insufficiency	NN	_	1	nmod
5	or	or	CC	_	4	cc
6	renal	renal	JJ	_	7	amod
7	failure	failure	NN	_	4	conj
8	may	may	MD	_	11	aux
9	be	be	VB	_	11	cop
10	at	at	IN	_	11	case
11	risk	risk	NN	_	0	ROOT
12	for	for	IN	_	15	case
13	further	further	JJ	_	15	amod
14	kidney	kidney	NN	_	15	compound
15	damage	damage	NN	_	11	nmod
16	as	as	RB	_	15	cc
17	well	well	RB	_	16	mwe
18	as	as	IN	_	16	mwe
19	complications	complication	NNS	_	15	conj
20	related	relate	VBN	_	19	acl
21	to	to	TO	_	22	case
22	interactions	interaction	NNS	_	20	nmod
23	of	of	IN	_	25	case
24	herbal	herbal	JJ	_	25	amod
25	remedies	remedy	NNS	_	22	nmod
26	with	with	IN	_	30	case
27	complex	complex	JJ	_	30	amod
28	renal	renal	JJ	_	30	amod
29	therapy	therapy	NN	_	30	compound
30	regimens	regimen	NNS	_	22	nmod
31	.	.	.	_	11	punct

1	This	this	DT	_	2	det
2	article	article	NN	_	4	nsubj
3	will	will	MD	_	4	aux
4	describe	describe	VB	_	0	ROOT
5	the	the	DT	_	7	det
6	escalating	escalate	VBG	_	7	amod
7	use	use	NN	_	4	dobj
8	of	of	IN	_	10	case
9	herbal	herbal	JJ	_	10	amod
10	therapy	therapy	NN	_	7	nmod
11	and	and	CC	_	10	cc
12	the	the	DT	_	13	det
13	hazards	hazard	NNS	_	10	conj
14	of	of	IN	_	17	case
15	herbal	herbal	JJ	_	17	amod
16	remedy	remedy	NN	_	17	compound
17	use	use	NN	_	13	nmod
18	among	among	IN	_	19	case
19	patients	patient	NNS	_	17	nmod
20	.	.	.	_	4	punct

1	drug1	drug1	NN	_	0	ROOT
2	and	and	CC	_	1	cc
3	their	they	PRP$	_	4	nmod:poss
4	complications	complication	NNS	_	1	conj
5	.	.	.	_	1	punct

1	Drugs	drug	NNS	_	9	nsubjpass
2	that	that	WDT	_	3	nsubj
3	suppress	suppress	VBP	_	1	acl:relcl
4	the	the	DT	_	6	det
5	immune	immune	JJ	_	6	amod
6	system	system	NN	_	3	dobj
7	are	be	VBP	_	9	auxpass
8	widely	widely	RB	_	9	advmod
9	used	use	VBN	_	0	ROOT
10	.	.	.	_	9	punct

1	They	they	PRP	_	3	nsubj
2	are	be	VBP	_	3	cop
3	part	part	NN	_	0	ROOT
4	of	of	IN	_	6	case
5	the	the	DT	_	6	det
6	treatment	treatment	NN	_	3	nmod
7	of	of	IN	_	8	case
8	patients	patient	NNS	_	6	nmod
9	with	with	IN	_	11	case
10	organ	organ	NN	_	11	compound
11	transplants	transplant	NNS	_	8	nmod
12	,	,	,	_	11	punct
13	malignancy	malignancy	NN	_	11	conj
14	,	,	,	_	11	punct
15	and	and	CC	_	11	cc
16	increasingly	increasingly	RB	_	17	advmod
17	those	those	DT	_	11	conj
18	with	with	IN	_	19	case
19	conditions	condition	NNS	_	17	nmod
20	such	such	JJ	_	22	case
21	as	as	IN	_	20	mwe
22	psoriasis	psoriasis	NN	_	19	nmod
23	,	,	,	_	22	punct
24	rheumatoid	rheumatoid	JJ	_	25	amod
25	arthritis	arthritis	NN	_	22	conj
26	,	,	,	_	22	punct
27	and	and	CC	_	22	cc
28	liver	liver	NN	_	31	compound
29	and	and	CC	_	28	cc
30	bowel	bowel	NN	_	28	conj
31	disease	disease	NN	_	22	conj
32	in	in	IN	_	33	case
33	which	which	WDT	_	38	nmod
34	inflammation	inflammation	NN	_	38	nsubj
35	is	be	VBZ	_	38	cop
36	an	a	DT	_	38	det
37	aetiological	aetiological	JJ	_	38	amod
38	factor	factor	NN	_	22	acl:relcl
39	.	.	.	_	3	punct

1	Because	because	IN	_	5	case
2	of	of	IN	_	1	mwe
3	the	the	DT	_	5	det
4	broadening	broaden	VBG	_	5	amod
5	indications	indication	NNS	_	28	nmod
6	for	for	IN	_	7	case
7	drug1	drug1	NN	_	5	nmod
8	,	,	,	_	5	punct
9	and	and	CC	_	5	cc
10	the	the	DT	_	12	det
11	prolonged	prolonged	JJ	_	12	amod
12	survival	survival	NN	_	5	conj
13	in	in	IN	_	14	case
14	conditions	condition	NNS	_	12	nmod
15	for	for	IN	_	16	case
16	which	which	WDT	_	20	nmod
17	they	they	PRP	_	20	nsubjpass
18	are	be	VBP	_	20	aux
19	being	be	VBG	_	20	auxpass
20	used	use	VBN	_	14	acl:relcl
21	,	,	,	_	28	punct
22	many	many	JJ	_	23	amod
23	patients	patient	NNS	_	28	nsubjpass
24	on	on	IN	_	25	case
25	immunosuppression	immunosuppression	NN	_	23	nmod
26	are	be	VBP	_	28	auxpass
27	now	now	RB	_	28	advmod
28	cared	care	VBN	_	0	ROOT
29	for	for	IN	_	32	case
30	in	in	IN	_	32	case
31	the	the	DT	_	32	det
32	community	community	NN	_	28	nmod
33	or	or	CC	_	32	cc
34	seen	see	VBN	_	32	conj
35	in	in	IN	_	37	case
36	non-specialist	non-specialist	JJ	_	37	amod
37	hospitals	hospital	NNS	_	34	nmod
38	,	,	,	_	28	punct
39	usually	usually	RB	_	42	advmod
40	in	in	IN	_	42	case
41	close	close	JJ	_	42	amod
42	collaboration	collaboration	NN	_	28	nmod
43	with	with	IN	_	45	case
44	a	a	DT	_	45	det
45	specialist	specialist	NN	_	42	nmod
46	.	.	.	_	28	punct

1	This	this	DT	_	2	det
2	article	article	NN	_	3	nsubj
3	looks	look	VBZ	_	0	ROOT
4	at	at	IN	_	8	case
5	five	five	CD	_	8	nummod
6	commonly	commonly	RB	_	7	advmod
7	used	use	VBN	_	8	amod
8	drug1	drug1	NN	_	3	nmod
9	in	in	IN	_	10	case
10	turn	turn	NN	_	3	nmod
11	-LRB-	-lrb-	-LRB-	_	12	punct
12	drug2	drug2	NN	_	10	dep
13	,	,	,	_	12	punct
14	drug3	drug3	NN	_	12	conj
15	,	,	,	_	12	punct
16	drug4	drug4	NN	_	12	conj
17	,	,	,	_	12	punct
18	drug5	drug5	NN	_	12	conj
19	,	,	,	_	12	punct
20	drug6	drug6	NN	_	12	appos
21	-RRB-	-rrb-	-RRB-	_	12	punct
22	,	,	,	_	3	punct
23	discussing	discuss	VBG	_	3	advcl
24	the	the	DT	_	30	det
25	main	main	JJ	_	30	amod
26	,	,	,	_	25	punct
27	non-infection	non-infection	JJ	_	25	dep
28	,	,	,	_	25	punct
29	unwanted	unwanted	JJ	_	25	dep
30	effects	effect	NNS	_	23	dobj
31	,	,	,	_	3	punct
32	ways	way	NNS	_	3	dobj
33	to	to	TO	_	34	mark
34	avoid	avoid	VB	_	32	acl
35	them	they	PRP	_	34	dobj
36	and	and	CC	_	34	cc
37	what	what	WP	_	39	nsubj
38	to	to	TO	_	39	mark
39	do	do	VB	_	34	conj
40	if	if	IN	_	42	mark
41	problems	problem	NNS	_	42	nsubj
42	arise	arise	VBP	_	39	advcl
43	.	.	.	_	3	punct

1	The	the	DT	_	2	det
2	management	management	NN	_	6	nsubjpass
3	of	of	IN	_	4	case
4	infection	infection	NN	_	2	nmod
5	is	be	VBZ	_	6	auxpass
6	dealt	deal	VBN	_	0	ROOT
7	with	with	IN	_	11	case
8	as	as	IN	_	11	case
9	a	a	DT	_	11	det
10	separate	separate	JJ	_	11	amod
11	section	section	NN	_	6	nmod
12	.	.	.	_	6	punct

1	drug1	drug1	NN	_	5	nsubj
2	and	and	CC	_	1	cc
3	drug2	drug2	NN	_	1	conj
4	similarly	similarly	RB	_	5	advmod
5	inhibit	inhibit	VBP	_	0	ROOT
6	and	and	CC	_	5	cc
7	stimulate	stimulate	VBP	_	5	conj
8	drug3	drug3	NN	_	5	dobj
9	-	-	:	_	8	punct
10	or	or	CC	_	8	cc
11	drug4	drug4	NN	_	8	conj
12	-	-	:	_	8	punct
13	induced	induce	VBN	_	14	amod
14	proliferation	proliferation	NN	_	8	dep
15	of	of	IN	_	17	case
16	prostatic	prostatic	JJ	_	17	amod
17	epithelium	epithelium	NN	_	14	nmod
18	.	.	.	_	5	punct

1	Prostatic	prostatic	JJ	_	2	amod
2	epithelium	epithelium	NN	_	3	nsubj
3	proliferates	proliferate	VBZ	_	0	ROOT
4	in	in	IN	_	7	case
5	a	a	DT	_	7	det
6	defined	define	VBN	_	7	amod
7	medium	medium	NN	_	3	nmod
8	consisting	consist	VBG	_	7	acl
9	of	of	IN	_	12	case
10	basal	basal	JJ	_	12	amod
11	medium	medium	NN	_	12	compound
12	RPMI1640	rpmi1640	NN	_	8	nmod
13	containing	contain	VBG	_	12	acl
14	drug1	drug1	NN	_	13	dobj
15	-LRB-	-lrb-	-LRB-	_	17	punct
16	1	1	CD	_	17	nummod
17	microgram/ml	microgram/ml	NN	_	14	appos
18	-RRB-	-rrb-	-RRB-	_	17	punct
19	,	,	,	_	14	punct
20	drug2	drug2	NN	_	14	conj
21	-LRB-	-lrb-	-LRB-	_	23	punct
22	10	10	CD	_	23	nummod
23	ng/ml	ng/ml	NN	_	20	appos
24	-RRB-	-rrb-	-RRB-	_	23	punct
25	,	,	,	_	14	punct
26	and	and	CC	_	14	cc
27	drug3	drug3	NN	_	14	conj
28	-LRB-	-lrb-	-LRB-	_	30	punct
29	3.7	3.7	CD	_	30	nummod
30	micrograms/ml	micrograms/ml	NNS	_	27	dep
31	or	or	CC	_	30	cc
32	0.1	0.1	CD	_	33	nummod
33	IU/ml	iu/ml	NN	_	30	conj
34	-RRB-	-rrb-	-RRB-	_	30	punct
35	.	.	.	_	3	punct

1	Although	although	IN	_	6	mark
2	neither	neither	DT	_	3	cc:preconj
3	drug1	drug1	NN	_	6	nsubj
4	nor	nor	CC	_	3	cc
5	drug2	drug2	NN	_	3	conj
6	affected	affect	VBD	_	19	advcl
7	the	the	DT	_	8	det
8	proliferation	proliferation	NN	_	6	dobj
9	of	of	IN	_	11	case
10	prostatic	prostatic	JJ	_	11	amod
11	epithelium	epithelium	NN	_	8	nmod
12	in	in	IN	_	13	case
13	RPMI1640	rpmi1640	NN	_	8	nmod
14	containing	contain	VBG	_	13	acl
15	drug3	drug3	NN	_	14	dobj
16	alone	alone	RB	_	15	advmod
17	,	,	,	_	19	punct
18	they	they	PRP	_	19	nsubj
19	modify	modify	VBP	_	0	ROOT
20	the	the	DT	_	22	det
21	mitogenic	mitogenic	JJ	_	22	amod
22	effect	effect	NN	_	19	dobj
23	of	of	IN	_	24	case
24	drug4	drug4	NN	_	22	nmod
25	and	and	CC	_	24	cc
26	drug5	drug5	NN	_	24	conj
27	.	.	.	_	19	punct

1	drug1	drug1	NN	_	19	nsubj
2	at	at	IN	_	7	case
3	10	10	CD	_	7	nummod
4	-LRB-	-lrb-	-LRB-	_	5	punct
5	-10	-10	CD	_	3	appos
6	-RRB-	-rrb-	-RRB-	_	5	punct
7	M	m	NN	_	1	nmod
8	or	or	CC	_	7	cc
9	drug2	drug2	NN	_	7	conj
10	at	at	IN	_	13	case
11	about	about	IN	_	12	advmod
12	3	3	CD	_	13	nummod
13	X	x	NN	_	1	nmod
14	10	10	CD	_	13	nummod
15	-LRB-	-lrb-	-LRB-	_	16	punct
16	-9	-9	CD	_	13	appos
17	-RRB-	-rrb-	-RRB-	_	16	punct
18	M	m	NN	_	1	dep
19	inhibits	inhibit	VBZ	_	0	ROOT
20	proliferation	proliferation	NN	_	19	dobj
21	stimulated	stimulate	VBN	_	20	acl
22	by	by	IN	_	23	case
23	drug3	drug3	NN	_	21	nmod
24	.	.	.	_	19	punct

1	Higher	higher	JJR	_	2	amod
2	concentrations	concentration	NNS	_	0	ROOT
3	of	of	IN	_	4	case
4	drug1	drug1	NN	_	2	nmod
5	-LRB-	-lrb-	-LRB-	_	8	punct
6	10	10	CD	_	8	nummod
7	-LRB-	-lrb-	-LRB-	_	8	punct
8	-8	-8	CD	_	4	appos
9	-RRB-	-rrb-	-RRB-	_	8	punct
10	-	-	:	_	4	punct
11	10	10	CD	_	4	dep
12	-LRB-	-lrb-	-LRB-	_	15	punct
13	-6	-6	CD	_	15	nummod
14	-RRB-	-rrb-	-RRB-	_	15	punct
15	M	m	NN	_	11	appos
16	-RRB-	-rrb-	-RRB-	_	15	punct
17	or	or	CC	_	11	cc
18	drug2	drug2	NN	_	11	conj
19	-LRB-	-lrb-	-LRB-	_	21	punct
20	3	3	CD	_	21	nummod
21	X	x	NN	_	18	dep
22	10	10	CD	_	21	nummod
23	-LRB-	-lrb-	-LRB-	_	24	punct
24	-8	-8	CD	_	21	appos
25	-RRB-	-rrb-	-RRB-	_	24	punct
26	-	-	:	_	21	punct
27	10	10	CD	_	21	dep
28	-LRB-	-lrb-	-LRB-	_	31	punct
29	-7	-7	CD	_	31	nummod
30	-RRB-	-rrb-	-RRB-	_	31	punct
31	M	m	NN	_	27	appos
32	-RRB-	-rrb-	-RRB-	_	31	punct
33	enhance	enhance	VBP	_	21	dep
34	the	the	DT	_	36	det
35	mitogenic	mitogenic	JJ	_	36	amod
36	activity	activity	NN	_	33	dobj
37	of	of	IN	_	38	case
38	drug3	drug3	NN	_	36	nmod
39	.	.	.	_	2	punct

1	drug1	drug1	NN	_	2	nsubj
2	had	have	VBD	_	0	ROOT
3	a	a	DT	_	5	det
4	similar	similar	JJ	_	5	amod
5	effect	effect	NN	_	2	dobj
6	in	in	IN	_	8	case
7	the	the	DT	_	8	det
8	presence	presence	NN	_	2	nmod
9	of	of	IN	_	10	case
10	drug2	drug2	NN	_	8	nmod
11	.	.	.	_	2	punct

1	However	however	RB	_	4	advmod
2	,	,	,	_	4	punct
3	drug1	drug1	NN	_	4	nsubj
4	stimulated	stimulate	VBD	_	0	ROOT
5	,	,	,	_	4	punct
6	but	but	CC	_	4	cc
7	did	do	VBD	_	10	aux
8	not	not	RB	_	10	neg
9	significantly	significantly	RB	_	10	advmod
10	inhibit	inhibit	VB	_	4	conj
11	,	,	,	_	10	punct
12	proliferation	proliferation	NN	_	10	dobj
13	in	in	IN	_	15	case
14	the	the	DT	_	15	det
15	presence	presence	NN	_	12	nmod
16	of	of	IN	_	17	case
17	drug2	drug2	NN	_	15	nmod
18	.	.	.	_	4	punct

1	These	these	DT	_	2	det
2	results	result	NNS	_	3	nsubj
3	suggest	suggest	VBP	_	0	ROOT
4	that	that	IN	_	18	mark
5	both	both	CC	_	6	cc:preconj
6	drug1	drug1	NN	_	18	nsubj
7	and	and	CC	_	6	cc
8	drug2	drug2	NN	_	6	conj
9	,	,	,	_	6	punct
10	and	and	CC	_	6	cc
11	possibly	possibly	RB	_	13	advmod
12	other	other	JJ	_	13	amod
13	drug3	drug3	NN	_	6	conj
14	and	and	CC	_	13	cc
15	drug4	drug4	NN	_	13	conj
16	,	,	,	_	6	punct
17	may	may	MD	_	18	aux
18	regulate	regulate	VB	_	3	ccomp
19	the	the	DT	_	20	det
20	proliferation	proliferation	NN	_	18	dobj
21	of	of	IN	_	23	case
22	prostate	prostate	NN	_	23	compound
23	epithelium	epithelium	NN	_	20	nmod
24	by	by	IN	_	27	case
25	a	a	DT	_	27	det
26	dose-dependent	dose-dependent	JJ	_	27	amod
27	modification	modification	NN	_	18	nmod
28	of	of	IN	_	30	case
29	the	the	DT	_	30	det
30	activity	activity	NN	_	27	nmod
31	of	of	IN	_	32	case
32	drug5	drug5	NN	_	30	nmod
33	and	and	CC	_	32	cc
34	drug6	drug6	NN	_	32	conj
35	.	.	.	_	3	punct

1	Death	death	NN	_	0	ROOT
2	in	in	IN	_	4	case
3	drug1	drug1	NN	_	4	compound
4	users	user	NNS	_	1	nmod
5	:	:	:	_	1	punct
6	causes	cause	NNS	_	1	dep
7	and	and	CC	_	6	cc
8	rates	rate	NNS	_	6	conj
9	.	.	.	_	1	punct

1	The	the	DT	_	4	det
2	world	world	NN	_	4	compound
3	medical	medical	JJ	_	4	amod
4	literature	literature	NN	_	5	nsubj
5	contains	contain	VBZ	_	0	ROOT
6	43	43	CD	_	7	nummod
7	reports	report	NNS	_	5	dobj
8	of	of	IN	_	9	case
9	deaths	death	NNS	_	7	nmod
10	associated	associate	VBN	_	9	acl
11	with	with	IN	_	12	case
12	drug1	drug1	NN	_	10	nmod
13	in	in	IN	_	16	case
14	a	a	DT	_	16	det
15	35-year	35-year	JJ	_	16	amod
16	period	period	NN	_	10	nmod
17	.	.	.	_	5	punct

1	These	these	DT	_	2	nsubj
2	included	include	VBD	_	0	ROOT
3	seven	seven	CD	_	5	nummod
4	cerebrovascular	cerebrovascular	JJ	_	5	amod
5	accidents	accident	NNS	_	2	dobj
6	,	,	,	_	5	punct
7	six	six	CD	_	10	nummod
8	sudden	sudden	JJ	_	10	amod
9	cardiac	cardiac	JJ	_	10	amod
10	deaths	death	NNS	_	5	conj
11	,	,	,	_	5	punct
12	three	three	CD	_	13	nummod
13	cases	case	NNS	_	5	conj
14	of	of	IN	_	15	case
15	hyperpyrexia	hyperpyrexia	NN	_	13	nmod
16	,	,	,	_	5	punct
17	eight	eight	CD	_	18	nummod
18	poisonings	poisoning	NNS	_	5	conj
19	of	of	IN	_	21	case
20	uncertain	uncertain	JJ	_	21	amod
21	mechanism	mechanism	NN	_	18	nmod
22	and	and	CC	_	5	cc
23	seven	seven	CD	_	24	nummod
24	cases	case	NNS	_	5	conj
25	of	of	IN	_	27	case
26	medical	medical	JJ	_	27	amod
27	complications	complication	NNS	_	24	nmod
28	of	of	IN	_	30	case
29	intravenous	intravenous	JJ	_	30	amod
30	injection	injection	NN	_	27	nmod
31	;	;	:	_	2	punct

1	the	the	DT	_	2	det
2	remainder	remainder	NN	_	6	nsubj
3	were	be	VBD	_	6	cop
4	of	of	IN	_	6	case
5	uncertain	uncertain	JJ	_	6	amod
6	cause	cause	NN	_	0	ROOT
7	.	.	.	_	6	punct

1	In	in	IN	_	2	case
2	contrast	contrast	NN	_	13	nmod
3	,	,	,	_	13	punct
4	in	in	IN	_	5	case
5	Ontario	Ontario	NNP	_	13	nmod
6	alone	alone	RB	_	5	advmod
7	,	,	,	_	13	punct
8	in	in	IN	_	9	case
9	1972	1972	CD	_	13	nmod
10	and	and	CC	_	9	cc
11	1973	1973	CD	_	9	conj
12	there	there	EX	_	13	expl
13	were	be	VBD	_	0	ROOT
14	26	26	CD	_	15	nummod
15	deaths	death	NNS	_	13	nsubj
16	in	in	IN	_	18	case
17	drug1	drug1	NN	_	18	compound
18	users	user	NNS	_	15	nmod
19	,	,	,	_	15	punct
20	of	of	IN	_	21	case
21	which	which	WDT	_	24	nmod
22	16	16	CD	_	24	nsubj
23	were	be	VBD	_	24	cop
24	due	due	JJ	_	15	acl:relcl
25	to	to	TO	_	27	case
26	accident	accident	NN	_	27	compound
27	suicide	suicide	NN	_	24	nmod
28	or	or	CC	_	27	cc
29	homicide	homicide	NN	_	27	conj
30	.	.	.	_	13	punct

1	Of	of	IN	_	4	case
2	the	the	DT	_	4	det
3	remaining	remain	VBG	_	4	amod
4	cases	case	NNS	_	8	nmod
5	,	,	,	_	8	punct
6	two	two	CD	_	8	nsubj
7	were	be	VBD	_	8	cop
8	cardiac	cardiac	JJ	_	0	ROOT
9	,	,	,	_	8	punct
10	two	two	CD	_	11	nummod
11	hepatic	hepatic	JJ	_	8	conj
12	and	and	CC	_	8	cc
13	the	the	DT	_	14	det
14	rest	rest	NN	_	18	nsubj
15	were	be	VBD	_	18	cop
16	mixed	mixed	JJ	_	18	amod
17	drug	drug	NN	_	18	compound
18	overdose	overdose	NN	_	8	conj
19	.	.	.	_	8	punct

1	Pulmonary	pulmonary	JJ	_	2	amod
2	granulomata	granulomata	NN	_	16	nsubj
3	,	,	,	_	2	punct
4	subacute	subacute	NN	_	5	compound
5	hepatitis	hepatitis	NN	_	2	conj
6	and	and	CC	_	2	cc
7	other	other	JJ	_	8	amod
8	lesions	lesion	NNS	_	2	conj
9	resulting	result	VBG	_	8	acl
10	from	from	IN	_	13	case
11	intravenous	intravenous	JJ	_	13	amod
12	drug	drug	NN	_	13	compound
13	use	use	NN	_	9	nmod
14	were	be	VBD	_	16	cop
15	common	common	JJ	_	16	amod
16	findings	finding	NNS	_	0	ROOT
17	at	at	IN	_	18	case
18	autopsy	autopsy	NN	_	16	nmod
19	.	.	.	_	16	punct

1	On	on	IN	_	3	case
2	the	the	DT	_	3	det
3	basis	basis	NN	_	27	nmod
4	of	of	IN	_	7	case
5	the	the	DT	_	7	det
6	estimated	estimate	VBN	_	7	amod
7	number	number	NN	_	3	nmod
8	of	of	IN	_	10	case
9	regular	regular	JJ	_	10	amod
10	users	user	NNS	_	7	nmod
11	of	of	IN	_	13	case
12	intravenous	intravenous	JJ	_	13	amod
13	drug1	drug1	NN	_	10	nmod
14	in	in	IN	_	15	case
15	Ontario	Ontario	NNP	_	13	nmod
16	,	,	,	_	27	punct
17	the	the	DT	_	19	det
18	mortality	mortality	NN	_	19	compound
19	rate	rate	NN	_	27	nsubj
20	in	in	IN	_	22	case
21	such	such	JJ	_	22	amod
22	users	user	NNS	_	19	nmod
23	is	be	VBZ	_	27	cop
24	at	at	IN	_	25	case
25	least	least	JJS	_	26	nmod:npmod
26	four	four	CD	_	27	nummod
27	times	time	NNS	_	0	ROOT
28	as	as	RB	_	29	advmod
29	high	high	JJ	_	27	advmod
30	as	as	IN	_	34	case
31	in	in	IN	_	34	case
32	the	the	DT	_	34	det
33	general	general	JJ	_	34	amod
34	population	population	NN	_	29	nmod
35	of	of	IN	_	38	case
36	the	the	DT	_	38	det
37	same	same	JJ	_	38	amod
38	age	age	NN	_	34	nmod
39	,	,	,	_	27	punct
40	and	and	CC	_	27	cc
41	is	be	VBZ	_	42	cop
42	comparable	comparable	JJ	_	27	conj
43	to	to	TO	_	44	case
44	that	that	DT	_	42	nmod
45	in	in	IN	_	46	case
46	alcoholics	alcoholic	NNS	_	44	nmod
47	and	and	CC	_	46	cc
48	drug2	drug2	NN	_	49	compound
49	addicts	addict	NNS	_	46	conj
50	.	.	.	_	27	punct

1	However	however	RB	_	13	advmod
2	,	,	,	_	13	punct
3	the	the	DT	_	5	det
4	absolute	absolute	JJ	_	5	amod
5	number	number	NN	_	13	nsubj
6	of	of	IN	_	7	case
7	drug1	drug1	NN	_	5	nmod
8	-	-	:	_	7	punct
9	related	related	JJ	_	10	amod
10	deaths	death	NNS	_	7	dep
11	is	be	VBZ	_	13	cop
12	far	far	RB	_	13	advmod
13	greater	greater	JJR	_	0	ROOT
14	than	than	IN	_	16	case
15	the	the	DT	_	16	det
16	number	number	NN	_	13	nmod
17	of	of	IN	_	18	case
18	deaths	death	NNS	_	16	nmod
19	in	in	IN	_	20	case
20	drug2	drug2	NN	_	18	nmod
21	or	or	CC	_	20	cc
22	drug3	drug3	NN	_	23	compound
23	users	user	NNS	_	20	conj
24	.	.	.	_	13	punct

1	-LSB-	-lsb-	-LRB-	_	4	punct
2	A	a	DT	_	4	det
3	pharmacological	pharmacological	JJ	_	4	amod
4	analysis	analysis	NN	_	0	ROOT
5	of	of	IN	_	7	case
6	the	the	DT	_	7	det
7	effect	effect	NN	_	23	nmod
8	of	of	IN	_	9	case
9	drug1	drug1	NN	_	7	nmod
10	on	on	IN	_	13	case
11	stimulated	stimulate	VBN	_	13	amod
12	gastric	gastric	JJ	_	13	amod
13	secretion	secretion	NN	_	23	nmod
14	-RSB-	-rsb-	-RRB-	_	13	punct
15	Chronic	chronic	JJ	_	16	amod
16	experiments	experiment	NNS	_	23	nsubjpass
17	on	on	IN	_	18	case
18	dogs	dog	NNS	_	16	nmod
19	with	with	IN	_	21	case
20	gastric	gastric	JJ	_	21	amod
21	fistulas	fistula	NNS	_	18	nmod
22	were	be	VBD	_	23	auxpass
23	carried	carry	VBN	_	4	acl
24	out	out	RP	_	23	compound:prt
25	to	to	TO	_	26	mark
26	study	study	VB	_	23	xcomp
27	the	the	DT	_	28	det
28	influence	influence	NN	_	26	dobj
29	of	of	IN	_	30	case
30	drug2	drug2	NN	_	28	nmod
31	and	and	CC	_	30	cc
32	drug3	drug3	NN	_	30	conj
33	on	on	IN	_	34	case
34	drug4	drug4	NN	_	28	nmod
35	-	-	:	_	4	punct
36	and	and	CC	_	4	cc
37	drug5	drug5	NN	_	4	conj
38	-	-	:	_	37	punct
39	induced	induce	VBN	_	42	amod
40	gastric	gastric	JJ	_	42	amod
41	acid	acid	NN	_	42	compound
42	secretion	secretion	NN	_	37	dep
43	.	.	.	_	4	punct

1	It	it	PRP	_	3	nsubjpass
2	was	be	VBD	_	3	auxpass
3	established	establish	VBN	_	0	ROOT
4	that	that	IN	_	7	mark
5	both	both	CC	_	6	det
6	angiotensins	angiotensin	NNS	_	7	nsubj
7	inhibited	inhibit	VBD	_	3	ccomp
8	gastric	gastric	JJ	_	10	amod
9	acid	acid	NN	_	10	compound
10	secretion	secretion	NN	_	7	dobj
11	stimulated	stimulate	VBN	_	10	acl
12	by	by	IN	_	13	case
13	drug1	drug1	NN	_	11	nmod
14	but	but	CC	_	13	cc
15	not	not	RB	_	17	neg
16	by	by	IN	_	17	case
17	drug2	drug2	NN	_	13	conj
18	.	.	.	_	3	punct

1	Comparative	comparative	JJ	_	2	amod
2	analysis	analysis	NN	_	21	nsubj
3	of	of	IN	_	5	case
4	the	the	DT	_	5	det
5	effects	effect	NNS	_	2	nmod
6	of	of	IN	_	7	case
7	stimulation	stimulation	NN	_	5	nmod
8	and	and	CC	_	7	cc
9	inhibition	inhibition	NN	_	7	conj
10	of	of	IN	_	11	case
11	cholino	cholino	NN	_	7	nmod
12	-	-	:	_	11	punct
13	and	and	CC	_	11	cc
14	adrenoreceptors	adrenoreceptor	NNS	_	11	conj
15	on	on	IN	_	18	case
16	this	this	DT	_	18	det
17	inhibitory	inhibitory	JJ	_	18	amod
18	action	action	NN	_	5	nmod
19	of	of	IN	_	20	case
20	drug1	drug1	NN	_	18	nmod
21	suggested	suggest	VBD	_	0	ROOT
22	the	the	DT	_	23	det
23	mediation	mediation	NN	_	21	dobj
24	of	of	IN	_	26	case
25	drug2	drug2	NN	_	26	compound
26	influence	influence	NN	_	23	nmod
27	through	through	IN	_	29	case
28	the	the	DT	_	29	det
29	modulation	modulation	NN	_	21	nmod
30	of	of	IN	_	32	case
31	cholinergic	cholinergic	JJ	_	32	amod
32	reactions	reaction	NNS	_	29	nmod
33	of	of	IN	_	35	case
34	parietal	parietal	JJ	_	35	amod
35	cells	cell	NNS	_	32	nmod
36	in	in	IN	_	38	case
37	the	the	DT	_	38	det
38	stomach	stomach	NN	_	32	nmod
39	.	.	.	_	21	punct

1	-LSB-	-lsb-	-LRB-	_	2	punct
2	Stimulation	stimulation	NN	_	26	dep
3	by	by	IN	_	4	case
4	drug1	drug1	NN	_	2	nmod
5	--	--	:	_	2	punct
6	an	a	DT	_	7	det
7	analog	analog	NN	_	2	dep
8	of	of	IN	_	11	case
9	the	the	DT	_	11	det
10	octapeptide	octapeptide	NN	_	11	compound
11	cholecystokinin	cholecystokinin	NN	_	7	nmod
12	--	--	:	_	2	punct
13	of	of	IN	_	15	case
14	drug2	drug2	NN	_	15	compound
15	binding	binding	NN	_	2	nmod
16	after	after	IN	_	19	case
17	the	the	DT	_	19	det
18	long-term	long-term	JJ	_	19	amod
19	administration	administration	NN	_	15	nmod
20	of	of	IN	_	21	case
21	drug3	drug3	NN	_	19	nmod
22	-RSB-	-rsb-	-RRB-	_	2	punct
23	It	it	PRP	_	26	nsubjpass
24	has	have	VBZ	_	26	aux
25	been	be	VBN	_	26	auxpass
26	established	establish	VBN	_	56	csubj
27	in	in	IN	_	28	case
28	experiments	experiment	NNS	_	26	nmod
29	on	on	IN	_	32	case
30	white	white	JJ	_	32	amod
31	male	male	JJ	_	32	amod
32	rats	rat	NNS	_	28	nmod
33	that	that	WDT	_	34	nsubj
34	prolonged	prolong	VBD	_	32	acl:relcl
35	administration	administration	NN	_	34	dobj
36	-LRB-	-lrb-	-LRB-	_	39	punct
37	twice	twice	RB	_	39	advmod
38	a	a	DT	_	39	det
39	day	day	NN	_	34	dep
40	for	for	IN	_	42	case
41	14	14	CD	_	42	nummod
42	days	day	NNS	_	39	nmod
43	-RRB-	-rrb-	-RRB-	_	39	punct
44	of	of	IN	_	45	case
45	drug4	drug4	NN	_	34	nmod
46	-LRB-	-lrb-	-LRB-	_	48	punct
47	0.25	0.25	CD	_	48	nummod
48	mg/kg	mg/kg	NN	_	45	appos
49	-RRB-	-rrb-	-RRB-	_	48	punct
50	and	and	CC	_	45	cc
51	drug5	drug5	NN	_	45	conj
52	-LRB-	-lrb-	-LRB-	_	54	punct
53	0.25	0.25	CD	_	54	nummod
54	mg/kg	mg/kg	NN	_	51	appos
55	-RRB-	-rrb-	-RRB-	_	54	punct
56	resulted	result	VBD	_	0	ROOT
57	in	in	IN	_	60	case
58	the	the	DT	_	60	det
59	reduced	reduce	VBN	_	60	amod
60	interaction	interaction	NN	_	56	nmod
61	between	between	IN	_	62	case
62	drug6	drug6	NN	_	60	nmod
63	and	and	CC	_	62	cc
64	low	low	JJ	_	67	amod
65	affinity	affinity	NN	_	67	compound
66	binding	binding	NN	_	67	compound
67	sites	site	NNS	_	62	conj
68	for	for	IN	_	69	case
69	drug7	drug7	NN	_	60	nmod
70	in	in	IN	_	72	case
71	subcortical	subcortical	JJ	_	72	amod
72	structures	structure	NNS	_	69	nmod
73	,	,	,	_	56	punct
74	whereas	whereas	IN	_	84	mark
75	drug8	drug8	NN	_	76	compound
76	binding	binding	NN	_	84	nsubj
77	with	with	IN	_	81	case
78	high	high	JJ	_	81	amod
79	affinity	affinity	NN	_	81	compound
80	binding	binding	NN	_	81	compound
81	sites	site	NNS	_	76	nmod
82	for	for	IN	_	83	case
83	drug9	drug9	NN	_	81	nmod
84	increased	increase	VBD	_	56	advcl
85	both	both	CC	_	89	cc:preconj
86	in	in	IN	_	89	case
87	the	the	DT	_	89	det
88	frontal	frontal	JJ	_	89	amod
89	cortex	cortex	NN	_	84	nmod
90	and	and	CC	_	89	cc
91	subcortical	subcortical	JJ	_	92	amod
92	structures	structure	NNS	_	89	conj
93	of	of	IN	_	95	case
94	the	the	DT	_	95	det
95	forebrain	forebrain	NN	_	92	nmod
96	.	.	.	_	56	punct

1	After	after	IN	_	3	case
2	prolonged	prolonged	JJ	_	3	amod
3	administration	administration	NN	_	19	nmod
4	of	of	IN	_	5	case
5	drug1	drug1	NN	_	3	nmod
6	the	the	DT	_	8	det
7	displacing	displace	VBG	_	8	amod
8	effect	effect	NN	_	19	nsubjpass
9	of	of	IN	_	10	case
10	drug2	drug2	NN	_	8	nmod
11	,	,	,	_	10	punct
12	an	a	DT	_	13	det
13	analog	analog	NN	_	10	appos
14	of	of	IN	_	16	case
15	cholecystokinin	cholecystokinin	NN	_	16	compound
16	octapeptide	octapeptide	NN	_	13	nmod
17	,	,	,	_	8	punct
18	was	be	VBD	_	19	auxpass
19	replaced	replace	VBN	_	0	ROOT
20	by	by	IN	_	23	case
21	the	the	DT	_	23	det
22	stimulant	stimulant	NN	_	23	compound
23	action	action	NN	_	19	nmod
24	on	on	IN	_	26	case
25	drug3	drug3	NN	_	26	compound
26	binding	binding	NN	_	23	nmod
27	.	.	.	_	19	punct

1	It	it	PRP	_	3	nsubjpass
2	is	be	VBZ	_	3	auxpass
3	assumed	assume	VBN	_	0	ROOT
4	that	that	IN	_	21	mark
5	increased	increase	VBN	_	6	amod
6	interaction	interaction	NN	_	21	nsubj
7	between	between	IN	_	8	case
8	drug1	drug1	NN	_	6	nmod
9	and	and	CC	_	8	cc
10	high	high	JJ	_	13	amod
11	affinity	affinity	NN	_	13	compound
12	binding	binding	NN	_	13	compound
13	sites	site	NNS	_	8	conj
14	for	for	IN	_	15	case
15	drug2	drug2	NN	_	6	nmod
16	on	on	IN	_	17	case
17	dopamine2	dopamine2	NN	_	15	nmod
18	-	-	:	_	6	punct
19	and	and	CC	_	6	cc
20	serotonin2-receptors	serotonin2-receptor	NNS	_	6	conj
21	underlies	underlie	VBZ	_	3	ccomp
22	the	the	DT	_	24	det
23	antipsychotic	antipsychotic	JJ	_	24	amod
24	action	action	NN	_	21	dobj
25	of	of	IN	_	26	case
26	drug3	drug3	NN	_	24	nmod
27	after	after	IN	_	30	case
28	their	they	PRP$	_	30	nmod:poss
29	prolonged	prolonged	JJ	_	30	amod
30	administration	administration	NN	_	21	nmod
31	.	.	.	_	3	punct

1	Cholecystokinin	cholecystokinin	NN	_	2	compound
2	octapeptide	octapeptide	NN	_	6	nsubj
3	is	be	VBZ	_	6	cop
4	a	a	DT	_	6	det
5	necessary	necessary	JJ	_	6	amod
6	factor	factor	NN	_	0	ROOT
7	for	for	IN	_	8	case
8	realization	realization	NN	_	6	nmod
9	of	of	IN	_	11	case
10	this	this	DT	_	11	det
11	action	action	NN	_	8	nmod
12	of	of	IN	_	13	case
13	drug1	drug1	NN	_	11	nmod
14	.	.	.	_	6	punct

1	Interaction	interaction	NN	_	0	ROOT
2	of	of	IN	_	3	case
3	drug1	drug1	NN	_	1	nmod
4	and	and	CC	_	3	cc
5	drug2	drug2	NN	_	3	conj
6	in	in	IN	_	7	case
7	rats	rat	NNS	_	1	nmod
8	.	.	.	_	1	punct

1	The	the	DT	_	2	det
2	interaction	interaction	NN	_	18	nsubjpass
3	of	of	IN	_	6	case
4	intramuscularly	intramuscularly	JJ	_	6	amod
5	injected	inject	VBN	_	6	amod
6	drug1	drug1	NN	_	2	nmod
7	and	and	CC	_	6	cc
8	its	its	PRP$	_	10	nmod:poss
9	N-demethylated	n-demethylated	JJ	_	10	amod
10	metabolite	metabolite	NN	_	6	conj
11	-LRB-	-lrb-	-LRB-	_	13	punct
12	metabolite	metabolite	NN	_	13	compound
13	I	i	NN	_	10	appos
14	-RRB-	-rrb-	-RRB-	_	13	punct
15	with	with	IN	_	16	case
16	drug2	drug2	NN	_	2	nmod
17	was	be	VBD	_	18	auxpass
18	evaluated	evaluate	VBN	_	0	ROOT
19	in	in	IN	_	20	case
20	rats	rat	NNS	_	18	nmod
21	.	.	.	_	18	punct

1	Five	five	CD	_	25	nsubj
2	,	,	,	_	1	punct
3	10	10	CD	_	9	nummod
4	,	,	,	_	3	punct
5	20	20	CD	_	3	conj
6	,	,	,	_	3	punct
7	or	or	CC	_	3	cc
8	50	50	CD	_	3	conj
9	mg/kg	mg/kg	NN	_	1	appos
10	of	of	IN	_	11	case
11	drug1	drug1	NN	_	9	nmod
12	alone	alone	RB	_	11	advmod
13	or	or	CC	_	11	cc
14	20	20	CD	_	20	nummod
15	,	,	,	_	14	punct
16	50	50	CD	_	14	conj
17	,	,	,	_	14	punct
18	or	or	CC	_	14	cc
19	100	100	CD	_	14	conj
20	mg/kg	mg/kg	NN	_	11	conj
21	of	of	IN	_	23	case
22	metabolite	metabolite	NN	_	23	compound
23	I	i	NN	_	20	nmod
24	alone	alone	RB	_	23	advmod
25	produced	produce	VBD	_	0	ROOT
26	less	less	JJR	_	28	advmod
27	than	than	IN	_	26	mwe
28	10	10	CD	_	29	nummod
29	minutes	minute	NNS	_	25	dobj
30	of	of	IN	_	31	case
31	hypnosis	hypnosis	NN	_	29	nmod
32	.	.	.	_	25	punct

1	However	however	RB	_	12	advmod
2	,	,	,	_	12	punct
3	drug1	drug1	NN	_	5	compound
4	anesthetic	anesthetic	NN	_	5	compound
5	requirement	requirement	NN	_	12	nsubjpass
6	-LRB-	-lrb-	-LRB-	_	9	punct
7	i.e.	i.e.	FW	_	9	dep
8	,	,	,	_	9	punct
9	MAC	MAC	NNP	_	5	appos
10	-RRB-	-rrb-	-RRB-	_	9	punct
11	was	be	VBD	_	12	auxpass
12	depressed	depress	VBN	_	0	ROOT
13	in	in	IN	_	16	case
14	a	a	DT	_	16	det
15	dose-dependent	dose-dependent	JJ	_	16	amod
16	fashion	fashion	NN	_	12	nmod
17	as	as	RB	_	20	advmod
18	much	much	RB	_	20	advmod
19	as	as	IN	_	20	advmod
20	56	56	CD	_	21	nummod
21	%	%	NN	_	12	dobj
22	1-2	1-2	CD	_	23	nummod
23	hours	hour	NNS	_	21	nmod:npmod
24	and	and	CC	_	21	cc
25	as	as	RB	_	28	advmod
26	much	much	JJ	_	28	advmod
27	as	as	IN	_	28	advmod
28	14	14	CD	_	29	nummod
29	%	%	NN	_	21	conj
30	5-6	5-6	CD	_	31	nummod
31	hours	hour	NNS	_	29	nmod:npmod
32	after	after	IN	_	33	case
33	injection	injection	NN	_	29	nmod
34	of	of	IN	_	35	case
35	drug2	drug2	NN	_	33	nmod
36	,	,	,	_	21	punct
37	50	50	CD	_	38	nummod
38	mg/kg	mg/kg	NN	_	21	conj
39	,	,	,	_	21	punct
40	im	im	NN	_	21	conj
41	.	.	.	_	12	punct

1	The	the	DT	_	2	det
2	reduction	reduction	NN	_	6	nsubjpass
3	in	in	IN	_	4	case
4	MAC	MAC	NNP	_	2	nmod
5	was	be	VBD	_	6	auxpass
6	correlated	correlate	VBN	_	0	ROOT
7	with	with	IN	_	9	case
8	brain	brain	NN	_	9	compound
9	levels	level	NNS	_	6	nmod
10	of	of	IN	_	11	case
11	drug1	drug1	NN	_	9	nmod
12	or	or	CC	_	11	cc
13	metabolite	metabolite	NN	_	11	conj
14	I	I	PRP	_	11	dep
15	,	,	,	_	6	punct
16	suggesting	suggest	VBG	_	6	xcomp
17	a	a	DT	_	18	det
18	drug2	drug2	NN	_	16	dobj
19	:	:	:	_	18	punct
20	metabolite	metabolite	NN	_	23	compound
21	I	I	PRP	_	23	compound
22	potency	potency	NN	_	23	compound
23	ration	ration	NN	_	18	dep
24	of	of	IN	_	25	case
25	3:1	3:1	CD	_	23	nmod
26	.	.	.	_	6	punct

1	The	the	DT	_	2	det
2	half-life	half-life	NN	_	10	nsubj
3	of	of	IN	_	4	case
4	drug1	drug1	NN	_	2	nmod
5	in	in	IN	_	6	case
6	plasma	plasma	NN	_	2	nmod
7	and	and	CC	_	6	cc
8	brain	brain	NN	_	6	conj
9	was	be	VBD	_	10	cop
10	longer	longer	RBR	_	0	ROOT
11	in	in	IN	_	13	case
12	the	the	DT	_	13	det
13	presence	presence	NN	_	10	nmod
14	of	of	IN	_	15	case
15	drug2	drug2	NN	_	13	nmod
16	than	than	IN	_	20	mark
17	when	when	WRB	_	20	advmod
18	drug3	drug3	NN	_	20	nsubjpass
19	was	be	VBD	_	20	auxpass
20	given	give	VBN	_	10	advcl
21	alone	alone	RB	_	20	advmod
22	.	.	.	_	10	punct

1	It	it	PRP	_	3	nsubjpass
2	is	be	VBZ	_	3	auxpass
3	concluded	conclude	VBN	_	0	ROOT
4	that	that	IN	_	10	mark
5	drug1	drug1	NN	_	10	nsubj
6	is	be	VBZ	_	10	cop
7	not	not	RB	_	10	neg
8	a	a	DT	_	10	det
9	short-acting	short-acting	JJ	_	10	amod
10	drug	drug	NN	_	3	ccomp
11	and	and	CC	_	10	cc
12	that	that	IN	_	19	mark
13	concomitant	concomitant	JJ	_	14	amod
14	use	use	NN	_	19	nsubjpass
15	with	with	IN	_	16	case
16	drug2	drug2	NN	_	14	nmod
17	would	would	MD	_	19	aux
18	be	be	VB	_	19	auxpass
19	expected	expect	VBN	_	10	conj
20	to	to	TO	_	21	mark
21	prolong	prolong	VB	_	19	xcomp
22	further	further	RB	_	21	advmod
23	the	the	DT	_	24	det
24	duration	duration	NN	_	21	dobj
25	of	of	IN	_	27	case
26	its	its	PRP$	_	27	nmod:poss
27	action	action	NN	_	24	nmod
28	on	on	IN	_	32	case
29	the	the	DT	_	32	det
30	central	central	JJ	_	32	amod
31	nervous	nervous	JJ	_	32	amod
32	system	system	NN	_	27	nmod
33	.	.	.	_	3	punct

1	In	in	FW	_	3	amod
2	vitro	vitro	FW	_	1	dep
3	interaction	interaction	NN	_	0	ROOT
4	of	of	IN	_	5	case
5	drug1	drug1	NN	_	3	nmod
6	and	and	CC	_	5	cc
7	drug2	drug2	NN	_	5	conj
8	in	in	IN	_	10	case
9	placental	placental	JJ	_	10	amod
10	vessels	vessel	NNS	_	3	nmod
11	.	.	.	_	3	punct

1	The	the	DT	_	2	det
2	interaction	interaction	NN	_	12	nsubjpass
3	of	of	IN	_	4	case
4	drug1	drug1	NN	_	2	nmod
5	and	and	CC	_	4	cc
6	synthetic	synthetic	JJ	_	7	amod
7	drug2	drug2	NN	_	4	conj
8	on	on	IN	_	10	case
9	placental	placental	JJ	_	10	amod
10	vessels	vessel	NNS	_	2	nmod
11	was	be	VBD	_	12	auxpass
12	studied	study	VBN	_	0	ROOT
13	in	in	FW	_	14	compound
14	vitro	vitro	FW	_	12	advmod
15	.	.	.	_	12	punct

1	Resistance	resistance	NN	_	3	nsubjpass
2	was	be	VBD	_	3	auxpass
3	measured	measure	VBN	_	0	ROOT
4	near	near	IN	_	7	case
5	the	the	DT	_	7	det
6	placental	placental	JJ	_	7	amod
7	margin	margin	NN	_	3	nmod
8	after	after	IN	_	11	case
9	spontaneous	spontaneous	JJ	_	11	amod
10	term	term	NN	_	11	compound
11	delivery	delivery	NN	_	3	nmod
12	.	.	.	_	3	punct

1	In	in	IN	_	4	case
2	seven	seven	CD	_	4	nummod
3	experiments	experiment	NNS	_	4	compound
4	reactions	reaction	NNS	_	10	nmod
5	to	to	TO	_	6	case
6	drug1	drug1	NN	_	4	nmod
7	and	and	CC	_	6	cc
8	drug2	drug2	NN	_	6	conj
9	were	be	VBD	_	10	cop
10	drug3	drug3	NN	_	0	ROOT
11	.	.	.	_	10	punct

1	drug1	drug1	NN	_	2	nsubj
2	produced	produce	VBD	_	0	ROOT
3	significantly	significantly	RB	_	4	advmod
4	increased	increase	VBN	_	5	amod
5	vasoconstriction	vasoconstriction	NN	_	2	dobj
6	after	after	IN	_	9	case
7	a	a	DT	_	9	det
8	single	single	JJ	_	9	amod
9	administration	administration	NN	_	2	nmod
10	of	of	IN	_	11	case
11	drug2	drug2	NN	_	9	nmod
12	.	.	.	_	2	punct

1	In	in	IN	_	3	case
2	eight	eight	CD	_	3	nummod
3	experiments	experiment	NNS	_	7	nmod
4	the	the	DT	_	6	det
5	perfusion	perfusion	NN	_	6	compound
6	medium	medium	NN	_	7	nsubj
7	contained	contain	VBD	_	0	ROOT
8	drug1	drug1	NN	_	7	dobj
9	.	.	.	_	7	punct

1	There	there	EX	_	2	expl
2	was	be	VBD	_	0	ROOT
3	no	no	DT	_	4	neg
4	change	change	NN	_	2	nsubj
5	after	after	IN	_	8	case
6	a	a	DT	_	8	det
7	single	single	JJ	_	8	amod
8	dose	dose	NN	_	2	nmod
9	of	of	IN	_	10	case
10	drug1	drug1	NN	_	8	nmod
11	.	.	.	_	2	punct

1	The	the	DT	_	2	det
2	reaction	reaction	NN	_	5	nsubj
3	after	after	IN	_	4	case
4	drug1	drug1	NN	_	2	nmod
5	remained	remain	VBD	_	0	ROOT
6	the	the	DT	_	7	det
7	same	same	JJ	_	5	xcomp
8	in	in	IN	_	10	case
9	both	both	DT	_	10	det
10	groups	group	NNS	_	7	nmod
11	of	of	IN	_	12	case
12	experiments	experiment	NNS	_	10	nmod
13	.	.	.	_	5	punct

1	There	there	EX	_	2	expl
2	is	be	VBZ	_	0	ROOT
3	thus	thus	RB	_	2	advmod
4	an	a	DT	_	6	det
5	enhancement	enhancement	NN	_	6	compound
6	effect	effect	NN	_	2	nsubj

1	There	there	EX	_	2	expl
2	is	be	VBZ	_	0	ROOT
3	thus	thus	RB	_	2	advmod
4	an	a	DT	_	6	det
5	enhancement	enhancement	NN	_	6	compound
6	effect	effect	NN	_	2	nsubj
7	of	of	IN	_	8	case
8	drug1	drug1	NN	_	6	nmod
9	upon	upon	IN	_	11	case
10	the	the	DT	_	11	det
11	reaction	reaction	NN	_	2	nmod
12	of	of	IN	_	14	case
13	placental	placental	JJ	_	14	amod
14	vessels	vessel	NNS	_	11	nmod
15	to	to	TO	_	16	mark
16	drug2	drug2	VB	_	11	acl
17	in	in	FW	_	18	compound
18	vitro	vitro	FW	_	16	advmod
19	.	.	.	_	2	punct

1	Note	note	VB	_	0	ROOT
2	:	:	:	_	1	punct
3	dissolution	dissolution	NN	_	1	dep
4	of	of	IN	_	6	case
5	aerosol	aerosol	NN	_	6	compound
6	particles	particle	NNS	_	3	nmod
7	of	of	IN	_	8	case
8	drug1	drug1	NN	_	6	nmod
9	in	in	IN	_	10	case
10	drug2	drug2	NN	_	3	nmod
11	,	,	,	_	3	punct
12	a	a	DT	_	14	det
13	model	model	NN	_	14	compound
14	drug3	drug3	NN	_	3	appos
15	.	.	.	_	1	punct

1	The	the	DT	_	2	det
2	effect	effect	NN	_	23	nsubjpass
3	of	of	IN	_	6	case
4	a	a	DT	_	6	det
5	drug1	drug1	NN	_	6	compound
6	extract	extract	NN	_	2	nmod
7	from	from	IN	_	9	case
8	bovine	bovine	JJ	_	9	amod
9	lung	lung	NN	_	6	nmod
10	,	,	,	_	9	punct
11	drug2	drug2	NN	_	9	appos
12	,	,	,	_	9	punct
13	on	on	IN	_	16	case
14	the	the	DT	_	16	det
15	dissolution	dissolution	NN	_	16	compound
16	rate	rate	NN	_	2	nmod
17	of	of	IN	_	19	case
18	aerosol	aerosol	NN	_	19	compound
19	particles	particle	NNS	_	16	nmod
20	of	of	IN	_	21	case
21	drug3	drug3	NN	_	19	nmod
22	was	be	VBD	_	23	auxpass
23	determined	determine	VBN	_	0	ROOT
24	.	.	.	_	23	punct

1	Aerosol	Aerosol	NNP	_	2	compound
2	particles	particle	NNS	_	6	nsubjpass
3	of	of	IN	_	4	case
4	drug1	drug1	NN	_	2	nmod
5	were	be	VBD	_	6	auxpass
6	generated	generate	VBN	_	0	ROOT
7	from	from	IN	_	10	case
8	an	a	DT	_	10	det
9	drug2	drug2	NN	_	10	compound
10	solution	solution	NN	_	6	nmod
11	,	,	,	_	6	punct
12	dried	dry	VBD	_	6	conj
13	,	,	,	_	6	punct
14	and	and	CC	_	6	cc
15	collected	collect	VBN	_	6	conj
16	by	by	IN	_	19	case
17	a	a	DT	_	19	det
18	cascade	cascade	NN	_	19	compound
19	impactor	impactor	NN	_	15	nmod
20	for	for	IN	_	21	case
21	characterization	characterization	NN	_	19	nmod
22	or	or	CC	_	19	cc
23	by	by	IN	_	26	case
24	a	a	DT	_	26	det
25	liquid	liquid	JJ	_	26	amod
26	impinger	impinger	NN	_	19	conj
27	for	for	IN	_	29	case
28	dissolution	dissolution	NN	_	29	compound
29	experiments	experiment	NNS	_	26	nmod
30	.	.	.	_	6	punct

1	Powder	Powder	NNP	_	3	compound
2	x-ray	x-ray	NN	_	3	compound
3	diffraction	diffraction	NN	_	18	nsubjpass
4	,	,	,	_	3	punct
5	differential	differential	JJ	_	7	amod
6	scanning	scanning	NN	_	7	compound
7	calorimetry	calorimetry	NN	_	3	conj
8	,	,	,	_	3	punct
9	differential	differential	JJ	_	11	amod
10	thermal	thermal	JJ	_	11	amod
11	analysis	analysis	NN	_	3	conj
12	,	,	,	_	3	punct
13	and	and	CC	_	3	cc
14	scanning	scanning	NN	_	16	compound
15	electron	electron	NN	_	16	compound
16	microscopy	microscopy	NN	_	3	conj
17	were	be	VBD	_	18	auxpass
18	used	use	VBN	_	0	ROOT
19	to	to	TO	_	20	mark
20	characterize	characterize	VB	_	18	xcomp
21	the	the	DT	_	23	det
22	aerosol	aerosol	NN	_	23	compound
23	particles	particle	NNS	_	20	dobj
24	and	and	CC	_	20	cc
25	starting	start	VBG	_	26	case
26	material	material	NN	_	20	conj
27	.	.	.	_	18	punct

1	No	no	DT	_	2	neg
2	change	change	NN	_	6	nsubjpass
3	in	in	IN	_	4	case
4	phase	phase	NN	_	2	nmod
5	was	be	VBD	_	6	auxpass
6	detected	detect	VBN	_	0	ROOT
7	,	,	,	_	6	punct
8	although	although	IN	_	12	mark
9	the	the	DT	_	11	det
10	aerosol	aerosol	NN	_	11	compound
11	particles	particle	NNS	_	12	nsubj
12	appeared	appear	VBD	_	6	advcl
13	to	to	TO	_	14	mark
14	contain	contain	VB	_	12	xcomp
15	residual	residual	JJ	_	16	amod
16	drug1	drug1	NN	_	14	dobj
17	.	.	.	_	6	punct

1	The	the	DT	_	3	det
2	dissolution	dissolution	NN	_	3	compound
3	rate	rate	NN	_	11	nsubj
4	of	of	IN	_	7	case
5	the	the	DT	_	7	det
6	aerosol	aerosol	NN	_	7	compound
7	particles	particle	NNS	_	3	nmod
8	in	in	IN	_	9	case
9	saline	saline	NN	_	3	nmod
10	was	be	VBD	_	11	cop
11	low	low	JJ	_	0	ROOT
12	and	and	CC	_	11	cc
13	variable	variable	JJ	_	11	conj
14	.	.	.	_	11	punct

1	drug1	drug1	NN	_	2	nsubj
2	increased	increase	VBD	_	0	ROOT
3	the	the	DT	_	4	det
4	extent	extent	NN	_	2	dobj
5	of	of	IN	_	6	case
6	dissolution	dissolution	NN	_	4	nmod
7	of	of	IN	_	8	case
8	drug2	drug2	NN	_	6	nmod
9	in	in	IN	_	10	case
10	proportion	proportion	NN	_	2	nmod
11	to	to	TO	_	14	case
12	the	the	DT	_	14	det
13	added	add	VBN	_	14	amod
14	concentration	concentration	NN	_	10	nmod
15	,	,	,	_	14	punct
16	which	which	WDT	_	19	nsubjpass
17	was	be	VBD	_	19	auxpass
18	also	also	RB	_	19	advmod
19	verified	verify	VBN	_	14	acl:relcl
20	by	by	IN	_	23	case
21	equilibrium	equilibrium	NN	_	23	compound
22	solubilization	solubilization	NN	_	23	compound
23	studies	study	NNS	_	19	nmod
24	.	.	.	_	2	punct

1	drug1	drug1	NN	_	3	nsubj
2	also	also	RB	_	3	advmod
3	increased	increase	VBD	_	0	ROOT
4	rate	rate	NN	_	3	dobj
5	of	of	IN	_	6	case
6	dissolution	dissolution	NN	_	4	nmod
7	,	,	,	_	3	punct
8	in	in	IN	_	10	case
9	a	a	DT	_	10	det
10	manner	manner	NN	_	3	nmod
11	similar	similar	JJ	_	10	amod
12	to	to	TO	_	13	case
13	drug2	drug2	NN	_	11	nmod
14	.	.	.	_	3	punct

1	Analysis	analysis	NN	_	9	nsubj
2	of	of	IN	_	4	case
3	the	the	DT	_	4	det
4	concentration	concentration	NN	_	1	nmod
5	of	of	IN	_	6	case
6	drug1	drug1	NN	_	4	nmod
7	following	follow	VBG	_	8	case
8	ultracentrifugation	ultracentrifugation	NN	_	4	nmod
9	indicated	indicate	VBD	_	0	ROOT
10	that	that	IN	_	12	mark
11	there	there	EX	_	12	expl
12	is	be	VBZ	_	9	ccomp
13	rapid	rapid	JJ	_	14	amod
14	equilibration	equilibration	NN	_	12	nsubj
15	of	of	IN	_	16	case
16	drug2	drug2	NN	_	14	nmod
17	between	between	IN	_	22	case
18	the	the	DT	_	22	det
19	drug3	drug3	NN	_	22	amod
20	and	and	CC	_	19	cc
21	aqueous	aqueous	JJ	_	19	conj
22	phase	phase	NN	_	12	nmod
23	.	.	.	_	9	punct

1	These	these	DT	_	2	det
2	results	result	NNS	_	3	nsubj
3	show	show	VBP	_	0	ROOT
4	that	that	IN	_	6	mark
5	drug1	drug1	NN	_	6	nsubj
6	has	have	VBZ	_	3	ccomp
7	the	the	DT	_	8	det
8	potential	potential	NN	_	6	dobj
9	of	of	IN	_	10	mark
10	enhancing	enhance	VBG	_	8	acl
11	the	the	DT	_	12	det
12	rate	rate	NN	_	10	dobj
13	and	and	CC	_	12	cc
14	extent	extent	NN	_	12	conj
15	of	of	IN	_	16	case
16	dissolution	dissolution	NN	_	12	nmod
17	of	of	IN	_	18	case
18	drugs	drug	NNS	_	16	nmod
19	administered	administer	VBN	_	18	acl
20	to	to	TO	_	22	case
21	the	the	DT	_	22	det
22	lung	lung	NN	_	19	nmod
23	.	.	.	_	3	punct

1	Anaesthesia	Anaesthesia	NNP	_	0	ROOT
2	and	and	CC	_	1	cc
3	the	the	DT	_	5	det
4	epileptic	epileptic	JJ	_	5	amod
5	pateint	pateint	NN	_	1	conj
6	.	.	.	_	1	punct

1	A	a	DT	_	2	det
2	review	review	NN	_	0	ROOT
3	.	.	.	_	2	punct

1	A	a	DT	_	2	det
2	review	review	NN	_	4	nsubjpass
3	is	be	VBZ	_	4	auxpass
4	presented	present	VBN	_	0	ROOT
5	of	of	IN	_	6	case
6	some	some	DT	_	4	nmod
7	of	of	IN	_	9	case
8	the	the	DT	_	9	det
9	problems	problem	NNS	_	6	nmod
10	that	that	WDT	_	12	nsubj
11	may	may	MD	_	12	aux
12	arise	arise	VB	_	9	acl:relcl
13	in	in	IN	_	14	case
14	association	association	NN	_	12	nmod
15	with	with	IN	_	16	case
16	anaesthesia	anaesthesia	NN	_	14	nmod
17	for	for	IN	_	19	case
18	epileptic	epileptic	JJ	_	19	amod
19	patients	patient	NNS	_	14	nmod
20	.	.	.	_	4	punct

1	There	there	EX	_	2	expl
2	is	be	VBZ	_	0	ROOT
3	the	the	DT	_	4	det
4	possibility	possibility	NN	_	2	nsubj
5	of	of	IN	_	6	mark
6	precipitating	precipitate	VBG	_	4	acl
7	anticonvulsant	anticonvulsant	JJ	_	9	amod
8	drug	drug	NN	_	9	compound
9	toxicity	toxicity	NN	_	6	dobj
10	.	.	.	_	2	punct

1	Numerous	numerous	JJ	_	3	amod
2	drug	drug	NN	_	3	compound
3	interactions	interaction	NNS	_	5	nsubj
4	are	be	VBP	_	5	cop
5	possible	possible	JJ	_	0	ROOT
6	with	with	IN	_	8	case
7	some	some	DT	_	8	det
8	drug1	drug1	NN	_	5	nmod
9	,	,	,	_	8	punct
10	such	such	JJ	_	12	case
11	as	as	IN	_	10	mwe
12	drug2	drug2	NN	_	8	nmod
13	and	and	CC	_	12	cc
14	drug3	drug3	NN	_	12	conj
15	,	,	,	_	8	punct
16	which	which	WDT	_	17	nsubj
17	affect	affect	VBP	_	8	acl:relcl
18	hepatic	hepatic	JJ	_	21	amod
19	microsomal	microsomal	JJ	_	21	amod
20	enzyme	enzyme	NN	_	21	compound
21	systems	system	NNS	_	17	dobj
22	.	.	.	_	5	punct

1	There	there	EX	_	2	expl
2	is	be	VBZ	_	0	ROOT
3	the	the	DT	_	4	det
4	risk	risk	NN	_	2	nsubj
5	of	of	IN	_	6	case
6	convulsions	convulsion	NNS	_	4	nmod
7	occurring	occur	VBG	_	6	acl
8	in	in	IN	_	10	case
9	susceptible	susceptible	JJ	_	10	amod
10	patients	patient	NNS	_	7	nmod
11	following	follow	VBG	_	13	case
12	the	the	DT	_	13	det
13	use	use	NN	_	7	nmod
14	of	of	IN	_	17	case
15	the	the	DT	_	17	det
16	new	new	JJ	_	17	amod
17	drug1	drug1	NN	_	13	nmod
18	which	which	WDT	_	20	nsubj
19	are	be	VBP	_	20	cop
20	capable	capable	JJ	_	17	acl:relcl
21	of	of	IN	_	22	mark
22	inducing	induce	VBG	_	20	advcl
23	CNS	cns	NN	_	24	compound
24	excitability	excitability	NN	_	22	dobj
25	.	.	.	_	2	punct

1	Interaction	interaction	NN	_	0	ROOT
2	between	between	IN	_	3	case
3	drug1	drug1	NN	_	1	nmod
4	and	and	CC	_	3	cc
5	drug2	drug2	NN	_	3	conj
6	in	in	IN	_	8	case
7	the	the	DT	_	8	det
8	development	development	NN	_	1	nmod
9	of	of	IN	_	11	case
10	spontaneous	spontaneous	JJ	_	11	amod
11	motility	motility	NN	_	8	nmod
12	in	in	IN	_	14	case
13	chick	chick	NN	_	14	compound
14	embryos	embryo	NNS	_	11	nmod
15	.	.	.	_	1	punct

1	In	in	IN	_	3	case
2	this	this	DT	_	3	det
3	study	study	NN	_	5	nmod
4	we	we	PRP	_	5	nsubj
5	investigated	investigate	VBD	_	0	ROOT
6	whether	whether	IN	_	9	mark
7	also	also	RB	_	9	advmod
8	drug1	drug1	NN	_	9	nsubj
9	fulfils	fulfil	VBZ	_	5	ccomp
10	the	the	DT	_	11	det
11	function	function	NN	_	9	dobj
12	as	as	IN	_	13	case
13	co-activator	co-activator	NN	_	9	nmod
14	in	in	IN	_	16	case
15	glutamatergic	glutamatergic	JJ	_	16	amod
16	activation	activation	NN	_	9	nmod
17	of	of	IN	_	19	case
18	NMDA	nmda	NN	_	19	compound
19	receptors	receptor	NNS	_	16	nmod
20	in	in	IN	_	23	case
21	the	the	DT	_	23	det
22	neuronal	neuronal	JJ	_	23	amod
23	apparatus	apparatus	NN	_	16	nmod
24	of	of	IN	_	26	case
25	spontaneous	spontaneous	JJ	_	26	amod
26	motility	motility	NN	_	23	nmod
27	in	in	IN	_	29	case
28	chick	chick	NN	_	29	compound
29	embryos	embryo	NNS	_	26	nmod
30	.	.	.	_	5	punct

1	The	the	DT	_	3	det
2	successive	successive	JJ	_	3	amod
3	application	application	NN	_	0	ROOT
4	of	of	IN	_	5	case
5	drug1	drug1	NN	_	3	nmod
6	-LRB-	-lrb-	-LRB-	_	12	punct
7	5	5	CD	_	12	nummod
8	or	or	CC	_	7	cc
9	10	10	CD	_	7	conj
10	mg/kg	mg/kg	NN	_	12	compound
11	egg	egg	NN	_	12	compound
12	weight	weight	NN	_	5	dep
13	-LRB-	-lrb-	-LRB-	_	14	punct
14	e.w.	e.w.	NN	_	12	appos
15	-RRB-	-rrb-	-RRB-	_	14	punct

1	and	and	CC	_	0	ROOT
2	drug1	drug1	NN	_	1	dep
3	-LRB-	-lrb-	-LRB-	_	6	punct
4	15	15	CD	_	6	nummod
5	mg/kg	mg/kg	NN	_	6	compound
6	e.w.	e.w.	NN	_	2	appos
7	-RRB-	-rrb-	-RRB-	_	6	punct

1	The	the	DT	_	3	det
2	successive	successive	JJ	_	3	amod
3	application	application	NN	_	29	nsubj
4	of	of	IN	_	5	case
5	drug1	drug1	NN	_	29	nmod
6	-LRB-	-lrb-	-LRB-	_	12	punct
7	5	5	CD	_	12	nummod
8	or	or	CC	_	7	cc
9	10	10	CD	_	7	conj
10	mg/kg	mg/kg	NN	_	12	compound
11	egg	egg	NN	_	12	compound
12	weight	weight	NN	_	29	nsubj
13	-LRB-	-lrb-	-LRB-	_	14	punct
14	e.w.	e.w.	NN	_	12	appos
15	-RRB-	-rrb-	-RRB-	_	14	punct
16	and	and	CC	_	12	cc
17	drug2	drug2	NN	_	12	conj
18	-LRB-	-lrb-	-LRB-	_	21	punct
19	15	15	CD	_	21	nummod
20	mg/kg	mg/kg	NN	_	21	compound
21	e.w.	e.w.	NN	_	17	appos
22	-RRB-	-rrb-	-RRB-	_	21	punct
23	in	in	IN	_	27	case
24	a	a	DT	_	27	det
25	10	10	CD	_	26	compound
26	min	min	NN	_	27	amod
27	interval	interval	NN	_	12	nmod
28	significantly	significantly	RB	_	29	advmod
29	increased	increase	VBD	_	0	ROOT
30	the	the	DT	_	31	det
31	activation	activation	NN	_	29	dobj
32	of	of	IN	_	34	case
33	spontaneous	spontaneous	JJ	_	34	amod
34	motility	motility	NN	_	31	nmod
35	of	of	IN	_	38	case
36	17-day-old	17-day-old	JJ	_	38	amod
37	chick	chick	NN	_	38	compound
38	embryos	embryo	NNS	_	34	nmod
39	in	in	IN	_	40	case
40	comparison	comparison	NN	_	29	nmod
41	with	with	IN	_	43	case
42	the	the	DT	_	43	det
43	effect	effect	NN	_	40	nmod
44	of	of	IN	_	45	case
45	drug3	drug3	NN	_	43	nmod
46	alone	alone	RB	_	45	advmod
47	.	.	.	_	29	punct

1	This	this	DT	_	2	det
2	effect	effect	NN	_	5	nsubj
3	did	do	VBD	_	5	aux
4	not	not	RB	_	5	neg
5	depend	depend	VB	_	0	ROOT
6	on	on	IN	_	8	case
7	the	the	DT	_	8	det
8	order	order	NN	_	5	nmod
9	of	of	IN	_	10	case
10	application	application	NN	_	8	nmod
11	of	of	IN	_	13	case
12	the	the	DT	_	13	det
13	drugs	drug	NNS	_	10	nmod
14	.	.	.	_	5	punct

1	In	in	IN	_	3	case
2	13-day-old	13-day-old	JJ	_	3	amod
3	embryos	embryo	NNS	_	7	nmod
4	,	,	,	_	7	punct
5	drug1	drug1	NN	_	7	nsubj
6	was	be	VBD	_	7	cop
7	ineffective	ineffective	JJ	_	0	ROOT
8	in	in	IN	_	10	case
9	both	both	CC	_	10	det
10	doses	dose	NNS	_	7	nmod
11	.	.	.	_	7	punct

1	It	it	PRP	_	3	nsubjpass
2	is	be	VBZ	_	3	auxpass
3	concluded	conclude	VBN	_	0	ROOT
4	from	from	IN	_	6	case
5	these	these	DT	_	6	det
6	results	result	NNS	_	3	nmod
7	that	that	IN	_	18	mark
8	the	the	DT	_	10	det
9	modulatory	modulatory	JJ	_	10	amod
10	effect	effect	NN	_	18	nsubj
11	of	of	IN	_	12	case
12	drug1	drug1	NN	_	10	nmod
13	is	be	VBZ	_	18	cop
14	evidently	evidently	RB	_	18	advmod
15	a	a	DT	_	18	det
16	later	later	JJ	_	18	amod
17	developmental	developmental	JJ	_	18	amod
18	acquisition	acquisition	NN	_	3	ccomp
19	-LRB-	-lrb-	-LRB-	_	21	punct
20	after	after	IN	_	21	case
21	day	day	NN	_	18	nmod
22	15	15	CD	_	21	nummod
23	of	of	IN	_	24	case
24	incubation	incubation	NN	_	21	nmod
25	-RRB-	-rrb-	-RRB-	_	21	punct
26	in	in	IN	_	28	case
27	the	the	DT	_	28	det
28	embryogenesis	embryogenesis	NN	_	18	nmod
29	of	of	IN	_	31	case
30	NMDA-ergic	nmda-ergic	JJ	_	31	amod
31	activation	activation	NN	_	28	nmod
32	of	of	IN	_	34	case
33	spontaneous	spontaneous	JJ	_	34	amod
34	motility	motility	NN	_	31	nmod
35	in	in	IN	_	37	case
36	chick	chick	NN	_	37	compound
37	embryos	embryo	NNS	_	31	nmod
38	similarly	similarly	RB	_	41	advmod
39	as	as	IN	_	41	case
40	glycinergic	glycinergic	JJ	_	41	amod
41	inhibition	inhibition	NN	_	37	nmod
42	.	.	.	_	3	punct

1	Acute	acute	JJ	_	2	amod
2	effect	effect	NN	_	0	ROOT
3	of	of	IN	_	5	case
4	different	different	JJ	_	5	amod
5	drug1	drug1	NN	_	2	nmod
6	on	on	IN	_	7	case
7	glycemia	glycemia	NN	_	2	nmod
8	in	in	IN	_	12	case
9	diabetic	diabetic	JJ	_	12	amod
10	and	and	CC	_	9	cc
11	non-diabetic	non-diabetic	JJ	_	9	conj
12	rats	rat	NNS	_	2	nmod
13	.	.	.	_	2	punct

1	Diabetic	Diabetic	NNP	_	2	compound
2	patients	patient	NNS	_	3	nsubj
3	have	have	VBP	_	0	ROOT
4	a	a	DT	_	8	det
5	20	20	CD	_	6	compound
6	%	%	NN	_	7	nmod:npmod
7	higher	higher	JJR	_	8	amod
8	risk	risk	NN	_	3	dobj
9	of	of	IN	_	10	case
10	depression	depression	NN	_	8	nmod
11	than	than	IN	_	14	case
12	the	the	DT	_	14	det
13	general	general	JJ	_	14	amod
14	population	population	NN	_	8	nmod
15	.	.	.	_	3	punct

1	Treatment	treatment	NN	_	6	nsubj
2	with	with	IN	_	3	case
3	drug1	drug1	NN	_	1	nmod
4	can	can	MD	_	6	aux
5	directly	directly	RB	_	6	advmod
6	interfere	interfere	VB	_	0	ROOT
7	with	with	IN	_	10	case
8	blood	blood	NN	_	10	compound
9	glucose	glucose	NN	_	10	compound
10	levels	level	NNS	_	6	nmod
11	or	or	CC	_	6	cc
12	may	may	MD	_	13	aux
13	interact	interact	VB	_	6	conj
14	with	with	IN	_	15	case
15	drug2	drug2	NN	_	13	nmod
16	.	.	.	_	6	punct

1	The	the	DT	_	2	det
2	treatment	treatment	NN	_	9	nsubj
3	of	of	IN	_	4	case
4	depression	depression	NN	_	2	nmod
5	in	in	IN	_	7	case
6	diabetic	diabetic	JJ	_	7	amod
7	patients	patient	NNS	_	2	nmod
8	must	must	MD	_	9	aux
9	take	take	VB	_	0	ROOT
10	into	into	IN	_	12	case
11	account	account	NN	_	12	compound
12	variations	variation	NNS	_	9	nmod
13	of	of	IN	_	15	case
14	glycemic	glycemic	JJ	_	15	amod
15	levels	level	NNS	_	12	nmod
16	at	at	IN	_	18	case
17	different	different	JJ	_	18	amod
18	times	time	NNS	_	9	nmod
19	and	and	CC	_	9	cc
20	a	a	DT	_	21	det
21	comparison	comparison	NN	_	27	nsubj
22	of	of	IN	_	25	case
23	the	the	DT	_	25	det
24	available	available	JJ	_	25	amod
25	drug1	drug1	NN	_	21	nmod
26	is	be	VBZ	_	27	cop
27	important	important	JJ	_	9	conj
28	.	.	.	_	9	punct

1	In	in	IN	_	4	case
2	the	the	DT	_	4	det
3	present	present	JJ	_	4	amod
4	study	study	NN	_	6	nmod
5	we	we	PRP	_	6	nsubj
6	evaluated	evaluate	VBD	_	0	ROOT
7	the	the	DT	_	8	det
8	interference	interference	NN	_	6	dobj
9	of	of	IN	_	10	case
10	drug1	drug1	NN	_	8	nmod
11	with	with	IN	_	14	case
12	blood	blood	NN	_	14	compound
13	glucose	glucose	NN	_	14	compound
14	levels	level	NNS	_	8	nmod
15	of	of	IN	_	19	case
16	diabetic	diabetic	JJ	_	19	amod
17	and	and	CC	_	16	cc
18	non-diabetic	non-diabetic	JJ	_	16	conj
19	rats	rat	NNS	_	14	nmod
20	.	.	.	_	6	punct

1	In	in	IN	_	4	case
2	a	a	DT	_	4	det
3	first	first	JJ	_	4	amod
4	experiment	experiment	NN	_	11	nmod
5	,	,	,	_	11	punct
6	male	male	JJ	_	9	amod
7	adult	adult	JJ	_	9	amod
8	Wistar	Wistar	NNP	_	9	compound
9	rats	rat	NNS	_	11	nsubjpass
10	were	be	VBD	_	11	auxpass
11	fasted	fast	VBN	_	0	ROOT
12	for	for	IN	_	14	case
13	12	12	CD	_	14	nummod
14	h.	h.	NN	_	11	nmod

1	drug1	drug1	NN	_	32	nsubjpass
2	-LRB-	-lrb-	-LRB-	_	4	punct
3	5	5	CD	_	4	nummod
4	mg/kg	mg/kg	NN	_	1	appos
5	-RRB-	-rrb-	-RRB-	_	4	punct
6	,	,	,	_	1	punct
7	drug2	drug2	NN	_	1	conj
8	-LRB-	-lrb-	-LRB-	_	10	punct
9	30	30	CD	_	10	nummod
10	mg/kg	mg/kg	NN	_	7	appos
11	-RRB-	-rrb-	-RRB-	_	10	punct
12	,	,	,	_	1	punct
13	drug3	drug3	NN	_	1	conj
14	-LRB-	-lrb-	-LRB-	_	16	punct
15	0.25	0.25	CD	_	16	nummod
16	mg/kg	mg/kg	NN	_	13	appos
17	-RRB-	-rrb-	-RRB-	_	16	punct
18	,	,	,	_	1	punct
19	drug4	drug4	NN	_	24	compound
20	-LRB-	-lrb-	-LRB-	_	22	punct
21	20	20	CD	_	22	nummod
22	mg/kg	mg/kg	NN	_	19	appos
23	-RRB-	-rrb-	-RRB-	_	22	punct
24	drug5	drug5	NN	_	1	conj
25	-LRB-	-lrb-	-LRB-	_	27	punct
26	30	30	CD	_	27	nummod
27	mg/kg	mg/kg	NN	_	24	appos
28	-RRB-	-rrb-	-RRB-	_	27	punct
29	or	or	CC	_	1	cc
30	vehicle	vehicle	NN	_	1	conj
31	was	be	VBD	_	32	auxpass
32	administered	administer	VBN	_	0	ROOT
33	.	.	.	_	32	punct

1	After	after	IN	_	3	case
2	30	30	CD	_	3	nummod
3	min	min	NN	_	8	nmod
4	,	,	,	_	8	punct
5	fasting	fast	VBG	_	6	amod
6	glycemia	glycemia	NN	_	8	nsubjpass
7	was	be	VBD	_	8	auxpass
8	measured	measure	VBN	_	0	ROOT
9	.	.	.	_	8	punct

1	An	a	DT	_	4	det
2	oral	oral	JJ	_	4	amod
3	drug1	drug1	NN	_	4	compound
4	overload	overload	NN	_	15	nsubjpass
5	of	of	IN	_	7	case
6	1	1	CD	_	7	nummod
7	ml	ml	NN	_	4	nmod
8	of	of	IN	_	13	case
9	a	a	DT	_	13	det
10	50	50	CD	_	11	compound
11	%	%	NN	_	13	amod
12	drug2	drug2	NN	_	13	compound
13	solution	solution	NN	_	7	nmod
14	was	be	VBD	_	15	auxpass
15	given	give	VBN	_	22	csubjpass
16	to	to	TO	_	17	case
17	rats	rat	NNS	_	15	nmod
18	and	and	CC	_	17	cc
19	blood	blood	NN	_	20	compound
20	glucose	glucose	NN	_	17	conj
21	was	be	VBD	_	22	auxpass
22	determined	determine	VBN	_	0	ROOT
23	after	after	IN	_	24	case
24	30	30	CD	_	22	nmod
25	,	,	,	_	24	punct
26	60	60	CD	_	24	conj
27	and	and	CC	_	24	cc
28	90	90	CD	_	24	conj
29	min	min	NN	_	24	dep
30	.	.	.	_	22	punct

1	drug1	drug1	NN	_	6	nsubj
2	and	and	CC	_	1	cc
3	drug2	drug2	NN	_	1	conj
4	did	do	VBD	_	6	aux
5	not	not	RB	_	6	neg
6	change	change	VB	_	0	ROOT
7	fasting	fasting	NN	_	10	compound
8	or	or	CC	_	7	cc
9	overload	overload	NN	_	7	conj
10	glycemia	glycemia	NN	_	6	dobj
11	.	.	.	_	6	punct

1	drug1	drug1	NN	_	4	nsubj
2	and	and	CC	_	1	cc
3	drug2	drug2	NN	_	1	conj
4	increased	increase	VBD	_	0	ROOT
5	blood	blood	NN	_	6	compound
6	drug3	drug3	NN	_	4	dobj
7	at	at	IN	_	9	case
8	different	different	JJ	_	9	amod
9	times	time	NNS	_	4	nmod
10	after	after	IN	_	13	case
11	the	the	DT	_	13	det
12	glucose	glucose	NN	_	13	compound
13	overload	overload	NN	_	4	nmod
14	.	.	.	_	4	punct

1	drug1	drug1	NN	_	2	nsubj
2	neutralized	neutralize	VBD	_	0	ROOT
3	the	the	DT	_	4	det
4	increase	increase	NN	_	2	dobj
5	of	of	IN	_	6	case
6	glycemia	glycemia	NN	_	4	nmod
7	induced	induce	VBN	_	6	acl
8	by	by	IN	_	11	case
9	oral	oral	JJ	_	11	amod
10	drug2	drug2	NN	_	11	compound
11	overload	overload	NN	_	7	nmod
12	.	.	.	_	2	punct

1	In	in	IN	_	4	case
2	the	the	DT	_	4	det
3	second	second	JJ	_	4	amod
4	experiment	experiment	NN	_	12	nmod
5	,	,	,	_	12	punct
6	non-diabetic	non-diabetic	JJ	_	10	amod
7	and	and	CC	_	6	cc
8	streptozotocin-induced	streptozotocin-induced	JJ	_	6	conj
9	diabetic	diabetic	JJ	_	10	amod
10	rats	rat	NNS	_	12	nsubjpass
11	were	be	VBD	_	12	auxpass
12	fasted	fast	VBN	_	0	ROOT
13	,	,	,	_	12	punct
14	and	and	CC	_	12	cc
15	the	the	DT	_	17	det
16	same	same	JJ	_	17	amod
17	procedures	procedure	NNS	_	19	nsubjpass
18	were	be	VBD	_	19	auxpass
19	followed	follow	VBN	_	12	conj
20	for	for	IN	_	21	case
21	estimation	estimation	NN	_	19	nmod
22	of	of	IN	_	24	case
23	drug1	drug1	NN	_	24	compound
24	tolerance	tolerance	NN	_	21	nmod
25	30	30	CD	_	26	nummod
26	min	min	NN	_	24	nmod
27	after	after	IN	_	26	case
28	drug2	drug2	NN	_	29	compound
29	overload	overload	NN	_	26	dep
30	.	.	.	_	12	punct

1	Again	again	RB	_	4	advmod
2	,	,	,	_	4	punct
3	drug1	drug1	NN	_	4	nsubj
4	neutralized	neutralize	VBD	_	0	ROOT
5	the	the	DT	_	6	det
6	increase	increase	NN	_	4	dobj
7	in	in	IN	_	8	case
8	glycemia	glycemia	NN	_	6	nmod
9	after	after	IN	_	11	case
10	drug2	drug2	NN	_	11	compound
11	overload	overload	NN	_	6	nmod
12	both	both	CC	_	14	cc:preconj
13	in	in	IN	_	14	case
14	diabetic	diabetic	JJ	_	11	nmod
15	and	and	CC	_	14	cc
16	non-diabetic	non-diabetic	JJ	_	14	conj
17	rats	rat	NNS	_	14	dep
18	.	.	.	_	4	punct

1	These	these	DT	_	2	det
2	data	datum	NNS	_	3	nsubj
3	raise	raise	VBP	_	0	ROOT
4	the	the	DT	_	5	det
5	question	question	NN	_	3	dobj
6	of	of	IN	_	12	mark
7	whether	whether	IN	_	12	mark
8	drug1	drug1	NN	_	12	nsubj
9	is	be	VBZ	_	12	cop
10	the	the	DT	_	12	det
11	best	best	JJS	_	12	amod
12	choice	choice	NN	_	5	acl
13	for	for	IN	_	15	case
14	prolonged	prolonged	JJ	_	15	amod
15	use	use	NN	_	12	nmod
16	for	for	IN	_	18	case
17	diabetic	diabetic	JJ	_	18	amod
18	individuals	individual	NNS	_	15	nmod
19	,	,	,	_	12	punct
20	because	because	IN	_	24	case
21	of	of	IN	_	20	mwe
22	its	its	PRP$	_	24	nmod:poss
23	antihyperglycemic	antihyperglycemic	JJ	_	24	amod
24	effects	effect	NNS	_	12	nmod
25	.	.	.	_	3	punct

1	drug1	drug1	NN	_	4	nsubj
2	would	would	MD	_	4	aux
3	be	be	VB	_	4	cop
4	useful	useful	JJ	_	0	ROOT
5	in	in	IN	_	6	case
6	cases	case	NNS	_	4	nmod
7	with	with	IN	_	9	case
8	potential	potential	JJ	_	9	amod
9	risk	risk	NN	_	6	nmod
10	of	of	IN	_	11	case
11	hypoglycemia	hypoglycemia	NN	_	9	nmod
12	.	.	.	_	4	punct

1	drug1	drug1	NN	_	2	nsubj
2	promotes	promote	VBZ	_	0	ROOT
3	the	the	DT	_	4	det
4	translocation	translocation	NN	_	2	dobj
5	of	of	IN	_	7	case
6	phosphatidate	phosphatidate	NN	_	7	compound
7	phosphohydrolase	phosphohydrolase	NN	_	4	nmod
8	from	from	IN	_	10	case
9	the	the	DT	_	10	det
10	cytosol	cytosol	NN	_	4	nmod
11	to	to	TO	_	14	case
12	the	the	DT	_	14	det
13	microsomal	microsomal	JJ	_	14	amod
14	fraction	fraction	NN	_	4	nmod
15	of	of	IN	_	17	case
16	rat	rat	NN	_	17	compound
17	liver	liver	NN	_	14	nmod
18	and	and	CC	_	2	cc
19	it	it	PRP	_	20	nsubj
20	enhances	enhance	VBZ	_	2	conj
21	the	the	DT	_	22	det
22	effects	effect	NNS	_	20	dobj
23	of	of	IN	_	24	case
24	oleate	oleate	NN	_	22	nmod
25	in	in	IN	_	27	case
26	this	this	DT	_	27	det
27	respect	respect	NN	_	22	nmod
28	.	.	.	_	2	punct

1	drug1	drug1	NN	_	6	nsubj
2	-LRB-	-lrb-	-LRB-	_	4	punct
3	0.5-2	0.5-2	CD	_	4	nummod
4	mM	mm	NN	_	1	appos
5	-RRB-	-rrb-	-RRB-	_	4	punct
6	promoted	promote	VBD	_	0	ROOT
7	the	the	DT	_	8	det
8	translocation	translocation	NN	_	6	dobj
9	of	of	IN	_	11	case
10	phosphatidate	phosphatidate	NN	_	11	compound
11	phosphohydrolase	phosphohydrolase	NN	_	8	nmod
12	from	from	IN	_	14	case
13	the	the	DT	_	14	det
14	soluble	soluble	JJ	_	8	nmod
15	to	to	TO	_	18	case
16	the	the	DT	_	18	det
17	microsomal	microsomal	JJ	_	18	amod
18	fraction	fraction	NN	_	8	nmod
19	in	in	IN	_	22	case
20	a	a	DT	_	22	det
21	cell-free	cell-free	JJ	_	22	amod
22	system	system	NN	_	6	nmod
23	derived	derive	VBN	_	22	acl
24	from	from	IN	_	26	case
25	rat	rat	NN	_	26	compound
26	liver	liver	NN	_	23	nmod
27	.	.	.	_	6	punct

1	By	by	IN	_	2	case
2	contrast	contrast	NN	_	15	nmod
3	,	,	,	_	15	punct
4	drug1	drug1	NN	_	15	nsubj
5	-LRB-	-lrb-	-LRB-	_	7	punct
6	1	1	CD	_	7	nummod
7	mM	mm	NN	_	4	appos
8	-RRB-	-rrb-	-RRB-	_	7	punct
9	and	and	CC	_	4	cc
10	drug2	drug2	NN	_	4	conj
11	-LRB-	-lrb-	-LRB-	_	13	punct
12	1	1	CD	_	13	nummod
13	mM	mm	NN	_	10	appos
14	-RRB-	-rrb-	-RRB-	_	13	punct
15	had	have	VBD	_	0	ROOT
16	no	no	DT	_	18	neg
17	significant	significant	JJ	_	18	amod
18	effect	effect	NN	_	15	dobj
19	on	on	IN	_	21	case
20	the	the	DT	_	21	det
21	translocation	translocation	NN	_	15	nmod
22	when	when	WRB	_	23	advmod
23	added	add	VBN	_	15	advcl
24	alone	alone	RB	_	23	advmod
25	.	.	.	_	15	punct

1	drug1	drug1	NN	_	11	nsubj
2	,	,	,	_	1	punct
3	and	and	CC	_	1	cc
4	to	to	TO	_	7	case
5	a	a	DT	_	7	det
6	lesser	lesser	JJR	_	7	amod
7	extent	extent	NN	_	1	conj
8	,	,	,	_	7	punct
9	drug2	drug2	NN	_	7	appos
10	,	,	,	_	7	punct
11	enhanced	enhance	VBD	_	0	ROOT
12	the	the	DT	_	14	det
13	translocating	translocating	JJ	_	14	amod
14	action	action	NN	_	11	dobj
15	of	of	IN	_	16	case
16	oleate	oleate	NN	_	14	nmod
17	and	and	CC	_	11	cc
18	increased	increase	VBD	_	11	conj
19	its	its	PRP$	_	20	nmod:poss
20	effectiveness	effectiveness	NN	_	18	dobj
21	in	in	IN	_	22	mark
22	transferring	transfer	VBG	_	18	advcl
23	the	the	DT	_	24	det
24	phosphohydrolase	phosphohydrolase	NN	_	22	dobj
25	from	from	IN	_	27	case
26	the	the	DT	_	27	det
27	soluble	soluble	JJ	_	22	nmod
28	to	to	TO	_	31	case
29	the	the	DT	_	31	det
30	microsomal	microsomal	JJ	_	31	amod
31	fraction	fraction	NN	_	22	nmod
32	.	.	.	_	11	punct

1	It	it	PRP	_	3	nsubjpass
2	is	be	VBZ	_	3	auxpass
3	proposed	propose	VBN	_	0	ROOT
4	that	that	IN	_	7	mark
5	the	the	DT	_	6	det
6	phosphohydrolase	phosphohydrolase	NN	_	7	nsubj
7	becomes	become	VBZ	_	3	ccomp
8	metabolically	metabolically	RB	_	9	advmod
9	active	active	JJ	_	7	xcomp
10	when	when	WRB	_	12	advmod
11	it	it	PRP	_	12	nsubj
12	combines	combine	VBZ	_	7	advcl
13	with	with	IN	_	14	case
14	membranes	membrane	NNS	_	12	nmod
15	and	and	CC	_	12	cc
16	that	that	IN	_	19	mark
17	polyamines	polyamine	NNS	_	19	nsubj
18	might	might	MD	_	19	aux
19	help	help	VB	_	12	conj
20	to	to	TO	_	21	mark
21	regulate	regulate	VB	_	19	xcomp
22	this	this	DT	_	23	det
23	interaction	interaction	NN	_	21	dobj
24	.	.	.	_	3	punct

1	This	this	DT	_	3	nsubj
2	could	could	MD	_	3	aux
3	facilitate	facilitate	VB	_	0	ROOT
4	the	the	DT	_	5	det
5	action	action	NN	_	3	dobj
6	of	of	IN	_	8	case
7	fatty	fatty	JJ	_	8	amod
8	acids	acid	NNS	_	5	nmod
9	and	and	CC	_	3	cc
10	enable	enable	VBP	_	3	conj
11	cells	cell	NNS	_	10	dobj
12	to	to	TO	_	13	mark
13	increase	increase	VB	_	10	xcomp
14	their	they	PRP$	_	15	nmod:poss
15	capacity	capacity	NN	_	13	dobj
16	for	for	IN	_	18	case
17	triacylglycerol	triacylglycerol	NN	_	18	compound
18	synthesis	synthesis	NN	_	15	nmod
19	to	to	TO	_	20	mark
20	match	match	VB	_	13	advcl
21	an	a	DT	_	23	det
22	increased	increase	VBN	_	23	amod
23	availability	availability	NN	_	20	dobj
24	of	of	IN	_	26	case
25	fatty	fatty	JJ	_	26	amod
26	acids	acid	NNS	_	23	nmod
27	.	.	.	_	3	punct

1	The	the	DT	_	2	det
2	effects	effect	NNS	_	0	ROOT
3	of	of	IN	_	4	case
4	drug1	drug1	NN	_	2	nmod
5	and	and	CC	_	4	cc
6	of	of	IN	_	8	case
7	drug2	drug2	NN	_	8	compound
8	anesthesia	anesthesia	NN	_	4	conj
9	on	on	IN	_	11	case
10	drug3	drug3	NN	_	11	compound
11	tolerance	tolerance	NN	_	2	nmod
12	in	in	IN	_	13	case
13	dogs	dog	NNS	_	11	nmod
14	.	.	.	_	2	punct

1	In	in	IN	_	3	case
2	a	a	DT	_	3	det
3	comparison	comparison	NN	_	22	nmod
4	of	of	IN	_	6	case
5	drug1	drug1	NN	_	6	compound
6	tolerance	tolerance	NN	_	3	nmod
7	in	in	IN	_	8	case
8	dogs	dog	NNS	_	6	nmod
9	anesthetized	anesthetized	JJ	_	8	amod
10	with	with	IN	_	11	case
11	drug2	drug2	NN	_	9	nmod
12	,	,	,	_	11	punct
13	drug3	drug3	NN	_	11	conj
14	,	,	,	_	11	punct
15	or	or	CC	_	11	cc
16	drug4	drug4	NN	_	11	conj
17	,	,	,	_	22	punct
18	the	the	DT	_	19	det
19	dosage	dosage	NN	_	22	nsubj
20	of	of	IN	_	21	case
21	drug5	drug5	NN	_	19	nmod
22	needed	need	VBN	_	29	csubj
23	to	to	TO	_	24	mark
24	cause	cause	VB	_	22	xcomp
25	ventricular	ventricular	JJ	_	26	amod
26	tachycardia	tachycardia	NN	_	24	dobj
27	was	be	VBD	_	29	cop
28	significantly	significantly	RB	_	29	advmod
29	higher	higher	JJR	_	0	ROOT
30	,	,	,	_	29	punct
31	as	as	IN	_	34	mark
32	was	be	VBD	_	34	cop
33	the	the	DT	_	34	det
34	LD50	ld50	NN	_	29	advcl
35	of	of	IN	_	36	case
36	drug6	drug6	NN	_	34	nmod
37	,	,	,	_	29	punct
38	with	with	IN	_	39	case
39	drug7	drug7	NN	_	29	nmod
40	or	or	CC	_	39	cc
41	drug8	drug8	NN	_	39	conj
42	than	than	IN	_	44	case
43	with	with	IN	_	44	case
44	drug9	drug9	NN	_	39	nmod
45	.	.	.	_	29	punct

1	Ventricular	ventricular	JJ	_	2	amod
2	tachycardia	tachycardia	NN	_	8	nsubjpass
3	induced	induce	VBN	_	2	acl
4	by	by	IN	_	5	case
5	drug1	drug1	NN	_	3	nmod
6	was	be	VBD	_	8	auxpass
7	generally	generally	RB	_	8	advmod
8	converted	convert	VBN	_	0	ROOT
9	to	to	TO	_	11	case
10	sinus	sinus	NN	_	11	compound
11	rhythm	rhythm	NN	_	8	nmod
12	following	follow	VBG	_	13	case
13	administration	administration	NN	_	8	nmod
14	of	of	IN	_	15	case
15	drug2	drug2	NN	_	13	nmod
16	,	,	,	_	15	punct
17	drug3	drug3	NN	_	15	conj
18	,	,	,	_	15	punct
19	or	or	CC	_	15	cc
20	drug4	drug4	NN	_	15	conj
21	but	but	CC	_	13	cc
22	not	not	RB	_	24	neg
23	after	after	IN	_	24	case
24	administration	administration	NN	_	13	conj
25	of	of	IN	_	26	case
26	drug5	drug5	NN	_	24	nmod
27	alone	alone	RB	_	26	advmod
28	or	or	CC	_	24	cc
29	after	after	IN	_	30	case
30	drug6	drug6	NN	_	24	conj
31	.	.	.	_	8	punct

1	Excretion	excretion	NN	_	0	ROOT
2	of	of	IN	_	3	case
3	thioethers	thioether	NNS	_	1	nmod
4	in	in	IN	_	5	case
5	urine	urine	NN	_	1	nmod
6	after	after	IN	_	7	case
7	exposure	exposure	NN	_	1	nmod
8	to	to	TO	_	10	case
9	electrophilic	electrophilic	JJ	_	10	amod
10	chemicals	chemical	NNS	_	7	nmod
11	.	.	.	_	1	punct

1	Electrophilic	electrophilic	JJ	_	2	amod
2	agents	agent	NNS	_	16	nsubjpass
3	--	--	:	_	2	punct
4	a	a	DT	_	5	det
5	class	class	NN	_	2	dep
6	of	of	IN	_	7	case
7	chemicals	chemical	NNS	_	5	nmod
8	that	that	WDT	_	9	nsubj
9	includes	include	VBZ	_	5	acl:relcl
10	most	most	RBS	_	11	advmod
11	genotoxic	genotoxic	JJ	_	12	amod
12	compounds	compound	NNS	_	9	dobj
13	--	--	:	_	2	punct
14	can	can	MD	_	16	aux
15	be	be	VB	_	16	auxpass
16	inactivated	inactivate	VBN	_	0	ROOT
17	by	by	IN	_	18	case
18	reaction	reaction	NN	_	16	nmod
19	with	with	IN	_	20	case
20	glutathione	glutathione	NN	_	18	nmod
21	or	or	CC	_	20	cc
22	other	other	JJ	_	24	amod
23	SH-bearing	sh-bearing	JJ	_	24	amod
24	molecules	molecule	NNS	_	20	conj
25	.	.	.	_	16	punct

1	The	the	DT	_	2	det
2	conjugates	conjugate	NNS	_	4	nsubj
3	so	so	RB	_	4	advmod
4	formed	form	VBD	_	0	ROOT
5	often	often	RB	_	6	advmod
6	appear	appear	VB	_	4	ccomp
7	in	in	IN	_	9	case
8	the	the	DT	_	9	det
9	urine	urine	NN	_	6	nmod
10	as	as	IN	_	12	case
11	mercapturic	mercapturic	JJ	_	12	amod
12	acids	acid	NNS	_	6	nmod
13	or	or	CC	_	12	cc
14	other	other	JJ	_	16	amod
15	thioether	thioether	NN	_	16	compound
16	products	product	NNS	_	12	conj
17	.	.	.	_	4	punct

1	This	this	DT	_	2	det
2	paper	paper	NN	_	4	nsubj
3	critically	critically	RB	_	4	advmod
4	reviews	review	VBZ	_	0	ROOT
5	the	the	DT	_	6	det
6	suitability	suitability	NN	_	4	dobj
7	of	of	IN	_	11	case
8	the	the	DT	_	11	det
9	urinary	urinary	JJ	_	11	amod
10	thioether	thioether	NN	_	11	compound
11	assay	assay	NN	_	6	nmod
12	as	as	IN	_	14	case
13	a	a	DT	_	14	det
14	method	method	NN	_	4	nmod
15	for	for	IN	_	17	case
16	the	the	DT	_	17	det
17	detection	detection	NN	_	14	nmod
18	of	of	IN	_	19	case
19	exposure	exposure	NN	_	17	nmod
20	to	to	TO	_	22	case
21	electrophilic	electrophilic	JJ	_	22	amod
22	agents	agent	NNS	_	19	nmod
23	or	or	CC	_	22	cc
24	their	they	PRP$	_	25	nmod:poss
25	precursors	precursor	NNS	_	22	conj
26	.	.	.	_	4	punct

1	In	in	IN	_	2	case
2	practice	practice	NN	_	11	nmod
3	,	,	,	_	11	punct
4	the	the	DT	_	6	det
5	greatest	greatest	JJS	_	6	amod
6	value	value	NN	_	11	nsubj
7	of	of	IN	_	10	case
8	the	the	DT	_	10	det
9	thioether	thioether	NN	_	10	compound
10	assay	assay	NN	_	6	nmod
11	appears	appear	VBZ	_	0	ROOT
12	to	to	TO	_	13	mark
13	lie	lie	VB	_	11	xcomp
14	in	in	IN	_	17	case
15	its	its	PRP$	_	17	nmod:poss
16	signal	signal	NN	_	17	compound
17	function	function	NN	_	13	nmod
18	.	.	.	_	11	punct

1	This	this	DT	_	3	nsubjpass
2	is	be	VBZ	_	3	auxpass
3	demonstrated	demonstrate	VBN	_	0	ROOT
4	for	for	IN	_	6	case
5	cigarette	cigarette	NN	_	6	compound
6	smokers	smoker	NNS	_	3	nmod
7	and	and	CC	_	6	cc
8	industrial	industrial	JJ	_	9	amod
9	workers	worker	NNS	_	6	conj
10	involved	involve	VBN	_	6	acl
11	in	in	IN	_	14	case
12	chemical	chemical	NN	_	14	compound
13	waste	waste	NN	_	14	compound
14	incineration	incineration	NN	_	10	nmod
15	.	.	.	_	3	punct

1	Whenever	Whenever	NNP	_	2	nsubj
2	increased	increase	VBD	_	10	advcl
3	thioether	thioether	RB	_	4	advmod
4	excretion	excretion	NN	_	2	dobj
5	is	be	VBZ	_	6	auxpass
6	observed	observe	VBN	_	2	dep
7	,	,	,	_	10	punct
8	it	it	PRP	_	10	nsubj
9	is	be	VBZ	_	10	cop
10	likely	likely	JJ	_	0	ROOT
11	to	to	TO	_	15	mark
12	be	be	VB	_	15	cop
13	due	due	JJ	_	15	case
14	to	to	TO	_	13	mwe
15	exposure	exposure	NN	_	10	xcomp
16	to	to	TO	_	17	case
17	one	one	CD	_	15	nmod
18	or	or	CC	_	17	cc
19	more	more	JJR	_	17	conj
20	suspect	suspect	JJ	_	21	amod
21	compounds	compound	NNS	_	17	dep
22	.	.	.	_	10	punct

1	However	however	RB	_	0	ROOT
2	,	,	,	_	1	punct
3	when	when	WRB	_	2	root
4	the	the	DT	_	7	det
5	thioether	thioether	JJ	_	7	amod
6	concentration	concentration	NN	_	7	compound
7	ranges	range	NNS	_	3	dep
8	within	within	IN	_	10	case
9	the	the	DT	_	10	det
10	limits	limit	NNS	_	7	nmod
11	of	of	IN	_	14	case
12	the	the	DT	_	14	det
13	normal	normal	JJ	_	14	amod
14	value	value	NN	_	10	nmod
15	,	,	,	_	7	punct
16	one	one	CD	_	19	nsubj
17	must	must	MD	_	19	aux
18	not	not	RB	_	19	neg
19	conclude	conclude	VB	_	7	acl:relcl
20	that	that	IN	_	22	mark
21	there	there	EX	_	22	expl
22	is	be	VBZ	_	19	ccomp
23	no	no	DT	_	28	neg
24	,	,	,	_	23	punct
25	or	or	CC	_	23	cc
26	negligible	negligible	JJ	_	23	conj
27	,	,	,	_	28	punct
28	exposure	exposure	NN	_	22	nsubj
29	.	.	.	_	3	punct

1	More	more	RBR	_	2	advmod
2	specific	specific	JJ	_	3	amod
3	applications	application	NNS	_	12	nsubj
4	of	of	IN	_	6	case
5	the	the	DT	_	6	det
6	assay	assay	NN	_	3	nmod
7	of	of	IN	_	9	case
8	thio	thio	NN	_	9	compound
9	compounds	compound	NNS	_	6	nmod
10	in	in	IN	_	11	case
11	urine	urine	NN	_	6	nmod
12	allow	allow	VBP	_	0	ROOT
13	development	development	NN	_	12	dobj
14	of	of	IN	_	16	case
15	selective	selective	JJ	_	16	amod
16	methods	method	NNS	_	13	nmod
17	that	that	WDT	_	20	nsubj
18	may	may	MD	_	20	aux
19	be	be	VB	_	20	cop
20	useful	useful	JJ	_	16	acl:relcl
21	for	for	IN	_	23	case
22	biological	biological	JJ	_	23	amod
23	monitoring	monitoring	NN	_	20	nmod
24	.	.	.	_	12	punct

1	Rhabdomyolysis	Rhabdomyolysis	NNP	_	0	ROOT
2	secondary	secondary	JJ	_	1	amod
3	to	to	TO	_	6	case
4	a	a	DT	_	6	det
5	drug	drug	NN	_	6	compound
6	interaction	interaction	NN	_	2	nmod
7	between	between	IN	_	8	case
8	drug1	drug1	NN	_	6	nmod
9	and	and	CC	_	8	cc
10	drug2	drug2	NN	_	8	conj
11	.	.	.	_	1	punct

1	OBJECTIVE	objective	NN	_	0	ROOT
2	:	:	:	_	1	punct
3	To	to	TO	_	4	mark
4	report	report	VB	_	1	acl
5	a	a	DT	_	6	det
6	case	case	NN	_	4	dobj
7	of	of	IN	_	8	case
8	rhabdomyolysis	rhabdomyolysis	NN	_	6	nmod
9	resulting	result	VBG	_	8	acl
10	from	from	IN	_	12	case
11	concomitant	concomitant	JJ	_	12	amod
12	use	use	NN	_	9	nmod
13	of	of	IN	_	14	case
14	drug1	drug1	NN	_	12	nmod
15	and	and	CC	_	14	cc
16	drug2	drug2	NN	_	14	conj
17	.	.	.	_	1	punct

1	CASE	case	NN	_	2	compound
2	SUMMARY	summary	NN	_	0	ROOT
3	:	:	:	_	2	punct
4	A	a	DT	_	7	det
5	64-year-old	64-year-old	JJ	_	7	amod
6	African-American	african-american	JJ	_	7	amod
7	man	man	NN	_	9	nsubjpass
8	was	be	VBD	_	9	auxpass
9	admitted	admit	VBN	_	2	dep
10	to	to	TO	_	12	case
11	the	the	DT	_	12	det
12	hospital	hospital	NN	_	9	nmod
13	for	for	IN	_	14	mark
14	worsening	worsen	VBG	_	9	advcl
15	renal	renal	JJ	_	16	amod
16	failure	failure	NN	_	14	dobj
17	,	,	,	_	9	punct
18	elevated	elevated	JJ	_	20	amod
19	creatine	creatine	NN	_	20	compound
20	phosphokinase	phosphokinase	NN	_	9	xcomp
21	,	,	,	_	20	punct
22	diffuse	diffuse	JJ	_	24	amod
23	muscle	muscle	NN	_	24	compound
24	pain	pain	NN	_	20	conj
25	,	,	,	_	20	punct
26	and	and	CC	_	20	cc
27	severe	severe	JJ	_	29	amod
28	muscle	muscle	NN	_	29	compound
29	weakness	weakness	NN	_	20	conj
30	.	.	.	_	2	punct

1	About	about	IN	_	3	amod
2	three	three	CD	_	3	nummod
3	weeks	week	NNS	_	11	nmod:tmod
4	prior	prior	RB	_	3	advmod
5	to	to	TO	_	6	case
6	admission	admission	NN	_	4	nmod
7	,	,	,	_	11	punct
8	the	the	DT	_	9	det
9	patient	patient	NN	_	11	nsubjpass
10	was	be	VBD	_	11	auxpass
11	started	start	VBN	_	0	ROOT
12	on	on	IN	_	13	case
13	drug1	drug1	NN	_	11	nmod
14	for	for	IN	_	15	case
15	sinusitis	sinusitis	NN	_	13	nmod
16	.	.	.	_	11	punct

1	The	the	DT	_	2	det
2	patient	patient	NN	_	5	nsubj
3	had	have	VBD	_	5	aux
4	been	be	VBN	_	5	aux
5	receiving	receive	VBG	_	0	ROOT
6	drug1	drug1	NN	_	5	dobj
7	for	for	IN	_	10	case
8	approximately	approximately	RB	_	9	advmod
9	six	six	CD	_	10	nummod
10	months	month	NNS	_	5	nmod
11	.	.	.	_	5	punct

1	He	he	PRP	_	3	nsubjpass
2	was	be	VBD	_	3	auxpass
3	treated	treat	VBN	_	0	ROOT
4	aggressively	aggressively	RB	_	3	advmod
5	with	with	IN	_	7	case
6	intravenous	intravenous	JJ	_	7	amod
7	hydration	hydration	NN	_	3	nmod
8	,	,	,	_	7	punct
9	drug1	drug1	NN	_	7	conj
10	,	,	,	_	7	punct
11	and	and	CC	_	7	cc
12	hemodialysis	hemodialysis	NN	_	7	conj
13	.	.	.	_	3	punct

1	A	a	DT	_	3	det
2	muscle	muscle	NN	_	3	compound
3	biopsy	biopsy	NN	_	4	nsubj
4	revealed	reveal	VBD	_	0	ROOT
5	necrotizing	necrotizing	JJ	_	6	amod
6	myopathy	myopathy	NN	_	4	dobj
7	secondary	secondary	JJ	_	6	amod
8	to	to	TO	_	10	case
9	a	a	DT	_	10	det
10	toxin	toxin	NN	_	7	nmod
11	.	.	.	_	4	punct

1	The	the	DT	_	2	det
2	patient	patient	NN	_	3	nsubj
3	continued	continue	VBD	_	0	ROOT
4	to	to	TO	_	5	mark
5	receive	receive	VB	_	3	xcomp
6	intermittent	intermittent	JJ	_	7	amod
7	hemodialysis	hemodialysis	NN	_	5	dobj
8	until	until	IN	_	10	case
9	his	he	PRP$	_	10	nmod:poss
10	death	death	NN	_	5	nmod
11	from	from	IN	_	13	case
12	infectious	infectious	JJ	_	13	amod
13	complications	complication	NNS	_	10	nmod
14	that	that	WDT	_	15	nsubj
15	occurred	occur	VBD	_	13	acl:relcl
16	three	three	CD	_	17	nummod
17	months	month	NNS	_	15	nmod
18	after	after	IN	_	17	case
19	admission	admission	NN	_	17	dep
20	.	.	.	_	3	punct

1	There	there	EX	_	2	expl
2	were	be	VBD	_	0	ROOT
3	several	several	JJ	_	4	amod
4	factors	factor	NNS	_	2	nsubj
5	that	that	WDT	_	8	nsubj
6	could	could	MD	_	8	aux
7	have	have	VB	_	8	aux
8	increased	increase	VBN	_	4	acl:relcl
9	his	he	PRP$	_	10	nmod:poss
10	risk	risk	NN	_	8	dobj
11	for	for	IN	_	12	mark
12	developing	develop	VBG	_	10	acl
13	rhabdomyolysis	rhabdomyolysis	NN	_	12	dobj
14	,	,	,	_	13	punct
15	including	include	VBG	_	18	case
16	chronic	chronic	JJ	_	18	amod
17	renal	renal	JJ	_	18	amod
18	failure	failure	NN	_	13	nmod
19	.	.	.	_	2	punct

1	DISCUSSION	discussion	NN	_	0	ROOT
2	:	:	:	_	1	punct
3	drug1	drug1	NN	_	7	nsubj
4	is	be	VBZ	_	7	cop
5	a	a	DT	_	7	det
6	potent	potent	JJ	_	7	amod
7	inhibitor	inhibitor	NN	_	1	parataxis
8	of	of	IN	_	9	case
9	CYP3A4	cyp3a4	NN	_	7	nmod
10	,	,	,	_	7	punct
11	the	the	DT	_	13	det
12	major	major	JJ	_	13	amod
13	enzyme	enzyme	NN	_	7	appos
14	responsible	responsible	JJ	_	13	amod
15	for	for	IN	_	17	case
16	drug2	drug2	NN	_	17	compound
17	metabolism	metabolism	NN	_	14	nmod
18	.	.	.	_	1	punct

1	The	the	DT	_	3	det
2	concomitant	concomitant	JJ	_	3	amod
3	administration	administration	NN	_	10	nsubj
4	of	of	IN	_	5	case
5	drug1	drug1	NN	_	3	nmod
6	and	and	CC	_	5	cc
7	other	other	JJ	_	8	amod
8	drug2	drug2	NN	_	5	conj
9	have	have	VBP	_	10	aux
10	resulted	result	VBN	_	0	ROOT
11	in	in	IN	_	13	case
12	previous	previous	JJ	_	13	amod
13	reports	report	NNS	_	10	nmod
14	of	of	IN	_	15	case
15	rhabdomyolysis	rhabdomyolysis	NN	_	13	nmod
16	.	.	.	_	10	punct

1	Other	other	JJ	_	2	amod
2	factors	factor	NNS	_	4	nsubj
3	may	may	MD	_	4	aux
4	increase	increase	VB	_	0	ROOT
5	the	the	DT	_	6	det
6	risk	risk	NN	_	4	dobj
7	of	of	IN	_	10	case
8	this	this	DT	_	10	det
9	drug	drug	NN	_	10	compound
10	interaction	interaction	NN	_	6	nmod
11	,	,	,	_	6	punct
12	including	include	VBG	_	14	case
13	the	the	DT	_	14	det
14	administration	administration	NN	_	6	nmod
15	of	of	IN	_	17	case
16	other	other	JJ	_	17	amod
17	medications	medication	NNS	_	14	nmod
18	that	that	WDT	_	20	nsubjpass
19	are	be	VBP	_	20	auxpass
20	associated	associate	VBN	_	17	acl:relcl
21	with	with	IN	_	22	case
22	myopathy	myopathy	NN	_	20	nmod
23	,	,	,	_	6	punct
24	underlying	underlie	VBG	_	6	acl
25	renal	renal	JJ	_	26	amod
26	insufficiency	insufficiency	NN	_	24	dobj
27	,	,	,	_	4	punct
28	and	and	CC	_	4	cc
29	administration	administration	NN	_	4	conj
30	of	of	IN	_	32	case
31	high	high	JJ	_	32	amod
32	doses	dose	NNS	_	29	nmod
33	of	of	IN	_	34	case
34	drug1	drug1	NN	_	32	nmod
35	.	.	.	_	4	punct

1	CONCLUSIONS	conclusion	NNS	_	0	ROOT
2	:	:	:	_	1	punct
3	drug1	drug1	NN	_	4	nsubj
4	inhibit	inhibit	VBP	_	1	appos
5	the	the	DT	_	6	det
6	metabolism	metabolism	NN	_	4	dobj
7	of	of	IN	_	8	case
8	drug2	drug2	NN	_	6	nmod
9	that	that	WDT	_	11	nsubjpass
10	are	be	VBP	_	11	auxpass
11	metabolized	metabolize	VBN	_	8	acl:relcl
12	by	by	IN	_	13	case
13	CYP3A4	cyp3a4	NN	_	11	nmod
14	-LRB-	-lrb-	-LRB-	_	17	punct
15	i.e.	i.e.	FW	_	17	dep
16	,	,	,	_	17	punct
17	drug3	drug3	NN	_	13	dep
18	,	,	,	_	17	punct
19	drug4	drug4	NN	_	17	conj
20	,	,	,	_	17	punct
21	drug5	drug5	NN	_	17	conj
22	,	,	,	_	17	punct
23	drug6	drug6	NN	_	17	appos
24	-RRB-	-rrb-	-RRB-	_	17	punct
25	.	.	.	_	1	punct

1	This	this	DT	_	2	det
2	interaction	interaction	NN	_	4	nsubj
3	may	may	MD	_	4	aux
4	result	result	VB	_	0	ROOT
5	in	in	IN	_	6	case
6	myopathy	myopathy	NN	_	4	nmod
7	and	and	CC	_	6	cc
8	rhabdomyolysis	rhabdomyolysis	NN	_	6	conj
9	,	,	,	_	6	punct
10	particularly	particularly	RB	_	12	advmod
11	in	in	IN	_	12	case
12	patients	patient	NNS	_	6	nmod
13	with	with	IN	_	15	case
14	renal	renal	JJ	_	15	amod
15	insufficiency	insufficiency	NN	_	12	nmod
16	or	or	CC	_	15	cc
17	those	those	DT	_	15	conj
18	who	who	WP	_	21	nsubj
19	are	be	VBP	_	21	aux
20	concurrently	concurrently	RB	_	21	advmod
21	taking	take	VBG	_	17	acl:relcl
22	medications	medication	NNS	_	21	dobj
23	associated	associate	VBN	_	22	acl
24	with	with	IN	_	25	case
25	myopathy	myopathy	NN	_	23	nmod
26	.	.	.	_	4	punct

1	Optimal	optimal	JJ	_	2	amod
2	designs	design	NNS	_	0	ROOT
3	for	for	IN	_	12	case
4	the	the	DT	_	12	det
5	individual	individual	JJ	_	12	amod
6	and	and	CC	_	5	cc
7	joint	joint	JJ	_	5	conj
8	exposure	exposure	NN	_	12	compound
9	general	general	JJ	_	12	amod
10	logistic	logistic	JJ	_	12	amod
11	regression	regression	NN	_	12	compound
12	models	model	NNS	_	2	nmod
13	.	.	.	_	2	punct

1	Interest	interest	NN	_	7	nsubj
2	in	in	IN	_	3	mark
3	administering	administer	VBG	_	1	acl
4	compounds	compound	NNS	_	3	dobj
5	in	in	IN	_	6	case
6	combination	combination	NN	_	3	nmod
7	lies	lie	VBZ	_	0	ROOT
8	both	both	CC	_	10	cc:preconj
9	in	in	IN	_	10	mark
10	enhancing	enhance	VBG	_	7	dep
11	efficacious	efficacious	JJ	_	12	amod
12	effects	effect	NNS	_	10	dobj
13	and	and	CC	_	10	cc
14	in	in	IN	_	15	mark
15	limiting	limit	VBG	_	10	conj
16	adverse	adverse	JJ	_	17	amod
17	effects	effect	NNS	_	15	dobj
18	.	.	.	_	7	punct

1	Although	although	IN	_	6	mark
2	much	much	JJ	_	4	amod
3	statistical	statistical	JJ	_	4	amod
4	work	work	NN	_	6	nsubj
5	has	have	VBZ	_	6	aux
6	focused	focus	VBN	_	21	advcl
7	on	on	IN	_	8	mark
8	developing	develop	VBG	_	6	advcl
9	mathematical	mathematical	JJ	_	10	amod
10	functions	function	NNS	_	8	dobj
11	to	to	TO	_	12	mark
12	model	model	VB	_	10	acl
13	the	the	DT	_	16	det
14	joint	joint	JJ	_	16	amod
15	dose-response	dose-response	JJ	_	16	amod
16	curves	curve	NNS	_	12	dobj
17	,	,	,	_	21	punct
18	relatively	relatively	RB	_	19	advmod
19	little	little	JJ	_	20	amod
20	work	work	NN	_	21	nsubj
21	exists	exist	VBZ	_	0	ROOT
22	in	in	IN	_	23	case
23	regard	regard	NN	_	21	nmod
24	to	to	TO	_	25	mark
25	designing	design	VBG	_	23	acl
26	experiments	experiment	NNS	_	25	dobj
27	for	for	IN	_	28	mark
28	assessing	assess	VBG	_	26	acl
29	joint	joint	JJ	_	30	amod
30	action	action	NN	_	28	dobj
31	.	.	.	_	21	punct

1	A	a	DT	_	2	det
2	variety	variety	NN	_	18	nsubjpass
3	of	of	IN	_	6	case
4	parametric	parametric	JJ	_	6	amod
5	dose-response	dose-response	JJ	_	6	amod
6	models	model	NNS	_	2	nmod
7	based	base	VBN	_	2	acl
8	on	on	IN	_	15	case
9	either	either	CC	_	15	cc:preconj
10	the	the	DT	_	15	det
11	normal	normal	JJ	_	15	amod
12	or	or	CC	_	11	cc
13	logistic	logistic	JJ	_	11	conj
14	probability	probability	NN	_	15	compound
15	distribution	distribution	NN	_	7	nmod
16	have	have	VBP	_	18	aux
17	been	be	VBN	_	18	auxpass
18	proposed	propose	VBN	_	0	ROOT
19	in	in	IN	_	21	case
20	the	the	DT	_	21	det
21	literature	literature	NN	_	18	nmod
22	.	.	.	_	18	punct

1	These	these	DT	_	2	det
2	models	model	NNS	_	5	nsubj
3	are	be	VBP	_	5	cop
4	typically	typically	RB	_	5	advmod
5	nonlinear	nonlinear	JJ	_	0	ROOT
6	in	in	IN	_	8	case
7	the	the	DT	_	8	det
8	parameters	parameter	NNS	_	5	nmod
9	,	,	,	_	5	punct
10	and	and	CC	_	5	cc
11	as	as	IN	_	12	case
12	such	such	JJ	_	22	nmod
13	,	,	,	_	22	punct
14	a	a	DT	_	19	det
15	nonlinear	nonlinear	JJ	_	19	amod
16	weighted	weighted	JJ	_	19	amod
17	least	least	JJS	_	19	amod
18	squares	square	NNS	_	19	compound
19	approach	approach	NN	_	22	nsubjpass
20	can	can	MD	_	22	aux
21	be	be	VB	_	22	auxpass
22	employed	employ	VBN	_	5	conj
23	for	for	IN	_	25	case
24	the	the	DT	_	25	det
25	purpose	purpose	NN	_	22	nmod
26	of	of	IN	_	27	mark
27	designing	design	VBG	_	25	acl
28	experiments	experiment	NNS	_	27	dobj
29	.	.	.	_	5	punct

1	The	the	DT	_	2	det
2	approach	approach	NN	_	4	nsubj
3	is	be	VBZ	_	4	cop
4	applicable	applicable	JJ	_	0	ROOT
5	across	across	IN	_	8	case
6	a	a	DT	_	8	det
7	wide	wide	JJ	_	8	amod
8	variety	variety	NN	_	4	nmod
9	of	of	IN	_	10	case
10	settings	setting	NNS	_	8	nmod
11	commonly	commonly	RB	_	12	advmod
12	associated	associate	VBN	_	10	acl
13	with	with	IN	_	16	case
14	joint	joint	JJ	_	16	amod
15	action	action	NN	_	16	compound
16	data	datum	NNS	_	12	nmod
17	,	,	,	_	16	punct
18	including	include	VBG	_	22	case
19	continuous	continuous	JJ	_	22	amod
20	and	and	CC	_	19	cc
21	discrete	discrete	JJ	_	19	conj
22	responses	response	NNS	_	16	nmod
23	,	,	,	_	22	punct
24	alternative	alternative	JJ	_	26	amod
25	error	error	NN	_	26	compound
26	structures	structure	NNS	_	22	conj
27	,	,	,	_	22	punct
28	and	and	CC	_	22	cc
29	nonzero	nonzero	NN	_	31	compound
30	background	background	NN	_	31	compound
31	response	response	NN	_	22	conj
32	.	.	.	_	4	punct

1	Further	further	RB	_	6	advmod
2	,	,	,	_	6	punct
3	designs	design	NNS	_	6	nsubjpass
4	can	can	MD	_	6	aux
5	be	be	VB	_	6	auxpass
6	expressed	express	VBN	_	0	ROOT
7	in	in	IN	_	8	case
8	terms	term	NNS	_	6	nmod
9	of	of	IN	_	11	case
10	proportionate	proportionate	JJ	_	11	amod
11	responses	response	NNS	_	8	nmod
12	associated	associate	VBN	_	11	acl
13	with	with	IN	_	16	case
14	the	the	DT	_	16	det
15	individual	individual	JJ	_	16	amod
16	compounds	compound	NNS	_	12	nmod
17	rather	rather	RB	_	16	cc
18	than	than	IN	_	17	mwe
19	dose	dose	NN	_	20	compound
20	levels	level	NNS	_	16	conj
21	,	,	,	_	6	punct
22	thereby	thereby	RB	_	23	advmod
23	providing	provide	VBG	_	6	advcl
24	for	for	IN	_	25	case
25	results	result	NNS	_	23	nmod
26	that	that	WDT	_	28	nsubj
27	are	be	VBP	_	28	cop
28	applicable	applicable	JJ	_	25	acl:relcl
29	across	across	IN	_	30	case
30	compounds	compound	NNS	_	28	nmod
31	.	.	.	_	6	punct

1	As	as	IN	_	3	case
2	a	a	DT	_	3	det
3	precursor	precursor	NN	_	26	nmod
4	to	to	TO	_	6	case
5	this	this	DT	_	6	det
6	effort	effort	NN	_	3	nmod
7	,	,	,	_	26	punct
8	optimal	optimal	JJ	_	12	amod
9	and	and	CC	_	8	cc
10	minimal	minimal	JJ	_	8	conj
11	experimental	experimental	JJ	_	12	amod
12	designs	design	NNS	_	26	nsubjpass
13	for	for	IN	_	15	case
14	the	the	DT	_	15	det
15	case	case	NN	_	12	nmod
16	in	in	IN	_	17	case
17	which	which	WDT	_	22	nmod
18	a	a	DT	_	20	det
19	single	single	JJ	_	20	amod
20	compound	compound	NN	_	22	nsubjpass
21	is	be	VBZ	_	22	auxpass
22	administered	administer	VBN	_	15	acl:relcl
23	have	have	VBP	_	26	aux
24	also	also	RB	_	26	advmod
25	been	be	VBN	_	26	auxpass
26	developed	develop	VBN	_	0	ROOT
27	.	.	.	_	26	punct

1	Although	although	IN	_	11	mark
2	the	the	DT	_	4	det
3	proposed	propose	VBN	_	4	amod
4	methodology	methodology	NN	_	11	nsubjpass
5	for	for	IN	_	6	mark
6	deriving	derive	VBG	_	4	acl
7	experimental	experimental	JJ	_	8	amod
8	designs	design	NNS	_	6	dobj
9	can	can	MD	_	11	aux
10	be	be	VB	_	11	auxpass
11	applied	apply	VBN	_	21	advcl
12	to	to	TO	_	16	case
13	any	any	DT	_	16	det
14	nonlinear	nonlinear	JJ	_	16	amod
15	regression	regression	NN	_	16	compound
16	model	model	NN	_	11	nmod
17	,	,	,	_	21	punct
18	primary	primary	JJ	_	19	amod
19	focus	focus	NN	_	21	nsubjpass
20	is	be	VBZ	_	21	auxpass
21	given	give	VBN	_	0	ROOT
22	to	to	TO	_	29	case
23	the	the	DT	_	29	det
24	additive	additive	JJ	_	29	amod
25	and	and	CC	_	24	cc
26	nonadditive	nonadditive	JJ	_	24	conj
27	independent	independent	JJ	_	29	amod
28	joint	joint	JJ	_	29	amod
29	action	action	NN	_	21	nmod
30	-LRB-	-lrb-	-LRB-	_	31	punct
31	IJA	ija	NN	_	29	appos
32	-RRB-	-rrb-	-RRB-	_	31	punct
33	models	model	NNS	_	29	dep
34	for	for	IN	_	38	case
35	individual	individual	JJ	_	38	amod
36	and	and	CC	_	35	cc
37	combined	combined	JJ	_	35	conj
38	exposures	exposure	NNS	_	33	nmod
39	proposed	propose	VBN	_	38	acl
40	by	by	IN	_	41	case
41	Barton	Barton	NNP	_	39	nmod
42	,	,	,	_	41	punct
43	Braunberg	Braunberg	NNP	_	41	conj
44	,	,	,	_	41	punct
45	and	and	CC	_	41	cc
46	Friedman	Friedman	NNP	_	41	conj
47	-LRB-	-lrb-	-LRB-	_	48	punct
48	1	1	LS	_	46	appos
49	-RRB-	-rrb-	-RRB-	_	48	punct
50	.	.	.	_	21	punct

1	-LSB-	-lsb-	-LRB-	_	4	punct
2	The	the	DT	_	4	det
3	GABA-ergic	gaba-ergic	JJ	_	4	amod
4	system	system	NN	_	12	dep
5	and	and	CC	_	4	cc
6	brain	brain	NN	_	7	compound
7	edema	edema	NN	_	4	conj
8	-RSB-	-rsb-	-RRB-	_	4	punct
9	It	it	PRP	_	12	nsubjpass
10	has	have	VBZ	_	12	aux
11	been	be	VBN	_	12	auxpass
12	shown	show	VBN	_	0	ROOT
13	in	in	IN	_	14	case
14	rats	rat	NNS	_	12	nmod
15	with	with	IN	_	17	case
16	experimental	experimental	JJ	_	17	amod
17	toxic	toxic	JJ	_	14	nmod
18	and	and	CC	_	17	cc
19	traumatic	traumatic	JJ	_	17	conj
20	edemas	edema	NNS	_	17	dep
21	that	that	WDT	_	22	nsubj
22	drug1	drug1	VBP	_	17	acl:relcl
23	-LRB-	-lrb-	-LRB-	_	25	punct
24	1	1	CD	_	25	nummod
25	mg/kg	mg/kg	NN	_	22	dep
26	-RRB-	-rrb-	-RRB-	_	25	punct
27	removes	remove	VBZ	_	12	dep
28	the	the	DT	_	30	det
29	antiedematous	antiedematous	JJ	_	30	amod
30	action	action	NN	_	27	dobj
31	of	of	IN	_	32	case
32	drug2	drug2	NN	_	30	nmod
33	,	,	,	_	32	punct
34	drug3	drug3	NN	_	32	conj
35	,	,	,	_	32	punct
36	drug4	drug4	NN	_	32	conj
37	and	and	CC	_	32	cc
38	drug5	drug5	NN	_	32	conj
39	and	and	CC	_	27	cc
40	reduces	reduce	VBZ	_	27	conj
41	the	the	DT	_	42	det
42	action	action	NN	_	40	dobj
43	of	of	IN	_	44	case
44	drug6	drug6	NN	_	42	nmod
45	.	.	.	_	12	punct

1	When	when	WRB	_	7	advmod
2	the	the	DT	_	3	det
3	dose	dose	NN	_	7	nsubjpass
4	of	of	IN	_	5	case
5	drug1	drug1	NN	_	3	nmod
6	is	be	VBZ	_	7	auxpass
7	minimized	minimize	VBN	_	0	ROOT
8	to	to	TO	_	10	case
9	0.5	0.5	CD	_	10	nummod
10	mg/kg	mg/kg	NN	_	7	nmod
11	such	such	JJ	_	13	amod
12	an	a	DT	_	13	det
13	effect	effect	NN	_	16	nsubjpass
14	is	be	VBZ	_	16	auxpass
15	not	not	RB	_	16	neg
16	observed	observe	VBN	_	10	acl:relcl
17	.	.	.	_	7	punct

1	Prolonged	prolonged	JJ	_	3	amod
2	daily	daily	JJ	_	3	amod
3	administration	administration	NN	_	12	nsubj
4	of	of	IN	_	5	case
5	drug1	drug1	NN	_	3	nmod
6	in	in	IN	_	8	case
7	a	a	DT	_	8	det
8	dose	dose	NN	_	3	nmod
9	of	of	IN	_	11	case
10	1	1	CD	_	11	nummod
11	mg/kg	mg/kg	NN	_	8	nmod
12	results	result	VBZ	_	0	ROOT
13	in	in	IN	_	15	case
14	the	the	DT	_	15	det
15	development	development	NN	_	12	nmod
16	of	of	IN	_	18	case
17	brain	brain	NN	_	18	compound
18	edema	edema	NN	_	15	nmod
19	.	.	.	_	12	punct

1	It	it	PRP	_	3	nsubjpass
2	is	be	VBZ	_	3	auxpass
3	recommended	recommend	VBN	_	0	ROOT
4	that	that	IN	_	8	mark
5	GABA-positive	gaba-positive	JJ	_	6	amod
6	drugs	drug	NNS	_	8	nsubjpass
7	be	be	VB	_	8	auxpass
8	included	include	VBN	_	3	ccomp
9	into	into	IN	_	11	case
10	a	a	DT	_	11	det
11	complex	complex	NN	_	8	nmod
12	of	of	IN	_	14	case
13	treatment	treatment	NN	_	14	compound
14	measures	measure	NNS	_	11	nmod
15	for	for	IN	_	16	case
16	edema	edema	NN	_	14	nmod
17	.	.	.	_	3	punct

1	New	New	NNP	_	3	amod
2	oral	oral	JJ	_	3	amod
3	therapies	therapy	NNS	_	0	ROOT
4	for	for	IN	_	8	case
5	type	type	NN	_	8	compound
6	2	2	CD	_	8	nummod
7	diabetes	diabetes	NN	_	8	compound
8	mellitus	mellitus	NN	_	3	nmod
9	:	:	:	_	3	punct
10	The	the	DT	_	11	det
11	drug1	drug1	NN	_	3	dep
12	or	or	CC	_	11	cc
13	insulin	insulin	NN	_	14	compound
14	sensitizers	sensitizer	NNS	_	11	conj
15	.	.	.	_	3	punct

1	Type	type	NN	_	4	compound
2	2	2	CD	_	4	nummod
3	diabetes	diabetes	NN	_	4	compound
4	mellitus	mellitus	NN	_	8	nsubj
5	is	be	VBZ	_	8	cop
6	a	a	DT	_	8	det
7	growing	grow	VBG	_	8	amod
8	problem	problem	NN	_	0	ROOT
9	not	not	RB	_	10	neg
10	only	only	RB	_	14	cc:preconj
11	in	in	IN	_	14	case
12	the	the	DT	_	14	det
13	United	United	NNP	_	14	compound
14	States	States	NNPS	_	8	nmod
15	but	but	CC	_	14	cc
16	also	also	RB	_	19	advmod
17	across	across	IN	_	19	case
18	the	the	DT	_	19	det
19	world	world	NN	_	14	conj
20	.	.	.	_	8	punct

1	There	there	EX	_	2	expl
2	is	be	VBZ	_	0	ROOT
3	now	now	RB	_	2	advmod
4	strong	strong	JJ	_	5	amod
5	evidence	evidence	NN	_	2	nsubj
6	that	that	IN	_	14	mark
7	intensive	intensive	JJ	_	8	amod
8	control	control	NN	_	14	nsubj
9	of	of	IN	_	11	case
10	blood	blood	NN	_	11	compound
11	glucose	glucose	NN	_	8	nmod
12	can	can	MD	_	14	aux
13	significantly	significantly	RB	_	14	advmod
14	reduce	reduce	VB	_	5	ccomp
15	and	and	CC	_	14	cc
16	retard	retard	VB	_	14	conj
17	the	the	DT	_	19	det
18	microvascular	microvascular	JJ	_	19	amod
19	complications	complication	NNS	_	14	dobj
20	of	of	IN	_	21	case
21	retinopathy	retinopathy	NN	_	19	nmod
22	,	,	,	_	21	punct
23	nephropathy	nephropathy	NN	_	21	conj
24	,	,	,	_	21	punct
25	and	and	CC	_	21	cc
26	neuropathy	neuropathy	NN	_	21	conj
27	.	.	.	_	2	punct

1	Ultimately	ultimately	RB	_	2	advmod
2	however	however	RB	_	12	advmod
3	,	,	,	_	12	punct
4	up	up	IN	_	6	dep
5	to	to	TO	_	4	mwe
6	80	80	CD	_	7	nummod
7	%	%	NN	_	12	nsubj
8	of	of	IN	_	11	case
9	type	type	NN	_	11	compound
10	2	2	CD	_	11	nummod
11	diabetics	diabetic	NNS	_	7	nmod
12	die	die	VBP	_	0	ROOT
13	from	from	IN	_	16	case
14	macrovascular	macrovascular	JJ	_	16	amod
15	cardiovascular	cardiovascular	JJ	_	16	amod
16	disease	disease	NN	_	12	nmod
17	.	.	.	_	12	punct

1	This	this	DT	_	2	nsubj
2	increased	increase	VBD	_	9	csubjpass
3	incidence	incidence	NN	_	2	dobj
4	of	of	IN	_	6	case
5	atherosclerotic	atherosclerotic	JJ	_	6	amod
6	disease	disease	NN	_	3	nmod
7	is	be	VBZ	_	9	auxpass
8	intricately	intricately	RB	_	9	advmod
9	associated	associate	VBN	_	0	ROOT
10	with	with	IN	_	12	case
11	insulin	insulin	NN	_	12	compound
12	resistance	resistance	NN	_	9	nmod
13	,	,	,	_	12	punct
14	which	which	WDT	_	19	nsubj
15	is	be	VBZ	_	19	cop
16	a	a	DT	_	19	det
17	major	major	JJ	_	19	amod
18	pathophysiologic	pathophysiologic	JJ	_	19	amod
19	abnormality	abnormality	NN	_	12	acl:relcl
20	in	in	IN	_	23	case
21	type	type	NN	_	23	compound
22	2	2	CD	_	23	nummod
23	diabetes	diabetes	NN	_	19	nmod
24	.	.	.	_	9	punct

1	There	there	EX	_	2	expl
2	is	be	VBZ	_	0	ROOT
3	strong	strong	JJ	_	4	amod
4	evidence	evidence	NN	_	2	nsubj
5	that	that	IN	_	9	mark
6	insulin	insulin	NN	_	7	compound
7	resistance	resistance	NN	_	9	nsubjpass
8	is	be	VBZ	_	9	auxpass
9	involved	involve	VBN	_	4	ccomp
10	in	in	IN	_	12	case
11	the	the	DT	_	12	det
12	development	development	NN	_	9	nmod
13	of	of	IN	_	16	case
14	not	not	RB	_	15	neg
15	only	only	RB	_	16	cc:preconj
16	hyperglycemia	hyperglycemia	NN	_	12	nmod
17	,	,	,	_	2	punct
18	but	but	CC	_	2	cc
19	also	also	RB	_	2	advmod
20	dyslipidemia	dyslipidemia	NN	_	2	nsubj
21	,	,	,	_	20	punct
22	hypertension	hypertension	NN	_	20	conj
23	,	,	,	_	20	punct
24	hypercoagulation	hypercoagulation	NN	_	20	conj
25	,	,	,	_	20	punct
26	vasculopathy	vasculopathy	NN	_	20	conj
27	,	,	,	_	20	punct
28	and	and	CC	_	20	cc
29	ultimately	ultimately	RB	_	30	advmod
30	atherosclerotic	atherosclerotic	JJ	_	32	amod
31	cardiovascular	cardiovascular	JJ	_	32	amod
32	disease	disease	NN	_	20	conj
33	.	.	.	_	2	punct

1	This	this	DT	_	2	det
2	cluster	cluster	NN	_	8	nsubjpass
3	of	of	IN	_	5	case
4	metabolic	metabolic	JJ	_	5	amod
5	abnormalities	abnormality	NNS	_	2	nmod
6	has	have	VBZ	_	8	aux
7	been	be	VBN	_	8	auxpass
8	termed	term	VBN	_	0	ROOT
9	the	the	DT	_	11	det
10	insulin	insulin	NN	_	11	compound
11	resistance	resistance	NN	_	8	xcomp
12	or	or	CC	_	11	cc
13	cardiovascular	cardiovascular	JJ	_	15	amod
14	dysmetabolic	dysmetabolic	JJ	_	15	amod
15	syndrome	syndrome	NN	_	11	conj
16	.	.	.	_	8	punct

1	The	the	DT	_	2	det
2	drug1	drug1	NN	_	19	nsubj
3	-LRB-	-lrb-	-LRB-	_	4	punct
4	drug2	drug2	NN	_	2	dep
5	and	and	CC	_	4	cc
6	drug3	drug3	NN	_	4	conj
7	-RRB-	-rrb-	-RRB-	_	4	punct
8	,	,	,	_	2	punct
9	a	a	DT	_	11	det
10	new	new	JJ	_	11	amod
11	class	class	NN	_	2	appos
12	of	of	IN	_	14	case
13	oral	oral	JJ	_	14	amod
14	drug4	drug4	NN	_	11	nmod
15	,	,	,	_	2	punct
16	are	be	VBP	_	19	cop
17	``	``	``	_	19	punct
18	insulin	insulin	NN	_	19	compound
19	sensitizers	sensitizer	NNS	_	0	ROOT
20	''	''	''	_	19	punct

1	and	and	CC	_	2	cc
2	exert	exert	VB	_	0	ROOT
3	direct	direct	JJ	_	4	amod
4	effects	effect	NNS	_	2	dobj
5	on	on	IN	_	7	case
6	the	the	DT	_	7	det
7	mechanisms	mechanism	NNS	_	2	nmod
8	of	of	IN	_	10	case
9	insulin	insulin	NN	_	10	compound
10	resistance	resistance	NN	_	7	nmod
11	.	.	.	_	2	punct

1	These	these	DT	_	2	det
2	effects	effect	NNS	_	5	nsubj
3	not	not	RB	_	4	neg
4	only	only	RB	_	5	cc:preconj
5	improve	improve	VB	_	0	ROOT
6	insulin	insulin	NN	_	7	compound
7	sensitivity	sensitivity	NN	_	5	dobj
8	and	and	CC	_	7	cc
9	glycemic	glycemic	JJ	_	10	amod
10	control	control	NN	_	7	conj
11	with	with	IN	_	14	case
12	reduced	reduce	VBN	_	14	amod
13	insulin	insulin	NN	_	14	compound
14	requirements	requirement	NNS	_	7	nmod
15	,	,	,	_	5	punct
16	but	but	CC	_	5	cc
17	also	also	RB	_	18	advmod
18	have	have	VBP	_	5	conj
19	potentially	potentially	RB	_	20	advmod
20	favorable	favorable	JJ	_	21	amod
21	effects	effect	NNS	_	18	dobj
22	on	on	IN	_	24	case
23	other	other	JJ	_	24	amod
24	components	component	NNS	_	18	nmod
25	of	of	IN	_	29	case
26	the	the	DT	_	29	det
27	cardiovascular	cardiovascular	JJ	_	29	amod
28	dysmetabolic	dysmetabolic	JJ	_	29	amod
29	syndrome	syndrome	NN	_	24	nmod
30	.	.	.	_	5	punct

1	Long-term	long-term	JJ	_	2	amod
2	studies	study	NNS	_	4	nsubjpass
3	are	be	VBP	_	4	auxpass
4	needed	need	VBN	_	0	ROOT
5	to	to	TO	_	6	mark
6	determine	determine	VB	_	4	xcomp
7	whether	whether	IN	_	15	mark
8	the	the	DT	_	10	det
9	insulin-sensitizing	insulin-sensitizing	JJ	_	10	amod
10	effects	effect	NNS	_	15	nsubj
11	of	of	IN	_	13	case
12	the	the	DT	_	13	det
13	drug1	drug1	NN	_	10	nmod
14	can	can	MD	_	15	aux
15	prevent	prevent	VB	_	6	ccomp
16	or	or	CC	_	15	cc
17	delay	delay	VB	_	15	conj
18	premature	premature	JJ	_	21	amod
19	atherosclerotic	atherosclerotic	JJ	_	21	amod
20	cardiovascular	cardiovascular	JJ	_	21	amod
21	disease	disease	NN	_	15	dobj
22	,	,	,	_	21	punct
23	morbidity	morbidity	NN	_	21	conj
24	,	,	,	_	21	punct
25	and	and	CC	_	21	cc
26	death	death	NN	_	21	conj
27	.	.	.	_	4	punct

1	Effect	effect	NN	_	0	ROOT
2	of	of	IN	_	3	case
3	drug1	drug1	NN	_	1	nmod
4	on	on	IN	_	7	case
5	the	the	DT	_	7	det
6	apparent	apparent	JJ	_	7	amod
7	volume	volume	NN	_	1	nmod
8	of	of	IN	_	9	case
9	distribution	distribution	NN	_	7	nmod
10	and	and	CC	_	9	cc
11	elimination	elimination	NN	_	9	conj
12	of	of	IN	_	13	case
13	drug2	drug2	NN	_	9	nmod
14	.	.	.	_	1	punct

1	According	accord	VBG	_	5	case
2	to	to	TO	_	1	mwe
3	Gibaldi	Gibaldi	NNP	_	5	compound
4	et	et	FW	_	5	compound
5	al.	al.	FW	_	0	ROOT
6	.	.	.	_	5	punct

1	-LRB-	-lrb-	-LRB-	_	4	punct
2	1968	1968	CD	_	4	nummod
3	,	,	,	_	4	punct
4	1970	1970	CD	_	0	ROOT
5	-RRB-	-rrb-	-RRB-	_	4	punct
6	,	,	,	_	4	punct
7	the	the	DT	_	10	det
8	higher	higher	JJR	_	10	amod
9	serum	serum	NN	_	10	compound
10	concentrations	concentration	NNS	_	15	nsubj
11	of	of	IN	_	12	case
12	drug1	drug1	NN	_	10	nmod
13	and	and	CC	_	12	cc
14	drug2	drug2	NN	_	12	conj
15	reached	reach	VBD	_	4	acl:relcl
16	after	after	IN	_	21	mark
17	administration	administration	NN	_	21	nsubj
18	of	of	IN	_	19	case
19	drug3	drug3	NN	_	17	nmod
20	are	be	VBP	_	21	cop
21	due	due	JJ	_	15	advcl
22	not	not	RB	_	23	neg
23	only	only	RB	_	27	cc:preconj
24	to	to	TO	_	27	case
25	slower	slower	JJR	_	27	amod
26	renal	renal	JJ	_	27	amod
27	elimination	elimination	NN	_	21	nmod
28	but	but	CC	_	27	cc
29	also	also	RB	_	33	advmod
30	to	to	TO	_	33	case
31	an	a	DT	_	33	det
32	altered	altered	JJ	_	33	amod
33	distribution	distribution	NN	_	27	conj
34	in	in	IN	_	36	case
35	the	the	DT	_	36	det
36	body	body	NN	_	33	nmod
37	.	.	.	_	4	punct

1	To	to	TO	_	2	mark
2	determine	determine	VB	_	22	advcl
3	whether	whether	IN	_	5	mark
4	drug1	drug1	NN	_	5	nsubj
5	has	have	VBZ	_	2	ccomp
6	a	a	DT	_	8	det
7	direct	direct	JJ	_	8	amod
8	effect	effect	NN	_	5	dobj
9	on	on	IN	_	11	case
10	the	the	DT	_	11	det
11	distribution	distribution	NN	_	5	nmod
12	of	of	IN	_	13	case
13	drug2	drug2	NN	_	11	nmod
14	,	,	,	_	22	punct
15	the	the	DT	_	16	det
16	elimination	elimination	NN	_	22	nsubjpass
17	and	and	CC	_	16	cc
18	distribution	distribution	NN	_	16	conj
19	of	of	IN	_	20	case
20	drug3	drug3	NN	_	16	nmod
21	was	be	VBD	_	22	auxpass
22	studied	study	VBN	_	0	ROOT
23	in	in	IN	_	25	case
24	six	six	CD	_	25	nummod
25	patients	patient	NNS	_	22	nmod
26	,	,	,	_	25	punct
27	five	five	CD	_	25	appos
28	lacking	lack	VBG	_	27	acl
29	kidney	kidney	NN	_	30	compound
30	function	function	NN	_	28	dobj
31	and	and	CC	_	27	cc
32	one	one	CD	_	27	conj
33	with	with	IN	_	38	case
34	a	a	DT	_	38	det
35	partially	partially	RB	_	36	advmod
36	impaired	impaired	JJ	_	38	amod
37	renal	renal	JJ	_	38	amod
38	function	function	NN	_	32	nmod
39	,	,	,	_	25	punct
40	in	in	IN	_	42	case
41	the	the	DT	_	42	dep
42	presence	presence	NN	_	25	nmod
43	or	or	CC	_	42	cc
44	absence	absence	NN	_	42	conj
45	of	of	IN	_	46	case
46	drug4	drug4	NN	_	42	nmod
47	.	.	.	_	22	punct

1	No	no	DT	_	3	neg
2	significant	significant	JJ	_	3	amod
3	difference	difference	NN	_	5	nsubjpass
4	was	be	VBD	_	5	auxpass
5	found	find	VBN	_	0	ROOT
6	between	between	IN	_	9	case
7	the	the	DT	_	9	det
8	mean	mean	NN	_	9	compound
9	values	value	NNS	_	5	nmod
10	of	of	IN	_	12	case
11	the	the	DT	_	12	det
12	volume	volume	NN	_	9	nmod
13	of	of	IN	_	14	case
14	distribution	distribution	NN	_	12	nmod
15	of	of	IN	_	16	case
16	drug1	drug1	NN	_	14	nmod
17	with	with	IN	_	5	nmod
18	and	and	CC	_	17	dep
19	without	without	IN	_	20	case
20	drug2	drug2	NN	_	18	conj
21	-LRB-	-lrb-	-LRB-	_	25	punct
22	13.0	13.0	CD	_	25	nummod
23	and	and	CC	_	22	cc
24	12.6	12.6	CD	_	22	conj
25	liters	liter	NNS	_	20	dep
26	,	,	,	_	25	punct
27	respectively	respectively	RB	_	25	advmod
28	-RRB-	-rrb-	-RRB-	_	25	punct
29	.	.	.	_	5	punct

1	Thus	thus	RB	_	0	ROOT
2	,	,	,	_	1	punct
3	the	the	DT	_	4	det
4	hypothesis	hypothesis	NN	_	2	root
5	of	of	IN	_	6	case
6	Gibaldi	Gibaldi	NNP	_	4	nmod
7	et	et	FW	_	6	compound
8	al.	al.	FW	_	6	dep
9	.	.	.	_	4	punct

1	could	could	MD	_	4	aux
2	not	not	RB	_	4	neg
3	be	be	VB	_	4	auxpass
4	confirmed	confirm	VBN	_	0	ROOT
5	for	for	IN	_	6	case
6	drug1	drug1	NN	_	4	nmod
7	in	in	IN	_	8	case
8	patients	patient	NNS	_	6	nmod
9	lacking	lack	VBG	_	8	acl
10	kidney	kidney	NN	_	11	compound
11	function	function	NN	_	9	dobj
12	.	.	.	_	4	punct

1	In	in	IN	_	2	case
2	spite	spite	NN	_	19	nmod
3	of	of	IN	_	5	case
4	the	the	DT	_	5	det
5	absence	absence	NN	_	2	nmod
6	of	of	IN	_	8	case
7	kidney	kidney	NN	_	8	compound
8	function	function	NN	_	5	nmod
9	,	,	,	_	19	punct
10	the	the	DT	_	11	det
11	value	value	NN	_	19	nsubjpass
12	of	of	IN	_	16	case
13	the	the	DT	_	16	det
14	elimination	elimination	NN	_	16	compound
15	rate	rate	NN	_	16	compound
16	constant	constant	NN	_	11	nmod
17	was	be	VBD	_	19	auxpass
18	significantly	significantly	RB	_	19	advmod
19	decreased	decrease	VBN	_	0	ROOT
20	in	in	IN	_	24	case
21	the	the	DT	_	24	dep
22	presence	presence	NN	_	24	dep
23	of	of	IN	_	24	case
24	drug1	drug1	NN	_	19	nmod
25	-LRB-	-lrb-	-LRB-	_	31	punct
26	from	from	IN	_	27	case
27	0.326	0.326	CD	_	31	nmod
28	to	to	TO	_	29	dep
29	0.263	0.263	CD	_	31	nummod
30	/	/	:	_	31	punct
31	h	h	NN	_	24	dep
32	-RRB-	-rrb-	-RRB-	_	31	punct
33	.	.	.	_	19	punct

1	This	this	DT	_	4	nsubjpass
2	might	might	MD	_	4	aux
3	be	be	VB	_	4	auxpass
4	explained	explain	VBN	_	0	ROOT
5	by	by	IN	_	7	case
6	a	a	DT	_	7	det
7	blockade	blockade	NN	_	4	nmod
8	by	by	IN	_	9	case
9	drug1	drug1	NN	_	7	nmod
10	of	of	IN	_	12	case
11	the	the	DT	_	12	det
12	elimination	elimination	NN	_	9	nmod
13	of	of	IN	_	14	case
14	drug2	drug2	NN	_	12	nmod
15	by	by	IN	_	17	case
16	the	the	DT	_	17	det
17	liver	liver	NN	_	7	nmod
18	.	.	.	_	4	punct

1	Stereoselective	stereoselective	JJ	_	3	amod
2	behavioral	behavioral	JJ	_	3	amod
3	effects	effect	NNS	_	0	ROOT
4	of	of	IN	_	5	case
5	drug1	drug1	NN	_	3	nmod
6	in	in	IN	_	7	case
7	pigeons	pigeon	NNS	_	3	nmod
8	and	and	CC	_	7	cc
9	squirrel	squirrel	NN	_	10	compound
10	monkeys	monkey	NNS	_	7	conj
11	.	.	.	_	3	punct

1	The	the	DT	_	3	det
2	behavioral	behavioral	JJ	_	3	amod
3	effects	effect	NNS	_	13	nsubjpass
4	of	of	IN	_	6	case
5	the	the	DT	_	6	det
6	stereoisomers	stereoisomer	NNS	_	3	nmod
7	of	of	IN	_	8	case
8	drug1	drug1	NN	_	6	nmod
9	-LRB-	-lrb-	-LRB-	_	10	punct
10	drug2	drug2	NN	_	8	appos
11	-RRB-	-rrb-	-RRB-	_	10	punct
12	were	be	VBD	_	13	auxpass
13	compared	compare	VBN	_	0	ROOT
14	with	with	IN	_	15	case
15	those	those	DT	_	13	nmod
16	of	of	IN	_	17	case
17	drug3	drug3	NN	_	15	nmod
18	-LRB-	-lrb-	-LRB-	_	19	punct
19	drug4	drug4	NN	_	17	appos
20	-RRB-	-rrb-	-RRB-	_	19	punct
21	in	in	IN	_	22	case
22	pigeons	pigeon	NNS	_	17	nmod
23	and	and	CC	_	22	cc
24	squirrel	squirrel	NN	_	25	compound
25	monkeys	monkey	NNS	_	22	conj
26	responding	respond	VBG	_	15	acl
27	under	under	IN	_	31	case
28	a	a	DT	_	31	det
29	multiple	multiple	JJ	_	31	amod
30	fixed-interval	fixed-interval	JJ	_	31	amod
31	fixed-ratio	fixed-ratio	NN	_	26	nmod
32	-LRB-	-lrb-	-LRB-	_	34	punct
33	FI	fi	NN	_	34	compound
34	FR	fr	NN	_	31	appos
35	-RRB-	-rrb-	-RRB-	_	34	punct
36	schedule	schedule	NN	_	31	dep
37	of	of	IN	_	39	case
38	food	food	NN	_	39	compound
39	presentation	presentation	NN	_	36	nmod
40	.	.	.	_	13	punct

1	Intermediate	Intermediate	NNP	_	2	compound
2	doses	dose	NNS	_	7	nsubj
3	of	of	IN	_	4	case
4	drug1	drug1	NN	_	2	nmod
5	or	or	CC	_	4	cc
6	drug2	drug2	NN	_	4	conj
7	produced	produce	VBD	_	0	ROOT
8	transient	transient	JJ	_	9	amod
9	increases	increase	NNS	_	7	dobj
10	in	in	IN	_	11	case
11	FI	fi	NN	_	9	nmod
12	responding	respond	VBG	_	11	acl
13	in	in	IN	_	14	case
14	monkeys	monkey	NNS	_	12	nmod
15	and	and	CC	_	14	cc
16	sustained	sustained	JJ	_	17	amod
17	increases	increase	NNS	_	14	conj
18	in	in	IN	_	19	case
19	FI	fi	NN	_	12	nmod
20	responding	respond	VBG	_	19	acl
21	in	in	IN	_	22	case
22	pigeons	pigeon	NNS	_	20	nmod
23	;	;	:	_	7	punct

1	higher	higher	JJR	_	2	amod
2	doses	dose	NNS	_	3	nsubj
3	decreased	decrease	VBD	_	0	ROOT
4	FI	fi	NN	_	3	dobj
5	and	and	CC	_	4	cc
6	FR	fr	NN	_	4	conj
7	responding	respond	VBG	_	4	acl
8	in	in	IN	_	10	case
9	both	both	CC	_	10	det
10	species	species	NNS	_	7	nmod
11	.	.	.	_	3	punct

1	In	in	IN	_	2	case
2	contrast	contrast	NN	_	8	nmod
3	to	to	TO	_	5	case
4	its	its	PRP$	_	5	nmod:poss
5	enantiomer	enantiomer	NN	_	2	nmod
6	,	,	,	_	8	punct
7	drug1	drug1	NN	_	8	nsubj
8	failed	fail	VBD	_	0	ROOT
9	to	to	TO	_	10	mark
10	increase	increase	VB	_	8	xcomp
11	FI	fi	NN	_	10	dobj
12	responding	respond	VBG	_	11	acl
13	significantly	significantly	RB	_	12	advmod
14	in	in	IN	_	16	case
15	either	either	CC	_	16	det
16	species	species	NNS	_	12	nmod
17	;	;	:	_	8	punct

1	at	at	IN	_	3	case
2	high	high	JJ	_	3	amod
3	doses	dose	NNS	_	6	nmod
4	,	,	,	_	6	punct
5	drug1	drug1	NN	_	6	nsubj
6	decreased	decrease	VBD	_	0	ROOT
7	FI	fi	NN	_	6	dobj
8	and	and	CC	_	7	cc
9	FR	fr	NN	_	7	conj
10	responding	respond	VBG	_	7	dep
11	.	.	.	_	6	punct

1	In	in	IN	_	2	case
2	monkeys	monkey	NNS	_	10	nmod
3	,	,	,	_	10	punct
4	drug1	drug1	NN	_	10	nsubj
5	was	be	VBD	_	10	cop
6	about	about	IN	_	8	advmod
7	10	10	CD	_	8	compound
8	times	time	NNS	_	10	dep
9	more	more	RBR	_	8	advmod
10	potent	potent	JJ	_	0	ROOT
11	than	than	IN	_	12	case
12	drug2	drug2	NN	_	10	nmod
13	in	in	IN	_	14	mark
14	decreasing	decrease	VBG	_	10	advcl
15	responding	respond	VBG	_	14	xcomp
16	,	,	,	_	10	punct
17	whereas	whereas	IN	_	23	mark
18	in	in	IN	_	20	case
19	pigeons	pigeon	NNS	_	20	compound
20	drug3	drug3	NN	_	23	nmod
21	was	be	VBD	_	23	cop
22	about	about	IN	_	23	advmod
23	equipotent	equipotent	JJ	_	10	advcl
24	with	with	IN	_	25	case
25	drug4	drug4	NN	_	23	nmod
26	.	.	.	_	10	punct

1	In	in	IN	_	3	case
2	both	both	DT	_	3	det
3	species	species	NNS	_	11	nmod
4	,	,	,	_	11	punct
5	drug1	drug1	NN	_	11	nsubj
6	,	,	,	_	5	punct
7	but	but	CC	_	8	cc
8	not	not	RB	_	5	cc
9	drug2	drug2	NN	_	5	conj
10	,	,	,	_	5	punct
11	antagonized	antagonize	VBD	_	0	ROOT
12	the	the	DT	_	14	det
13	rate-decreasing	rate-decreasing	JJ	_	14	amod
14	effects	effect	NNS	_	11	dobj
15	of	of	IN	_	16	case
16	drug3	drug3	NN	_	14	nmod
17	on	on	IN	_	18	case
18	FI	fi	NN	_	14	nmod
19	and	and	CC	_	18	cc
20	FR	fr	NN	_	18	conj
21	responding	respond	VBG	_	18	acl
22	.	.	.	_	11	punct

1	In	in	IN	_	2	case
2	monkeys	monkey	NNS	_	16	nmod
3	,	,	,	_	16	punct
4	the	the	DT	_	5	det
5	effects	effect	NNS	_	16	nsubjpass
6	of	of	IN	_	7	case
7	drug1	drug1	NN	_	5	nmod
8	,	,	,	_	7	punct
9	but	but	CC	_	10	cc
10	not	not	RB	_	7	cc
11	drug2	drug2	NN	_	7	conj
12	or	or	CC	_	11	cc
13	drug3	drug3	NN	_	11	conj
14	,	,	,	_	7	punct
15	were	be	VBD	_	16	auxpass
16	antagonized	antagonize	VBN	_	0	ROOT
17	by	by	IN	_	18	case
18	drug4	drug4	NN	_	16	nmod
19	;	;	:	_	16	punct

1	the	the	DT	_	2	det
2	doses	dose	NNS	_	17	nsubj
3	of	of	IN	_	4	case
4	drug1	drug1	NN	_	2	nmod
5	required	require	VBN	_	2	acl
6	to	to	TO	_	7	mark
7	antagonize	antagonize	VB	_	5	xcomp
8	the	the	DT	_	9	det
9	effects	effect	NNS	_	7	dobj
10	of	of	IN	_	11	case
11	drug2	drug2	NN	_	9	nmod
12	were	be	VBD	_	17	cop
13	more	more	JJR	_	16	advmod
14	than	than	IN	_	13	mwe
15	100	100	CD	_	16	compound
16	times	time	NNS	_	17	nmod:npmod
17	higher	higher	JJR	_	0	ROOT
18	than	than	IN	_	19	case
19	those	those	DT	_	17	nmod
20	required	require	VBN	_	19	acl
21	to	to	TO	_	22	mark
22	antagonize	antagonize	VB	_	20	xcomp
23	the	the	DT	_	24	det
24	effects	effect	NNS	_	22	dobj
25	of	of	IN	_	26	case
26	drug3	drug3	NN	_	24	nmod
27	.	.	.	_	17	punct

1	In	in	IN	_	2	case
2	pigeons	pigeon	NNS	_	8	nmod
3	,	,	,	_	8	punct
4	drug1	drug1	NN	_	8	nsubj
5	did	do	VBD	_	8	aux
6	not	not	RB	_	8	neg
7	systematically	systematically	RB	_	8	advmod
8	alter	alter	VB	_	0	ROOT
9	the	the	DT	_	10	det
10	effects	effect	NNS	_	8	dobj
11	of	of	IN	_	12	case
12	drug2	drug2	NN	_	10	nmod
13	,	,	,	_	12	punct
14	drug3	drug3	NN	_	12	conj
15	or	or	CC	_	12	cc
16	drug4	drug4	NN	_	12	conj
17	.	.	.	_	8	punct

1	drug1	drug1	NN	_	2	nsubj
2	reduced	reduce	VBD	_	0	ROOT
3	or	or	CC	_	2	cc
4	eliminated	eliminate	VBD	_	2	conj
5	the	the	DT	_	6	det
6	increases	increase	NNS	_	2	dobj
7	in	in	IN	_	8	case
8	FI	fi	NN	_	6	nmod
9	responding	respond	VBG	_	8	acl
10	produced	produce	VBN	_	9	dobj
11	by	by	IN	_	13	case
12	intermediate	intermediate	JJ	_	13	amod
13	doses	dose	NNS	_	10	nmod
14	of	of	IN	_	16	case
15	either	either	CC	_	16	cc:preconj
16	drug2	drug2	NN	_	13	nmod
17	or	or	CC	_	16	cc
18	drug3	drug3	NN	_	16	conj
19	in	in	IN	_	20	case
20	pigeons	pigeon	NNS	_	13	nmod
21	,	,	,	_	2	punct
22	but	but	CC	_	2	cc
23	did	do	VBD	_	25	aux
24	not	not	RB	_	25	neg
25	antagonize	antagonize	VB	_	2	conj
26	the	the	DT	_	27	det
27	decreases	decrease	NNS	_	25	dobj
28	in	in	IN	_	29	case
29	FI	fi	NN	_	27	nmod
30	or	or	CC	_	29	cc
31	FR	fr	NN	_	29	conj
32	responding	respond	VBG	_	29	dep
33	produced	produce	VBN	_	32	acl
34	by	by	IN	_	36	case
35	high	high	JJ	_	36	amod
36	doses	dose	NNS	_	33	nmod
37	of	of	IN	_	38	case
38	PCP	pcp	NN	_	36	nmod
39	or	or	CC	_	36	cc
40	either	either	CC	_	41	cc:preconj
41	stereoisomer	stereoisomer	NN	_	36	conj
42	of	of	IN	_	43	case
43	drug4	drug4	NN	_	41	nmod
44	.	.	.	_	2	punct

1	The	the	DT	_	2	det
2	results	result	NNS	_	3	nsubj
3	demonstrate	demonstrate	VBP	_	0	ROOT
4	a	a	DT	_	6	det
5	high	high	JJ	_	6	amod
6	degree	degree	NN	_	3	dobj
7	of	of	IN	_	8	case
8	stereoselectivity	stereoselectivity	NN	_	6	nmod
9	in	in	IN	_	12	case
10	the	the	DT	_	12	det
11	behavioral	behavioral	JJ	_	12	amod
12	effects	effect	NNS	_	6	nmod
13	of	of	IN	_	14	case
14	drug1	drug1	NN	_	12	nmod
15	.	.	.	_	3	punct

1	The	the	DT	_	3	det
2	levorotatory	levorotatory	JJ	_	3	amod
3	isomer	isomer	NN	_	4	nsubj
4	had	have	VBD	_	0	ROOT
5	opioid-antagonist	opioid-antagonist	JJ	_	9	amod
6	and	and	CC	_	5	cc
7	non-opioid	non-opioid	JJ	_	5	conj
8	agonist	agonist	NN	_	9	compound
9	effects	effect	NNS	_	4	dobj
10	in	in	IN	_	11	case
11	pigeons	pigeon	NNS	_	4	nmod
12	and	and	CC	_	11	cc
13	mixed	mixed	JJ	_	16	amod
14	opioid	opioid	JJ	_	16	amod
15	agonist-antagonist	agonist-antagonist	JJ	_	16	amod
16	effects	effect	NNS	_	11	conj
17	in	in	IN	_	18	case
18	monkeys	monkey	NNS	_	11	nmod
19	.	.	.	_	4	punct

1	The	the	DT	_	3	det
2	dextrorotatory	dextrorotatory	JJ	_	3	amod
3	isomer	isomer	NN	_	10	nsubj
4	,	,	,	_	10	punct
5	on	on	IN	_	8	case
6	the	the	DT	_	8	det
7	other	other	JJ	_	8	amod
8	hand	hand	NN	_	10	nmod
9	,	,	,	_	10	punct
10	had	have	VBD	_	0	ROOT
11	effects	effect	NNS	_	10	dobj
12	similar	similar	JJ	_	11	amod
13	to	to	TO	_	14	case
14	those	those	DT	_	12	nmod
15	of	of	IN	_	16	case
16	drug1	drug1	NN	_	14	nmod
17	in	in	IN	_	19	case
18	both	both	CC	_	19	det
19	species	species	NNS	_	14	nmod
20	.	.	.	_	10	punct

1	Cancer	cancer	NN	_	0	ROOT
2	in	in	IN	_	4	case
3	the	the	DT	_	4	det
4	elderly	elderly	JJ	_	1	nmod
5	:	:	:	_	1	punct
6	basic	basic	JJ	_	7	amod
7	science	science	NN	_	1	dep
8	and	and	CC	_	7	cc
9	clinical	clinical	JJ	_	10	amod
10	aspects	aspect	NNS	_	7	conj
11	.	.	.	_	1	punct

1	The	the	DT	_	2	det
2	incidence	incidence	NN	_	5	nsubj
3	of	of	IN	_	4	case
4	cancer	cancer	NN	_	2	nmod
5	increases	increase	VBZ	_	0	ROOT
6	progressively	progressively	RB	_	5	advmod
7	with	with	IN	_	8	case
8	age	age	NN	_	5	nmod
9	.	.	.	_	5	punct

1	Rearrangements	rearrangement	NNS	_	6	nsubjpass
2	of	of	IN	_	3	case
3	genomes	genome	NNS	_	1	nmod
4	have	have	VBP	_	6	aux
5	been	be	VBN	_	6	auxpass
6	found	find	VBN	_	0	ROOT
7	to	to	TO	_	8	mark
8	accompany	accompany	VB	_	6	xcomp
9	cellular	cellular	JJ	_	10	amod
10	aging	aging	NN	_	8	dobj
11	.	.	.	_	6	punct

1	These	these	DT	_	2	det
2	factors	factor	NNS	_	17	nsubj
3	,	,	,	_	17	punct
4	in	in	IN	_	8	case
5	concert	concert	NN	_	8	dep
6	with	with	IN	_	8	case
7	age-dependent	age-dependent	JJ	_	8	amod
8	alterations	alteration	NNS	_	17	nmod
9	in	in	IN	_	11	case
10	immune	immune	JJ	_	11	amod
11	function	function	NN	_	8	nmod
12	and	and	CC	_	11	cc
13	host	host	NN	_	14	compound
14	defense	defense	NN	_	11	conj
15	,	,	,	_	17	punct
16	may	may	MD	_	17	aux
17	help	help	VB	_	0	ROOT
18	to	to	TO	_	19	mark
19	explain	explain	VB	_	17	xcomp
20	the	the	DT	_	22	det
21	increased	increase	VBN	_	22	amod
22	risk	risk	NN	_	19	dobj
23	of	of	IN	_	25	case
24	malignant	malignant	JJ	_	25	amod
25	disease	disease	NN	_	22	nmod
26	in	in	IN	_	28	case
27	aged	aged	JJ	_	28	amod
28	persons	person	NNS	_	22	nmod
29	.	.	.	_	17	punct

1	The	the	DT	_	3	det
2	clinical	clinical	JJ	_	3	amod
3	presentation	presentation	NN	_	11	nsubjpass
4	and	and	CC	_	3	cc
5	natural	natural	JJ	_	6	amod
6	history	history	NN	_	3	conj
7	of	of	IN	_	8	case
8	neoplasia	neoplasia	NN	_	3	nmod
9	are	be	VBP	_	11	auxpass
10	also	also	RB	_	11	advmod
11	affected	affect	VBN	_	0	ROOT
12	by	by	IN	_	13	case
13	aging	aging	NN	_	11	nmod
14	.	.	.	_	11	punct

1	This	this	DT	_	2	det
2	conference	conference	NN	_	3	nsubj
3	reviews	review	VBZ	_	0	ROOT
4	recent	recent	JJ	_	5	amod
5	developments	development	NNS	_	3	dobj
6	in	in	IN	_	8	case
7	these	these	DT	_	8	det
8	areas	area	NNS	_	5	nmod
9	,	,	,	_	3	punct
10	examines	examine	VBZ	_	3	conj
11	the	the	DT	_	12	det
12	effects	effect	NNS	_	10	dobj
13	of	of	IN	_	15	case
14	drug	drug	NN	_	15	compound
15	use	use	NN	_	12	nmod
16	in	in	IN	_	18	case
17	the	the	DT	_	18	det
18	elderly	elderly	JJ	_	12	nmod
19	and	and	CC	_	18	cc
20	implications	implication	NNS	_	18	conj
21	for	for	IN	_	22	case
22	management	management	NN	_	12	nmod
23	,	,	,	_	3	punct
24	and	and	CC	_	3	cc
25	discusses	discuss	VBZ	_	3	conj
26	current	current	JJ	_	27	amod
27	information	information	NN	_	25	dobj
28	on	on	IN	_	32	mark
29	how	how	WRB	_	32	advmod
30	age	age	NN	_	32	nsubj
31	may	may	MD	_	32	aux
32	influence	influence	VB	_	25	advcl
33	the	the	DT	_	34	det
34	response	response	NN	_	32	dobj
35	of	of	IN	_	36	case
36	cancer	cancer	NN	_	34	nmod
37	to	to	TO	_	38	case
38	therapy	therapy	NN	_	34	nmod
39	.	.	.	_	3	punct

1	Prescribing	prescribe	VBG	_	0	ROOT
2	.	.	.	_	1	punct

1	Keys	Keys	NNP	_	0	ROOT
2	to	to	TO	_	3	mark
3	maximizing	maximize	VBG	_	1	acl
4	benefit	benefit	NN	_	3	dobj
5	while	while	IN	_	6	mark
6	avoiding	avoid	VBG	_	1	advcl
7	adverse	adverse	JJ	_	9	amod
8	drug	drug	NN	_	9	compound
9	effects	effect	NNS	_	6	dobj
10	.	.	.	_	1	punct

1	When	when	WRB	_	2	advmod
2	prescribing	prescribe	VBG	_	11	advcl
3	for	for	IN	_	5	case
4	older	older	JJR	_	5	amod
5	patients	patient	NNS	_	2	nmod
6	,	,	,	_	11	punct
7	some	some	DT	_	8	det
8	physicians	physician	NNS	_	11	nsubj
9	are	be	VBP	_	11	cop
10	overly	overly	RB	_	11	advmod
11	cautious	cautious	JJ	_	0	ROOT
12	,	,	,	_	11	punct
13	and	and	CC	_	11	cc
14	this	this	DT	_	15	det
15	strategy	strategy	NN	_	17	nsubj
16	can	can	MD	_	17	aux
17	result	result	VB	_	11	conj
18	in	in	IN	_	17	nmod
19	a	a	DT	_	18	dep
20	less	less	JJR	_	19	amod
21	than	than	IN	_	24	case
22	optimal	optimal	JJ	_	24	amod
23	treatment	treatment	NN	_	24	compound
24	outcome	outcome	NN	_	20	nmod
25	.	.	.	_	11	punct

1	The	the	DT	_	2	det
2	reluctance	reluctance	NN	_	7	nsubj
3	to	to	TO	_	4	mark
4	treat	treat	VB	_	2	acl
5	aggressively	aggressively	RB	_	4	advmod
6	is	be	VBZ	_	7	cop
7	understandable	understandable	JJ	_	0	ROOT
8	because	because	IN	_	13	mark
9	the	the	DT	_	11	det
10	geriatric	geriatric	JJ	_	11	amod
11	population	population	NN	_	13	nsubj
12	is	be	VBZ	_	13	cop
13	susceptible	susceptible	JJ	_	7	advcl
14	to	to	TO	_	17	case
15	adverse	adverse	JJ	_	17	amod
16	drug	drug	NN	_	17	compound
17	reactions	reaction	NNS	_	13	nmod
18	.	.	.	_	7	punct

1	The	the	DT	_	2	det
2	key	key	NN	_	6	nsubj
3	to	to	TO	_	4	mark
4	maximizing	maximize	VBG	_	2	acl
5	therapy	therapy	NN	_	4	dobj
6	lies	lie	VBZ	_	0	ROOT
7	in	in	IN	_	8	mark
8	individualizing	individualize	VBG	_	6	advcl
9	it	it	PRP	_	8	dobj
10	as	as	RB	_	11	advmod
11	much	much	RB	_	8	advmod
12	as	as	IN	_	13	case
13	possible	possible	JJ	_	11	advcl
14	.	.	.	_	6	punct

1	There	there	EX	_	2	expl
2	are	be	VBP	_	0	ROOT
3	a	a	DT	_	4	det
4	number	number	NN	_	9	nsubj
5	of	of	IN	_	7	case
6	steps	step	NNS	_	7	compound
7	physicians	physician	NNS	_	4	nmod
8	can	can	MD	_	9	aux
9	take	take	VB	_	2	ccomp
10	to	to	TO	_	11	mark
11	ensure	ensure	VB	_	9	xcomp
12	that	that	IN	_	18	mark
13	their	they	PRP$	_	14	nmod:poss
14	patients	patient	NNS	_	18	nsubj
15	are	be	VBP	_	18	aux
16	not	not	RB	_	18	neg
17	being	be	VBG	_	18	cop
18	undertreated	undertreated	JJ	_	11	ccomp
19	.	.	.	_	2	punct

1	These	these	DT	_	2	det
2	steps	step	NNS	_	3	nsubj
3	include	include	VBP	_	0	ROOT
4	regular	regular	JJ	_	5	amod
5	reevaluations	reevaluation	NNS	_	3	dobj
6	of	of	IN	_	7	case
7	dosages	dosage	NNS	_	5	nmod
8	and	and	CC	_	7	cc
9	plasma	plasma	NN	_	11	compound
10	drug	drug	NN	_	11	compound
11	concentrations	concentration	NNS	_	7	conj
12	,	,	,	_	7	punct
13	recognition	recognition	NN	_	7	conj
14	and	and	CC	_	7	cc
15	understanding	understanding	NN	_	7	conj
16	of	of	IN	_	19	case
17	drug	drug	NN	_	19	compound
18	side	side	NN	_	19	compound
19	effects	effect	NNS	_	15	nmod
20	,	,	,	_	5	punct
21	and	and	CC	_	5	cc
22	avoidance	avoidance	NN	_	5	conj
23	of	of	IN	_	25	case
24	certain	certain	JJ	_	25	amod
25	agents	agent	NNS	_	22	nmod
26	.	.	.	_	3	punct

1	Close	close	JJ	_	2	amod
2	monitoring	monitoring	NN	_	3	nsubj
3	allows	allow	VBZ	_	0	ROOT
4	physicians	physician	NNS	_	3	dobj
5	to	to	TO	_	6	mark
6	minimize	minimize	VB	_	3	xcomp
7	risks	risk	NNS	_	6	dobj
8	,	,	,	_	6	punct
9	maximize	maximize	VB	_	6	conj
10	benefits	benefit	NNS	_	9	dobj
11	,	,	,	_	6	punct
12	and	and	CC	_	6	cc
13	get	get	VB	_	6	conj
14	the	the	DT	_	16	det
15	most	most	RBS	_	16	advmod
16	out	out	RB	_	13	dobj
17	of	of	IN	_	22	mark
18	what	what	WP	_	22	dobj
19	modern	modern	JJ	_	20	amod
20	medications	medication	NNS	_	22	nsubj
21	can	can	MD	_	22	aux
22	do	do	VB	_	16	acl
23	to	to	TO	_	24	mark
24	help	help	VB	_	22	xcomp
25	older	older	JJR	_	26	amod
26	patients	patient	NNS	_	24	dobj
27	.	.	.	_	3	punct

1	Determinants	determinant	NNS	_	0	ROOT
2	of	of	IN	_	4	case
3	cellular	cellular	JJ	_	4	amod
4	sensitivity	sensitivity	NN	_	1	nmod
5	to	to	TO	_	6	case
6	drug1	drug1	NN	_	4	nmod
7	.	.	.	_	1	punct

1	It	it	PRP	_	4	nsubj
2	is	be	VBZ	_	4	cop
3	now	now	RB	_	4	advmod
4	clear	clear	JJ	_	0	ROOT
5	that	that	IN	_	12	mark
6	topoisomerase	topoisomerase	NN	_	8	compound
7	activity	activity	NN	_	8	compound
8	level	level	NN	_	12	nsubj
9	is	be	VBZ	_	12	cop
10	an	a	DT	_	12	det
11	important	important	JJ	_	12	amod
12	determinant	determinant	NN	_	4	ccomp
13	of	of	IN	_	14	case
14	sensitivity	sensitivity	NN	_	12	nmod
15	to	to	TO	_	17	case
16	topo	topo	NN	_	17	compound
17	drugs	drug	NNS	_	14	nmod
18	.	.	.	_	4	punct

1	The	the	DT	_	2	det
2	regulation	regulation	NN	_	8	nsubj
3	of	of	IN	_	4	case
4	topoisomerases	topoisomerase	NNS	_	2	nmod
5	is	be	VBZ	_	8	cop
6	no	no	DT	_	8	neg
7	doubt	doubt	NN	_	8	compound
8	complex	complex	NN	_	0	ROOT
9	and	and	CC	_	8	cc
10	multifaceted	multifaceted	JJ	_	8	conj
11	and	and	CC	_	8	cc
12	is	be	VBZ	_	14	auxpass
13	probably	probably	RB	_	14	advmod
14	accomplished	accomplish	VBN	_	8	conj
15	through	through	IN	_	16	case
16	redundancy	redundancy	NN	_	14	nmod
17	at	at	IN	_	20	case
18	many	many	JJ	_	20	amod
19	control	control	NN	_	20	compound
20	levels	level	NNS	_	14	nmod
21	.	.	.	_	8	punct

1	The	the	DT	_	4	det
2	mechanism	mechanism	NN	_	4	compound
3	-LRB-	-lrb-	-LRB-	_	4	punct
4	s	s	NNS	_	16	nsubj
5	-RRB-	-rrb-	-RRB-	_	4	punct
6	of	of	IN	_	10	case
7	altered	altered	JJ	_	10	amod
8	topo	topo	NN	_	10	compound
9	I	i	NN	_	10	compound
10	expression	expression	NN	_	4	nmod
11	in	in	IN	_	14	case
12	certain	certain	JJ	_	14	amod
13	tumor	tumor	NN	_	14	compound
14	types	type	NNS	_	10	nmod
15	is	be	VBZ	_	16	cop
16	unknown	unknown	JJ	_	0	ROOT
17	,	,	,	_	16	punct
18	but	but	CC	_	16	cc
19	may	may	MD	_	21	aux
20	be	be	VB	_	21	cop
21	related	relate	VBN	_	16	conj
22	to	to	TO	_	25	case
23	the	the	DT	_	25	det
24	central	central	JJ	_	25	amod
25	importance	importance	NN	_	21	nmod
26	of	of	IN	_	27	case
27	topoisomerases	topoisomerase	NNS	_	25	nmod
28	in	in	IN	_	31	case
29	proliferating	proliferate	VBG	_	31	amod
30	cell	cell	NN	_	31	compound
31	functions	function	NNS	_	25	nmod
32	-LRB-	-lrb-	-LRB-	_	33	punct
33	transcription	transcription	NN	_	31	dep
34	,	,	,	_	33	punct
35	replication	replication	NN	_	33	conj
36	,	,	,	_	33	punct
37	etc.	etc.	FW	_	33	dep
38	-RRB-	-rrb-	-RRB-	_	33	punct
39	,	,	,	_	16	punct
40	and	and	CC	_	16	cc
41	the	the	DT	_	45	det
42	aberrant	aberrant	JJ	_	45	amod
43	and	and	CC	_	42	cc
44	chronic	chronic	JJ	_	42	conj
45	activation	activation	NN	_	16	conj
46	of	of	IN	_	48	case
47	these	these	DT	_	48	det
48	functions	function	NNS	_	45	nmod
49	as	as	IN	_	51	case
50	a	a	DT	_	51	det
51	result	result	NN	_	45	nmod
52	of	of	IN	_	55	case
53	specific	specific	JJ	_	55	amod
54	tumorigenic	tumorigenic	JJ	_	55	amod
55	alterations	alteration	NNS	_	51	nmod
56	.	.	.	_	16	punct

1	Small	small	JJ	_	2	amod
2	differences	difference	NNS	_	8	nsubj
3	in	in	IN	_	4	case
4	sensitivity	sensitivity	NN	_	2	nmod
5	to	to	TO	_	6	case
6	chemotherapy	chemotherapy	NN	_	4	nmod
7	can	can	MD	_	8	aux
8	have	have	VB	_	0	ROOT
9	a	a	DT	_	11	det
10	dramatic	dramatic	JJ	_	11	amod
11	effect	effect	NN	_	8	dobj
12	on	on	IN	_	14	case
13	cure	cure	NN	_	14	compound
14	rates	rate	NNS	_	11	nmod
15	,	,	,	_	8	punct
16	and	and	CC	_	8	cc
17	therefore	therefore	RB	_	18	advmod
18	subtle	subtle	JJ	_	21	amod
19	cell	cell	NN	_	20	nmod:npmod
20	type-specific	type-specific	JJ	_	21	amod
21	differences	difference	NNS	_	25	nsubj
22	may	may	MD	_	25	aux
23	be	be	VB	_	25	cop
24	important	important	JJ	_	25	amod
25	determinants	determinant	NNS	_	8	conj
26	of	of	IN	_	28	case
27	drug	drug	NN	_	28	compound
28	sensitivity	sensitivity	NN	_	25	nmod
29	.	.	.	_	8	punct

1	Whether	whether	IN	_	9	mark
2	abnormal	abnormal	JJ	_	4	amod
3	topoisomerase	topoisomerase	NN	_	4	compound
4	quantity	quantity	NN	_	9	nsubjpass
5	and	and	CC	_	4	cc
6	specific	specific	JJ	_	7	amod
7	activity	activity	NN	_	4	conj
8	are	be	VBP	_	9	auxpass
9	associated	associate	VBN	_	23	csubjpass
10	with	with	IN	_	11	case
11	resistance	resistance	NN	_	9	nmod
12	or	or	CC	_	11	cc
13	sensitivity	sensitivity	NN	_	11	conj
14	to	to	TO	_	16	case
15	topoisomerase-targeted	topoisomerase-targeted	JJ	_	16	amod
16	chemotherapy	chemotherapy	NN	_	13	nmod
17	in	in	IN	_	19	case
18	the	the	DT	_	19	det
19	clinic	clinic	NN	_	11	nmod
20	is	be	VBZ	_	23	aux
21	now	now	RB	_	23	advmod
22	being	be	VBG	_	23	auxpass
23	studied	study	VBN	_	0	ROOT
24	.	.	.	_	23	punct

1	Determinants	determinant	NNS	_	28	nsubj
2	downstream	downstream	RB	_	1	advmod
3	of	of	IN	_	6	case
4	cleavable	cleavable	JJ	_	6	amod
5	complex	complex	NN	_	6	compound
6	formation	formation	NN	_	2	nmod
7	that	that	WDT	_	8	nsubj
8	affect	affect	VBP	_	1	acl:relcl
9	the	the	DT	_	10	det
10	sensitivity	sensitivity	NN	_	8	dobj
11	of	of	IN	_	12	case
12	tumor	tumor	NN	_	10	nmod
13	versus	versus	CC	_	12	cc
14	normal	normal	JJ	_	15	amod
15	cells	cell	NNS	_	12	conj
16	to	to	TO	_	18	case
17	topo	topo	NN	_	18	compound
18	drugs	drug	NNS	_	10	nmod
19	in	in	IN	_	20	case
20	particular	particular	JJ	_	10	nmod
21	and	and	CC	_	20	cc
22	DNA-damaging	dna-damaging	JJ	_	20	conj
23	agents	agent	NNS	_	20	dep
24	in	in	IN	_	25	case
25	general	general	JJ	_	8	nmod
26	are	be	VBP	_	28	cop
27	little	little	JJ	_	28	advmod
28	known	known	JJ	_	0	ROOT
29	.	.	.	_	28	punct

1	The	the	DT	_	2	det
2	goal	goal	NN	_	0	ROOT
3	of	of	IN	_	4	mark
4	enhancing	enhance	VBG	_	2	acl
5	selective	selective	JJ	_	8	amod
6	tumor	tumor	NN	_	8	compound
7	cell	cell	NN	_	8	compound
8	killing	killing	NN	_	4	dobj
9	relative	relative	JJ	_	4	advmod
10	to	to	TO	_	13	case
11	the	the	DT	_	13	det
12	normal	normal	JJ	_	13	amod
13	cells	cell	NNS	_	9	nmod
14	that	that	WDT	_	20	nsubjpass
15	are	be	VBP	_	20	auxpass
16	dose	dose	NN	_	20	nsubjpass
17	limiting	limit	VBG	_	16	acl
18	may	may	MD	_	20	aux
19	be	be	VB	_	20	auxpass
20	achieved	achieve	VBN	_	13	acl:relcl
21	either	either	CC	_	23	cc:preconj
22	by	by	IN	_	23	mark
23	overcoming	overcome	VBG	_	20	dep
24	tumor	tumor	NN	_	26	compound
25	cell	cell	NN	_	26	compound
26	resistance	resistance	NN	_	23	dobj
27	or	or	CC	_	23	cc
28	by	by	IN	_	29	mark
29	protecting	protect	VBG	_	23	conj
30	normal	normal	JJ	_	31	amod
31	cells	cell	NNS	_	29	dobj
32	.	.	.	_	2	punct

1	Both	both	DT	_	6	nsubj
2	of	of	IN	_	4	case
3	these	these	DT	_	4	det
4	strategies	strategy	NNS	_	1	nmod
5	will	will	MD	_	6	aux
6	become	become	VB	_	0	ROOT
7	more	more	RBR	_	8	advmod
8	feasible	feasible	JJ	_	6	xcomp
9	as	as	IN	_	12	case
10	specific	specific	JJ	_	12	amod
11	molecular	molecular	JJ	_	12	amod
12	differences	difference	NNS	_	6	nmod
13	between	between	IN	_	14	case
14	tumor	tumor	NN	_	12	nmod
15	and	and	CC	_	14	cc
16	normal	normal	JJ	_	17	amod
17	cells	cell	NNS	_	14	conj
18	are	be	VBP	_	21	aux
19	being	be	VBG	_	21	auxpass
20	rapidly	rapidly	RB	_	21	advmod
21	identified	identify	VBN	_	6	dep
22	and	and	CC	_	21	cc
23	new	new	JJ	_	25	amod
24	combination	combination	NN	_	25	compound
25	therapies	therapy	NNS	_	34	nsubjpass
26	that	that	WDT	_	27	nsubj
27	take	take	VBP	_	25	acl:relcl
28	advantage	advantage	NN	_	27	dobj
29	of	of	IN	_	31	case
30	these	these	DT	_	31	det
31	differences	difference	NNS	_	27	nmod
32	are	be	VBP	_	34	aux
33	being	be	VBG	_	34	auxpass
34	designed	design	VBN	_	21	conj
35	and	and	CC	_	21	cc
36	tested	test	VBN	_	21	conj
37	.	.	.	_	6	punct

1	Interactions	interaction	NNS	_	0	ROOT
2	of	of	IN	_	3	case
3	drug1	drug1	NN	_	1	nmod
4	and	and	CC	_	3	cc
5	drug2	drug2	NN	_	3	conj
6	in	in	IN	_	7	case
7	absorption	absorption	NN	_	1	nmod
8	and	and	CC	_	7	cc
9	retention	retention	NN	_	7	conj
10	.	.	.	_	1	punct

1	The	the	DT	_	2	det
2	effects	effect	NNS	_	36	nsubjpass
3	of	of	IN	_	6	case
4	supplementary	supplementary	JJ	_	6	amod
5	oral	oral	JJ	_	6	amod
6	drug1	drug1	NN	_	2	nmod
7	and	and	CC	_	6	cc
8	drug2	drug2	NN	_	6	conj
9	,	,	,	_	6	punct
10	as	as	RB	_	6	cc
11	well	well	RB	_	10	mwe
12	as	as	IN	_	10	mwe
13	the	the	DT	_	14	det
14	interaction	interaction	NN	_	6	conj
15	between	between	IN	_	16	case
16	both	both	DT	_	14	nmod
17	at	at	IN	_	20	case
18	the	the	DT	_	20	det
19	absorption	absorption	NN	_	20	compound
20	site	site	NN	_	14	nmod
21	,	,	,	_	20	punct
22	fecal	fecal	JJ	_	25	amod
23	and	and	CC	_	22	cc
24	urinary	urinary	JJ	_	22	conj
25	excretion	excretion	NN	_	20	appos
26	as	as	RB	_	25	cc
27	well	well	RB	_	26	mwe
28	as	as	IN	_	26	mwe
29	the	the	DT	_	30	det
30	retention	retention	NN	_	25	conj
31	of	of	IN	_	34	case
32	these	these	DT	_	34	det
33	trace	trace	NN	_	34	compound
34	elements	element	NNS	_	30	nmod
35	were	be	VBD	_	36	auxpass
36	determined	determine	VBN	_	0	ROOT
37	by	by	IN	_	38	mark
38	using	use	VBG	_	36	advcl
39	four	four	CD	_	40	nummod
40	diets	diet	NNS	_	38	dobj
41	containing	contain	VBG	_	40	acl
42	either	either	CC	_	46	cc:preconj
43	9	9	CD	_	46	nummod
44	or	or	CC	_	43	cc
45	63	63	CD	_	43	conj
46	micrograms/kg	micrograms/kg	NNS	_	41	dobj
47	of	of	IN	_	48	case
48	drug3	drug3	NN	_	46	nmod
49	and	and	CC	_	46	cc
50	48	48	CD	_	53	nummod
51	or	or	CC	_	50	cc
52	446	446	CD	_	50	conj
53	mg/kg	mg/kg	NN	_	46	conj
54	of	of	IN	_	55	case
55	drug4	drug4	NN	_	53	nmod
56	over	over	IN	_	58	case
57	a	a	DT	_	58	det
58	period	period	NN	_	38	nmod
59	of	of	IN	_	61	case
60	19	19	CD	_	61	nummod
61	days	day	NNS	_	58	nmod
62	in	in	IN	_	64	case
63	a	a	DT	_	64	det
64	total	total	NN	_	58	nmod
65	of	of	IN	_	67	case
66	24	24	CD	_	67	nummod
67	rats	rat	NNS	_	64	nmod
68	.	.	.	_	36	punct

1	Retention	retention	NN	_	3	nsubjpass
2	was	be	VBD	_	3	auxpass
3	calculated	calculate	VBN	_	0	ROOT
4	by	by	IN	_	7	case
5	the	the	DT	_	7	det
6	balance	balance	NN	_	7	compound
7	technique	technique	NN	_	3	nmod
8	and	and	CC	_	7	cc
9	by	by	IN	_	13	case
10	the	the	DT	_	13	det
11	comparative	comparative	JJ	_	13	amod
12	slaughter	slaughter	NN	_	13	compound
13	technique	technique	NN	_	7	conj
14	.	.	.	_	3	punct

1	After	after	IN	_	3	case
2	one	one	CD	_	3	nummod
3	day	day	NN	_	16	nmod
4	,	,	,	_	16	punct
5	fecal	fecal	JJ	_	10	amod
6	as	as	RB	_	5	cc
7	well	well	RB	_	6	mwe
8	as	as	IN	_	6	mwe
9	urinary	urinary	JJ	_	5	conj
10	excretion	excretion	NN	_	16	nsubj
11	of	of	IN	_	13	case
12	both	both	CC	_	13	det
13	elements	element	NNS	_	10	nmod
14	had	have	VBD	_	16	aux
15	already	already	RB	_	16	advmod
16	responded	respond	VBN	_	0	ROOT
17	to	to	TO	_	20	case
18	the	the	DT	_	20	det
19	dietary	dietary	JJ	_	20	amod
20	treatments	treatment	NNS	_	16	nmod
21	,	,	,	_	16	punct
22	with	with	IN	_	26	mark
23	constant	constant	JJ	_	24	amod
24	values	value	NNS	_	26	nsubjpass
25	being	be	VBG	_	26	auxpass
26	reached	reach	VBN	_	16	advcl
27	after	after	IN	_	30	case
28	approximately	approximately	RB	_	29	advmod
29	three	three	CD	_	30	nummod
30	days	day	NNS	_	26	nmod
31	.	.	.	_	16	punct

1	drug1	drug1	NN	_	2	compound
2	excretion	excretion	NN	_	4	nsubjpass
3	was	be	VBD	_	4	auxpass
4	enhanced	enhance	VBN	_	0	ROOT
5	by	by	IN	_	7	case
6	supplementary	supplementary	JJ	_	7	amod
7	drug2	drug2	NN	_	4	nmod
8	;	;	:	_	4	punct

1	fecal	fecal	JJ	_	2	amod
2	excretion	excretion	NN	_	7	nsubjpass
3	,	,	,	_	7	punct
4	too	too	RB	_	7	advmod
5	,	,	,	_	7	punct
6	was	be	VBD	_	7	auxpass
7	increased	increase	VBN	_	0	ROOT
8	by	by	IN	_	10	case
9	supplementary	supplementary	JJ	_	10	amod
10	drug1	drug1	NN	_	7	nmod
11	;	;	:	_	7	punct

1	whereas	whereas	IN	_	5	mark
2	urinary	urinary	JJ	_	3	amod
3	excretion	excretion	NN	_	5	nsubjpass
4	was	be	VBD	_	5	auxpass
5	decreased	decrease	VBN	_	0	ROOT
6	in	in	IN	_	8	case
7	both	both	DT	_	8	det
8	cases	case	NNS	_	5	nmod
9	.	.	.	_	5	punct

1	Additional	additional	JJ	_	2	amod
2	drug1	drug1	NN	_	4	nsubj
3	significantly	significantly	RB	_	4	advmod
4	inhibited	inhibit	VBD	_	0	ROOT
5	the	the	DT	_	6	det
6	absorption	absorption	NN	_	4	dobj
7	of	of	IN	_	8	case
8	drug2	drug2	NN	_	6	nmod
9	in	in	IN	_	13	case
10	both	both	CC	_	13	det
11	dietary	dietary	JJ	_	13	amod
12	drug3	drug3	NN	_	13	compound
13	treatments	treatment	NNS	_	6	nmod
14	.	.	.	_	4	punct

1	The	the	DT	_	3	det
2	lower	lower	JJR	_	3	amod
3	rate	rate	NN	_	22	nsubj
4	of	of	IN	_	5	case
5	absorption	absorption	NN	_	3	nmod
6	in	in	IN	_	8	case
7	the	the	DT	_	8	det
8	groups	group	NNS	_	3	nmod
9	receiving	receive	VBG	_	8	acl
10	446	446	CD	_	12	nummod
11	mg	mg	NN	_	12	compound
12	drug1	drug1	NN	_	9	dobj
13	instead	instead	RB	_	16	case
14	of	of	IN	_	13	mwe
15	48	48	CD	_	16	nummod
16	mg	mg	NN	_	9	nmod
17	of	of	IN	_	18	case
18	drug2	drug2	NN	_	16	nmod
19	per	per	IN	_	21	case
20	kg	kg	NN	_	21	compound
21	diet	diet	NN	_	16	nmod
22	resulted	result	VBD	_	0	ROOT
23	in	in	IN	_	27	case
24	a	a	DT	_	27	det
25	decreased	decrease	VBN	_	27	amod
26	renal	renal	JJ	_	27	amod
27	excretion	excretion	NN	_	22	nmod
28	of	of	IN	_	29	case
29	drug3	drug3	NN	_	27	nmod
30	.	.	.	_	22	punct

1	Consequently	consequently	RB	_	13	advmod
2	,	,	,	_	13	punct
3	the	the	DT	_	4	det
4	effect	effect	NN	_	13	nsubj
5	of	of	IN	_	6	case
6	drug1	drug1	NN	_	4	nmod
7	on	on	IN	_	9	case
8	the	the	DT	_	9	det
9	retention	retention	NN	_	4	nmod
10	of	of	IN	_	11	case
11	drug2	drug2	NN	_	9	nmod
12	was	be	VBD	_	13	cop
13	lower	lower	JJR	_	0	ROOT
14	than	than	IN	_	16	case
15	on	on	IN	_	16	case
16	absorption	absorption	NN	_	13	nmod
17	.	.	.	_	13	punct

1	This	this	DT	_	2	nsubj
2	suggests	suggest	VBZ	_	0	ROOT
3	that	that	IN	_	10	mark
4	interactions	interaction	NNS	_	10	nsubj
5	between	between	IN	_	8	case
6	the	the	DT	_	8	det
7	two	two	CD	_	8	nummod
8	elements	element	NNS	_	4	nmod
9	only	only	RB	_	10	advmod
10	take	take	VB	_	2	ccomp
11	place	place	NN	_	10	dobj
12	at	at	IN	_	14	case
13	the	the	DT	_	14	det
14	site	site	NN	_	10	nmod
15	of	of	IN	_	16	case
16	absorption	absorption	NN	_	14	nmod
17	.	.	.	_	2	punct

1	Because	because	IN	_	7	case
2	of	of	IN	_	1	mwe
3	the	the	DT	_	7	det
4	low	low	JJ	_	7	amod
5	dietary	dietary	JJ	_	7	amod
6	drug1	drug1	NN	_	7	compound
7	concentration	concentration	NN	_	27	nmod
8	as	as	IN	_	9	mark
9	compared	compare	VBN	_	7	dep
10	to	to	TO	_	13	case
11	the	the	DT	_	13	det
12	drug2	drug2	NN	_	13	compound
13	contents	contents	NNS	_	9	nmod
14	of	of	IN	_	16	case
15	the	the	DT	_	16	det
16	diets	diet	NNS	_	13	nmod
17	,	,	,	_	27	punct
18	no	no	DT	_	19	neg
19	effect	effect	NN	_	27	nsubj
20	of	of	IN	_	21	case
21	drug3	drug3	NN	_	19	nmod
22	on	on	IN	_	24	case
23	drug4	drug4	NN	_	24	compound
24	absorption	absorption	NN	_	19	nmod
25	and	and	CC	_	24	cc
26	excretion	excretion	NN	_	24	conj
27	occurred	occur	VBD	_	0	ROOT
28	.	.	.	_	27	punct

1	Differences	difference	NNS	_	7	nsubjpass
2	in	in	IN	_	4	case
3	drug1	drug1	NN	_	4	compound
4	balance	balance	NN	_	1	nmod
5	were	be	VBD	_	7	auxpass
6	only	only	RB	_	7	advmod
7	observed	observe	VBN	_	0	ROOT
8	between	between	IN	_	11	case
9	both	both	DT	_	11	det
10	dietary	dietary	JJ	_	11	amod
11	concentrations	concentration	NNS	_	7	nmod
12	,	,	,	_	7	punct
13	showing	show	VBG	_	7	xcomp
14	a	a	DT	_	16	det
15	higher	higher	JJR	_	16	amod
16	absolute	absolute	JJ	_	13	dobj
17	but	but	CC	_	16	cc
18	a	a	DT	_	21	det
19	lower	lower	JJR	_	21	amod
20	relative	relative	JJ	_	21	amod
21	absorption	absorption	NN	_	16	conj
22	as	as	RB	_	21	cc
23	well	well	RB	_	22	mwe
24	as	as	IN	_	22	mwe
25	retention	retention	NN	_	21	conj
26	in	in	IN	_	28	case
27	the	the	DT	_	28	det
28	groups	group	NNS	_	25	nmod
29	fed	feed	VBN	_	28	acl
30	further	further	RB	_	31	advmod
31	drug2	drug2	NN	_	29	dobj
32	.	.	.	_	31	punct
33	-LRB-	-lrb-	-LRB-	_	34	punct
34	ABSTRACT	abstract	NN	_	31	appos
35	TRUNCATED	truncate	VBN	_	34	acl
36	AT	at	IN	_	38	case
37	250	250	CD	_	38	nummod
38	WORDS	word	NNS	_	35	nmod
39	-RRB-	-rrb-	-RRB-	_	34	punct

1	-LSB-	-lsb-	-LRB-	_	2	punct
2	Importance	importance	NN	_	7	dep
3	of	of	IN	_	4	case
4	pharmacogenetics	pharmacogenetic	NNS	_	2	nmod
5	-RSB-	-rsb-	-RRB-	_	2	punct
6	Pharmacogenetics	Pharmacogenetics	NNPS	_	7	compound
7	deals	deal	NNS	_	0	ROOT
8	with	with	IN	_	10	case
9	the	the	DT	_	10	det
10	differences	difference	NNS	_	7	nmod
11	in	in	IN	_	12	case
12	effect	effect	NN	_	10	nmod
13	of	of	IN	_	14	case
14	drugs	drug	NNS	_	12	nmod
15	caused	cause	VBN	_	14	acl
16	by	by	IN	_	18	case
17	genetic	genetic	JJ	_	18	amod
18	variation	variation	NN	_	15	nmod
19	.	.	.	_	7	punct

1	Differences	difference	NNS	_	3	nsubj
2	can	can	MD	_	3	aux
3	occur	occur	VB	_	0	ROOT
4	in	in	IN	_	6	case
5	therapeutic	therapeutic	JJ	_	6	amod
6	effect	effect	NN	_	3	nmod
7	and	and	CC	_	6	cc
8	in	in	IN	_	10	case
9	adverse	adverse	JJ	_	10	amod
10	events	event	NNS	_	6	conj
11	.	.	.	_	3	punct

1	Genetic	genetic	JJ	_	2	amod
2	variation	variation	NN	_	6	nsubj
3	in	in	IN	_	4	case
4	metabolism	metabolism	NN	_	2	nmod
5	may	may	MD	_	6	aux
6	result	result	VB	_	0	ROOT
7	in	in	IN	_	9	case
8	high	high	JJ	_	9	amod
9	concentrations	concentration	NNS	_	6	nmod
10	of	of	IN	_	11	case
11	drugs	drug	NNS	_	9	nmod
12	and	and	CC	_	9	cc
13	an	a	DT	_	15	det
14	increased	increase	VBN	_	15	amod
15	risk	risk	NN	_	9	conj
16	of	of	IN	_	18	case
17	adverse	adverse	JJ	_	18	amod
18	effects	effect	NNS	_	15	nmod
19	in	in	IN	_	21	case
20	slow	slow	JJ	_	21	amod
21	metabolizers	metabolizer	NNS	_	18	nmod
22	,	,	,	_	21	punct
23	which	which	WDT	_	25	nsubj
24	is	be	VBZ	_	25	cop
25	important	important	JJ	_	21	acl:relcl
26	when	when	WRB	_	27	advmod
27	using	use	VBG	_	25	advcl
28	for	for	IN	_	30	case
29	example	example	NN	_	30	compound
30	drug1	drug1	NN	_	27	nmod
31	or	or	CC	_	30	cc
32	chemotherapy	chemotherapy	NN	_	30	conj
33	.	.	.	_	6	punct

1	Genetic	genetic	JJ	_	2	amod
2	variation	variation	NN	_	4	nsubj
3	also	also	RB	_	4	advmod
4	occurs	occur	VBZ	_	0	ROOT
5	in	in	IN	_	6	case
6	proteins	protein	NNS	_	4	nmod
7	interacting	interact	VBG	_	6	acl
8	with	with	IN	_	9	case
9	drugs	drug	NNS	_	7	nmod
10	,	,	,	_	6	punct
11	which	which	WDT	_	13	nsubj
12	may	may	MD	_	13	aux
13	change	change	VB	_	6	acl:relcl
14	the	the	DT	_	15	det
15	effect	effect	NN	_	13	dobj
16	of	of	IN	_	17	case
17	e.g.	e.g.	FW	_	15	nmod

1	asthma	asthma	NN	_	2	compound
2	drugs	drug	NNS	_	0	ROOT
3	and	and	CC	_	2	cc
4	drug1	drug1	NN	_	2	conj
5	.	.	.	_	2	punct

1	The	the	DT	_	2	det
2	selection	selection	NN	_	10	nsubjpass
3	of	of	IN	_	4	case
4	drugs	drug	NNS	_	2	nmod
5	and	and	CC	_	4	cc
6	their	they	PRP$	_	7	nmod:poss
7	dosages	dosage	NNS	_	4	conj
8	may	may	MD	_	10	aux
9	be	be	VB	_	10	auxpass
10	improved	improve	VBN	_	0	ROOT
11	,	,	,	_	10	punct
12	and	and	CC	_	10	cc
13	the	the	DT	_	14	det
14	number	number	NN	_	10	conj
15	of	of	IN	_	17	case
16	adverse	adverse	JJ	_	17	amod
17	effects	effect	NNS	_	14	nmod
18	reduced	reduce	VBN	_	17	acl
19	by	by	IN	_	21	case
20	pharmacogenetic	pharmacogenetic	JJ	_	21	amod
21	investigations	investigation	NNS	_	18	nmod
22	.	.	.	_	10	punct

1	However	however	RB	_	6	advmod
2	,	,	,	_	6	punct
3	it	it	PRP	_	6	nsubj
4	may	may	MD	_	6	aux
5	be	be	VB	_	6	cop
6	important	important	JJ	_	0	ROOT
7	also	also	RB	_	9	advmod
8	in	in	IN	_	9	case
9	case	case	NN	_	6	nmod
10	of	of	IN	_	12	case
11	medical	medical	JJ	_	12	amod
12	examinations	examination	NNS	_	9	nmod
13	for	for	IN	_	14	case
14	insurances	insurance	NNS	_	12	nmod
15	and	and	CC	_	14	cc
16	job	job	NN	_	17	compound
17	appointments	appointment	NNS	_	14	conj
18	,	,	,	_	6	punct
19	since	since	IN	_	23	mark
20	some	some	DT	_	21	det
21	patients	patient	NNS	_	23	nsubj
22	may	may	MD	_	23	aux
23	turn	turn	VB	_	6	advcl
24	out	out	RP	_	23	compound:prt
25	to	to	TO	_	26	mark
26	need	need	VB	_	23	xcomp
27	expensive	expensive	JJ	_	28	amod
28	drugs	drug	NNS	_	26	dobj
29	or	or	CC	_	26	cc
30	to	to	TO	_	32	mark
31	be	be	VB	_	32	cop
32	susceptible	susceptible	JJ	_	26	conj
33	to	to	TO	_	36	case
34	a	a	DT	_	36	det
35	certain	certain	JJ	_	36	amod
36	disease	disease	NN	_	32	nmod
37	.	.	.	_	6	punct

1	Therefore	therefore	RB	_	11	advmod
2	,	,	,	_	11	punct
3	the	the	DT	_	4	det
4	use	use	NN	_	11	nsubj
5	of	of	IN	_	7	case
6	genetic	genetic	JJ	_	7	amod
7	data	datum	NNS	_	4	nmod
8	in	in	IN	_	10	case
9	these	these	DT	_	10	det
10	instances	instance	NNS	_	4	nmod
11	has	have	VBZ	_	0	ROOT
12	to	to	TO	_	14	mark
13	be	be	VB	_	14	auxpass
14	regulated	regulate	VBN	_	11	xcomp
15	.	.	.	_	11	punct

1	drug1	drug1	NN	_	2	compound
2	overdose	overdose	NN	_	0	ROOT
3	recognized	recognize	VBN	_	2	acl
4	by	by	IN	_	7	case
5	a	a	DT	_	7	det
6	drug2	drug2	NN	_	7	compound
7	assay	assay	NN	_	3	nmod
8	.	.	.	_	2	punct

1	Altered	altered	JJ	_	3	amod
2	mental	mental	JJ	_	3	amod
3	status	status	NN	_	7	nsubj
4	in	in	IN	_	6	case
5	an	a	DT	_	6	det
6	adolescent	adolescent	JJ	_	3	nmod
7	presents	present	VBZ	_	0	ROOT
8	a	a	DT	_	10	det
9	diagnostic	diagnostic	JJ	_	10	amod
10	challenge	challenge	NN	_	7	dobj
11	,	,	,	_	7	punct
12	and	and	CC	_	7	cc
13	the	the	DT	_	14	det
14	clinician	clinician	NN	_	15	nsubj
15	depends	depend	VBZ	_	7	conj
16	on	on	IN	_	18	case
17	clinical	clinical	JJ	_	18	amod
18	evaluation	evaluation	NN	_	15	nmod
19	and	and	CC	_	18	cc
20	laboratory	laboratory	NN	_	21	compound
21	studies	study	NNS	_	18	conj
22	to	to	TO	_	23	mark
23	determine	determine	VB	_	15	xcomp
24	therapy	therapy	NN	_	23	dobj
25	and	and	CC	_	24	cc
26	prognosis	prognosis	NN	_	24	conj
27	.	.	.	_	7	punct

1	We	we	PRP	_	2	nsubj
2	report	report	VBP	_	0	ROOT
3	the	the	DT	_	4	det
4	case	case	NN	_	2	dobj
5	of	of	IN	_	7	case
6	an	a	DT	_	7	det
7	adolescent	adolescent	JJ	_	4	nmod
8	with	with	IN	_	10	case
9	altered	altered	JJ	_	10	amod
10	consciousness	consciousness	NN	_	7	nmod
11	caused	cause	VBN	_	10	acl
12	by	by	IN	_	14	case
13	drug1	drug1	NN	_	14	compound
14	overdose	overdose	NN	_	11	nmod
15	with	with	IN	_	19	case
16	a	a	DT	_	19	det
17	positive	positive	JJ	_	19	amod
18	drug2	drug2	NN	_	19	compound
19	level	level	NN	_	14	nmod
20	to	to	TO	_	22	case
21	alert	alert	JJ	_	22	amod
22	clinicians	clinician	NNS	_	19	nmod
23	to	to	TO	_	25	case
24	the	the	DT	_	25	det
25	cross-reactivity	cross-reactivity	NN	_	22	nmod
26	of	of	IN	_	27	case
27	drug3	drug3	NN	_	25	nmod
28	with	with	IN	_	31	case
29	a	a	DT	_	31	det
30	toxicology	toxicology	NN	_	31	compound
31	screen	screen	NN	_	19	nmod
32	for	for	IN	_	33	case
33	drug4	drug4	NN	_	31	nmod
34	.	.	.	_	2	punct

1	drug1	drug1	NN	_	0	ROOT
2	.	.	.	_	1	punct

1	Treatment	treatment	NN	_	2	compound
2	plans	plan	NNS	_	8	nsubj
3	for	for	IN	_	4	case
4	patients	patient	NNS	_	2	nmod
5	taking	take	VBG	_	4	acl
6	drug1	drug1	NN	_	5	dobj
7	can	can	MD	_	8	aux
8	become	become	VB	_	0	ROOT
9	complicated	complicated	JJ	_	8	xcomp
10	.	.	.	_	8	punct

1	drug1	drug1	NN	_	2	nsubj
2	predispose	predispose	VB	_	0	ROOT
3	a	a	DT	_	4	det
4	patient	patient	NN	_	2	dobj
5	to	to	TO	_	6	mark
6	bleeding	bleed	VBG	_	4	acl
7	problems	problem	NNS	_	6	dobj
8	.	.	.	_	2	punct

1	Many	many	JJ	_	2	amod
2	drugs	drug	NNS	_	9	nsubjpass
3	used	use	VBN	_	2	acl
4	in	in	IN	_	5	case
5	dentistry	dentistry	NN	_	3	nmod
6	can	can	MD	_	9	aux
7	not	not	RB	_	9	neg
8	be	be	VB	_	9	auxpass
9	taken	take	VBN	_	0	ROOT
10	concomitantly	concomitantly	RB	_	9	advmod
11	with	with	IN	_	13	case
12	these	these	DT	_	13	det
13	medications	medication	NNS	_	9	nmod
14	.	.	.	_	9	punct

1	Acute	acute	JJ	_	3	amod
2	drug1	drug1	NN	_	3	compound
3	administration	administration	NN	_	6	nsubj
4	does	do	VBZ	_	6	aux
5	not	not	RB	_	6	neg
6	affect	affect	VB	_	0	ROOT
7	subjective	subjective	JJ	_	8	amod
8	responses	response	NNS	_	6	dobj
9	to	to	TO	_	10	mark
10	drug2	drug2	VB	_	8	acl
11	in	in	IN	_	12	case
12	humans	human	NNS	_	10	nmod
13	.	.	.	_	6	punct

1	RATIONALE	rationale	NN	_	0	ROOT
2	:	:	:	_	1	punct
3	Stress	stress	NN	_	6	nsubj
4	and	and	CC	_	3	cc
5	drug1	drug1	NN	_	3	conj
6	facilitate	facilitate	VBP	_	1	appos
7	and	and	CC	_	6	cc
8	reinstate	reinstate	VBP	_	6	conj
9	psychostimulant	psychostimulant	NN	_	10	compound
10	self-administration	self-administration	NN	_	6	dobj
11	in	in	IN	_	12	case
12	rodents	rodent	NNS	_	10	nmod
13	.	.	.	_	1	punct

1	However	however	RB	_	21	advmod
2	,	,	,	_	21	punct
3	the	the	DT	_	4	det
4	effects	effect	NNS	_	21	nsubjpass
5	of	of	IN	_	6	case
6	stress	stress	NN	_	4	nmod
7	and	and	CC	_	6	cc
8	drug1	drug1	NN	_	6	conj
9	on	on	IN	_	14	case
10	the	the	DT	_	14	det
11	subjective	subjective	JJ	_	14	amod
12	and	and	CC	_	11	cc
13	behavioral	behavioral	JJ	_	11	conj
14	effects	effect	NNS	_	4	nmod
15	of	of	IN	_	16	case
16	drug2	drug2	NN	_	14	nmod
17	have	have	VBP	_	21	aux
18	not	not	RB	_	21	neg
19	been	be	VBN	_	21	auxpass
20	well	well	RB	_	21	advmod
21	studied	study	VBN	_	0	ROOT
22	in	in	IN	_	23	case
23	humans	human	NNS	_	21	nmod
24	.	.	.	_	21	punct

1	OBJECTIVES	objective	NNS	_	0	ROOT
2	:	:	:	_	1	punct
3	To	to	TO	_	4	mark
4	examine	examine	VB	_	1	acl
5	the	the	DT	_	6	det
6	effects	effect	NNS	_	4	dobj
7	of	of	IN	_	10	case
8	acute	acute	JJ	_	10	amod
9	drug1	drug1	NN	_	10	compound
10	pretreatment	pretreatment	NN	_	6	nmod
11	on	on	IN	_	16	case
12	the	the	DT	_	16	det
13	subjective	subjective	JJ	_	16	amod
14	and	and	CC	_	13	cc
15	behavioral	behavioral	JJ	_	13	conj
16	effects	effect	NNS	_	6	nmod
17	of	of	IN	_	18	case
18	drug2	drug2	NN	_	16	nmod
19	.	.	.	_	4	punct

1	METHODS	method	NNS	_	0	ROOT
2	:	:	:	_	1	punct
3	drug1	drug1	NN	_	15	nsubjpass
4	-LRB-	-lrb-	-LRB-	_	6	punct
5	100	100	CD	_	6	nummod
6	mg	mg	NN	_	3	appos
7	-RRB-	-rrb-	-RRB-	_	6	punct
8	and	and	CC	_	3	cc
9	drug2	drug2	NN	_	3	conj
10	-LRB-	-lrb-	-LRB-	_	12	punct
11	20	20	CD	_	12	nummod
12	mg	mg	NN	_	9	appos
13	-RRB-	-rrb-	-RRB-	_	12	punct
14	were	be	VBD	_	15	auxpass
15	administered	administer	VBN	_	1	appos
16	orally	orally	RB	_	15	advmod
17	to	to	TO	_	20	case
18	16	16	CD	_	20	nummod
19	healthy	healthy	JJ	_	20	amod
20	male	male	NN	_	15	nmod
21	and	and	CC	_	15	cc
22	female	female	JJ	_	23	amod
23	volunteers	volunteer	NNS	_	15	conj
24	in	in	IN	_	33	case
25	a	a	DT	_	33	det
26	four-session	four-session	JJ	_	33	dep
27	,	,	,	_	26	punct
28	placebo-controlled	placebo-controlled	JJ	_	26	dep
29	,	,	,	_	26	punct
30	within-subject	within-subject	NN	_	26	dep
31	,	,	,	_	26	punct
32	crossover	crossover	NN	_	33	compound
33	design	design	NN	_	23	nmod
34	.	.	.	_	1	punct

1	To	to	TO	_	2	mark
2	prevent	prevent	VB	_	7	advcl
3	stomach	stomach	NN	_	4	compound
4	irritation	irritation	NN	_	2	dobj
5	,	,	,	_	7	punct
6	subjects	subject	NNS	_	7	nsubj
7	received	receive	VBD	_	0	ROOT
8	drug1	drug1	NN	_	7	dobj
9	before	before	IN	_	12	case
10	each	each	DT	_	12	det
11	experimental	experimental	JJ	_	12	amod
12	session	session	NN	_	7	nmod
13	.	.	.	_	7	punct

1	Dependent	dependent	JJ	_	2	amod
2	measures	measure	NNS	_	3	nsubj
3	included	include	VBN	_	0	ROOT
4	self-reported	self-reported	JJ	_	5	amod
5	mood	mood	NN	_	3	dobj
6	and	and	CC	_	5	cc
7	subjective	subjective	JJ	_	8	amod
8	effects	effect	NNS	_	5	conj
9	-LRB-	-lrb-	-LRB-	_	13	punct
10	Addiction	Addiction	NNP	_	13	compound
11	Research	Research	NNP	_	13	compound
12	Center	Center	NNP	_	13	compound
13	inventory	inventory	NN	_	5	dep
14	,	,	,	_	13	punct
15	the	the	DT	_	16	det
16	profile	profile	NN	_	13	appos
17	of	of	IN	_	19	case
18	mood	mood	NN	_	19	compound
19	states	state	NNS	_	16	nmod
20	,	,	,	_	13	punct
21	and	and	CC	_	13	cc
22	a	a	DT	_	23	det
23	series	series	NN	_	13	conj
24	of	of	IN	_	27	case
25	visual	visual	JJ	_	27	amod
26	analogue	analogue	NN	_	27	compound
27	scales	scale	NNS	_	23	nmod
28	-RRB-	-rrb-	-RRB-	_	13	punct
29	,	,	,	_	5	punct
30	vital	vital	JJ	_	31	amod
31	signs	sign	NNS	_	5	conj
32	,	,	,	_	5	punct
33	salivary	salivary	JJ	_	34	amod
34	cortisol	cortisol	NN	_	5	conj
35	,	,	,	_	5	punct
36	and	and	CC	_	5	cc
37	psychomotor	psychomotor	NN	_	38	compound
38	performance	performance	NN	_	5	conj
39	.	.	.	_	3	punct

1	RESULTS	result	NNS	_	0	ROOT
2	:	:	:	_	1	punct
3	drug1	drug1	NN	_	7	compound
4	elevated	elevated	JJ	_	7	amod
5	salivary	salivary	JJ	_	7	amod
6	cortisol	cortisol	NN	_	7	compound
7	levels	level	NNS	_	1	dep
8	,	,	,	_	7	punct
9	produced	produce	VBD	_	7	conj
10	modest	modest	JJ	_	11	amod
11	dysphoria	dysphoria	NN	_	9	dobj
12	,	,	,	_	7	punct
13	and	and	CC	_	7	cc
14	reduced	reduce	VBD	_	7	conj
15	subjects	subject	NNS	_	17	nmod:poss
16	'	'	POS	_	15	case
17	reports	report	NNS	_	14	dobj
18	of	of	IN	_	19	mark
19	wanting	want	VBG	_	17	acl
20	more	more	RBR	_	21	amod
21	drug	drug	NN	_	19	dobj
22	.	.	.	_	1	punct

1	However	however	RB	_	7	advmod
2	,	,	,	_	7	punct
3	drug1	drug1	NN	_	4	compound
4	pretreatment	pretreatment	NN	_	7	nsubj
5	did	do	VBD	_	7	aux
6	not	not	RB	_	7	neg
7	affect	affect	VB	_	0	ROOT
8	any	any	DT	_	7	dobj
9	of	of	IN	_	17	case
10	the	the	DT	_	17	det
11	physiological	physiological	JJ	_	17	amod
12	,	,	,	_	11	punct
13	behavioral	behavioral	JJ	_	11	conj
14	,	,	,	_	11	punct
15	or	or	CC	_	11	cc
16	subjective	subjective	JJ	_	11	conj
17	effects	effect	NNS	_	8	nmod
18	of	of	IN	_	19	case
19	drug2	drug2	NN	_	17	nmod
20	.	.	.	_	7	punct

1	CONCLUSIONS	conclusion	NNS	_	0	ROOT
2	:	:	:	_	1	punct
3	In	in	IN	_	4	case
4	contrast	contrast	NN	_	16	nmod
5	to	to	TO	_	7	case
6	the	the	DT	_	7	det
7	effects	effect	NNS	_	4	nmod
8	of	of	IN	_	9	case
9	drug1	drug1	NN	_	7	nmod
10	in	in	IN	_	12	case
11	rodent	rodent	JJ	_	12	amod
12	studies	study	NNS	_	7	nmod
13	,	,	,	_	16	punct
14	these	these	DT	_	15	det
15	results	result	NNS	_	16	nsubj
16	indicate	indicate	VBP	_	1	appos
17	that	that	IN	_	25	mark
18	an	a	DT	_	20	det
19	acute	acute	JJ	_	20	amod
20	increase	increase	NN	_	25	nsubj
21	in	in	IN	_	22	case
22	cortisol	cortisol	NN	_	20	nmod
23	does	do	VBZ	_	25	aux
24	not	not	RB	_	25	neg
25	enhance	enhance	VB	_	16	ccomp
26	the	the	DT	_	28	det
27	psychostimulant	psychostimulant	JJ	_	28	amod
28	effects	effect	NNS	_	25	dobj
29	of	of	IN	_	30	case
30	drug2	drug2	NN	_	28	nmod
31	in	in	IN	_	32	case
32	humans	human	NNS	_	28	nmod
33	.	.	.	_	1	punct

1	Effect	effect	NN	_	0	ROOT
2	of	of	IN	_	3	case
3	drug1	drug1	NN	_	1	nmod
4	on	on	IN	_	5	case
5	drug2	drug2	NN	_	1	nmod
6	-	-	:	_	1	punct
7	induced	induce	VBN	_	8	amod
8	changes	change	NNS	_	1	dep
9	in	in	IN	_	12	case
10	steroid	steroid	NN	_	12	compound
11	hormone	hormone	NN	_	12	compound
12	levels	level	NNS	_	8	nmod
13	and	and	CC	_	12	cc
14	lethality	lethality	NN	_	12	conj
15	in	in	IN	_	17	case
16	male	male	JJ	_	17	amod
17	rats	rat	NNS	_	8	nmod
18	.	.	.	_	1	punct

1	We	we	PRP	_	2	nsubj
2	examined	examine	VBD	_	0	ROOT
3	the	the	DT	_	4	det
4	effect	effect	NN	_	2	dobj
5	of	of	IN	_	7	case
6	exogenous	exogenous	JJ	_	7	amod
7	drug1	drug1	NN	_	4	nmod
8	on	on	IN	_	10	case
9	the	the	DT	_	10	det
10	changes	change	NNS	_	4	nmod
11	in	in	IN	_	15	case
12	serum	serum	NN	_	15	compound
13	steroid	steroid	NN	_	15	compound
14	hormone	hormone	NN	_	15	compound
15	levels	level	NNS	_	10	nmod
16	induced	induce	VBN	_	15	acl
17	by	by	IN	_	20	case
18	a	a	DT	_	20	det
19	nonlethal	nonlethal	JJ	_	20	amod
20	dose	dose	NN	_	16	nmod
21	of	of	IN	_	24	case
22	Escherichia	escherichia	FW	_	24	compound
23	coli	coli	FW	_	24	compound
24	drug2	drug2	NN	_	20	nmod
25	in	in	IN	_	27	case
26	male	male	JJ	_	27	amod
27	rats	rat	NNS	_	16	nmod
28	and	and	CC	_	4	cc
29	the	the	DT	_	30	det
30	deaths	death	NNS	_	4	conj
31	due	due	JJ	_	36	case
32	to	to	TO	_	31	mwe
33	nonlethal	nonlethal	JJ	_	36	amod
34	and	and	CC	_	33	cc
35	lethal	lethal	JJ	_	33	conj
36	doses	dose	NNS	_	30	nmod
37	of	of	IN	_	38	case
38	drug3	drug3	NN	_	36	nmod
39	.	.	.	_	2	punct

1	Injection	injection	NN	_	12	nsubj
2	of	of	IN	_	3	case
3	drug1	drug1	NN	_	1	nmod
4	5	5	CD	_	5	nummod
5	min	min	NN	_	3	dep
6	before	before	IN	_	9	case
7	a	a	DT	_	9	det
8	nonlethal	nonlethal	JJ	_	9	amod
9	dose	dose	NN	_	1	nmod
10	of	of	IN	_	11	case
11	drug2	drug2	NN	_	9	nmod
12	changed	change	VBD	_	0	ROOT
13	the	the	DT	_	18	det
14	serum	serum	NN	_	18	compound
15	sex	sex	NN	_	18	compound
16	steroid	steroid	NN	_	18	compound
17	hormone	hormone	NN	_	18	compound
18	response	response	NN	_	12	dobj
19	of	of	IN	_	21	case
20	male	male	JJ	_	21	amod
21	rats	rat	NNS	_	18	nmod
22	to	to	TO	_	23	case
23	drug3	drug3	NN	_	18	nmod
24	.	.	.	_	12	punct

1	The	the	DT	_	4	det
2	serum	serum	NN	_	4	compound
3	estrogen	estrogen	NN	_	4	compound
4	concentrations	concentration	NNS	_	0	ROOT
5	of	of	IN	_	6	case
6	drug1	drug1	NN	_	4	nmod
7	+	+	CC	_	6	cc
8	drug2	drug2	NN	_	6	conj
9	-	-	:	_	6	punct
10	treated	treat	VBN	_	11	amod
11	rats	rat	NNS	_	6	dep
12	decreased	decrease	VBN	_	11	acl
13	by	by	IN	_	15	case
14	50	50	CD	_	15	nummod
15	%	%	NN	_	12	nmod
16	,	,	,	_	4	punct
17	while	while	IN	_	25	mark
18	those	those	DT	_	25	nsubj
19	of	of	IN	_	21	case
20	the	the	DT	_	21	det
21	drug3	drug3	NN	_	18	nmod
22	-	-	:	_	21	punct
23	treated	treat	VBN	_	24	amod
24	rats	rat	NNS	_	21	dep
25	increased	increase	VBD	_	16	root
26	-LRB-	-lrb-	-LRB-	_	27	punct
27	2	2	LS	_	25	dep
28	-	-	:	_	27	punct
29	to	to	TO	_	30	case
30	5-fold	5-fold	RB	_	27	nmod
31	-RRB-	-rrb-	-RRB-	_	27	punct
32	.	.	.	_	25	punct

1	The	the	DT	_	4	det
2	serum	serum	NN	_	4	compound
3	androgen	androgen	NN	_	4	compound
4	concentrations	concentration	NNS	_	14	nsubj
5	of	of	IN	_	6	case
6	drug1	drug1	NN	_	4	nmod
7	+	+	CC	_	6	cc
8	drug2	drug2	NN	_	6	conj
9	-	-	:	_	6	punct
10	treated	treat	VBN	_	11	amod
11	rats	rat	NNS	_	6	dep
12	did	do	VBD	_	14	aux
13	not	not	RB	_	14	neg
14	change	change	VB	_	0	ROOT
15	significantly	significantly	RB	_	14	advmod
16	,	,	,	_	14	punct
17	while	while	IN	_	24	mark
18	those	those	DT	_	24	nsubj
19	of	of	IN	_	20	case
20	drug3	drug3	NN	_	18	nmod
21	-	-	:	_	20	punct
22	treated	treat	VBN	_	23	amod
23	rats	rat	NNS	_	20	dep
24	dropped	drop	VBD	_	14	advcl
25	to	to	TO	_	27	case
26	30-40	30-40	CD	_	27	nummod
27	%	%	NN	_	24	nmod

1	0.001	0.001	CD	_	0	ROOT
2	.	.	.	_	1	punct

1	Exogenous	exogenous	JJ	_	2	amod
2	drug1	drug1	NN	_	4	nsubj
3	also	also	RB	_	4	advmod
4	appeared	appear	VBD	_	0	ROOT
5	to	to	TO	_	6	mark
6	influence	influence	VB	_	4	xcomp
7	the	the	DT	_	8	det
8	percentage	percentage	NN	_	6	dobj
9	of	of	IN	_	10	case
10	drug2	drug2	NN	_	8	nmod
11	-	-	:	_	8	punct
12	induced	induce	VBN	_	13	amod
13	deaths	death	NNS	_	8	dep
14	in	in	IN	_	17	case
15	a	a	DT	_	17	det
16	dose-dependent	dose-dependent	JJ	_	17	amod
17	manner	manner	NN	_	13	nmod
18	.	.	.	_	4	punct

1	It	it	PRP	_	2	nsubj
2	reduced	reduce	VBD	_	0	ROOT
3	the	the	DT	_	4	det
4	number	number	NN	_	2	dobj
5	of	of	IN	_	6	case
6	deaths	death	NNS	_	4	nmod
7	induced	induce	VBN	_	6	acl
8	by	by	IN	_	14	case
9	nonlethal	nonlethal	JJ	_	14	amod
10	-LRB-	-lrb-	-LRB-	_	12	punct
11	2	2	CD	_	12	nummod
12	mg/kg	mg/kg	NN	_	9	dep
13	-RRB-	-rrb-	-RRB-	_	12	punct
14	dose	dose	NN	_	7	nmod
15	of	of	IN	_	16	case
16	drug1	drug1	NN	_	14	nmod
17	but	but	CC	_	2	cc
18	increased	increase	VBD	_	2	conj
19	the	the	DT	_	20	det
20	number	number	NN	_	18	dobj
21	of	of	IN	_	22	case
22	deaths	death	NNS	_	20	nmod
23	induced	induce	VBN	_	22	acl
24	by	by	IN	_	28	case
25	a	a	DT	_	28	det
26	highly	highly	RB	_	27	advmod
27	lethal	lethal	JJ	_	28	amod
28	dose	dose	NN	_	23	nmod
29	-LRB-	-lrb-	-LRB-	_	31	punct
30	8	8	CD	_	31	nummod
31	mg/kg	mg/kg	NN	_	28	appos
32	-RRB-	-rrb-	-RRB-	_	31	punct
33	.	.	.	_	2	punct

1	These	these	DT	_	2	det
2	results	result	NNS	_	16	nsubj
3	,	,	,	_	2	punct
4	together	together	RB	_	8	advmod
5	with	with	IN	_	8	case
6	the	the	DT	_	8	det
7	known	known	JJ	_	8	amod
8	relationships	relationship	NNS	_	2	nmod
9	between	between	IN	_	10	case
10	drug1	drug1	NN	_	8	nmod
11	and	and	CC	_	10	cc
12	the	the	DT	_	14	det
13	immune	immune	JJ	_	14	amod
14	response	response	NN	_	10	conj
15	,	,	,	_	2	punct
16	suggest	suggest	VBP	_	0	ROOT
17	that	that	IN	_	19	mark
18	drug2	drug2	NN	_	19	nsubj
19	affect	affect	VBP	_	16	ccomp
20	the	the	DT	_	21	det
21	course	course	NN	_	19	dobj
22	of	of	IN	_	24	case
23	septic	septic	JJ	_	24	amod
24	shock	shock	NN	_	21	nmod
25	in	in	IN	_	28	case
26	a	a	DT	_	28	det
27	complex	complex	JJ	_	28	amod
28	fashion	fashion	NN	_	19	nmod
29	and	and	CC	_	19	cc
30	may	may	MD	_	31	aux
31	have	have	VB	_	19	conj
32	either	either	CC	_	33	cc:preconj
33	protective	protective	JJ	_	36	amod
34	or	or	CC	_	33	cc
35	deleterious	deleterious	JJ	_	33	conj
36	effect	effect	NN	_	31	dobj
37	.	.	.	_	16	punct

1	Studies	study	NNS	_	0	ROOT
2	on	on	IN	_	4	case
3	the	the	DT	_	4	det
4	mechanism	mechanism	NN	_	1	nmod
5	of	of	IN	_	6	case
6	action	action	NN	_	4	nmod
7	of	of	IN	_	8	case
8	drug1	drug1	NN	_	6	nmod
9	:	:	:	_	1	punct
10	effect	effect	NN	_	1	dep
11	of	of	IN	_	12	case
12	drug2	drug2	NN	_	10	nmod
13	on	on	IN	_	14	case
14	respiration	respiration	NN	_	10	nmod
15	and	and	CC	_	14	cc
16	cell	cell	NN	_	17	compound
17	permeability	permeability	NN	_	14	conj
18	of	of	IN	_	20	case
19	Candida	candida	NN	_	20	compound
20	albicans	albican	NNS	_	14	nmod
21	.	.	.	_	1	punct

1	The	the	DT	_	6	dep
2	drug1	drug1	NN	_	6	nsubj
3	,	,	,	_	2	punct
4	drug2	drug2	NN	_	2	appos
5	,	,	,	_	2	punct
6	inhibits	inhibit	VBZ	_	0	ROOT
7	the	the	DT	_	8	det
8	growth	growth	NN	_	6	dobj
9	of	of	IN	_	11	case
10	several	several	JJ	_	11	amod
11	species	species	NNS	_	8	nmod
12	of	of	IN	_	13	case
13	Candida	candida	NN	_	11	nmod
14	.	.	.	_	6	punct

1	Candida	candida	NN	_	2	compound
2	albicans	albican	NNS	_	12	nsubjpass
3	,	,	,	_	2	punct
4	one	one	CD	_	2	appos
5	of	of	IN	_	8	case
6	the	the	DT	_	8	det
7	pathogenic	pathogenic	JJ	_	8	amod
8	species	species	NNS	_	4	nmod
9	,	,	,	_	2	punct
10	was	be	VBD	_	12	auxpass
11	totally	totally	RB	_	12	advmod
12	inhibited	inhibit	VBN	_	0	ROOT
13	at	at	IN	_	15	case
14	a	a	DT	_	15	det
15	concentration	concentration	NN	_	12	nmod
16	of	of	IN	_	19	case
17	approximately	approximately	RB	_	18	advmod
18	10	10	CD	_	19	nummod
19	mug/ml	mug/ml	NN	_	15	nmod
20	.	.	.	_	12	punct

1	Endogenous	endogenous	JJ	_	2	amod
2	respiration	respiration	NN	_	4	nsubj
3	was	be	VBD	_	4	aux
4	unaffected	unaffected	JJ	_	0	ROOT
5	by	by	IN	_	7	case
6	the	the	DT	_	7	det
7	drug	drug	NN	_	4	nmod
8	at	at	IN	_	10	case
9	a	a	DT	_	10	det
10	concentration	concentration	NN	_	4	nmod
11	as	as	RB	_	12	advmod
12	high	high	JJ	_	10	amod
13	as	as	IN	_	15	case
14	100	100	CD	_	15	nummod
15	mug/ml	mug/ml	NN	_	12	nmod
16	,	,	,	_	4	punct
17	whereas	whereas	IN	_	4	dep
18	exogenous	exogenous	JJ	_	19	amod
19	respiration	respiration	NN	_	22	nsubj
20	was	be	VBD	_	22	cop
21	markedly	markedly	RB	_	22	advmod
22	sensitive	sensitive	JJ	_	4	parataxis
23	and	and	CC	_	22	cc
24	inhibited	inhibit	VBD	_	22	conj
25	to	to	TO	_	27	case
26	an	a	DT	_	27	det
27	extent	extent	NN	_	24	nmod
28	of	of	IN	_	30	case
29	85	85	CD	_	30	nummod
30	%	%	NN	_	27	nmod
31	.	.	.	_	4	punct

1	The	the	DT	_	2	det
2	permeability	permeability	NN	_	8	nsubjpass
3	of	of	IN	_	6	case
4	the	the	DT	_	6	det
5	cell	cell	NN	_	6	compound
6	membrane	membrane	NN	_	2	nmod
7	was	be	VBD	_	8	auxpass
8	changed	change	VBN	_	0	ROOT
9	as	as	IN	_	10	mark
10	evidenced	evidence	VBN	_	8	advcl
11	by	by	IN	_	13	case
12	the	the	DT	_	13	det
13	leakage	leakage	NN	_	10	nmod
14	of	of	IN	_	17	case
15	260-nm	260-nm	JJ	_	17	amod
16	absorbing	absorb	VBG	_	17	amod
17	materials	material	NNS	_	13	nmod
18	,	,	,	_	17	punct
19	amino	amino	NN	_	20	compound
20	acids	acid	NNS	_	17	conj
21	,	,	,	_	17	punct
22	proteins	protein	NNS	_	17	conj
23	,	,	,	_	17	punct
24	and	and	CC	_	17	cc
25	inorganic	inorganic	JJ	_	26	amod
26	cations	cation	NNS	_	17	conj
27	.	.	.	_	8	punct

1	The	the	DT	_	2	det
2	results	result	NNS	_	6	nsubj
3	we	we	PRP	_	4	nsubj
4	present	present	VBP	_	2	acl:relcl
5	clearly	clearly	RB	_	4	advmod
6	show	show	VB	_	0	ROOT
7	that	that	IN	_	10	mark
8	the	the	DT	_	9	det
9	drug	drug	NN	_	10	nsubj
10	alters	alter	VBZ	_	6	ccomp
11	the	the	DT	_	13	det
12	cellular	cellular	JJ	_	13	amod
13	permeability	permeability	NN	_	10	dobj
14	,	,	,	_	10	punct
15	and	and	CC	_	10	cc
16	thus	thus	RB	_	20	advmod
17	the	the	DT	_	19	det
18	exogenous	exogenous	JJ	_	19	amod
19	respiration	respiration	NN	_	20	nsubj
20	becomes	become	VBZ	_	10	conj
21	sensitive	sensitive	JJ	_	20	xcomp
22	to	to	TO	_	24	case
23	the	the	DT	_	24	det
24	drug	drug	NN	_	21	nmod
25	.	.	.	_	6	punct

1	Interferon	interferon	NN	_	2	compound
2	induction	induction	NN	_	0	ROOT
3	:	:	:	_	2	punct
4	tool	tool	NN	_	2	dep
5	for	for	IN	_	6	mark
6	establishing	establish	VBG	_	4	acl
7	interactions	interaction	NNS	_	6	dobj
8	among	among	IN	_	9	case
9	homopolyribonucleotides	homopolyribonucleotide	NNS	_	7	nmod
10	.	.	.	_	2	punct

1	Hitherto	hitherto	RB	_	2	advmod
2	unrecognized	unrecognized	JJ	_	3	amod
3	interactions	interaction	NNS	_	10	nsubjpass
4	between	between	IN	_	5	case
5	homopolyribonucleotides	homopolyribonucleotide	NNS	_	3	nmod
6	and	and	CC	_	5	cc
7	complexes	complex	NNS	_	5	conj
8	thereof	thereof	RB	_	10	advmod
9	are	be	VBP	_	10	auxpass
10	suggested	suggest	VBN	_	0	ROOT
11	by	by	IN	_	14	case
12	interferon	interferon	NN	_	14	compound
13	induction	induction	NN	_	14	compound
14	data	datum	NNS	_	10	nmod
15	obtained	obtain	VBN	_	14	acl
16	in	in	IN	_	21	case
17	a	a	DT	_	21	det
18	highly	highly	RB	_	19	advmod
19	sensitive	sensitive	JJ	_	21	amod
20	assay	assay	NN	_	21	compound
21	system	system	NN	_	15	nmod
22	of	of	IN	_	27	case
23	primary	primary	JJ	_	27	amod
24	rabbit	rabbit	NN	_	27	compound
25	kidney	kidney	NN	_	27	compound
26	cell	cell	NN	_	27	compound
27	cultures	culture	NNS	_	21	nmod
28	superinduced	superinduce	VBN	_	27	acl
29	by	by	IN	_	31	case
30	metabolic	metabolic	JJ	_	31	amod
31	inhibitors	inhibitor	NNS	_	28	nmod
32	.	.	.	_	10	punct

1	drug1	drug1	NN	_	0	ROOT
2	:	:	:	_	1	punct
3	a	a	DT	_	4	det
4	therapeutic	therapeutic	JJ	_	5	nsubj
5	update	update	VBP	_	1	dep
6	.	.	.	_	1	punct

1	BACKGROUND	background	NN	_	0	ROOT
2	:	:	:	_	1	punct
3	Since	since	IN	_	5	case
4	its	its	PRP$	_	5	nmod:poss
5	approval	approval	NN	_	20	nmod
6	by	by	IN	_	9	case
7	the	the	DT	_	9	det
8	US	US	NNP	_	9	compound
9	Food	Food	NNP	_	5	nmod
10	and	and	CC	_	9	cc
11	Drug	Drug	NNP	_	12	compound
12	Administration	Administration	NNP	_	9	conj
13	in	in	IN	_	14	case
14	March	March	NNP	_	5	nmod
15	1998	1998	CD	_	14	nummod
16	,	,	,	_	20	punct
17	drug1	drug1	NN	_	20	nsubjpass
18	has	have	VBZ	_	20	aux
19	been	be	VBN	_	20	auxpass
20	used	use	VBN	_	1	dep
21	by	by	IN	_	22	case
22	millions	million	NNS	_	20	nmod
23	of	of	IN	_	24	case
24	men	man	NNS	_	22	nmod
25	for	for	IN	_	27	case
26	the	the	DT	_	27	det
27	treatment	treatment	NN	_	20	nmod
28	of	of	IN	_	30	case
29	erectile	erectile	JJ	_	30	amod
30	dysfunction	dysfunction	NN	_	27	nmod
31	.	.	.	_	1	punct

1	Recent	recent	JJ	_	2	amod
2	studies	study	NNS	_	7	nsubj
3	and	and	CC	_	2	cc
4	consensus	consensus	NN	_	5	compound
5	reports	report	NNS	_	2	conj
6	have	have	VBP	_	7	aux
7	expanded	expand	VBN	_	0	ROOT
8	our	we	PRP$	_	9	nmod:poss
9	understanding	understanding	NN	_	7	dobj
10	of	of	IN	_	12	case
11	its	its	PRP$	_	12	nmod:poss
12	efficacy	efficacy	NN	_	9	nmod
13	,	,	,	_	12	punct
14	safety	safety	NN	_	12	conj
15	,	,	,	_	12	punct
16	contraindications	contraindication	NNS	_	12	conj
17	,	,	,	_	12	punct
18	and	and	CC	_	12	cc
19	drug	drug	NN	_	20	compound
20	interactions	interaction	NNS	_	12	conj
21	.	.	.	_	7	punct

1	OBJECTIVE	objective	NN	_	0	ROOT
2	:	:	:	_	1	punct
3	This	this	DT	_	4	det
4	paper	paper	NN	_	5	nsubj
5	reviews	review	VBZ	_	1	dep
6	recent	recent	JJ	_	7	amod
7	studies	study	NNS	_	5	dobj
8	of	of	IN	_	10	case
9	the	the	DT	_	10	det
10	efficacy	efficacy	NN	_	7	nmod
11	of	of	IN	_	12	case
12	drug1	drug1	NN	_	10	nmod
13	,	,	,	_	10	punct
14	its	its	PRP$	_	16	nmod:poss
15	adverse	adverse	JJ	_	16	amod
16	effects	effect	NNS	_	10	conj
17	and	and	CC	_	10	cc
18	drug	drug	NN	_	19	compound
19	interactions	interaction	NNS	_	10	conj
20	,	,	,	_	5	punct
21	and	and	CC	_	5	cc
22	socioeconomic	socioeconomic	JJ	_	23	amod
23	factors	factor	NNS	_	5	conj
24	involved	involve	VBN	_	23	acl
25	in	in	IN	_	27	case
26	its	its	PRP$	_	27	nmod:poss
27	use	use	NN	_	24	nmod
28	,	,	,	_	23	punct
29	with	with	IN	_	31	case
30	a	a	DT	_	31	det
31	focus	focus	NN	_	23	nmod
32	on	on	IN	_	35	case
33	specific	specific	JJ	_	35	amod
34	patient	patient	NN	_	35	compound
35	populations	population	NNS	_	31	nmod
36	-LRB-	-lrb-	-LRB-	_	38	punct
37	prostate	prostate	NN	_	38	compound
38	cancer	cancer	NN	_	35	dep
39	,	,	,	_	38	punct
40	diabetes	diabetes	NN	_	41	compound
41	mellitus	mellitus	NN	_	38	conj
42	,	,	,	_	38	punct
43	ischemic	ischemic	JJ	_	45	amod
44	heart	heart	NN	_	45	compound
45	disease	disease	NN	_	38	conj
46	,	,	,	_	38	punct
47	spinal	spinal	JJ	_	49	amod
48	cord	cord	NN	_	49	compound
49	injuries	injury	NNS	_	38	conj
50	,	,	,	_	38	punct
51	neurologic	neurologic	JJ	_	52	amod
52	disorders	disorder	NNS	_	38	appos
53	-RRB-	-rrb-	-RRB-	_	38	punct
54	.	.	.	_	1	punct

1	METHODS	method	NNS	_	0	ROOT
2	:	:	:	_	1	punct
3	Clinical	clinical	JJ	_	4	amod
4	studies	study	NNS	_	27	nsubjpass
5	,	,	,	_	4	punct
6	case	case	NN	_	7	compound
7	reports	report	NNS	_	4	conj
8	,	,	,	_	4	punct
9	and	and	CC	_	4	cc
10	commentaries	commentary	NNS	_	4	conj
11	and	and	CC	_	10	cc
12	editorials	editorial	NNS	_	10	conj
13	concerning	concern	VBG	_	14	case
14	drug1	drug1	NN	_	10	nmod
15	published	publish	VBN	_	14	acl
16	in	in	IN	_	19	case
17	the	the	DT	_	19	det
18	international	international	JJ	_	19	amod
19	literature	literature	NN	_	15	nmod
20	between	between	IN	_	21	case
21	January	January	NNP	_	19	nmod
22	1999	1999	CD	_	21	nummod
23	and	and	CC	_	21	cc
24	August	August	NNP	_	21	conj
25	2000	2000	CD	_	24	nummod
26	were	be	VBD	_	27	auxpass
27	identified	identify	VBN	_	1	dep
28	through	through	IN	_	29	case
29	searches	search	NNS	_	27	nmod
30	of	of	IN	_	31	case
31	MEDLINE	medline	NN	_	29	nmod
32	,	,	,	_	31	punct
33	PREMEDLINE	premedline	NN	_	31	conj
34	,	,	,	_	31	punct
35	and	and	CC	_	31	cc
36	International	International	NNP	_	38	compound
37	Pharmaceutical	Pharmaceutical	NNP	_	38	compound
38	Abstracts	Abstracts	NNPS	_	31	conj
39	,	,	,	_	27	punct
40	using	use	VBG	_	27	xcomp
41	the	the	DT	_	42	det
42	terms	term	NNS	_	40	dobj
43	drug2	drug2	NN	_	42	dep
44	,	,	,	_	43	punct
45	drug3	drug3	NN	_	43	conj
46	,	,	,	_	43	punct
47	and	and	CC	_	43	cc
48	erectile	erectile	NN	_	49	compound
49	dysfunction	dysfunction	NN	_	43	conj
50	.	.	.	_	1	punct

1	RESULTS	result	NNS	_	0	ROOT
2	:	:	:	_	1	punct
3	drug1	drug1	NN	_	5	nsubj
4	has	have	VBZ	_	5	aux
5	demonstrated	demonstrate	VBN	_	1	appos
6	effectiveness	effectiveness	NN	_	5	dobj
7	in	in	IN	_	8	case
8	men	man	NNS	_	6	nmod
9	with	with	IN	_	11	case
10	erectile	erectile	JJ	_	11	amod
11	dysfunction	dysfunction	NN	_	8	nmod
12	associated	associate	VBN	_	11	acl
13	with	with	IN	_	14	case
14	prostatectomy	prostatectomy	NN	_	12	nmod
15	,	,	,	_	14	punct
16	radiation	radiation	NN	_	17	compound
17	therapy	therapy	NN	_	14	conj
18	,	,	,	_	14	punct
19	diabetes	diabetes	NN	_	20	compound
20	mellitus	mellitus	NN	_	14	conj
21	,	,	,	_	14	punct
22	certain	certain	JJ	_	24	amod
23	neurologic	neurologic	JJ	_	24	amod
24	disorders	disorder	NNS	_	14	conj
25	,	,	,	_	14	punct
26	and	and	CC	_	14	cc
27	drug	drug	NN	_	28	compound
28	therapy	therapy	NN	_	14	conj
29	-LRB-	-lrb-	-LRB-	_	32	punct
30	eg	eg	FW	_	32	dep
31	,	,	,	_	32	punct
32	drug2	drug2	NN	_	28	dep
33	-LSB-	-lsb-	-LRB-	_	34	punct
34	drug3	drug3	NN	_	32	appos
35	-RSB-	-rsb-	-RRB-	_	34	punct
36	-RRB-	-rrb-	-RRB-	_	32	punct
37	.	.	.	_	1	punct

1	It	it	PRP	_	6	nsubj
2	has	have	VBZ	_	6	aux
3	not	not	RB	_	6	neg
4	been	be	VBN	_	6	cop
5	as	as	IN	_	6	advmod
6	effective	effective	JJ	_	0	ROOT
7	in	in	IN	_	8	case
8	women	woman	NNS	_	6	nmod
9	with	with	IN	_	11	case
10	sexual	sexual	JJ	_	11	amod
11	dysfunction	dysfunction	NN	_	8	nmod
12	,	,	,	_	6	punct
13	with	with	IN	_	15	case
14	the	the	DT	_	15	det
15	exception	exception	NN	_	6	nmod
16	of	of	IN	_	17	case
17	drug1	drug1	NN	_	15	nmod
18	-	-	:	_	15	punct
19	associated	associate	VBN	_	21	amod
20	sexual	sexual	JJ	_	21	amod
21	dysfunction	dysfunction	NN	_	15	dep
22	.	.	.	_	6	punct

1	Some	some	DT	_	2	det
2	disorders	disorder	NNS	_	16	nsubj
3	unrelated	unrelated	JJ	_	2	amod
4	to	to	TO	_	6	case
5	sexual	sexual	JJ	_	6	amod
6	dysfunction	dysfunction	NN	_	3	nmod
7	-LRB-	-lrb-	-LRB-	_	12	punct
8	eg	eg	FW	_	12	compound
9	,	,	,	_	12	punct
10	esophageal	esophageal	JJ	_	12	amod
11	motility	motility	NN	_	12	compound
12	dysfunction	dysfunction	NN	_	6	appos
13	-RRB-	-rrb-	-RRB-	_	12	punct
14	may	may	MD	_	16	aux
15	also	also	RB	_	16	advmod
16	respond	respond	VB	_	0	ROOT
17	to	to	TO	_	18	case
18	drug1	drug1	NN	_	16	nmod
19	.	.	.	_	16	punct

1	In	in	IN	_	4	case
2	the	the	DT	_	4	det
3	general	general	JJ	_	4	amod
4	population	population	NN	_	8	nmod
5	,	,	,	_	8	punct
6	drug1	drug1	NN	_	8	nsubjpass
7	is	be	VBZ	_	8	auxpass
8	considered	consider	VBN	_	0	ROOT
9	to	to	TO	_	10	mark
10	have	have	VB	_	8	xcomp
11	an	a	DT	_	14	det
12	acceptable	acceptable	JJ	_	14	amod
13	tolerability	tolerability	NN	_	14	compound
14	profile	profile	NN	_	10	dobj
15	;	;	:	_	8	punct

1	however	however	RB	_	18	advmod
2	,	,	,	_	18	punct
3	patients	patient	NNS	_	18	nsubj
4	with	with	IN	_	5	case
5	moderate	moderate	JJ	_	3	nmod
6	to	to	TO	_	9	case
7	severe	severe	JJ	_	9	amod
8	cardiovascular	cardiovascular	JJ	_	9	amod
9	disease	disease	NN	_	5	nmod
10	or	or	CC	_	5	cc
11	those	those	DT	_	5	conj
12	taking	take	VBG	_	11	acl
13	drug1	drug1	NN	_	14	compound
14	therapy	therapy	NN	_	12	dobj
15	are	be	VBP	_	18	cop
16	at	at	IN	_	18	case
17	increased	increase	VBN	_	18	amod
18	risk	risk	NN	_	0	ROOT
19	for	for	IN	_	24	case
20	potentially	potentially	RB	_	21	advmod
21	serious	serious	JJ	_	24	amod
22	cardiovascular	cardiovascular	JJ	_	24	amod
23	adverse	adverse	JJ	_	24	amod
24	effects	effect	NNS	_	18	nmod
25	with	with	IN	_	27	case
26	drug2	drug2	NN	_	27	compound
27	therapy	therapy	NN	_	24	nmod
28	.	.	.	_	18	punct

1	In	in	IN	_	2	case
2	addition	addition	NN	_	20	nmod
3	,	,	,	_	20	punct
4	patients	patient	NNS	_	20	nsubj
5	taking	take	VBG	_	4	acl
6	drugs	drug	NNS	_	5	dobj
7	that	that	WDT	_	8	nsubj
8	inhibit	inhibit	VBP	_	6	acl:relcl
9	the	the	DT	_	13	det
10	cytochrome	cytochrome	NN	_	13	compound
11	P450	p450	NN	_	13	compound
12	3A4	3a4	NN	_	13	compound
13	isozyme	isozyme	NN	_	8	dobj
14	,	,	,	_	13	punct
15	which	which	WDT	_	16	nsubj
16	metabolizes	metabolize	VBZ	_	13	acl:relcl
17	drug1	drug1	NN	_	16	dobj
18	,	,	,	_	20	punct
19	may	may	MD	_	20	aux
20	experience	experience	VB	_	0	ROOT
21	increased	increase	VBN	_	23	amod
22	drug	drug	NN	_	23	compound
23	concentrations	concentration	NNS	_	20	dobj
24	and	and	CC	_	23	cc
25	possible	possible	JJ	_	26	amod
26	toxicity	toxicity	NN	_	23	conj
27	from	from	IN	_	29	case
28	normal	normal	JJ	_	29	amod
29	doses	dose	NNS	_	20	nmod
30	of	of	IN	_	31	case
31	drug2	drug2	NN	_	29	nmod
32	.	.	.	_	20	punct

1	CONCLUSIONS	conclusion	NNS	_	0	ROOT
2	:	:	:	_	1	punct
3	drug1	drug1	NN	_	8	nsubj
4	is	be	VBZ	_	8	cop
5	an	a	DT	_	8	det
6	effective	effective	JJ	_	8	amod
7	first-line	first-line	JJ	_	8	amod
8	therapy	therapy	NN	_	1	dep
9	for	for	IN	_	11	case
10	erectile	erectile	JJ	_	11	amod
11	dysfunction	dysfunction	NN	_	8	nmod
12	in	in	IN	_	13	case
13	men	man	NNS	_	11	nmod
14	.	.	.	_	1	punct

1	The	the	DT	_	2	det
2	decision	decision	NN	_	8	nsubj
3	to	to	TO	_	4	mark
4	prescribe	prescribe	VB	_	2	acl
5	this	this	DT	_	6	det
6	agent	agent	NN	_	4	dobj
7	should	should	MD	_	8	aux
8	include	include	VB	_	0	ROOT
9	such	such	JJ	_	10	amod
10	considerations	consideration	NNS	_	8	dobj
11	as	as	IN	_	14	case
12	the	the	DT	_	14	det
13	cost-risk-benefit	cost-risk-benefit	JJ	_	14	amod
14	balance	balance	NN	_	10	nmod
15	,	,	,	_	14	punct
16	patient	patient	NN	_	17	compound
17	access	access	NN	_	14	conj
18	,	,	,	_	14	punct
19	drug	drug	NN	_	21	compound
20	distribution	distribution	NN	_	21	compound
21	pathways	pathway	NNS	_	14	conj
22	,	,	,	_	14	punct
23	and	and	CC	_	14	cc
24	prescription	prescription	NN	_	26	compound
25	drug	drug	NN	_	26	compound
26	coverage	coverage	NN	_	14	conj
27	.	.	.	_	8	punct

1	Tumor	tumor	NN	_	2	compound
2	phenotype	phenotype	NN	_	0	ROOT
3	and	and	CC	_	2	cc
4	susceptibility	susceptibility	NN	_	2	conj
5	to	to	TO	_	6	case
6	progression	progression	NN	_	4	nmod
7	as	as	IN	_	9	case
8	an	a	DT	_	9	det
9	expression	expression	NN	_	2	nmod
10	of	of	IN	_	11	case
11	subpopulations	subpopulation	NNS	_	9	nmod
12	of	of	IN	_	15	case
13	initiated	initiate	VBN	_	15	amod
14	murine	murine	JJ	_	15	amod
15	cells	cell	NNS	_	11	nmod
16	.	.	.	_	2	punct

1	Currently	currently	RB	_	5	advmod
2	,	,	,	_	5	punct
3	it	it	PRP	_	5	nsubjpass
4	is	be	VBZ	_	5	auxpass
5	conceived	conceive	VBN	_	0	ROOT
6	that	that	IN	_	16	mark
7	a	a	DT	_	8	det
8	number	number	NN	_	16	nsubjpass
9	of	of	IN	_	10	case
10	events	event	NNS	_	8	nmod
11	,	,	,	_	10	punct
12	or	or	CC	_	10	cc
13	hits	hit	NNS	_	10	conj
14	,	,	,	_	8	punct
15	are	be	VBP	_	16	auxpass
16	required	require	VBN	_	5	ccomp
17	for	for	IN	_	19	case
18	the	the	DT	_	19	det
19	induction	induction	NN	_	16	nmod
20	of	of	IN	_	21	case
21	tumors	tumor	NNS	_	19	nmod
22	by	by	IN	_	24	case
23	chemical	chemical	NN	_	24	compound
24	agents	agent	NNS	_	19	nmod
25	.	.	.	_	5	punct

1	The	the	DT	_	3	det
2	first	first	JJ	_	3	amod
3	phase	phase	NN	_	11	nsubjpass
4	of	of	IN	_	6	case
5	this	this	DT	_	6	det
6	sequence	sequence	NN	_	3	nmod
7	,	,	,	_	3	punct
8	initiation	initiation	NN	_	3	appos
9	,	,	,	_	3	punct
10	is	be	VBZ	_	11	auxpass
11	considered	consider	VBN	_	0	ROOT
12	to	to	TO	_	13	mark
13	result	result	VB	_	11	xcomp
14	from	from	IN	_	18	case
15	at	at	IN	_	16	case
16	least	least	JJS	_	17	nmod:npmod
17	one	one	CD	_	18	nummod
18	event	event	NN	_	13	nmod
19	in	in	IN	_	22	case
20	the	the	DT	_	22	det
21	genetic	genetic	JJ	_	22	amod
22	apparatus	apparatus	NN	_	18	nmod
23	.	.	.	_	11	punct

1	Analyses	analysis	NNS	_	9	nsubj
2	of	of	IN	_	4	case
3	this	this	DT	_	4	det
4	sequence	sequence	NN	_	1	nmod
5	,	,	,	_	9	punct
6	however	however	RB	_	9	advmod
7	,	,	,	_	9	punct
8	usually	usually	RB	_	9	advmod
9	give	give	VBP	_	0	ROOT
10	little	little	JJ	_	11	amod
11	consideration	consideration	NN	_	9	dobj
12	to	to	TO	_	14	case
13	the	the	DT	_	14	det
14	nature	nature	NN	_	9	nmod
15	of	of	IN	_	18	case
16	the	the	DT	_	18	det
17	target	target	NN	_	18	compound
18	cell	cell	NN	_	14	nmod
19	or	or	CC	_	14	cc
20	to	to	TO	_	22	case
21	the	the	DT	_	22	det
22	characteristics	characteristic	NNS	_	14	conj
23	of	of	IN	_	26	case
24	the	the	DT	_	26	det
25	resultant	resultant	JJ	_	26	amod
26	tumors	tumor	NNS	_	22	nmod
27	.	.	.	_	9	punct

1	Vesselinovitch	Vesselinovitch	NNP	_	3	compound
2	et	et	FW	_	3	compound
3	al.	al.	FW	_	0	ROOT
4	.	.	.	_	3	punct

1	-LRB-	-lrb-	-LRB-	_	3	punct
2	Cancer	cancer	NN	_	3	compound
3	Res.	res.	NN	_	12	nsubj
4	,	,	,	_	3	punct
5	38	38	CD	_	3	amod
6	:	:	:	_	5	punct
7	2003-2010	2003-2010	CD	_	9	nummod
8	,	,	,	_	9	punct
9	1978	1978	CD	_	5	dep
10	-RRB-	-rrb-	-RRB-	_	3	punct
11	have	have	VBP	_	12	aux
12	reported	report	VBN	_	0	ROOT
13	that	that	IN	_	22	mark
14	a	a	DT	_	18	det
15	single	single	JJ	_	18	amod
16	,	,	,	_	18	punct
17	small	small	JJ	_	18	amod
18	pulse	pulse	NN	_	22	nsubj
19	of	of	IN	_	20	case
20	carcinogen	carcinogen	NN	_	18	nmod
21	can	can	MD	_	22	aux
22	induce	induce	VB	_	12	ccomp
23	early	early	JJ	_	27	amod
24	and	and	CC	_	23	cc
25	numerous	numerous	JJ	_	23	conj
26	liver	liver	NN	_	27	compound
27	tumors	tumor	NNS	_	22	dobj
28	when	when	WRB	_	29	advmod
29	administered	administer	VBN	_	22	advcl
30	neonatally	neonatally	RB	_	29	advmod
31	to	to	TO	_	32	case
32	mice	mouse	NNS	_	29	nmod
33	with	with	IN	_	36	case
34	a	a	DT	_	36	det
35	genetic	genetic	JJ	_	36	amod
36	predisposition	predisposition	NN	_	29	nmod
37	to	to	TO	_	38	case
38	hepatotumorigenesis	hepatotumorigenesis	NN	_	36	nmod
39	.	.	.	_	12	punct

1	In	in	IN	_	4	case
2	the	the	DT	_	4	det
3	current	current	JJ	_	4	amod
4	study	study	NN	_	12	nmod
5	,	,	,	_	12	punct
6	the	the	DT	_	9	det
7	nonpredisposed	nonpredisposed	JJ	_	9	amod
8	strain	strain	NN	_	9	compound
9	C57BL/6N	c57bl/6n	NN	_	12	nsubjpass
10	was	be	VBD	_	12	auxpass
11	also	also	RB	_	12	advmod
12	shown	show	VBN	_	0	ROOT
13	to	to	TO	_	16	mark
14	be	be	VB	_	16	cop
15	highly	highly	RB	_	16	advmod
16	susceptible	susceptible	JJ	_	12	xcomp
17	to	to	TO	_	18	case
18	diethylnitrosamine	diethylnitrosamine	NN	_	16	nmod
19	during	during	IN	_	22	case
20	the	the	DT	_	22	det
21	neonatal	neonatal	JJ	_	22	amod
22	period	period	NN	_	16	nmod
23	.	.	.	_	12	punct

1	C57BL/6N	c57bl/6n	NN	_	2	nsubj
2	demonstrated	demonstrate	VBD	_	0	ROOT
3	large	large	JJ	_	4	amod
4	numbers	number	NNS	_	2	dobj
5	of	of	IN	_	6	case
6	two	two	CD	_	4	nmod
7	of	of	IN	_	10	case
8	the	the	DT	_	10	det
9	three	three	CD	_	10	nummod
10	types	type	NNS	_	6	nmod
11	of	of	IN	_	13	case
12	liver	liver	NN	_	13	compound
13	tumors	tumor	NNS	_	10	nmod
14	seen	see	VBN	_	10	acl
15	in	in	IN	_	16	case
16	livers	liver	NNS	_	14	nmod
17	of	of	IN	_	20	case
18	genetically	genetically	RB	_	19	advmod
19	predisposed	predispose	VBN	_	20	amod
20	mice	mouse	NNS	_	16	nmod
21	,	,	,	_	4	punct
22	one	one	CD	_	25	nsubj
23	of	of	IN	_	24	case
24	which	which	WDT	_	22	nmod
25	required	require	VBD	_	4	acl:relcl
26	the	the	DT	_	28	det
27	additional	additional	JJ	_	28	amod
28	stimulus	stimulus	NN	_	25	dobj
29	of	of	IN	_	31	case
30	dietary	dietary	JJ	_	31	amod
31	drug1	drug1	NN	_	28	nmod
32	for	for	IN	_	33	case
33	growth	growth	NN	_	25	nmod
34	.	.	.	_	2	punct

1	Tumors	tumor	NNS	_	7	nsubjpass
2	of	of	IN	_	5	case
3	more	more	JJR	_	5	amod
4	malignant	malignant	JJ	_	5	amod
5	phenotype	phenotype	NN	_	1	nmod
6	were	be	VBD	_	7	auxpass
7	demonstrated	demonstrate	VBN	_	0	ROOT
8	only	only	RB	_	12	advmod
9	in	in	IN	_	12	case
10	genetically	genetically	RB	_	11	advmod
11	predisposed	predispose	VBN	_	12	amod
12	mice	mouse	NNS	_	7	nmod
13	-LRB-	-lrb-	-LRB-	_	17	punct
14	C57BL/6N	c57bl/6n	NN	_	17	compound
15	X	x	NN	_	17	compound
16	C3H/HeN	c3h/hen	NN	_	17	compound
17	F1	f1	NN	_	12	appos
18	-RRB-	-rrb-	-RRB-	_	17	punct
19	that	that	WDT	_	20	nsubj
20	received	receive	VBD	_	12	acl:relcl
21	one	one	CD	_	22	nummod
22	dose	dose	NN	_	20	dobj
23	of	of	IN	_	24	case
24	carcinogen	carcinogen	NN	_	22	nmod
25	.	.	.	_	7	punct

1	These	these	DT	_	2	det
2	findings	finding	NNS	_	3	nsubj
3	suggest	suggest	VBP	_	0	ROOT
4	that	that	IN	_	20	mark
5	the	the	DT	_	6	det
6	phenotype	phenotype	NN	_	20	nsubj
7	of	of	IN	_	9	case
8	a	a	DT	_	9	det
9	tumor	tumor	NN	_	6	nmod
10	that	that	WDT	_	11	nsubj
11	results	result	VBZ	_	9	acl:relcl
12	from	from	IN	_	14	case
13	a	a	DT	_	14	det
14	pulse	pulse	NN	_	11	nmod
15	of	of	IN	_	18	case
16	a	a	DT	_	18	det
17	chemical	chemical	NN	_	18	compound
18	carcinogen	carcinogen	NN	_	14	nmod
19	may	may	MD	_	20	aux
20	depend	depend	VB	_	3	ccomp
21	upon	upon	IN	_	24	case
22	the	the	DT	_	24	det
23	target	target	NN	_	24	compound
24	cell	cell	NN	_	20	nmod
25	.	.	.	_	3	punct

1	The	the	DT	_	3	det
2	initiated	initiate	VBN	_	3	amod
3	cells	cell	NNS	_	10	nsubj
4	that	that	WDT	_	5	nsubj
5	result	result	VBP	_	3	acl:relcl
6	from	from	IN	_	8	case
7	this	this	DT	_	8	det
8	hit	hit	NN	_	5	nmod
9	may	may	MD	_	10	aux
10	vary	vary	VB	_	0	ROOT
11	from	from	IN	_	12	case
12	those	those	DT	_	10	nmod
13	that	that	WDT	_	14	nsubj
14	demonstrate	demonstrate	VBP	_	12	acl:relcl
15	very	very	RB	_	16	advmod
16	little	little	JJ	_	17	amod
17	progression	progression	NN	_	14	dobj
18	in	in	IN	_	20	case
19	cell	cell	NN	_	20	compound
20	type	type	NN	_	17	nmod
21	and	and	CC	_	14	cc
22	may	may	MD	_	26	aux
23	or	or	CC	_	26	cc
24	may	may	MD	_	26	aux
25	not	not	RB	_	26	neg
26	require	require	VB	_	14	conj
27	exogenous	exogenous	JJ	_	28	amod
28	enhancement	enhancement	NN	_	26	dobj
29	of	of	IN	_	30	case
30	growth	growth	NN	_	28	nmod
31	to	to	TO	_	32	case
32	those	those	DT	_	28	nmod
33	that	that	WDT	_	35	nsubj
34	can	can	MD	_	35	aux
35	progress	progress	VB	_	32	acl:relcl
36	very	very	RB	_	37	advmod
37	rapidly	rapidly	RB	_	35	advmod
38	to	to	TO	_	41	case
39	fully	fully	RB	_	40	advmod
40	malignant	malignant	JJ	_	41	amod
41	behavior	behavior	NN	_	35	nmod
42	.	.	.	_	10	punct

1	The	the	DT	_	2	det
2	latter	latter	JJ	_	4	nsubj
3	might	might	MD	_	4	aux
4	arise	arise	VB	_	0	ROOT
5	from	from	IN	_	7	case
6	a	a	DT	_	7	det
7	hit	hit	NN	_	4	nmod
8	in	in	IN	_	12	case
9	a	a	DT	_	12	det
10	genetically	genetically	RB	_	11	advmod
11	initiated	initiate	VBN	_	12	amod
12	cell	cell	NN	_	7	nmod
13	,	,	,	_	4	punct
14	the	the	DT	_	15	det
15	result	result	NN	_	22	nsubj
16	of	of	IN	_	17	case
17	which	which	WDT	_	15	nmod
18	is	be	VBZ	_	22	cop
19	a	a	DT	_	22	det
20	more	more	RBR	_	21	advmod
21	rapid	rapid	JJ	_	22	amod
22	progression	progression	NN	_	4	ccomp
23	in	in	IN	_	25	case
24	tumor	tumor	NN	_	25	compound
25	type	type	NN	_	22	nmod
26	.	.	.	_	4	punct

1	Effects	effect	NNS	_	0	ROOT
2	of	of	IN	_	3	case
3	drug1	drug1	NN	_	1	nmod
4	upon	upon	IN	_	6	case
5	the	the	DT	_	6	det
6	metabolism	metabolism	NN	_	1	nmod
7	of	of	IN	_	9	case
8	chylomicron-like	chylomicron-like	JJ	_	9	amod
9	emulsions	emulsion	NNS	_	6	nmod
10	in	in	IN	_	11	case
11	patients	patient	NNS	_	9	nmod
12	with	with	IN	_	15	case
13	coronary	coronary	JJ	_	15	amod
14	artery	artery	NN	_	15	compound
15	disease	disease	NN	_	11	nmod
16	.	.	.	_	1	punct

1	Slow	slow	JJ	_	4	amod
2	chylomicron	chylomicron	NN	_	4	compound
3	intravascular	intravascular	JJ	_	4	amod
4	catabolism	catabolism	NN	_	7	nsubjpass
5	has	have	VBZ	_	7	aux
6	been	be	VBN	_	7	auxpass
7	associated	associate	VBN	_	23	csubj
8	with	with	IN	_	11	case
9	coronary	coronary	JJ	_	11	amod
10	artery	artery	NN	_	11	compound
11	disease	disease	NN	_	7	nmod
12	and	and	CC	_	11	cc
13	screening	screening	NN	_	11	conj
14	for	for	IN	_	15	case
15	drugs	drug	NNS	_	7	nmod
16	that	that	WDT	_	18	nsubj
17	can	can	MD	_	18	aux
18	speed-up	speed-up	VB	_	15	acl:relcl
19	this	this	DT	_	20	det
20	process	process	NN	_	18	dobj
21	can	can	MD	_	23	aux
22	be	be	VB	_	23	cop
23	important	important	JJ	_	0	ROOT
24	.	.	.	_	23	punct

1	In	in	IN	_	3	case
2	this	this	DT	_	3	det
3	study	study	NN	_	13	nmod
4	,	,	,	_	13	punct
5	the	the	DT	_	6	det
6	effects	effect	NNS	_	13	nsubjpass
7	of	of	IN	_	8	case
8	drug1	drug1	NN	_	6	nmod
9	upon	upon	IN	_	11	case
10	chylomicron	chylomicron	NN	_	11	compound
11	metabolism	metabolism	NN	_	6	nmod
12	was	be	VBD	_	13	auxpass
13	tested	test	VBN	_	0	ROOT
14	by	by	IN	_	15	case
15	determination	determination	NN	_	13	nmod
16	of	of	IN	_	19	case
17	the	the	DT	_	19	det
18	plasma	plasma	NN	_	19	compound
19	kinetics	kinetics	NNS	_	15	nmod
20	of	of	IN	_	24	case
21	a	a	DT	_	24	det
22	chylomicron-like	chylomicron-like	JJ	_	24	amod
23	emulsion	emulsion	NN	_	24	compound
24	model	model	NN	_	19	nmod
25	in	in	IN	_	27	case
26	12	12	CD	_	27	nummod
27	patients	patient	NNS	_	24	nmod
28	with	with	IN	_	31	case
29	coronary	coronary	JJ	_	31	amod
30	artery	artery	NN	_	31	compound
31	disease	disease	NN	_	27	nmod
32	,	,	,	_	15	punct
33	aged	aged	JJ	_	15	dep
34	59	59	CD	_	33	dep
35	+	+	CC	_	34	cc
36	/	/	:	_	38	punct
37	-11	-11	CD	_	38	nummod
38	years	year	NNS	_	34	conj
39	,	,	,	_	34	punct
40	-LRB-	-lrb-	-LRB-	_	42	punct
41	total	total	JJ	_	42	amod
42	cholesterol	cholesterol	NN	_	34	appos
43	:	:	:	_	42	punct
44	240	240	CD	_	42	dep
45	+	+	CC	_	44	cc
46	/	/	:	_	48	punct
47	-41	-41	CD	_	48	nummod
48	mg/dl	mg/dl	NN	_	44	conj
49	;	;	:	_	42	punct
50	triglycerides	triglyceride	NNS	_	42	dep
51	:	:	:	_	50	punct
52	188	188	CD	_	50	dep
53	+	+	CC	_	52	cc
54	/	/	:	_	56	punct
55	-42	-42	CD	_	56	nummod
56	mg/dl	mg/dl	NN	_	52	conj
57	-RRB-	-rrb-	-RRB-	_	56	punct
58	submitted	submit	VBN	_	52	acl
59	to	to	TO	_	58	nmod
60	a	a	DT	_	59	dep
61	randomized	randomize	VBN	_	60	dep
62	,	,	,	_	61	punct
63	crossover	crossover	NN	_	62	root
64	,	,	,	_	63	punct
65	double-blind	double-blind	JJ	_	63	amod
66	,	,	,	_	63	punct
67	placebo-controlled	placebo-controlled	JJ	_	68	amod
68	study	study	NN	_	63	appos
69	with	with	IN	_	70	case
70	administration	administration	NN	_	68	nmod
71	of	of	IN	_	73	case
72	1	1	CD	_	73	nummod
73	g	g	NN	_	70	nmod
74	per	per	IN	_	75	case
75	day	day	NN	_	73	nmod
76	drug2	drug2	CD	_	75	nummod
77	or	or	CC	_	73	cc
78	placebo	placebo	NN	_	73	conj
79	for	for	IN	_	80	case
80	1-month	1-month	NN	_	78	nmod
81	.	.	.	_	63	punct

1	A	a	DT	_	4	det
2	1-month	1-month	JJ	_	4	amod
3	washout	washout	NN	_	4	compound
4	period	period	NN	_	6	nsubjpass
5	was	be	VBD	_	6	auxpass
6	inserted	insert	VBN	_	0	ROOT
7	between	between	IN	_	10	case
8	the	the	DT	_	10	det
9	treatment	treatment	NN	_	10	compound
10	periods	period	NNS	_	6	nmod
11	.	.	.	_	6	punct

1	Patients	patient	NNS	_	4	nsubjpass
2	were	be	VBD	_	4	auxpass
3	intravenously	intravenously	RB	_	4	advmod
4	injected	inject	VBN	_	0	ROOT
5	a	a	DT	_	7	det
6	chylomicron-like	chylomicron-like	JJ	_	7	amod
7	emulsion	emulsion	NN	_	4	dobj
8	doubly	doubly	RB	_	9	advmod
9	labeled	label	VBN	_	7	dep
10	with	with	IN	_	12	case
11	14C-cholesteryl	14c-cholesteryl	NN	_	12	compound
12	oleate	oleate	NN	_	9	nmod
13	and	and	CC	_	12	cc
14	3H-triolein	3h-triolein	NN	_	12	conj
15	at	at	IN	_	16	case
16	baseline	baseline	NN	_	9	nmod
17	and	and	CC	_	9	cc
18	after	after	IN	_	19	case
19	treatments	treatment	NNS	_	9	conj
20	.	.	.	_	4	punct

1	After	after	IN	_	3	case
2	drug1	drug1	NN	_	3	compound
3	treatment	treatment	NN	_	6	nmod
4	,	,	,	_	6	punct
5	there	there	EX	_	6	expl
6	was	be	VBD	_	0	ROOT
7	decrease	decrease	NN	_	6	nsubj
8	of	of	IN	_	10	case
9	total	total	JJ	_	10	amod
10	cholesterol	cholesterol	NN	_	7	nmod
11	and	and	CC	_	10	cc
12	triglyceride	triglyceride	NN	_	14	compound
13	plasma	plasma	NN	_	14	compound
14	levels	level	NNS	_	10	conj
15	and	and	CC	_	7	cc
16	a	a	DT	_	17	det
17	trend	trend	NN	_	7	conj
18	to	to	TO	_	19	mark
19	increase	increase	VB	_	17	acl
20	high-density	high-density	JJ	_	24	amod
21	lipoprotein	lipoprotein	NN	_	24	compound
22	cholesterol	cholesterol	NN	_	24	compound
23	plasma	plasma	NN	_	24	compound
24	levels	level	NNS	_	19	dobj
25	.	.	.	_	6	punct

1	drug1	drug1	NN	_	2	nsubj
2	elicited	elicit	VBD	_	0	ROOT
3	62	62	CD	_	4	compound
4	%	%	NN	_	5	amod
5	enhancement	enhancement	NN	_	2	dobj
6	of	of	IN	_	11	case
7	post	post	NN	_	11	compound
8	-	-	:	_	11	punct
9	drug2	drug2	NN	_	11	compound
10	lipolytic	lipolytic	JJ	_	11	amod
11	activity	activity	NN	_	5	nmod
12	and	and	CC	_	5	cc
13	100	100	CD	_	14	compound
14	%	%	NN	_	15	amod
15	increase	increase	NN	_	5	conj
16	of	of	IN	_	20	case
17	3H-triglyceride	3h-triglyceride	NN	_	20	compound
18	fractional	fractional	JJ	_	20	amod
19	clearance	clearance	NN	_	20	compound
20	rate	rate	NN	_	15	nmod
21	compared	compare	VBN	_	24	case
22	with	with	IN	_	24	case
23	placebo	placebo	NN	_	24	compound
24	treatment	treatment	NN	_	15	nmod
25	.	.	.	_	2	punct

1	14C-cholesterol	14c-cholesterol	NN	_	5	compound
2	ester	ester	NN	_	5	compound
3	fractional	fractional	JJ	_	5	amod
4	clearance	clearance	NN	_	5	compound
5	rate	rate	NN	_	9	nsubj
6	was	be	VBD	_	9	cop
7	260	260	CD	_	8	nummod
8	%	%	NN	_	9	nmod:npmod
9	greater	greater	JJR	_	0	ROOT
10	after	after	IN	_	11	case
11	drug1	drug1	NN	_	9	nmod
12	than	than	IN	_	14	case
13	after	after	IN	_	14	case
14	placebo	placebo	NN	_	9	nmod
15	.	.	.	_	9	punct

1	Therefore	therefore	RB	_	16	advmod
2	,	,	,	_	16	punct
3	a	a	DT	_	5	det
4	potent	potent	JJ	_	5	amod
5	effect	effect	NN	_	16	nsubjpass
6	of	of	IN	_	7	case
7	drug1	drug1	NN	_	5	nmod
8	on	on	IN	_	11	case
9	both	both	DT	_	11	cc:preconj
10	chylomicron	chylomicron	NN	_	11	compound
11	lipolysis	lipolysis	NN	_	5	nmod
12	and	and	CC	_	11	cc
13	remnant	remnant	NN	_	14	compound
14	removal	removal	NN	_	11	conj
15	was	be	VBD	_	16	auxpass
16	achieved	achieve	VBN	_	0	ROOT
17	,	,	,	_	16	punct
18	indicating	indicate	VBG	_	16	xcomp
19	that	that	IN	_	24	mark
20	this	this	DT	_	21	det
21	drug	drug	NN	_	24	nsubjpass
22	can	can	MD	_	24	aux
23	be	be	VB	_	24	auxpass
24	used	use	VBN	_	18	ccomp
25	to	to	TO	_	26	mark
26	improve	improve	VB	_	24	xcomp
27	this	this	DT	_	28	det
28	metabolism	metabolism	NN	_	26	dobj
29	in	in	IN	_	32	case
30	future	future	JJ	_	32	amod
31	prospective	prospective	JJ	_	32	amod
32	studies	study	NNS	_	26	nmod
33	.	.	.	_	16	punct

1	Selective	selective	JJ	_	2	amod
2	survival	survival	NN	_	0	ROOT
3	in	in	IN	_	4	case
4	drug1	drug1	NN	_	2	nmod
5	and	and	CC	_	4	cc
6	drug2	drug2	NN	_	4	conj
7	of	of	IN	_	11	case
8	Pseudomonas	pseudomonas	FW	_	11	compound
9	aeruginosa	aeruginosa	FW	_	11	compound
10	serotype	serotype	NN	_	11	compound
11	O11	o11	NN	_	4	nmod
12	from	from	IN	_	14	case
13	drug	drug	NN	_	14	compound
14	addicts	addict	NNS	_	11	nmod
15	.	.	.	_	2	punct

1	The	the	DT	_	2	det
2	growth	growth	NN	_	0	ROOT
3	of	of	IN	_	5	case
4	Pseudomonas	pseudomonas	FW	_	5	compound
5	aeruginosa	aeruginosa	FW	_	2	nmod
6	,	,	,	_	5	punct
7	particularly	particularly	RB	_	8	advmod
8	serotype	serotype	NN	_	9	amod
9	O11	o11	NN	_	5	appos
10	,	,	,	_	5	punct
11	in	in	IN	_	12	case
12	drug1	drug1	NN	_	2	nmod
13	and	and	CC	_	12	cc
14	drug2	drug2	NN	_	12	conj

1	was	be	VBD	_	2	auxpass
2	evaluated	evaluate	VBN	_	0	ROOT
3	as	as	IN	_	6	case
4	a	a	DT	_	6	det
5	possible	possible	JJ	_	6	amod
6	explanation	explanation	NN	_	2	nmod
7	for	for	IN	_	9	case
8	the	the	DT	_	9	det
9	association	association	NN	_	6	nmod
10	of	of	IN	_	12	case
11	deep-seated	deep-seated	JJ	_	12	amod
12	infection	infection	NN	_	9	nmod
13	with	with	IN	_	15	case
14	this	this	DT	_	15	det
15	organism	organism	NN	_	12	nmod
16	and	and	CC	_	12	cc
17	abuse	abuse	NN	_	12	conj
18	of	of	IN	_	20	case
19	these	these	DT	_	20	det
20	drugs	drug	NNS	_	17	nmod
21	.	.	.	_	2	punct

1	The	the	DT	_	3	det
2	mean	mean	JJ	_	3	amod
3	reduction	reduction	NN	_	12	nsubj
4	of	of	IN	_	5	case
5	growth	growth	NN	_	3	nmod
6	caused	cause	VBN	_	5	acl
7	by	by	IN	_	9	case
8	the	the	DT	_	9	det
9	drugs	drug	NNS	_	6	nmod
10	was	be	VBD	_	12	cop
11	1,000-fold	1,000-fold	RB	_	12	advmod
12	greater	greater	JJR	_	0	ROOT
13	for	for	IN	_	16	case
14	49	49	CD	_	16	nummod
15	Pseudomonas	pseudomonas	FW	_	16	compound
16	strains	strain	NNS	_	12	nmod
17	from	from	IN	_	19	case
18	normal	normal	JJ	_	19	amod
19	subjects	subject	NNS	_	16	nmod
20	than	than	IN	_	23	case
21	for	for	IN	_	23	case
22	32	32	CD	_	23	nummod
23	strains	strain	NNS	_	12	nmod
24	from	from	IN	_	26	case
25	drug	drug	NN	_	26	compound
26	addicts	addict	NNS	_	23	nmod
27	-LRB-	-lrb-	-LRB-	_	31	punct
28	4.2	4.2	CD	_	31	nummod
29	vs.	vs.	CC	_	28	cc
30	1.3	1.3	CD	_	28	conj
31	logs	log	NNS	_	23	dep
32	of	of	IN	_	33	case
33	reduction	reduction	NN	_	31	nmod
34	at	at	IN	_	36	case
35	2	2	CD	_	36	nummod
36	hr	hr	NN	_	31	nmod
37	,	,	,	_	31	punct
38	P	p	NN	_	31	appos
39	less	less	JJR	_	38	amod
40	than	than	IN	_	41	case
41	.0005	.0005	CD	_	39	nmod
42	-RRB-	-rrb-	-RRB-	_	31	punct
43	.	.	.	_	12	punct

1	A	a	DT	_	4	det
2	common	common	JJ	_	4	amod
3	phenotypic	phenotypic	JJ	_	4	amod
4	subset	subset	NN	_	15	nsubj
5	of	of	IN	_	9	case
6	the	the	DT	_	9	det
7	serotype	serotype	NN	_	9	compound
8	O11	o11	NN	_	9	compound
9	strains	strain	NNS	_	4	nmod
10	from	from	IN	_	12	case
11	drug	drug	NN	_	12	compound
12	addicts	addict	NNS	_	9	nmod
13	was	be	VBD	_	15	cop
14	especially	especially	RB	_	15	advmod
15	resistant	resistant	JJ	_	0	ROOT
16	to	to	TO	_	19	case
17	the	the	DT	_	19	det
18	inhibitory	inhibitory	JJ	_	19	amod
19	effects	effect	NNS	_	15	nmod
20	.	.	.	_	15	punct

1	Twelve	twelve	CD	_	2	nummod
2	strains	strain	NNS	_	26	nsubjpass
3	of	of	IN	_	5	case
4	Staphylococcus	staphylococcus	FW	_	5	compound
5	aureus	aureus	FW	_	2	nmod
6	-LRB-	-lrb-	-LRB-	_	9	punct
7	a	a	DT	_	9	det
8	frequent	frequent	JJ	_	9	amod
9	cause	cause	NN	_	5	dep
10	of	of	IN	_	11	case
11	infection	infection	NN	_	9	nmod
12	in	in	IN	_	13	case
13	drug1	drug1	NN	_	11	nmod
14	,	,	,	_	9	punct
15	but	but	CC	_	9	cc
16	not	not	RB	_	18	neg
17	in	in	IN	_	18	case
18	drug2	drug2	NN	_	9	conj
19	and	and	CC	_	18	cc
20	drug3	drug3	NN	_	18	conj
21	,	,	,	_	9	punct
22	addicts	addict	NNS	_	9	appos
23	-RRB-	-rrb-	-RRB-	_	9	punct
24	were	be	VBD	_	26	auxpass
25	completely	completely	RB	_	26	advmod
26	inhibited	inhibit	VBN	_	0	ROOT
27	by	by	IN	_	30	case
28	the	the	DT	_	30	det
29	drug	drug	NN	_	30	compound
30	combination	combination	NN	_	26	nmod
31	.	.	.	_	26	punct

1	Dose-response	dose-response	JJ	_	2	amod
2	curves	curve	NNS	_	18	nsubj
3	-LRB-	-lrb-	-LRB-	_	4	punct
4	derived	derive	VBN	_	2	dep
5	from	from	IN	_	7	case
6	the	the	DT	_	7	det
7	results	result	NNS	_	4	nmod
8	of	of	IN	_	9	mark
9	using	use	VBG	_	7	acl
10	the	the	DT	_	11	det
11	tablets	tablet	NNS	_	9	dobj
12	as	as	RB	_	11	cc
13	well	well	RB	_	12	mwe
14	as	as	IN	_	12	mwe
15	pure	pure	JJ	_	16	amod
16	powders	powder	NNS	_	11	conj
17	-RRB-	-rrb-	-RRB-	_	4	punct
18	showed	show	VBD	_	0	ROOT
19	that	that	IN	_	22	mark
20	drug1	drug1	NN	_	22	nsubj
21	was	be	VBD	_	22	cop
22	responsible	responsible	JJ	_	18	ccomp
23	for	for	IN	_	26	case
24	the	the	DT	_	26	det
25	inhibitory	inhibitory	JJ	_	26	amod
26	activity	activity	NN	_	22	nmod
27	,	,	,	_	26	punct
28	which	which	WDT	_	31	nsubjpass
29	was	be	VBD	_	31	auxpass
30	partially	partially	RB	_	31	advmod
31	antagonized	antagonize	VBN	_	26	acl:relcl
32	by	by	IN	_	33	case
33	drug2	drug2	NN	_	31	nmod
34	.	.	.	_	18	punct

1	We	we	PRP	_	2	nsubj
2	conclude	conclude	VBP	_	0	ROOT
3	that	that	IN	_	2	dobj
4	an	a	DT	_	5	det
5	ability	ability	NN	_	3	root
6	of	of	IN	_	8	case
7	some	some	DT	_	8	det
8	P.	p.	FW	_	5	nmod

1	aeruginosa	aeruginosa	FW	_	4	compound
2	serotype	serotype	NN	_	4	compound
3	O11	o11	NN	_	4	compound
4	strains	strain	NNS	_	0	ROOT
5	,	,	,	_	4	punct
6	but	but	CC	_	7	cc
7	not	not	RB	_	4	cc
8	S.	S.	NNP	_	4	conj

1	aureus	aureus	NN	_	0	ROOT
2	,	,	,	_	4	punct
3	to	to	TO	_	4	mark
4	survive	survive	VB	_	1	dep
5	in	in	IN	_	6	case
6	drug1	drug1	NN	_	4	nmod
7	and	and	CC	_	4	cc
8	drug2	drug2	NN	_	10	nsubj
9	may	may	MD	_	10	aux
10	explain	explain	VB	_	4	conj
11	in	in	IN	_	12	case
12	part	part	NN	_	10	nmod
13	a	a	DT	_	14	det
14	shift	shift	NN	_	10	dobj
15	from	from	IN	_	16	case
16	S.	S.	NNP	_	14	nmod

1	aureus	aureus	NN	_	0	ROOT
2	to	to	TO	_	3	case
3	P.	P.	NNP	_	1	nmod

1	aeruginosa	aeruginosa	FW	_	0	ROOT
2	as	as	IN	_	4	case
3	common	common	JJ	_	4	amod
4	pathogens	pathogen	NNS	_	1	nmod
5	of	of	IN	_	7	case
6	drug	drug	NN	_	7	compound
7	addicts	addict	NNS	_	4	nmod
8	in	in	IN	_	9	case
9	areas	area	NNS	_	7	nmod
10	where	where	WRB	_	18	advmod
11	abuse	abuse	NN	_	18	nsubj
12	of	of	IN	_	14	case
13	this	this	DT	_	14	det
14	combination	combination	NN	_	11	nmod
15	of	of	IN	_	16	case
16	drugs	drug	NNS	_	14	nmod
17	has	have	VBZ	_	18	aux
18	increased	increase	VBN	_	9	acl:relcl
19	.	.	.	_	1	punct

1	Influence	influence	NN	_	0	ROOT
2	of	of	IN	_	3	case
3	coadministration	coadministration	NN	_	1	nmod
4	of	of	IN	_	5	case
5	drug1	drug1	NN	_	3	nmod
6	on	on	IN	_	8	case
7	drug2	drug2	NN	_	8	compound
8	pharmacokinetics	pharmacokinetic	NNS	_	1	nmod
9	and	and	CC	_	8	cc
10	QTc	qtc	NN	_	11	compound
11	intervals	interval	NNS	_	8	conj
12	in	in	IN	_	14	case
13	healthy	healthy	JJ	_	14	amod
14	volunteers	volunteer	NNS	_	8	nmod
15	.	.	.	_	1	punct

1	STUDY	study	NN	_	2	compound
2	OBJECTIVE	objective	NN	_	0	ROOT
3	:	:	:	_	2	punct
4	To	to	TO	_	5	mark
5	evaluate	evaluate	VB	_	2	acl
6	the	the	DT	_	7	det
7	effect	effect	NN	_	5	dobj
8	of	of	IN	_	9	case
9	drug1	drug1	NN	_	7	nmod
10	on	on	IN	_	12	case
11	the	the	DT	_	12	det
12	pharmacokinetics	pharmacokinetic	NNS	_	7	nmod
13	and	and	CC	_	12	cc
14	cardiovascular	cardiovascular	JJ	_	15	amod
15	safety	safety	NN	_	12	conj
16	of	of	IN	_	17	case
17	drug2	drug2	NN	_	12	nmod
18	at	at	IN	_	20	case
19	steady	steady	JJ	_	20	amod
20	state	state	NN	_	5	nmod
21	in	in	IN	_	23	case
22	healthy	healthy	JJ	_	23	amod
23	men	man	NNS	_	5	nmod
24	.	.	.	_	2	punct

1	DESIGN	design	NN	_	0	ROOT
2	:	:	:	_	1	punct
3	Open-label	open-label	JJ	_	8	amod
4	,	,	,	_	3	punct
5	three-phase	three-phase	JJ	_	3	conj
6	,	,	,	_	3	punct
7	sequential	sequential	JJ	_	3	dep
8	study	study	NN	_	1	dep
9	.	.	.	_	1	punct

1	SETTING	SETTING	NNP	_	0	ROOT
2	:	:	:	_	1	punct
3	Clinical	clinical	JJ	_	5	amod
4	research	research	NN	_	5	compound
5	center	center	NN	_	1	dep
6	.	.	.	_	1	punct

1	SUBJECTS	subject	NNS	_	0	ROOT
2	:	:	:	_	1	punct
3	Twelve	twelve	CD	_	6	nummod
4	healthy	healthy	JJ	_	6	amod
5	male	male	JJ	_	6	amod
6	volunteers	volunteer	NNS	_	1	dep
7	.	.	.	_	1	punct

1	INTERVENTIONS	intervention	NNS	_	0	ROOT
2	:	:	:	_	1	punct
3	Each	each	DT	_	4	det
4	subject	subject	NN	_	6	nsubjpass
5	was	be	VBD	_	6	auxpass
6	treated	treat	VBN	_	1	appos
7	according	accord	VBG	_	11	case
8	to	to	TO	_	7	mwe
9	the	the	DT	_	11	det
10	following	following	JJ	_	11	amod
11	sequence	sequence	NN	_	6	nmod
12	:	:	:	_	6	punct
13	baseline	baseline	NN	_	6	dep
14	;	;	:	_	1	punct

1	phase	phase	NN	_	0	ROOT
2	1	1	CD	_	1	nummod
3	-LRB-	-lrb-	-LRB-	_	4	punct
4	days	day	NNS	_	1	appos
5	1-6	1-6	CD	_	4	nummod
6	-RRB-	-rrb-	-RRB-	_	4	punct
7	:	:	:	_	1	punct
8	drug1	drug1	NN	_	10	compound
9	10	10	CD	_	10	nummod
10	mg	mg	NN	_	1	dep
11	4	4	CD	_	12	nummod
12	times/day	times/day	NN	_	10	dep
13	;	;	:	_	1	punct

1	washout	washout	NN	_	0	ROOT
2	-LRB-	-lrb-	-LRB-	_	3	punct
3	days	day	NNS	_	1	appos
4	7-13	7-13	CD	_	3	nummod
5	-RRB-	-rrb-	-RRB-	_	3	punct
6	;	;	:	_	1	punct

1	phase	phase	NN	_	0	ROOT
2	2	2	CD	_	1	nummod
3	-LRB-	-lrb-	-LRB-	_	4	punct
4	days	day	NNS	_	1	appos
5	14-44	14-44	CD	_	4	nummod
6	-RRB-	-rrb-	-RRB-	_	4	punct
7	:	:	:	_	1	punct
8	drug1	drug1	NN	_	10	compound
9	20	20	CD	_	10	nummod
10	mg/day	mg/day	NN	_	1	dep
11	;	;	:	_	1	punct

1	and	and	CC	_	0	ROOT
2	phase	phase	NN	_	1	dep
3	3	3	CD	_	2	nummod
4	-LRB-	-lrb-	-LRB-	_	5	punct
5	days	day	NNS	_	2	appos
6	45-52	45-52	CD	_	5	nummod
7	-RRB-	-rrb-	-RRB-	_	5	punct
8	:	:	:	_	2	punct
9	drug1	drug1	NN	_	11	compound
10	10	10	CD	_	11	nummod
11	mg	mg	NN	_	2	dep
12	4	4	CD	_	13	nummod
13	times/day	times/day	NN	_	11	dep
14	-LRB-	-lrb-	-LRB-	_	15	punct
15	days	day	NNS	_	11	dep
16	45-51	45-51	CD	_	15	nummod
17	-RRB-	-rrb-	-RRB-	_	15	punct
18	plus	plus	CC	_	11	cc
19	drug2	drug2	NN	_	21	compound
20	20	20	CD	_	21	nummod
21	mg/day	mg/day	NN	_	11	conj
22	-LRB-	-lrb-	-LRB-	_	23	punct
23	days	day	NNS	_	21	appos
24	45-52	45-52	CD	_	23	nummod
25	-RRB-	-rrb-	-RRB-	_	23	punct
26	.	.	.	_	1	punct

1	MEASUREMENTS	measurement	NNS	_	4	compound
2	and	and	CC	_	1	cc
3	MAIN	MAIN	NNP	_	1	conj
4	RESULTS	result	NNS	_	0	ROOT
5	:	:	:	_	4	punct
6	Blood	blood	NN	_	7	compound
7	samples	sample	NNS	_	9	nsubjpass
8	were	be	VBD	_	9	auxpass
9	drawn	draw	VBN	_	4	dep
10	and	and	CC	_	9	cc
11	12-lead	12-lead	JJ	_	12	amod
12	electrocardiograms	electrocardiogram	NNS	_	9	conj
13	performed	perform	VBN	_	12	acl
14	at	at	IN	_	17	case
15	specified	specify	VBN	_	17	amod
16	time	time	NN	_	17	compound
17	points	point	NNS	_	13	nmod
18	after	after	IN	_	22	case
19	the	the	DT	_	22	det
20	last	last	JJ	_	22	amod
21	morning	morning	NN	_	22	compound
22	dose	dose	NN	_	9	nmod
23	of	of	IN	_	24	case
24	drug1	drug1	NN	_	22	nmod
25	in	in	IN	_	26	case
26	phases	phase	NNS	_	22	nmod
27	1	1	CD	_	26	dep
28	and	and	CC	_	27	cc
29	3	3	CD	_	27	conj
30	.	.	.	_	4	punct

1	Blood	blood	NN	_	2	compound
2	samples	sample	NNS	_	5	nsubjpass
3	also	also	RB	_	5	advmod
4	were	be	VBD	_	5	auxpass
5	taken	take	VBN	_	0	ROOT
6	before	before	IN	_	8	case
7	morning	morning	NN	_	8	compound
8	doses	dose	NNS	_	5	nmod
9	on	on	IN	_	17	case
10	the	the	DT	_	17	det
11	3rd	3rd	JJ	_	17	amod
12	,	,	,	_	11	punct
13	4th	4th	JJ	_	11	conj
14	,	,	,	_	11	punct
15	and	and	CC	_	11	cc
16	5th	5th	JJ	_	11	conj
17	days	day	NNS	_	5	nmod
18	of	of	IN	_	19	case
19	phases	phase	NNS	_	17	nmod
20	1	1	CD	_	19	dep
21	and	and	CC	_	20	cc
22	3	3	CD	_	20	conj
23	.	.	.	_	5	punct

1	Electrocardiograms	electrocardiogram	NNS	_	3	nsubjpass
2	were	be	VBD	_	3	auxpass
3	done	do	VBN	_	0	ROOT
4	at	at	IN	_	5	case
5	baseline	baseline	NN	_	3	nmod
6	and	and	CC	_	5	cc
7	on	on	IN	_	10	case
8	the	the	DT	_	10	det
9	last	last	JJ	_	10	amod
10	day	day	NN	_	5	conj
11	of	of	IN	_	14	case
12	the	the	DT	_	14	det
13	washout	washout	NN	_	14	compound
14	period	period	NN	_	10	nmod
15	and	and	CC	_	5	cc
16	phase	phase	NN	_	5	conj
17	2	2	CD	_	16	nummod
18	.	.	.	_	3	punct

1	Coadministration	coadministration	NN	_	5	nsubj
2	of	of	IN	_	3	case
3	drug1	drug1	NN	_	1	nmod
4	significantly	significantly	RB	_	5	advmod
5	decreased	decrease	VBD	_	0	ROOT
6	drug2	drug2	NN	_	8	compound
7	plasma	plasma	NN	_	8	compound
8	concentrations	concentration	NNS	_	5	dobj
9	.	.	.	_	5	punct

1	There	there	EX	_	2	expl
2	were	be	VBD	_	0	ROOT
3	no	no	DT	_	6	neg
4	clinically	clinically	RB	_	5	advmod
5	significant	significant	JJ	_	6	amod
6	changes	change	NNS	_	2	nsubj
7	in	in	IN	_	10	case
8	corrected	correct	VBN	_	10	amod
9	QT	qt	NN	_	10	compound
10	intervals	interval	NNS	_	6	nmod
11	during	during	IN	_	12	case
12	administration	administration	NN	_	2	nmod
13	of	of	IN	_	14	case
14	drug1	drug1	NN	_	12	nmod
15	alone	alone	RB	_	14	advmod
16	or	or	CC	_	14	cc
17	with	with	IN	_	18	case
18	drug2	drug2	NN	_	14	conj
19	.	.	.	_	2	punct

1	drug1	drug1	NN	_	4	nsubjpass
2	was	be	VBD	_	4	auxpass
3	well	well	RB	_	4	advmod
4	tolerated	tolerate	VBN	_	0	ROOT
5	when	when	WRB	_	6	advmod
6	administered	administer	VBN	_	4	advcl
7	alone	alone	RB	_	6	advmod
8	or	or	CC	_	6	cc
9	with	with	IN	_	10	case
10	drug2	drug2	NN	_	6	conj
11	.	.	.	_	4	punct

1	CONCLUSION	conclusion	NN	_	0	ROOT
2	:	:	:	_	1	punct
3	drug1	drug1	NN	_	6	nsubjpass
4	can	can	MD	_	6	aux
5	be	be	VB	_	6	auxpass
6	administered	administer	VBN	_	1	dep
7	safely	safely	RB	_	6	advmod
8	to	to	TO	_	9	case
9	patients	patient	NNS	_	6	nmod
10	receiving	receive	VBG	_	9	acl
11	low	low	JJ	_	13	amod
12	therapeutic	therapeutic	JJ	_	13	amod
13	dosages	dosage	NNS	_	10	dobj
14	of	of	IN	_	15	case
15	drug2	drug2	NN	_	13	nmod
16	.	.	.	_	1	punct

1	Activity	activity	NN	_	0	ROOT
2	of	of	IN	_	3	case
3	drug1	drug1	NN	_	1	nmod
4	alone	alone	RB	_	3	advmod
5	and	and	CC	_	3	cc
6	in	in	IN	_	7	case
7	combination	combination	NN	_	3	conj
8	with	with	IN	_	9	case
9	drug2	drug2	NN	_	7	nmod
10	and	and	CC	_	9	cc
11	drug3	drug3	NN	_	9	conj
12	against	against	IN	_	14	case
13	Cryptosporidium	cryptosporidium	NN	_	14	compound
14	parvum	parvum	NN	_	9	nmod
15	in	in	IN	_	17	case
16	cell	cell	NN	_	17	compound
17	culture	culture	NN	_	14	nmod
18	.	.	.	_	1	punct

1	The	the	DT	_	5	det
2	in	in	FW	_	5	amod
3	vitro	vitro	FW	_	2	dep
4	anti-cryptosporidial	anti-cryptosporidial	JJ	_	5	amod
5	activity	activity	NN	_	17	nsubjpass
6	of	of	IN	_	7	case
7	drug1	drug1	NN	_	5	nmod
8	alone	alone	RB	_	7	advmod
9	and	and	CC	_	7	cc
10	in	in	IN	_	11	case
11	combination	combination	NN	_	7	conj
12	with	with	IN	_	13	case
13	drug2	drug2	NN	_	11	nmod
14	and	and	CC	_	13	cc
15	drug3	drug3	NN	_	13	conj
16	was	be	VBD	_	17	auxpass
17	investigated	investigate	VBN	_	0	ROOT
18	.	.	.	_	17	punct

1	drug1	drug1	NN	_	2	nsubj
2	showed	show	VBD	_	0	ROOT
3	moderate	moderate	JJ	_	4	amod
4	activity	activity	NN	_	2	dobj
5	,	,	,	_	4	punct
6	which	which	WDT	_	7	nsubj
7	increased	increase	VBD	_	4	acl:relcl
8	with	with	IN	_	10	case
9	increasing	increase	VBG	_	10	amod
10	concentration	concentration	NN	_	7	nmod
11	to	to	TO	_	14	case
12	55.7	55.7	CD	_	13	compound
13	%	%	NN	_	14	amod
14	suppression	suppression	NN	_	7	nmod
15	of	of	IN	_	16	case
16	growth	growth	NN	_	14	nmod
17	at	at	IN	_	19	case
18	20	20	CD	_	19	nummod
19	microM	microm	NN	_	7	nmod
20	.	.	.	_	2	punct

1	Moreover	moreover	RB	_	6	advmod
2	,	,	,	_	6	punct
3	its	its	PRP$	_	4	nmod:poss
4	activity	activity	NN	_	6	nsubjpass
5	was	be	VBD	_	6	auxpass
6	enhanced	enhance	VBN	_	0	ROOT
7	when	when	WRB	_	10	advmod
8	it	it	PRP	_	10	nsubjpass
9	was	be	VBD	_	10	auxpass
10	combined	combine	VBN	_	6	advcl
11	with	with	IN	_	13	case
12	either	either	CC	_	13	cc:preconj
13	drug1	drug1	NN	_	10	nmod
14	or	or	CC	_	13	cc
15	drug2	drug2	NN	_	13	conj
16	with	with	IN	_	20	case
17	90	90	CD	_	18	compound
18	%	%	NN	_	20	amod
19	parasite	parasite	JJ	_	20	amod
20	reduction	reduction	NN	_	10	nmod
21	at	at	IN	_	24	case
22	the	the	DT	_	24	det
23	highest	highest	JJS	_	24	amod
24	concentration	concentration	NN	_	20	nmod
25	tested	test	VBN	_	24	acl
26	.	.	.	_	6	punct

1	drug1	drug1	NN	_	4	nsubj
2	may	may	MD	_	4	aux
3	be	be	VB	_	4	cop
4	active	active	JJ	_	0	ROOT
5	in	in	IN	_	6	mark
6	inhibiting	inhibit	VBG	_	4	advcl
7	Cryptosporidium	cryptosporidium	NN	_	9	compound
8	parvum	parvum	NN	_	9	compound
9	growth	growth	NN	_	6	dobj
10	in	in	FW	_	11	compound
11	vitro	vitro	FW	_	6	advmod
12	upon	upon	IN	_	13	case
13	combination	combination	NN	_	6	nmod
14	with	with	IN	_	16	case
15	either	either	CC	_	16	cc:preconj
16	drug2	drug2	NN	_	13	nmod
17	or	or	CC	_	16	cc
18	drug3	drug3	NN	_	16	conj
19	.	.	.	_	4	punct

1	Modification	modification	NN	_	6	nsubj
2	of	of	IN	_	5	case
3	surface	surface	NN	_	5	compound
4	histidine	histidine	NN	_	5	compound
5	residues	residue	NNS	_	1	nmod
6	abolishes	abolish	VBZ	_	0	ROOT
7	the	the	DT	_	9	det
8	cytotoxic	cytotoxic	JJ	_	9	amod
9	activity	activity	NN	_	6	dobj
10	of	of	IN	_	11	case
11	drug1	drug1	NN	_	9	nmod
12	.	.	.	_	6	punct

1	drug1	drug1	NN	_	2	nsubj
2	displays	display	VBZ	_	0	ROOT
3	both	both	CC	_	4	cc:preconj
4	cytotoxic	cytotoxic	JJ	_	7	amod
5	and	and	CC	_	4	cc
6	enterotoxic	enterotoxic	JJ	_	4	conj
7	activities	activity	NNS	_	2	dobj
8	.	.	.	_	2	punct

1	It	it	PRP	_	5	nsubjpass
2	has	have	VBZ	_	5	aux
3	recently	recently	RB	_	5	advmod
4	been	be	VBN	_	5	auxpass
5	demonstrated	demonstrate	VBN	_	0	ROOT
6	that	that	IN	_	8	mark
7	drug1	drug1	NN	_	8	nsubj
8	exerts	exert	VBZ	_	5	ccomp
9	its	its	PRP$	_	11	nmod:poss
10	cytotoxic	cytotoxic	JJ	_	11	amod
11	effect	effect	NN	_	8	dobj
12	by	by	IN	_	14	case
13	the	the	DT	_	14	det
14	glucosylation	glucosylation	NN	_	8	nmod
15	of	of	IN	_	19	case
16	the	the	DT	_	19	det
17	small	small	JJ	_	19	amod
18	GTP-binding	gtp-binding	JJ	_	19	amod
19	proteins	protein	NNS	_	14	nmod
20	of	of	IN	_	23	case
21	the	the	DT	_	23	det
22	Rho	rho	NN	_	23	compound
23	family	family	NN	_	19	nmod
24	.	.	.	_	5	punct

1	drug1	drug1	NN	_	8	nsubjpass
2	,	,	,	_	8	punct
3	at	at	IN	_	4	case
4	pH	ph	NN	_	8	nmod
5	7.0	7.0	CD	_	4	nummod
6	,	,	,	_	8	punct
7	was	be	VBD	_	8	auxpass
8	used	use	VBN	_	0	ROOT
9	to	to	TO	_	11	mark
10	chemically	chemically	RB	_	11	advmod
11	modify	modify	VB	_	8	xcomp
12	exposed	expose	VBN	_	14	amod
13	histidine	histidine	NN	_	14	compound
14	residues	residue	NNS	_	11	dobj
15	on	on	IN	_	16	case
16	drug2	drug2	NN	_	11	nmod
17	.	.	.	_	8	punct

1	Modification	modification	NN	_	6	nsubj
2	of	of	IN	_	3	case
3	drug1	drug1	NN	_	1	nmod
4	with	with	IN	_	5	case
5	drug2	drug2	NN	_	1	nmod
6	abolished	abolish	VBD	_	0	ROOT
7	both	both	CC	_	10	cc:preconj
8	its	its	PRP$	_	10	nmod:poss
9	cytotoxic	cytotoxic	JJ	_	10	amod
10	activity	activity	NN	_	6	dobj
11	and	and	CC	_	10	cc
12	the	the	DT	_	13	det
13	ability	ability	NN	_	10	conj
14	of	of	IN	_	16	case
15	the	the	DT	_	16	det
16	toxin	toxin	NN	_	13	nmod
17	to	to	TO	_	18	mark
18	bind	bind	VB	_	13	acl
19	Zn-Sepharose	zn-sepharose	NN	_	20	compound
20	gel	gel	NN	_	18	dobj
21	.	.	.	_	6	punct

1	Treatment	treatment	NN	_	0	ROOT
2	of	of	IN	_	3	case
3	drug1	drug1	NN	_	1	nmod
4	with	with	IN	_	9	case
5	-LSB-	-lsb-	-LRB-	_	9	punct
6	-LRB-	-lrb-	-LRB-	_	9	punct
7	14	14	CD	_	9	nummod
8	-RRB-	-rrb-	-RRB-	_	9	punct
9	C	c	NN	_	1	nmod
10	-RSB-	-rsb-	-RRB-	_	9	punct
11	-	-	:	_	1	punct
12	drug2	drug2	NN	_	13	nsubj
13	revealed	reveal	VBD	_	1	dep
14	concentration	concentration	NN	_	15	nmod:npmod
15	dependent	dependent	JJ	_	16	amod
16	labelling	labelling	NN	_	13	dobj
17	of	of	IN	_	19	case
18	histidine	histidine	NN	_	19	compound
19	residues	residue	NNS	_	16	nmod
20	on	on	IN	_	23	case
21	the	the	DT	_	23	det
22	toxin	toxin	NN	_	23	compound
23	molecules	molecule	NNS	_	16	nmod
24	.	.	.	_	1	punct

1	The	the	DT	_	2	det
2	effects	effect	NNS	_	7	nsubjpass
3	of	of	IN	_	4	case
4	drug1	drug1	NN	_	2	nmod
5	could	could	MD	_	7	aux
6	be	be	VB	_	7	auxpass
7	reversed	reverse	VBN	_	0	ROOT
8	by	by	IN	_	10	case
9	drug2	drug2	NN	_	10	compound
10	treatment	treatment	NN	_	7	nmod
11	.	.	.	_	7	punct

1	These	these	DT	_	2	det
2	data	datum	NNS	_	3	nsubj
3	suggest	suggest	VBP	_	0	ROOT
4	the	the	DT	_	7	det
5	modified	modify	VBN	_	7	amod
6	histidine	histidine	NN	_	7	compound
7	residues	residue	NNS	_	11	nsubj
8	on	on	IN	_	9	case
9	drug1	drug1	NN	_	7	nmod
10	are	be	VBP	_	11	cop
11	critical	critical	JJ	_	3	ccomp
12	to	to	TO	_	15	case
13	its	its	PRP$	_	15	nmod:poss
14	cytotoxic	cytotoxic	JJ	_	15	amod
15	activity	activity	NN	_	11	nmod
16	.	.	.	_	3	punct

1	Histidine	histidine	NN	_	2	compound
2	modification	modification	NN	_	3	nsubj
3	had	have	VBD	_	0	ROOT
4	no	no	DT	_	5	neg
5	effect	effect	NN	_	3	dobj
6	on	on	IN	_	11	case
7	the	the	DT	_	11	det
8	glucosyl	glucosyl	NN	_	11	compound
9	transferase	transferase	NN	_	11	compound
10	enzyme	enzyme	NN	_	11	compound
11	activity	activity	NN	_	3	nmod
12	of	of	IN	_	13	case
13	drug1	drug1	NN	_	11	nmod
14	.	.	.	_	3	punct

1	However	however	RB	_	4	advmod
2	,	,	,	_	4	punct
3	modification	modification	NN	_	4	nsubj
4	abolished	abolish	VBD	_	0	ROOT
5	the	the	DT	_	9	det
6	`	`	``	_	9	punct
7	cold	cold	JJ	_	9	amod
8	'	'	''	_	9	punct
9	binding	binding	NN	_	4	dobj
10	of	of	IN	_	11	case
11	toxin	toxin	NN	_	9	nmod
12	to	to	TO	_	14	case
13	bovine	bovine	JJ	_	14	amod
14	thyroglobulin	thyroglobulin	NN	_	9	nmod
15	in	in	IN	_	17	case
16	an	a	DT	_	17	det
17	ELISA	elisa	NN	_	9	nmod
18	and	and	CC	_	4	cc
19	reduced	reduce	VBD	_	4	conj
20	ligand	ligand	NN	_	22	compound
21	binding	binding	NN	_	22	compound
22	activity	activity	NN	_	19	dobj
23	in	in	IN	_	28	case
24	a	a	DT	_	28	det
25	rabbit	rabbit	NN	_	28	compound
26	erythrocyte	erythrocyte	NN	_	28	compound
27	haemagglutination	haemagglutination	NN	_	28	compound
28	assay	assay	NN	_	19	nmod
29	.	.	.	_	4	punct

1	The	the	DT	_	2	det
2	data	datum	NNS	_	3	nsubj
3	suggest	suggest	VBP	_	0	ROOT
4	that	that	IN	_	10	mark
5	the	the	DT	_	7	det
6	histidine	histidine	NN	_	7	compound
7	residues	residue	NNS	_	10	nsubj
8	may	may	MD	_	10	aux
9	be	be	VB	_	10	cop
10	crucial	crucial	JJ	_	3	ccomp
11	to	to	TO	_	14	case
12	the	the	DT	_	14	det
13	receptor-binding	receptor-binding	JJ	_	14	amod
14	activity	activity	NN	_	10	nmod
15	of	of	IN	_	16	case
16	drug1	drug1	NN	_	14	nmod
17	.	.	.	_	3	punct

1	Exposed	expose	VBN	_	2	amod
2	histidines	histidine	NNS	_	6	nsubj
3	on	on	IN	_	4	case
4	drug1	drug1	NN	_	2	nmod
5	are	be	VBP	_	6	cop
6	available	available	JJ	_	0	ROOT
7	for	for	IN	_	9	case
8	drug2	drug2	NN	_	9	compound
9	chelation	chelation	NN	_	6	nmod
10	,	,	,	_	6	punct
11	and	and	CC	_	6	cc
12	these	these	DT	_	15	nsubjpass
13	have	have	VBP	_	15	aux
14	been	be	VBN	_	15	auxpass
15	exploited	exploit	VBN	_	6	conj
16	in	in	IN	_	18	case
17	the	the	DT	_	18	det
18	development	development	NN	_	15	nmod
19	of	of	IN	_	23	case
20	a	a	DT	_	23	det
21	novel	novel	JJ	_	23	amod
22	purification	purification	NN	_	23	compound
23	protocol	protocol	NN	_	18	nmod
24	for	for	IN	_	25	case
25	drug3	drug3	NN	_	23	nmod
26	using	use	VBG	_	15	xcomp
27	drug4	drug4	NN	_	26	dobj
28	-	-	:	_	6	punct
29	chelating	chelate	VBG	_	30	amod
30	chromatography	chromatography	NN	_	6	dep
31	.	.	.	_	6	punct

1	Interaction	interaction	NN	_	0	ROOT
2	of	of	IN	_	3	case
3	drug1	drug1	NN	_	1	nmod
4	and	and	CC	_	3	cc
5	drug2	drug2	NN	_	3	conj
6	in	in	FW	_	7	compound
7	vitro	vitro	FW	_	1	advmod
8	.	.	.	_	1	punct

1	The	the	DT	_	4	det
2	minimal	minimal	JJ	_	4	amod
3	inhibitory	inhibitory	JJ	_	4	amod
4	concentrations	concentration	NNS	_	14	nsubjpass
5	of	of	IN	_	6	case
6	drug1	drug1	NN	_	4	nmod
7	and	and	CC	_	6	cc
8	drug2	drug2	NN	_	6	conj
9	alone	alone	RB	_	6	advmod
10	and	and	CC	_	6	cc
11	in	in	IN	_	12	case
12	combinations	combination	NNS	_	6	conj
13	were	be	VBD	_	14	auxpass
14	determined	determine	VBN	_	0	ROOT
15	by	by	IN	_	18	case
16	a	a	DT	_	18	det
17	microdilution	microdilution	NN	_	18	compound
18	method	method	NN	_	14	nmod
19	for	for	IN	_	28	case
20	163	163	CD	_	28	nummod
21	aerobic	aerobic	JJ	_	28	amod
22	,	,	,	_	21	punct
23	facultative	facultative	JJ	_	21	conj
24	,	,	,	_	21	punct
25	and	and	CC	_	21	cc
26	anaerobic	anaerobic	JJ	_	21	conj
27	clinical	clinical	JJ	_	28	amod
28	isolates	isolate	NNS	_	18	nmod
29	.	.	.	_	14	punct

1	All	all	DT	_	3	det
2	77	77	CD	_	3	nummod
3	strains	strain	NNS	_	26	nsubjpass
4	of	of	IN	_	6	case
5	Staphylococcus	staphylococcus	FW	_	6	compound
6	aureus	aureus	FW	_	3	nmod
7	,	,	,	_	3	punct
8	Diplococcus	diplococcus	NN	_	9	compound
9	pneumoniae	pneumoniae	FW	_	3	appos
10	,	,	,	_	9	punct
11	Streptococcus	streptococcus	NN	_	12	compound
12	pyogenes	pyogene	NNS	_	9	conj
13	,	,	,	_	9	punct
14	and	and	CC	_	9	cc
15	anaerobic	anaerobic	JJ	_	16	amod
16	bacteria	bacterium	NNS	_	9	conj
17	-LRB-	-lrb-	-LRB-	_	21	punct
18	except	except	IN	_	21	case
19	for	for	IN	_	21	case
20	three	three	CD	_	21	nummod
21	strains	strain	NNS	_	16	nmod
22	of	of	IN	_	23	case
23	Clostridium	clostridium	NN	_	21	nmod
24	-RRB-	-rrb-	-RRB-	_	21	punct
25	were	be	VBD	_	26	auxpass
26	inhibited	inhibit	VBN	_	0	ROOT
27	by	by	IN	_	29	case
28	1.6	1.6	CD	_	29	nummod
29	mug	mug	NN	_	26	nmod
30	or	or	CC	_	29	cc
31	less	less	JJR	_	29	conj
32	of	of	IN	_	33	case
33	drug1	drug1	NN	_	31	nmod
34	per	per	IN	_	35	case
35	ml	ml	NN	_	33	nmod
36	.	.	.	_	26	punct

1	drug1	drug1	NN	_	4	nsubj
2	did	do	VBD	_	4	aux
3	not	not	RB	_	4	neg
4	interfere	interfere	VB	_	0	ROOT
5	with	with	IN	_	7	case
6	the	the	DT	_	7	det
7	activity	activity	NN	_	4	nmod
8	of	of	IN	_	9	case
9	drug2	drug2	NN	_	7	nmod
10	within	within	IN	_	12	case
11	the	the	DT	_	12	det
12	range	range	NN	_	7	nmod
13	of	of	IN	_	14	case
14	concentrations	concentration	NNS	_	12	nmod
15	tested	test	VBN	_	14	acl
16	-LRB-	-lrb-	-LRB-	_	20	punct
17	0.1	0.1	CD	_	19	compound
18	to	to	TO	_	19	dep
19	100	100	CD	_	20	nummod
20	mug/ml	mug/ml	NN	_	7	appos
21	-RRB-	-rrb-	-RRB-	_	20	punct
22	;	;	:	_	4	punct

1	for	for	IN	_	4	case
2	some	some	DT	_	4	det
3	strains	strain	NNS	_	4	compound
4	combinations	combination	NNS	_	6	nmod
5	were	be	VBD	_	6	cop
6	synergistic	synergistic	JJ	_	0	ROOT
7	.	.	.	_	6	punct

1	Sixty-two	sixty-two	CD	_	7	compound
2	-LRB-	-lrb-	-LRB-	_	4	punct
3	94	94	CD	_	4	nummod
4	%	%	NN	_	1	appos
5	-RRB-	-rrb-	-RRB-	_	4	punct
6	of	of	IN	_	7	advmod
7	66	66	CD	_	8	nummod
8	strains	strain	NNS	_	15	nsubjpass
9	of	of	IN	_	10	case
10	Enterobacteriaceae	Enterobacteriaceae	NNP	_	8	nmod
11	and	and	CC	_	10	cc
12	Pseudomonas	pseudomonas	FW	_	13	compound
13	aeruginosa	aeruginosa	FW	_	10	conj
14	were	be	VBD	_	15	auxpass
15	inhibited	inhibit	VBN	_	0	ROOT
16	by	by	IN	_	18	case
17	6.2	6.2	CD	_	18	nummod
18	mug	mug	NN	_	15	nmod
19	or	or	CC	_	18	cc
20	less	less	JJR	_	18	conj
21	of	of	IN	_	22	case
22	drug1	drug1	NN	_	20	nmod
23	per	per	IN	_	24	case
24	ml	ml	NN	_	22	nmod
25	.	.	.	_	15	punct

1	Combinations	combination	NNS	_	7	nsubj
2	of	of	IN	_	3	case
3	drug1	drug1	NN	_	1	nmod
4	and	and	CC	_	3	cc
5	drug2	drug2	NN	_	3	conj
6	were	be	VBD	_	7	cop
7	indifferent	indifferent	JJ	_	0	ROOT
8	for	for	IN	_	10	case
9	29	29	CD	_	10	nummod
10	strains	strain	NNS	_	7	nmod
11	and	and	CC	_	10	cc
12	synergistic	synergistic	JJ	_	10	conj
13	for	for	IN	_	15	case
14	33	33	CD	_	15	nummod
15	strains	strain	NNS	_	12	nmod
16	.	.	.	_	7	punct

1	All	all	DT	_	3	det
2	20	20	CD	_	3	nummod
3	strains	strain	NNS	_	25	nsubj
4	of	of	IN	_	5	case
5	enterococcus	enterococcus	NN	_	3	nmod
6	,	,	,	_	3	punct
7	three	three	CD	_	8	nummod
8	strains	strain	NNS	_	3	conj
9	of	of	IN	_	10	case
10	Clostridium	Clostridium	NNP	_	8	nmod
11	,	,	,	_	3	punct
12	three	three	CD	_	13	nummod
13	strains	strain	NNS	_	3	conj
14	of	of	IN	_	16	case
15	Escherichia	escherichia	FW	_	16	compound
16	coli	coli	FW	_	13	nmod
17	,	,	,	_	3	punct
18	and	and	CC	_	3	cc
19	one	one	CD	_	20	nummod
20	strain	strain	NN	_	3	conj
21	of	of	IN	_	23	case
22	Proteus	Proteus	NNP	_	23	compound
23	rettgeri	rettgeri	NN	_	20	nmod
24	were	be	VBD	_	25	cop
25	resistant	resistant	JJ	_	0	ROOT
26	to	to	TO	_	28	case
27	both	both	DT	_	28	cc:preconj
28	drug1	drug1	NN	_	25	nmod
29	-LRB-	-lrb-	-LRB-	_	32	punct
30	minimal	minimal	JJ	_	32	amod
31	inhibitory	inhibitory	JJ	_	32	amod
32	concentration	concentration	NN	_	28	dep
33	greater	greater	JJR	_	32	amod
34	than	than	IN	_	36	case
35	3.1	3.1	CD	_	36	nummod
36	mug/ml	mug/ml	NN	_	33	nmod
37	-RRB-	-rrb-	-RRB-	_	32	punct
38	and	and	CC	_	28	cc
39	drug2	drug2	NN	_	28	conj
40	-LRB-	-lrb-	-LRB-	_	43	punct
41	minimal	minimal	JJ	_	43	amod
42	inhibitory	inhibitory	JJ	_	43	amod
43	concentration	concentration	NN	_	39	dep
44	greater	greater	JJR	_	43	amod
45	than	than	IN	_	47	case
46	6.2	6.2	CD	_	47	nummod
47	mug/ml	mug/ml	NN	_	44	nmod
48	-RRB-	-rrb-	-RRB-	_	43	punct
49	.	.	.	_	25	punct

1	Combinations	combination	NNS	_	7	nsubj
2	of	of	IN	_	3	case
3	drug1	drug1	NN	_	1	nmod
4	and	and	CC	_	3	cc
5	drug2	drug2	NN	_	3	conj
6	were	be	VBD	_	7	cop
7	indifferent	indifferent	JJ	_	0	ROOT
8	for	for	IN	_	9	case
9	16	16	CD	_	7	nmod
10	and	and	CC	_	7	cc
11	synergistic	synergistic	JJ	_	7	conj
12	for	for	IN	_	13	case
13	11	11	CD	_	11	nmod
14	of	of	IN	_	17	case
15	the	the	DT	_	17	det
16	resistant	resistant	JJ	_	17	amod
17	strains	strain	NNS	_	13	nmod
18	.	.	.	_	7	punct

1	Except	except	IN	_	3	case
2	for	for	IN	_	3	case
3	drug1	drug1	NN	_	11	nmod
4	-	-	:	_	3	punct
5	sensitive	sensitive	JJ	_	6	amod
6	isolates	isolate	NNS	_	3	dep
7	,	,	,	_	11	punct
8	synergy	synergy	NN	_	11	nsubjpass
9	was	be	VBD	_	11	auxpass
10	usually	usually	RB	_	11	advmod
11	observed	observe	VBN	_	0	ROOT
12	only	only	RB	_	14	advmod
13	at	at	IN	_	14	case
14	concentrations	concentration	NNS	_	11	nmod
15	of	of	IN	_	16	case
16	one	one	CD	_	14	nmod
17	or	or	CC	_	16	cc
18	both	both	DT	_	16	conj
19	drugs	drug	NNS	_	16	dep
20	which	which	WDT	_	24	nsubj
21	are	be	VBP	_	24	cop
22	not	not	RB	_	24	neg
23	readily	readily	RB	_	24	advmod
24	obtainable	obtainable	JJ	_	16	acl:relcl
25	in	in	FW	_	26	compound
26	vivo	vivo	FW	_	24	advmod
27	.	.	.	_	11	punct

1	Antagonism	antagonism	NN	_	4	nsubjpass
2	was	be	VBD	_	4	auxpass
3	never	never	RB	_	4	neg
4	observed	observe	VBN	_	0	ROOT
5	.	.	.	_	4	punct

1	drug1	drug1	NN	_	0	ROOT
2	and	and	CC	_	1	cc
3	the	the	DT	_	5	det
4	common	common	JJ	_	5	amod
5	cold	cold	NN	_	1	conj
6	.	.	.	_	1	punct

1	Evaluation	evaluation	NN	_	0	ROOT
2	of	of	IN	_	4	case
3	its	its	PRP$	_	4	nmod:poss
4	efficacy	efficacy	NN	_	1	nmod
5	and	and	CC	_	4	cc
6	toxicity	toxicity	NN	_	4	conj
7	.	.	.	_	1	punct

1	We	we	PRP	_	2	nsubj
2	reviewed	review	VBD	_	0	ROOT
3	the	the	DT	_	5	det
4	clinical	clinical	JJ	_	5	amod
5	data	datum	NNS	_	2	dobj
6	relating	relate	VBG	_	5	acl
7	to	to	TO	_	9	case
8	the	the	DT	_	9	det
9	efficacy	efficacy	NN	_	6	nmod
10	and	and	CC	_	9	cc
11	safety	safety	NN	_	9	conj
12	of	of	IN	_	14	case
13	pharmacologic	pharmacologic	JJ	_	14	amod
14	doses	dose	NNS	_	9	nmod
15	of	of	IN	_	16	case
16	drug1	drug1	NN	_	14	nmod
17	in	in	IN	_	19	case
18	the	the	DT	_	19	det
19	prevention	prevention	NN	_	9	nmod
20	and	and	CC	_	19	cc
21	treatment	treatment	NN	_	19	conj
22	of	of	IN	_	25	case
23	the	the	DT	_	25	det
24	common	common	JJ	_	25	amod
25	cold	cold	NN	_	19	nmod
26	.	.	.	_	2	punct

1	Although	although	IN	_	5	mark
2	one	one	CD	_	3	nummod
3	study	study	NN	_	5	nsubj
4	tentatively	tentatively	RB	_	5	advmod
5	supports	support	VBZ	_	0	ROOT
6	the	the	DT	_	7	det
7	hypothesis	hypothesis	NN	_	5	dobj
8	that	that	IN	_	15	mark
9	such	such	JJ	_	10	amod
10	doses	dose	NNS	_	15	nsubj
11	of	of	IN	_	12	case
12	drug1	drug1	NN	_	10	nmod
13	may	may	MD	_	15	aux
14	be	be	VB	_	15	cop
15	efficacious	efficacious	JJ	_	7	ccomp
16	,	,	,	_	15	punct
17	a	a	DT	_	19	det
18	second	second	JJ	_	19	amod
19	study	study	NN	_	26	nsubj
20	by	by	IN	_	23	case
21	the	the	DT	_	23	det
22	same	same	JJ	_	23	amod
23	group	group	NN	_	19	nmod
24	did	do	VBD	_	26	aux
25	not	not	RB	_	26	neg
26	confirm	confirm	VB	_	15	ccomp
27	the	the	DT	_	29	det
28	significant	significant	JJ	_	29	amod
29	findings	finding	NNS	_	26	dobj
30	,	,	,	_	15	punct
31	and	and	CC	_	15	cc
32	no	no	DT	_	36	neg
33	clear	clear	JJ	_	36	amod
34	,	,	,	_	36	punct
35	reproducible	reproducible	JJ	_	36	amod
36	pattern	pattern	NN	_	40	nsubj
37	of	of	IN	_	38	case
38	efficacy	efficacy	NN	_	36	nmod
39	has	have	VBZ	_	40	aux
40	emerged	emerge	VBN	_	15	conj
41	from	from	IN	_	43	case
42	the	the	DT	_	43	det
43	review	review	NN	_	40	nmod
44	of	of	IN	_	47	case
45	all	all	PDT	_	47	det:predet
46	the	the	DT	_	47	det
47	evidence	evidence	NN	_	43	nmod
48	.	.	.	_	5	punct

1	Similarly	similarly	RB	_	4	advmod
2	,	,	,	_	4	punct
3	there	there	EX	_	4	expl
4	is	be	VBZ	_	0	ROOT
5	currently	currently	RB	_	8	advmod
6	little	little	JJ	_	8	amod
7	adequate	adequate	JJ	_	8	amod
8	evidence	evidence	NN	_	4	nsubj
9	on	on	IN	_	12	case
10	either	either	CC	_	12	cc:preconj
11	the	the	DT	_	12	det
12	presence	presence	NN	_	8	nmod
13	or	or	CC	_	12	cc
14	the	the	DT	_	15	det
15	absence	absence	NN	_	12	conj
16	of	of	IN	_	19	case
17	serious	serious	JJ	_	19	amod
18	adverse	adverse	JJ	_	19	amod
19	reactions	reaction	NNS	_	15	nmod
20	to	to	TO	_	22	case
21	such	such	JJ	_	22	amod
22	doses	dose	NNS	_	19	nmod
23	of	of	IN	_	24	case
24	drug1	drug1	NN	_	22	nmod
25	,	,	,	_	8	punct
26	although	although	IN	_	32	mark
27	many	many	JJ	_	29	amod
28	such	such	JJ	_	29	amod
29	reactions	reaction	NNS	_	32	nsubjpass
30	have	have	VBP	_	32	aux
31	been	be	VBN	_	32	auxpass
32	hypothesized	hypothesize	VBN	_	8	advcl
33	.	.	.	_	4	punct

1	The	the	DT	_	3	det
2	unrestricted	unrestricted	JJ	_	3	amod
3	use	use	NN	_	12	nsubjpass
4	of	of	IN	_	5	case
5	drug1	drug1	NN	_	3	nmod
6	for	for	IN	_	8	case
7	these	these	DT	_	8	det
8	purposes	purpose	NNS	_	3	nmod
9	can	can	MD	_	12	aux
10	not	not	RB	_	12	neg
11	be	be	VB	_	12	auxpass
12	advocated	advocate	VBN	_	0	ROOT
13	on	on	IN	_	15	case
14	the	the	DT	_	15	det
15	basis	basis	NN	_	12	nmod
16	of	of	IN	_	18	case
17	the	the	DT	_	18	det
18	evidence	evidence	NN	_	15	nmod
19	currently	currently	RB	_	20	advmod
20	available	available	JJ	_	18	amod
21	.	.	.	_	12	punct

1	Effects	effect	NNS	_	0	ROOT
2	of	of	IN	_	3	case
3	drug1	drug1	NN	_	1	nmod
4	in	in	IN	_	7	case
5	a	a	DT	_	7	det
6	light/dark	light/dark	JJ	_	7	amod
7	test	test	NN	_	1	nmod
8	in	in	IN	_	9	case
9	mice	mouse	NNS	_	7	nmod
10	and	and	CC	_	1	cc
11	the	the	DT	_	12	det
12	contribution	contribution	NN	_	1	conj
13	of	of	IN	_	15	case
14	adenosine	adenosine	NN	_	15	compound
15	receptors	receptor	NNS	_	12	nmod
16	.	.	.	_	1	punct

1	We	we	PRP	_	2	nsubj
2	investigated	investigate	VBD	_	0	ROOT
3	the	the	DT	_	4	det
4	effects	effect	NNS	_	2	dobj
5	of	of	IN	_	8	case
6	adenosine	adenosine	NN	_	8	compound
7	receptor	receptor	NN	_	8	compound
8	antagonists	antagonist	NNS	_	4	nmod
9	,	,	,	_	8	punct
10	drug1	drug1	NN	_	8	conj
11	,	,	,	_	8	punct
12	drug2	drug2	NN	_	8	conj
13	,	,	,	_	8	punct
14	drug3	drug3	NN	_	8	conj
15	,	,	,	_	8	punct
16	and	and	CC	_	8	cc
17	drug4	drug4	NN	_	8	conj
18	-LRB-	-lrb-	-LRB-	_	19	punct
19	drug5	drug5	NN	_	17	appos
20	-RRB-	-rrb-	-RRB-	_	19	punct
21	,	,	,	_	4	punct
22	in	in	IN	_	25	case
23	a	a	DT	_	25	det
24	light/dark	light/dark	JJ	_	25	amod
25	test	test	NN	_	4	nmod
26	in	in	IN	_	27	case
27	mice	mouse	NNS	_	25	nmod
28	.	.	.	_	2	punct

1	All	all	DT	_	2	det
2	antagonists	antagonist	NNS	_	3	nsubj
3	decreased	decrease	VBD	_	0	ROOT
4	the	the	DT	_	5	det
5	time	time	NN	_	3	dobj
6	spent	spend	VBN	_	5	acl
7	in	in	IN	_	10	case
8	the	the	DT	_	10	det
9	light	light	JJ	_	10	amod
10	zone	zone	NN	_	6	nmod
11	in	in	IN	_	13	case
12	this	this	DT	_	13	det
13	test	test	NN	_	6	nmod
14	,	,	,	_	5	punct
15	which	which	WDT	_	16	nsubj
16	suggested	suggest	VBD	_	5	acl:relcl
17	that	that	IN	_	20	mark
18	these	these	DT	_	19	det
19	compounds	compound	NNS	_	20	nsubj
20	have	have	VBP	_	16	ccomp
21	anxiogenic	anxiogenic	JJ	_	22	amod
22	effects	effect	NNS	_	20	dobj
23	.	.	.	_	3	punct

1	The	the	DT	_	3	det
2	anxiogenic	anxiogenic	JJ	_	3	amod
3	effects	effect	NNS	_	7	nsubjpass
4	of	of	IN	_	5	case
5	drug1	drug1	NN	_	3	nmod
6	were	be	VBD	_	7	auxpass
7	reduced	reduce	VBN	_	0	ROOT
8	by	by	IN	_	9	case
9	pretreatment	pretreatment	NN	_	7	nmod
10	with	with	IN	_	11	case
11	drug2	drug2	NN	_	9	nmod
12	,	,	,	_	11	punct
13	an	a	DT	_	15	det
14	A2-selective	a2-selective	JJ	_	15	amod
15	agonist	agonist	NN	_	11	appos
16	,	,	,	_	11	punct
17	but	but	CC	_	11	cc
18	not	not	RB	_	20	neg
19	by	by	IN	_	20	case
20	drug3	drug3	NN	_	11	conj
21	-LRB-	-lrb-	-LRB-	_	22	punct
22	drug4	drug4	NN	_	20	appos
23	-RRB-	-rrb-	-RRB-	_	22	punct
24	,	,	,	_	20	punct
25	an	a	DT	_	27	det
26	A1-selective	a1-selective	JJ	_	27	amod
27	agonist	agonist	NN	_	20	appos
28	.	.	.	_	7	punct

1	However	however	RB	_	16	advmod
2	,	,	,	_	16	punct
3	the	the	DT	_	4	det
4	antagonism	antagonism	NN	_	16	nsubjpass
5	of	of	IN	_	7	case
6	the	the	DT	_	7	det
7	drug1	drug1	NN	_	4	nmod
8	-	-	:	_	7	punct
9	induced	induce	VBN	_	11	amod
10	anxiogenic	anxiogenic	JJ	_	11	amod
11	effects	effect	NNS	_	7	dep
12	by	by	IN	_	13	case
13	drug2	drug2	NN	_	11	nmod
14	was	be	VBD	_	16	auxpass
15	only	only	RB	_	16	advmod
16	observed	observe	VBN	_	0	ROOT
17	in	in	IN	_	19	case
18	the	the	DT	_	19	det
19	time	time	NN	_	16	nmod
20	spent	spend	VBN	_	19	acl
21	in	in	IN	_	24	case
22	the	the	DT	_	24	det
23	light	light	JJ	_	24	amod
24	zone	zone	NN	_	20	nmod
25	,	,	,	_	16	punct
26	and	and	CC	_	16	cc
27	drug3	drug3	NN	_	16	conj
28	-	-	:	_	27	punct
29	induced	induce	VBN	_	31	amod
30	anxiogenic	anxiogenic	JJ	_	31	amod
31	effects	effect	NNS	_	34	nsubjpass
32	were	be	VBD	_	34	auxpass
33	neither	neither	DT	_	34	dep
34	reversed	reverse	VBN	_	27	dep
35	by	by	IN	_	36	case
36	drug4	drug4	NN	_	34	nmod
37	nor	nor	CC	_	36	cc
38	by	by	IN	_	39	case
39	drug5	drug5	NN	_	36	conj
40	.	.	.	_	16	punct

1	Finally	finally	RB	_	5	advmod
2	,	,	,	_	5	punct
3	it	it	PRP	_	5	nsubj
4	is	be	VBZ	_	5	cop
5	notable	notable	JJ	_	0	ROOT
6	that	that	IN	_	13	mark
7	xanthine-derived	xanthine-derived	JJ	_	9	amod
8	adenosine	adenosine	NN	_	9	compound
9	antagonists	antagonist	NNS	_	13	nsubj
10	tested	test	VBN	_	9	acl
11	here	here	RB	_	10	advmod
12	commonly	commonly	RB	_	13	advmod
13	showed	show	VBD	_	5	ccomp
14	anxiogenic	anxiogenic	JJ	_	15	amod
15	effects	effect	NNS	_	13	dobj
16	in	in	IN	_	19	case
17	the	the	DT	_	19	det
18	light/dark	light/dark	NN	_	19	compound
19	test	test	NN	_	15	nmod
20	in	in	IN	_	21	case
21	mice	mouse	NNS	_	19	nmod
22	.	.	.	_	5	punct

1	It	it	PRP	_	3	nsubjpass
2	is	be	VBZ	_	3	auxpass
3	suggested	suggest	VBN	_	0	ROOT
4	that	that	IN	_	6	mark
5	there	there	EX	_	6	expl
6	is	be	VBZ	_	3	ccomp
7	a	a	DT	_	9	det
8	minor	minor	JJ	_	9	amod
9	contribution	contribution	NN	_	6	nsubj
10	of	of	IN	_	12	case
11	adenosine	adenosine	NN	_	12	compound
12	receptors	receptor	NNS	_	9	nmod
13	to	to	TO	_	15	case
14	these	these	DT	_	15	det
15	effects	effect	NNS	_	9	nmod
16	,	,	,	_	6	punct
17	although	although	IN	_	24	mark
18	drug1	drug1	NN	_	24	dep
19	-	-	:	_	18	punct
20	induced	induce	VBN	_	22	amod
21	anxiogenic	anxiogenic	JJ	_	22	amod
22	effects	effect	NNS	_	24	nsubjpass
23	were	be	VBD	_	24	auxpass
24	antagonized	antagonize	VBN	_	6	advcl
25	by	by	IN	_	29	case
26	an	a	DT	_	29	det
27	A2	a2	NN	_	29	compound
28	receptor	receptor	NN	_	29	compound
29	agonist	agonist	NN	_	24	nmod
30	.	.	.	_	3	punct

1	Restoration	restoration	NN	_	0	ROOT
2	of	of	IN	_	4	case
3	drug1	drug1	NN	_	4	compound
4	susceptibility	susceptibility	NN	_	1	nmod
5	in	in	IN	_	7	case
6	Enterococcus	enterococcus	NN	_	7	compound
7	faecalis	faecalis	NN	_	4	nmod
8	by	by	IN	_	12	case
9	antiresistance	antiresistance	JJ	_	12	amod
10	determinant	determinant	NN	_	12	compound
11	gene	gene	NN	_	12	compound
12	transfer	transfer	NN	_	1	nmod
13	.	.	.	_	1	punct

1	We	we	PRP	_	2	nsubj
2	assessed	assess	VBD	_	0	ROOT
3	the	the	DT	_	4	det
4	ability	ability	NN	_	2	dobj
5	of	of	IN	_	7	case
6	gene	gene	NN	_	7	compound
7	transfer	transfer	NN	_	4	nmod
8	to	to	TO	_	9	mark
9	reverse	reverse	VB	_	4	acl
10	drug1	drug1	NN	_	11	compound
11	resistance	resistance	NN	_	9	dobj
12	in	in	IN	_	14	case
13	class	class	NN	_	14	compound
14	A	a	NN	_	11	nmod
15	-LRB-	-lrb-	-LRB-	_	16	punct
16	VanA	vana	NN	_	14	appos
17	-RRB-	-rrb-	-RRB-	_	16	punct
18	glycopeptide-resistant	glycopeptide-resistant	JJ	_	20	amod
19	Enterococcus	enterococcus	NN	_	20	compound
20	faecalis	faecalis	NN	_	14	dep
21	.	.	.	_	2	punct

1	Recombinant	recombinant	JJ	_	3	amod
2	shuttle	shuttle	NN	_	3	compound
3	vectors	vector	NNS	_	12	nsubj
4	containing	contain	VBG	_	3	acl
5	a	a	DT	_	10	det
6	vanH	vanh	NN	_	10	compound
7	promoter-vanA	promoter-vana	NN	_	10	compound
8	antisense	antisense	JJ	_	10	amod
9	gene	gene	NN	_	10	compound
10	cassette	cassette	NN	_	4	dobj
11	fully	fully	RB	_	12	advmod
12	restored	restore	VBD	_	0	ROOT
13	drug1	drug1	NN	_	14	compound
14	susceptibility	susceptibility	NN	_	12	dobj
15	through	through	IN	_	22	case
16	a	a	DT	_	22	det
17	combined	combined	JJ	_	22	amod
18	transcriptional	transcriptional	JJ	_	22	amod
19	activator	activator	NN	_	22	compound
20	binding	binding	NN	_	22	compound
21	domain	domain	NN	_	22	compound
22	decoy	decoy	NN	_	12	nmod
23	and	and	CC	_	22	cc
24	inducible	inducible	JJ	_	28	amod
25	vanA	vana	NN	_	28	compound
26	antisense	antisense	JJ	_	28	amod
27	RNA	rna	NN	_	28	compound
28	effect	effect	NN	_	22	conj
29	.	.	.	_	12	punct

1	Induction	induction	NN	_	0	ROOT
2	of	of	IN	_	3	case
3	apoptosis	apoptosis	NN	_	1	nmod
4	in	in	IN	_	7	case
5	breast	breast	NN	_	7	compound
6	cancer	cancer	NN	_	7	compound
7	cells	cell	NNS	_	1	nmod
8	in	in	IN	_	9	case
9	response	response	NN	_	1	nmod
10	to	to	TO	_	11	case
11	drug1	drug1	NN	_	9	nmod
12	and	and	CC	_	11	cc
13	drug2	drug2	NN	_	11	conj
14	.	.	.	_	1	punct

1	1	1	CD	_	17	nummod
2	,	,	,	_	17	punct
3	drug1	drug1	NN	_	17	nsubj
4	-LRB-	-lrb-	-LRB-	_	5	punct
5	drug2	drug2	NN	_	3	appos
6	-RRB-	-rrb-	-RRB-	_	5	punct
7	,	,	,	_	3	punct
8	the	the	DT	_	10	det
9	active	active	JJ	_	10	amod
10	metabolite	metabolite	NN	_	3	appos
11	of	of	IN	_	12	case
12	drug3	drug3	NN	_	10	nmod
13	,	,	,	_	3	punct
14	is	be	VBZ	_	17	cop
15	a	a	DT	_	17	det
16	potent	potent	JJ	_	17	amod
17	inhibitor	inhibitor	NN	_	0	ROOT
18	of	of	IN	_	22	case
19	breast	breast	NN	_	22	compound
20	cancer	cancer	NN	_	22	compound
21	cell	cell	NN	_	22	compound
22	growth	growth	NN	_	17	nmod
23	both	both	CC	_	26	cc:preconj
24	in	in	FW	_	25	compound
25	vivo	vivo	FW	_	26	advmod
26	and	and	CC	_	17	advmod
27	in	in	FW	_	28	compound
28	vitro	vitro	FW	_	26	advmod
29	.	.	.	_	17	punct

1	We	we	PRP	_	3	nsubj
2	have	have	VBP	_	3	aux
3	shown	show	VBN	_	0	ROOT
4	that	that	IN	_	12	mark
5	MCF-7	mcf-7	NN	_	6	compound
6	cells	cell	NNS	_	12	nsubj
7	treated	treat	VBN	_	6	acl
8	with	with	IN	_	11	case
9	100	100	CD	_	10	compound
10	nM	nm	NN	_	11	amod
11	drug1	drug1	NN	_	7	nmod
12	exhibit	exhibit	VBP	_	3	ccomp
13	characteristic	characteristic	JJ	_	15	amod
14	apoptotic	apoptotic	JJ	_	15	amod
15	morphology	morphology	NN	_	12	dobj
16	-LRB-	-lrb-	-LRB-	_	18	punct
17	pyknotic	pyknotic	JJ	_	18	amod
18	nuclei	nucleus	NNS	_	15	dep
19	,	,	,	_	18	punct
20	chromatin	chromatin	NN	_	18	conj
21	and	and	CC	_	18	cc
22	cytoplasmic	cytoplasmic	JJ	_	23	amod
23	condensation	condensation	NN	_	18	conj
24	,	,	,	_	18	punct
25	nuclear	nuclear	JJ	_	28	amod
26	matrix	matrix	NN	_	28	compound
27	protein	protein	NN	_	28	compound
28	reorganization	reorganization	NN	_	18	appos
29	-RRB-	-rrb-	-RRB-	_	18	punct
30	within	within	IN	_	32	case
31	48	48	CD	_	32	nummod
32	h	h	NN	_	12	nmod
33	.	.	.	_	3	punct

1	In	in	IN	_	3	case
2	the	the	DT	_	3	det
3	experiments	experiment	NNS	_	8	nmod
4	reported	report	VBN	_	3	acl
5	here	here	RB	_	4	advmod
6	,	,	,	_	8	punct
7	we	we	PRP	_	8	nsubj
8	examined	examine	VBD	_	0	ROOT
9	the	the	DT	_	10	det
10	interactions	interaction	NNS	_	8	dobj
11	between	between	IN	_	12	case
12	drug1	drug1	NN	_	10	nmod
13	and	and	CC	_	12	cc
14	the	the	DT	_	16	det
15	drug2	drug2	NN	_	16	compound
16	drug3	drug3	NN	_	12	conj
17	-LRB-	-lrb-	-LRB-	_	18	punct
18	drug4	drug4	NN	_	16	appos
19	-RRB-	-rrb-	-RRB-	_	18	punct
20	,	,	,	_	16	punct
21	which	which	WDT	_	23	nsubj
22	also	also	RB	_	23	advmod
23	induces	induce	VBZ	_	16	acl:relcl
24	apoptosis	apoptosis	NN	_	23	dobj
25	in	in	IN	_	27	case
26	MCF-7	mcf-7	NN	_	27	compound
27	cells	cell	NNS	_	24	nmod
28	.	.	.	_	8	punct

1	Our	we	PRP$	_	2	nmod:poss
2	data	datum	NNS	_	3	nsubj
3	suggest	suggest	VBP	_	0	ROOT
4	that	that	IN	_	7	mark
5	drug1	drug1	NN	_	7	nsubj
6	significantly	significantly	RB	_	7	advmod
7	potentiates	potentiate	VBZ	_	3	ccomp
8	the	the	DT	_	9	det
9	reduction	reduction	NN	_	7	dobj
10	in	in	IN	_	12	case
11	cell	cell	NN	_	12	compound
12	number	number	NN	_	9	nmod
13	induced	induce	VBN	_	12	acl
14	by	by	IN	_	15	case
15	drug2	drug2	NN	_	13	nmod
16	alone	alone	RB	_	15	advmod
17	.	.	.	_	3	punct

1	Combined	combined	JJ	_	2	amod
2	treatment	treatment	NN	_	7	nsubj
3	with	with	IN	_	4	case
4	drug1	drug1	NN	_	2	nmod
5	and	and	CC	_	4	cc
6	drug2	drug2	NN	_	4	conj
7	enhances	enhance	VBZ	_	0	ROOT
8	the	the	DT	_	9	det
9	degree	degree	NN	_	7	dobj
10	of	of	IN	_	11	case
11	apoptosis	apoptosis	NN	_	9	nmod
12	assessed	assess	VBN	_	11	acl
13	using	use	VBG	_	12	xcomp
14	morphological	morphological	JJ	_	15	amod
15	markers	marker	NNS	_	13	dobj
16	that	that	WDT	_	17	nsubj
17	identify	identify	VBP	_	15	acl:relcl
18	chromatin	chromatin	NN	_	23	compound
19	and	and	CC	_	18	cc
20	nuclear	nuclear	JJ	_	22	amod
21	matrix	matrix	NN	_	22	compound
22	protein	protein	NN	_	18	conj
23	condensation	condensation	NN	_	17	dobj
24	.	.	.	_	7	punct

1	We	we	PRP	_	3	nsubj
2	have	have	VBP	_	3	aux
3	selected	select	VBN	_	0	ROOT
4	a	a	DT	_	5	det
5	subclone	subclone	NN	_	3	dobj
6	of	of	IN	_	8	case
7	MCF-7	mcf-7	NN	_	8	compound
8	cells	cell	NNS	_	5	nmod
9	resistant	resistant	JJ	_	8	amod
10	to	to	TO	_	11	case
11	drug1	drug1	NN	_	9	nmod
12	-LRB-	-lrb-	-LRB-	_	13	punct
13	MCF-7D3Res	mcf-7d3re	NNS	_	11	appos
14	-RRB-	-rrb-	-RRB-	_	13	punct
15	.	.	.	_	3	punct

1	These	these	DT	_	2	det
2	cells	cell	NNS	_	3	nsubj
3	express	express	VBP	_	0	ROOT
4	the	the	DT	_	7	det
5	vitamin	vitamin	NN	_	7	compound
6	D	d	NN	_	7	compound
7	receptor	receptor	NN	_	3	dobj
8	and	and	CC	_	3	cc
9	exhibit	exhibit	VBP	_	3	conj
10	doubling	double	VBG	_	9	xcomp
11	times	time	NNS	_	10	dobj
12	comparable	comparable	JJ	_	11	amod
13	to	to	TO	_	17	case
14	the	the	DT	_	17	det
15	parental	parental	JJ	_	17	amod
16	MCF-7	mcf-7	NN	_	17	compound
17	cells	cell	NNS	_	12	nmod
18	,	,	,	_	10	punct
19	even	even	RB	_	20	advmod
20	when	when	WRB	_	21	advmod
21	grown	grow	VBN	_	10	advcl
22	in	in	IN	_	25	case
23	100	100	CD	_	25	nummod
24	mM	mm	NN	_	25	compound
25	drug1	drug1	NN	_	21	nmod
26	.	.	.	_	3	punct

1	Treatment	treatment	NN	_	11	nsubj
2	of	of	IN	_	8	case
3	both	both	CC	_	4	cc:preconj
4	parental	parental	JJ	_	8	amod
5	and	and	CC	_	4	cc
6	resistant	resistant	JJ	_	4	conj
7	MCF-7	mcf-7	NN	_	8	compound
8	cells	cell	NNS	_	1	nmod
9	with	with	IN	_	10	case
10	drug1	drug1	NN	_	1	nmod
11	induces	induce	VBZ	_	0	ROOT
12	apoptosis	apoptosis	NN	_	11	dobj
13	and	and	CC	_	12	cc
14	clusterin	clusterin	NN	_	12	conj
15	.	.	.	_	11	punct

1	These	these	DT	_	2	det
2	data	datum	NNS	_	3	nsubj
3	emphasize	emphasize	VBP	_	0	ROOT
4	that	that	IN	_	8	mark
5	apoptosis	apoptosis	NN	_	8	nsubjpass
6	can	can	MD	_	8	aux
7	be	be	VB	_	8	auxpass
8	induced	induce	VBN	_	3	ccomp
9	in	in	IN	_	11	case
10	MCF-7	mcf-7	NN	_	11	compound
11	cells	cell	NNS	_	8	nmod
12	either	either	CC	_	14	cc:preconj
13	by	by	IN	_	14	case
14	activation	activation	NN	_	8	nmod
15	of	of	IN	_	16	case
16	drug1	drug1	NN	_	14	nmod
17	-	-	:	_	8	punct
18	mediated	mediate	VBN	_	19	amod
19	signalling	signalling	NN	_	8	dep
20	or	or	CC	_	19	cc
21	disruption	disruption	NN	_	19	conj
22	of	of	IN	_	23	case
23	drug2	drug2	NN	_	19	nmod
24	-	-	:	_	19	punct
25	dependent	dependent	JJ	_	26	amod
26	signalling	signalling	NN	_	19	dep
27	.	.	.	_	3	punct

1	Cholinergic	cholinergic	JJ	_	2	amod
2	role	role	NN	_	0	ROOT
3	in	in	IN	_	6	case
4	drug1	drug1	NN	_	6	nmod:poss
5	's	's	POS	_	4	case
6	effects	effect	NNS	_	2	nmod
7	on	on	IN	_	9	case
8	evoked	evoke	VBN	_	9	amod
9	potentials	potential	NNS	_	6	nmod
10	in	in	IN	_	12	case
11	visual	visual	JJ	_	12	amod
12	cortex	cortex	NN	_	6	nmod
13	of	of	IN	_	16	case
14	the	the	DT	_	16	det
15	albino	albino	NN	_	16	compound
16	rat	rat	NN	_	12	nmod
17	.	.	.	_	2	punct

1	Photic	photic	JJ	_	3	amod
2	evoked	evoke	VBN	_	3	amod
3	potentials	potential	NNS	_	5	nsubjpass
4	were	be	VBD	_	5	auxpass
5	recorded	record	VBN	_	0	ROOT
6	from	from	IN	_	9	case
7	the	the	DT	_	9	det
8	visual	visual	JJ	_	9	amod
9	cortex	cortex	NN	_	5	nmod
10	of	of	IN	_	14	case
11	chronically	chronically	RB	_	12	advmod
12	implanted	implant	VBN	_	14	amod
13	albino	albino	NN	_	14	compound
14	rats	rat	NNS	_	9	nmod
15	.	.	.	_	5	punct

1	Since	since	IN	_	7	mark
2	photic	photic	JJ	_	5	amod
3	evoked	evoke	VBN	_	5	amod
4	potential	potential	JJ	_	5	amod
5	components	component	NNS	_	7	nsubj
6	are	be	VBP	_	7	cop
7	representations	representation	NNS	_	28	advcl
8	of	of	IN	_	10	case
9	neural	neural	JJ	_	10	amod
10	pathways	pathway	NNS	_	7	nmod
11	which	which	WDT	_	13	nsubjpass
12	are	be	VBP	_	13	auxpass
13	activated	activate	VBN	_	10	acl:relcl
14	during	during	IN	_	16	case
15	photic	photic	JJ	_	16	amod
16	stimulation	stimulation	NN	_	13	nmod
17	,	,	,	_	28	punct
18	study	study	NN	_	28	nsubj
19	of	of	IN	_	21	case
20	the	the	DT	_	21	det
21	effects	effect	NNS	_	18	nmod
22	of	of	IN	_	23	case
23	drug1	drug1	NN	_	21	nmod
24	on	on	IN	_	26	case
25	these	these	DT	_	26	det
26	components	component	NNS	_	21	nmod
27	may	may	MD	_	28	aux
28	help	help	VB	_	0	ROOT
29	to	to	TO	_	31	case
30	trace	trace	NN	_	31	compound
31	pathways	pathway	NNS	_	28	nmod
32	which	which	WDT	_	34	nsubjpass
33	are	be	VBP	_	34	auxpass
34	affected	affect	VBN	_	31	acl:relcl
35	by	by	IN	_	36	case
36	drug2	drug2	NN	_	34	nmod
37	.	.	.	_	28	punct

1	In	in	IN	_	4	case
2	the	the	DT	_	4	det
3	present	present	JJ	_	4	amod
4	study	study	NN	_	9	nmod
5	,	,	,	_	9	punct
6	evoked	evoke	VBD	_	7	amod
7	potentials	potential	NNS	_	9	nsubjpass
8	were	be	VBD	_	9	auxpass
9	recorded	record	VBN	_	0	ROOT
10	at	at	IN	_	11	case
11	5	5	CD	_	9	nmod
12	,	,	,	_	11	punct
13	20	20	CD	_	11	conj
14	,	,	,	_	11	punct
15	and	and	CC	_	11	cc
16	40	40	CD	_	11	conj
17	min	min	NN	_	11	dep
18	following	follow	VBG	_	20	case
19	IP	IP	NNP	_	20	compound
20	injections	injection	NNS	_	9	nmod
21	of	of	IN	_	22	case
22	saline	saline	NN	_	20	nmod
23	,	,	,	_	22	punct
24	drug1	drug1	NN	_	22	conj
25	-LRB-	-lrb-	-LRB-	_	27	punct
26	2.0	2.0	CD	_	27	nummod
27	g/kg	g/kg	NN	_	24	appos
28	-RRB-	-rrb-	-RRB-	_	27	punct
29	,	,	,	_	22	punct
30	drug2	drug2	NN	_	22	conj
31	-LRB-	-lrb-	-LRB-	_	33	punct
32	0.6	0.6	CD	_	33	nummod
33	mg/kg	mg/kg	NN	_	30	appos
34	-RRB-	-rrb-	-RRB-	_	33	punct
35	or	or	CC	_	22	cc
36	drug3	drug3	NN	_	22	conj
37	-LRB-	-lrb-	-LRB-	_	39	punct
38	15.0	15.0	CD	_	39	nummod
39	mg/kg	mg/kg	NN	_	36	appos
40	-RRB-	-rrb-	-RRB-	_	39	punct
41	on	on	IN	_	43	case
42	separate	separate	JJ	_	43	amod
43	days	day	NNS	_	20	nmod
44	.	.	.	_	9	punct

1	drug1	drug1	NN	_	2	nsubj
2	depressed	depress	VBD	_	0	ROOT
3	the	the	DT	_	4	det
4	amplitudes	amplitude	NNS	_	2	dobj
5	of	of	IN	_	9	case
6	most	most	JJS	_	9	amod
7	evoked	evoke	VBN	_	9	amod
8	potential	potential	JJ	_	9	amod
9	components	component	NNS	_	4	nmod
10	in	in	IN	_	11	case
11	comparison	comparison	NN	_	2	nmod
12	to	to	TO	_	14	case
13	saline	saline	NN	_	14	compound
14	administration	administration	NN	_	11	nmod
15	.	.	.	_	2	punct

1	Component	component	NN	_	2	compound
2	P2	p2	NN	_	7	nsubjpass
3	,	,	,	_	7	punct
4	however	however	RB	_	7	advmod
5	,	,	,	_	7	punct
6	was	be	VBD	_	7	auxpass
7	increased	increase	VBN	_	0	ROOT
8	in	in	IN	_	9	case
9	amplitude	amplitude	NN	_	7	nmod
10	.	.	.	_	7	punct

1	drug1	drug1	NN	_	2	compound
2	briefly	briefly	NN	_	3	nsubj
3	reduced	reduce	VBD	_	0	ROOT
4	the	the	DT	_	5	det
5	amplitude	amplitude	NN	_	3	dobj
6	of	of	IN	_	8	case
7	most	most	JJS	_	8	amod
8	components	component	NNS	_	5	nmod
9	,	,	,	_	8	punct
10	including	include	VBG	_	11	case
11	P2	p2	NN	_	8	nmod
12	.	.	.	_	3	punct

1	In	in	IN	_	2	case
2	contrast	contrast	NN	_	5	nmod
3	,	,	,	_	5	punct
4	drug1	drug1	NN	_	5	nsubj
5	increased	increase	VBD	_	0	ROOT
6	the	the	DT	_	7	det
7	amplitudes	amplitude	NNS	_	5	dobj
8	of	of	IN	_	9	case
9	components	component	NNS	_	7	nmod
10	P1	p1	NN	_	9	dep
11	and	and	CC	_	10	cc
12	P2	p2	NN	_	10	conj
13	,	,	,	_	5	punct
14	while	while	IN	_	5	dep
15	decreasing	decrease	VBG	_	17	amod
16	components	component	NNS	_	17	compound
17	N1	n1	NN	_	14	root
18	,	,	,	_	17	punct
19	N2	n2	NN	_	17	conj
20	and	and	CC	_	17	cc
21	N3	n3	NN	_	17	conj
22	for	for	IN	_	24	case
23	varying	vary	VBG	_	24	amod
24	durations	duration	NNS	_	21	nmod
25	of	of	IN	_	26	case
26	time	time	NN	_	24	nmod
27	.	.	.	_	17	punct

1	drug1	drug1	NN	_	2	compound
2	pretreatment	pretreatment	NN	_	3	nsubj
3	augmented	augment	VBD	_	0	ROOT
4	the	the	DT	_	6	det
5	depressant	depressant	NN	_	6	compound
6	effect	effect	NN	_	3	dobj
7	of	of	IN	_	8	case
8	drug2	drug2	NN	_	6	nmod
9	on	on	IN	_	12	case
10	the	the	DT	_	12	det
11	early	early	JJ	_	12	amod
12	components	component	NNS	_	3	nmod
13	P1	p1	NN	_	12	dep
14	and	and	CC	_	13	cc
15	N1	n1	NN	_	13	conj
16	,	,	,	_	3	punct
17	while	while	IN	_	18	mark
18	attenuating	attenuate	VBG	_	3	advcl
19	drug3	drug3	NN	_	21	nmod:poss
20	's	's	POS	_	19	case
21	influence	influence	NN	_	18	dobj
22	on	on	IN	_	24	case
23	components	component	NNS	_	24	compound
24	P2	p2	NN	_	21	nmod
25	and	and	CC	_	24	cc
26	P3	p3	NN	_	24	conj
27	.	.	.	_	3	punct

1	Pretreatment	pretreatment	NN	_	6	nsubj
2	with	with	IN	_	3	case
3	drug1	drug1	NN	_	1	nmod
4	likewise	likewise	RB	_	6	advmod
5	further	further	RB	_	6	advmod
6	reduced	reduce	VBD	_	0	ROOT
7	the	the	DT	_	8	det
8	amplitudes	amplitude	NNS	_	6	dobj
9	of	of	IN	_	10	case
10	components	component	NNS	_	8	nmod
11	P1	p1	NN	_	10	dep
12	and	and	CC	_	11	cc
13	N1	n1	NN	_	11	conj
14	,	,	,	_	6	punct
15	and	and	CC	_	6	cc
16	produced	produce	VBD	_	6	conj
17	a	a	DT	_	19	det
18	similar	similar	JJ	_	19	amod
19	effect	effect	NN	_	16	dobj
20	on	on	IN	_	22	case
21	component	component	NN	_	22	compound
22	N3	n3	NN	_	19	nmod
23	.	.	.	_	6	punct

1	drug1	drug1	NN	_	11	nsubj
2	,	,	,	_	1	punct
3	either	either	CC	_	1	dep
4	alone	alone	RB	_	3	dep
5	or	or	CC	_	3	cc
6	in	in	IN	_	7	case
7	combination	combination	NN	_	3	conj
8	with	with	IN	_	9	case
9	drug2	drug2	NN	_	7	nmod
10	,	,	,	_	1	punct
11	produced	produce	VBD	_	0	ROOT
12	approximately	approximately	RB	_	15	advmod
13	the	the	DT	_	15	det
14	same	same	JJ	_	15	amod
15	degree	degree	NN	_	11	dobj
16	of	of	IN	_	17	case
17	enhancement	enhancement	NN	_	15	nmod
18	of	of	IN	_	20	case
19	component	component	NN	_	20	compound
20	P2	p2	NN	_	17	nmod
21	.	.	.	_	11	punct

1	In	in	IN	_	2	case
2	comparison	comparison	NN	_	10	nmod
3	to	to	TO	_	5	case
4	saline	saline	NN	_	5	compound
5	values	value	NNS	_	2	nmod
6	,	,	,	_	10	punct
7	all	all	DT	_	9	det
8	three	three	CD	_	9	nummod
9	agents	agent	NNS	_	10	nsubj
10	produced	produce	VBD	_	0	ROOT
11	reliable	reliable	JJ	_	12	amod
12	increases	increase	NNS	_	10	dobj
13	in	in	IN	_	15	case
14	peak	peak	JJ	_	15	amod
15	latency	latency	NN	_	12	nmod
16	for	for	IN	_	17	case
17	most	most	JJS	_	12	nmod
18	of	of	IN	_	20	case
19	the	the	DT	_	20	det
20	components	component	NNS	_	17	nmod
21	,	,	,	_	10	punct
22	with	with	IN	_	25	mark
23	only	only	RB	_	24	advmod
24	N3	n3	NN	_	25	nsubj
25	showing	show	VBG	_	10	advcl
26	no	no	DT	_	27	neg
27	effects	effect	NNS	_	25	dobj
28	.	.	.	_	10	punct

1	The	the	DT	_	3	det
2	amplitude	amplitude	NN	_	3	compound
3	data	datum	NNS	_	7	nsubj
4	from	from	IN	_	6	case
5	this	this	DT	_	6	det
6	study	study	NN	_	3	nmod
7	suggest	suggest	VBP	_	0	ROOT
8	that	that	IN	_	16	mark
9	drug1	drug1	NN	_	11	nmod:poss
10	's	's	POS	_	9	case
11	augmentation	augmentation	NN	_	16	nsubj
12	of	of	IN	_	14	case
13	component	component	NN	_	14	compound
14	P2	p2	NN	_	11	nmod
15	may	may	MD	_	16	aux
16	result	result	VB	_	7	ccomp
17	,	,	,	_	16	punct
18	at	at	IN	_	21	advmod
19	least	least	JJS	_	18	mwe
20	in	in	IN	_	21	case
21	part	part	NN	_	16	nmod
22	,	,	,	_	16	punct
23	from	from	IN	_	24	case
24	alterations	alteration	NNS	_	16	nmod
25	in	in	IN	_	27	case
26	cholinergic	cholinergic	JJ	_	27	amod
27	functions	function	NNS	_	24	nmod
28	.	.	.	_	7	punct

1	Increased	increase	VBN	_	2	amod
2	hepatotoxicity	hepatotoxicity	NN	_	0	ROOT
3	of	of	IN	_	4	case
4	drug1	drug1	NN	_	2	nmod
5	by	by	IN	_	7	case
6	concomitant	concomitant	JJ	_	7	amod
7	administration	administration	NN	_	2	nmod
8	of	of	IN	_	9	case
9	drug2	drug2	NN	_	7	nmod
10	in	in	IN	_	12	case
11	the	the	DT	_	12	det
12	rat	rat	NN	_	7	nmod
13	.	.	.	_	2	punct

1	Since	since	IN	_	5	mark
2	drug1	drug1	NN	_	5	nsubjpass
3	is	be	VBZ	_	5	auxpass
4	frequently	frequently	RB	_	5	advmod
5	co-administered	co-administer	VBN	_	13	advcl
6	with	with	IN	_	7	case
7	drug2	drug2	NN	_	5	nmod
8	,	,	,	_	13	punct
9	it	it	PRP	_	13	nsubj
10	is	be	VBZ	_	13	cop
11	of	of	IN	_	13	case
12	clinical	clinical	JJ	_	13	amod
13	interest	interest	NN	_	0	ROOT
14	to	to	TO	_	15	mark
15	study	study	VB	_	13	acl
16	the	the	DT	_	17	det
17	effect	effect	NN	_	15	dobj
18	of	of	IN	_	19	case
19	drug3	drug3	NN	_	17	nmod
20	on	on	IN	_	22	case
21	the	the	DT	_	22	det
22	hepatotoxicity	hepatotoxicity	NN	_	17	nmod
23	of	of	IN	_	24	case
24	drug4	drug4	NN	_	22	nmod
25	.	.	.	_	13	punct

1	In	in	IN	_	4	case
2	male	male	JJ	_	4	amod
3	Sprague-Dawley	sprague-dawley	JJ	_	4	amod
4	rats	rat	NNS	_	0	ROOT
5	fasted	fast	VBD	_	4	acl
6	for	for	IN	_	8	case
7	18	18	CD	_	8	nummod
8	h	h	NN	_	5	nmod
9	,	,	,	_	4	punct
10	concomitant	concomitant	JJ	_	11	amod
11	administration	administration	NN	_	9	root
12	of	of	IN	_	13	case
13	drug1	drug1	NN	_	11	nmod
14	-LRB-	-lrb-	-LRB-	_	16	punct
15	0.1	0.1	CD	_	16	nummod
16	g/kg	g/kg	NN	_	13	appos
17	,	,	,	_	16	punct
18	i.p.	i.p.	RB	_	16	advmod
19	-RRB-	-rrb-	-RRB-	_	16	punct

1	as	as	IN	_	2	mark
2	judged	judge	VBN	_	0	ROOT
3	by	by	IN	_	7	case
4	increased	increase	VBN	_	7	amod
5	serum	serum	NN	_	7	compound
6	enzyme	enzyme	NN	_	7	compound
7	activities	activity	NNS	_	2	nmod
8	and	and	CC	_	7	cc
9	increased	increase	VBD	_	10	amod
10	incidence	incidence	NN	_	7	conj
11	of	of	IN	_	13	case
12	hepatic	hepatic	JJ	_	13	amod
13	necrosis	necrosis	NN	_	10	nmod
14	.	.	.	_	2	punct

1	Careful	careful	JJ	_	2	amod
2	observations	observation	NNS	_	6	nsubjpass
3	on	on	IN	_	4	case
4	hepatotoxicity	hepatotoxicity	NN	_	2	nmod
5	are	be	VBP	_	6	auxpass
6	suggested	suggest	VBN	_	0	ROOT
7	when	when	WRB	_	10	advmod
8	drug1	drug1	NN	_	10	nsubjpass
9	is	be	VBZ	_	10	auxpass
10	prescribed	prescribe	VBN	_	6	advcl
11	with	with	IN	_	12	case
12	drug2	drug2	NN	_	10	nmod
13	.	.	.	_	6	punct

1	Dual	dual	JJ	_	2	amod
2	effect	effect	NN	_	0	ROOT
3	of	of	IN	_	4	case
4	drug1	drug1	NN	_	2	nmod
5	on	on	IN	_	7	case
6	the	the	DT	_	7	det
7	drug2	drug2	NN	_	2	nmod
8	-	-	:	_	2	punct
9	induced	induce	VBN	_	10	amod
10	contraction	contraction	NN	_	2	dep
11	and	and	CC	_	10	cc
12	norepinephrine	norepinephrine	NN	_	13	compound
13	release	release	NN	_	10	conj
14	in	in	IN	_	18	case
15	the	the	DT	_	18	det
16	guinea-pig	guinea-pig	JJ	_	18	amod
17	vas	vas	NN	_	18	compound
18	deferens	deferen	NNS	_	10	nmod
19	.	.	.	_	2	punct

1	drug1	drug1	NN	_	16	nsubj
2	-LRB-	-lrb-	-LRB-	_	3	punct
3	drug2	drug2	NN	_	1	appos
4	-RRB-	-rrb-	-RRB-	_	3	punct
5	,	,	,	_	1	punct
6	C129H223N3O54	c129h223n3o54	NN	_	1	appos
7	,	,	,	_	1	punct
8	isolated	isolate	VBN	_	1	acl
9	from	from	IN	_	11	case
10	marine	marine	JJ	_	11	amod
11	coelenterates	coelenterate	NNS	_	8	nmod
12	of	of	IN	_	14	case
13	Palythoa	palythoa	NN	_	14	compound
14	tuberculosa	tuberculosa	NN	_	11	nmod
15	,	,	,	_	1	punct
16	caused	cause	VBD	_	0	ROOT
17	a	a	DT	_	20	det
18	first	first	JJ	_	20	amod
19	rapid	rapid	JJ	_	20	amod
20	contraction	contraction	NN	_	16	dobj
21	followed	follow	VBN	_	20	acl
22	by	by	IN	_	26	case
23	the	the	DT	_	26	det
24	slow	slow	JJ	_	26	amod
25	phasic	phasic	JJ	_	26	amod
26	contraction	contraction	NN	_	21	nmod
27	of	of	IN	_	30	case
28	guinea-pig	guinea-pig	JJ	_	30	amod
29	vas	va	NNS	_	30	compound
30	deferens	deferen	NNS	_	26	nmod
31	.	.	.	_	16	punct

1	In	in	IN	_	5	case
2	the	the	DT	_	5	dep
3	presence	presence	NN	_	5	dep
4	of	of	IN	_	5	case
5	drug1	drug1	NN	_	22	nmod
6	-LRB-	-lrb-	-LRB-	_	11	punct
7	10	10	CD	_	11	nummod
8	-LRB-	-lrb-	-LRB-	_	9	punct
9	-5	-5	CD	_	7	appos
10	-RRB-	-rrb-	-RRB-	_	9	punct
11	M	m	NN	_	5	appos
12	-RRB-	-rrb-	-RRB-	_	11	punct
13	,	,	,	_	22	punct
14	drug2	drug2	NN	_	22	nsubj
15	-LRB-	-lrb-	-LRB-	_	20	punct
16	10	10	CD	_	20	nummod
17	-LRB-	-lrb-	-LRB-	_	20	punct
18	-8	-8	CD	_	20	nummod
19	-RRB-	-rrb-	-RRB-	_	20	punct
20	M	m	NN	_	14	appos
21	-RRB-	-rrb-	-RRB-	_	20	punct
22	failed	fail	VBD	_	0	ROOT
23	to	to	TO	_	24	mark
24	cause	cause	VB	_	22	xcomp
25	the	the	DT	_	27	det
26	first	first	JJ	_	27	amod
27	contraction	contraction	NN	_	24	dobj
28	;	;	:	_	22	punct

1	however	however	RB	_	7	advmod
2	,	,	,	_	7	punct
3	the	the	DT	_	5	det
4	second	second	JJ	_	5	amod
5	contraction	contraction	NN	_	7	nsubjpass
6	was	be	VBD	_	7	auxpass
7	potentiated	potentiate	VBN	_	0	ROOT
8	.	.	.	_	7	punct

1	In	in	IN	_	5	case
2	the	the	DT	_	5	dep
3	presence	presence	NN	_	5	dep
4	of	of	IN	_	5	case
5	drug1	drug1	NN	_	18	nmod
6	-LRB-	-lrb-	-LRB-	_	11	punct
7	10	10	CD	_	11	nummod
8	-LRB-	-lrb-	-LRB-	_	11	punct
9	-6	-6	CD	_	11	nummod
10	-RRB-	-rrb-	-RRB-	_	11	punct
11	M	m	NN	_	5	appos
12	-RRB-	-rrb-	-RRB-	_	11	punct
13	,	,	,	_	18	punct
14	the	the	DT	_	16	det
15	second	second	JJ	_	16	amod
16	contraction	contraction	NN	_	18	nsubjpass
17	was	be	VBD	_	18	auxpass
18	inhibited	inhibit	VBN	_	0	ROOT
19	selectively	selectively	RB	_	18	advmod
20	.	.	.	_	18	punct

1	When	when	WRB	_	4	advmod
2	drug1	drug1	NN	_	4	nsubjpass
3	was	be	VBD	_	4	auxpass
4	applied	apply	VBN	_	23	advcl
5	to	to	TO	_	7	case
6	the	the	DT	_	7	det
7	muscle	muscle	NN	_	4	nmod
8	in	in	IN	_	10	case
9	the	the	DT	_	10	det
10	presence	presence	NN	_	4	nmod
11	of	of	IN	_	12	case
12	drug2	drug2	NN	_	10	nmod
13	,	,	,	_	23	punct
14	both	both	CC	_	15	cc:preconj
15	first	first	RB	_	23	advmod
16	and	and	CC	_	15	cc
17	second	second	RB	_	15	conj
18	contractile	contractile	JJ	_	19	amod
19	responses	response	NNS	_	23	nsubjpass
20	to	to	TO	_	21	case
21	drug3	drug3	NN	_	19	nmod
22	were	be	VBD	_	23	auxpass
23	abolished	abolish	VBN	_	0	ROOT
24	.	.	.	_	23	punct

1	When	when	WRB	_	5	advmod
2	the	the	DT	_	3	det
3	muscle	muscle	NN	_	5	nsubjpass
4	was	be	VBD	_	5	auxpass
5	exposed	expose	VBN	_	19	advcl
6	to	to	TO	_	9	case
7	the	the	DT	_	9	det
8	potassium-depleted	potassium-depleted	JJ	_	9	amod
9	solution	solution	NN	_	5	nmod
10	,	,	,	_	19	punct
11	the	the	DT	_	14	det
12	first	first	JJ	_	14	amod
13	contractile	contractile	NN	_	14	compound
14	response	response	NN	_	19	nsubj
15	to	to	TO	_	16	case
16	drug1	drug1	NN	_	14	nmod
17	was	be	VBD	_	19	cop
18	rather	rather	RB	_	19	advmod
19	potentiated	potentiated	JJ	_	0	ROOT
20	.	.	.	_	19	punct

1	drug1	drug1	NN	_	2	nsubj
2	caused	cause	VBD	_	0	ROOT
3	the	the	DT	_	4	det
4	release	release	NN	_	2	dobj
5	of	of	IN	_	6	case
6	norepinephrine	norepinephrine	NN	_	4	nmod
7	from	from	IN	_	9	case
8	the	the	DT	_	9	det
9	muscle	muscle	NN	_	4	nmod
10	.	.	.	_	2	punct

1	Exposure	exposure	NN	_	15	nsubj
2	of	of	IN	_	4	case
3	the	the	DT	_	4	det
4	muscle	muscle	NN	_	1	nmod
5	to	to	TO	_	6	case
6	drug1	drug1	NN	_	1	nmod
7	-LRB-	-lrb-	-LRB-	_	12	punct
8	10	10	CD	_	12	nummod
9	-LRB-	-lrb-	-LRB-	_	10	punct
10	-5	-5	CD	_	8	appos
11	-RRB-	-rrb-	-RRB-	_	10	punct
12	M	m	NN	_	6	appos
13	-RRB-	-rrb-	-RRB-	_	12	punct
14	markedly	markedly	RB	_	15	advmod
15	increased	increase	VBD	_	0	ROOT
16	the	the	DT	_	17	det
17	drug2	drug2	NN	_	15	dobj
18	-	-	:	_	17	punct
19	induced	induce	VBN	_	20	amod
20	release	release	NN	_	17	dep
21	.	.	.	_	15	punct

1	It	it	PRP	_	3	nsubjpass
2	is	be	VBZ	_	3	auxpass
3	indicated	indicate	VBN	_	0	ROOT
4	that	that	IN	_	13	mark
5	the	the	DT	_	10	det
6	first	first	JJ	_	10	amod
7	and	and	CC	_	6	cc
8	second	second	JJ	_	6	conj
9	contractile	contractile	NN	_	10	compound
10	responses	response	NNS	_	13	nsubj
11	to	to	TO	_	12	case
12	drug1	drug1	NN	_	10	nmod
13	have	have	VBP	_	3	ccomp
14	entirely	entirely	RB	_	15	advmod
15	different	different	JJ	_	16	amod
16	properties	property	NNS	_	13	dobj
17	.	.	.	_	3	punct

1	The	the	DT	_	3	det
2	second	second	JJ	_	3	amod
3	response	response	NN	_	5	nsubj
4	is	be	VBZ	_	5	cop
5	due	due	JJ	_	0	ROOT
6	to	to	TO	_	8	case
7	a	a	DT	_	8	det
8	release	release	NN	_	5	nmod
9	of	of	IN	_	10	case
10	norepinephrine	norepinephrine	NN	_	8	nmod
11	from	from	IN	_	12	case
12	nerves	nerve	NNS	_	8	nmod
13	and	and	CC	_	5	cc
14	was	be	VBD	_	15	auxpass
15	potentiated	potentiate	VBN	_	5	conj
16	by	by	IN	_	17	case
17	drug1	drug1	NN	_	15	nmod
18	through	through	IN	_	20	case
19	the	the	DT	_	20	det
20	increase	increase	NN	_	15	nmod
21	in	in	IN	_	24	case
22	the	the	DT	_	24	det
23	norepinephrine	norepinephrine	NN	_	24	compound
24	release	release	NN	_	20	nmod
25	,	,	,	_	5	punct
26	whereas	whereas	IN	_	36	mark
27	the	the	DT	_	29	det
28	first	first	JJ	_	29	amod
29	response	response	NN	_	36	nsubj
30	was	be	VBD	_	36	cop
31	not	not	RB	_	36	neg
32	due	due	JJ	_	36	case
33	to	to	TO	_	32	mwe
34	the	the	DT	_	36	det
35	norepinephrine	norepinephrine	NN	_	36	compound
36	release	release	NN	_	5	advcl
37	but	but	CC	_	36	cc
38	presumably	presumably	RB	_	42	advmod
39	to	to	TO	_	42	case
40	a	a	DT	_	42	det
41	direct	direct	JJ	_	42	amod
42	action	action	NN	_	36	conj
43	on	on	IN	_	46	case
44	smooth	smooth	JJ	_	46	amod
45	muscle	muscle	NN	_	46	compound
46	cell	cell	NN	_	42	nmod
47	and	and	CC	_	5	cc
48	was	be	VBD	_	49	auxpass
49	inhibited	inhibit	VBN	_	5	conj
50	by	by	IN	_	51	case
51	drug2	drug2	NN	_	49	nmod
52	.	.	.	_	5	punct

1	The	the	DT	_	2	det
2	mechanism	mechanism	NN	_	9	nsubjpass
3	of	of	IN	_	5	case
4	the	the	DT	_	5	det
5	action	action	NN	_	2	nmod
6	of	of	IN	_	7	case
7	drug1	drug1	NN	_	5	nmod
8	was	be	VBD	_	9	auxpass
9	discussed	discuss	VBN	_	0	ROOT
10	in	in	IN	_	12	case
11	the	the	DT	_	12	det
12	relation	relation	NN	_	9	nmod
13	with	with	IN	_	14	case
14	Na,K-ATPase	na,k-atpase	NN	_	12	nmod
15	.	.	.	_	9	punct

1	Analgesic	analgesic	JJ	_	2	amod
2	effects	effect	NNS	_	0	ROOT
3	of	of	IN	_	4	case
4	drug1	drug1	NN	_	2	nmod
5	.	.	.	_	2	punct

1	The	the	DT	_	2	det
2	literature	literature	NN	_	3	nsubj
3	provides	provide	VBZ	_	0	ROOT
4	considerable	considerable	JJ	_	5	amod
5	evidence	evidence	NN	_	3	dobj
6	indicating	indicate	VBG	_	5	acl
7	that	that	IN	_	17	mark
8	several	several	JJ	_	17	nsubj
9	,	,	,	_	8	punct
10	but	but	CC	_	8	cc
11	not	not	RB	_	13	neg
12	all	all	DT	_	13	det
13	drug1	drug1	NN	_	8	conj
14	,	,	,	_	17	punct
15	are	be	VBP	_	17	cop
16	indeed	indeed	RB	_	17	advmod
17	drug2	drug2	NN	_	6	ccomp
18	and	and	CC	_	17	cc
19	some	some	DT	_	21	nsubj
20	are	be	VBP	_	21	cop
21	drug3	drug3	NN	_	17	conj
22	as	as	RB	_	21	advmod
23	well	well	RB	_	22	mwe
24	.	.	.	_	3	punct

1	Those	those	DT	_	7	nsubj
2	for	for	IN	_	3	case
3	which	which	WDT	_	6	nmod
4	effectiveness	effectiveness	NN	_	6	nsubjpass
5	is	be	VBZ	_	6	auxpass
6	reported	report	VBN	_	1	acl:relcl
7	includes	include	VBZ	_	0	ROOT
8	drug1	drug1	NN	_	7	dobj
9	,	,	,	_	8	punct
10	drug2	drug2	NN	_	8	conj
11	,	,	,	_	8	punct
12	drug3	drug3	NN	_	8	conj
13	,	,	,	_	8	punct
14	drug4	drug4	NN	_	8	conj
15	,	,	,	_	8	punct
16	drug5	drug5	NN	_	8	conj
17	,	,	,	_	8	punct
18	drug6	drug6	NN	_	8	conj
19	,	,	,	_	8	punct
20	drug7	drug7	NN	_	8	conj
21	,	,	,	_	8	punct
22	and	and	CC	_	8	cc
23	drug8	drug8	NN	_	8	conj
24	.	.	.	_	7	punct

1	The	the	DT	_	3	det
2	proposed	proposed	JJ	_	3	amod
3	mechanisms	mechanism	NNS	_	10	nsubjpass
4	of	of	IN	_	6	case
5	analgesic	analgesic	JJ	_	6	amod
6	action	action	NN	_	3	nmod
7	of	of	IN	_	8	case
8	drug1	drug1	NN	_	6	nmod
9	are	be	VBP	_	10	auxpass
10	reviewed	review	VBN	_	0	ROOT
11	and	and	CC	_	10	cc
12	discussed	discuss	VBN	_	10	conj
13	.	.	.	_	10	punct

1	The	the	DT	_	2	det
2	literature	literature	NN	_	3	nsubj
3	suggests	suggest	VBZ	_	0	ROOT
4	that	that	IN	_	11	mark
5	more	more	JJR	_	7	advmod
6	than	than	IN	_	5	mwe
7	one	one	CD	_	8	nummod
8	mechanism	mechanism	NN	_	11	nsubj
9	of	of	IN	_	10	case
10	action	action	NN	_	8	nmod
11	exists	exist	VBZ	_	3	ccomp
12	for	for	IN	_	13	case
13	them	they	PRP	_	11	nmod
14	.	.	.	_	3	punct

1	There	there	EX	_	2	expl
2	is	be	VBZ	_	0	ROOT
3	considerable	considerable	JJ	_	4	amod
4	evidence	evidence	NN	_	2	nsubj
5	suggesting	suggest	VBG	_	4	acl
6	that	that	IN	_	13	mark
7	histaminergic	histaminergic	JJ	_	11	amod
8	and	and	CC	_	7	cc
9	serotoninergic	serotoninergic	JJ	_	7	conj
10	central	central	JJ	_	11	amod
11	pathways	pathway	NNS	_	13	nsubjpass
12	are	be	VBP	_	13	auxpass
13	involved	involve	VBN	_	5	ccomp
14	in	in	IN	_	15	case
15	nociception	nociception	NN	_	13	nmod
16	and	and	CC	_	13	cc
17	that	that	IN	_	21	mark
18	drug1	drug1	NN	_	19	compound
19	drugs	drug	NNS	_	21	nsubj
20	can	can	MD	_	21	aux
21	modulate	modulate	VB	_	13	conj
22	their	they	PRP$	_	23	nmod:poss
23	responses	response	NNS	_	21	dobj
24	-LRB-	-lrb-	-LRB-	_	25	punct
25	1	1	CD	_	23	appos
26	-RRB-	-rrb-	-RRB-	_	25	punct
27	.	.	.	_	2	punct

1	The	the	DT	_	2	det
2	evidence	evidence	NN	_	20	nsubjpass
3	for	for	IN	_	5	case
4	a	a	DT	_	5	det
5	role	role	NN	_	2	nmod
6	for	for	IN	_	7	case
7	norepinephrine	norepinephrine	NN	_	5	nmod
8	and	and	CC	_	7	cc
9	dopamine	dopamine	NN	_	7	conj
10	and	and	CC	_	5	cc
11	the	the	DT	_	12	det
12	effects	effect	NNS	_	5	conj
13	of	of	IN	_	14	case
14	drug1	drug1	NN	_	12	nmod
15	on	on	IN	_	16	case
16	them	they	PRP	_	12	nmod
17	are	be	VBP	_	20	auxpass
18	less	less	RBR	_	19	advmod
19	well	well	RB	_	20	advmod
20	established	establish	VBN	_	0	ROOT
21	.	.	.	_	20	punct

1	Still	still	RB	_	6	advmod
2	other	other	JJ	_	3	amod
3	pathways	pathway	NNS	_	6	nsubjpass
4	have	have	VBP	_	6	aux
5	been	be	VBN	_	6	auxpass
6	proposed	propose	VBN	_	0	ROOT
7	.	.	.	_	6	punct

1	A	a	DT	_	3	det
2	greater	greater	JJR	_	3	amod
3	understanding	understanding	NN	_	8	nsubj
4	of	of	IN	_	6	case
5	pain	pain	NN	_	6	compound
6	mechanisms	mechanism	NNS	_	3	nmod
7	will	will	MD	_	8	aux
8	aid	aid	VB	_	0	ROOT
9	in	in	IN	_	10	mark
10	elucidating	elucidate	VBG	_	8	advcl
11	the	the	DT	_	12	det
12	role	role	NN	_	10	dobj
13	of	of	IN	_	14	case
14	drug1	drug1	NN	_	12	nmod
15	in	in	IN	_	16	case
16	analgesia	analgesia	NN	_	12	nmod
17	.	.	.	_	8	punct

1	Effect	effect	NN	_	0	ROOT
2	of	of	IN	_	3	case
3	drug1	drug1	NN	_	1	nmod
4	on	on	IN	_	6	case
5	voltage-dependent	voltage-dependent	JJ	_	6	amod
6	Ca	ca	NN	_	1	nmod
7	-LRB-	-lrb-	-LRB-	_	12	punct
8	2	2	CD	_	12	nummod
9	+	+	CC	_	8	cc
10	-RRB-	-rrb-	-RRB-	_	12	punct
11	channel	channel	NN	_	12	compound
12	subtypes	subtype	NNS	_	6	dep
13	in	in	IN	_	16	case
14	bovine	bovine	JJ	_	16	amod
15	chromaffin	chromaffin	NN	_	16	compound
16	cells	cell	NNS	_	12	nmod
17	.	.	.	_	12	punct

1	In	in	IN	_	3	case
2	previous	previous	JJ	_	3	amod
3	reports	report	NNS	_	6	nmod
4	we	we	PRP	_	6	nsubj
5	have	have	VBP	_	6	aux
6	shown	show	VBN	_	0	ROOT
7	that	that	IN	_	9	mark
8	drug1	drug1	NN	_	9	nsubj
9	inhibit	inhibit	VBP	_	6	ccomp
10	high	high	JJ	_	13	amod
11	threshold	threshold	NN	_	13	compound
12	voltage-dependent	voltage-dependent	JJ	_	13	amod
13	Ca	ca	NN	_	9	dobj
14	-LRB-	-lrb-	-LRB-	_	18	punct
15	2	2	CD	_	18	nummod
16	+	+	CC	_	15	cc
17	-RRB-	-rrb-	-RRB-	_	18	punct
18	channels	channel	NNS	_	13	dep
19	in	in	IN	_	21	case
20	neuronal	neuronal	JJ	_	21	amod
21	cells	cell	NNS	_	18	nmod
22	.	.	.	_	18	punct

1	However	however	RB	_	7	advmod
2	,	,	,	_	7	punct
3	these	these	DT	_	4	det
4	studies	study	NNS	_	7	nsubj
5	did	do	VBD	_	7	aux
6	not	not	RB	_	7	neg
7	show	show	VB	_	0	ROOT
8	whether	whether	IN	_	7	dobj
9	drug1	drug1	NN	_	12	compound
10	-	-	:	_	12	punct
11	induced	induce	VBN	_	12	amod
12	inhibition	inhibition	NN	_	8	root
13	of	of	IN	_	14	case
14	Ca	ca	NN	_	12	nmod
15	-LRB-	-lrb-	-LRB-	_	20	punct
16	2	2	CD	_	20	nsubj
17	+	+	CC	_	16	cc
18	-RRB-	-rrb-	-RRB-	_	19	punct
19	currents	current	NNS	_	16	conj
20	discriminates	discriminate	VBZ	_	14	dep
21	among	among	IN	_	24	case
22	the	the	DT	_	24	det
23	various	various	JJ	_	24	amod
24	Ca	ca	NN	_	20	nmod
25	-LRB-	-lrb-	-LRB-	_	30	punct
26	2	2	CD	_	30	nummod
27	+	+	CC	_	26	cc
28	-RRB-	-rrb-	-RRB-	_	30	punct
29	channel	channel	NN	_	30	compound
30	subtypes	subtype	NNS	_	24	dep
31	,	,	,	_	30	punct
32	although	although	IN	_	35	mark
33	it	it	PRP	_	35	nsubjpass
34	is	be	VBZ	_	35	auxpass
35	known	know	VBN	_	30	dep
36	that	that	IN	_	38	mark
37	there	there	EX	_	38	expl
38	are	be	VBP	_	35	ccomp
39	at	at	IN	_	40	case
40	least	least	JJS	_	41	nmod:npmod
41	five	five	CD	_	43	nummod
42	different	different	JJ	_	43	amod
43	Ca	ca	NN	_	38	nsubj
44	-LRB-	-lrb-	-LRB-	_	49	punct
45	2	2	CD	_	49	nummod
46	+	+	CC	_	45	cc
47	-RRB-	-rrb-	-RRB-	_	49	punct
48	channel	channel	NN	_	49	compound
49	subtypes	subtype	NNS	_	43	dep
50	in	in	IN	_	52	case
51	neuronal	neuronal	JJ	_	52	amod
52	cells	cell	NNS	_	49	nmod
53	.	.	.	_	49	punct

1	In	in	IN	_	3	case
2	this	this	DT	_	3	det
3	study	study	NN	_	5	nmod
4	we	we	PRP	_	5	nsubj
5	investigated	investigate	VBD	_	0	ROOT
6	the	the	DT	_	7	det
7	effect	effect	NN	_	5	dobj
8	of	of	IN	_	9	case
9	drug1	drug1	NN	_	7	nmod
10	on	on	IN	_	14	case
11	high	high	JJ	_	14	amod
12	threshold	threshold	NN	_	14	compound
13	voltage-dependent	voltage-dependent	JJ	_	14	amod
14	Ca	ca	NN	_	7	nmod
15	-LRB-	-lrb-	-LRB-	_	20	punct
16	2	2	CD	_	20	nummod
17	+	+	CC	_	16	cc
18	-RRB-	-rrb-	-RRB-	_	20	punct
19	channel	channel	NN	_	20	compound
20	subtypes	subtype	NNS	_	14	appos
21	using	use	VBG	_	20	acl
22	their	they	PRP$	_	24	nmod:poss
23	drug2	drug2	NN	_	24	compound
24	drug3	drug3	NN	_	21	dobj
25	-LRB-	-lrb-	-LRB-	_	26	punct
26	L-type	l-type	JJ	_	24	dep
27	-RRB-	-rrb-	-RRB-	_	26	punct
28	,	,	,	_	24	punct
29	drug4	drug4	NN	_	24	conj
30	-LRB-	-lrb-	-LRB-	_	31	punct
31	N-type	n-type	NN	_	29	appos
32	-RRB-	-rrb-	-RRB-	_	31	punct
33	,	,	,	_	24	punct
34	or	or	CC	_	24	cc
35	drug5	drug5	NN	_	24	conj
36	-LRB-	-lrb-	-LRB-	_	37	punct
37	P-type	p-type	JJ	_	35	appos
38	-RRB-	-rrb-	-RRB-	_	37	punct
39	in	in	IN	_	42	case
40	bovine	bovine	JJ	_	42	amod
41	chromaffin	chromaffin	NN	_	42	compound
42	cells	cell	NNS	_	21	nmod
43	.	.	.	_	5	punct

1	We	we	PRP	_	3	nsubj
2	could	could	MD	_	3	aux
3	observe	observe	VB	_	0	ROOT
4	that	that	IN	_	6	mark
5	drug1	drug1	NN	_	6	nsubj
6	inhibited	inhibit	VBD	_	3	ccomp
7	high	high	JJ	_	10	amod
8	threshold	threshold	NN	_	10	compound
9	voltage-dependent	voltage-dependent	JJ	_	10	amod
10	Ca	ca	NN	_	6	dobj
11	-LRB-	-lrb-	-LRB-	_	15	punct
12	2	2	CD	_	15	nummod
13	+	+	CC	_	12	cc
14	-RRB-	-rrb-	-RRB-	_	15	punct
15	currents	current	NNS	_	10	dep
16	in	in	IN	_	19	case
17	a	a	DT	_	19	det
18	dose-dependent	dose-dependent	JJ	_	19	amod
19	manner	manner	NN	_	15	nmod
20	.	.	.	_	3	punct

1	The	the	DT	_	2	det
2	IC	ic	NN	_	9	nsubj
3	-LRB-	-lrb-	-LRB-	_	4	punct
4	50	50	CD	_	2	appos
5	-RRB-	-rrb-	-RRB-	_	4	punct
6	was	be	VBD	_	9	cop
7	about	about	RB	_	8	advmod
8	120	120	CD	_	9	nummod
9	microgram/ml	microgram/ml	NN	_	0	ROOT
10	.	.	.	_	9	punct

1	drug1	drug1	NN	_	2	nsubj
2	had	have	VBD	_	0	ROOT
3	no	no	DT	_	4	neg
4	effect	effect	NN	_	2	dobj
5	on	on	IN	_	7	case
6	drug2	drug2	NN	_	7	compound
7	response	response	NN	_	2	nmod
8	.	.	.	_	2	punct

1	These	these	DT	_	2	det
2	data	datum	NNS	_	3	nsubj
3	suggest	suggest	VBP	_	0	ROOT
4	that	that	IN	_	8	mark
5	drug1	drug1	NN	_	8	nsubjpass
6	are	be	VBP	_	8	auxpass
7	negatively	negatively	RB	_	8	advmod
8	coupled	couple	VBN	_	3	ccomp
9	to	to	TO	_	11	case
10	three	three	CD	_	11	nummod
11	types	type	NNS	_	8	nmod
12	of	of	IN	_	14	case
13	calcium	calcium	NN	_	14	compound
14	channels	channel	NNS	_	11	nmod
15	in	in	IN	_	18	case
16	bovine	bovine	JJ	_	18	amod
17	chromaffin	chromaffin	NN	_	18	compound
18	cell	cell	NN	_	8	nmod
19	,	,	,	_	8	punct
20	including	include	VBG	_	28	case
21	an	a	DT	_	28	det
22	drug2	drug2	NN	_	24	dep
23	-	-	:	_	24	punct
24	sensitive	sensitive	JJ	_	28	amod
25	-LRB-	-lrb-	-LRB-	_	26	punct
26	N-type	n-type	JJ	_	24	dep
27	-RRB-	-rrb-	-RRB-	_	26	punct
28	channel	channel	NN	_	8	nmod
29	,	,	,	_	28	punct
30	an	a	DT	_	31	det
31	drug3	drug3	NN	_	28	appos
32	-	-	:	_	28	punct
33	sensitive	sensitive	JJ	_	37	amod
34	-LRB-	-lrb-	-LRB-	_	35	punct
35	P-type	p-type	JJ	_	33	dep
36	-RRB-	-rrb-	-RRB-	_	35	punct
37	channel	channel	NN	_	28	dep
38	and	and	CC	_	37	cc
39	drug4	drug4	NN	_	37	conj
40	/	/	:	_	28	punct
41	drug5	drug5	NN	_	43	compound
42	/	/	:	_	43	punct
43	drug6	drug6	NN	_	28	dep
44	-	-	:	_	43	punct
45	resistant	resistant	JJ	_	50	amod
46	-LRB-	-lrb-	-LRB-	_	50	punct
47	presumptive	presumptive	JJ	_	50	amod
48	Q-type	q-type	JJ	_	50	amod
49	-RRB-	-rrb-	-RRB-	_	50	punct
50	channel	channel	NN	_	43	dep
51	.	.	.	_	3	punct

1	Thus	thus	RB	_	0	ROOT
2	,	,	,	_	1	punct
3	the	the	DT	_	5	det
4	selective	selective	JJ	_	5	amod
5	regulation	regulation	NN	_	2	root
6	of	of	IN	_	8	case
7	voltage-dependent	voltage-dependent	JJ	_	8	amod
8	Ca	ca	NN	_	24	nmod
9	-LRB-	-lrb-	-LRB-	_	13	punct
10	2	2	CD	_	13	nummod
11	+	+	CC	_	10	cc
12	-RRB-	-rrb-	-RRB-	_	13	punct
13	subtypes	subtype	NNS	_	24	nsubj
14	by	by	IN	_	15	case
15	drug1	drug1	NN	_	13	nmod
16	in	in	IN	_	19	case
17	bovine	bovine	JJ	_	19	amod
18	chromaffin	chromaffin	NN	_	19	compound
19	cell	cell	NN	_	13	nmod
20	could	could	MD	_	24	aux
21	be	be	VB	_	24	cop
22	the	the	DT	_	24	det
23	cellular	cellular	JJ	_	24	amod
24	basis	basis	NN	_	5	nmod
25	of	of	IN	_	27	case
26	antistress	antistress	JJ	_	27	amod
27	effects	effect	NNS	_	24	nmod
28	induced	induce	VBN	_	27	acl
29	by	by	IN	_	30	case
30	drug2	drug2	NN	_	28	nmod
31	.	.	.	_	5	punct

1	A	a	DT	_	3	det
2	proposed	propose	VBN	_	3	amod
3	mechanism	mechanism	NN	_	0	ROOT
4	for	for	IN	_	6	case
5	the	the	DT	_	6	det
6	potentiation	potentiation	NN	_	3	nmod
7	of	of	IN	_	10	case
8	cAMP-mediated	camp-mediated	JJ	_	10	amod
9	acid	acid	NN	_	10	compound
10	secretion	secretion	NN	_	6	nmod
11	by	by	IN	_	12	case
12	drug1	drug1	NN	_	6	nmod
13	.	.	.	_	3	punct

1	Acid	acid	NN	_	2	compound
2	secretion	secretion	NN	_	9	nsubjpass
3	in	in	IN	_	7	case
4	isolated	isolate	VBN	_	7	amod
5	rabbit	rabbit	NN	_	7	compound
6	gastric	gastric	JJ	_	7	amod
7	glands	gland	NNS	_	2	nmod
8	was	be	VBD	_	9	auxpass
9	monitored	monitor	VBN	_	0	ROOT
10	by	by	IN	_	12	case
11	the	the	DT	_	12	det
12	accumulation	accumulation	NN	_	9	nmod
13	of	of	IN	_	20	case
14	-LSB-	-lsb-	-LRB-	_	18	punct
15	-LRB-	-lrb-	-LRB-	_	18	punct
16	14	14	CD	_	18	nummod
17	-RRB-	-rrb-	-RRB-	_	18	punct
18	C	c	NN	_	20	dep
19	-RSB-	-rsb-	-RRB-	_	18	punct
20	drug1	drug1	NN	_	12	nmod
21	.	.	.	_	9	punct

1	Stimulation	stimulation	NN	_	8	nsubj
2	of	of	IN	_	4	case
3	the	the	DT	_	4	det
4	glands	gland	NNS	_	1	nmod
5	with	with	IN	_	6	case
6	drug1	drug1	NN	_	1	nmod
7	synergistically	synergistically	RB	_	8	advmod
8	augmented	augment	VBD	_	0	ROOT
9	the	the	DT	_	10	det
10	response	response	NN	_	8	dobj
11	to	to	TO	_	13	case
12	dibutyryl	dibutyryl	NN	_	13	compound
13	cAMP	camp	NN	_	10	nmod
14	.	.	.	_	8	punct

1	The	the	DT	_	2	det
2	augmentation	augmentation	NN	_	3	nsubj
3	persisted	persist	VBD	_	0	ROOT
4	even	even	RB	_	8	advmod
5	after	after	IN	_	8	mark
6	drug1	drug1	NN	_	8	nsubjpass
7	was	be	VBD	_	8	auxpass
8	washed	wash	VBN	_	3	advcl
9	out	out	RP	_	8	compound:prt
10	and	and	CC	_	8	cc
11	was	be	VBD	_	12	cop
12	resistant	resistant	JJ	_	8	conj
13	to	to	TO	_	16	case
14	chelated	chelated	JJ	_	16	amod
15	extracellular	extracellular	JJ	_	16	amod
16	Ca	ca	NN	_	12	nmod
17	-LRB-	-lrb-	-LRB-	_	19	punct
18	2	2	CD	_	19	nummod
19	+	+	CC	_	16	dep
20	-RRB-	-rrb-	-RRB-	_	19	punct
21	and	and	CC	_	16	cc
22	to	to	TO	_	23	case
23	inhibitors	inhibitor	NNS	_	16	conj
24	of	of	IN	_	28	case
25	either	either	CC	_	28	cc:preconj
26	protein	protein	NN	_	28	compound
27	kinase	kinase	NN	_	28	compound
28	C	c	NN	_	23	nmod
29	or	or	CC	_	28	cc
30	calmodulin	calmodulin	NN	_	31	compound
31	kinase	kinase	NN	_	28	conj
32	II	ii	CD	_	31	nummod
33	.	.	.	_	3	punct

1	drug1	drug1	NN	_	6	nsubj
2	at	at	IN	_	4	case
3	10	10	CD	_	4	nummod
4	microM	microm	NN	_	1	nmod
5	preferentially	preferentially	RB	_	6	advmod
6	blocked	block	VBD	_	0	ROOT
7	the	the	DT	_	9	det
8	secretory	secretory	JJ	_	9	amod
9	effect	effect	NN	_	6	dobj
10	of	of	IN	_	11	case
11	drug2	drug2	NN	_	9	nmod
12	and	and	CC	_	11	cc
13	its	its	PRP$	_	14	nmod:poss
14	synergism	synergism	NN	_	11	conj
15	with	with	IN	_	16	case
16	cAMP	camp	NN	_	14	nmod
17	,	,	,	_	6	punct
18	whereas	whereas	IN	_	6	dep
19	it	it	PRP	_	20	nsubj
20	had	have	VBD	_	6	parataxis
21	no	no	DT	_	22	neg
22	effect	effect	NN	_	20	dobj
23	on	on	IN	_	24	case
24	histamine	histamine	NN	_	22	nmod
25	-	-	:	_	24	punct
26	or	or	CC	_	24	cc
27	cAMP-stimulated	camp-stimulated	JJ	_	29	amod
28	acid	acid	NN	_	29	compound
29	secretion	secretion	NN	_	24	conj
30	within	within	IN	_	32	case
31	15	15	CD	_	32	nummod
32	min	min	NN	_	20	nmod
33	.	.	.	_	6	punct

1	drug1	drug1	NN	_	2	nsubj
2	inhibited	inhibit	VBD	_	0	ROOT
3	the	the	DT	_	4	det
4	drug2	drug2	NN	_	2	dobj
5	-	-	:	_	4	punct
6	stimulated	stimulate	VBN	_	8	amod
7	intracellular	intracellular	JJ	_	8	amod
8	Ca	ca	NN	_	4	dep
9	-LRB-	-lrb-	-LRB-	_	13	punct
10	2	2	CD	_	13	nummod
11	+	+	CC	_	10	cc
12	-RRB-	-rrb-	-RRB-	_	13	punct
13	concentration	concentration	NN	_	8	dep
14	-LRB-	-lrb-	-LRB-	_	16	punct
15	-LSB-	-lsb-	-LRB-	_	16	punct
16	Ca	ca	NN	_	13	dep
17	-LRB-	-lrb-	-LRB-	_	16	punct
18	2	2	CD	_	16	nummod
19	+	+	CC	_	16	dep
20	-RRB-	-rrb-	-RRB-	_	16	punct
21	-RSB-	-rsb-	-RRB-	_	13	punct
22	-LRB-	-lrb-	-LRB-	_	23	punct
23	i	i	LS	_	8	dep
24	-RRB-	-rrb-	-RRB-	_	23	punct
25	-RRB-	-rrb-	-RRB-	_	23	punct
26	increase	increase	NN	_	8	dep
27	due	due	JJ	_	26	amod
28	to	to	TO	_	29	mark
29	release	release	VB	_	27	xcomp
30	from	from	IN	_	32	case
31	the	the	DT	_	32	det
32	Ca	ca	NN	_	29	nmod
33	-LRB-	-lrb-	-LRB-	_	37	punct
34	2	2	CD	_	37	nummod
35	+	+	CC	_	34	cc
36	-RRB-	-rrb-	-RRB-	_	37	punct
37	store	store	NN	_	32	dep
38	.	.	.	_	2	punct

1	Treatment	treatment	NN	_	7	nsubj
2	of	of	IN	_	4	case
3	the	the	DT	_	4	det
4	glands	gland	NNS	_	1	nmod
5	with	with	IN	_	6	case
6	drug1	drug1	NN	_	1	nmod
7	redistributed	redistribute	VBD	_	0	ROOT
8	type	type	NN	_	12	compound
9	3	3	CD	_	12	nummod
10	inositol	inositol	NN	_	12	compound
11	1,4,5-trisphosphate	1,4,5-trisphosphate	NN	_	12	compound
12	receptor	receptor	NN	_	7	dobj
13	-LRB-	-lrb-	-LRB-	_	16	punct
14	the	the	DT	_	16	det
15	major	major	JJ	_	16	amod
16	subtype	subtype	NN	_	12	dep
17	in	in	IN	_	20	case
18	the	the	DT	_	20	det
19	parietal	parietal	JJ	_	20	amod
20	cell	cell	NN	_	16	nmod
21	-RRB-	-rrb-	-RRB-	_	16	punct
22	from	from	IN	_	24	case
23	the	the	DT	_	24	det
24	fraction	fraction	NN	_	7	nmod
25	containing	contain	VBG	_	24	acl
26	membranes	membrane	NNS	_	25	dobj
27	of	of	IN	_	29	case
28	large	large	JJ	_	29	amod
29	size	size	NN	_	26	nmod
30	to	to	TO	_	33	case
31	the	the	DT	_	33	det
32	microsomal	microsomal	JJ	_	33	amod
33	fraction	fraction	NN	_	7	nmod
34	,	,	,	_	7	punct
35	suggesting	suggest	VBG	_	7	advcl
36	a	a	DT	_	37	det
37	dissociation	dissociation	NN	_	35	dobj
38	of	of	IN	_	40	case
39	the	the	DT	_	40	det
40	store	store	NN	_	37	nmod
41	from	from	IN	_	44	case
42	the	the	DT	_	44	det
43	plasma	plasma	NN	_	44	compound
44	membrane	membrane	NN	_	37	nmod
45	.	.	.	_	7	punct

1	These	these	DT	_	2	det
2	findings	finding	NNS	_	3	nsubj
3	suggest	suggest	VBP	_	0	ROOT
4	that	that	IN	_	16	mark
5	intracellular	intracellular	JJ	_	6	amod
6	Ca	ca	NN	_	16	dep
7	-LRB-	-lrb-	-LRB-	_	11	punct
8	2	2	CD	_	11	nummod
9	+	+	CC	_	8	cc
10	-RRB-	-rrb-	-RRB-	_	11	punct
11	release	release	NN	_	16	nsubj
12	by	by	IN	_	14	case
13	cholinergic	cholinergic	JJ	_	14	amod
14	stimulation	stimulation	NN	_	11	nmod
15	is	be	VBZ	_	16	cop
16	critical	critical	JJ	_	3	ccomp
17	for	for	IN	_	18	mark
18	determining	determine	VBG	_	16	advcl
19	synergism	synergism	NN	_	18	dobj
20	with	with	IN	_	21	case
21	cAMP	camp	NN	_	19	nmod
22	in	in	IN	_	25	case
23	parietal	parietal	JJ	_	25	amod
24	cell	cell	NN	_	25	compound
25	activation	activation	NN	_	18	nmod
26	and	and	CC	_	16	cc
27	that	that	IN	_	42	mark
28	functional	functional	JJ	_	29	amod
29	coupling	coupling	NN	_	42	nsubjpass
30	between	between	IN	_	32	case
31	the	the	DT	_	32	det
32	Ca	ca	NN	_	29	nmod
33	-LRB-	-lrb-	-LRB-	_	37	punct
34	2	2	CD	_	37	nummod
35	+	+	CC	_	34	cc
36	-RRB-	-rrb-	-RRB-	_	37	punct
37	store	store	NN	_	32	dep
38	and	and	CC	_	37	cc
39	the	the	DT	_	40	det
40	receptor	receptor	NN	_	37	conj
41	is	be	VBZ	_	42	auxpass
42	maintained	maintain	VBN	_	16	conj
43	by	by	IN	_	45	case
44	actin	actin	NN	_	45	compound
45	microfilaments	microfilament	NNS	_	42	nmod
46	.	.	.	_	3	punct

1	Phenytoin	Phenytoin	NNP	_	2	compound
2	intoxication	intoxication	NN	_	0	ROOT
3	induced	induce	VBN	_	2	acl
4	by	by	IN	_	5	case
5	drug1	drug1	NN	_	3	nmod
6	.	.	.	_	2	punct

1	A	a	DT	_	2	det
2	patient	patient	NN	_	3	nsubj
3	had	have	VBD	_	0	ROOT
4	phenytoin	phenytoin	NN	_	5	compound
5	intoxication	intoxication	NN	_	3	dobj
6	after	after	IN	_	7	case
7	administration	administration	NN	_	3	nmod
8	of	of	IN	_	9	case
9	drug1	drug1	NN	_	7	nmod
10	,	,	,	_	9	punct
11	a	a	DT	_	15	det
12	selective	selective	JJ	_	15	amod
13	serotonin	serotonin	NN	_	15	compound
14	reuptake	reuptake	NN	_	15	compound
15	inhibitor	inhibitor	NN	_	9	appos
16	.	.	.	_	3	punct

1	The	the	DT	_	3	det
2	serum	serum	NN	_	3	compound
3	concentration	concentration	NN	_	6	nsubj
4	of	of	IN	_	5	case
5	drug1	drug1	NN	_	3	nmod
6	increased	increase	VBD	_	0	ROOT
7	dramatically	dramatically	RB	_	6	advmod
8	from	from	IN	_	9	case
9	16.6	16.6	CD	_	6	nmod
10	to	to	TO	_	12	case
11	49.1	49.1	CD	_	12	nummod
12	microg/mL	microg/ml	NN	_	6	nmod
13	when	when	WRB	_	16	advmod
14	drug2	drug2	NN	_	16	nsubjpass
15	was	be	VBD	_	16	auxpass
16	coadministered	coadminister	VBN	_	6	advcl
17	,	,	,	_	6	punct
18	although	although	IN	_	29	mark
19	the	the	DT	_	21	det
20	daily	daily	JJ	_	21	amod
21	dosage	dosage	NN	_	29	nsubjpass
22	of	of	IN	_	23	case
23	drug3	drug3	NN	_	21	nmod
24	and	and	CC	_	23	cc
25	other	other	JJ	_	26	amod
26	drug4	drug4	NN	_	23	conj
27	had	have	VBD	_	29	aux
28	not	not	RB	_	29	neg
29	changed	change	VBN	_	6	advcl
30	.	.	.	_	6	punct

1	During	during	IN	_	2	case
2	drug1	drug1	NN	_	17	nmod
3	and	and	CC	_	2	cc
4	fluvoxamine	fluvoxamine	NN	_	5	compound
5	treatment	treatment	NN	_	2	conj
6	,	,	,	_	17	punct
7	ataxia	ataxia	NN	_	17	nsubjpass
8	,	,	,	_	7	punct
9	a	a	DT	_	12	det
10	typical	typical	JJ	_	12	amod
11	side	side	NN	_	12	compound
12	effect	effect	NN	_	7	appos
13	of	of	IN	_	14	case
14	drug2	drug2	NN	_	12	nmod
15	,	,	,	_	7	punct
16	was	be	VBD	_	17	auxpass
17	observed	observe	VBN	_	0	ROOT
18	.	.	.	_	17	punct

1	The	the	DT	_	2	det
2	genotypes	genotype	NNS	_	16	nsubj
3	of	of	IN	_	4	case
4	drug1	drug1	NN	_	2	nmod
5	and	and	CC	_	4	cc
6	2C19	2c19	NN	_	4	conj
7	,	,	,	_	2	punct
8	the	the	DT	_	9	det
9	enzymes	enzyme	NNS	_	2	appos
10	responsible	responsible	JJ	_	9	amod
11	for	for	IN	_	13	case
12	phenytoin	phenytoin	NN	_	13	compound
13	metabolism	metabolism	NN	_	10	nmod
14	,	,	,	_	2	punct
15	were	be	VBD	_	16	cop
16	homozygous	homozygous	JJ	_	0	ROOT
17	for	for	IN	_	20	case
18	the	the	DT	_	20	det
19	wild-type	wild-type	JJ	_	20	amod
20	alleles	allele	NNS	_	16	nmod
21	-LRB-	-lrb-	-LRB-	_	22	punct
22	drug2	drug2	NN	_	20	appos
23	*	*	SYM	_	24	dep
24	1	1	CD	_	22	nummod
25	/	/	:	_	22	punct
26	*	*	SYM	_	27	dep
27	1	1	CD	_	22	dep
28	and	and	CC	_	27	cc
29	2C19	2c19	CD	_	31	compound
30	*	*	SYM	_	31	dep
31	1	1	CD	_	27	conj
32	/	/	:	_	22	punct
33	*	*	SYM	_	34	punct
34	1	1	LS	_	22	dep
35	-RRB-	-rrb-	-RRB-	_	22	punct
36	.	.	.	_	16	punct

1	The	the	DT	_	2	det
2	interaction	interaction	NN	_	6	nsubj
3	may	may	MD	_	6	aux
4	be	be	VB	_	6	cop
5	a	a	DT	_	6	det
6	result	result	NN	_	0	ROOT
7	of	of	IN	_	8	case
8	inhibition	inhibition	NN	_	6	nmod
9	of	of	IN	_	11	case
10	both	both	CC	_	11	cc:preconj
11	drug1	drug1	NN	_	8	nmod
12	and	and	CC	_	11	cc
13	2C19	2c19	NN	_	11	conj
14	by	by	IN	_	15	case
15	drug2	drug2	NN	_	8	nmod
16	.	.	.	_	6	punct

1	Pharmacokinetic	pharmacokinetic	JJ	_	2	amod
2	evaluation	evaluation	NN	_	0	ROOT
3	of	of	IN	_	8	case
4	the	the	DT	_	8	det
5	drug1	drug1	NN	_	8	compound
6	-	-	:	_	8	punct
7	drug2	drug2	NN	_	8	compound
8	interaction	interaction	NN	_	2	nmod
9	.	.	.	_	2	punct

1	drug1	drug1	NN	_	3	nsubjpass
2	is	be	VBZ	_	3	auxpass
3	known	know	VBN	_	0	ROOT
4	to	to	TO	_	5	mark
5	raise	raise	VB	_	3	xcomp
6	serum	serum	NN	_	8	compound
7	drug2	drug2	NN	_	8	compound
8	levels	level	NNS	_	5	dobj
9	.	.	.	_	3	punct

1	This	this	DT	_	2	det
2	study	study	NN	_	4	nsubjpass
3	was	be	VBD	_	4	auxpass
4	designed	design	VBN	_	0	ROOT
5	to	to	TO	_	6	mark
6	evaluate	evaluate	VB	_	4	xcomp
7	the	the	DT	_	9	det
8	pharmacokinetic	pharmacokinetic	JJ	_	9	amod
9	basis	basis	NN	_	6	dobj
10	of	of	IN	_	12	case
11	this	this	DT	_	12	det
12	interaction	interaction	NN	_	9	nmod
13	in	in	IN	_	16	case
14	10	10	CD	_	16	nummod
15	normal	normal	JJ	_	16	amod
16	subjects	subject	NNS	_	12	nmod
17	.	.	.	_	4	punct

1	The	the	DT	_	3	det
2	pharmacokinetic	pharmacokinetic	JJ	_	3	amod
3	variables	variable	NNS	_	7	nsubjpass
4	for	for	IN	_	5	case
5	drug1	drug1	NN	_	3	nmod
6	were	be	VBD	_	7	auxpass
7	determined	determine	VBN	_	0	ROOT
8	after	after	IN	_	13	case
9	a	a	DT	_	13	det
10	1.0	1.0	CD	_	11	compound
11	mg	mg	NN	_	13	amod
12	intravenous	intravenous	JJ	_	13	amod
13	dose	dose	NN	_	7	nmod
14	of	of	IN	_	15	case
15	drug2	drug2	NN	_	13	nmod
16	in	in	IN	_	18	case
17	each	each	DT	_	18	det
18	subject	subject	NN	_	13	nmod
19	,	,	,	_	7	punct
20	before	before	IN	_	24	nmod
21	and	and	CC	_	20	cc
22	after	after	IN	_	20	conj
23	oral	oral	JJ	_	24	amod
24	drug3	drug3	NN	_	7	nmod
25	,	,	,	_	24	punct
26	400	400	CD	_	27	nummod
27	mg	mg	NN	_	24	appos
28	daily	daily	RB	_	27	advmod
29	for	for	IN	_	31	case
30	3	3	CD	_	31	nummod
31	weeks	week	NNS	_	27	nmod
32	.	.	.	_	7	punct

1	During	during	IN	_	3	case
2	drug1	drug1	NN	_	3	compound
3	administration	administration	NN	_	10	nmod
4	,	,	,	_	10	punct
5	systemic	systemic	JJ	_	6	amod
6	clearance	clearance	NN	_	10	nsubjpass
7	of	of	IN	_	8	case
8	drug2	drug2	NN	_	6	nmod
9	was	be	VBD	_	10	auxpass
10	reduced	reduce	VBN	_	0	ROOT
11	from	from	IN	_	12	case
12	234	234	CD	_	10	nmod
13	+	+	CC	_	12	cc
14	/	/	:	_	17	punct
15	-	-	:	_	17	punct
16	72	72	CD	_	17	nummod
17	ml/min	ml/min	NN	_	12	conj
18	-LRB-	-lrb-	-LRB-	_	19	punct
19	mean	mean	NN	_	17	dep
20	+	+	CC	_	19	cc
21	/	/	:	_	19	punct
22	-	-	:	_	19	punct
23	standard	standard	JJ	_	24	amod
24	deviation	deviation	NN	_	19	dep
25	-RRB-	-rrb-	-RRB-	_	19	punct
26	to	to	TO	_	17	dep
27	172	172	CD	_	26	dobj
28	+	+	CC	_	27	cc
29	/	/	:	_	32	punct
30	-	-	:	_	32	punct
31	33	33	CD	_	32	nummod
32	ml/min	ml/min	NN	_	27	conj
33	-LRB-	-lrb-	-LRB-	_	32	punct
34	p	p	NN	_	33	root
35	less	less	JJR	_	34	amod
36	than	than	IN	_	37	case
37	0.01	0.01	CD	_	35	nmod
38	-RRB-	-rrb-	-RRB-	_	34	punct
39	.	.	.	_	34	punct

1	This	this	DT	_	3	nsubj
2	was	be	VBD	_	3	cop
3	due	due	JJ	_	0	ROOT
4	to	to	TO	_	5	case
5	reductions	reduction	NNS	_	3	nmod
6	in	in	IN	_	9	case
7	both	both	DT	_	9	det
8	renal	renal	JJ	_	9	amod
9	clearance	clearance	NN	_	5	nmod
10	-LRB-	-lrb-	-LRB-	_	9	punct
11	from	from	IN	_	12	case
12	105	105	CD	_	10	root
13	+	+	CC	_	12	cc
14	/	/	:	_	12	punct
15	-	-	:	_	14	punct
16	39	39	CD	_	18	compound
17	to	to	TO	_	18	dep
18	84	84	CD	_	15	root
19	+	+	CC	_	18	cc
20	/	/	:	_	23	punct
21	-	-	:	_	23	punct
22	15	15	CD	_	23	nummod
23	ml/min	ml/min	NN	_	18	conj
24	-RRB-	-rrb-	-RRB-	_	23	punct
25	-LRB-	-lrb-	-LRB-	_	29	punct
26	p	p	NN	_	29	dep
27	less	less	JJR	_	29	advmod
28	than	than	IN	_	27	mwe
29	0.05	0.05	CD	_	18	dep
30	-RRB-	-rrb-	-RRB-	_	29	punct
31	and	and	CC	_	18	cc
32	nonrenal	nonrenal	JJ	_	33	amod
33	clearance	clearance	NN	_	18	conj
34	-LRB-	-lrb-	-LRB-	_	33	punct
35	from	from	IN	_	36	case
36	130	130	CD	_	34	root
37	+	+	CC	_	36	cc
38	/	/	:	_	36	punct
39	-	-	:	_	38	punct
40	38	38	CD	_	42	compound
41	to	to	TO	_	42	dep
42	88	88	CD	_	39	root
43	+	+	CC	_	42	cc
44	/	/	:	_	47	punct
45	-	-	:	_	47	punct
46	20	20	CD	_	47	nummod
47	ml/min	ml/min	NN	_	42	conj
48	-RRB-	-rrb-	-RRB-	_	47	punct
49	-LRB-	-lrb-	-LRB-	_	42	punct
50	p	p	NN	_	49	root
51	less	less	JJR	_	50	amod
52	than	than	IN	_	53	case
53	0.01	0.01	CD	_	51	nmod
54	-RRB-	-rrb-	-RRB-	_	50	punct
55	.	.	.	_	50	punct

1	drug1	drug1	NN	_	2	compound
2	half-life	half-life	NN	_	6	nsubjpass
3	of	of	IN	_	4	case
4	elimination	elimination	NN	_	2	nmod
5	was	be	VBD	_	6	auxpass
6	prolonged	prolong	VBN	_	0	ROOT
7	from	from	IN	_	8	case
8	34	34	CD	_	6	nmod
9	+	+	CC	_	8	cc
10	/	/	:	_	8	punct
11	-	-	:	_	10	punct
12	13	13	CD	_	14	compound
13	to	to	TO	_	14	dep
14	40	40	CD	_	11	root
15	+	+	CC	_	14	cc
16	/	/	:	_	14	punct
17	-	-	:	_	16	punct
18	16	16	CD	_	19	nummod
19	hours	hour	NNS	_	17	root
20	-LRB-	-lrb-	-LRB-	_	19	dep
21	p	p	NN	_	20	root
22	less	less	JJR	_	21	amod
23	than	than	IN	_	24	case
24	0.05	0.05	CD	_	22	nmod
25	-RRB-	-rrb-	-RRB-	_	21	punct
26	.	.	.	_	21	punct

1	drug1	drug1	NN	_	2	compound
2	volume	volume	NN	_	8	nsubjpass
3	of	of	IN	_	4	case
4	distribution	distribution	NN	_	2	nmod
5	was	be	VBD	_	8	auxpass
6	not	not	RB	_	8	neg
7	significantly	significantly	RB	_	8	advmod
8	changed	change	VBD	_	0	ROOT
9	.	.	.	_	8	punct

1	drug1	drug1	NN	_	2	nsubj
2	caused	cause	VBD	_	0	ROOT
3	a	a	DT	_	8	det
4	three	three	CD	_	7	dep
5	-	-	:	_	4	punct
6	to	to	TO	_	7	dep
7	fivefold	fivefold	JJ	_	8	amod
8	increase	increase	NN	_	2	dobj
9	in	in	IN	_	13	case
10	serum	serum	NN	_	13	compound
11	reverse	reverse	JJ	_	13	amod
12	triiodothyronine	triiodothyronine	NN	_	13	compound
13	levels	level	NNS	_	8	nmod
14	,	,	,	_	2	punct
15	but	but	CC	_	2	cc
16	changes	change	NNS	_	23	nsubj
17	in	in	IN	_	19	case
18	thyroid	thyroid	NN	_	19	compound
19	function	function	NN	_	16	nmod
20	were	be	VBD	_	23	cop
21	not	not	RB	_	23	neg
22	quantitatively	quantitatively	RB	_	23	advmod
23	related	related	JJ	_	2	conj
24	to	to	TO	_	26	case
25	the	the	DT	_	26	det
26	changes	change	NNS	_	23	nmod
27	in	in	IN	_	29	case
28	drug2	drug2	NN	_	29	compound
29	pharmacokinetics	pharmacokinetic	NNS	_	26	nmod
30	.	.	.	_	2	punct

1	These	these	DT	_	2	det
2	alterations	alteration	NNS	_	9	nsubj
3	in	in	IN	_	5	case
4	drug1	drug1	NN	_	5	compound
5	pharmacokinetics	pharmacokinetic	NNS	_	2	nmod
6	produced	produce	VBN	_	5	acl
7	by	by	IN	_	8	case
8	drug2	drug2	NN	_	6	nmod
9	explain	explain	VBP	_	0	ROOT
10	the	the	DT	_	11	det
11	increase	increase	NN	_	9	dobj
12	in	in	IN	_	15	case
13	serum	serum	NN	_	15	compound
14	drug3	drug3	NN	_	15	compound
15	level	level	NN	_	11	nmod
16	that	that	WDT	_	19	nsubjpass
17	has	have	VBZ	_	19	aux
18	been	be	VBN	_	19	auxpass
19	observed	observe	VBN	_	11	acl:relcl
20	when	when	WRB	_	26	advmod
21	this	this	DT	_	23	det
22	drug	drug	NN	_	23	compound
23	combination	combination	NN	_	26	nsubjpass
24	has	have	VBZ	_	26	aux
25	been	be	VBN	_	26	auxpass
26	used	use	VBN	_	19	advcl
27	clinically	clinically	RB	_	26	advmod
28	.	.	.	_	9	punct

1	Activation	activation	NN	_	0	ROOT
2	of	of	IN	_	7	case
3	an	a	DT	_	7	det
4	effector	effector	NN	_	7	compound
5	immediate-early	immediate-early	JJ	_	7	amod
6	gene	gene	NN	_	7	compound
7	arc	arc	NN	_	1	nmod
8	by	by	IN	_	9	case
9	drug1	drug1	NN	_	1	nmod
10	.	.	.	_	1	punct

1	As	as	IN	_	8	mark
2	immediate-early	immediate-early	JJ	_	3	amod
3	genes	gene	NNS	_	8	nsubjpass
4	-LRB-	-lrb-	-LRB-	_	5	punct
5	IEGs	ieg	NNS	_	3	appos
6	-RRB-	-rrb-	-RRB-	_	5	punct
7	are	be	VBP	_	8	auxpass
8	thought	think	VBN	_	30	advcl
9	to	to	TO	_	10	mark
10	play	play	VB	_	8	xcomp
11	a	a	DT	_	13	det
12	critical	critical	JJ	_	13	amod
13	role	role	NN	_	10	dobj
14	in	in	IN	_	15	mark
15	mediating	mediate	VBG	_	10	advcl
16	stimulus-induced	stimulus-induced	JJ	_	18	amod
17	neural	neural	JJ	_	18	amod
18	plasticity	plasticity	NN	_	15	dobj
19	,	,	,	_	18	punct
20	IEG	ieg	NN	_	21	compound
21	response	response	NN	_	18	appos
22	induced	induce	VBN	_	21	acl
23	by	by	IN	_	24	case
24	drug1	drug1	NN	_	22	nmod
25	-LRB-	-lrb-	-LRB-	_	26	punct
26	drug2	drug2	NN	_	24	appos
27	-RRB-	-rrb-	-RRB-	_	26	punct
28	has	have	VBZ	_	30	aux
29	been	be	VBN	_	30	auxpass
30	characterized	characterize	VBN	_	0	ROOT
31	to	to	TO	_	32	mark
32	define	define	VB	_	30	xcomp
33	the	the	DT	_	34	det
34	changes	change	NNS	_	32	dobj
35	in	in	IN	_	37	case
36	gene	gene	NN	_	37	compound
37	expression	expression	NN	_	34	nmod
38	that	that	WDT	_	40	nsubj
39	may	may	MD	_	40	aux
40	underlie	underlie	VB	_	34	acl:relcl
41	its	its	PRP$	_	44	nmod:poss
42	long-lasting	long-lasting	JJ	_	44	amod
43	behavioral	behavioral	JJ	_	44	amod
44	effects	effect	NNS	_	40	dobj
45	.	.	.	_	30	punct

1	Although	although	IN	_	10	mark
2	activation	activation	NN	_	10	nsubjpass
3	of	of	IN	_	7	case
4	several	several	JJ	_	7	amod
5	transcription	transcription	NN	_	7	compound
6	factor	factor	NN	_	7	compound
7	IEGs	ieg	NNS	_	2	nmod
8	has	have	VBZ	_	10	aux
9	been	be	VBN	_	10	auxpass
10	described	describe	VBN	_	14	advcl
11	,	,	,	_	14	punct
12	little	little	JJ	_	14	nsubjpass
13	is	be	VBZ	_	14	auxpass
14	known	know	VBN	_	0	ROOT
15	about	about	IN	_	17	case
16	effector	effector	NN	_	17	compound
17	IEGs	ieg	NNS	_	14	nmod
18	.	.	.	_	14	punct

1	Here	here	RB	_	5	advmod
2	,	,	,	_	5	punct
3	we	we	PRP	_	5	nsubj
4	have	have	VBP	_	5	aux
5	examined	examine	VBN	_	0	ROOT
6	whether	whether	IN	_	9	mark
7	drug1	drug1	NN	_	8	compound
8	administration	administration	NN	_	9	nsubj
9	affects	affect	VBZ	_	5	ccomp
10	expression	expression	NN	_	9	dobj
11	of	of	IN	_	15	case
12	an	a	DT	_	15	det
13	effector	effector	NN	_	15	compound
14	IEG	IEG	NNP	_	15	compound
15	arc	arc	NN	_	10	nmod
16	-LRB-	-lrb-	-LRB-	_	17	punct
17	activity-regulated	activity-regulated	JJ	_	15	dep
18	,	,	,	_	17	punct
19	cytoskeleton-associated	cytoskeleton-associated	JJ	_	17	dep
20	-RRB-	-rrb-	-RRB-	_	17	punct
21	that	that	WDT	_	22	nsubj
22	encodes	encode	VBZ	_	15	acl:relcl
23	a	a	DT	_	24	det
24	protein	protein	NN	_	22	dobj
25	with	with	IN	_	26	case
26	homology	homology	NN	_	24	nmod
27	to	to	TO	_	28	case
28	spectrin	spectrin	NN	_	26	nmod
29	.	.	.	_	5	punct

1	Using	use	VBG	_	7	advcl
2	in	in	FW	_	4	amod
3	situ	situ	FW	_	2	dep
4	hybridization	hybridization	NN	_	1	dobj
5	,	,	,	_	7	punct
6	we	we	PRP	_	7	nsubj
7	observed	observe	VBD	_	0	ROOT
8	that	that	IN	_	10	mark
9	drug1	drug1	NN	_	10	nsubj
10	caused	cause	VBD	_	7	ccomp
11	a	a	DT	_	16	det
12	rapid	rapid	JJ	_	16	amod
13	and	and	CC	_	12	cc
14	transient	transient	JJ	_	12	conj
15	dose-dependent	dose-dependent	JJ	_	16	amod
16	increase	increase	NN	_	10	dobj
17	in	in	IN	_	20	case
18	arc	arc	NN	_	20	compound
19	mRNA	mrna	NN	_	20	compound
20	level	level	NN	_	16	nmod
21	in	in	IN	_	23	case
22	the	the	DT	_	23	det
23	striatum	striatum	NN	_	16	nmod
24	and	and	CC	_	23	cc
25	cortex	cortex	NN	_	23	conj
26	that	that	WDT	_	28	nsubjpass
27	was	be	VBD	_	28	auxpass
28	abolished	abolish	VBN	_	23	acl:relcl
29	by	by	IN	_	30	case
30	pretreatment	pretreatment	NN	_	28	nmod
31	with	with	IN	_	38	case
32	the	the	DT	_	38	det
33	specific	specific	JJ	_	38	amod
34	dopamine	dopamine	NN	_	38	compound
35	D1	d1	NN	_	38	compound
36	receptor	receptor	NN	_	38	compound
37	antagonist	antagonist	NN	_	38	compound
38	drug2	drug2	NN	_	30	nmod
39	but	but	CC	_	38	cc
40	not	not	RB	_	44	neg
41	by	by	IN	_	44	case
42	an	a	DT	_	44	det
43	drug3	drug3	NN	_	44	compound
44	drug4	drug4	NN	_	38	conj
45	.	.	.	_	7	punct

1	drug1	drug1	NN	_	2	nsubj
2	induced	induce	VBD	_	17	csubj
3	arc	arc	NN	_	4	compound
4	mRNA	mrna	NN	_	2	dobj
5	in	in	IN	_	6	case
6	layers	layer	NNS	_	2	nmod
7	IV	iv	CD	_	6	nummod
8	and	and	CC	_	6	cc
9	VI	VI	NNP	_	6	conj
10	of	of	IN	_	12	case
11	the	the	DT	_	12	det
12	cortex	cortex	NN	_	6	nmod
13	which	which	WDT	_	15	det
14	dopamine	dopamine	NN	_	15	compound
15	receptor	receptor	NN	_	12	dep
16	are	be	VBP	_	17	cop
17	localized	localized	JJ	_	0	ROOT
18	to	to	TO	_	17	nmod
19	.	.	.	_	17	punct

1	These	these	DT	_	2	det
2	results	result	NNS	_	3	nsubj
3	suggest	suggest	VBP	_	0	ROOT
4	that	that	IN	_	8	mark
5	D1	d1	NN	_	6	compound
6	receptors	receptor	NNS	_	8	nsubjpass
7	are	be	VBP	_	8	auxpass
8	coupled	couple	VBN	_	3	ccomp
9	to	to	TO	_	10	case
10	activation	activation	NN	_	8	nmod
11	of	of	IN	_	13	case
12	arc	arc	NN	_	13	compound
13	gene	gene	NN	_	10	nmod
14	,	,	,	_	10	punct
15	which	which	WDT	_	18	nsubjpass
16	may	may	MD	_	18	aux
17	be	be	VB	_	18	auxpass
18	involved	involve	VBN	_	10	acl:relcl
19	in	in	IN	_	23	case
20	functional	functional	JJ	_	23	amod
21	or	or	CC	_	20	cc
22	structural	structural	JJ	_	20	conj
23	alterations	alteration	NNS	_	18	nmod
24	underlying	underlie	VBG	_	23	acl
25	neural	neural	JJ	_	26	amod
26	plasticity	plasticity	NN	_	24	dobj
27	triggered	trigger	VBN	_	26	acl
28	by	by	IN	_	29	case
29	drug1	drug1	NN	_	27	nmod
30	.	.	.	_	3	punct

1	Differential	differential	JJ	_	2	amod
2	actions	action	NNS	_	0	ROOT
3	of	of	IN	_	5	case
4	intrathecal	intrathecal	JJ	_	5	amod
5	drug1	drug1	NN	_	2	nmod
6	on	on	IN	_	7	mark
7	blocking	block	VBG	_	2	acl
8	the	the	DT	_	10	det
9	tail-flick	tail-flick	JJ	_	10	amod
10	inhibition	inhibition	NN	_	7	dobj
11	induced	induce	VBN	_	10	acl
12	by	by	IN	_	14	case
13	intraventricular	intraventricular	JJ	_	14	amod
14	drug2	drug2	NN	_	11	nmod
15	and	and	CC	_	14	cc
16	drug3	drug3	NN	_	14	conj
17	in	in	IN	_	18	case
18	rats	rat	NNS	_	11	nmod
19	.	.	.	_	2	punct

1	In	in	IN	_	4	case
2	the	the	DT	_	4	det
3	present	present	JJ	_	4	amod
4	study	study	NN	_	8	nmod
5	,	,	,	_	8	punct
6	it	it	PRP	_	8	nsubjpass
7	is	be	VBZ	_	8	auxpass
8	proposed	propose	VBN	_	0	ROOT
9	that	that	IN	_	12	mark
10	the	the	DT	_	11	det
11	drug1	drug1	NN	_	12	nsubj
12	applied	apply	VBD	_	8	ccomp
13	to	to	TO	_	16	case
14	supraspinal	supraspinal	JJ	_	16	amod
15	brain	brain	NN	_	16	compound
16	sites	site	NNS	_	12	nmod
17	produced	produce	VBD	_	12	xcomp
18	their	they	PRP$	_	20	nmod:poss
19	analgesic	analgesic	JJ	_	20	amod
20	effects	effect	NNS	_	17	dobj
21	by	by	IN	_	23	case
22	the	the	DT	_	23	det
23	activation	activation	NN	_	17	nmod
24	of	of	IN	_	29	case
25	different	different	JJ	_	29	amod
26	descending	descend	VBG	_	29	amod
27	pain	pain	NN	_	29	compound
28	inhibitory	inhibitory	JJ	_	29	amod
29	systems	system	NNS	_	23	nmod
30	.	.	.	_	8	punct

1	The	the	DT	_	2	det
2	blockade	blockade	NN	_	25	nsubjpass
3	of	of	IN	_	7	case
4	the	the	DT	_	7	det
5	spinal	spinal	JJ	_	7	amod
6	endorphinergic	endorphinergic	JJ	_	7	amod
7	system	system	NN	_	2	nmod
8	by	by	IN	_	10	case
9	intrathecal	intrathecal	JJ	_	10	amod
10	drug1	drug1	NN	_	2	nmod
11	on	on	IN	_	13	case
12	the	the	DT	_	13	det
13	production	production	NN	_	2	nmod
14	of	of	IN	_	16	case
15	tail-flick	tail-flick	JJ	_	16	amod
16	inhibition	inhibition	NN	_	13	nmod
17	induced	induce	VBN	_	16	acl
18	by	by	IN	_	20	case
19	intraventricular	intraventricular	JJ	_	20	amod
20	drug2	drug2	NN	_	17	nmod
21	and	and	CC	_	20	cc
22	drug3	drug3	NN	_	20	conj
23	was	be	VBD	_	25	auxpass
24	then	then	RB	_	25	advmod
25	studied	study	VBN	_	0	ROOT
26	.	.	.	_	25	punct

1	Intraventricular	intraventricular	JJ	_	2	amod
2	injection	injection	NN	_	7	nsubj
3	of	of	IN	_	4	case
4	drug1	drug1	NN	_	2	nmod
5	and	and	CC	_	4	cc
6	drug2	drug2	NN	_	4	conj
7	produced	produce	VBD	_	0	ROOT
8	an	a	DT	_	9	det
9	inhibition	inhibition	NN	_	7	dobj
10	of	of	IN	_	13	case
11	the	the	DT	_	13	det
12	tail-flick	tail-flick	NN	_	13	compound
13	response	response	NN	_	9	nmod
14	to	to	TO	_	17	case
15	the	the	DT	_	17	det
16	heat	heat	NN	_	17	compound
17	stimulus	stimulus	NN	_	13	nmod
18	in	in	IN	_	19	case
19	rats	rat	NNS	_	13	nmod
20	.	.	.	_	7	punct

1	Intrathecal	intrathecal	JJ	_	2	amod
2	injection	injection	NN	_	12	nsubj
3	of	of	IN	_	4	case
4	drug1	drug1	NN	_	2	nmod
5	at	at	IN	_	6	case
6	doses	dose	NNS	_	2	nmod
7	of	of	IN	_	11	case
8	0.4	0.4	CD	_	10	compound
9	to	to	TO	_	10	dep
10	40	40	CD	_	11	nummod
11	micrograms	microgram	NNS	_	6	nmod
12	caused	cause	VBD	_	0	ROOT
13	a	a	DT	_	15	det
14	dose-related	dose-related	JJ	_	15	amod
15	blockade	blockade	NN	_	12	dobj
16	of	of	IN	_	18	case
17	the	the	DT	_	18	det
18	inhibition	inhibition	NN	_	15	nmod
19	of	of	IN	_	22	case
20	the	the	DT	_	22	det
21	tail-flick	tail-flick	NN	_	22	compound
22	response	response	NN	_	18	nmod
23	induced	induce	VBN	_	22	acl
24	by	by	IN	_	26	case
25	intraventricular	intraventricular	JJ	_	26	amod
26	injection	injection	NN	_	23	nmod
27	of	of	IN	_	28	case
28	drug2	drug2	NN	_	26	nmod
29	,	,	,	_	12	punct
30	and	and	CC	_	12	cc
31	a	a	DT	_	33	det
32	high	high	JJ	_	33	amod
33	dose	dose	NN	_	41	nsubj
34	of	of	IN	_	35	case
35	drug3	drug3	NN	_	33	nmod
36	-LRB-	-lrb-	-LRB-	_	38	punct
37	40	40	CD	_	38	nummod
38	micrograms	microgram	NNS	_	33	appos
39	-RRB-	-rrb-	-RRB-	_	38	punct
40	completely	completely	RB	_	41	advmod
41	blocked	block	VBD	_	12	conj
42	the	the	DT	_	44	det
43	tail-flick	tail-flick	JJ	_	44	amod
44	inhibition	inhibition	NN	_	41	dobj
45	induced	induce	VBN	_	44	acl
46	by	by	IN	_	48	case
47	intraventricular	intraventricular	JJ	_	48	amod
48	drug4	drug4	NN	_	45	nmod
49	-LRB-	-lrb-	-LRB-	_	51	punct
50	16	16	CD	_	51	nummod
51	micrograms	microgram	NNS	_	48	appos
52	-RRB-	-rrb-	-RRB-	_	51	punct
53	.	.	.	_	12	punct

1	On	on	IN	_	4	case
2	the	the	DT	_	4	det
3	other	other	JJ	_	4	amod
4	hand	hand	NN	_	12	nmod
5	,	,	,	_	12	punct
6	intrathecal	intrathecal	JJ	_	7	amod
7	drug1	drug1	NN	_	12	nsubj
8	-LRB-	-lrb-	-LRB-	_	10	punct
9	12-120	12-120	CD	_	10	nummod
10	micrograms	microgram	NNS	_	7	appos
11	-RRB-	-rrb-	-RRB-	_	10	punct
12	had	have	VBD	_	0	ROOT
13	only	only	RB	_	17	advmod
14	a	a	DT	_	17	det
15	very	very	RB	_	16	advmod
16	weak	weak	JJ	_	17	amod
17	effect	effect	NN	_	12	dobj
18	on	on	IN	_	21	case
19	the	the	DT	_	21	det
20	tail-flick	tail-flick	JJ	_	21	amod
21	inhibition	inhibition	NN	_	17	nmod
22	induced	induce	VBN	_	21	acl
23	by	by	IN	_	25	case
24	intraventricular	intraventricular	JJ	_	25	amod
25	drug2	drug2	NN	_	22	nmod
26	-LRB-	-lrb-	-LRB-	_	28	punct
27	40	40	CD	_	28	nummod
28	micrograms	microgram	NNS	_	25	appos
29	-RRB-	-rrb-	-RRB-	_	28	punct
30	.	.	.	_	12	punct

1	Intraventricular	intraventricular	JJ	_	2	amod
2	injection	injection	NN	_	13	nsubj
3	of	of	IN	_	4	case
4	drug1	drug1	NN	_	2	nmod
5	at	at	IN	_	6	case
6	doses	dose	NNS	_	2	nmod
7	of	of	IN	_	11	case
8	1.2	1.2	CD	_	10	compound
9	to	to	TO	_	10	dep
10	12	12	CD	_	11	nummod
11	micrograms	microgram	NNS	_	6	nmod
12	equally	equally	RB	_	13	advmod
13	antagonized	antagonize	VBD	_	0	ROOT
14	in	in	IN	_	17	case
15	a	a	DT	_	17	det
16	dose-dependent	dose-dependent	JJ	_	17	amod
17	manner	manner	NN	_	13	nmod
18	the	the	DT	_	20	det
19	tail-flick	tail-flick	NN	_	20	compound
20	inhibition	inhibition	NN	_	13	dobj
21	induced	induce	VBN	_	20	acl
22	by	by	IN	_	24	case
23	intraventricular	intraventricular	JJ	_	24	amod
24	drug2	drug2	NN	_	21	nmod
25	and	and	CC	_	24	cc
26	drug3	drug3	NN	_	24	conj
27	.	.	.	_	13	punct

1	The	the	DT	_	2	det
2	results	result	NNS	_	3	nsubj
3	indicate	indicate	VBP	_	0	ROOT
4	that	that	IN	_	13	mark
5	a	a	DT	_	7	det
6	spinal	spinal	JJ	_	7	amod
7	drug1	drug1	NN	_	13	nsubjpass
8	-	-	:	_	7	punct
9	sensitive	sensitive	JJ	_	11	amod
10	endorphinergic	endorphinergic	JJ	_	11	amod
11	system	system	NN	_	7	dep
12	is	be	VBZ	_	13	auxpass
13	involved	involve	VBN	_	3	ccomp
14	in	in	IN	_	16	case
15	the	the	DT	_	16	det
16	production	production	NN	_	13	nmod
17	of	of	IN	_	18	case
18	drug2	drug2	NN	_	16	nmod
19	but	but	CC	_	20	cc
20	not	not	RB	_	18	cc
21	drug3	drug3	NN	_	18	conj
22	-	-	:	_	18	punct
23	induced	induce	VBN	_	25	amod
24	tail-flick	tail-flick	NN	_	25	compound
25	inhibition	inhibition	NN	_	18	conj
26	,	,	,	_	18	punct
27	and	and	CC	_	3	cc
28	suggest	suggest	VBP	_	3	conj
29	that	that	IN	_	34	mark
30	intraventricular	intraventricular	JJ	_	31	amod
31	drug4	drug4	NN	_	34	nsubj
32	and	and	CC	_	31	cc
33	drug5	drug5	NN	_	31	conj
34	elicit	elicit	VBP	_	28	ccomp
35	their	they	PRP$	_	37	nmod:poss
36	pharmacological	pharmacological	JJ	_	37	amod
37	actions	action	NNS	_	34	dobj
38	via	via	IN	_	40	case
39	the	the	DT	_	40	det
40	activation	activation	NN	_	34	nmod
41	of	of	IN	_	46	case
42	different	different	JJ	_	46	amod
43	descending	descend	VBG	_	46	amod
44	pain	pain	NN	_	46	compound
45	inhibitory	inhibitory	JJ	_	46	amod
46	systems	system	NNS	_	40	nmod
47	;	;	:	_	3	punct

1	descending	descend	VBG	_	14	dep
2	epsilon	epsilon	NN	_	5	compound
3	and	and	CC	_	2	cc
4	mu	mu	NN	_	2	conj
5	systems	system	NNS	_	1	dobj
6	for	for	IN	_	7	case
7	drug1	drug1	NN	_	5	nmod
8	and	and	CC	_	7	cc
9	drug2	drug2	NN	_	7	conj
10	,	,	,	_	14	punct
11	respectively	respectively	RB	_	14	advmod
12	,	,	,	_	14	punct
13	are	be	VBP	_	14	auxpass
14	proposed	propose	VBN	_	0	ROOT
15	.	.	.	_	14	punct

1	Pharmacological	pharmacological	JJ	_	2	amod
2	treatment	treatment	NN	_	0	ROOT
3	of	of	IN	_	4	case
4	depression	depression	NN	_	2	nmod
5	:	:	:	_	2	punct
6	the	the	DT	_	7	det
7	role	role	NN	_	2	dep
8	of	of	IN	_	9	case
9	drug1	drug1	NN	_	7	nmod
10	.	.	.	_	2	punct

1	Depression	depression	NN	_	3	nsubj
2	is	be	VBZ	_	3	aux
3	reaching	reach	VBG	_	0	ROOT
4	epidemic	epidemic	JJ	_	5	amod
5	proportions	proportion	NNS	_	3	dobj
6	in	in	IN	_	9	case
7	the	the	DT	_	9	det
8	western	western	JJ	_	9	amod
9	world	world	NN	_	3	nmod
10	.	.	.	_	3	punct

1	With	with	IN	_	0	ROOT
2	each	each	DT	_	4	det
3	successive	successive	JJ	_	4	amod
4	generation	generation	NN	_	1	dep
5	more	more	JJR	_	6	amod
6	people	people	NNS	_	8	nsubj
7	are	be	VBP	_	8	aux
8	becoming	become	VBG	_	4	acl:relcl
9	more	more	RBR	_	10	advmod
10	severely	severely	RB	_	11	advmod
11	depressed	depress	VBN	_	8	xcomp
12	at	at	IN	_	15	case
13	a	a	DT	_	15	det
14	younger	younger	JJR	_	15	amod
15	age	age	NN	_	11	nmod
16	.	.	.	_	1	punct

1	Drug	drug	NN	_	2	compound
2	interactions	interaction	NNS	_	0	ROOT
3	:	:	:	_	2	punct
4	How	how	WRB	_	6	advmod
5	to	to	TO	_	6	mark
6	identify	identify	VB	_	2	dep
7	them	they	PRP	_	6	dobj
8	.	.	.	_	2	punct

1	Interactions	interaction	NNS	_	7	nsubjpass
2	between	between	IN	_	4	case
3	theraputic	theraputic	JJ	_	4	amod
4	agents	agent	NNS	_	1	nmod
5	have	have	VBP	_	7	aux
6	been	be	VBN	_	7	auxpass
7	recognized	recognize	VBN	_	25	csubj
8	as	as	IN	_	11	case
9	increasingly	increasingly	RB	_	10	advmod
10	important	important	JJ	_	11	amod
11	causes	cause	NNS	_	7	nmod
12	of	of	IN	_	13	case
13	drug	drug	NN	_	11	nmod
14	at	at	IN	_	18	case
15	their	they	PRP$	_	18	nmod:poss
16	usual	usual	JJ	_	18	amod
17	recommended	recommend	VBN	_	18	amod
18	dose	dose	NN	_	11	nmod
19	may	may	MD	_	25	aux
20	,	,	,	_	25	punct
21	under	under	IN	_	23	case
22	certain	certain	JJ	_	23	amod
23	conditions	condition	NNS	_	25	nmod
24	,	,	,	_	25	punct
25	produce	produce	VBP	_	0	ROOT
26	toxicity	toxicity	NN	_	25	dobj
27	of	of	IN	_	29	case
28	life-endangering	life-endangering	JJ	_	29	amod
29	proportions	proportion	NNS	_	26	nmod
30	.	.	.	_	25	punct

1	While	while	IN	_	12	mark
2	the	the	DT	_	3	det
3	recognition	recognition	NN	_	12	nsubj
4	of	of	IN	_	6	case
5	drug	drug	NN	_	6	compound
6	toxicity	toxicity	NN	_	3	nmod
7	resulting	result	VBG	_	3	acl
8	from	from	IN	_	9	case
9	interactions	interaction	NNS	_	7	nmod
10	is	be	VBZ	_	12	cop
11	of	of	IN	_	12	case
12	importance	importance	NN	_	0	ROOT
13	to	to	TO	_	15	case
14	all	all	DT	_	15	det
15	physciains	physciain	NNS	_	12	nmod
16	,	,	,	_	12	punct
17	it	it	PRP	_	16	root
18	is	be	VBZ	_	17	dep
19	especially	especially	RB	_	20	advmod
20	so	so	RB	_	18	advmod
21	for	for	IN	_	23	case
22	the	the	DT	_	23	det
23	clinician	clinician	NN	_	20	nmod
24	responsible	responsible	JJ	_	23	amod
25	for	for	IN	_	27	case
26	the	the	DT	_	27	det
27	welfare	welfare	NN	_	24	nmod
28	of	of	IN	_	29	case
29	those	those	DT	_	27	nmod
30	in	in	IN	_	33	case
31	the	the	DT	_	33	det
32	aerospace	aerospace	NN	_	33	compound
33	environment	environment	NN	_	29	nmod
34	.	.	.	_	18	punct

1	This	this	DT	_	2	det
2	paper	paper	NN	_	3	nsubj
3	attempts	attempt	VBZ	_	0	ROOT
4	to	to	TO	_	5	mark
5	provide	provide	VB	_	3	xcomp
6	a	a	DT	_	7	det
7	basis	basis	NN	_	5	dobj
8	for	for	IN	_	10	case
9	the	the	DT	_	10	det
10	understanding	understanding	NN	_	7	nmod
11	and	and	CC	_	10	cc
12	identifications	identification	NNS	_	10	conj
13	of	of	IN	_	16	case
14	important	important	JJ	_	16	amod
15	drug	drug	NN	_	16	compound
16	interactions	interaction	NNS	_	10	nmod
17	.	.	.	_	3	punct

1	Guidelines	guideline	NNS	_	3	nsubjpass
2	are	be	VBP	_	3	auxpass
3	provided	provide	VBN	_	0	ROOT
4	to	to	TO	_	5	mark
5	assist	assist	VB	_	3	xcomp
6	the	the	DT	_	7	det
7	clinician	clinician	NN	_	5	dobj
8	in	in	IN	_	11	case
9	his	he	PRP$	_	11	nmod:poss
10	logical	logical	JJ	_	11	amod
11	approach	approach	NN	_	5	nmod
12	to	to	TO	_	14	case
13	the	the	DT	_	14	det
14	identification	identification	NN	_	11	nmod
15	of	of	IN	_	17	case
16	drug	drug	NN	_	17	compound
17	interactions	interaction	NNS	_	14	nmod
18	when	when	WRB	_	23	advmod
19	serious	serious	JJ	_	21	amod
20	drug	drug	NN	_	21	compound
21	toxicity	toxicity	NN	_	23	nsubjpass
22	is	be	VBZ	_	23	auxpass
23	encountered	encounter	VBN	_	5	advcl
24	in	in	IN	_	26	case
25	a	a	DT	_	26	det
26	pateint	pateint	NN	_	23	nmod
27	.	.	.	_	3	punct

1	Only	only	RB	_	3	advmod
2	with	with	IN	_	3	case
3	knowledge	knowledge	NN	_	12	nmod
4	of	of	IN	_	6	case
5	the	the	DT	_	6	det
6	interaction	interaction	NN	_	3	nmod
7	can	can	MD	_	12	aux
8	the	the	DT	_	10	det
9	therapeutic	therapeutic	JJ	_	10	amod
10	regimen	regimen	NN	_	12	nsubjpass
11	be	be	VB	_	12	auxpass
12	altered	alter	VBN	_	0	ROOT
13	so	so	RB	_	16	advmod
14	as	as	IN	_	16	mark
15	to	to	TO	_	16	mark
16	provide	provide	VB	_	12	advcl
17	therapeutic	therapeutic	JJ	_	18	amod
18	levels	level	NNS	_	16	dobj
19	of	of	IN	_	21	case
20	necessary	necessary	JJ	_	21	amod
21	drugs	drug	NNS	_	18	nmod
22	while	while	IN	_	23	mark
23	avoiding	avoid	VBG	_	16	advcl
24	toxicity	toxicity	NN	_	23	dobj
25	.	.	.	_	12	punct

1	Changes	change	NNS	_	0	ROOT
2	in	in	IN	_	4	case
3	urinary	urinary	JJ	_	4	amod
4	homocysteine	homocysteine	NN	_	1	nmod
5	following	follow	VBG	_	9	case
6	drug1	drug1	NN	_	9	compound
7	and	and	CC	_	6	cc
8	drug2	drug2	NN	_	6	conj
9	administration	administration	NN	_	1	nmod
10	to	to	TO	_	11	case
11	rats	rat	NNS	_	9	nmod
12	.	.	.	_	1	punct

1	The	the	DT	_	3	det
2	present	present	JJ	_	3	amod
3	work	work	NN	_	4	nsubj
4	involved	involve	VBD	_	0	ROOT
5	the	the	DT	_	6	det
6	administration	administration	NN	_	4	dobj
7	of	of	IN	_	9	case
8	both	both	CC	_	9	cc:preconj
9	drug1	drug1	NN	_	6	nmod
10	and	and	CC	_	9	cc
11	drug2	drug2	NN	_	9	conj
12	to	to	TO	_	13	case
13	groups	group	NNS	_	6	nmod
14	of	of	IN	_	15	case
15	rats	rat	NNS	_	13	nmod
16	,	,	,	_	4	punct
17	followed	follow	VBN	_	4	advcl
18	by	by	IN	_	19	case
19	determination	determination	NN	_	17	nmod
20	of	of	IN	_	24	case
21	the	the	DT	_	24	det
22	homocysteine	homocysteine	NN	_	24	compound
23	excretion	excretion	NN	_	24	compound
24	rate	rate	NN	_	19	nmod
25	in	in	IN	_	26	case
26	urine	urine	NN	_	24	nmod
27	.	.	.	_	4	punct

1	The	the	DT	_	2	det
2	results	result	NNS	_	3	nsubj
3	indicate	indicate	VBP	_	0	ROOT
4	that	that	IN	_	9	mark
5	a	a	DT	_	8	det
6	statistically	statistically	RB	_	7	advmod
7	significant	significant	JJ	_	8	amod
8	difference	difference	NN	_	9	nsubj
9	exists	exist	VBZ	_	3	ccomp
10	between	between	IN	_	13	case
11	the	the	DT	_	13	det
12	excreted	excreted	JJ	_	13	amod
13	levels	level	NNS	_	9	nmod
14	of	of	IN	_	15	case
15	homocysteine	homocysteine	NN	_	13	nmod
16	in	in	IN	_	18	case
17	the	the	DT	_	18	det
18	urine	urine	NN	_	13	nmod
19	of	of	IN	_	21	case
20	both	both	DT	_	21	cc:preconj
21	control	control	NN	_	18	nmod
22	and	and	CC	_	21	cc
23	drug1	drug1	NN	_	21	conj
24	-	-	:	_	9	punct
25	treated	treat	VBN	_	26	amod
26	rats	rat	NNS	_	9	dobj
27	and	and	CC	_	26	cc
28	the	the	DT	_	29	det
29	levels	level	NNS	_	26	conj
30	shown	show	VBN	_	29	acl
31	by	by	IN	_	32	case
32	rats	rat	NNS	_	30	nmod
33	treated	treat	VBN	_	32	acl
34	with	with	IN	_	35	case
35	drug2	drug2	NN	_	33	nmod
36	.	.	.	_	3	punct

1	The	the	DT	_	2	det
2	implications	implication	NNS	_	7	nsubjpass
3	of	of	IN	_	5	case
4	these	these	DT	_	5	det
5	results	result	NNS	_	2	nmod
6	are	be	VBP	_	7	auxpass
7	discussed	discuss	VBN	_	0	ROOT
8	,	,	,	_	7	punct
9	especially	especially	RB	_	11	advmod
10	with	with	IN	_	11	case
11	respect	respect	NN	_	7	nmod
12	to	to	TO	_	13	case
13	observations	observation	NNS	_	11	nmod
14	which	which	WDT	_	15	nsubj
15	indicate	indicate	VBP	_	13	acl:relcl
16	that	that	IN	_	22	mark
17	homocysteine	homocysteine	NN	_	22	nsubj
18	may	may	MD	_	22	aux
19	be	be	VB	_	22	cop
20	a	a	DT	_	22	det
21	precipitating	precipitate	VBG	_	22	amod
22	factor	factor	NN	_	15	ccomp
23	in	in	IN	_	25	case
24	the	the	DT	_	25	det
25	development	development	NN	_	22	nmod
26	of	of	IN	_	27	case
27	thrombosis	thrombosis	NN	_	25	nmod
28	.	.	.	_	7	punct

1	Also	also	RB	_	2	advmod
2	included	include	VBN	_	0	ROOT
3	in	in	IN	_	5	case
4	this	this	DT	_	5	det
5	paper	paper	NN	_	2	nmod
6	is	be	VBZ	_	2	auxpass
7	a	a	DT	_	8	det
8	study	study	NN	_	2	nsubjpass
9	which	which	WDT	_	10	nsubj
10	confirms	confirm	VBZ	_	8	acl:relcl
11	the	the	DT	_	12	det
12	identity	identity	NN	_	10	dobj
13	of	of	IN	_	16	case
14	the	the	DT	_	16	det
15	HPLC	hplc	NN	_	16	compound
16	peak	peak	NN	_	12	nmod
17	as	as	IN	_	19	mark
18	being	be	VBG	_	19	cop
19	homocysteine	homocysteine	NN	_	10	advcl
20	by	by	IN	_	21	mark
21	forming	form	VBG	_	19	advcl
22	a	a	DT	_	24	det
23	radioactive	radioactive	JJ	_	24	amod
24	derivative	derivative	NN	_	21	dobj
25	of	of	IN	_	30	case
26	this	this	DT	_	30	det
27	particular	particular	JJ	_	30	amod
28	sulphydryl-containing	sulphydryl-containing	JJ	_	30	amod
29	amino	amino	NN	_	30	compound
30	acid	acid	NN	_	24	nmod
31	,	,	,	_	10	punct
32	and	and	CC	_	10	cc
33	then	then	RB	_	34	advmod
34	analysing	analyse	VBG	_	10	conj
35	the	the	DT	_	37	det
36	resulting	result	VBG	_	37	amod
37	mixture	mixture	NN	_	34	dobj
38	by	by	IN	_	39	case
39	TLC	tlc	NN	_	34	nmod
40	.	.	.	_	2	punct

1	Effect	effect	NN	_	0	ROOT
2	of	of	IN	_	3	case
3	drug1	drug1	NN	_	1	nmod
4	and	and	CC	_	3	cc
5	drug2	drug2	NN	_	3	conj
6	on	on	IN	_	9	case
7	the	the	DT	_	9	det
8	antinociceptive	antinociceptive	JJ	_	9	amod
9	effect	effect	NN	_	1	nmod
10	of	of	IN	_	11	case
11	drug3	drug3	NN	_	9	nmod
12	,	,	,	_	11	punct
13	drug4	drug4	NN	_	11	conj
14	and	and	CC	_	11	cc
15	drug5	drug5	NN	_	11	conj
16	in	in	IN	_	17	case
17	mice	mouse	NNS	_	9	nmod
18	.	.	.	_	1	punct

1	The	the	DT	_	2	det
2	influence	influence	NN	_	29	nsubjpass
3	of	of	IN	_	4	case
4	drug1	drug1	NN	_	2	nmod
5	and	and	CC	_	4	cc
6	drug2	drug2	NN	_	4	conj
7	on	on	IN	_	9	case
8	antinociceptive	antinociceptive	JJ	_	9	amod
9	effect	effect	NN	_	2	nmod
10	of	of	IN	_	11	case
11	drug3	drug3	NN	_	9	nmod
12	-LRB-	-lrb-	-LRB-	_	14	punct
13	10	10	CD	_	14	nummod
14	mg/kg	mg/kg	NN	_	11	appos
15	-RRB-	-rrb-	-RRB-	_	14	punct
16	,	,	,	_	11	punct
17	drug4	drug4	NN	_	11	conj
18	-LRB-	-lrb-	-LRB-	_	20	punct
19	500	500	CD	_	20	nummod
20	mg/kg	mg/kg	NN	_	17	appos
21	-RRB-	-rrb-	-RRB-	_	20	punct
22	and	and	CC	_	11	cc
23	drug5	drug5	NN	_	11	conj
24	-LRB-	-lrb-	-LRB-	_	26	punct
25	10	10	CD	_	26	nummod
26	mg/kg	mg/kg	NN	_	23	appos
27	-RRB-	-rrb-	-RRB-	_	26	punct
28	was	be	VBD	_	29	auxpass
29	investigated	investigate	VBN	_	0	ROOT
30	in	in	IN	_	33	case
31	a	a	DT	_	33	det
32	mouse	mouse	NN	_	33	compound
33	model	model	NN	_	29	nmod
34	using	use	VBG	_	33	acl
35	the	the	DT	_	39	det
36	tail-flick	tail-flick	NN	_	39	compound
37	and	and	CC	_	36	cc
38	hot-plate	hot-plate	NN	_	36	conj
39	tests	test	NNS	_	34	dobj
40	.	.	.	_	29	punct

1	All	all	DT	_	2	det
2	drugs	drug	NNS	_	4	nsubjpass
3	were	be	VBD	_	4	auxpass
4	injected	inject	VBN	_	0	ROOT
5	intraperitoneally	intraperitoneally	RB	_	4	advmod
6	.	.	.	_	4	punct

1	drug1	drug1	NN	_	3	nsubjpass
2	were	be	VBD	_	3	auxpass
3	administered	administer	VBN	_	0	ROOT
4	to	to	TO	_	5	case
5	mice	mouse	NNS	_	3	nmod
6	30	30	CD	_	7	nummod
7	min	min	NN	_	3	dobj
8	before	before	IN	_	9	mark
9	applying	apply	VBG	_	7	acl
10	the	the	DT	_	11	det
11	drug2	drug2	NN	_	9	dobj
12	.	.	.	_	3	punct

1	Measurement	measurement	NN	_	5	nsubjpass
2	of	of	IN	_	3	case
3	nociception	nociception	NN	_	1	nmod
4	was	be	VBD	_	5	auxpass
5	performed	perform	VBN	_	0	ROOT
6	within	within	IN	_	8	case
7	2	2	CD	_	8	nummod
8	h	h	NN	_	5	nmod
9	after	after	IN	_	11	case
10	drug1	drug1	NN	_	11	compound
11	administration	administration	NN	_	5	nmod
12	.	.	.	_	5	punct

1	drug1	drug1	NN	_	14	nsubjpass
2	at	at	IN	_	3	case
3	doses	dose	NNS	_	1	nmod
4	of	of	IN	_	6	case
5	0.25	0.25	CD	_	6	nummod
6	mg/kg	mg/kg	NN	_	3	nmod
7	and	and	CC	_	6	cc
8	2.5	2.5	CD	_	9	nummod
9	mg/kg	mg/kg	NN	_	6	conj
10	injected	inject	VBN	_	3	acl
11	with	with	IN	_	12	case
12	drug2	drug2	NN	_	10	nmod
13	was	be	VBD	_	14	auxpass
14	found	find	VBN	_	0	ROOT
15	to	to	TO	_	16	mark
16	decrease	decrease	VB	_	14	xcomp
17	the	the	DT	_	19	det
18	antinociceptive	antinociceptive	JJ	_	19	amod
19	effect	effect	NN	_	16	dobj
20	of	of	IN	_	21	case
21	drug3	drug3	NN	_	19	nmod
22	.	.	.	_	14	punct

1	Similarly	similarly	RB	_	4	advmod
2	,	,	,	_	4	punct
3	drug1	drug1	NN	_	4	nsubj
4	decreased	decrease	VBD	_	0	ROOT
5	the	the	DT	_	7	det
6	antinociceptive	antinociceptive	JJ	_	7	amod
7	effect	effect	NN	_	4	dobj
8	of	of	IN	_	9	case
9	drug2	drug2	NN	_	7	nmod
10	-LRB-	-lrb-	-LRB-	_	15	punct
11	only	only	RB	_	15	advmod
12	in	in	IN	_	15	case
13	the	the	DT	_	15	det
14	tail-flick	tail-flick	JJ	_	15	amod
15	test	test	NN	_	4	dep
16	-RRB-	-rrb-	-RRB-	_	15	punct
17	and	and	CC	_	4	cc
18	drug3	drug3	NN	_	4	conj
19	.	.	.	_	4	punct

1	drug1	drug1	NN	_	2	nsubj
2	used	use	VBD	_	0	ROOT
3	at	at	IN	_	4	case
4	doses	dose	NNS	_	2	nmod
5	of	of	IN	_	7	case
6	1.25	1.25	CD	_	7	nummod
7	mg/kg	mg/kg	NN	_	4	nmod
8	and	and	CC	_	7	cc
9	2.5	2.5	CD	_	10	nummod
10	mg/kg	mg/kg	NN	_	7	conj
11	decreased	decrease	VBD	_	2	dep
12	the	the	DT	_	14	det
13	antinociceptive	antinociceptive	JJ	_	14	amod
14	effect	effect	NN	_	11	dobj
15	of	of	IN	_	16	case
16	drug2	drug2	NN	_	14	nmod
17	,	,	,	_	16	punct
18	drug3	drug3	NN	_	16	conj
19	-LRB-	-lrb-	-LRB-	_	24	punct
20	only	only	RB	_	24	advmod
21	in	in	IN	_	24	case
22	the	the	DT	_	24	det
23	tail-flick	tail-flick	JJ	_	24	amod
24	test	test	NN	_	18	appos
25	-RRB-	-rrb-	-RRB-	_	24	punct
26	and	and	CC	_	16	cc
27	drug4	drug4	NN	_	16	conj
28	.	.	.	_	2	punct

1	-LSB-	-lsb-	-LRB-	_	3	punct
2	The	the	DT	_	3	det
3	effect	effect	NN	_	0	ROOT
4	of	of	IN	_	5	case
5	drug1	drug1	NN	_	3	nmod
6	on	on	IN	_	9	case
7	the	the	DT	_	9	det
8	renal	renal	JJ	_	9	amod
9	excretion	excretion	NN	_	3	nmod
10	of	of	IN	_	11	case
11	drug2	drug2	NN	_	9	nmod
12	and	and	CC	_	11	cc
13	drug3	drug3	NN	_	11	conj
14	in	in	IN	_	15	case
15	dogs	dog	NNS	_	9	nmod
16	-RSB-	-rsb-	-RRB-	_	3	punct
17	The	the	DT	_	19	det
18	intravenous	intravenous	JJ	_	19	amod
19	injection	injection	NN	_	28	nsubj
20	of	of	IN	_	21	case
21	drug4	drug4	NN	_	19	nmod
22	in	in	IN	_	24	case
23	a	a	DT	_	24	det
24	dose	dose	NN	_	19	nmod
25	of	of	IN	_	27	case
26	20	20	CD	_	27	nummod
27	mg/kg	mg/kg	NN	_	24	nmod
28	enhanced	enhance	VBD	_	3	acl:relcl
29	drug5	drug5	NN	_	32	compound
30	and	and	CC	_	29	cc
31	drug6	drug6	NN	_	29	conj
32	excretion	excretion	NN	_	28	dobj
33	in	in	IN	_	36	case
34	chronic	chronic	JJ	_	36	amod
35	canine	canine	JJ	_	36	amod
36	experiments	experiment	NNS	_	28	nmod
37	.	.	.	_	3	punct

1	The	the	DT	_	3	det
2	higher	higher	JJR	_	3	amod
3	drug1	drug1	NN	_	8	nsubj
4	and	and	CC	_	3	cc
5	drug2	drug2	NN	_	6	compound
6	excretion	excretion	NN	_	3	conj
7	was	be	VBD	_	8	cop
8	due	due	JJ	_	0	ROOT
9	to	to	TO	_	14	case
10	their	they	PRP$	_	14	nmod:poss
11	increased	increase	VBN	_	14	amod
12	renal	renal	JJ	_	14	amod
13	tubular	tubular	JJ	_	14	amod
14	secretion	secretion	NN	_	8	nmod
15	.	.	.	_	8	punct

1	In	in	IN	_	2	case
2	dogs	dog	NNS	_	5	nmod
3	,	,	,	_	5	punct
4	drug1	drug1	NN	_	5	nsubj
5	unchanged	unchanged	JJ	_	0	ROOT
6	the	the	DT	_	7	det
7	secretion	secretion	NN	_	5	dobj
8	of	of	IN	_	9	case
9	drug2	drug2	NN	_	7	nmod
10	,	,	,	_	7	punct
11	a	a	DT	_	13	det
12	test	test	NN	_	13	compound
13	agent	agent	NN	_	7	appos
14	for	for	IN	_	16	case
15	anionic	anionic	JJ	_	16	amod
16	transport	transport	NN	_	13	nmod
17	.	.	.	_	5	punct

1	Possible	possible	JJ	_	3	amod
2	extrarenal	extrarenal	JJ	_	3	amod
3	mechanisms	mechanism	NNS	_	15	nsubjpass
4	of	of	IN	_	5	case
5	action	action	NN	_	3	nmod
6	of	of	IN	_	7	case
7	drug1	drug1	NN	_	5	nmod
8	on	on	IN	_	9	case
9	drug2	drug2	NN	_	5	nmod
10	and	and	CC	_	9	cc
11	drug3	drug3	NN	_	12	compound
12	transport	transport	NN	_	9	conj
13	were	be	VBD	_	15	auxpass
14	also	also	RB	_	15	advmod
15	examined	examine	VBN	_	0	ROOT
16	.	.	.	_	15	punct

1	Differential	differential	JJ	_	2	amod
2	regulation	regulation	NN	_	0	ROOT
3	of	of	IN	_	5	case
4	tyrosine	tyrosine	NN	_	5	compound
5	phosphorylation	phosphorylation	NN	_	2	nmod
6	in	in	IN	_	8	case
7	tumor	tumor	NN	_	8	compound
8	cells	cell	NNS	_	5	nmod
9	by	by	IN	_	10	case
10	drug1	drug1	NN	_	2	nmod
11	,	,	,	_	10	punct
12	a	a	DT	_	14	det
13	homodimeric	homodimeric	JJ	_	14	amod
14	disintegrin	disintegrin	NN	_	10	appos
15	,	,	,	_	10	punct
16	and	and	CC	_	10	cc
17	monomeric	monomeric	JJ	_	19	amod
18	disintegrins	disintegrin	NNS	_	19	compound
19	drug2	drug2	NN	_	10	conj
20	and	and	CC	_	19	cc
21	drug3	drug3	NN	_	19	conj
22	.	.	.	_	2	punct

1	The	the	DT	_	4	det
2	homodimeric	homodimeric	JJ	_	4	amod
3	disintegrin	disintegrin	NN	_	4	compound
4	drug1	drug1	NN	_	6	nsubjpass
5	was	be	VBD	_	6	auxpass
6	compared	compare	VBN	_	0	ROOT
7	directly	directly	RB	_	6	advmod
8	to	to	TO	_	12	case
9	the	the	DT	_	12	det
10	monomeric	monomeric	JJ	_	12	amod
11	disintegrins	disintegrin	NNS	_	12	compound
12	drug2	drug2	NN	_	6	nmod
13	and	and	CC	_	12	cc
14	drug3	drug3	NN	_	12	conj
15	for	for	IN	_	17	case
16	the	the	DT	_	17	det
17	ability	ability	NN	_	6	nmod
18	to	to	TO	_	19	mark
19	affect	affect	VB	_	17	acl
20	protein	protein	NN	_	22	compound
21	tyrosine	tyrosine	NN	_	22	compound
22	phosphorylation	phosphorylation	NN	_	19	dobj
23	in	in	IN	_	25	case
24	tumor	tumor	NN	_	25	compound
25	cells	cell	NNS	_	22	nmod
26	.	.	.	_	6	punct

1	It	it	PRP	_	3	nsubjpass
2	was	be	VBD	_	3	auxpass
3	observed	observe	VBN	_	0	ROOT
4	that	that	IN	_	6	mark
5	drug1	drug1	NN	_	6	nsubj
6	had	have	VBD	_	3	ccomp
7	a	a	DT	_	9	det
8	dramatic	dramatic	JJ	_	9	amod
9	effect	effect	NN	_	6	dobj
10	on	on	IN	_	14	case
11	the	the	DT	_	14	det
12	tyrosine	tyrosine	NN	_	14	compound
13	phosphorylation	phosphorylation	NN	_	14	compound
14	status	status	NN	_	6	nmod
15	of	of	IN	_	17	case
16	several	several	JJ	_	17	amod
17	proteins	protein	NNS	_	14	nmod
18	in	in	IN	_	23	case
19	T24	t24	NN	_	23	compound
20	human	human	JJ	_	23	amod
21	bladder	bladder	NN	_	23	compound
22	cancer	cancer	NN	_	23	compound
23	cells	cell	NNS	_	14	nmod
24	,	,	,	_	23	punct
25	including	include	VBG	_	27	case
26	robust	robust	JJ	_	27	amod
27	induction	induction	NN	_	23	nmod
28	of	of	IN	_	29	case
29	phosphorylation	phosphorylation	NN	_	27	nmod
30	of	of	IN	_	31	case
31	proteins	protein	NNS	_	29	nmod
32	in	in	IN	_	34	case
33	the	the	DT	_	34	det
34	range	range	NN	_	27	nmod
35	of	of	IN	_	37	case
36	120-140	120-140	CD	_	37	nummod
37	kDa	kda	NN	_	34	nmod
38	.	.	.	_	3	punct

1	drug1	drug1	NN	_	3	nsubj
2	alone	alone	RB	_	1	advmod
3	had	have	VBD	_	0	ROOT
4	no	no	DT	_	5	neg
5	effect	effect	NN	_	3	dobj
6	on	on	IN	_	8	case
7	tyrosine	tyrosine	NN	_	8	compound
8	phosphorylation	phosphorylation	NN	_	3	nmod
9	in	in	IN	_	11	case
10	T24	t24	NN	_	11	compound
11	cells	cell	NNS	_	8	nmod
12	,	,	,	_	3	punct
13	but	but	CC	_	3	cc
14	dose-dependently	dose-dependently	RB	_	15	advmod
15	inhibits	inhibit	VBZ	_	3	conj
16	the	the	DT	_	17	det
17	effects	effect	NNS	_	15	dobj
18	of	of	IN	_	19	case
19	drug2	drug2	NN	_	17	nmod
20	when	when	WRB	_	23	advmod
21	both	both	DT	_	23	nsubjpass
22	are	be	VBP	_	23	auxpass
23	added	add	VBN	_	15	advcl
24	simultaneously	simultaneously	RB	_	23	advmod
25	.	.	.	_	3	punct

1	Among	among	IN	_	3	case
2	the	the	DT	_	3	det
3	proteins	protein	NNS	_	13	nmod
4	that	that	WDT	_	5	nsubj
5	undergo	undergo	VBP	_	3	acl:relcl
6	tyrosine	tyrosine	NN	_	7	compound
7	phosphorylation	phosphorylation	NN	_	5	dobj
8	in	in	IN	_	9	case
9	response	response	NN	_	5	nmod
10	to	to	TO	_	12	case
11	drug1	drug1	NN	_	12	compound
12	treatment	treatment	NN	_	9	nmod
13	is	be	VBZ	_	0	ROOT
14	CAS	CAS	NNP	_	13	nsubj
15	,	,	,	_	14	punct
16	a	a	DT	_	20	det
17	130	130	CD	_	18	compound
18	kDa	kda	NN	_	20	amod
19	adapter	adapter	NN	_	20	compound
20	protein	protein	NN	_	14	appos
21	involved	involve	VBN	_	20	acl
22	in	in	IN	_	24	case
23	integrin	integrin	NN	_	24	compound
24	signaling	signaling	NN	_	21	nmod
25	.	.	.	_	13	punct

1	drug1	drug1	NN	_	4	nsubjpass
2	alone	alone	RB	_	1	advmod
3	was	be	VBD	_	4	auxpass
4	found	find	VBN	_	0	ROOT
5	to	to	TO	_	6	mark
6	have	have	VB	_	4	xcomp
7	no	no	DT	_	8	neg
8	effect	effect	NN	_	6	dobj
9	on	on	IN	_	10	case
10	CAS	CAS	NNP	_	6	nmod
11	,	,	,	_	4	punct
12	but	but	CC	_	4	cc
13	can	can	MD	_	15	aux
14	completely	completely	RB	_	15	advmod
15	block	block	VB	_	4	conj
16	drug2	drug2	NN	_	15	dobj
17	-	-	:	_	16	punct
18	induced	induce	VBN	_	19	amod
19	phosphorylation	phosphorylation	NN	_	16	dep
20	of	of	IN	_	22	case
21	this	this	DT	_	22	det
22	protein	protein	NN	_	19	nmod
23	in	in	IN	_	25	case
24	MDA-MB-435	mda-mb-435	NN	_	25	compound
25	cells	cell	NNS	_	19	nmod
26	.	.	.	_	4	punct

1	These	these	DT	_	2	det
2	observations	observation	NNS	_	4	nsubj
3	strongly	strongly	RB	_	4	advmod
4	suggest	suggest	VBP	_	0	ROOT
5	that	that	IN	_	12	mark
6	the	the	DT	_	8	det
7	homodimeric	homodimeric	JJ	_	8	amod
8	structure	structure	NN	_	12	nsubj
9	of	of	IN	_	10	case
10	drug1	drug1	NN	_	8	nmod
11	functionally	functionally	RB	_	12	advmod
12	distinguishes	distinguish	VBZ	_	4	ccomp
13	it	it	PRP	_	12	dobj
14	from	from	IN	_	17	case
15	other	other	JJ	_	17	amod
16	monomeric	monomeric	JJ	_	17	amod
17	members	member	NNS	_	12	nmod
18	of	of	IN	_	21	case
19	the	the	DT	_	21	det
20	disintegrin	disintegrin	NN	_	21	compound
21	family	family	NN	_	17	nmod
22	.	.	.	_	4	punct

1	Toxicity	toxicity	NN	_	0	ROOT
2	of	of	IN	_	3	case
3	cadmium	cadmium	NN	_	1	nmod
4	and	and	CC	_	3	cc
5	drug1	drug1	NN	_	3	conj
6	to	to	TO	_	7	case
7	miracidia	miracidia	NN	_	1	nmod
8	of	of	IN	_	10	case
9	Schistosoma	schistosoma	NN	_	10	compound
10	mansoni	mansonus	NNS	_	7	nmod
11	.	.	.	_	1	punct

1	The	the	DT	_	3	det
2	specific	specific	JJ	_	3	amod
3	objectives	objective	NNS	_	7	nsubj
4	of	of	IN	_	6	case
5	this	this	DT	_	6	det
6	study	study	NN	_	3	nmod
7	were	be	VBD	_	0	ROOT
8	to	to	TO	_	9	mark
9	elucidate	elucidate	VB	_	7	xcomp
10	metal	metal	NN	_	11	compound
11	toxicity	toxicity	NN	_	9	dobj
12	to	to	TO	_	13	case
13	hatching	hatching	NN	_	11	nmod
14	,	,	,	_	13	punct
15	survival	survival	NN	_	13	conj
16	and	and	CC	_	13	cc
17	avoidance	avoidance	NN	_	18	compound
18	behaviour	behaviour	NN	_	13	conj
19	of	of	IN	_	22	case
20	Schistosoma	schistosoma	NN	_	22	compound
21	mansoni	mansoni	NN	_	22	compound
22	miracidia	miracidia	NN	_	13	nmod
23	.	.	.	_	7	punct

1	The	the	DT	_	2	det
2	toxicity	toxicity	NN	_	20	nsubjpass
3	of	of	IN	_	4	case
4	cadmium	cadmium	NN	_	2	nmod
5	,	,	,	_	4	punct
6	drug1	drug1	NN	_	4	conj
7	,	,	,	_	4	punct
8	and	and	CC	_	4	cc
9	cadmium/zinc	cadmium/zinc	NN	_	10	compound
10	mixtures	mixture	NNS	_	4	conj
11	at	at	IN	_	12	case
12	concentrations	concentration	NNS	_	2	nmod
13	ranging	range	VBG	_	12	acl
14	from	from	IN	_	18	case
15	10000	10000	CD	_	17	compound
16	to	to	TO	_	17	dep
17	10	10	CD	_	18	nummod
18	microg/l	microg/l	NN	_	13	nmod
19	was	be	VBD	_	20	auxpass
20	investigated	investigate	VBN	_	0	ROOT
21	.	.	.	_	20	punct

1	Metal	metal	NN	_	4	compound
2	mixture	mixture	NN	_	4	compound
3	toxicity	toxicity	NN	_	4	compound
4	investigation	investigation	NN	_	6	nsubjpass
5	was	be	VBD	_	6	auxpass
6	undertaken	undertake	VBN	_	0	ROOT
7	with	with	IN	_	9	case
8	equal	equal	JJ	_	9	amod
9	concentrations	concentration	NNS	_	6	nmod
10	of	of	IN	_	12	case
11	the	the	DT	_	12	det
12	metals	metal	NNS	_	9	nmod
13	.	.	.	_	6	punct

1	The	the	DT	_	2	det
2	hatching	hatching	NN	_	8	nsubjpass
3	of	of	IN	_	4	case
4	miracidia	miracidia	NN	_	2	nmod
5	from	from	IN	_	6	case
6	eggs	egg	NNS	_	2	nmod
7	was	be	VBD	_	8	auxpass
8	inhibited	inhibit	VBN	_	0	ROOT
9	by	by	IN	_	10	case
10	concentrations	concentration	NNS	_	8	nmod
11	of	of	IN	_	13	case
12	1000-10000	1000-10000	CD	_	13	nummod
13	microg/l	microg/l	NN	_	10	nmod
14	of	of	IN	_	16	case
15	single	single	JJ	_	16	amod
16	metals	metal	NNS	_	13	nmod
17	.	.	.	_	8	punct

1	Metal	metal	NN	_	2	compound
2	mixtures	mixture	NNS	_	3	nsubj
3	had	have	VBD	_	0	ROOT
4	no	no	DT	_	5	neg
5	effect	effect	NN	_	3	dobj
6	on	on	IN	_	8	case
7	drug1	drug1	NN	_	8	compound
8	hatching	hatching	NN	_	3	nmod
9	.	.	.	_	3	punct

1	Survival	survival	NN	_	5	nsubjpass
2	of	of	IN	_	3	case
3	miracidia	miracidia	NN	_	1	nmod
4	was	be	VBD	_	5	auxpass
5	reduced	reduce	VBN	_	0	ROOT
6	by	by	IN	_	7	mark
7	increasing	increase	VBG	_	5	advcl
8	metal	metal	NN	_	9	compound
9	concentration	concentration	NN	_	7	dobj
10	except	except	IN	_	12	case
11	at	at	IN	_	12	case
12	concentrations	concentration	NNS	_	7	nmod
13	of	of	IN	_	15	case
14	10	10	CD	_	15	nummod
15	microg/l	microg/l	NN	_	12	nmod
16	for	for	IN	_	19	case
17	single	single	JJ	_	19	amod
18	metal	metal	NN	_	19	compound
19	toxicity	toxicity	NN	_	15	nmod
20	where	where	WRB	_	23	advmod
21	survival	survival	NN	_	23	nsubjpass
22	was	be	VBD	_	23	auxpass
23	increased	increase	VBN	_	19	acl:relcl
24	above	above	IN	_	26	case
25	the	the	DT	_	26	det
26	control	control	NN	_	23	nmod
27	.	.	.	_	5	punct

1	Miracidia	Miracidia	NNP	_	2	nsubj
2	demonstrated	demonstrate	VBD	_	0	ROOT
3	a	a	DT	_	6	det
4	rapid	rapid	JJ	_	6	amod
5	avoidance	avoidance	NN	_	6	compound
6	behaviour	behaviour	NN	_	2	dobj
7	when	when	WRB	_	9	advmod
8	briefly	briefly	NN	_	9	nsubj
9	exposed	expose	VBN	_	2	advcl
10	to	to	TO	_	12	case
11	heavy	heavy	JJ	_	12	amod
12	metals	metal	NNS	_	9	nmod
13	.	.	.	_	2	punct

1	The	the	DT	_	2	det
2	mechanisms	mechanism	NNS	_	10	nsubjpass
3	of	of	IN	_	5	case
4	metal	metal	NN	_	5	compound
5	toxicity	toxicity	NN	_	2	nmod
6	to	to	TO	_	7	case
7	miracidia	miracidia	NN	_	5	nmod
8	are	be	VBP	_	10	auxpass
9	briefly	briefly	RB	_	10	advmod
10	discussed	discuss	VBN	_	0	ROOT
11	.	.	.	_	10	punct

1	Drug-lab	drug-lab	JJ	_	2	amod
2	interactions	interaction	NNS	_	0	ROOT
3	:	:	:	_	2	punct
4	implications	implication	NNS	_	2	dep
5	for	for	IN	_	7	case
6	nutrition	nutrition	NN	_	7	compound
7	support	support	NN	_	4	nmod
8	.	.	.	_	2	punct

1	drug1	drug1	NN	_	2	compound
2	interference	interference	NN	_	0	ROOT
3	with	with	IN	_	6	case
4	urine	urine	NN	_	6	compound
5	ketone	ketone	NN	_	6	compound
6	test	test	NN	_	2	nmod
7	.	.	.	_	2	punct

1	It	it	PRP	_	3	nsubj
2	is	be	VBZ	_	3	cop
3	important	important	JJ	_	0	ROOT
4	that	that	IN	_	9	mark
5	health	health	NN	_	7	compound
6	care	care	NN	_	7	compound
7	professionals	professional	NNS	_	9	nsubj
8	be	be	VB	_	9	cop
9	aware	aware	JJ	_	3	ccomp
10	of	of	IN	_	12	case
11	the	the	DT	_	12	det
12	potential	potential	NN	_	9	nmod
13	for	for	IN	_	16	mark
14	medications	medication	NNS	_	16	nsubj
15	to	to	TO	_	16	mark
16	interfere	interfere	VB	_	12	acl
17	with	with	IN	_	20	case
18	clinical	clinical	JJ	_	20	amod
19	laboratory	laboratory	NN	_	20	compound
20	tests	test	NNS	_	16	nmod
21	.	.	.	_	3	punct

1	Medications	medication	NNS	_	3	nsubj
2	can	can	MD	_	3	aux
3	cause	cause	VB	_	0	ROOT
4	in	in	FW	_	6	amod
5	vivo	vivo	FW	_	4	dep
6	effects	effect	NNS	_	3	dobj
7	when	when	WRB	_	16	advmod
8	the	the	DT	_	9	det
9	concentration	concentration	NN	_	16	nsubjpass
10	or	or	CC	_	9	cc
11	activity	activity	NN	_	9	conj
12	of	of	IN	_	14	case
13	the	the	DT	_	14	det
14	analyte	analyte	NN	_	9	nmod
15	is	be	VBZ	_	16	auxpass
16	altered	alter	VBN	_	3	advcl
17	before	before	IN	_	19	case
18	the	the	DT	_	19	det
19	analysis	analysis	NN	_	16	nmod
20	and	and	CC	_	16	cc
21	therefore	therefore	RB	_	26	advmod
22	the	the	DT	_	24	det
23	assay	assay	NN	_	24	compound
24	result	result	NN	_	26	nsubj
25	is	be	VBZ	_	26	cop
26	true	true	JJ	_	16	conj
27	and	and	CC	_	26	cc
28	accurate	accurate	JJ	_	26	conj
29	.	.	.	_	3	punct

1	An	a	DT	_	4	det
2	in	in	FW	_	4	amod
3	vitro	vitro	FW	_	2	dep
4	effect	effect	NN	_	5	nsubj
5	occurs	occur	VBZ	_	0	ROOT
6	when	when	WRB	_	9	advmod
7	the	the	DT	_	8	det
8	medication	medication	NN	_	9	nsubj
9	interferes	interfere	VBZ	_	5	advcl
10	with	with	IN	_	12	case
11	the	the	DT	_	12	det
12	assay	assay	NN	_	9	nmod
13	,	,	,	_	5	punct
14	and	and	CC	_	5	cc
15	the	the	DT	_	16	det
16	result	result	NN	_	18	nsubj
17	is	be	VBZ	_	18	cop
18	erroneous	erroneous	JJ	_	5	conj
19	and	and	CC	_	18	cc
20	can	can	MD	_	23	aux
21	not	not	RB	_	23	neg
22	be	be	VB	_	23	auxpass
23	interpreted	interpret	VBN	_	18	conj
24	.	.	.	_	5	punct

1	This	this	DT	_	2	det
2	report	report	NN	_	3	nsubj
3	describes	describe	VBZ	_	0	ROOT
4	a	a	DT	_	7	det
5	recently	recently	RB	_	6	advmod
6	identified	identify	VBN	_	7	amod
7	case	case	NN	_	3	dobj
8	of	of	IN	_	9	case
9	interference	interference	NN	_	7	nmod
10	of	of	IN	_	11	case
11	drug1	drug1	NN	_	9	nmod
12	with	with	IN	_	15	case
13	the	the	DT	_	15	det
14	urine	urine	NN	_	15	compound
15	test	test	NN	_	9	nmod
16	for	for	IN	_	17	case
17	ketones	ketone	NNS	_	15	nmod
18	and	and	CC	_	3	cc
19	demonstrates	demonstrate	VBZ	_	3	conj
20	the	the	DT	_	21	det
21	importance	importance	NN	_	19	dobj
22	of	of	IN	_	26	case
23	a	a	DT	_	26	det
24	thorough	thorough	JJ	_	26	amod
25	medication	medication	NN	_	26	compound
26	review	review	NN	_	21	nmod
27	in	in	IN	_	28	mark
28	evaluating	evaluate	VBG	_	26	acl
29	abnormal	abnormal	JJ	_	31	amod
30	laboratory	laboratory	NN	_	31	compound
31	tests	test	NNS	_	28	dobj
32	.	.	.	_	3	punct

1	-LSB-	-lsb-	-LRB-	_	3	punct
2	Pharmacologic	pharmacologic	JJ	_	3	amod
3	interactions	interaction	NNS	_	0	ROOT
4	in	in	IN	_	6	case
5	chronic	chronic	JJ	_	6	amod
6	treatments	treatment	NNS	_	3	nmod
7	:	:	:	_	3	punct
8	corrective	corrective	JJ	_	9	amod
9	measures	measure	NNS	_	3	dep
10	for	for	IN	_	12	case
11	its	its	PRP$	_	12	nmod:poss
12	prevention	prevention	NN	_	9	nmod
13	in	in	IN	_	16	case
14	a	a	DT	_	16	det
15	basic	basic	JJ	_	16	amod
16	area	area	NN	_	12	nmod
17	of	of	IN	_	19	case
18	rural	rural	JJ	_	19	amod
19	health	health	NN	_	16	nmod
20	-RSB-	-rsb-	-RRB-	_	3	punct
21	OBJECTIVES	objective	NNS	_	3	dep
22	:	:	:	_	3	punct
23	To	to	TO	_	24	mark
24	identify	identify	VB	_	3	dep
25	the	the	DT	_	27	det
26	pharmacological	pharmacological	JJ	_	27	amod
27	interactions	interaction	NNS	_	24	dobj
28	of	of	IN	_	30	case
29	clinical	clinical	JJ	_	30	amod
30	relevance	relevance	NN	_	27	nmod
31	-LRB-	-lrb-	-LRB-	_	32	punct
32	PICR	picr	NN	_	30	appos
33	-RRB-	-rrb-	-RRB-	_	32	punct
34	in	in	IN	_	38	case
35	the	the	DT	_	38	det
36	medication	medication	NN	_	38	compound
37	authorization	authorization	NN	_	38	compound
38	cards	card	NNS	_	27	nmod
39	-LRB-	-lrb-	-LRB-	_	40	punct
40	MAC	MAC	NNP	_	38	appos
41	-RRB-	-rrb-	-RRB-	_	40	punct
42	of	of	IN	_	45	case
43	the	the	DT	_	45	det
44	chronically	chronically	RB	_	45	advmod
45	ill	ill	JJ	_	38	nmod
46	and	and	CC	_	24	cc
47	to	to	TO	_	48	mark
48	establish	establish	VB	_	24	conj
49	strategies	strategy	NNS	_	48	dobj
50	to	to	TO	_	51	mark
51	minimise	minimise	VB	_	49	acl
52	their	they	PRP$	_	53	nmod:poss
53	appearance	appearance	NN	_	51	dobj
54	.	.	.	_	3	punct

1	DESIGN	design	NN	_	0	ROOT
2	:	:	:	_	1	punct
3	Cross-sectional	cross-sectional	JJ	_	5	amod
4	descriptive	descriptive	JJ	_	5	amod
5	study	study	NN	_	1	dep
6	.	.	.	_	1	punct

1	SETTING	SETTING	NNP	_	0	ROOT
2	:	:	:	_	1	punct
3	Rural	Rural	NNP	_	6	compound
4	primary	primary	JJ	_	6	amod
5	care	care	NN	_	6	compound
6	centre	centre	NN	_	1	dep
7	.	.	.	_	1	punct

1	PATIENTS	patient	NNS	_	0	ROOT
2	:	:	:	_	1	punct
3	Random	Random	NNP	_	4	compound
4	sample	sample	NN	_	1	dep
5	of	of	IN	_	7	case
6	626	626	CD	_	7	nummod
7	MAC	MAC	NNP	_	4	nmod
8	out	out	IN	_	11	case
9	of	of	IN	_	11	case
10	a	a	DT	_	11	det
11	total	total	NN	_	4	nmod
12	of	of	IN	_	13	case
13	1306	1306	CD	_	11	nmod
14	.	.	.	_	1	punct

1	MEASUREMENTS	measurement	NNS	_	4	compound
2	AND	and	CC	_	1	cc
3	MAIN	main	NNS	_	1	conj
4	RESULTS	result	NNS	_	0	ROOT
5	:	:	:	_	4	punct
6	In	in	IN	_	7	case
7	December	December	NNP	_	13	nmod
8	1998	1998	CD	_	7	nummod
9	,	,	,	_	13	punct
10	the	the	DT	_	11	det
11	following	following	NN	_	13	nsubjpass
12	was	be	VBD	_	13	auxpass
13	gathered	gather	VBN	_	4	dep
14	for	for	IN	_	16	case
15	every	every	DT	_	16	det
16	MAC	MAC	NNP	_	13	nmod
17	with	with	IN	_	22	case
18	more	more	JJR	_	20	advmod
19	than	than	IN	_	18	mwe
20	one	one	CD	_	22	nummod
21	drug	drug	NN	_	22	compound
22	treatment	treatment	NN	_	13	nmod
23	:	:	:	_	22	punct
24	age	age	NN	_	22	dep
25	,	,	,	_	24	punct
26	sex	sex	NN	_	24	conj
27	,	,	,	_	24	punct
28	number	number	NN	_	24	conj
29	of	of	IN	_	30	case
30	drugs	drug	NNS	_	28	nmod
31	,	,	,	_	24	punct
32	intrinsic	intrinsic	JJ	_	33	amod
33	value	value	NN	_	24	conj
34	,	,	,	_	24	punct
35	drugs	drug	NNS	_	42	compound
36	prescribed	prescribe	VBN	_	42	amod
37	,	,	,	_	36	punct
38	daily	daily	RB	_	39	advmod
39	dose	dose	NN	_	36	conj
40	and	and	CC	_	36	cc
41	pharmacological	pharmacological	JJ	_	36	conj
42	interactions	interaction	NNS	_	24	conj
43	-LRB-	-lrb-	-LRB-	_	44	punct
44	PI	pi	NN	_	42	appos
45	-RRB-	-rrb-	-RRB-	_	44	punct
46	,	,	,	_	24	punct
47	classified	classify	VBN	_	24	dep
48	-LRB-	-lrb-	-LRB-	_	49	punct
49	using	use	VBG	_	47	dep
50	the	the	DT	_	51	det
51	scale	scale	NN	_	49	dobj
52	of	of	IN	_	53	case
53	Hansten	Hansten	NNP	_	51	nmod
54	1996	1996	CD	_	53	nummod
55	-RRB-	-rrb-	-RRB-	_	49	punct
56	into	into	IN	_	57	case
57	light	light	NN	_	47	nmod
58	and	and	CC	_	47	cc
59	clinically	clinically	RB	_	60	advmod
60	relevant	relevant	JJ	_	47	conj
61	.	.	.	_	4	punct

1	Statistical	statistical	JJ	_	2	amod
2	analysis	analysis	NN	_	0	ROOT
3	:	:	:	_	2	punct
4	Mantel-Haenszel	Mantel-Haenszel	NNP	_	2	dep
5	-LRB-	-lrb-	-LRB-	_	6	punct
6	alpha	alpha	NN	_	4	dep
7	=	=	JJ	_	6	amod
8	0.05	0.05	CD	_	7	dep
9	-RRB-	-rrb-	-RRB-	_	6	punct
10	.	.	.	_	2	punct

1	Patients	patient	NNS	_	4	nmod:poss
2	'	'	POS	_	1	case
3	mean	mean	NN	_	4	compound
4	age	age	NN	_	10	nsubj
5	was	be	VBD	_	10	cop
6	69.1	69.1	CD	_	10	nummod
7	-LRB-	-lrb-	-LRB-	_	10	punct
8	95	95	CD	_	9	compound
9	%	%	NN	_	10	amod
10	CI	ci	NN	_	0	ROOT
11	,	,	,	_	10	punct
12	+	+	CC	_	10	cc
13	/	/	:	_	15	punct
14	-	-	:	_	15	punct
15	1.2	1.2	CD	_	10	conj
16	-RRB-	-rrb-	-RRB-	_	15	punct
17	.	.	.	_	10	punct

1	Mean	mean	NN	_	2	compound
2	number	number	NN	_	12	nsubj
3	of	of	IN	_	4	case
4	drugs	drug	NNS	_	2	nmod
5	per	per	IN	_	6	case
6	MAC	MAC	NNP	_	4	nmod
7	was	be	VBD	_	12	cop
8	4	4	CD	_	12	nummod
9	-LRB-	-lrb-	-LRB-	_	12	punct
10	95	95	CD	_	11	compound
11	%	%	NN	_	12	amod
12	CI	ci	NN	_	0	ROOT
13	,	,	,	_	12	punct
14	+	+	CC	_	12	cc
15	/	/	:	_	12	punct
16	-	-	:	_	12	punct
17	0.2	0.2	CD	_	12	dep
18	-RRB-	-rrb-	-RRB-	_	12	punct
19	.	.	.	_	12	punct

1	341	341	CD	_	2	nummod
2	PI	pi	NN	_	20	nsubjpass
3	affecting	affect	VBG	_	2	acl
4	197	197	CD	_	5	nummod
5	patients	patient	NNS	_	3	dobj
6	-LRB-	-lrb-	-LRB-	_	8	punct
7	31.5	31.5	CD	_	8	nummod
8	%	%	NN	_	5	dep
9	,	,	,	_	8	punct
10	95	95	CD	_	11	nummod
11	%	%	NN	_	8	appos
12	CI	ci	NN	_	11	dep
13	,	,	,	_	8	punct
14	+	+	CC	_	8	cc
15	/	/	:	_	8	punct
16	-	-	:	_	8	punct
17	3.6	3.6	CD	_	8	dep
18	-RRB-	-rrb-	-RRB-	_	8	punct
19	were	be	VBD	_	20	auxpass
20	identified	identify	VBN	_	0	ROOT
21	.	.	.	_	20	punct

1	24.9	24.9	CD	_	2	nummod
2	%	%	NN	_	14	nsubj
3	-LRB-	-lrb-	-LRB-	_	6	punct
4	95	95	CD	_	5	compound
5	%	%	NN	_	6	amod
6	CI	ci	NN	_	2	appos
7	,	,	,	_	6	punct
8	+	+	CC	_	6	cc
9	/	/	:	_	6	punct
10	-	-	:	_	6	punct
11	4.5	4.5	CD	_	6	dep
12	-RRB-	-rrb-	-RRB-	_	6	punct
13	were	be	VBD	_	14	cop
14	PICR	picr	NN	_	0	ROOT
15	,	,	,	_	14	punct
16	detected	detect	VBN	_	14	acl
17	in	in	IN	_	19	case
18	11.7	11.7	CD	_	19	nummod
19	%	%	NN	_	16	nmod
20	-LRB-	-lrb-	-LRB-	_	23	punct
21	95	95	CD	_	22	compound
22	%	%	NN	_	23	amod
23	CI	ci	NN	_	19	dep
24	,	,	,	_	23	punct
25	+	+	CC	_	23	cc
26	/	/	:	_	23	punct
27	-	-	:	_	23	punct
28	2.5	2.5	CD	_	23	dep
29	-RRB-	-rrb-	-RRB-	_	23	punct
30	of	of	IN	_	32	case
31	the	the	DT	_	32	det
32	MAC	MAC	NNP	_	19	nmod
33	.	.	.	_	14	punct

1	The	the	DT	_	2	det
2	existence	existence	NN	_	6	nsubjpass
3	of	of	IN	_	4	case
4	PI	pi	NN	_	2	nmod
5	was	be	VBD	_	6	auxpass
6	related	relate	VBN	_	0	ROOT
7	to	to	TO	_	9	case
8	the	the	DT	_	9	det
9	number	number	NN	_	6	nmod
10	of	of	IN	_	11	case
11	drugs	drug	NNS	_	9	nmod
12	prescribed	prescribe	VBN	_	11	acl
13	to	to	TO	_	15	case
14	each	each	DT	_	15	det
15	patient	patient	NN	_	12	nmod
16	-LRB-	-lrb-	-LRB-	_	18	punct
17	p	p	NN	_	18	dep
18	<	<	JJR	_	6	parataxis
19	0.01	0.01	CD	_	18	nummod
20	-RRB-	-rrb-	-RRB-	_	18	punct
21	.	.	.	_	6	punct

1	There	there	EX	_	2	expl
2	were	be	VBD	_	0	ROOT
3	26	26	CD	_	4	nummod
4	PI	pi	NN	_	2	nsubj
5	with	with	IN	_	6	case
6	drugs	drug	NNS	_	4	nmod
7	of	of	IN	_	10	case
8	low	low	JJ	_	10	amod
9	intrinsic	intrinsic	JJ	_	10	amod
10	value	value	NN	_	6	nmod
11	-LRB-	-lrb-	-LRB-	_	13	punct
12	7.6	7.6	CD	_	13	nummod
13	%	%	NN	_	4	dep
14	;	;	:	_	13	punct
15	95	95	CD	_	16	nummod
16	%	%	NN	_	13	dep
17	CI	ci	NN	_	16	dep
18	,	,	,	_	13	punct
19	+	+	CC	_	13	cc
20	/	/	:	_	13	punct
21	-	-	:	_	13	punct
22	2.8	2.8	CD	_	13	dep
23	-RRB-	-rrb-	-RRB-	_	13	punct
24	.	.	.	_	2	punct

1	74.1	74.1	CD	_	2	nummod
2	%	%	NN	_	19	nsubjpass
3	-LRB-	-lrb-	-LRB-	_	6	punct
4	95	95	CD	_	5	compound
5	%	%	NN	_	6	amod
6	CI	ci	NN	_	2	appos
7	,	,	,	_	6	punct
8	+	+	CC	_	6	cc
9	/	/	:	_	6	punct
10	-	-	:	_	6	punct
11	9.3	9.3	CD	_	6	dep
12	-RRB-	-rrb-	-RRB-	_	6	punct
13	of	of	IN	_	16	case
14	the	the	DT	_	16	det
15	total	total	JJ	_	16	amod
16	PICR	picr	NN	_	2	nmod
17	could	could	MD	_	19	aux
18	be	be	VB	_	19	auxpass
19	avoided	avoid	VBN	_	0	ROOT
20	by	by	IN	_	22	case
21	simple	simple	JJ	_	22	amod
22	recommendations	recommendation	NNS	_	19	nmod
23	;	;	:	_	19	punct

1	and	and	CC	_	0	ROOT
2	the	the	DT	_	5	det
3	remaining	remain	VBG	_	5	amod
4	25.9	25.9	CD	_	5	nummod
5	%	%	NN	_	1	dep
6	-LRB-	-lrb-	-LRB-	_	9	punct
7	95	95	CD	_	8	compound
8	%	%	NN	_	9	amod
9	CI	ci	NN	_	5	appos
10	,	,	,	_	9	punct
11	+	+	CC	_	9	cc
12	/	/	:	_	9	punct
13	-	-	:	_	9	punct
14	9.3	9.3	CD	_	9	dep
15	-RRB-	-rrb-	-RRB-	_	9	punct
16	by	by	IN	_	17	case
17	monitoring	monitor	VBG	_	5	nmod
18	and	and	CC	_	17	cc
19	follow-up	follow-up	NN	_	17	conj
20	of	of	IN	_	21	case
21	patients	patient	NNS	_	19	nmod
22	.	.	.	_	1	punct

1	CONCLUSIONS	conclusion	NNS	_	0	ROOT
2	:	:	:	_	1	punct
3	It	it	PRP	_	5	nsubj
4	is	be	VBZ	_	5	cop
5	important	important	JJ	_	1	dep
6	to	to	TO	_	7	mark
7	identify	identify	VB	_	5	xcomp
8	the	the	DT	_	9	det
9	medications	medication	NNS	_	7	dobj
10	most	most	RBS	_	11	advmod
11	commonly	commonly	RB	_	12	advmod
12	involved	involve	VBN	_	9	acl
13	in	in	IN	_	15	case
14	the	the	DT	_	15	det
15	PICR	picr	NN	_	12	nmod
16	so	so	RB	_	19	advmod
17	as	as	IN	_	19	mark
18	to	to	TO	_	19	mark
19	establish	establish	VB	_	7	advcl
20	corrective	corrective	JJ	_	21	amod
21	measures	measure	NNS	_	19	dobj
22	to	to	TO	_	23	mark
23	minimise	minimise	VB	_	21	acl
24	the	the	DT	_	25	det
25	risks	risk	NNS	_	23	dobj
26	arising	arise	VBG	_	25	acl
27	from	from	IN	_	29	case
28	multiple	multiple	JJ	_	29	amod
29	medication	medication	NN	_	26	nmod
30	.	.	.	_	1	punct

1	Four	four	CD	_	3	nummod
2	educational	educational	JJ	_	3	amod
3	messages	message	NNS	_	4	nsubj
4	advise	advise	VBP	_	0	ROOT
5	on	on	IN	_	4	compound:prt
6	over	over	IN	_	7	advmod
7	60	60	CD	_	8	nummod
8	%	%	NN	_	4	dobj
9	of	of	IN	_	11	case
10	the	the	DT	_	11	det
11	PICR	picr	NN	_	8	nmod
12	detected	detect	VBN	_	11	acl
13	.	.	.	_	4	punct

1	Neurochemical	neurochemical	JJ	_	4	amod
2	and	and	CC	_	1	cc
3	functional	functional	JJ	_	1	conj
4	consequences	consequence	NNS	_	0	ROOT
5	following	follow	VBG	_	4	acl
6	drug1	drug1	NN	_	5	dobj
7	-LRB-	-lrb-	-LRB-	_	8	punct
8	drug2	drug2	NN	_	6	appos
9	-RRB-	-rrb-	-RRB-	_	8	punct
10	and	and	CC	_	6	cc
11	drug3	drug3	NN	_	6	conj
12	.	.	.	_	4	punct

1	The	the	DT	_	5	det
2	neurochemical	neurochemical	JJ	_	5	amod
3	and	and	CC	_	2	cc
4	functional	functional	JJ	_	2	conj
5	consequences	consequence	NNS	_	13	nsubjpass
6	following	follow	VBG	_	8	case
7	drug1	drug1	NN	_	8	compound
8	administration	administration	NN	_	5	nmod
9	to	to	TO	_	11	case
10	the	the	DT	_	11	det
11	rat	rat	NN	_	8	nmod
12	were	be	VBD	_	13	auxpass
13	evaluated	evaluate	VBN	_	0	ROOT
14	and	and	CC	_	13	cc
15	compared	compare	VBN	_	18	case
16	to	to	TO	_	18	case
17	similar	similar	JJ	_	18	amod
18	effects	effect	NNS	_	13	conj
19	following	follow	VBG	_	21	case
20	drug2	drug2	NN	_	21	compound
21	administration	administration	NN	_	18	nmod
22	.	.	.	_	13	punct

1	It	it	PRP	_	3	nsubjpass
2	was	be	VBD	_	3	auxpass
3	observed	observe	VBN	_	0	ROOT
4	that	that	IN	_	6	mark
5	drug1	drug1	NN	_	6	nsubj
6	induced	induce	VBD	_	3	ccomp
7	long	long	JJ	_	9	amod
8	lasting	lasting	JJ	_	9	amod
9	depletions	depletion	NNS	_	6	dobj
10	of	of	IN	_	13	case
11	striatal	striatal	JJ	_	13	amod
12	dopamine	dopamine	NN	_	13	compound
13	concentrations	concentration	NNS	_	9	nmod
14	and	and	CC	_	6	cc
15	this	this	DT	_	17	det
16	neurotoxic	neurotoxic	JJ	_	17	amod
17	effect	effect	NN	_	20	nsubjpass
18	could	could	MD	_	20	aux
19	be	be	VB	_	20	auxpass
20	prevented	prevent	VBN	_	6	conj
21	by	by	IN	_	23	case
22	drug2	drug2	NN	_	23	compound
23	pretreatment	pretreatment	NN	_	20	nmod
24	.	.	.	_	3	punct

1	The	the	DT	_	2	det
2	drug1	drug1	NN	_	0	ROOT
3	-	-	:	_	2	punct
4	induced	induce	VBN	_	6	amod
5	neuronal	neuronal	JJ	_	6	amod
6	damage	damage	NN	_	7	nsubj
7	produced	produce	VBD	_	2	dep
8	a	a	DT	_	9	det
9	tolerance	tolerance	NN	_	7	dobj
10	to	to	TO	_	13	case
11	the	the	DT	_	13	det
12	disruptive	disruptive	JJ	_	13	amod
13	effects	effect	NNS	_	9	nmod
14	of	of	IN	_	15	case
15	drug2	drug2	NN	_	13	nmod
16	and	and	CC	_	15	cc
17	a	a	DT	_	18	det
18	supersensitivity	supersensitivity	NN	_	15	conj
19	to	to	TO	_	22	case
20	the	the	DT	_	22	det
21	disruptive	disruptive	JJ	_	22	amod
22	effects	effect	NNS	_	18	nmod
23	of	of	IN	_	24	case
24	drug3	drug3	NN	_	22	nmod
25	in	in	IN	_	26	case
26	rats	rat	NNS	_	22	nmod
27	responding	respond	VBG	_	26	acl
28	in	in	IN	_	30	case
29	a	a	DT	_	30	det
30	schedule	schedule	NN	_	27	nmod
31	controlled	control	VBN	_	32	amod
32	paradigm	paradigm	NN	_	30	dep
33	.	.	.	_	2	punct

1	drug1	drug1	NN	_	6	nsubj
2	,	,	,	_	6	punct
3	like	like	IN	_	4	case
4	drug2	drug2	NN	_	6	nmod
5	,	,	,	_	6	punct
6	produced	produce	VBD	_	0	ROOT
7	depletions	depletion	NNS	_	6	dobj
8	of	of	IN	_	10	case
9	striatal	striatal	JJ	_	10	amod
10	dopamine	dopamine	NN	_	7	nmod
11	but	but	CC	_	6	cc
12	these	these	DT	_	13	det
13	actions	action	NNS	_	15	nsubjpass
14	were	be	VBD	_	15	auxpass
15	potentiated	potentiate	VBN	_	6	conj
16	by	by	IN	_	18	case
17	drug3	drug3	NN	_	18	compound
18	pretreatment	pretreatment	NN	_	15	nmod
19	.	.	.	_	6	punct

1	These	these	DT	_	2	det
2	observations	observation	NNS	_	4	nsubjpass
3	are	be	VBP	_	4	auxpass
4	discussed	discuss	VBN	_	0	ROOT
5	in	in	IN	_	6	case
6	reference	reference	NN	_	4	nmod
7	to	to	TO	_	10	case
8	possible	possible	JJ	_	10	amod
9	deleterious	deleterious	JJ	_	10	amod
10	effects	effect	NNS	_	6	nmod
11	following	follow	VBG	_	13	case
12	the	the	DT	_	13	det
13	administration	administration	NN	_	10	nmod
14	of	of	IN	_	15	case
15	drug1	drug1	NN	_	13	nmod
16	to	to	TO	_	17	case
17	patients	patient	NNS	_	13	nmod
18	with	with	IN	_	21	case
19	Parkinson	Parkinson	NNP	_	21	nmod:poss
20	's	's	POS	_	19	case
21	Disease	disease	NN	_	17	nmod
22	.	.	.	_	4	punct

1	Responses	response	NNS	_	0	ROOT
2	to	to	TO	_	3	case
3	drug1	drug1	NN	_	1	nmod
4	of	of	IN	_	7	case
5	the	the	DT	_	7	det
6	perfused	perfused	JJ	_	7	amod
7	pancreas	pancreas	NN	_	3	nmod
8	of	of	IN	_	13	case
9	the	the	DT	_	13	det
10	genetically	genetically	RB	_	11	advmod
11	diabetic	diabetic	JJ	_	13	amod
12	Chinese	chinese	JJ	_	13	amod
13	hamster	hamster	NN	_	7	nmod
14	.	.	.	_	1	punct

1	Nonketotic	Nonketotic	NNP	_	0	ROOT
2	,	,	,	_	1	punct
3	genetically	genetically	RB	_	4	advmod
4	diabetic	diabetic	JJ	_	6	amod
5	Cinese	cinese	JJ	_	6	amod
6	hamsters	hamster	NNS	_	7	nsubj
7	show	show	VBP	_	1	acl:relcl
8	subnormal	subnormal	JJ	_	11	amod
9	pancreatic	pancreatic	JJ	_	11	amod
10	insulin	insulin	NN	_	11	compound
11	release	release	NN	_	7	dobj
12	and	and	CC	_	11	cc
13	impaired	impaired	JJ	_	14	amod
14	suppression	suppression	NN	_	11	conj
15	of	of	IN	_	16	case
16	glucagon	glucagon	NN	_	14	nmod
17	in	in	IN	_	18	case
18	response	response	NN	_	7	nmod
19	to	to	TO	_	20	case
20	glucose	glucose	NN	_	18	nmod
21	.	.	.	_	1	punct

1	To	to	TO	_	2	mark
2	study	study	VB	_	16	csubjpass
3	the	the	DT	_	5	det
4	pancreatic	pancreatic	JJ	_	5	amod
5	effects	effect	NNS	_	2	dobj
6	of	of	IN	_	8	case
7	other	other	JJ	_	8	amod
8	agents	agent	NNS	_	5	nmod
9	,	,	,	_	8	punct
10	dynamic	dynamic	JJ	_	11	amod
11	insulin	insulin	NN	_	8	conj
12	and	and	CC	_	8	cc
13	glucagon	glucagon	NN	_	14	compound
14	release	release	NN	_	8	conj
15	was	be	VBD	_	16	auxpass
16	measured	measure	VBN	_	0	ROOT
17	from	from	IN	_	22	case
18	the	the	DT	_	22	det
19	in	in	FW	_	22	amod
20	vitro	vitro	FW	_	19	dep
21	perfused	perfused	JJ	_	22	amod
22	pancreases	pancreas	NNS	_	16	nmod
23	of	of	IN	_	28	case
24	normal	normal	JJ	_	28	amod
25	and	and	CC	_	24	cc
26	diabetic	diabetic	JJ	_	24	conj
27	Chinese	chinese	JJ	_	28	amod
28	hamsters	hamster	NNS	_	22	nmod
29	in	in	IN	_	30	case
30	response	response	NN	_	16	nmod
31	to	to	TO	_	33	case
32	various	various	JJ	_	33	amod
33	combinations	combination	NNS	_	30	nmod
34	of	of	IN	_	35	case
35	drug1	drug1	NN	_	33	nmod
36	-LRB-	-lrb-	-LRB-	_	37	punct
37	20mM	20mm	NN	_	35	appos
38	-RRB-	-rrb-	-RRB-	_	37	punct
39	,	,	,	_	35	punct
40	drug2	drug2	NN	_	35	conj
41	-LRB-	-lrb-	-LRB-	_	45	punct
42	100	100	CD	_	45	nummod
43	or	or	CC	_	42	cc
44	150	150	CD	_	42	conj
45	mg	mg	NN	_	40	appos
46	.	.	.	_	45	punct
47	per	per	IN	_	49	case
48	100	100	CD	_	49	nummod
49	ml	ml	NN	_	45	nmod
50	.	.	.	_	45	punct
51	-RRB-	-rrb-	-RRB-	_	45	punct
52	,	,	,	_	35	punct
53	and	and	CC	_	35	cc
54	drug3	drug3	NN	_	35	conj
55	-LRB-	-lrb-	-LRB-	_	57	punct
56	10	10	CD	_	57	nummod
57	mM	mm	NN	_	54	appos
58	-RRB-	-rrb-	-RRB-	_	57	punct
59	.	.	.	_	16	punct

1	drug1	drug1	NN	_	3	nsubj
2	alone	alone	RB	_	1	advmod
3	caused	cause	VBD	_	0	ROOT
4	identical	identical	JJ	_	5	amod
5	insulin	insulin	NN	_	3	dobj
6	and	and	CC	_	5	cc
7	glucagon	glucagon	NN	_	8	compound
8	release	release	NN	_	5	conj
9	in	in	IN	_	10	case
10	diabetics	diabetic	NNS	_	5	nmod
11	and	and	CC	_	10	cc
12	normals	normal	NNS	_	10	conj
13	.	.	.	_	3	punct

1	drug1	drug1	NN	_	11	nsubj
2	,	,	,	_	1	punct
3	alone	alone	RB	_	1	conj
4	and	and	CC	_	1	cc
5	in	in	IN	_	7	case
6	the	the	DT	_	7	det
7	presence	presence	NN	_	1	conj
8	of	of	IN	_	9	case
9	drug2	drug2	NN	_	7	nmod
10	,	,	,	_	1	punct
11	caused	cause	VBD	_	0	ROOT
12	subnormal	subnormal	JJ	_	14	amod
13	insulin	insulin	NN	_	14	compound
14	release	release	NN	_	11	dobj
15	and	and	CC	_	14	cc
16	less	less	JJR	_	17	amod
17	suppression	suppression	NN	_	14	conj
18	of	of	IN	_	20	case
19	glucagon	glucagon	NN	_	20	compound
20	release	release	NN	_	17	nmod
21	in	in	IN	_	23	case
22	the	the	DT	_	23	det
23	diabectics	diabectic	NNS	_	20	nmod
24	than	than	IN	_	27	case
25	in	in	IN	_	27	case
26	the	the	DT	_	27	det
27	normals	normal	NNS	_	14	nmod
28	.	.	.	_	11	punct

1	drug1	drug1	NN	_	11	nsubj
2	,	,	,	_	11	punct
3	in	in	IN	_	5	case
4	the	the	DT	_	5	det
5	presence	presence	NN	_	11	nmod
6	of	of	IN	_	7	case
7	drug2	drug2	NN	_	5	nmod
8	and	and	CC	_	7	cc
9	drug3	drug3	NN	_	7	conj
10	,	,	,	_	11	punct
11	caused	cause	VBD	_	0	ROOT
12	excessive	excessive	JJ	_	14	amod
13	glucagon	glucagon	NN	_	14	compound
14	release	release	NN	_	11	dobj
15	but	but	CC	_	14	cc
16	nearly	nearly	RB	_	17	advmod
17	normal	normal	JJ	_	19	amod
18	insulin	insulin	NN	_	19	compound
19	release	release	NN	_	14	conj
20	in	in	IN	_	22	case
21	the	the	DT	_	22	det
22	diabetics	diabetic	NNS	_	19	nmod
23	.	.	.	_	11	punct

1	drug1	drug1	NN	_	11	nsubj
2	,	,	,	_	11	punct
3	in	in	IN	_	5	case
4	the	the	DT	_	5	det
5	absence	absence	NN	_	11	nmod
6	of	of	IN	_	7	case
7	drug2	drug2	NN	_	5	nmod
8	or	or	CC	_	7	cc
9	drug3	drug3	NN	_	7	conj
10	,	,	,	_	11	punct
11	caused	cause	VBD	_	0	ROOT
12	excessive	excessive	JJ	_	14	amod
13	glucagon	glucagon	NN	_	14	compound
14	release	release	NN	_	11	dobj
15	in	in	IN	_	17	case
16	the	the	DT	_	17	det
17	diabetics	diabetic	NNS	_	14	nmod
18	and	and	CC	_	14	cc
19	undetectable	undetectable	JJ	_	21	amod
20	insulin	insulin	NN	_	21	compound
21	release	release	NN	_	14	conj
22	in	in	IN	_	24	case
23	either	either	CC	_	24	cc:preconj
24	diabetics	diabetic	NNS	_	21	nmod
25	or	or	CC	_	24	cc
26	normals	normal	NNS	_	24	conj
27	.	.	.	_	11	punct

1	Pancreatic	pancreatic	JJ	_	2	amod
2	content	content	NN	_	7	nsubj
3	after	after	IN	_	4	case
4	perfusion	perfusion	NN	_	2	nmod
5	did	do	VBD	_	7	aux
6	not	not	RB	_	7	neg
7	correlate	correlate	VB	_	0	ROOT
8	with	with	IN	_	9	case
9	release	release	NN	_	7	nmod
10	during	during	IN	_	11	case
11	perfusion	perfusion	NN	_	7	nmod
12	.	.	.	_	7	punct

1	Infusion	infusion	NN	_	6	nsubj
2	of	of	IN	_	3	case
3	drug1	drug1	NN	_	1	nmod
4	alone	alone	RB	_	1	advmod
5	markedly	markedly	RB	_	6	advmod
6	decreased	decrease	VBD	_	0	ROOT
7	the	the	DT	_	8	det
8	amount	amount	NN	_	6	dobj
9	of	of	IN	_	12	case
10	extractable	extractable	JJ	_	12	amod
11	pancreatic	pancreatic	JJ	_	12	amod
12	insulin	insulin	NN	_	8	nmod
13	and	and	CC	_	12	cc
14	glucagon	glucagon	NN	_	12	conj
15	.	.	.	_	6	punct

1	These	these	DT	_	2	det
2	results	result	NNS	_	3	nsubj
3	indicate	indicate	VBP	_	0	ROOT
4	that	that	IN	_	14	mark
5	the	the	DT	_	8	det
6	pancreatic	pancreatic	JJ	_	8	amod
7	alpha	alpha	NN	_	8	compound
8	cell	cell	NN	_	14	nsubj
9	of	of	IN	_	13	case
10	the	the	DT	_	13	det
11	diabetic	diabetic	JJ	_	13	amod
12	Chinese	chinese	JJ	_	13	amod
13	hamster	hamster	NN	_	8	nmod
14	responds	respond	VBZ	_	3	ccomp
15	excessively	excessively	RB	_	14	advmod
16	to	to	TO	_	17	case
17	drug1	drug1	NN	_	14	nmod
18	,	,	,	_	14	punct
19	as	as	RB	_	21	mark
20	is	be	VBZ	_	21	auxpass
21	seen	see	VBN	_	14	advcl
22	in	in	IN	_	25	case
23	the	the	DT	_	25	det
24	human	human	JJ	_	25	amod
25	diabetic	diabetic	JJ	_	21	nmod
26	.	.	.	_	3	punct

1	This	this	DT	_	2	det
2	defect	defect	NN	_	5	nsubj
3	is	be	VBZ	_	5	cop
4	not	not	RB	_	5	neg
5	related	relate	VBN	_	0	ROOT
6	to	to	TO	_	9	case
7	acute	acute	JJ	_	9	amod
8	insulin	insulin	NN	_	9	compound
9	release	release	NN	_	5	nmod
10	or	or	CC	_	9	cc
11	the	the	DT	_	12	det
12	presence	presence	NN	_	9	conj
13	of	of	IN	_	14	case
14	drug1	drug1	NN	_	12	nmod
15	.	.	.	_	5	punct

1	Further	further	RB	_	5	advmod
2	,	,	,	_	5	punct
3	these	these	DT	_	4	det
4	results	result	NNS	_	5	nsubj
5	confirm	confirm	VBP	_	0	ROOT
6	that	that	IN	_	16	mark
7	the	the	DT	_	10	det
8	diabetic	diabetic	JJ	_	10	amod
9	Chinese	chinese	JJ	_	10	amod
10	hamster	hamster	NN	_	12	nmod:poss
11	's	's	POS	_	10	case
12	alpha	alpha	NN	_	16	nsubj
13	and	and	CC	_	12	cc
14	beta	beta	NN	_	15	compound
15	cells	cell	NNS	_	12	conj
16	respond	respond	VBP	_	5	ccomp
17	normally	normally	RB	_	16	advmod
18	to	to	TO	_	19	case
19	drug1	drug1	NN	_	16	nmod
20	,	,	,	_	16	punct
21	but	but	CC	_	16	cc
22	are	be	VBP	_	24	cop
23	relatively	relatively	RB	_	24	advmod
24	insensitive	insensitive	JJ	_	16	conj
25	to	to	TO	_	26	case
26	drug2	drug2	NN	_	24	nmod
27	.	.	.	_	5	punct

1	Interference	interference	NN	_	0	ROOT
2	of	of	IN	_	3	case
3	biocytin	biocytin	NN	_	1	nmod
4	with	with	IN	_	5	case
5	drug1	drug1	NN	_	1	nmod
6	-	-	:	_	1	punct
7	evoked	evoke	VBN	_	8	amod
8	hyperpolarization	hyperpolarization	NN	_	1	dep
9	and	and	CC	_	8	cc
10	membrane	membrane	NN	_	11	compound
11	properties	property	NNS	_	8	conj
12	of	of	IN	_	17	case
13	rat	rat	NN	_	17	compound
14	spinal	spinal	JJ	_	17	amod
15	substantia	substantia	NN	_	17	compound
16	gelatinosa	gelatinosa	NN	_	17	compound
17	neurons	neuron	NNS	_	8	nmod
18	.	.	.	_	1	punct

1	In	in	IN	_	3	case
2	our	we	PRP$	_	3	nmod:poss
3	laboratory	laboratory	NN	_	23	nmod
4	,	,	,	_	23	punct
5	preliminary	preliminary	JJ	_	10	amod
6	whole-cell	whole-cell	JJ	_	10	amod
7	,	,	,	_	10	punct
8	tight	tight	JJ	_	10	amod
9	seal	seal	NN	_	10	compound
10	recordings	recording	NNS	_	23	nsubj
11	of	of	IN	_	16	case
12	rat	rat	NN	_	16	compound
13	spinal	spinal	JJ	_	16	amod
14	substantia	substantia	NN	_	16	compound
15	gelatinosa	gelatinosa	NN	_	16	compound
16	neurons	neuron	NNS	_	10	nmod
17	including	include	VBG	_	18	case
18	biocytin	biocytin	NN	_	16	nmod
19	in	in	IN	_	22	case
20	the	the	DT	_	22	det
21	patch	patch	NN	_	22	compound
22	pipette	pipette	NN	_	18	nmod
23	yielded	yield	VBD	_	0	ROOT
24	a	a	DT	_	27	det
25	significantly	significantly	RB	_	26	advmod
26	smaller	smaller	JJR	_	27	amod
27	proportion	proportion	NN	_	23	dobj
28	of	of	IN	_	29	case
29	neurons	neuron	NNS	_	27	nmod
30	hyperpolarized	hyperpolarize	VBN	_	29	acl
31	by	by	IN	_	32	case
32	drug1	drug1	NN	_	30	nmod
33	compared	compare	VBN	_	35	case
34	with	with	IN	_	35	case
35	recordings	recording	NNS	_	23	advcl
36	without	without	IN	_	37	case
37	biocytin	biocytin	NN	_	35	nmod
38	.	.	.	_	23	punct

1	Therefore	therefore	RB	_	4	advmod
2	,	,	,	_	4	punct
3	we	we	PRP	_	4	nsubj
4	investigated	investigate	VBD	_	0	ROOT
5	the	the	DT	_	6	det
6	effects	effect	NNS	_	4	dobj
7	of	of	IN	_	9	case
8	biocytin	biocytin	NN	_	9	compound
9	inclusion	inclusion	NN	_	6	nmod
10	on	on	IN	_	12	case
11	drug1	drug1	NN	_	12	compound
12	responses	response	NNS	_	6	nmod
13	and	and	CC	_	12	cc
14	other	other	JJ	_	16	amod
15	membrane	membrane	NN	_	16	compound
16	properties	property	NNS	_	12	conj
17	during	during	IN	_	22	case
18	whole-cell	whole-cell	JJ	_	22	amod
19	,	,	,	_	22	punct
20	tight	tight	JJ	_	22	amod
21	seal	seal	NN	_	22	compound
22	recordings	recording	NNS	_	4	nmod
23	of	of	IN	_	25	case
24	these	these	DT	_	25	det
25	neurons	neuron	NNS	_	22	nmod
26	.	.	.	_	4	punct

1	The	the	DT	_	2	det
2	percentage	percentage	NN	_	15	nsubjpass
3	of	of	IN	_	4	case
4	neurons	neuron	NNS	_	2	nmod
5	hyperpolarized	hyperpolarize	VBN	_	4	acl
6	by	by	IN	_	7	case
7	drug1	drug1	NN	_	5	nmod
8	,	,	,	_	7	punct
9	drug2	drug2	NN	_	7	conj
10	,	,	,	_	7	punct
11	and	and	CC	_	7	cc
12	drug3	drug3	NN	_	7	conj
13	was	be	VBD	_	15	auxpass
14	significantly	significantly	RB	_	15	advmod
15	reduced	reduce	VBN	_	0	ROOT
16	when	when	WRB	_	15	dep
17	1	1	CD	_	18	nummod
18	%	%	NN	_	16	root
19	but	but	CC	_	18	cc
20	not	not	RB	_	21	neg
21	<	<	JJR	_	18	conj

1	or	or	CC	_	7	cc
2	=	=	JJ	_	5	amod
3	0.2	0.2	CD	_	4	compound
4	%	%	NN	_	5	amod
5	biocytin	biocytin	NN	_	7	nsubjpass
6	was	be	VBD	_	7	auxpass
7	included	include	VBN	_	0	ROOT
8	in	in	IN	_	11	case
9	the	the	DT	_	11	det
10	recording	recording	NN	_	11	compound
11	pipette	pipette	NN	_	7	nmod
12	,	,	,	_	7	punct
13	compared	compare	VBN	_	15	case
14	with	with	IN	_	15	case
15	neurons	neuron	NNS	_	7	advcl
16	recorded	record	VBN	_	15	acl
17	without	without	IN	_	18	case
18	biocytin	biocytin	NN	_	16	nmod
19	.	.	.	_	7	punct

1	However	however	RB	_	9	advmod
2	,	,	,	_	9	punct
3	a	a	DT	_	6	det
4	significantly	significantly	RB	_	5	advmod
5	higher	higher	JJR	_	6	amod
6	proportion	proportion	NN	_	9	nsubj
7	of	of	IN	_	8	case
8	neurons	neuron	NNS	_	6	nmod
9	fired	fire	VBD	_	0	ROOT
10	spontaneous	spontaneous	JJ	_	12	amod
11	action	action	NN	_	12	compound
12	potentials	potential	NNS	_	9	dobj
13	with	with	IN	_	16	case
14	either	either	CC	_	16	cc:preconj
15	0.05-0	0.05-0	CD	_	16	nummod
16	.2	.2	NN	_	9	nmod
17	or	or	CC	_	16	cc
18	1	1	CD	_	19	compound
19	%	%	NN	_	20	amod
20	biocytin	biocytin	NN	_	16	conj
21	compared	compare	VBN	_	24	case
22	to	to	TO	_	24	case
23	no	no	DT	_	24	neg
24	biocytin	biocytin	NN	_	9	advcl
25	.	.	.	_	9	punct

1	Resting	rest	VBG	_	3	amod
2	membrane	membrane	NN	_	3	compound
3	potential	potential	NN	_	19	nsubjpass
4	,	,	,	_	3	punct
5	input	input	NN	_	6	compound
6	impedance	impedance	NN	_	3	conj
7	and	and	CC	_	3	cc
8	the	the	DT	_	9	det
9	proportion	proportion	NN	_	3	conj
10	of	of	IN	_	11	case
11	neurons	neuron	NNS	_	9	nmod
12	displaying	display	VBG	_	11	acl
13	transient	transient	JJ	_	15	amod
14	outward	outward	JJ	_	15	amod
15	rectification	rectification	NN	_	12	dobj
16	were	be	VBD	_	19	auxpass
17	each	each	DT	_	19	dep
18	significantly	significantly	RB	_	19	advmod
19	altered	alter	VBN	_	0	ROOT
20	for	for	IN	_	21	case
21	neurons	neuron	NNS	_	19	nmod
22	recorded	record	VBN	_	21	acl
23	with	with	IN	_	25	case
24	1	1	CD	_	25	nummod
25	%	%	NN	_	22	nmod
26	but	but	CC	_	25	cc
27	not	not	RB	_	31	neg
28	0.05-0	0.05-0	CD	_	31	nummod
29	.2	.2	NN	_	31	compound
30	%	%	NN	_	31	compound
31	biocytin	biocytin	NN	_	25	conj
32	.	.	.	_	19	punct

1	These	these	DT	_	2	det
2	effects	effect	NNS	_	10	nsubj
3	may	may	MD	_	10	aux
4	be	be	VB	_	10	cop
5	due	due	JJ	_	10	case
6	to	to	TO	_	5	mwe
7	a	a	DT	_	10	det
8	relatively	relatively	RB	_	9	advmod
9	specific	specific	JJ	_	10	amod
10	blockade	blockade	NN	_	0	ROOT
11	of	of	IN	_	15	case
12	diverse	diverse	JJ	_	15	amod
13	potassium	potassium	NN	_	15	compound
14	channel	channel	NN	_	15	compound
15	types	type	NNS	_	10	nmod
16	.	.	.	_	10	punct

1	Because	because	IN	_	6	mark
2	efficient	efficient	JJ	_	3	amod
3	labeling	labeling	NN	_	6	nsubjpass
4	can	can	MD	_	6	aux
5	be	be	VB	_	6	auxpass
6	achieved	achieve	VBN	_	18	advcl
7	with	with	IN	_	10	case
8	0.1	0.1	CD	_	9	compound
9	%	%	NN	_	10	amod
10	biocytin	biocytin	NN	_	6	nmod
11	with	with	IN	_	13	case
12	whole-cell	whole-cell	JJ	_	13	amod
13	recording	recording	NN	_	10	nmod
14	,	,	,	_	18	punct
15	higher	higher	JJR	_	16	amod
16	concentrations	concentration	NNS	_	18	nsubjpass
17	are	be	VBP	_	18	auxpass
18	contraindicated	contraindicate	VBN	_	0	ROOT
19	.	.	.	_	18	punct

1	drug1	drug1	NN	_	0	ROOT
2	:	:	:	_	1	punct
3	in	in	FW	_	5	amod
4	vitro	vitro	FW	_	3	dep
5	evaluation	evaluation	NN	_	1	dep
6	of	of	IN	_	8	case
7	its	its	PRP$	_	8	nmod:poss
8	permeation	permeation	NN	_	5	nmod
9	enhancing	enhance	VBG	_	10	amod
10	effect	effect	NN	_	5	dep
11	on	on	IN	_	13	case
12	peptide	peptide	NN	_	13	compound
13	drugs	drug	NNS	_	10	nmod
14	.	.	.	_	1	punct

1	The	the	DT	_	2	det
2	purpose	purpose	NN	_	6	nsubj
3	of	of	IN	_	5	case
4	this	this	DT	_	5	det
5	study	study	NN	_	2	nmod
6	was	be	VBD	_	0	ROOT
7	to	to	TO	_	8	mark
8	evaluate	evaluate	VB	_	6	xcomp
9	the	the	DT	_	10	det
10	effect	effect	NN	_	8	dobj
11	of	of	IN	_	12	case
12	drug1	drug1	NN	_	10	nmod
13	-LRB-	-lrb-	-LRB-	_	14	punct
14	drug2	drug2	NN	_	12	appos
15	-RRB-	-rrb-	-RRB-	_	14	punct
16	and	and	CC	_	12	cc
17	drug3	drug3	NN	_	12	conj
18	-LRB-	-lrb-	-LRB-	_	19	punct
19	drug4	drug4	NN	_	17	appos
20	-RRB-	-rrb-	-RRB-	_	19	punct
21	conjugates	conjugate	VBZ	_	8	dep
22	on	on	IN	_	25	case
23	the	the	DT	_	25	det
24	intestinal	intestinal	JJ	_	25	amod
25	permeation	permeation	NN	_	21	nmod
26	of	of	IN	_	27	case
27	drug5	drug5	NN	_	25	nmod
28	-LRB-	-lrb-	-LRB-	_	29	punct
29	drug6	drug6	NN	_	27	appos
30	-RRB-	-rrb-	-RRB-	_	29	punct
31	and	and	CC	_	27	cc
32	model	model	NN	_	34	compound
33	peptide	peptide	NN	_	34	compound
34	drugs	drug	NNS	_	27	conj
35	,	,	,	_	27	punct
36	drug7	drug7	NN	_	27	conj
37	and	and	CC	_	27	cc
38	drug8	drug8	NN	_	27	conj
39	.	.	.	_	6	punct

1	drug1	drug1	NN	_	4	nsubjpass
2	was	be	VBD	_	4	auxpass
3	covalently	covalently	RB	_	4	advmod
4	linked	link	VBN	_	0	ROOT
5	to	to	TO	_	6	case
6	carbodiimide	carbodiimide	NN	_	4	nmod
7	activated	activate	VBD	_	8	amod
8	drug2	drug2	NN	_	6	dep
9	.	.	.	_	4	punct

1	Iodometric	iodometric	JJ	_	2	amod
2	titration	titration	NN	_	8	nsubjpass
3	of	of	IN	_	6	case
4	the	the	DT	_	6	det
5	polymer	polymer	NN	_	6	compound
6	conjugates	conjugate	NNS	_	2	nmod
7	was	be	VBD	_	8	auxpass
8	used	use	VBN	_	0	ROOT
9	to	to	TO	_	10	mark
10	determine	determine	VB	_	8	xcomp
11	the	the	DT	_	12	det
12	extent	extent	NN	_	10	dobj
13	of	of	IN	_	15	case
14	immobilised	immobilise	VBN	_	15	amod
15	drug1	drug1	NN	_	12	nmod
16	.	.	.	_	8	punct

1	Permeation	permeation	NN	_	2	compound
2	studies	study	NNS	_	4	nsubjpass
3	were	be	VBD	_	4	auxpass
4	performed	perform	VBN	_	0	ROOT
5	on	on	IN	_	10	case
6	guinea	guinea	NN	_	10	compound
7	pig	pig	NN	_	10	compound
8	small	small	JJ	_	10	amod
9	intestinal	intestinal	JJ	_	10	amod
10	mucosa	mucosa	NN	_	4	nmod
11	mounted	mount	VBD	_	4	dep
12	in	in	IN	_	14	case
13	Ussing-type	ussing-type	JJ	_	14	amod
14	chamber	chamber	NN	_	11	nmod
15	.	.	.	_	4	punct

1	Unmodified	unmodified	JJ	_	2	amod
2	drug1	drug1	NN	_	9	nsubj
3	-LRB-	-lrb-	-LRB-	_	6	punct
4	1	1	CD	_	5	compound
5	%	%	NN	_	6	amod
6	m/v	m/v	NN	_	2	appos
7	-RRB-	-rrb-	-RRB-	_	6	punct
8	significantly	significantly	RB	_	9	advmod
9	improved	improve	VBD	_	0	ROOT
10	the	the	DT	_	12	det
11	transport	transport	NN	_	12	compound
12	ratio	ratio	NN	_	9	dobj
13	-LRB-	-lrb-	-LRB-	_	38	punct
14	R	r	NN	_	38	compound
15	=	=	JJ	_	14	amod
16	P	p	NN	_	20	compound
17	-LRB-	-lrb-	-LRB-	_	18	punct
18	app	app	NN	_	16	appos
19	-RRB-	-rrb-	-RRB-	_	18	punct
20	polymer	polymer	NN	_	15	dep
21	/	/	:	_	26	punct
22	P	p	NN	_	26	compound
23	-LRB-	-lrb-	-LRB-	_	24	punct
24	app	app	NN	_	22	appos
25	-RRB-	-rrb-	-RRB-	_	24	punct
26	control	control	NN	_	14	appos
27	-RRB-	-rrb-	-RRB-	_	26	punct
28	of	of	IN	_	29	case
29	drug2	drug2	NN	_	14	nmod
30	to	to	TO	_	31	case
31	1.3	1.3	CD	_	29	nmod
32	and	and	CC	_	14	cc
33	1	1	CD	_	34	nummod
34	%	%	NN	_	14	conj
35	-LRB-	-lrb-	-LRB-	_	36	punct
36	m/v	m/v	NN	_	34	appos
37	-RRB-	-rrb-	-RRB-	_	36	punct
38	drug3	drug3	NN	_	43	nsubj
39	conjugated	conjugate	VBN	_	38	acl
40	with	with	IN	_	41	case
41	drug4	drug4	NN	_	39	nmod
42	further	further	RB	_	43	advmod
43	enhanced	enhance	VBD	_	12	acl:relcl
44	the	the	DT	_	45	det
45	permeation	permeation	NN	_	43	dobj
46	.	.	.	_	9	punct

1	drug1	drug1	NN	_	2	compound
2	conjugation	conjugation	NN	_	13	nsubj
3	at	at	IN	_	4	case
4	3.6	3.6	CD	_	2	nmod
5	,	,	,	_	4	punct
6	5.3	5.3	CD	_	4	conj
7	and	and	CC	_	4	cc
8	7.3	7.3	CD	_	9	nummod
9	%	%	NN	_	4	conj
10	-LRB-	-lrb-	-LRB-	_	11	punct
11	m/m	m/m	NN	_	9	appos
12	-RRB-	-rrb-	-RRB-	_	11	punct
13	resulted	result	VBD	_	0	ROOT
14	in	in	IN	_	15	case
15	R-values	r-value	NNS	_	13	nmod
16	of	of	IN	_	17	case
17	1.4	1.4	CD	_	15	nmod
18	,	,	,	_	17	punct
19	1.7	1.7	CD	_	17	conj
20	and	and	CC	_	17	cc
21	1.8	1.8	CD	_	17	conj
22	,	,	,	_	13	punct
23	respectively	respectively	RB	_	13	advmod
24	.	.	.	_	13	punct

1	Decreasing	decrease	VBG	_	0	ROOT
2	the	the	DT	_	3	det
3	concentration	concentration	NN	_	1	dobj
4	of	of	IN	_	5	case
5	drug1	drug1	NN	_	3	nmod
6	,	,	,	_	1	punct
7	exhibiting	exhibit	VBG	_	32	nsubj
8	7.3	7.3	CD	_	9	nummod
9	%	%	NN	_	7	dobj
10	-LRB-	-lrb-	-LRB-	_	11	punct
11	m/m	m/m	NN	_	9	appos
12	-RRB-	-rrb-	-RRB-	_	11	punct
13	of	of	IN	_	15	case
14	immobilised	immobilise	VBN	_	15	amod
15	drug2	drug2	NN	_	9	nmod
16	-LRB-	-lrb-	-LRB-	_	18	punct
17	CMC-Cys7	cmc-cys7	NN	_	18	compound
18	.3	.3	NN	_	15	appos
19	-RRB-	-rrb-	-RRB-	_	18	punct
20	from	from	IN	_	22	case
21	1	1	CD	_	22	nummod
22	%	%	NN	_	7	nmod
23	-LRB-	-lrb-	-LRB-	_	24	punct
24	m/v	m/v	NN	_	22	appos
25	-RRB-	-rrb-	-RRB-	_	24	punct
26	to	to	TO	_	28	case
27	0.5	0.5	CD	_	28	nummod
28	%	%	NN	_	7	nmod
29	-LRB-	-lrb-	-LRB-	_	30	punct
30	m/v	m/v	NN	_	28	appos
31	-RRB-	-rrb-	-RRB-	_	30	punct
32	decreased	decrease	VBD	_	1	advcl
33	the	the	DT	_	34	det
34	R-value	r-value	NN	_	32	dobj
35	of	of	IN	_	36	case
36	drug3	drug3	NN	_	34	nmod
37	from	from	IN	_	38	case
38	1.8	1.8	CD	_	32	nmod
39	to	to	TO	_	40	case
40	1.2	1.2	CD	_	38	nmod
41	.	.	.	_	1	punct

1	drug1	drug1	NN	_	14	nsubj
2	at	at	IN	_	4	case
3	1	1	CD	_	4	nummod
4	%	%	NN	_	1	nmod
5	-LRB-	-lrb-	-LRB-	_	6	punct
6	m/v	m/v	NN	_	4	appos
7	-RRB-	-rrb-	-RRB-	_	6	punct
8	in	in	IN	_	10	case
9	the	the	DT	_	10	det
10	presence	presence	NN	_	1	nmod
11	of	of	IN	_	13	case
12	free	free	JJ	_	13	amod
13	drug2	drug2	NN	_	10	nmod
14	had	have	VBD	_	0	ROOT
15	no	no	DT	_	17	neg
16	significant	significant	JJ	_	17	amod
17	effect	effect	NN	_	14	dobj
18	on	on	IN	_	20	case
19	the	the	DT	_	20	det
20	R-value	r-value	NN	_	14	nmod
21	of	of	IN	_	22	case
22	drug3	drug3	NN	_	20	nmod
23	compared	compare	VBN	_	25	case
24	to	to	TO	_	25	case
25	drug4	drug4	NN	_	14	advcl
26	alone	alone	RB	_	25	advmod
27	.	.	.	_	14	punct

1	Formulation	Formulation	NNP	_	19	nsubj
2	of	of	IN	_	5	case
3	fluorescence	fluorescence	NN	_	5	compound
4	labelled	label	VBN	_	5	amod
5	drug1	drug1	NN	_	1	nmod
6	and	and	CC	_	5	cc
7	drug2	drug2	NN	_	5	conj
8	in	in	IN	_	10	case
9	unconjugated	unconjugated	JJ	_	10	amod
10	drug3	drug3	NN	_	1	nmod
11	-LRB-	-lrb-	-LRB-	_	14	punct
12	1	1	CD	_	13	compound
13	%	%	NN	_	14	amod
14	m/v	m/v	NN	_	1	appos
15	-RRB-	-rrb-	-RRB-	_	14	punct
16	did	do	VBD	_	19	aux
17	not	not	RB	_	19	neg
18	significantly	significantly	RB	_	19	advmod
19	improve	improve	VB	_	0	ROOT
20	the	the	DT	_	21	det
21	permeation	permeation	NN	_	19	dobj
22	,	,	,	_	19	punct
23	however	however	RB	_	40	advmod
24	in	in	IN	_	26	case
25	the	the	DT	_	26	det
26	presence	presence	NN	_	40	nmod
27	of	of	IN	_	29	case
28	1	1	CD	_	29	nummod
29	%	%	NN	_	26	nmod
30	-LRB-	-lrb-	-LRB-	_	31	punct
31	m/v	m/v	NN	_	29	appos
32	-RRB-	-rrb-	-RRB-	_	31	punct
33	drug4	drug4	NN	_	29	dep
34	7.3	7.3	CD	_	33	nummod
35	a	a	DT	_	38	det
36	significantly	significantly	RB	_	37	advmod
37	improved	improve	VBN	_	38	amod
38	permeation	permeation	NN	_	40	nsubjpass
39	was	be	VBD	_	40	auxpass
40	observed	observe	VBN	_	19	advcl
41	-LRB-	-lrb-	-LRB-	_	42	punct
42	R	r	NN	_	40	dep
43	=	=	JJ	_	42	amod
44	1.3	1.3	CD	_	43	dep
45	-RRB-	-rrb-	-RRB-	_	42	punct
46	.	.	.	_	19	punct

1	Conjugation	conjugation	NN	_	8	nsubj
2	at	at	IN	_	3	case
3	drug1	drug1	NN	_	1	nmod
4	with	with	IN	_	6	case
5	drug2	drug2	NN	_	6	compound
6	moieties	moiety	NNS	_	3	nmod
7	significantly	significantly	RB	_	8	advmod
8	improves	improve	VBZ	_	0	ROOT
9	the	the	DT	_	11	det
10	intestinal	intestinal	JJ	_	11	amod
11	permeation	permeation	NN	_	8	dobj
12	of	of	IN	_	16	case
13	the	the	DT	_	16	det
14	hydrophilic	hydrophilic	JJ	_	16	amod
15	molecule	molecule	NN	_	16	compound
16	drug3	drug3	NN	_	11	nmod
17	and	and	CC	_	11	cc
18	the	the	DT	_	21	det
19	model	model	NN	_	21	compound
20	peptide	peptide	NN	_	21	compound
21	drugs	drug	NNS	_	11	conj
22	drug4	drug4	NN	_	21	dep
23	and	and	CC	_	22	cc
24	drug5	drug5	NN	_	22	conj
25	in	in	FW	_	26	compound
26	vitro	vitro	FW	_	8	advmod
27	,	,	,	_	8	punct
28	therefore	therefore	RB	_	31	advmod
29	this	this	DT	_	31	det
30	conjugated	conjugate	VBN	_	31	amod
31	system	system	NN	_	8	dobj
32	maybe	maybe	RB	_	33	advmod
33	useful	useful	JJ	_	31	amod
34	for	for	IN	_	36	case
35	peroral	peroral	JJ	_	36	amod
36	administration	administration	NN	_	33	nmod
37	of	of	IN	_	39	case
38	peptide	peptide	NN	_	39	compound
39	drugs	drug	NNS	_	36	nmod
40	in	in	IN	_	42	case
41	the	the	DT	_	42	det
42	future	future	NN	_	33	nmod
43	.	.	.	_	8	punct

1	Effects	effect	NNS	_	0	ROOT
2	of	of	IN	_	4	case
3	low	low	JJ	_	4	amod
4	temperatures	temperature	NNS	_	1	nmod
5	on	on	IN	_	6	case
6	microtubules	microtubule	NNS	_	1	nmod
7	in	in	IN	_	10	case
8	the	the	DT	_	10	det
9	non-myelinated	non-myelinated	JJ	_	10	amod
10	axons	axon	NNS	_	6	nmod
11	of	of	IN	_	14	case
12	post-ganglionic	post-ganglionic	JJ	_	14	amod
13	sympathetic	sympathetic	JJ	_	14	amod
14	nerves	nerve	NNS	_	10	nmod
15	.	.	.	_	1	punct

1	The	the	DT	_	2	det
2	effect	effect	NN	_	16	nsubjpass
3	of	of	IN	_	5	case
4	temperature	temperature	NN	_	5	compound
5	changes	change	NNS	_	2	nmod
6	on	on	IN	_	8	case
7	the	the	DT	_	8	det
8	number	number	NN	_	5	nmod
9	of	of	IN	_	10	case
10	microtubules	microtubule	NNS	_	8	nmod
11	in	in	IN	_	13	case
12	non-myelinated	non-myelinated	JJ	_	13	amod
13	axons	axon	NNS	_	8	nmod
14	has	have	VBZ	_	16	aux
15	been	be	VBN	_	16	auxpass
16	studied	study	VBN	_	0	ROOT
17	in	in	IN	_	23	case
18	cat	cat	NN	_	23	compound
19	inferior	inferior	JJ	_	23	amod
20	mesenteric	mesenteric	JJ	_	23	amod
21	ganglion/hypogastric	ganglion/hypogastric	JJ	_	23	amod
22	nerve	nerve	NN	_	23	compound
23	preparations	preparation	NNS	_	16	nmod
24	incubated	incubate	VBN	_	23	acl
25	at	at	IN	_	27	case
26	various	various	JJ	_	27	amod
27	temperatures	temperature	NNS	_	24	nmod
28	in	in	IN	_	34	case
29	Eagles	Eagles	NNPS	_	34	compound
30	minimal	minimal	JJ	_	34	amod
31	essential	essential	JJ	_	34	amod
32	tissue	tissue	NN	_	34	compound
33	culture	culture	NN	_	34	compound
34	medium	medium	NN	_	27	nmod
35	in	in	FW	_	36	compound
36	vitro	vitro	FW	_	24	advmod
37	.	.	.	_	16	punct

1	At	at	IN	_	4	case
2	37	37	CD	_	4	nummod
3	degrees	degree	NNS	_	4	compound
4	C	c	NN	_	8	nmod
5	the	the	DT	_	7	det
6	non-myelinated	non-myelinated	JJ	_	7	amod
7	axons	axon	NNS	_	8	nsubj
8	contained	contain	VBD	_	0	ROOT
9	28.4	28.4	CD	_	14	nummod
10	plus	plus	CC	_	9	cc
11	or	or	CC	_	9	cc
12	minus	minus	CC	_	13	advmod
13	0.8	0.8	CD	_	9	conj
14	S.E.M.	s.e.m.	NN	_	8	dobj

1	-LRB-	-lrb-	-LRB-	_	4	punct
2	54	54	CD	_	4	nummod
3	-RRB-	-rrb-	-RRB-	_	4	punct
4	microtubules	microtubule	NNS	_	0	ROOT
5	per	per	IN	_	6	case
6	axon	axon	NN	_	4	nmod
7	.	.	.	_	4	punct

1	After	after	IN	_	2	case
2	incubation	incubation	NN	_	12	nmod
3	at	at	IN	_	6	case
4	0	0	CD	_	6	nummod
5	degrees	degree	NNS	_	6	compound
6	C	c	NN	_	2	nmod
7	for	for	IN	_	9	case
8	4	4	CD	_	9	nummod
9	h	h	NN	_	2	nmod
10	this	this	DT	_	11	det
11	number	number	NN	_	12	nsubj
12	fell	fall	VBD	_	0	ROOT
13	to	to	TO	_	14	case
14	2.3	2.3	CD	_	12	nmod
15	plus	plus	CC	_	14	cc
16	or	or	CC	_	14	cc
17	minus	minus	CC	_	18	advmod
18	0.1	0.1	CD	_	14	conj
19	S.E.M.	s.e.m.	NN	_	14	dep

1	-LRB-	-lrb-	-LRB-	_	2	punct
2	41	41	CD	_	0	ROOT
3	-RRB-	-rrb-	-RRB-	_	2	punct
4	but	but	CC	_	2	cc
5	returned	return	VBD	_	2	conj
6	to	to	TO	_	8	case
7	normal	normal	JJ	_	8	amod
8	levels	level	NNS	_	5	nmod
9	when	when	WRB	_	13	advmod
10	the	the	DT	_	11	det
11	nerves	nerve	NNS	_	13	nsubjpass
12	were	be	VBD	_	13	auxpass
13	rewarmed	rewarm	VBN	_	5	advcl
14	.	.	.	_	2	punct

1	This	this	DT	_	2	det
2	loss	loss	NN	_	17	nsubj
3	of	of	IN	_	4	case
4	microtubules	microtubule	NNS	_	2	nmod
5	on	on	IN	_	6	mark
6	cooling	cool	VBG	_	2	acl
7	the	the	DT	_	8	det
8	nerves	nerve	NNS	_	6	dobj
9	and	and	CC	_	8	cc
10	their	they	PRP$	_	11	nmod:poss
11	reappearance	reappearance	NN	_	8	conj
12	on	on	IN	_	13	case
13	rewarming	rewarm	VBG	_	6	nmod
14	was	be	VBD	_	17	cop
15	a	a	DT	_	17	det
16	rapid	rapid	JJ	_	17	amod
17	process	process	NN	_	0	ROOT
18	;	;	:	_	17	punct

1	it	it	PRP	_	3	nsubj
2	was	be	VBD	_	3	cop
3	independent	independent	JJ	_	0	ROOT
4	of	of	IN	_	6	case
5	the	the	DT	_	6	det
6	influence	influence	NN	_	3	nmod
7	of	of	IN	_	11	case
8	the	the	DT	_	11	det
9	nueronal	nueronal	JJ	_	11	amod
10	cell	cell	NN	_	11	compound
11	body	body	NN	_	6	nmod
12	and	and	CC	_	11	cc
13	of	of	IN	_	15	case
14	protein	protein	NN	_	15	compound
15	synthesis	synthesis	NN	_	11	conj
16	within	within	IN	_	18	case
17	the	the	DT	_	18	det
18	axon	axon	NN	_	6	nmod
19	.	.	.	_	3	punct

1	The	the	DT	_	2	det
2	preservation	preservation	NN	_	7	nsubjpass
3	of	of	IN	_	5	case
4	the	the	DT	_	5	det
5	microtubules	microtubule	NNS	_	2	nmod
6	was	be	VBD	_	7	auxpass
7	improved	improve	VBN	_	0	ROOT
8	when	when	WRB	_	11	advmod
9	D2O	d2o	NN	_	11	nsubj
10	was	be	VBD	_	11	cop
11	present	present	JJ	_	7	advcl
12	in	in	IN	_	15	case
13	the	the	DT	_	15	det
14	incubation	incubation	NN	_	15	compound
15	medium	medium	NN	_	11	nmod
16	.	.	.	_	7	punct

1	Reformed	Reformed	NNP	_	2	compound
2	microtubules	microtubule	NNS	_	3	nsubj
3	appeared	appear	VBD	_	0	ROOT
4	to	to	TO	_	5	mark
5	function	function	VB	_	3	xcomp
6	normally	normally	RB	_	5	advmod
7	with	with	IN	_	8	case
8	respect	respect	NN	_	5	nmod
9	to	to	TO	_	12	case
10	their	they	PRP$	_	12	nmod:poss
11	possible	possible	JJ	_	12	amod
12	role	role	NN	_	8	nmod
13	in	in	IN	_	15	case
14	the	the	DT	_	15	det
15	transport	transport	NN	_	12	nmod
16	of	of	IN	_	19	case
17	noradrenaline	noradrenaline	NN	_	19	compound
18	storage	storage	NN	_	19	compound
19	vesicles	vesicle	NNS	_	15	nmod
20	along	along	IN	_	22	case
21	the	the	DT	_	22	det
22	axons	axon	NNS	_	12	nmod
23	.	.	.	_	3	punct

1	The	the	DT	_	2	det
2	drug1	drug1	NN	_	0	ROOT
3	for	for	IN	_	6	case
4	urinary	urinary	JJ	_	6	amod
5	tract	tract	NN	_	6	compound
6	infections	infection	NNS	_	2	nmod
7	:	:	:	_	2	punct
8	a	a	DT	_	9	det
9	review	review	NN	_	2	dep
10	.	.	.	_	2	punct

1	The	the	DT	_	2	det
2	drug1	drug1	NN	_	7	nsubj
3	are	be	VBP	_	7	cop
4	a	a	DT	_	7	det
5	rapidly	rapidly	RB	_	6	advmod
6	growing	grow	VBG	_	7	amod
7	class	class	NN	_	0	ROOT
8	of	of	IN	_	9	case
9	drug2	drug2	NN	_	7	nmod
10	with	with	IN	_	13	case
11	a	a	DT	_	13	det
12	broad	broad	JJ	_	13	amod
13	spectrum	spectrum	NN	_	7	nmod
14	of	of	IN	_	15	case
15	activity	activity	NN	_	13	nmod
16	against	against	IN	_	17	case
17	gram-negative	gram-negative	JJ	_	15	nmod
18	and	and	CC	_	17	cc
19	some	some	DT	_	22	det
20	gram-positive	gram-positive	JJ	_	22	amod
21	aerobic	aerobic	JJ	_	22	amod
22	bacteria	bacterium	NNS	_	17	conj
23	.	.	.	_	7	punct

1	These	these	DT	_	2	det
2	agents	agent	NNS	_	19	nsubjpass
3	,	,	,	_	2	punct
4	including	include	VBG	_	5	case
5	drug1	drug1	NN	_	2	nmod
6	,	,	,	_	5	punct
7	drug2	drug2	NN	_	5	conj
8	,	,	,	_	5	punct
9	drug3	drug3	NN	_	5	conj
10	,	,	,	_	5	punct
11	drug4	drug4	NN	_	5	conj
12	,	,	,	_	5	punct
13	and	and	CC	_	5	cc
14	drug5	drug5	NN	_	5	conj
15	,	,	,	_	2	punct
16	have	have	VBP	_	19	aux
17	been	be	VBN	_	19	auxpass
18	extensively	extensively	RB	_	19	advmod
19	studied	study	VBN	_	0	ROOT
20	and	and	CC	_	19	cc
21	have	have	VBP	_	22	aux
22	demonstrated	demonstrate	VBN	_	19	conj
23	efficacy	efficacy	NN	_	26	compound
24	and	and	CC	_	23	cc
25	safety	safety	NN	_	23	conj
26	profiles	profile	NNS	_	22	dobj
27	comparable	comparable	JJ	_	26	amod
28	to	to	TO	_	29	case
29	those	those	DT	_	27	nmod
30	of	of	IN	_	33	case
31	other	other	JJ	_	33	amod
32	traditional	traditional	JJ	_	33	amod
33	agents	agent	NNS	_	29	nmod
34	for	for	IN	_	36	case
35	the	the	DT	_	36	det
36	treatment	treatment	NN	_	29	nmod
37	of	of	IN	_	43	case
38	complicated	complicated	JJ	_	43	amod
39	or	or	CC	_	38	cc
40	uncomplicated	uncomplicated	JJ	_	38	conj
41	urinary	urinary	JJ	_	43	amod
42	tract	tract	NN	_	43	compound
43	infections	infection	NNS	_	36	nmod
44	and	and	CC	_	43	cc
45	prostatitis	prostatitis	NN	_	43	conj
46	.	.	.	_	19	punct

1	Advantages	advantage	NNS	_	8	nsubj
2	offered	offer	VBN	_	1	acl
3	by	by	IN	_	5	case
4	this	this	DT	_	5	det
5	class	class	NN	_	2	nmod
6	of	of	IN	_	7	case
7	drug1	drug1	NN	_	5	nmod
8	include	include	VBP	_	0	ROOT
9	optimal	optimal	JJ	_	10	amod
10	pharmacokinetics	pharmacokinetic	NNS	_	8	dobj
11	,	,	,	_	10	punct
12	effectiveness	effectiveness	NN	_	10	conj
13	against	against	IN	_	15	case
14	multidrug-resistant	multidrug-resistant	JJ	_	15	amod
15	organisms	organism	NNS	_	12	nmod
16	,	,	,	_	10	punct
17	and	and	CC	_	10	cc
18	oral	oral	JJ	_	19	amod
19	administration	administration	NN	_	10	conj
20	even	even	RB	_	21	advmod
21	when	when	WRB	_	26	advmod
22	parenteral	parenteral	JJ	_	23	amod
23	drug2	drug2	NN	_	26	nsubjpass
24	are	be	VBP	_	26	auxpass
25	generally	generally	RB	_	26	advmod
26	used	use	VBN	_	8	advcl
27	.	.	.	_	8	punct

1	The	the	DT	_	2	det
2	drug1	drug1	NN	_	6	nsubjpass
3	are	be	VBP	_	6	auxpass
4	also	also	RB	_	6	advmod
5	extensively	extensively	RB	_	6	advmod
6	used	use	VBN	_	0	ROOT
7	in	in	IN	_	9	case
8	urologic	urologic	JJ	_	9	amod
9	surgery	surgery	NN	_	6	nmod
10	.	.	.	_	6	punct

1	If	if	IN	_	2	mark
2	taken	take	VBN	_	14	advcl
3	1	1	CD	_	4	nummod
4	hour	hour	NN	_	2	nmod
5	before	before	IN	_	4	case
6	drug1	drug1	NN	_	4	dep
7	-LRB-	-lrb-	-LRB-	_	8	punct
8	drug2	drug2	NN	_	6	appos
9	-RRB-	-rrb-	-RRB-	_	8	punct
10	,	,	,	_	14	punct
11	drug3	drug3	NN	_	14	nsubj
12	does	do	VBZ	_	14	aux
13	not	not	RB	_	14	neg
14	affect	affect	VB	_	0	ROOT
15	drug4	drug4	NN	_	16	compound
16	exposure	exposure	NN	_	14	dobj
17	,	,	,	_	14	punct
18	despite	despite	IN	_	21	case
19	persistent	persistent	JJ	_	21	amod
20	buffering	buffering	NN	_	21	compound
21	effects	effect	NNS	_	14	nmod
22	.	.	.	_	14	punct

1	Concurrent	concurrent	JJ	_	2	amod
2	administration	administration	NN	_	8	nsubj
3	of	of	IN	_	4	case
4	drug1	drug1	NN	_	2	nmod
5	and	and	CC	_	4	cc
6	drug2	drug2	NN	_	4	conj
7	significantly	significantly	RB	_	8	advmod
8	reduces	reduce	VBZ	_	0	ROOT
9	the	the	DT	_	10	det
10	level	level	NN	_	8	dobj
11	of	of	IN	_	12	case
12	exposure	exposure	NN	_	10	nmod
13	to	to	TO	_	14	case
14	drug3	drug3	NN	_	12	nmod
15	,	,	,	_	8	punct
16	but	but	CC	_	8	cc
17	it	it	PRP	_	19	nsubj
18	is	be	VBZ	_	19	cop
19	unclear	unclear	JJ	_	8	conj
20	how	how	WRB	_	21	advmod
21	soon	soon	RB	_	28	advmod
22	after	after	IN	_	28	mark
23	drug4	drug4	NN	_	25	compound
24	administration	administration	NN	_	25	compound
25	drug5	drug5	NN	_	28	nsubjpass
26	may	may	MD	_	28	aux
27	be	be	VB	_	28	auxpass
28	given	give	VBN	_	19	advcl
29	safely	safely	RB	_	28	advmod
30	.	.	.	_	8	punct

1	We	we	PRP	_	2	nsubj
2	compared	compare	VBD	_	0	ROOT
3	drug1	drug1	NN	_	4	compound
4	pharmacokinetics	pharmacokinetic	NNS	_	2	dobj
5	and	and	CC	_	4	cc
6	gastric	gastric	JJ	_	7	amod
7	pH	ph	NN	_	4	conj
8	in	in	IN	_	13	case
9	12	12	CD	_	13	nummod
10	human	human	JJ	_	13	amod
11	immunodeficiency	immunodeficiency	NN	_	13	compound
12	virus-positive	virus-positive	JJ	_	13	amod
13	patients	patient	NNS	_	4	nmod
14	by	by	IN	_	15	case
15	use	use	NN	_	2	nmod
16	of	of	IN	_	18	case
17	800	800	CD	_	18	nummod
18	mg	mg	NN	_	15	nmod
19	of	of	IN	_	20	case
20	drug2	drug2	NN	_	18	nmod
21	alone	alone	RB	_	20	advmod
22	versus	versus	CC	_	18	cc
23	800	800	CD	_	24	nummod
24	mg	mg	NN	_	18	conj
25	of	of	IN	_	26	case
26	drug3	drug3	NN	_	24	nmod
27	administered	administer	VBN	_	18	acl
28	1	1	CD	_	29	nummod
29	h	h	NN	_	27	nmod
30	after	after	IN	_	29	case
31	drug4	drug4	NN	_	32	compound
32	administration	administration	NN	_	29	dep
33	.	.	.	_	2	punct

1	Median	median	JJ	_	3	amod
2	gastric	gastric	JJ	_	3	amod
3	pH	ph	NN	_	6	nsubj
4	was	be	VBD	_	6	cop
5	significantly	significantly	RB	_	6	advmod
6	higher	higher	JJR	_	0	ROOT
7	when	when	WRB	_	10	advmod
8	drug1	drug1	NN	_	10	nsubjpass
9	was	be	VBD	_	10	auxpass
10	taken	take	VBN	_	6	advcl
11	after	after	IN	_	13	case
12	drug2	drug2	NN	_	13	compound
13	administration	administration	NN	_	10	nmod
14	;	;	:	_	6	punct

1	however	however	RB	_	26	advmod
2	,	,	,	_	26	punct
3	no	no	DT	_	5	neg
4	significant	significant	JJ	_	5	amod
5	difference	difference	NN	_	26	nsubjpass
6	in	in	IN	_	9	case
7	the	the	DT	_	9	det
8	maximum	maximum	NN	_	9	compound
9	concentration	concentration	NN	_	5	nmod
10	in	in	IN	_	11	case
11	plasma	plasma	NN	_	9	nmod
12	or	or	CC	_	11	cc
13	the	the	DT	_	14	det
14	area	area	NN	_	11	conj
15	under	under	IN	_	18	case
16	the	the	DT	_	18	det
17	concentration-time	concentration-time	JJ	_	18	amod
18	curve	curve	NN	_	5	nmod
19	from	from	IN	_	20	case
20	time	time	NN	_	18	nmod
21	zero	zero	CD	_	20	nummod
22	to	to	TO	_	24	case
23	8	8	CD	_	24	nummod
24	h	h	NN	_	20	nmod
25	was	be	VBD	_	26	auxpass
26	observed	observe	VBN	_	0	ROOT
27	.	.	.	_	26	punct

1	drug1	drug1	NN	_	4	nsubjpass
2	may	may	MD	_	4	aux
3	be	be	VB	_	4	auxpass
4	taken	take	VBN	_	0	ROOT
5	with	with	IN	_	10	case
6	a	a	DT	_	10	det
7	light	light	JJ	_	10	amod
8	meal	meal	NN	_	10	compound
9	1	1	CD	_	10	nummod
10	h	h	NN	_	4	nmod
11	following	follow	VBG	_	13	case
12	the	the	DT	_	13	det
13	administration	administration	NN	_	10	nmod
14	of	of	IN	_	16	case
15	400	400	CD	_	16	nummod
16	mg	mg	NN	_	13	nmod
17	of	of	IN	_	18	case
18	drug2	drug2	NN	_	16	nmod
19	.	.	.	_	4	punct

1	Progestin-only	progestin-only	RB	_	2	advmod
2	oral	oral	JJ	_	3	amod
3	contraception	contraception	NN	_	0	ROOT
4	:	:	:	_	3	punct
5	a	a	DT	_	7	det
6	comprehensive	comprehensive	JJ	_	7	amod
7	review	review	NN	_	3	dep
8	.	.	.	_	3	punct

1	In	in	IN	_	4	mark
2	order	order	NN	_	1	mwe
3	to	to	TO	_	4	mark
4	provide	provide	VB	_	0	ROOT
5	information	information	NN	_	4	dobj
6	for	for	IN	_	11	case
7	the	the	DT	_	11	det
8	appropriate	appropriate	JJ	_	11	amod
9	package	package	NN	_	11	compound
10	insert	insert	NN	_	11	compound
11	labeling	labeling	NN	_	5	nmod
12	of	of	IN	_	13	case
13	drug1	drug1	NN	_	11	nmod
14	-LRB-	-lrb-	-LRB-	_	15	punct
15	drug2	drug2	NN	_	13	appos
16	-RRB-	-rrb-	-RRB-	_	15	punct
17	in	in	IN	_	19	case
18	the	the	DT	_	19	det
19	US	US	NNP	_	11	nmod
20	,	,	,	_	11	punct
21	a	a	DT	_	23	det
22	comprehensive	comprehensive	JJ	_	23	amod
23	review	review	NN	_	25	nsubjpass
24	was	be	VBD	_	25	auxpass
25	made	make	VBN	_	11	acl:relcl
26	of	of	IN	_	27	case
27	drug3	drug3	NN	_	25	nmod
28	-LRB-	-lrb-	-LRB-	_	30	punct
29	0.075	0.075	CD	_	30	nummod
30	mg	mg	NN	_	27	appos
31	-RRB-	-rrb-	-RRB-	_	30	punct
32	and	and	CC	_	27	cc
33	drug4	drug4	NN	_	27	conj
34	-LRB-	-lrb-	-LRB-	_	36	punct
35	0.35	0.35	CD	_	36	nummod
36	mg	mg	NN	_	33	appos
37	-RRB-	-rrb-	-RRB-	_	36	punct
38	,	,	,	_	11	punct
39	with	with	IN	_	42	case
40	the	the	DT	_	42	det
41	clinical	clinical	JJ	_	42	amod
42	differences	difference	NNS	_	11	nmod
43	indicated	indicate	VBD	_	42	acl
44	where	where	WRB	_	45	advmod
45	applicable	applicable	JJ	_	43	advcl
46	.	.	.	_	4	punct

1	The	the	DT	_	2	det
2	goal	goal	NN	_	6	nsubj
3	of	of	IN	_	5	case
4	this	this	DT	_	5	det
5	review	review	NN	_	2	nmod
6	was	be	VBD	_	0	ROOT
7	to	to	TO	_	8	mark
8	cite	cite	VB	_	6	xcomp
9	primary	primary	JJ	_	10	amod
10	sources	source	NNS	_	8	dobj
11	for	for	IN	_	10	acl
12	virtually	virtually	RB	_	13	advmod
13	all	all	DT	_	11	nmod
14	research	research	NN	_	13	dep
15	specific	specific	JJ	_	14	amod
16	to	to	TO	_	17	case
17	POPs	pop	NNS	_	15	nmod
18	since	since	IN	_	19	case
19	1975	1975	CD	_	14	nmod
20	.	.	.	_	6	punct

1	Conclusions	conclusion	NNS	_	12	nsubjpass
2	and	and	CC	_	1	cc
3	the	the	DT	_	4	det
4	types	type	NNS	_	1	conj
5	of	of	IN	_	6	case
6	studies	study	NNS	_	4	nmod
7	which	which	WDT	_	8	nsubj
8	support	support	VBP	_	4	acl:relcl
9	these	these	DT	_	10	det
10	conclusions	conclusion	NNS	_	8	dobj
11	are	be	VBP	_	12	auxpass
12	given	give	VBN	_	0	ROOT
13	for	for	IN	_	16	case
14	each	each	DT	_	16	det
15	major	major	JJ	_	16	amod
16	section	section	NN	_	12	nmod
17	.	.	.	_	12	punct

1	The	the	DT	_	3	det
2	introductory	introductory	JJ	_	3	amod
3	chapter	chapter	NN	_	4	nsubj
4	discusses	discuss	VBZ	_	0	ROOT
5	the	the	DT	_	6	det
6	advantages	advantage	NNS	_	4	dobj
7	and	and	CC	_	6	cc
8	disadvantages	disadvantage	NNS	_	6	conj
9	of	of	IN	_	10	case
10	drug1	drug1	NN	_	6	nmod
11	and	and	CC	_	10	cc
12	the	the	DT	_	13	det
13	magnitude	magnitude	NN	_	10	conj
14	and	and	CC	_	13	cc
15	prevalence	prevalence	NN	_	13	conj
16	of	of	IN	_	18	case
17	their	they	PRP$	_	18	nmod:poss
18	use	use	NN	_	13	nmod
19	.	.	.	_	4	punct

1	Future	future	JJ	_	2	amod
2	trends	trend	NNS	_	5	nsubjpass
3	are	be	VBP	_	5	auxpass
4	also	also	RB	_	5	advmod
5	predicted	predict	VBN	_	0	ROOT
6	.	.	.	_	5	punct

1	Chapter	chapter	NN	_	3	nsubj
2	2	2	CD	_	1	nummod
3	considers	consider	VBZ	_	0	ROOT
4	the	the	DT	_	5	det
5	mode	mode	NN	_	3	dobj
6	of	of	IN	_	7	case
7	action	action	NN	_	5	nmod
8	,	,	,	_	5	punct
9	including	include	VBG	_	11	case
10	ovulation	ovulation	NN	_	11	compound
11	prevention	prevention	NN	_	5	nmod
12	;	;	:	_	3	punct

1	suppression	suppression	NN	_	5	nsubj
2	of	of	IN	_	4	case
3	midcycle	midcycle	NN	_	4	compound
4	gonadotropin	gonadotropin	NN	_	1	nmod
5	peaks	peak	VBZ	_	0	ROOT
6	;	;	:	_	5	punct

1	changes	change	NNS	_	0	ROOT
2	in	in	IN	_	4	case
3	cervical	cervical	JJ	_	4	amod
4	mucus	mucus	NN	_	1	nmod
5	,	,	,	_	1	punct
6	the	the	DT	_	7	det
7	endometrium	endometrium	NN	_	1	conj
8	,	,	,	_	1	punct
9	and	and	CC	_	1	cc
10	the	the	DT	_	12	det
11	fallopian	fallopian	JJ	_	12	amod
12	tubes	tube	NNS	_	1	conj
13	;	;	:	_	1	punct

1	and	and	CC	_	3	cc
2	clinical	clinical	JJ	_	3	amod
3	implications	implication	NNS	_	0	ROOT
4	.	.	.	_	3	punct

1	Chapter	chapter	NN	_	3	nsubj
2	3	3	CD	_	1	nummod
3	covers	cover	VBZ	_	0	ROOT
4	pharmacology	pharmacology	NN	_	3	dobj
5	-LRB-	-lrb-	-LRB-	_	6	punct
6	pharmacokinetics	pharmacokinetic	NNS	_	4	dep
7	,	,	,	_	6	punct
8	pharmacodynamics	pharmacodynamic	NNS	_	6	conj
9	and	and	CC	_	6	cc
10	potency	potency	NN	_	6	conj
11	,	,	,	_	6	punct
12	and	and	CC	_	6	cc
13	clinical	clinical	JJ	_	14	amod
14	implications	implication	NNS	_	6	conj
15	-RRB-	-rrb-	-RRB-	_	6	punct
16	.	.	.	_	3	punct

1	The	the	DT	_	3	det
2	next	next	JJ	_	3	amod
3	chapter	chapter	NN	_	4	nsubj
4	presents	present	VBZ	_	0	ROOT
5	information	information	NN	_	4	dobj
6	on	on	IN	_	7	case
7	efficacy	efficacy	NN	_	5	nmod
8	and	and	CC	_	7	cc
9	pregnancy	pregnancy	NN	_	10	compound
10	outcomes	outcome	NNS	_	7	conj
11	in	in	IN	_	12	case
12	terms	term	NNS	_	5	nmod
13	of	of	IN	_	15	case
14	pregnancy	pregnancy	NN	_	15	compound
15	rates	rate	NNS	_	12	nmod
16	,	,	,	_	15	punct
17	compliance	compliance	NN	_	15	conj
18	and	and	CC	_	15	cc
19	efficacy	efficacy	NN	_	15	conj
20	,	,	,	_	19	punct
21	ectopic	ectopic	JJ	_	22	amod
22	pregnancies	pregnancy	NNS	_	19	conj
23	,	,	,	_	19	punct
24	the	the	DT	_	25	det
25	outcome	outcome	NN	_	19	conj
26	of	of	IN	_	27	case
27	pregnancies	pregnancy	NNS	_	25	nmod
28	conceived	conceive	VBN	_	25	acl
29	while	while	IN	_	30	mark
30	using	use	VBG	_	28	advcl
31	drug1	drug1	NN	_	30	dobj
32	,	,	,	_	19	punct
33	and	and	CC	_	19	cc
34	fertility	fertility	NN	_	19	conj
35	following	follow	VBG	_	36	case
36	discontinuation	discontinuation	NN	_	4	nmod
37	.	.	.	_	4	punct

1	Chapter	Chapter	NNP	_	3	nsubj
2	5	5	CD	_	1	nummod
3	focuses	focus	VBZ	_	0	ROOT
4	on	on	IN	_	6	case
5	metabolic	metabolic	JJ	_	6	amod
6	effects	effect	NNS	_	3	nmod
7	,	,	,	_	6	punct
8	specifically	specifically	RB	_	10	advmod
9	lipid	lipid	NN	_	10	compound
10	metabolism	metabolism	NN	_	6	appos
11	,	,	,	_	10	punct
12	carbohydrate	carbohydrate	NN	_	13	compound
13	metabolism	metabolism	NN	_	10	conj
14	and	and	CC	_	10	cc
15	diabetes	diabetes	NN	_	10	conj
16	,	,	,	_	6	punct
17	coagulation	coagulation	NN	_	18	compound
18	factors	factor	NNS	_	6	conj
19	,	,	,	_	6	punct
20	and	and	CC	_	6	cc
21	blood	blood	NN	_	22	compound
22	pressure	pressure	NN	_	6	conj
23	.	.	.	_	3	punct

1	Cardiovascular	Cardiovascular	NNP	_	2	compound
2	disease	disease	NN	_	4	nsubjpass
3	is	be	VBZ	_	4	auxpass
4	considered	consider	VBN	_	0	ROOT
5	in	in	IN	_	8	case
6	the	the	DT	_	8	det
7	next	next	JJ	_	8	amod
8	chapter	chapter	NN	_	4	nmod
9	,	,	,	_	4	punct
10	and	and	CC	_	4	cc
11	chapter	chapter	NN	_	13	nsubj
12	7	7	CD	_	11	nummod
13	presents	present	VBZ	_	4	conj
14	findings	finding	NNS	_	13	dobj
15	on	on	IN	_	26	case
16	endometrial	endometrial	JJ	_	26	amod
17	,	,	,	_	16	punct
18	ovarian	ovarian	JJ	_	16	conj
19	,	,	,	_	16	punct
20	cervical	cervical	JJ	_	16	conj
21	,	,	,	_	16	punct
22	breast	breast	NN	_	16	conj
23	,	,	,	_	16	punct
24	and	and	CC	_	16	cc
25	other	other	JJ	_	16	conj
26	cancers	cancer	NNS	_	14	nmod
27	.	.	.	_	4	punct

1	A	a	DT	_	2	det
2	host	host	NN	_	8	nsubjpass
3	of	of	IN	_	6	case
4	other	other	JJ	_	6	amod
5	medical	medical	JJ	_	6	amod
6	considerations	consideration	NNS	_	2	nmod
7	are	be	VBP	_	8	auxpass
8	discussed	discuss	VBN	_	0	ROOT
9	in	in	IN	_	10	case
10	chapter	chapter	NN	_	8	nmod
11	8	8	CD	_	10	nummod
12	,	,	,	_	10	punct
13	including	include	VBG	_	16	case
14	persistent	persistent	JJ	_	16	amod
15	ovarian	ovarian	JJ	_	16	amod
16	follicles	follicle	NNS	_	10	nmod
17	;	;	:	_	8	punct

1	reproductive	reproductive	JJ	_	3	amod
2	tract	tract	NN	_	3	compound
3	infections	infection	NNS	_	0	ROOT
4	;	;	:	_	3	punct

1	abnormal	abnormal	JJ	_	3	amod
2	vaginal	vaginal	JJ	_	3	amod
3	bleeding	bleeding	NN	_	0	ROOT
4	;	;	:	_	3	punct

1	uterine	uterine	JJ	_	2	amod
2	fibroids	fibroid	NNS	_	0	ROOT
3	;	;	:	_	2	punct

1	gestational	gestational	JJ	_	3	amod
2	trophoblastic	trophoblastic	JJ	_	3	amod
3	disease	disease	NN	_	0	ROOT
4	;	;	:	_	3	punct

1	benign	benign	JJ	_	3	amod
2	breast	breast	NN	_	3	compound
3	disease	disease	NN	_	0	ROOT
4	;	;	:	_	3	punct

1	diseases	disease	NNS	_	0	ROOT
2	of	of	IN	_	4	case
3	the	the	DT	_	4	det
4	liver	liver	NN	_	1	nmod
5	,	,	,	_	4	punct
6	gallbladder	gallbladder	NN	_	4	conj
7	,	,	,	_	4	punct
8	and	and	CC	_	4	cc
9	bowel	bowel	NN	_	4	conj
10	;	;	:	_	1	punct

1	endocrine	endocrine	JJ	_	2	amod
2	dysfunction	dysfunction	NN	_	0	ROOT
3	;	;	:	_	2	punct

1	epilepsy	epilepsy	NN	_	0	ROOT
2	;	;	:	_	1	punct

1	bone	bone	NN	_	2	compound
2	density	density	NN	_	0	ROOT
3	;	;	:	_	2	punct

1	sickle	sickle	JJ	_	3	amod
2	cell	cell	NN	_	3	compound
3	disease	disease	NN	_	0	ROOT
4	;	;	:	_	3	punct

1	ocular	ocular	JJ	_	2	amod
2	effects	effect	NNS	_	0	ROOT
3	;	;	:	_	2	punct

1	surgery	surgery	NN	_	0	ROOT
2	;	;	:	_	1	punct

1	and	and	CC	_	2	cc
2	overdose	overdose	NN	_	0	ROOT
3	.	.	.	_	2	punct

1	The	the	DT	_	4	det
2	last	last	JJ	_	4	amod
3	4	4	CD	_	4	nummod
4	chapters	chapter	NNS	_	5	nsubj
5	cover	cover	VBP	_	0	ROOT
6	interactions	interaction	NNS	_	5	dobj
7	with	with	IN	_	8	case
8	drugs	drug	NNS	_	6	nmod
9	and	and	CC	_	8	cc
10	laboratory	laboratory	NN	_	11	compound
11	tests	test	NNS	_	8	conj
12	,	,	,	_	8	punct
13	common	common	JJ	_	15	amod
14	side	side	NN	_	15	compound
15	effects	effect	NNS	_	8	conj
16	,	,	,	_	8	punct
17	breast	breast	NN	_	18	compound
18	feeding	feeding	NN	_	8	conj
19	,	,	,	_	8	punct
20	and	and	CC	_	8	cc
21	effective	effective	JJ	_	22	amod
22	use	use	NN	_	8	conj
23	of	of	IN	_	24	case
24	drug1	drug1	NN	_	22	nmod
25	.	.	.	_	5	punct

1	Information	information	NN	_	9	nsubj
2	on	on	IN	_	3	case
3	precautions	precaution	NNS	_	1	nmod
4	and	and	CC	_	3	cc
5	contraindications	contraindication	NNS	_	3	conj
6	,	,	,	_	3	punct
7	indications	indication	NNS	_	3	conj
8	,	,	,	_	3	punct
9	use	use	VBP	_	0	ROOT
10	instructions	instruction	NNS	_	9	dobj
11	,	,	,	_	9	punct
12	and	and	CC	_	9	cc
13	instructions	instruction	NNS	_	22	nsubjpass
14	for	for	IN	_	16	case
15	appropriate	appropriate	JJ	_	16	amod
16	actions	action	NNS	_	13	nmod
17	after	after	IN	_	18	mark
18	missing	miss	VBG	_	13	acl
19	a	a	DT	_	20	det
20	pill	pill	NN	_	18	dobj
21	is	be	VBZ	_	22	auxpass
22	appended	append	VBN	_	9	conj
23	.	.	.	_	9	punct

1	Hypothermia	Hypothermia	NNP	_	0	ROOT
2	as	as	IN	_	4	case
3	an	a	DT	_	4	det
4	index	index	NN	_	1	nmod
5	of	of	IN	_	10	case
6	the	the	DT	_	10	det
7	drug1	drug1	NN	_	10	compound
8	-	-	:	_	10	punct
9	drug2	drug2	NN	_	10	compound
10	reaction	reaction	NN	_	4	nmod
11	in	in	IN	_	13	case
12	the	the	DT	_	13	det
13	rat	rat	NN	_	10	nmod
14	.	.	.	_	1	punct

1	Decreased	decrease	VBN	_	3	amod
2	core	core	NN	_	3	compound
3	temperature	temperature	NN	_	8	nsubjpass
4	in	in	IN	_	6	case
5	female	female	JJ	_	6	amod
6	rats	rat	NNS	_	3	nmod
7	was	be	VBD	_	8	auxpass
8	investigated	investigate	VBN	_	0	ROOT
9	as	as	IN	_	12	case
10	one	one	CD	_	12	nummod
11	possible	possible	JJ	_	12	amod
12	index	index	NN	_	8	nmod
13	of	of	IN	_	18	case
14	the	the	DT	_	18	det
15	drug1	drug1	NN	_	18	compound
16	-	-	:	_	18	punct
17	drug2	drug2	NN	_	18	compound
18	reaction	reaction	NN	_	12	nmod
19	-LRB-	-lrb-	-LRB-	_	20	punct
20	DER	der	NN	_	18	appos
21	-RRB-	-rrb-	-RRB-	_	20	punct
22	.	.	.	_	8	punct

1	Core	core	NN	_	2	compound
2	temperature	temperature	NN	_	4	nsubjpass
3	was	be	VBD	_	4	auxpass
4	decreased	decrease	VBN	_	0	ROOT
5	in	in	IN	_	6	case
6	rats	rat	NNS	_	4	nmod
7	in	in	IN	_	10	case
8	a	a	DT	_	10	det
9	dose-dependent	dose-dependent	JJ	_	10	amod
10	manner	manner	NN	_	4	nmod
11	when	when	WRB	_	14	advmod
12	drug1	drug1	NN	_	14	nsubjpass
13	was	be	VBD	_	14	auxpass
14	administered	administer	VBN	_	4	advcl
15	to	to	TO	_	16	case
16	rats	rat	NNS	_	14	nmod
17	treated	treat	VBN	_	16	acl
18	with	with	IN	_	19	case
19	drug2	drug2	NN	_	17	nmod
20	8	8	CD	_	21	nummod
21	hours	hour	NNS	_	17	nmod
22	before	before	IN	_	21	case
23	the	the	DT	_	25	det
24	drug3	drug3	NN	_	25	compound
25	challenge	challenge	NN	_	21	dep
26	.	.	.	_	4	punct

1	The	the	DT	_	2	det
2	decrease	decrease	NN	_	5	nsubj
3	in	in	IN	_	4	case
4	temperature	temperature	NN	_	2	nmod
5	began	begin	VBD	_	0	ROOT
6	within	within	IN	_	8	case
7	20	20	CD	_	8	nummod
8	minutes	minute	NNS	_	5	nmod
9	after	after	IN	_	11	case
10	drug1	drug1	NN	_	11	compound
11	administration	administration	NN	_	8	nmod
12	,	,	,	_	5	punct
13	reaching	reach	VBG	_	5	advcl
14	a	a	DT	_	16	det
15	maximal	maximal	JJ	_	16	amod
16	decrease	decrease	NN	_	13	dobj
17	between	between	IN	_	21	case
18	60	60	CD	_	21	nummod
19	and	and	CC	_	18	cc
20	120	120	CD	_	18	conj
21	minutes	minute	NNS	_	16	nmod
22	post	post	JJ	_	23	amod
23	drug2	drug2	NN	_	21	dep
24	.	.	.	_	5	punct

1	The	the	DT	_	3	det
2	core	core	NN	_	3	compound
3	temperature	temperature	NN	_	4	nsubj
4	returned	return	VBD	_	0	ROOT
5	to	to	TO	_	8	case
6	normal	normal	JJ	_	8	amod
7	300	300	CD	_	8	nummod
8	minutes	minute	NNS	_	4	nmod
9	after	after	IN	_	10	case
10	drug1	drug1	NN	_	4	nmod
11	.	.	.	_	4	punct

1	The	the	DT	_	3	det
2	blood	blood	NN	_	3	compound
3	pressure	pressure	NN	_	8	nsubj
4	-LRB-	-lrb-	-LRB-	_	6	punct
5	carotid	carotid	NN	_	6	compound
6	cannulation	cannulation	NN	_	3	appos
7	-RRB-	-rrb-	-RRB-	_	6	punct
8	decreased	decrease	VBD	_	0	ROOT
9	along	along	IN	_	13	case
10	with	with	IN	_	13	case
11	the	the	DT	_	13	det
12	core	core	NN	_	13	compound
13	temperature	temperature	NN	_	8	nmod
14	.	.	.	_	8	punct

1	Maximal	maximal	JJ	_	2	amod
2	hypotension	hypotension	NN	_	4	nsubjpass
3	was	be	VBD	_	4	auxpass
4	found	find	VBN	_	0	ROOT
5	120	120	CD	_	6	nummod
6	minutes	minute	NNS	_	4	nmod:tmod
7	post	post	JJ	_	8	amod
8	drug1	drug1	NN	_	6	dep
9	,	,	,	_	4	punct
10	and	and	CC	_	4	cc
11	returned	return	VBD	_	4	conj
12	to	to	TO	_	15	case
13	normal	normal	JJ	_	15	amod
14	300	300	CD	_	15	nummod
15	minutes	minute	NNS	_	11	nmod
16	after	after	IN	_	17	case
17	drug2	drug2	NN	_	11	nmod
18	.	.	.	_	4	punct

1	Heart	Heart	NNP	_	2	compound
2	rate	rate	NN	_	3	nsubj
3	increased	increase	VBD	_	0	ROOT
4	initially	initially	RB	_	3	advmod
5	and	and	CC	_	3	cc
6	returned	return	VBD	_	3	conj
7	to	to	TO	_	10	case
8	normal	normal	JJ	_	10	amod
9	40	40	CD	_	10	nummod
10	minutes	minute	NNS	_	6	nmod
11	after	after	IN	_	13	case
12	drug1	drug1	NN	_	13	compound
13	challenge	challenge	NN	_	6	nmod
14	.	.	.	_	3	punct

1	Intestinal	intestinal	JJ	_	2	amod
2	absorption	absorption	NN	_	0	ROOT
3	of	of	IN	_	4	case
4	drug1	drug1	NN	_	2	nmod
5	in	in	IN	_	7	case
6	the	the	DT	_	7	det
7	chick	chick	NN	_	2	nmod
8	.	.	.	_	2	punct

1	The	the	DT	_	3	det
2	intestinal	intestinal	JJ	_	3	amod
3	absorption	absorption	NN	_	11	nsubjpass
4	of	of	IN	_	5	case
5	drug1	drug1	NN	_	3	nmod
6	-LRB-	-lrb-	-LRB-	_	7	punct
7	drug2	drug2	NN	_	5	appos
8	-RRB-	-rrb-	-RRB-	_	7	punct
9	has	have	VBZ	_	11	aux
10	been	be	VBN	_	11	auxpass
11	investigated	investigate	VBN	_	0	ROOT
12	in	in	IN	_	14	case
13	the	the	DT	_	14	det
14	chick	chick	NN	_	11	nmod
15	by	by	IN	_	16	case
16	means	means	NNS	_	11	nmod
17	of	of	IN	_	24	case
18	the	the	DT	_	24	det
19	in	in	FW	_	24	amod
20	situ	situ	FW	_	19	dep
21	ligated	ligate	VBN	_	24	amod
22	duodenal	duodenal	JJ	_	24	amod
23	loop	loop	NN	_	24	compound
24	technique	technique	NN	_	16	nmod
25	.	.	.	_	11	punct

1	By	by	IN	_	3	case
2	this	this	DT	_	3	det
3	procedure	procedure	NN	_	7	nmod
4	,	,	,	_	7	punct
5	it	it	PRP	_	7	nsubjpass
6	was	be	VBD	_	7	auxpass
7	observed	observe	VBN	_	0	ROOT
8	that	that	IN	_	15	mark
9	drug1	drug1	NN	_	15	nsubjpass
10	is	be	VBZ	_	15	auxpass
11	rapidly	rapidly	RB	_	12	advmod
12	and	and	CC	_	15	advmod
13	essentially	essentially	RB	_	12	advmod
14	completely	completely	RB	_	12	advmod
15	absorbed	absorb	VBN	_	7	ccomp
16	-LRB-	-lrb-	-LRB-	_	18	punct
17	80-95	80-95	CD	_	18	nummod
18	%	%	NN	_	15	dep
19	-RRB-	-rrb-	-RRB-	_	18	punct
20	from	from	IN	_	22	case
21	the	the	DT	_	22	det
22	lumen	lumen	NN	_	15	nmod
23	at	at	IN	_	25	case
24	drug2	drug2	NN	_	25	compound
25	concentrations	concentration	NNS	_	22	nmod
26	up	up	IN	_	28	advmod
27	to	to	TO	_	28	dep
28	5	5	CD	_	29	nummod
29	mM	mm	NN	_	22	dep
30	,	,	,	_	15	punct
31	declining	decline	VBG	_	15	xcomp
32	to	to	TO	_	36	case
33	about	about	IN	_	34	advmod
34	50	50	CD	_	35	dep
35	%	%	NN	_	36	dep
36	absorption	absorption	NN	_	31	nmod
37	at	at	IN	_	39	case
38	50	50	CD	_	39	nummod
39	mM	mm	NN	_	31	nmod
40	.	.	.	_	7	punct

1	Transfer	transfer	NN	_	19	nsubj
2	from	from	IN	_	5	case
3	the	the	DT	_	5	det
4	intestinal	intestinal	JJ	_	5	amod
5	lumen	lumen	NN	_	1	nmod
6	to	to	TO	_	9	case
7	the	the	DT	_	9	det
8	mucosal	mucosal	JJ	_	9	amod
9	cells	cell	NNS	_	1	nmod
10	at	at	IN	_	13	case
11	low	low	JJ	_	13	amod
12	drug1	drug1	NN	_	13	compound
13	concentration	concentration	NN	_	1	nmod
14	-LRB-	-lrb-	-LRB-	_	16	punct
15	0.1	0.1	CD	_	16	nummod
16	mM	mm	NN	_	13	appos
17	-RRB-	-rrb-	-RRB-	_	16	punct
18	is	be	VBZ	_	19	cop
19	rapid	rapid	JJ	_	0	ROOT
20	,	,	,	_	19	punct
21	while	while	IN	_	30	mark
22	transfer	transfer	NN	_	30	nsubj
23	from	from	IN	_	26	case
24	the	the	DT	_	26	det
25	mucosal	mucosal	JJ	_	26	amod
26	cells	cell	NNS	_	22	nmod
27	to	to	TO	_	29	case
28	the	the	DT	_	29	det
29	body	body	NN	_	22	nmod
30	occurs	occur	VBZ	_	19	advcl
31	more	more	RBR	_	32	advmod
32	slowly	slowly	RB	_	30	advmod
33	.	.	.	_	19	punct

1	At	at	IN	_	4	case
2	stable	stable	JJ	_	4	amod
3	drug1	drug1	NN	_	4	compound
4	concentrations	concentration	NNS	_	16	nmod
5	greater	greater	JJR	_	4	amod
6	than	than	IN	_	8	case
7	1	1	CD	_	8	nummod
8	mM	mm	NN	_	5	nmod
9	,	,	,	_	16	punct
10	fractional	fractional	JJ	_	13	amod
11	mucosal	mucosal	JJ	_	13	amod
12	cell	cell	NN	_	13	compound
13	accumulation	accumulation	NN	_	16	nsubj
14	of	of	IN	_	15	case
15	drug2	drug2	NN	_	13	nmod
16	remains	remain	VBZ	_	0	ROOT
17	constant	constant	JJ	_	16	xcomp
18	,	,	,	_	16	punct
19	while	while	IN	_	16	xcomp
20	fractional	fractional	JJ	_	21	amod
21	transfer	transfer	NN	_	19	dep
22	to	to	TO	_	25	case
23	the	the	DT	_	25	det
24	body	body	NN	_	25	compound
25	declines	decline	NNS	_	21	nmod
26	.	.	.	_	16	punct

1	However	however	RB	_	0	ROOT
2	,	,	,	_	1	punct
3	total	total	JJ	_	5	amod
4	mucosal	mucosal	JJ	_	5	amod
5	accumulation	accumulation	NN	_	2	root
6	of	of	IN	_	7	case
7	drug1	drug1	NN	_	5	nmod
8	and	and	CC	_	5	cc
9	that	that	IN	_	5	conj
10	transferred	transfer	VBN	_	9	acl
11	to	to	TO	_	14	case
12	the	the	DT	_	14	det
13	body	body	NN	_	14	compound
14	increase	increase	NN	_	10	nmod
15	in	in	IN	_	19	case
16	a	a	DT	_	19	det
17	linear	linear	JJ	_	19	amod
18	logarithmic	logarithmic	JJ	_	19	amod
19	fashion	fashion	NN	_	14	nmod
20	from	from	IN	_	25	case
21	0.05	0.05	CD	_	23	compound
22	to	to	TO	_	23	dep
23	5	5	CD	_	25	nummod
24	mm	mm	NN	_	25	compound
25	drug2	drug2	NN	_	14	nmod
26	.	.	.	_	5	punct

1	The	the	DT	_	2	det
2	results	result	NNS	_	3	nsubj
3	indicate	indicate	VBP	_	0	ROOT
4	that	that	IN	_	7	mark
5	drug1	drug1	NN	_	7	nsubj
6	readily	readily	RB	_	7	advmod
7	penetrates	penetrate	VBZ	_	3	ccomp
8	both	both	CC	_	10	cc:preconj
9	the	the	DT	_	10	dep
10	mucosal	mucosal	JJ	_	7	dobj
11	and	and	CC	_	10	cc
12	serosal	serosal	JJ	_	10	conj
13	surfaces	surface	NNS	_	10	dep
14	of	of	IN	_	17	case
15	the	the	DT	_	17	det
16	epithelial	epithelial	JJ	_	17	amod
17	membrane	membrane	NN	_	10	nmod
18	.	.	.	_	3	punct

1	Furthermore	furthermore	RB	_	8	advmod
2	,	,	,	_	8	punct
3	drug1	drug1	NN	_	8	nsubj
4	and	and	CC	_	3	cc
5	drug2	drug2	NN	_	3	conj
6	do	do	VBP	_	8	aux
7	not	not	RB	_	8	neg
8	appear	appear	VB	_	0	ROOT
9	to	to	TO	_	10	mark
10	share	share	VB	_	8	xcomp
11	a	a	DT	_	14	det
12	common	common	JJ	_	14	amod
13	transport	transport	NN	_	14	compound
14	pathway	pathway	NN	_	10	dobj
15	in	in	IN	_	17	case
16	the	the	DT	_	17	det
17	duodenum	duodenum	NN	_	14	nmod
18	and	and	CC	_	8	cc
19	no	no	DT	_	20	neg
20	evidence	evidence	NN	_	22	nsubjpass
21	was	be	VBD	_	22	auxpass
22	obtained	obtain	VBN	_	8	conj
23	for	for	IN	_	25	case
24	any	any	DT	_	25	det
25	interaction	interaction	NN	_	22	nmod
26	between	between	IN	_	28	case
27	the	the	DT	_	28	det
28	two	two	CD	_	25	nmod
29	at	at	IN	_	31	case
30	this	this	DT	_	31	det
31	level	level	NN	_	22	nmod
32	.	.	.	_	8	punct

1	drug1	drug1	NN	_	2	compound
2	administration	administration	NN	_	7	nsubj
3	to	to	TO	_	5	case
4	rachitic	rachitic	JJ	_	5	amod
5	chicks	chick	NNS	_	2	nmod
6	was	be	VBD	_	7	cop
7	effective	effective	JJ	_	0	ROOT
8	in	in	IN	_	10	mark
9	significantly	significantly	RB	_	10	advmod
10	elevating	elevate	VBG	_	7	advcl
11	duodenal	duodenal	JJ	_	13	amod
12	drug2	drug2	NN	_	13	compound
13	absorption	absorption	NN	_	10	dobj
14	,	,	,	_	7	punct
15	acting	act	VBG	_	7	xcomp
16	primarily	primarily	RB	_	15	advmod
17	to	to	TO	_	18	mark
18	enhance	enhance	VB	_	15	xcomp
19	serosal	serosal	JJ	_	20	amod
20	transport	transport	NN	_	18	dobj
21	.	.	.	_	7	punct

1	drug1	drug1	NN	_	0	ROOT
2	:	:	:	_	1	punct
3	an	a	DT	_	5	det
4	updated	update	VBN	_	5	amod
5	review	review	NN	_	1	dep
6	of	of	IN	_	8	case
7	its	its	PRP$	_	8	nmod:poss
8	use	use	NN	_	5	nmod
9	in	in	IN	_	11	case
10	the	the	DT	_	11	det
11	management	management	NN	_	8	nmod
12	of	of	IN	_	13	case
13	schizophrenia	schizophrenia	NN	_	11	nmod
14	.	.	.	_	1	punct

1	drug1	drug1	NN	_	8	nsubj
2	,	,	,	_	1	punct
3	a	a	DT	_	4	det
4	drug2	drug2	NN	_	1	appos
5	,	,	,	_	1	punct
6	is	be	VBZ	_	8	cop
7	a	a	DT	_	8	det
8	drug3	drug3	NN	_	0	ROOT
9	which	which	WDT	_	11	nsubj
10	has	have	VBZ	_	11	aux
11	proven	prove	VBN	_	8	acl:relcl
12	efficacy	efficacy	NN	_	11	dobj
13	against	against	IN	_	18	case
14	the	the	DT	_	18	det
15	positive	positive	JJ	_	18	amod
16	and	and	CC	_	15	cc
17	negative	negative	JJ	_	15	conj
18	symptoms	symptom	NNS	_	12	nmod
19	of	of	IN	_	20	case
20	schizophrenia	schizophrenia	NN	_	18	nmod
21	.	.	.	_	8	punct

1	Compared	compare	VBN	_	3	case
2	with	with	IN	_	3	case
3	drug1	drug1	NN	_	6	advcl
4	,	,	,	_	6	punct
5	it	it	PRP	_	6	nsubj
6	has	have	VBZ	_	0	ROOT
7	greater	greater	JJR	_	8	amod
8	affinity	affinity	NN	_	6	dobj
9	for	for	IN	_	11	case
10	serotonin	serotonin	NN	_	11	compound
11	5-HT2A	5-ht2a	NN	_	8	nmod
12	than	than	IN	_	16	case
13	for	for	IN	_	16	case
14	dopamine	dopamine	NN	_	16	compound
15	D2	d2	NN	_	16	compound
16	receptors	receptor	NNS	_	8	nmod
17	.	.	.	_	6	punct

1	In	in	IN	_	6	case
2	large	large	JJ	_	6	amod
3	,	,	,	_	6	punct
4	well	well	RB	_	5	advmod
5	controlled	controlled	JJ	_	6	amod
6	trials	trial	NNS	_	22	nmod
7	in	in	IN	_	8	case
8	patients	patient	NNS	_	6	nmod
9	with	with	IN	_	10	case
10	schizophrenia	schizophrenia	NN	_	8	nmod
11	or	or	CC	_	10	cc
12	related	related	JJ	_	13	amod
13	psychoses	psychosis	NNS	_	10	conj
14	,	,	,	_	22	punct
15	drug1	drug1	NN	_	19	compound
16	5	5	CD	_	18	compound
17	to	to	TO	_	18	dep
18	20	20	CD	_	19	nummod
19	mg/day	mg/day	NN	_	22	nsubj
20	was	be	VBD	_	22	cop
21	significantly	significantly	RB	_	22	advmod
22	superior	superior	JJ	_	0	ROOT
23	to	to	TO	_	24	mark
24	drug2	drug2	VB	_	22	xcomp
25	5	5	CD	_	27	compound
26	to	to	TO	_	27	dep
27	20	20	CD	_	28	nummod
28	mg/day	mg/day	NN	_	24	dobj
29	in	in	IN	_	31	case
30	overall	overall	JJ	_	31	amod
31	improvements	improvement	NNS	_	24	nmod
32	in	in	IN	_	35	case
33	psychopathology	psychopathology	NN	_	35	compound
34	rating	rating	NN	_	35	compound
35	scales	scale	NNS	_	31	nmod
36	and	and	CC	_	35	cc
37	in	in	IN	_	39	case
38	the	the	DT	_	39	det
39	treatment	treatment	NN	_	35	conj
40	of	of	IN	_	44	case
41	depressive	depressive	JJ	_	44	amod
42	and	and	CC	_	41	cc
43	negative	negative	JJ	_	41	conj
44	symptoms	symptom	NNS	_	39	nmod
45	,	,	,	_	22	punct
46	and	and	CC	_	22	cc
47	was	be	VBD	_	48	cop
48	comparable	comparable	JJ	_	22	conj
49	in	in	IN	_	50	case
50	effects	effect	NNS	_	48	nmod
51	on	on	IN	_	54	case
52	positive	positive	JJ	_	54	amod
53	psychotic	psychotic	JJ	_	54	amod
54	symptoms	symptom	NNS	_	50	nmod
55	.	.	.	_	22	punct

1	The	the	DT	_	3	det
2	1-year	1-year	JJ	_	3	amod
3	risk	risk	NN	_	11	nsubj
4	of	of	IN	_	5	case
5	relapse	relapse	NN	_	3	nmod
6	-LRB-	-lrb-	-LRB-	_	7	punct
7	rehospitalisation	rehospitalisation	NN	_	5	appos
8	-RRB-	-rrb-	-RRB-	_	7	punct
9	was	be	VBD	_	11	cop
10	significantly	significantly	RB	_	11	advmod
11	lower	lower	JJR	_	0	ROOT
12	with	with	IN	_	13	case
13	drug1	drug1	NN	_	11	nmod
14	than	than	IN	_	17	case
15	with	with	IN	_	17	case
16	drug2	drug2	NN	_	17	compound
17	treatment	treatment	NN	_	11	nmod
18	.	.	.	_	11	punct

1	In	in	IN	_	6	case
2	the	the	DT	_	6	det
3	first	first	JJ	_	6	amod
4	double-blind	double-blind	JJ	_	6	amod
5	comparative	comparative	JJ	_	6	amod
6	study	study	NN	_	20	nmod
7	-LRB-	-lrb-	-LRB-	_	8	punct
8	28-week	28-week	JJ	_	6	appos
9	-RRB-	-rrb-	-RRB-	_	8	punct
10	of	of	IN	_	11	case
11	drug1	drug1	NN	_	6	nmod
12	and	and	CC	_	11	cc
13	drug2	drug2	NN	_	11	conj
14	,	,	,	_	20	punct
15	drug3	drug3	NN	_	19	compound
16	10	10	CD	_	18	compound
17	to	to	TO	_	18	dep
18	20	20	CD	_	19	nummod
19	mg/day	mg/day	NN	_	20	nsubj
20	proved	prove	VBD	_	0	ROOT
21	to	to	TO	_	25	mark
22	be	be	VB	_	25	cop
23	significantly	significantly	RB	_	25	advmod
24	more	more	RBR	_	25	advmod
25	effective	effective	JJ	_	20	xcomp
26	than	than	IN	_	27	case
27	drug4	drug4	NN	_	25	nmod
28	4	4	CD	_	27	nummod
29	to	to	TO	_	27	dep
30	12	12	CD	_	27	nummod
31	mg/day	mg/day	NN	_	27	dep
32	in	in	IN	_	34	case
33	the	the	DT	_	34	det
34	treatment	treatment	NN	_	25	nmod
35	of	of	IN	_	39	case
36	negative	negative	JJ	_	39	amod
37	and	and	CC	_	36	cc
38	depressive	depressive	JJ	_	36	conj
39	symptoms	symptom	NNS	_	34	nmod
40	but	but	CC	_	39	cc
41	not	not	RB	_	45	neg
42	on	on	IN	_	45	case
43	overall	overall	JJ	_	45	amod
44	psychopathology	psychopathology	NN	_	45	compound
45	symptoms	symptom	NNS	_	39	conj
46	.	.	.	_	20	punct

1	In	in	IN	_	2	case
2	contrast	contrast	NN	_	11	nmod
3	,	,	,	_	11	punct
4	preliminary	preliminary	JJ	_	5	amod
5	results	result	NNS	_	11	nsubj
6	from	from	IN	_	10	case
7	an	a	DT	_	10	det
8	8-week	8-week	JJ	_	10	amod
9	controlled	controlled	JJ	_	10	amod
10	study	study	NN	_	5	nmod
11	suggested	suggest	VBD	_	0	ROOT
12	drug1	drug1	NN	_	16	compound
13	2	2	CD	_	15	compound
14	to	to	TO	_	15	dep
15	6	6	CD	_	16	nummod
16	mg/day	mg/day	NN	_	18	nsubj
17	was	be	VBD	_	18	cop
18	superior	superior	JJ	_	11	ccomp
19	to	to	TO	_	20	mark
20	drug2	drug2	VB	_	18	xcomp
21	5	5	CD	_	23	compound
22	to	to	TO	_	23	dep
23	20	20	CD	_	24	nummod
24	mg/day	mg/day	NN	_	20	dobj
25	against	against	IN	_	29	case
26	positive	positive	JJ	_	29	amod
27	and	and	CC	_	26	cc
28	anxiety/depressive	anxiety/depressive	JJ	_	26	conj
29	symptoms	symptom	NNS	_	20	nmod
30	-LRB-	-lrb-	-LRB-	_	32	punct
31	p	p	NN	_	32	dep
32	<	<	JJR	_	18	parataxis
33	0.05	0.05	CD	_	32	nummod
34	-RRB-	-rrb-	-RRB-	_	32	punct
35	,	,	,	_	18	punct
36	although	although	IN	_	45	mark
37	consistent	consistent	JJ	_	45	advmod
38	with	with	IN	_	41	case
39	the	the	DT	_	41	det
40	first	first	JJ	_	41	amod
41	study	study	NN	_	37	nmod
42	,	,	,	_	45	punct
43	both	both	DT	_	44	det
44	agents	agent	NNS	_	45	nsubj
45	demonstrated	demonstrate	VBD	_	18	advcl
46	similar	similar	JJ	_	47	amod
47	efficacy	efficacy	NN	_	45	dobj
48	on	on	IN	_	49	case
49	measures	measure	NNS	_	47	nmod
50	of	of	IN	_	52	case
51	overall	overall	JJ	_	52	amod
52	psychopathology	psychopathology	NN	_	49	nmod
53	.	.	.	_	11	punct

1	Improvements	Improvements	NNP	_	23	nsubj
2	in	in	IN	_	5	case
3	general	general	JJ	_	5	amod
4	cognitive	cognitive	JJ	_	5	amod
5	function	function	NN	_	1	nmod
6	seen	see	VBN	_	5	acl
7	with	with	IN	_	9	case
8	drug1	drug1	NN	_	9	compound
9	treatment	treatment	NN	_	6	nmod
10	in	in	IN	_	14	case
11	a	a	DT	_	14	det
12	1-year	1-year	JJ	_	14	amod
13	controlled	controlled	JJ	_	14	amod
14	study	study	NN	_	9	nmod
15	of	of	IN	_	16	case
16	patients	patient	NNS	_	14	nmod
17	with	with	IN	_	19	case
18	early-phase	early-phase	JJ	_	19	amod
19	schizophrenia	schizophrenia	NN	_	16	nmod
20	,	,	,	_	1	punct
21	were	be	VBD	_	23	cop
22	significantly	significantly	RB	_	23	advmod
23	greater	greater	JJR	_	0	ROOT
24	than	than	IN	_	25	case
25	changes	change	NNS	_	23	nmod
26	seen	see	VBN	_	25	acl
27	with	with	IN	_	29	case
28	either	either	CC	_	29	cc:preconj
29	drug2	drug2	NN	_	26	nmod
30	or	or	CC	_	29	cc
31	drug3	drug3	NN	_	29	conj
32	.	.	.	_	23	punct

1	However	however	RB	_	9	advmod
2	,	,	,	_	9	punct
3	preliminary	preliminary	JJ	_	4	amod
4	results	result	NNS	_	9	nsubj
5	from	from	IN	_	8	case
6	an	a	DT	_	8	det
7	8-week	8-week	JJ	_	8	amod
8	trial	trial	NN	_	4	nmod
9	showed	show	VBD	_	0	ROOT
10	comparable	comparable	JJ	_	13	amod
11	cognitive	cognitive	JJ	_	13	amod
12	enhancing	enhancing	JJ	_	13	amod
13	effects	effect	NNS	_	9	dobj
14	of	of	IN	_	15	case
15	drug1	drug1	NN	_	13	nmod
16	and	and	CC	_	15	cc
17	drug2	drug2	NN	_	18	compound
18	treatment	treatment	NN	_	15	conj
19	in	in	IN	_	20	case
20	patients	patient	NNS	_	13	nmod
21	with	with	IN	_	22	case
22	schizophrenia	schizophrenia	NN	_	20	nmod
23	or	or	CC	_	22	cc
24	schizoaffective	schizoaffective	JJ	_	25	amod
25	disorder	disorder	NN	_	22	conj
26	.	.	.	_	9	punct

1	Several	several	JJ	_	2	amod
2	studies	study	NNS	_	3	nsubj
3	indicate	indicate	VBP	_	0	ROOT
4	that	that	IN	_	6	mark
5	drug1	drug1	NN	_	6	nsubj
6	has	have	VBZ	_	3	ccomp
7	benefits	benefit	NNS	_	6	dobj
8	against	against	IN	_	9	case
9	symptoms	symptom	NNS	_	7	nmod
10	of	of	IN	_	11	case
11	aggression	aggression	NN	_	9	nmod
12	and	and	CC	_	11	cc
13	agitation	agitation	NN	_	11	conj
14	,	,	,	_	6	punct
15	while	while	IN	_	19	mark
16	other	other	JJ	_	17	amod
17	studies	study	NNS	_	19	nsubj
18	strongly	strongly	RB	_	19	advmod
19	support	support	VBP	_	6	advcl
20	the	the	DT	_	21	det
21	effectiveness	effectiveness	NN	_	19	dobj
22	of	of	IN	_	23	case
23	drug2	drug2	NN	_	21	nmod
24	in	in	IN	_	26	case
25	the	the	DT	_	26	det
26	treatment	treatment	NN	_	19	nmod
27	of	of	IN	_	29	case
28	depressive	depressive	JJ	_	29	amod
29	symptomatology	symptomatology	NN	_	26	nmod
30	.	.	.	_	3	punct

1	drug1	drug1	NN	_	3	nsubjpass
2	is	be	VBZ	_	3	auxpass
3	associated	associate	VBN	_	0	ROOT
4	with	with	IN	_	8	case
5	significantly	significantly	RB	_	6	advmod
6	fewer	fewer	JJR	_	8	amod
7	extrapyramidal	extrapyramidal	JJ	_	8	amod
8	symptoms	symptom	NNS	_	3	nmod
9	than	than	IN	_	10	case
10	drug2	drug2	NN	_	8	nmod
11	and	and	CC	_	10	cc
12	drug3	drug3	NN	_	10	conj
13	.	.	.	_	3	punct

1	In	in	IN	_	2	case
2	addition	addition	NN	_	7	nmod
3	,	,	,	_	7	punct
4	drug1	drug1	NN	_	7	nsubjpass
5	is	be	VBZ	_	7	auxpass
6	not	not	RB	_	7	neg
7	associated	associate	VBN	_	0	ROOT
8	with	with	IN	_	10	case
9	a	a	DT	_	10	det
10	risk	risk	NN	_	7	nmod
11	of	of	IN	_	12	case
12	agranulocytosis	agranulocytosis	NN	_	10	nmod
13	as	as	IN	_	14	mark
14	seen	see	VBN	_	7	advcl
15	with	with	IN	_	16	case
16	drug2	drug2	NN	_	14	nmod
17	or	or	CC	_	16	cc
18	clinically	clinically	RB	_	19	advmod
19	significant	significant	JJ	_	20	amod
20	hyperprolactinaemia	hyperprolactinaemia	NN	_	16	conj
21	as	as	IN	_	22	mark
22	seen	see	VBN	_	14	advcl
23	with	with	IN	_	24	case
24	drug3	drug3	NN	_	22	nmod
25	or	or	CC	_	24	cc
26	prolongation	prolongation	NN	_	24	conj
27	of	of	IN	_	30	case
28	the	the	DT	_	30	det
29	QT	QT	NNP	_	30	compound
30	interval	interval	NN	_	24	nmod
31	.	.	.	_	7	punct

1	The	the	DT	_	5	det
2	most	most	RBS	_	3	advmod
3	common	common	JJ	_	5	amod
4	adverse	adverse	JJ	_	5	amod
5	effects	effect	NNS	_	11	nsubj
6	reported	report	VBN	_	5	acl
7	with	with	IN	_	8	case
8	drug1	drug1	NN	_	6	nmod
9	are	be	VBP	_	11	cop
10	bodyweight	bodyweight	JJ	_	11	amod
11	gain	gain	NN	_	0	ROOT
12	,	,	,	_	11	punct
13	somnolence	somnolence	NN	_	11	conj
14	,	,	,	_	11	punct
15	dizziness	dizziness	NN	_	11	conj
16	,	,	,	_	11	punct
17	anticholinergic	anticholinergic	JJ	_	18	amod
18	effects	effect	NNS	_	11	conj
19	-LRB-	-lrb-	-LRB-	_	20	punct
20	constipation	constipation	NN	_	18	dep
21	and	and	CC	_	20	cc
22	dry	dry	JJ	_	23	amod
23	mouth	mouth	NN	_	20	conj
24	-RRB-	-rrb-	-RRB-	_	20	punct
25	and	and	CC	_	11	cc
26	transient	transient	JJ	_	30	amod
27	asymptomatic	asymptomatic	JJ	_	30	amod
28	liver	liver	NN	_	30	compound
29	enzyme	enzyme	NN	_	30	compound
30	elevations	elevation	NNS	_	11	conj
31	.	.	.	_	11	punct

1	In	in	IN	_	2	case
2	comparison	comparison	NN	_	9	nmod
3	with	with	IN	_	4	case
4	drug1	drug1	NN	_	2	nmod
5	,	,	,	_	9	punct
6	the	the	DT	_	8	det
7	adverse	adverse	JJ	_	8	amod
8	events	event	NNS	_	9	nsubj
9	reported	report	VBD	_	0	ROOT
10	significantly	significantly	RB	_	11	advmod
11	more	more	RBR	_	12	advmod
12	frequently	frequently	RB	_	9	advmod
13	with	with	IN	_	14	case
14	drug2	drug2	NN	_	9	nmod
15	in	in	IN	_	20	case
16	>	>	JJR	_	20	dep
17	or	or	CC	_	16	cc
18	=	=	JJ	_	16	conj
19	3.5	3.5	CD	_	20	nummod
20	%	%	NN	_	9	nmod
21	of	of	IN	_	22	case
22	patients	patient	NNS	_	20	nmod
23	were	be	VBD	_	25	cop
24	dry	dry	JJ	_	25	amod
25	mouth	mouth	NN	_	9	dep
26	,	,	,	_	25	punct
27	bodyweight	bodyweight	NN	_	28	compound
28	gain	gain	NN	_	25	conj
29	and	and	CC	_	25	cc
30	increased	increase	VBD	_	31	amod
31	appetite	appetite	NN	_	25	conj
32	and	and	CC	_	25	cc
33	compared	compare	VBN	_	35	case
34	with	with	IN	_	35	case
35	drug3	drug3	NN	_	25	conj
36	,	,	,	_	35	punct
37	only	only	RB	_	39	advmod
38	bodyweight	bodyweight	JJ	_	39	amod
39	gain	gain	NN	_	40	nsubj
40	occurred	occur	VBD	_	35	acl:relcl
41	significantly	significantly	RB	_	42	advmod
42	more	more	RBR	_	43	advmod
43	frequently	frequently	RB	_	40	advmod
44	with	with	IN	_	45	case
45	drug4	drug4	NN	_	43	nmod
46	.	.	.	_	9	punct

1	The	the	DT	_	4	det
2	high	high	JJ	_	4	amod
3	acquisition	acquisition	NN	_	4	compound
4	cost	cost	NN	_	8	nsubjpass
5	of	of	IN	_	6	case
6	drug1	drug1	NN	_	4	nmod
7	is	be	VBZ	_	8	auxpass
8	offset	offset	VBN	_	0	ROOT
9	by	by	IN	_	10	case
10	reductions	reduction	NNS	_	8	nmod
11	in	in	IN	_	14	case
12	other	other	JJ	_	14	amod
13	treatment	treatment	NN	_	14	compound
14	costs	cost	NNS	_	10	nmod
15	-LRB-	-lrb-	-LRB-	_	16	punct
16	inpatient	inpatient	NN	_	14	dep
17	and/or	and/or	CC	_	16	cc
18	outpatient	outpatient	NN	_	19	compound
19	services	service	NNS	_	16	conj
20	-RRB-	-rrb-	-RRB-	_	16	punct
21	of	of	IN	_	22	case
22	schizophrenia	schizophrenia	NN	_	14	nmod
23	.	.	.	_	8	punct

1	Pharmacoeconomic	pharmacoeconomic	JJ	_	2	amod
2	analyses	analysis	NNS	_	3	nsubj
3	indicate	indicate	VBP	_	0	ROOT
4	that	that	IN	_	9	mark
5	drug1	drug1	NN	_	9	nsubj
6	does	do	VBZ	_	9	aux
7	not	not	RB	_	9	neg
8	significantly	significantly	RB	_	9	advmod
9	increase	increase	VB	_	3	ccomp
10	,	,	,	_	9	punct
11	and	and	CC	_	9	cc
12	may	may	MD	_	14	aux
13	even	even	RB	_	14	advmod
14	decrease	decrease	VB	_	9	conj
15	,	,	,	_	14	punct
16	the	the	DT	_	20	det
17	overall	overall	JJ	_	20	amod
18	direct	direct	JJ	_	20	amod
19	treatment	treatment	NN	_	20	compound
20	costs	cost	NNS	_	14	dobj
21	of	of	IN	_	22	case
22	schizophrenia	schizophrenia	NN	_	20	nmod
23	,	,	,	_	20	punct
24	compared	compare	VBN	_	26	case
25	with	with	IN	_	26	case
26	drug2	drug2	NN	_	20	nmod
27	.	.	.	_	3	punct

1	Compared	compare	VBN	_	3	case
2	with	with	IN	_	3	case
3	drug1	drug1	NN	_	9	advcl
4	,	,	,	_	9	punct
5	drug2	drug2	NN	_	9	nsubjpass
6	has	have	VBZ	_	9	aux
7	also	also	RB	_	9	advmod
8	been	be	VBN	_	9	auxpass
9	reported	report	VBN	_	0	ROOT
10	to	to	TO	_	11	mark
11	decrease	decrease	VB	_	9	xcomp
12	overall	overall	JJ	_	14	amod
13	treatment	treatment	NN	_	14	compound
14	costs	cost	NNS	_	11	dobj
15	,	,	,	_	9	punct
16	despite	despite	IN	_	22	case
17	the	the	DT	_	22	det
18	several-fold	several-fold	RB	_	19	advmod
19	higher	higher	JJR	_	22	amod
20	daily	daily	JJ	_	22	amod
21	acquisition	acquisition	NN	_	22	compound
22	cost	cost	NN	_	9	nmod
23	of	of	IN	_	25	case
24	the	the	DT	_	25	det
25	drug	drug	NN	_	22	nmod
26	.	.	.	_	9	punct

1	drug1	drug1	NN	_	2	compound
2	treatment	treatment	NN	_	3	nsubj
3	improves	improve	VBZ	_	0	ROOT
4	quality	quality	NN	_	3	dobj
5	of	of	IN	_	6	case
6	life	life	NN	_	4	nmod
7	in	in	IN	_	8	case
8	patients	patient	NNS	_	3	nmod
9	with	with	IN	_	10	case
10	schizophrenia	schizophrenia	NN	_	8	nmod
11	and	and	CC	_	10	cc
12	related	related	JJ	_	13	amod
13	psychoses	psychosis	NNS	_	10	conj
14	to	to	TO	_	17	case
15	a	a	DT	_	17	det
16	greater	greater	JJR	_	17	amod
17	extent	extent	NN	_	8	nmod
18	than	than	IN	_	19	case
19	drug2	drug2	NN	_	8	nmod
20	,	,	,	_	3	punct
21	and	and	CC	_	3	cc
22	to	to	TO	_	26	case
23	broadly	broadly	RB	_	26	advmod
24	the	the	DT	_	26	det
25	same	same	JJ	_	26	amod
26	extent	extent	NN	_	3	conj
27	as	as	IN	_	28	case
28	drug3	drug3	NN	_	26	nmod
29	.	.	.	_	3	punct

1	CONCLUSIONS	conclusion	NNS	_	0	ROOT
2	:	:	:	_	1	punct
3	drug1	drug1	NN	_	4	nsubj
4	demonstrated	demonstrate	VBD	_	1	appos
5	superior	superior	JJ	_	7	amod
6	antipsychotic	antipsychotic	JJ	_	7	amod
7	efficacy	efficacy	NN	_	4	dobj
8	compared	compare	VBN	_	10	case
9	with	with	IN	_	10	case
10	drug2	drug2	NN	_	7	nmod
11	in	in	IN	_	13	case
12	the	the	DT	_	13	det
13	treatment	treatment	NN	_	10	nmod
14	of	of	IN	_	17	case
15	acute	acute	JJ	_	17	amod
16	phase	phase	NN	_	17	compound
17	schizophrenia	schizophrenia	NN	_	13	nmod
18	,	,	,	_	10	punct
19	and	and	CC	_	10	cc
20	in	in	IN	_	22	case
21	the	the	DT	_	22	det
22	treatment	treatment	NN	_	10	conj
23	of	of	IN	_	25	case
24	some	some	DT	_	25	det
25	patients	patient	NNS	_	22	nmod
26	with	with	IN	_	27	case
27	first-episode	first-episode	NN	_	25	nmod
28	or	or	CC	_	27	cc
29	treatment-resistant	treatment-resistant	JJ	_	30	amod
30	schizophrenia	schizophrenia	NN	_	27	conj
31	.	.	.	_	1	punct

1	The	the	DT	_	3	det
2	reduced	reduce	VBN	_	3	amod
3	risk	risk	NN	_	23	nsubj
4	of	of	IN	_	6	case
5	adverse	adverse	JJ	_	6	amod
6	events	event	NNS	_	3	nmod
7	and	and	CC	_	6	cc
8	therapeutic	therapeutic	JJ	_	9	amod
9	superiority	superiority	NN	_	6	conj
10	compared	compare	VBN	_	12	case
11	with	with	IN	_	12	case
12	drug1	drug1	NN	_	3	nmod
13	and	and	CC	_	12	cc
14	drug2	drug2	NN	_	12	conj
15	in	in	IN	_	17	case
16	the	the	DT	_	17	det
17	treatment	treatment	NN	_	12	nmod
18	of	of	IN	_	22	case
19	negative	negative	JJ	_	22	amod
20	and	and	CC	_	19	cc
21	depressive	depressive	JJ	_	19	conj
22	symptoms	symptom	NNS	_	17	nmod
23	support	support	VBP	_	0	ROOT
24	the	the	DT	_	25	det
25	choice	choice	NN	_	23	dobj
26	of	of	IN	_	27	case
27	drug3	drug3	NN	_	25	nmod
28	as	as	IN	_	31	case
29	a	a	DT	_	31	det
30	first-line	first-line	JJ	_	31	amod
31	option	option	NN	_	23	nmod
32	in	in	IN	_	34	case
33	the	the	DT	_	34	det
34	management	management	NN	_	31	nmod
35	of	of	IN	_	36	case
36	schizophrenia	schizophrenia	NN	_	34	nmod
37	in	in	IN	_	40	case
38	the	the	DT	_	40	det
39	acute	acute	JJ	_	40	amod
40	phase	phase	NN	_	31	nmod
41	and	and	CC	_	40	cc
42	for	for	IN	_	44	case
43	the	the	DT	_	44	det
44	maintenance	maintenance	NN	_	40	conj
45	of	of	IN	_	47	case
46	treatment	treatment	NN	_	47	compound
47	response	response	NN	_	44	nmod
48	.	.	.	_	23	punct

1	Antimicrobial	antimicrobial	JJ	_	2	amod
2	activity	activity	NN	_	0	ROOT
3	of	of	IN	_	4	case
4	drug1	drug1	NN	_	2	nmod
5	alone	alone	RB	_	4	advmod
6	and	and	CC	_	4	cc
7	in	in	IN	_	8	case
8	combination	combination	NN	_	4	conj
9	with	with	IN	_	11	case
10	some	some	DT	_	11	det
11	drug2	drug2	NN	_	8	nmod
12	.	.	.	_	2	punct

1	Antimicrobial	antimicrobial	JJ	_	2	amod
2	activity	activity	NN	_	21	nsubjpass
3	of	of	IN	_	4	case
4	drug1	drug1	NN	_	2	nmod
5	-LRB-	-lrb-	-LRB-	_	8	punct
6	the	the	DT	_	8	det
7	aqueous	aqueous	JJ	_	8	amod
8	extract	extract	NN	_	4	dep
9	from	from	IN	_	11	case
10	the	the	DT	_	11	det
11	carpophores	carpophore	NNS	_	8	nmod
12	of	of	IN	_	14	case
13	Ganoderma	ganoderma	NN	_	14	compound
14	lucidum	lucidum	NN	_	11	nmod
15	-LRB-	-lrb-	-LRB-	_	16	punct
16	FR	fr	NN	_	14	appos
17	-RRB-	-rrb-	-RRB-	_	16	punct
18	KARST	karst	NN	_	14	dep
19	-RRB-	-rrb-	-RRB-	_	8	punct
20	was	be	VBD	_	21	auxpass
21	tested	test	VBN	_	0	ROOT
22	in	in	FW	_	23	compound
23	vitro	vitro	FW	_	21	advmod
24	against	against	IN	_	26	case
25	Gram	gram	NN	_	26	nmod:npmod
26	positive	positive	JJ	_	21	advcl
27	and	and	CC	_	26	cc
28	Gram	gram	NN	_	30	compound
29	negative	negative	JJ	_	30	amod
30	bacteria	bacterium	NNS	_	26	conj
31	by	by	IN	_	35	case
32	serial	serial	NN	_	35	compound
33	broth	broth	NN	_	35	compound
34	dilution	dilution	NN	_	35	compound
35	method	method	NN	_	26	nmod
36	,	,	,	_	21	punct
37	and	and	CC	_	21	cc
38	the	the	DT	_	40	det
39	antimicrobial	antimicrobial	JJ	_	40	amod
40	activity	activity	NN	_	42	nsubjpass
41	was	be	VBD	_	42	auxpass
42	expressed	express	VBN	_	21	conj
43	by	by	IN	_	46	case
44	minimal	minimal	JJ	_	46	amod
45	inhibitory	inhibitory	JJ	_	46	amod
46	concentration	concentration	NN	_	42	nmod
47	-LRB-	-lrb-	-LRB-	_	48	punct
48	MIC	mic	NN	_	46	appos
49	-RRB-	-rrb-	-RRB-	_	48	punct
50	.	.	.	_	21	punct

1	Among	among	IN	_	3	case
2	fifteen	fifteen	CD	_	3	nummod
3	species	species	NNS	_	16	nmod
4	of	of	IN	_	5	case
5	bacteria	bacterium	NNS	_	3	nmod
6	tested	test	VBN	_	5	acl
7	,	,	,	_	16	punct
8	the	the	DT	_	10	det
9	antimicrobial	antimicrobial	JJ	_	10	amod
10	activity	activity	NN	_	16	nsubj
11	of	of	IN	_	12	case
12	drug1	drug1	NN	_	10	nmod
13	was	be	VBD	_	16	cop
14	the	the	DT	_	16	det
15	most	most	RBS	_	16	advmod
16	potent	potent	JJ	_	0	ROOT
17	against	against	IN	_	19	case
18	Micrococcus	Micrococcus	NNP	_	19	compound
19	luteus	luteus	NN	_	16	nmod
20	-LRB-	-lrb-	-LRB-	_	21	punct
21	MIC	mic	NN	_	19	dep
22	,	,	,	_	21	punct
23	0.75	0.75	CD	_	24	nummod
24	mg/ml	mg/ml	NN	_	21	appos
25	-RRB-	-rrb-	-RRB-	_	21	punct
26	.	.	.	_	16	punct

1	To	to	TO	_	2	mark
2	investigate	investigate	VB	_	34	advcl
3	the	the	DT	_	4	det
4	effects	effect	NNS	_	2	dobj
5	of	of	IN	_	7	case
6	antimicrobial	antimicrobial	JJ	_	7	amod
7	combinations	combination	NNS	_	4	nmod
8	of	of	IN	_	9	case
9	drug1	drug1	NN	_	7	nmod
10	with	with	IN	_	12	case
11	four	four	CD	_	12	nummod
12	kinds	kind	NNS	_	4	nmod
13	of	of	IN	_	14	case
14	drug2	drug2	NN	_	12	nmod
15	-LRB-	-lrb-	-LRB-	_	16	punct
16	drug3	drug3	NN	_	12	dep
17	,	,	,	_	16	punct
18	drug4	drug4	NN	_	16	conj
19	,	,	,	_	16	punct
20	drug5	drug5	NN	_	16	conj
21	and	and	CC	_	16	cc
22	drug6	drug6	NN	_	16	conj
23	-RRB-	-rrb-	-RRB-	_	16	punct
24	,	,	,	_	34	punct
25	the	the	DT	_	29	det
26	fractional	fractional	JJ	_	29	amod
27	inhibitory	inhibitory	JJ	_	29	amod
28	concentration	concentration	NN	_	29	compound
29	index	index	NN	_	34	nsubjpass
30	-LRB-	-lrb-	-LRB-	_	31	punct
31	FICI	fici	NN	_	29	appos
32	-RRB-	-rrb-	-RRB-	_	31	punct
33	was	be	VBD	_	34	auxpass
34	determined	determine	VBN	_	0	ROOT
35	by	by	IN	_	37	case
36	checkerboard	checkerboard	NN	_	37	compound
37	assay	assay	NN	_	34	nmod
38	for	for	IN	_	40	case
39	each	each	DT	_	40	det
40	strain	strain	NN	_	37	nmod
41	.	.	.	_	34	punct

1	The	the	DT	_	3	det
2	antimicrobial	antimicrobial	JJ	_	3	amod
3	combinations	combination	NNS	_	9	nsubj
4	of	of	IN	_	5	case
5	drug1	drug1	NN	_	3	nmod
6	with	with	IN	_	8	case
7	four	four	CD	_	8	nummod
8	drug2	drug2	NN	_	3	nmod
9	resulted	result	VBD	_	0	ROOT
10	in	in	IN	_	12	case
11	additive	additive	JJ	_	12	amod
12	effect	effect	NN	_	9	nmod
13	in	in	IN	_	15	case
14	most	most	JJS	_	15	amod
15	instances	instance	NNS	_	12	nmod
16	,	,	,	_	15	punct
17	synergism	synergism	NN	_	15	conj
18	in	in	IN	_	20	case
19	two	two	CD	_	20	nummod
20	instances	instance	NNS	_	17	nmod
21	,	,	,	_	15	punct
22	and	and	CC	_	15	cc
23	antagonism	antagonism	NN	_	15	conj
24	in	in	IN	_	26	case
25	two	two	CD	_	26	nummod
26	instances	instance	NNS	_	23	nmod
27	.	.	.	_	9	punct

1	Synergism	synergism	NN	_	3	nsubjpass
2	was	be	VBD	_	3	auxpass
3	observed	observe	VBN	_	0	ROOT
4	when	when	WRB	_	7	advmod
5	drug1	drug1	NN	_	7	nsubjpass
6	was	be	VBD	_	7	auxpass
7	combined	combine	VBN	_	3	advcl
8	with	with	IN	_	9	case
9	drug2	drug2	NN	_	7	nmod
10	against	against	IN	_	12	case
11	Bacillus	bacillus	NN	_	12	compound
12	subtilis	subtilis	NNS	_	9	nmod
13	and	and	CC	_	12	cc
14	Klebsiella	klebsiella	NN	_	15	compound
15	oxytoca	oxytoca	NN	_	12	conj
16	.	.	.	_	3	punct

1	drug1	drug1	NN	_	2	nsubj
2	protects	protect	VBZ	_	0	ROOT
3	mouse	mouse	NN	_	4	compound
4	tumour	tumour	NN	_	2	dobj
5	and	and	CC	_	4	cc
6	normal	normal	JJ	_	7	amod
7	tissues	tissue	NNS	_	4	conj
8	from	from	IN	_	10	case
9	the	the	DT	_	10	det
10	toxicity	toxicity	NN	_	2	nmod
11	of	of	IN	_	13	case
12	oral	oral	JJ	_	13	amod
13	drug2	drug2	NN	_	10	nmod
14	.	.	.	_	2	punct

1	Because	because	IN	_	6	mark
2	the	the	DT	_	4	det
3	drug1	drug1	NN	_	4	compound
4	drug2	drug2	NN	_	6	nsubjpass
5	is	be	VBZ	_	6	auxpass
6	given	give	VBN	_	17	advcl
7	exclusively	exclusively	RB	_	6	advmod
8	by	by	IN	_	11	case
9	the	the	DT	_	11	det
10	oral	oral	JJ	_	11	amod
11	route	route	NN	_	6	nmod
12	in	in	IN	_	13	case
13	man	man	NN	_	11	nmod
14	,	,	,	_	17	punct
15	we	we	PRP	_	17	nsubj
16	have	have	VBP	_	17	aux
17	carried	carry	VBN	_	0	ROOT
18	out	out	RP	_	17	compound:prt
19	studies	study	NNS	_	17	dobj
20	in	in	IN	_	21	case
21	mice	mouse	NNS	_	19	nmod
22	on	on	IN	_	25	case
23	the	the	DT	_	25	det
24	antitumour	antitumour	NN	_	25	compound
25	activity	activity	NN	_	19	nmod
26	,	,	,	_	25	punct
27	acute	acute	JJ	_	28	amod
28	toxicity	toxicity	NN	_	25	conj
29	and	and	CC	_	25	cc
30	pharmacokinetics	pharmacokinetic	NNS	_	25	conj
31	of	of	IN	_	33	case
32	oral	oral	JJ	_	33	amod
33	drug3	drug3	NN	_	30	nmod
34	,	,	,	_	25	punct
35	either	either	CC	_	25	dep
36	alone	alone	RB	_	35	dep
37	or	or	CC	_	35	cc
38	in	in	IN	_	39	case
39	combination	combination	NN	_	35	conj
40	with	with	IN	_	43	case
41	the	the	DT	_	43	det
42	chemosensitizer	chemosensitizer	NN	_	43	compound
43	drug4	drug4	NN	_	39	nmod
44	.	.	.	_	17	punct

1	In	in	IN	_	3	case
2	both	both	DT	_	3	cc:preconj
3	plasma	plasma	NN	_	0	ROOT
4	and	and	CC	_	3	cc
5	KHT	kht	NN	_	6	compound
6	tumour	tumour	NN	_	3	conj
7	the	the	DT	_	9	det
8	peak	peak	NN	_	9	compound
9	concentration	concentration	NN	_	3	dep
10	and	and	CC	_	9	cc
11	``	``	``	_	9	punct
12	early	early	JJ	_	11	root
13	''	''	''	_	12	punct

1	AUC	auc	NN	_	10	nsubj
2	for	for	IN	_	4	case
3	total	total	JJ	_	4	amod
4	drug1	drug1	NN	_	1	nmod
5	were	be	VBD	_	10	cop
6	about	about	IN	_	8	advmod
7	1.4-1	1.4-1	CD	_	8	compound
8	.5	.5	CD	_	9	nummod
9	fold	fold	NN	_	10	nmod:npmod
10	greater	greater	JJR	_	0	ROOT
11	for	for	IN	_	13	case
12	the	the	DT	_	13	det
13	oral	oral	JJ	_	10	nmod
14	compared	compare	VBN	_	17	case
15	to	to	TO	_	17	case
16	the	the	DT	_	17	det
17	i.p.	i.p.	RB	_	10	advcl

1	route	route	NN	_	0	ROOT
2	.	.	.	_	1	punct

1	These	these	DT	_	2	det
2	differences	difference	NNS	_	4	nsubjpass
3	were	be	VBD	_	4	auxpass
4	reflected	reflect	VBN	_	0	ROOT
5	in	in	IN	_	11	case
6	the	the	DT	_	11	det
7	roughly	roughly	RB	_	8	advmod
8	twofold	twofold	RB	_	9	advmod
9	greater	greater	JJR	_	11	amod
10	antitumour	antitumour	NN	_	11	compound
11	activity	activity	NN	_	4	nmod
12	for	for	IN	_	15	case
13	the	the	DT	_	15	det
14	oral	oral	JJ	_	15	amod
15	route	route	NN	_	11	nmod
16	.	.	.	_	4	punct

1	In	in	IN	_	2	case
2	contrast	contrast	NN	_	7	nmod
3	,	,	,	_	7	punct
4	acute	acute	JJ	_	6	amod
5	toxicity	toxicity	NN	_	6	compound
6	tests	test	NNS	_	7	nsubj
7	showed	show	VBD	_	0	ROOT
8	that	that	IN	_	15	mark
9	oral	oral	JJ	_	10	amod
10	drug1	drug1	NN	_	15	nsubj
11	was	be	VBD	_	15	cop
12	1.45	1.45	CD	_	13	compound
13	times	time	NNS	_	15	dep
14	less	less	RBR	_	15	advmod
15	toxic	toxic	JJ	_	7	ccomp
16	to	to	TO	_	18	case
17	normal	normal	JJ	_	18	amod
18	tissue	tissue	NN	_	15	nmod
19	,	,	,	_	15	punct
20	although	although	IN	_	26	mark
21	the	the	DT	_	23	det
22	dose-limiting	dose-limiting	JJ	_	23	amod
23	organ	organ	NN	_	26	nsubj
24	may	may	MD	_	26	aux
25	be	be	VB	_	26	cop
26	different	different	JJ	_	15	advcl
27	for	for	IN	_	30	case
28	the	the	DT	_	30	det
29	two	two	CD	_	30	nummod
30	routes	route	NNS	_	26	nmod
31	.	.	.	_	7	punct

1	drug1	drug1	NN	_	2	nsubj
2	reduced	reduce	VBD	_	0	ROOT
3	the	the	DT	_	5	det
4	antitumour	antitumour	NN	_	5	compound
5	activity	activity	NN	_	2	dobj
6	of	of	IN	_	8	case
7	oral	oral	JJ	_	8	amod
8	drug2	drug2	NN	_	5	nmod
9	by	by	IN	_	12	case
10	dose	dose	NN	_	12	compound
11	modifying	modifying	NN	_	12	compound
12	factors	factor	NNS	_	2	nmod
13	-LRB-	-lrb-	-LRB-	_	14	punct
14	DMF	dmf	NN	_	12	appos
15	-RRB-	-rrb-	-RRB-	_	14	punct
16	of	of	IN	_	18	case
17	0.58-0	0.58-0	CD	_	18	nummod
18	.71	.71	CD	_	12	nmod
19	.	.	.	_	2	punct

1	Similarly	similarly	RB	_	8	advmod
2	,	,	,	_	8	punct
3	the	the	DT	_	5	det
4	acute	acute	JJ	_	5	amod
5	toxicity	toxicity	NN	_	8	nsubjpass
6	was	be	VBD	_	8	auxpass
7	also	also	RB	_	8	advmod
8	diminished	diminish	VBN	_	0	ROOT
9	by	by	IN	_	11	case
10	a	a	DT	_	11	det
11	DMF	dmf	NN	_	8	nmod
12	of	of	IN	_	13	case
13	0.74	0.74	CD	_	11	nmod
14	.	.	.	_	8	punct

1	drug1	drug1	NN	_	2	nsubj
2	has	have	VBZ	_	0	ROOT
3	a	a	DT	_	5	det
4	complex	complex	JJ	_	5	amod
5	effect	effect	NN	_	2	dobj
6	on	on	IN	_	9	case
7	oral	oral	JJ	_	9	amod
8	drug2	drug2	NN	_	9	compound
9	pharmacokinetics	pharmacokinetic	NNS	_	5	nmod
10	.	.	.	_	2	punct

1	The	the	DT	_	8	det
2	plasma	plasma	NN	_	8	compound
3	and	and	CC	_	2	cc
4	tumour	tumour	NN	_	2	conj
5	total	total	JJ	_	8	amod
6	drug1	drug1	NN	_	8	compound
7	peak	peak	NN	_	8	compound
8	concentrations	concentration	NNS	_	10	nsubjpass
9	were	be	VBD	_	10	auxpass
10	reduced	reduce	VBN	_	0	ROOT
11	by	by	IN	_	12	case
12	1.5	1.5	CD	_	10	nmod
13	and	and	CC	_	12	cc
14	1.7	1.7	CD	_	12	conj
15	fold	fold	JJ	_	12	dep
16	respectively	respectively	RB	_	12	advmod
17	.	.	.	_	10	punct

1	drug1	drug1	NN	_	3	nsubj
2	also	also	RB	_	3	advmod
3	reduced	reduce	VBD	_	0	ROOT
4	the	the	DT	_	3	dep
5	``	``	``	_	4	punct
6	early	early	JJ	_	5	root
7	''	''	''	_	6	punct

1	drug1	drug1	NN	_	2	compound
2	AUC	auc	NN	_	0	ROOT
3	,	,	,	_	2	punct
4	with	with	IN	_	6	case
5	the	the	DT	_	6	det
6	extent	extent	NN	_	2	nmod
7	of	of	IN	_	9	case
8	the	the	DT	_	9	det
9	reduction	reduction	NN	_	6	nmod
10	depending	depend	VBG	_	15	case
11	on	on	IN	_	15	case
12	the	the	DT	_	15	det
13	minimum	minimum	JJ	_	15	amod
14	effective	effective	JJ	_	15	amod
15	concentration	concentration	NN	_	6	nmod
16	-LRB-	-lrb-	-LRB-	_	17	punct
17	MEC	mec	NN	_	15	appos
18	-RRB-	-rrb-	-RRB-	_	17	punct
19	chosen	choose	VBN	_	15	acl
20	.	.	.	_	2	punct

1	For	for	IN	_	2	case
2	example	example	NN	_	9	nmod
3	,	,	,	_	9	punct
4	the	the	DT	_	7	det
5	plasma	plasma	NN	_	7	compound
6	drug1	drug1	NN	_	7	compound
7	AUC	auc	NN	_	9	nsubjpass
8	was	be	VBD	_	9	auxpass
9	reduced	reduce	VBN	_	0	ROOT
10	by	by	IN	_	11	case
11	factors	factor	NNS	_	9	nmod
12	of	of	IN	_	13	case
13	1.05	1.05	CD	_	11	nmod
14	and	and	CC	_	13	cc
15	9.6	9.6	CD	_	13	conj
16	for	for	IN	_	18	case
17	MEC	mec	NN	_	18	compound
18	values	value	NNS	_	11	nmod
19	of	of	IN	_	23	case
20	1	1	CD	_	23	compound
21	and	and	CC	_	20	cc
22	2	2	CD	_	20	conj
23	micrograms	microgram	NNS	_	18	nmod
24	ml-1	ml-1	JJ	_	23	amod
25	respectively	respectively	RB	_	24	advmod
26	.	.	.	_	9	punct

1	We	we	PRP	_	2	nsubj
2	propose	propose	VBP	_	0	ROOT
3	these	these	DT	_	5	det
4	pharmacokinetic	pharmacokinetic	JJ	_	5	amod
5	changes	change	NNS	_	2	dobj
6	to	to	TO	_	10	mark
7	be	be	VB	_	10	cop
8	the	the	DT	_	10	det
9	underlying	underlie	VBG	_	10	amod
10	mechanism	mechanism	NN	_	5	acl
11	for	for	IN	_	13	case
12	the	the	DT	_	13	det
13	reduction	reduction	NN	_	10	nmod
14	of	of	IN	_	17	case
15	oral	oral	JJ	_	17	amod
16	drug1	drug1	NN	_	17	compound
17	cytotoxicity	cytotoxicity	NN	_	13	nmod
18	by	by	IN	_	19	case
19	drug2	drug2	NN	_	13	nmod
20	.	.	.	_	2	punct

1	Clinical	clinical	JJ	_	2	amod
2	trials	trial	NNS	_	8	nsubjpass
3	of	of	IN	_	5	case
4	such	such	JJ	_	5	amod
5	combinations	combination	NNS	_	2	nmod
6	should	should	MD	_	8	aux
7	be	be	VB	_	8	auxpass
8	accompanied	accompany	VBN	_	0	ROOT
9	by	by	IN	_	12	case
10	detailed	detailed	JJ	_	12	amod
11	pharmacokinetic	pharmacokinetic	JJ	_	12	amod
12	evaluation	evaluation	NN	_	8	nmod
13	.	.	.	_	8	punct

1	Pharmacokinetic	pharmacokinetic	JJ	_	2	amod
2	interaction	interaction	NN	_	0	ROOT
3	between	between	IN	_	6	case
4	single	single	JJ	_	6	amod
5	oral	oral	JJ	_	6	amod
6	doses	dose	NNS	_	2	nmod
7	of	of	IN	_	8	case
8	drug1	drug1	NN	_	6	nmod
9	and	and	CC	_	8	cc
10	drug2	drug2	NN	_	8	conj
11	in	in	IN	_	13	case
12	healthy	healthy	JJ	_	13	amod
13	volunteers	volunteer	NNS	_	2	nmod
14	.	.	.	_	2	punct

1	AIM	aim	NN	_	0	ROOT
2	AND	and	CC	_	1	cc
3	BACKGROUND	background	NN	_	1	conj
4	:	:	:	_	1	punct
5	The	the	DT	_	7	det
6	pharmacokinetic	pharmacokinetic	JJ	_	7	amod
7	interaction	interaction	NN	_	22	nsubjpass
8	between	between	IN	_	9	case
9	drug1	drug1	NN	_	7	nmod
10	,	,	,	_	9	punct
11	a	a	DT	_	12	det
12	drug2	drug2	NN	_	9	appos
13	metabolized	metabolize	VBN	_	12	acl
14	by	by	IN	_	15	case
15	CYP3A4	cyp3a4	NN	_	13	nmod
16	,	,	,	_	9	punct
17	and	and	CC	_	9	cc
18	the	the	DT	_	20	det
19	drug3	drug3	NN	_	20	compound
20	drug4	drug4	NN	_	9	conj
21	was	be	VBD	_	22	auxpass
22	studied	study	VBN	_	1	dep
23	in	in	IN	_	26	case
24	18	18	CD	_	26	nummod
25	healthy	healthy	JJ	_	26	amod
26	subjects	subject	NNS	_	22	nmod
27	.	.	.	_	22	punct

1	Several	several	JJ	_	4	amod
2	clinically	clinically	RB	_	3	advmod
3	important	important	JJ	_	4	amod
4	interactions	interaction	NNS	_	8	nsubjpass
5	have	have	VBP	_	8	aux
6	previously	previously	RB	_	8	advmod
7	been	be	VBN	_	8	auxpass
8	reported	report	VBN	_	0	ROOT
9	for	for	IN	_	11	case
10	other	other	JJ	_	11	amod
11	drug1	drug1	NN	_	8	nmod
12	that	that	WDT	_	14	nsubjpass
13	are	be	VBP	_	14	auxpass
14	metabolized	metabolize	VBN	_	11	acl:relcl
15	by	by	IN	_	18	case
16	the	the	DT	_	18	det
17	same	same	JJ	_	18	amod
18	enzyme	enzyme	NN	_	14	nmod
19	and	and	CC	_	18	cc
20	for	for	IN	_	21	case
21	drug2	drug2	NN	_	18	conj
22	.	.	.	_	8	punct

1	METHODS	method	NNS	_	0	ROOT
2	:	:	:	_	1	punct
3	Healthy	healthy	JJ	_	4	amod
4	subjects	subject	NNS	_	12	nsubj
5	who	who	WP	_	11	nsubj
6	were	be	VBD	_	11	cop
7	20	20	CD	_	9	compound
8	to	to	TO	_	9	dep
9	43	43	CD	_	10	nummod
10	years	year	NNS	_	11	nmod:npmod
11	old	old	JJ	_	4	acl:relcl
12	participated	participate	VBD	_	1	dep
13	in	in	IN	_	22	case
14	an	a	DT	_	22	det
15	open	open	JJ	_	22	amod
16	,	,	,	_	15	punct
17	three-period	three-period	JJ	_	15	dep
18	,	,	,	_	15	punct
19	randomized	randomize	VBN	_	15	dep
20	,	,	,	_	15	punct
21	crossover	crossover	NN	_	15	dep
22	study	study	NN	_	12	nmod
23	of	of	IN	_	25	case
24	the	the	DT	_	25	det
25	pharmacokinetics	pharmacokinetic	NNS	_	22	nmod
26	of	of	IN	_	31	case
27	a	a	DT	_	31	det
28	single	single	JJ	_	31	amod
29	10-mg	10-mg	JJ	_	31	amod
30	oral	oral	JJ	_	31	amod
31	dose	dose	NN	_	25	nmod
32	of	of	IN	_	33	case
33	drug1	drug1	NN	_	31	nmod
34	,	,	,	_	31	punct
35	a	a	DT	_	39	det
36	single	single	JJ	_	39	amod
37	oral	oral	JJ	_	39	amod
38	120-mg	120-mg	JJ	_	39	amod
39	dose	dose	NN	_	31	conj
40	of	of	IN	_	41	case
41	drug2	drug2	NN	_	39	nmod
42	,	,	,	_	31	punct
43	and	and	CC	_	31	cc
44	the	the	DT	_	46	det
45	two	two	CD	_	46	nummod
46	drugs	drug	NNS	_	31	conj
47	given	give	VBN	_	46	acl
48	together	together	RB	_	47	advmod
49	.	.	.	_	1	punct

1	The	the	DT	_	4	det
2	three	three	CD	_	4	nummod
3	study	study	NN	_	4	compound
4	periods	period	NNS	_	6	nsubjpass
5	were	be	VBD	_	6	auxpass
6	separated	separate	VBN	_	0	ROOT
7	by	by	IN	_	11	case
8	a	a	DT	_	11	det
9	21-day	21-day	JJ	_	11	amod
10	washout	washout	NN	_	11	compound
11	phase	phase	NN	_	6	nmod
12	.	.	.	_	6	punct

1	RESULTS	result	NNS	_	0	ROOT
2	:	:	:	_	1	punct
3	The	the	DT	_	5	det
4	geometric	geometric	JJ	_	5	amod
5	mean	mean	NN	_	21	nsubj
6	-LRB-	-lrb-	-LRB-	_	10	punct
7	90	90	CD	_	8	compound
8	%	%	NN	_	10	amod
9	confidence	confidence	NN	_	10	compound
10	interval	interval	NN	_	5	appos
11	-RRB-	-rrb-	-RRB-	_	10	punct
12	whole	whole	JJ	_	15	amod
13	blood	blood	NN	_	15	compound
14	drug1	drug1	NN	_	15	compound
15	area	area	NN	_	5	dep
16	under	under	IN	_	20	case
17	the	the	DT	_	20	det
18	plasma	plasma	NN	_	20	compound
19	concentration	concentration	NN	_	20	compound
20	time-curve	time-curve	NN	_	15	nmod
21	increased	increase	VBD	_	1	dep
22	60	60	CD	_	23	nummod
23	%	%	NN	_	21	dobj
24	-LRB-	-lrb-	-LRB-	_	26	punct
25	35	35	CD	_	26	nummod
26	%	%	NN	_	23	dep
27	-90	-90	CD	_	28	nummod
28	%	%	NN	_	26	dep
29	-RRB-	-rrb-	-RRB-	_	26	punct
30	,	,	,	_	21	punct
31	from	from	IN	_	32	case
32	736	736	CD	_	21	nmod
33	to	to	TO	_	34	dep
34	1178	1178	CD	_	32	nmod
35	ng	ng	NN	_	34	dep
36	x	x	CC	_	35	cc
37	h/mL	h/ml	NN	_	35	conj
38	,	,	,	_	21	punct
39	and	and	CC	_	21	cc
40	maximum	maximum	NN	_	41	compound
41	concentration	concentration	NN	_	42	nsubj
42	increased	increase	VBD	_	21	conj
43	43	43	CD	_	44	nummod
44	%	%	NN	_	42	dobj
45	-LRB-	-lrb-	-LRB-	_	47	punct
46	14	14	CD	_	47	nummod
47	%	%	NN	_	42	dep
48	-81	-81	CD	_	49	nummod
49	%	%	NN	_	47	dep
50	-RRB-	-rrb-	-RRB-	_	47	punct
51	,	,	,	_	21	punct
52	from	from	IN	_	53	case
53	67	67	CD	_	21	nmod
54	to	to	TO	_	55	dep
55	96	96	CD	_	56	nummod
56	ng/mL	ng/ml	NN	_	53	nmod:npmod
57	,	,	,	_	21	punct
58	with	with	IN	_	60	case
59	drug2	drug2	NN	_	60	compound
60	coadministration	coadministration	NN	_	21	nmod
61	,	,	,	_	21	punct
62	whereas	whereas	IN	_	21	dep
63	the	the	DT	_	66	det
64	mean	mean	NN	_	66	compound
65	elimination	elimination	NN	_	66	compound
66	half-life	half-life	NN	_	69	nsubj
67	of	of	IN	_	68	case
68	drug3	drug3	NN	_	66	nmod
69	decreased	decrease	VBD	_	21	parataxis
70	slightly	slightly	RB	_	69	advmod
71	,	,	,	_	69	punct
72	from	from	IN	_	76	case
73	79	79	CD	_	75	compound
74	to	to	TO	_	75	dep
75	67	67	CD	_	76	nummod
76	hours	hour	NNS	_	69	nmod
77	.	.	.	_	1	punct

1	Apparent	apparent	JJ	_	3	amod
2	oral	oral	JJ	_	3	amod
3	clearance	clearance	NN	_	10	nsubj
4	and	and	CC	_	3	cc
5	volume	volume	NN	_	3	conj
6	of	of	IN	_	7	case
7	distribution	distribution	NN	_	5	nmod
8	of	of	IN	_	9	case
9	drug1	drug1	NN	_	7	nmod
10	decreased	decrease	VBD	_	0	ROOT
11	with	with	IN	_	13	case
12	38	38	CD	_	13	nummod
13	%	%	NN	_	10	nmod
14	and	and	CC	_	13	cc
15	45	45	CD	_	16	nummod
16	%	%	NN	_	13	conj
17	,	,	,	_	13	punct
18	respectively	respectively	RB	_	13	advmod
19	,	,	,	_	13	punct
20	when	when	WRB	_	23	advmod
21	drug2	drug2	NN	_	23	nsubjpass
22	was	be	VBD	_	23	auxpass
23	given	give	VBN	_	13	acl:relcl
24	with	with	IN	_	25	case
25	drug3	drug3	NN	_	23	nmod
26	.	.	.	_	10	punct

1	The	the	DT	_	4	det
2	plasma	plasma	NN	_	4	compound
3	maximum	maximum	NN	_	4	compound
4	concentration	concentration	NN	_	20	nsubj
5	and	and	CC	_	4	cc
6	area	area	NN	_	4	conj
7	under	under	IN	_	11	case
8	the	the	DT	_	11	det
9	plasma	plasma	NN	_	11	compound
10	concentration-time	concentration-time	NN	_	11	compound
11	curve	curve	NN	_	4	nmod
12	of	of	IN	_	13	case
13	drug1	drug1	NN	_	11	nmod
14	,	,	,	_	13	punct
15	drug2	drug2	NN	_	13	conj
16	,	,	,	_	13	punct
17	and	and	CC	_	13	cc
18	drug3	drug3	NN	_	13	conj
19	were	be	VBD	_	20	cop
20	unchanged	unchanged	JJ	_	0	ROOT
21	after	after	IN	_	22	case
22	coadministration	coadministration	NN	_	20	nmod
23	of	of	IN	_	24	case
24	drug4	drug4	NN	_	22	nmod
25	,	,	,	_	20	punct
26	and	and	CC	_	20	cc
27	no	no	DT	_	28	neg
28	potentiation	potentiation	NN	_	46	nsubjpass
29	of	of	IN	_	31	case
30	the	the	DT	_	31	det
31	effects	effect	NNS	_	28	nmod
32	of	of	IN	_	33	case
33	drug5	drug5	NN	_	31	nmod
34	on	on	IN	_	39	case
35	diastolic	diastolic	JJ	_	39	amod
36	or	or	CC	_	35	cc
37	systolic	systolic	JJ	_	35	conj
38	blood	blood	NN	_	39	compound
39	pressure	pressure	NN	_	31	nmod
40	or	or	CC	_	39	cc
41	on	on	IN	_	44	case
42	the	the	DT	_	44	det
43	electrocardiographic	electrocardiographic	JJ	_	44	amod
44	parameters	parameter	NNS	_	39	conj
45	was	be	VBD	_	46	auxpass
46	seen	see	VBN	_	20	conj
47	.	.	.	_	20	punct

1	CONCLUSIONS	conclusion	NNS	_	0	ROOT
2	:	:	:	_	1	punct
3	Single-dose	single-dose	JJ	_	5	amod
4	drug1	drug1	NN	_	5	compound
5	coadministration	coadministration	NN	_	6	nsubj
6	leads	lead	VBZ	_	1	dep
7	to	to	TO	_	10	case
8	higher	higher	JJR	_	10	amod
9	drug2	drug2	NN	_	10	compound
10	exposure	exposure	NN	_	6	nmod
11	,	,	,	_	10	punct
12	presumably	presumably	RB	_	14	advmod
13	by	by	IN	_	14	case
14	inhibition	inhibition	NN	_	10	nmod
15	of	of	IN	_	18	case
16	the	the	DT	_	18	det
17	first-pass	first-pass	JJ	_	18	amod
18	metabolism	metabolism	NN	_	14	nmod
19	of	of	IN	_	20	case
20	drug3	drug3	NN	_	18	nmod
21	.	.	.	_	1	punct

1	Because	because	IN	_	6	case
2	of	of	IN	_	1	mwe
3	the	the	DT	_	6	det
4	pronounced	pronounced	JJ	_	6	amod
5	intersubject	intersubject	NN	_	6	compound
6	variability	variability	NN	_	23	nmod
7	in	in	IN	_	9	case
8	the	the	DT	_	9	det
9	extent	extent	NN	_	6	nmod
10	of	of	IN	_	15	case
11	the	the	DT	_	15	det
12	drug1	drug1	NN	_	15	compound
13	-	-	:	_	15	punct
14	drug2	drug2	NN	_	15	compound
15	interaction	interaction	NN	_	9	nmod
16	,	,	,	_	23	punct
17	whole	whole	JJ	_	20	amod
18	blood	blood	NN	_	20	compound
19	drug3	drug3	NN	_	20	compound
20	concentrations	concentration	NNS	_	23	nsubjpass
21	should	should	MD	_	23	aux
22	be	be	VB	_	23	auxpass
23	monitored	monitor	VBN	_	0	ROOT
24	closely	closely	RB	_	23	advmod
25	in	in	IN	_	26	case
26	patients	patient	NNS	_	23	nmod
27	treated	treat	VBN	_	26	acl
28	with	with	IN	_	31	case
29	the	the	DT	_	31	det
30	two	two	CD	_	31	nummod
31	drugs	drug	NNS	_	27	nmod
32	.	.	.	_	23	punct

1	drug1	drug1	NN	_	0	ROOT
2	,	,	,	_	1	punct
3	a	a	DT	_	5	det
4	trans-3	trans-3	JJ	_	5	amod
5	,4	,4	NN	_	1	appos
6	-	-	:	_	1	punct
7	dimethyl-4	dimethyl-4	NN	_	12	compound
8	-	-	:	_	12	punct
9	-LRB-	-lrb-	-LRB-	_	10	punct
10	3-hydroxyphenyl	3-hydroxyphenyl	NN	_	12	dep
11	-RRB-	-rrb-	-RRB-	_	10	punct
12	piperidine	piperidine	NN	_	14	nsubj
13	,	,	,	_	12	punct
14	prevents	prevent	VBZ	_	1	dep
15	gastrointestinal	gastrointestinal	JJ	_	16	amod
16	effects	effect	NNS	_	14	dobj
17	of	of	IN	_	19	case
18	intravenous	intravenous	JJ	_	19	amod
19	drug2	drug2	NN	_	16	nmod
20	without	without	IN	_	21	mark
21	affecting	affect	VBG	_	14	advcl
22	analgesia	analgesia	NN	_	21	dobj
23	.	.	.	_	1	punct

1	drug1	drug1	NN	_	5	nsubj
2	is	be	VBZ	_	5	cop
3	a	a	DT	_	5	det
4	novel	novel	JJ	_	5	amod
5	drug2	drug2	NN	_	0	ROOT
6	that	that	WDT	_	9	nsubj
7	may	may	MD	_	9	aux
8	selectively	selectively	RB	_	9	advmod
9	prevent	prevent	VB	_	5	acl:relcl
10	drug3	drug3	NN	_	9	dobj
11	-	-	:	_	9	punct
12	induced	induce	VBN	_	14	amod
13	gastrointestinal	gastrointestinal	JJ	_	14	amod
14	effects	effect	NNS	_	9	dobj
15	without	without	IN	_	16	mark
16	reversing	reverse	VBG	_	14	acl
17	analgesia	analgesia	NN	_	16	dobj
18	.	.	.	_	5	punct

1	Gastrointestinal	gastrointestinal	JJ	_	3	amod
2	transit	transit	NN	_	3	compound
3	time	time	NN	_	11	nsubjpass
4	-LRB-	-lrb-	-LRB-	_	8	punct
5	lactulose	lactulose	NN	_	8	compound
6	hydrogen	hydrogen	NN	_	8	compound
7	breath	breath	NN	_	8	compound
8	test	test	NN	_	3	appos
9	-RRB-	-rrb-	-RRB-	_	8	punct
10	was	be	VBD	_	11	auxpass
11	measured	measure	VBN	_	0	ROOT
12	in	in	IN	_	14	case
13	14	14	CD	_	14	nummod
14	volunteers	volunteer	NNS	_	11	nmod
15	with	with	IN	_	19	case
16	oral	oral	JJ	_	19	amod
17	and	and	CC	_	16	cc
18	intravenous	intravenous	JJ	_	16	conj
19	placebo	placebo	NN	_	14	nmod
20	,	,	,	_	14	punct
21	oral	oral	JJ	_	22	amod
22	placebo	placebo	NN	_	14	conj
23	and	and	CC	_	22	cc
24	intravenous	intravenous	JJ	_	25	amod
25	drug1	drug1	NN	_	22	conj
26	-LRB-	-lrb-	-LRB-	_	28	punct
27	0.05	0.05	CD	_	28	nummod
28	mg	mg	NN	_	25	dep
29	x	x	CC	_	28	cc
30	kg	kg	NN	_	28	conj
31	-LRB-	-lrb-	-LRB-	_	32	punct
32	-1	-1	CD	_	30	appos
33	-RRB-	-rrb-	-RRB-	_	32	punct
34	-RRB-	-rrb-	-RRB-	_	28	punct
35	,	,	,	_	14	punct
36	and	and	CC	_	14	cc
37	oral	oral	JJ	_	38	amod
38	drug2	drug2	NN	_	14	conj
39	-LRB-	-lrb-	-LRB-	_	41	punct
40	4	4	CD	_	41	nummod
41	mg	mg	NN	_	38	appos
42	-RRB-	-rrb-	-RRB-	_	41	punct
43	and	and	CC	_	38	cc
44	intravenous	intravenous	JJ	_	45	amod
45	drug3	drug3	NN	_	38	conj
46	-LRB-	-lrb-	-LRB-	_	48	punct
47	0.05	0.05	CD	_	48	nummod
48	mg	mg	NN	_	45	dep
49	x	x	CC	_	48	cc
50	kg	kg	NN	_	48	conj
51	-LRB-	-lrb-	-LRB-	_	52	punct
52	-1	-1	CD	_	50	appos
53	-RRB-	-rrb-	-RRB-	_	52	punct
54	-RRB-	-rrb-	-RRB-	_	48	punct
55	in	in	IN	_	61	case
56	a	a	DT	_	61	det
57	double	double	JJ	_	61	amod
58	blind	blind	JJ	_	61	amod
59	,	,	,	_	61	punct
60	cross-over	cross-over	JJ	_	61	amod
61	study	study	NN	_	11	nmod
62	.	.	.	_	11	punct

1	drug1	drug1	NN	_	2	nsubj
2	prolonged	prolong	VBD	_	0	ROOT
3	gastrointestinal	gastrointestinal	JJ	_	5	amod
4	transit	transit	NN	_	5	compound
5	time	time	NN	_	2	dobj
6	from	from	IN	_	10	case
7	69	69	CD	_	9	compound
8	to	to	TO	_	9	dep
9	103	103	CD	_	10	nummod
10	minutes	minute	NNS	_	2	nmod
11	-LRB-	-lrb-	-LRB-	_	13	punct
12	P	p	NN	_	13	nsubj
13	=	=	JJ	_	10	dep
14	.005	.005	NN	_	13	dobj
15	-RRB-	-rrb-	-RRB-	_	13	punct
16	;	;	:	_	2	punct

1	drug1	drug1	NN	_	2	nsubj
2	prolonged	prolong	VBD	_	0	ROOT
3	gastrointestinal	gastrointestinal	JJ	_	5	amod
4	transit	transit	NN	_	5	compound
5	time	time	NN	_	2	dobj
6	from	from	IN	_	10	case
7	69	69	CD	_	9	compound
8	to	to	TO	_	9	dep
9	103	103	CD	_	10	nummod
10	minutes	minute	NNS	_	2	nmod
11	-LRB-	-lrb-	-LRB-	_	13	punct
12	P	p	NN	_	13	nsubj
13	=	=	JJ	_	10	dep
14	.005	.005	NN	_	13	dobj
15	-RRB-	-rrb-	-RRB-	_	13	punct
16	;	;	:	_	2	punct
17	this	this	DT	_	19	nsubjpass
18	was	be	VBD	_	19	auxpass
19	prevented	prevent	VBN	_	2	parataxis
20	by	by	IN	_	21	case
21	drug2	drug2	NN	_	19	nmod
22	-LRB-	-lrb-	-LRB-	_	23	punct
23	P	p	NN	_	21	dep
24	=	=	JJ	_	23	amod
25	.004	.004	CD	_	24	dep
26	-RRB-	-rrb-	-RRB-	_	23	punct
27	.	.	.	_	2	punct

1	Postoperatively	postoperatively	RB	_	7	advmod
2	,	,	,	_	7	punct
3	45	45	CD	_	4	nummod
4	patients	patient	NNS	_	7	nsubjpass
5	were	be	VBD	_	7	auxpass
6	randomly	randomly	RB	_	7	advmod
7	assigned	assign	VBN	_	0	ROOT
8	in	in	IN	_	11	case
9	a	a	DT	_	11	det
10	double-blind	double-blind	JJ	_	11	amod
11	fashion	fashion	NN	_	7	nmod
12	to	to	TO	_	13	mark
13	receive	receive	VB	_	7	xcomp
14	drug1	drug1	NN	_	13	dobj
15	-LRB-	-lrb-	-LRB-	_	17	punct
16	4	4	CD	_	17	nummod
17	mg	mg	NN	_	14	appos
18	-RRB-	-rrb-	-RRB-	_	17	punct
19	or	or	CC	_	14	cc
20	placebo	placebo	NN	_	23	compound
21	and	and	CC	_	20	cc
22	intravenous	intravenous	JJ	_	20	conj
23	drug2	drug2	NN	_	14	conj
24	-LRB-	-lrb-	-LRB-	_	26	punct
25	0.15	0.15	CD	_	26	nummod
26	mg/kg	mg/kg	NN	_	23	appos
27	-RRB-	-rrb-	-RRB-	_	26	punct
28	or	or	CC	_	13	cc
29	to	to	TO	_	30	mark
30	receive	receive	VB	_	13	conj
31	oral	oral	JJ	_	34	amod
32	and	and	CC	_	31	cc
33	intravenous	intravenous	JJ	_	31	conj
34	placebo	placebo	NN	_	30	dobj
35	.	.	.	_	7	punct

1	Analgesia	Analgesia	NNP	_	4	compound
2	and	and	CC	_	1	cc
3	pupil	pupil	NN	_	1	conj
4	constriction	constriction	NN	_	6	nsubjpass
5	were	be	VBD	_	6	auxpass
6	measured	measure	VBN	_	0	ROOT
7	.	.	.	_	6	punct

1	drug1	drug1	NN	_	2	compound
2	analgesia	analgesia	NN	_	7	nsubj
3	and	and	CC	_	2	cc
4	pupil	pupil	NN	_	5	compound
5	constriction	constriction	NN	_	2	conj
6	were	be	VBD	_	7	aux
7	unaffected	unaffected	JJ	_	0	ROOT
8	by	by	IN	_	9	case
9	drug2	drug2	NN	_	7	nmod
10	and	and	CC	_	7	cc
11	differed	differ	VBD	_	7	conj
12	from	from	IN	_	13	case
13	placebo	placebo	NN	_	11	nmod
14	-LRB-	-lrb-	-LRB-	_	16	punct
15	P	p	NN	_	16	dep
16	<	<	JJR	_	11	parataxis
17	.002	.002	CD	_	16	nummod
18	-RRB-	-rrb-	-RRB-	_	16	punct
19	.	.	.	_	7	punct

1	We	we	PRP	_	2	nsubj
2	conclude	conclude	VBP	_	0	ROOT
3	that	that	IN	_	5	mark
4	drug1	drug1	NN	_	5	nsubj
5	prevents	prevent	VBZ	_	2	ccomp
6	drug2	drug2	NN	_	9	nsubj
7	-	-	:	_	9	punct
8	induced	induce	VBN	_	9	amod
9	increases	increase	NNS	_	5	ccomp
10	in	in	IN	_	13	case
11	gastrointestinal	gastrointestinal	JJ	_	13	amod
12	transit	transit	NN	_	13	compound
13	time	time	NN	_	9	nmod
14	by	by	IN	_	15	case
15	means	means	NNS	_	9	nmod
16	of	of	IN	_	20	case
17	selective	selective	JJ	_	20	amod
18	peripheral	peripheral	JJ	_	20	amod
19	opioid	opioid	NN	_	20	compound
20	anitagonism	anitagonism	NN	_	15	nmod
21	without	without	IN	_	22	mark
22	affecting	affect	VBG	_	9	advcl
23	central	central	JJ	_	25	amod
24	opioid	opioid	JJ	_	25	amod
25	analgesia	analgesia	NN	_	22	dobj
26	.	.	.	_	2	punct

1	The	the	DT	_	2	det
2	effects	effect	NNS	_	0	ROOT
3	of	of	IN	_	4	case
4	drug1	drug1	NN	_	2	nmod
5	,	,	,	_	4	punct
6	drug2	drug2	NN	_	4	conj
7	and	and	CC	_	4	cc
8	drug3	drug3	NN	_	4	conj
9	on	on	IN	_	11	case
10	bar-press	bar-press	NN	_	11	compound
11	behavior	behavior	NN	_	2	nmod
12	in	in	IN	_	13	case
13	normal	normal	JJ	_	11	nmod
14	and	and	CC	_	13	cc
15	genetically	genetically	RB	_	16	advmod
16	nervous	nervous	JJ	_	13	conj
17	dogs	dog	NNS	_	13	dep
18	.	.	.	_	2	punct

1	Studies	study	NNS	_	9	nsubj
2	on	on	IN	_	4	case
3	two	two	CD	_	4	nummod
4	strains	strain	NNS	_	1	nmod
5	of	of	IN	_	7	case
6	pointer	pointer	NN	_	7	compound
7	dogs	dog	NNS	_	4	nmod
8	have	have	VBP	_	9	aux
9	demonstrated	demonstrate	VBN	_	0	ROOT
10	that	that	IN	_	9	dobj
11	administration	administration	NN	_	10	root
12	of	of	IN	_	14	case
13	a	a	DT	_	14	det
14	drug1	drug1	NN	_	11	nmod
15	-LRB-	-lrb-	-LRB-	_	16	punct
16	drug2	drug2	NN	_	14	appos
17	-RRB-	-rrb-	-RRB-	_	16	punct
18	facilitates	facilitate	VBZ	_	14	acl
19	acquisition	acquisition	NN	_	18	dobj
20	of	of	IN	_	22	case
21	goal-directed	goal-directed	JJ	_	22	amod
22	behavior	behavior	NN	_	19	nmod
23	in	in	IN	_	26	case
24	``	``	``	_	26	punct
25	genetically	genetically	RB	_	26	advmod
26	nervous	nervous	JJ	_	19	acl
27	''	''	''	_	26	punct

1	subjects	subject	NNS	_	0	ROOT
2	.	.	.	_	1	punct

1	Continued	continue	VBN	_	2	amod
2	admistration	admistration	NN	_	7	nsubjpass
3	of	of	IN	_	5	case
4	the	the	DT	_	5	det
5	drug	drug	NN	_	2	nmod
6	is	be	VBZ	_	7	auxpass
7	required	require	VBN	_	0	ROOT
8	to	to	TO	_	9	mark
9	maintain	maintain	VB	_	7	xcomp
10	barpress	barpress	NN	_	11	compound
11	response	response	NN	_	9	dobj
12	in	in	IN	_	14	case
13	this	this	DT	_	14	det
14	strain	strain	NN	_	11	nmod
15	of	of	IN	_	16	case
16	dogs	dog	NNS	_	14	nmod
17	.	.	.	_	7	punct

1	The	the	DT	_	3	det
2	concomitant	concomitant	JJ	_	3	amod
3	administration	administration	NN	_	18	nsubj
4	of	of	IN	_	6	case
5	either	either	CC	_	6	cc:preconj
6	drug1	drug1	NN	_	3	nmod
7	or	or	CC	_	6	cc
8	drug2	drug2	NN	_	6	conj
9	,	,	,	_	6	punct
10	compounds	compound	NNS	_	6	appos
11	which	which	WDT	_	12	nsubj
12	inhibit	inhibit	VBP	_	10	acl:relcl
13	neuronal	neuronal	JJ	_	14	amod
14	reuptake	reuptake	NN	_	12	dobj
15	of	of	IN	_	16	case
16	norepinephrine	norepinephrine	NN	_	14	nmod
17	,	,	,	_	6	punct
18	disrupts	disrupt	VBZ	_	0	ROOT
19	the	the	DT	_	21	det
20	behavioral	behavioral	JJ	_	21	amod
21	response	response	NN	_	18	dobj
22	of	of	IN	_	27	case
23	the	the	DT	_	27	det
24	genetically	genetically	RB	_	25	advmod
25	nervous	nervous	JJ	_	27	amod
26	E-strain	e-strain	JJ	_	27	amod
27	subjects	subject	NNS	_	21	nmod
28	to	to	TO	_	32	case
29	a	a	DT	_	32	det
30	far	far	RB	_	31	advmod
31	greater	greater	JJR	_	32	amod
32	extent	extent	NN	_	21	nmod
33	than	than	IN	_	37	case
34	the	the	DT	_	37	det
35	stable	stable	JJ	_	37	amod
36	A-strain	a-strain	JJ	_	37	amod
37	subjects	subject	NNS	_	32	nmod
38	.	.	.	_	18	punct

1	It	it	PRP	_	4	nsubjpass
2	is	be	VBZ	_	4	auxpass
3	also	also	RB	_	4	advmod
4	shown	show	VBN	_	0	ROOT
5	that	that	IN	_	21	mark
6	after	after	IN	_	8	case
7	14	14	CD	_	8	nummod
8	days	day	NNS	_	21	nmod
9	of	of	IN	_	11	case
10	daily	daily	JJ	_	11	amod
11	administration	administration	NN	_	8	nmod
12	of	of	IN	_	13	case
13	drug1	drug1	NN	_	11	nmod
14	,	,	,	_	21	punct
15	withdrawal	withdrawal	NN	_	21	nsubj
16	of	of	IN	_	18	case
17	the	the	DT	_	18	det
18	drug	drug	NN	_	15	nmod
19	not	not	RB	_	20	neg
20	only	only	RB	_	21	cc:preconj
21	re-results	re-result	NNS	_	4	ccomp
22	in	in	IN	_	25	case
23	almost	almost	RB	_	24	advmod
24	complete	complete	JJ	_	25	amod
25	loss	loss	NN	_	21	nmod
26	of	of	IN	_	28	case
27	bar-press	bar-press	NN	_	28	compound
28	response	response	NN	_	25	nmod
29	in	in	IN	_	32	case
30	the	the	DT	_	32	det
31	E-strain	e-strain	JJ	_	32	amod
32	subjects	subject	NNS	_	21	nmod
33	but	but	CC	_	21	cc
34	also	also	RB	_	35	advmod
35	results	result	VBZ	_	21	conj
36	in	in	IN	_	39	case
37	a	a	DT	_	39	det
38	temporary	temporary	JJ	_	39	amod
39	decrease	decrease	NN	_	35	nmod
40	in	in	IN	_	44	case
41	the	the	DT	_	44	det
42	acquired	acquire	VBN	_	44	amod
43	behavioral	behavioral	JJ	_	44	amod
44	response	response	NN	_	39	nmod
45	of	of	IN	_	49	case
46	the	the	DT	_	49	det
47	stable	stable	JJ	_	49	amod
48	A-strain	a-strain	JJ	_	49	amod
49	subjects	subject	NNS	_	44	nmod
50	.	.	.	_	4	punct

1	Therapeutic	therapeutic	JJ	_	3	amod
2	drug	drug	NN	_	3	compound
3	monitoring	monitoring	NN	_	5	nsubj
4	can	can	MD	_	5	aux
5	avoid	avoid	VB	_	0	ROOT
6	iatrogenic	iatrogenic	JJ	_	7	amod
7	alterations	alteration	NNS	_	5	dobj
8	caused	cause	VBN	_	7	acl
9	by	by	IN	_	10	case
10	drug1	drug1	NN	_	8	nmod
11	-LRB-	-lrb-	-LRB-	_	12	punct
12	MDP	mdp	NN	_	10	appos
13	-RRB-	-rrb-	-RRB-	_	12	punct
14	-	-	:	_	10	punct
15	drug2	drug2	NN	_	16	compound
16	interaction	interaction	NN	_	10	dep
17	.	.	.	_	5	punct

1	drug1	drug1	NN	_	4	nsubj
2	is	be	VBZ	_	4	cop
3	an	a	DT	_	4	det
4	drug2	drug2	NN	_	0	ROOT
5	used	use	VBN	_	4	acl
6	to	to	TO	_	7	mark
7	treat	treat	VB	_	5	xcomp
8	a	a	DT	_	10	det
9	wide	wide	JJ	_	10	amod
10	variety	variety	NN	_	7	dobj
11	of	of	IN	_	12	case
12	infections	infection	NNS	_	10	nmod
13	caused	cause	VBN	_	12	acl
14	by	by	IN	_	16	case
15	gram-negative	gram-negative	JJ	_	16	amod
16	organisms	organism	NNS	_	13	nmod
17	,	,	,	_	4	punct
18	but	but	CC	_	4	cc
19	it	it	PRP	_	22	nsubj
20	is	be	VBZ	_	22	cop
21	potentially	potentially	RB	_	22	advmod
22	toxic	toxic	JJ	_	4	conj
23	to	to	TO	_	25	case
24	the	the	DT	_	25	det
25	kidneys	kidney	NNS	_	22	nmod
26	.	.	.	_	4	punct

1	Due	due	JJ	_	8	advmod
2	to	to	TO	_	4	case
3	its	its	PRP$	_	4	nmod:poss
4	nephrotoxicity	nephrotoxicity	NN	_	1	nmod
5	,	,	,	_	8	punct
6	drug1	drug1	NN	_	8	nsubj
7	may	may	MD	_	8	aux
8	cause	cause	VB	_	0	ROOT
9	abnormal	abnormal	JJ	_	11	amod
10	renal	renal	JJ	_	11	amod
11	uptake	uptake	NN	_	8	dobj
12	to	to	TO	_	14	mark
13	be	be	VB	_	14	auxpass
14	seen	see	VBN	_	11	acl
15	on	on	IN	_	18	case
16	drug2	drug2	NN	_	18	compound
17	bone	bone	NN	_	18	compound
18	scintigraphy	scintigraphy	NN	_	14	nmod
19	.	.	.	_	8	punct

1	The	the	DT	_	2	det
2	presence	presence	NN	_	18	nsubj
3	of	of	IN	_	5	case
4	the	the	DT	_	5	det
5	drug1	drug1	NN	_	2	nmod
6	in	in	IN	_	8	case
7	the	the	DT	_	8	det
8	kidneys	kidney	NNS	_	2	nmod
9	,	,	,	_	18	punct
10	along	along	IN	_	13	case
11	with	with	IN	_	13	case
12	an	a	DT	_	13	det
13	increase	increase	NN	_	18	nmod
14	in	in	IN	_	16	case
15	renal	renal	JJ	_	16	amod
16	retention	retention	NN	_	13	nmod
17	,	,	,	_	18	punct
18	tend	tend	VB	_	0	ROOT
19	to	to	TO	_	20	mark
20	produce	produce	VB	_	18	xcomp
21	scintigraphic	scintigraphic	JJ	_	22	amod
22	results	result	NNS	_	20	dobj
23	that	that	WDT	_	25	nsubj
24	falsely	falsely	RB	_	25	advmod
25	identify	identify	VBP	_	22	acl:relcl
26	characteristics	characteristic	NNS	_	25	dobj
27	related	related	JJ	_	26	amod
28	to	to	TO	_	29	case
29	diseases	disease	NNS	_	27	nmod
30	such	such	JJ	_	33	case
31	as	as	IN	_	30	mwe
32	renal	renal	JJ	_	33	amod
33	vascular	vascular	JJ	_	29	nmod
34	,	,	,	_	33	punct
35	or	or	CC	_	33	cc
36	urinary	urinary	JJ	_	38	amod
37	tract	tract	NN	_	38	compound
38	obstruction	obstruction	NN	_	33	conj
39	,	,	,	_	18	punct
40	and	and	CC	_	18	cc
41	even	even	RB	_	43	advmod
42	renal	renal	JJ	_	43	amod
43	cancer	cancer	NN	_	18	conj
44	.	.	.	_	18	punct

1	An	a	DT	_	3	det
2	altered	altered	JJ	_	3	amod
3	biodistribution	biodistribution	NN	_	5	nsubj
4	may	may	MD	_	5	aux
5	provide	provide	VB	_	0	ROOT
6	misleading	misleading	JJ	_	7	amod
7	information	information	NN	_	5	dobj
8	that	that	WDT	_	11	nsubj
9	can	can	MD	_	11	aux
10	either	either	CC	_	11	cc:preconj
11	mask	mask	NN	_	7	acl:relcl
12	or	or	CC	_	11	cc
13	mimic	mimic	VB	_	11	conj
14	certain	certain	JJ	_	16	amod
15	disease	disease	NN	_	16	compound
16	symptoms	symptom	NNS	_	11	dobj
17	.	.	.	_	5	punct

1	A	a	DT	_	2	det
2	method	method	NN	_	26	nsubj
3	to	to	TO	_	4	mark
4	maximize	maximize	VB	_	2	acl
5	the	the	DT	_	7	det
6	therapeutic	therapeutic	JJ	_	7	amod
7	benefit	benefit	NN	_	4	dobj
8	of	of	IN	_	9	case
9	drug1	drug1	NN	_	7	nmod
10	while	while	IN	_	11	mark
11	minimizing	minimize	VBG	_	4	advcl
12	the	the	DT	_	13	det
13	risk	risk	NN	_	11	dobj
14	of	of	IN	_	15	case
15	nephrotoxicity	nephrotoxicity	NN	_	13	nmod
16	and	and	CC	_	13	cc
17	the	the	DT	_	18	det
18	appearance	appearance	NN	_	13	conj
19	of	of	IN	_	22	case
20	a	a	DT	_	22	det
21	hot	hot	JJ	_	22	amod
22	kidney	kidney	NN	_	18	nmod
23	on	on	IN	_	24	case
24	scintigraphy	scintigraphy	NN	_	18	nmod
25	is	be	VBZ	_	26	cop
26	desirable	desirable	JJ	_	0	ROOT
27	.	.	.	_	26	punct

1	Serial	serial	JJ	_	3	amod
2	pharmacokinetic	pharmacokinetic	JJ	_	3	amod
3	dosing	dosing	NN	_	6	nsubjpass
4	has	have	VBZ	_	6	aux
5	been	be	VBN	_	6	auxpass
6	proposed	propose	VBN	_	0	ROOT
7	as	as	IN	_	9	case
8	a	a	DT	_	9	det
9	method	method	NN	_	6	nmod
10	to	to	TO	_	11	mark
11	accomplish	accomplish	VB	_	9	acl
12	this	this	DT	_	13	det
13	goal	goal	NN	_	11	dobj
14	.	.	.	_	6	punct

1	Therapeutic	therapeutic	JJ	_	3	amod
2	drug	drug	NN	_	3	compound
3	monitoring	monitoring	NN	_	0	ROOT
4	-LRB-	-lrb-	-LRB-	_	5	punct
5	TDM	tdm	NN	_	3	appos
6	-RRB-	-rrb-	-RRB-	_	5	punct
7	of	of	IN	_	9	case
8	drug1	drug1	NN	_	9	compound
9	therapy	therapy	NN	_	3	nmod
10	,	,	,	_	3	punct
11	and	and	CC	_	3	cc
12	bone	bone	NN	_	13	compound
13	scintigraphy	scintigraphy	NN	_	3	conj
14	employing	employ	VBG	_	13	acl
15	drug2	drug2	NN	_	14	dobj
16	as	as	IN	_	20	mark
17	the	the	DT	_	18	det
18	drug3	drug3	NN	_	20	nsubjpass
19	was	be	VBD	_	20	auxpass
20	carried	carry	VBN	_	14	advcl
21	out	out	RP	_	20	compound:prt
22	in	in	IN	_	24	case
23	22	22	CD	_	24	nummod
24	patients	patient	NNS	_	20	nmod
25	.	.	.	_	3	punct

1	The	the	DT	_	2	det
2	data	datum	NNS	_	5	nsubj
3	presented	present	VBN	_	2	acl
4	here	here	RB	_	3	advmod
5	demonstrate	demonstrate	VBP	_	0	ROOT
6	that	that	IN	_	23	mark
7	with	with	IN	_	10	case
8	serial	serial	JJ	_	10	amod
9	pharmacokinetic	pharmacokinetic	JJ	_	10	amod
10	dosing	dosing	NN	_	23	nmod
11	of	of	IN	_	12	case
12	drug1	drug1	NN	_	10	nmod
13	,	,	,	_	23	punct
14	the	the	DT	_	16	det
15	iatrogenic	iatrogenic	JJ	_	16	amod
16	alteration	alteration	NN	_	23	nsubjpass
17	caused	cause	VBN	_	16	acl
18	by	by	IN	_	20	case
19	drug2	drug2	NN	_	20	compound
20	therapy	therapy	NN	_	17	nmod
21	can	can	MD	_	23	aux
22	be	be	VB	_	23	auxpass
23	avoided	avoid	VBN	_	5	ccomp
24	.	.	.	_	5	punct

1	Interaction	interaction	NN	_	0	ROOT
2	of	of	IN	_	3	case
3	drug1	drug1	NN	_	1	nmod
4	and	and	CC	_	3	cc
5	drug2	drug2	NN	_	3	conj
6	in	in	IN	_	8	case
7	anaesthetised	anaesthetised	JJ	_	8	amod
8	horses	horse	NNS	_	1	nmod
9	.	.	.	_	1	punct

1	Evoked	evoke	VBN	_	6	amod
2	hind	hind	JJ	_	6	amod
3	limb	limb	NN	_	6	compound
4	digital	digital	JJ	_	6	amod
5	extensor	extensor	NN	_	6	compound
6	tension	tension	NN	_	12	nsubjpass
7	-LRB-	-lrb-	-LRB-	_	9	punct
8	hoof	hoof	NN	_	9	compound
9	twitch	twitch	VB	_	6	appos
10	-RRB-	-rrb-	-RRB-	_	9	punct
11	was	be	VBD	_	12	auxpass
12	maintained	maintain	VBN	_	0	ROOT
13	at	at	IN	_	15	case
14	40	40	CD	_	15	nummod
15	%	%	NN	_	12	nmod
16	of	of	IN	_	17	case
17	baseline	baseline	NN	_	15	nmod
18	for	for	IN	_	20	case
19	1	1	CD	_	20	nummod
20	h	h	NN	_	15	nmod
21	by	by	IN	_	23	case
22	drug1	drug1	NN	_	23	compound
23	infusion	infusion	NN	_	12	nmod
24	in	in	IN	_	26	case
25	7	7	CD	_	26	nummod
26	horses	horse	NNS	_	23	nmod
27	anaesthetised	anaesthetise	VBN	_	26	acl
28	with	with	IN	_	29	case
29	drug2	drug2	NN	_	27	nmod
30	.	.	.	_	12	punct

1	After	after	IN	_	3	case
2	1	1	CD	_	3	nummod
3	h	h	NN	_	7	nmod
4	,	,	,	_	7	punct
5	drug1	drug1	NN	_	7	nsubjpass
6	was	be	VBD	_	7	auxpass
7	discontinued	discontinue	VBN	_	0	ROOT
8	and	and	CC	_	7	cc
9	hoof	hoof	JJ	_	10	amod
10	twitch	twitch	VB	_	7	conj
11	allowed	allow	VBN	_	10	acl
12	to	to	TO	_	13	mark
13	recover	recover	VB	_	11	xcomp
14	to	to	TO	_	16	case
15	75	75	CD	_	16	nummod
16	%	%	NN	_	13	nmod
17	.	.	.	_	7	punct

1	drug1	drug1	NN	_	4	nsubjpass
2	was	be	VBD	_	4	auxpass
3	again	again	RB	_	4	advmod
4	given	give	VBN	_	0	ROOT
5	by	by	IN	_	6	case
6	infusion	infusion	NN	_	4	nmod
7	to	to	TO	_	8	mark
8	maintain	maintain	VB	_	4	xcomp
9	40	40	CD	_	10	nummod
10	%	%	NN	_	11	nsubj
11	twitch	twitch	VB	_	8	ccomp
12	for	for	IN	_	15	case
13	a	a	DT	_	15	det
14	second	second	JJ	_	15	amod
15	hour	hour	NN	_	11	nmod
16	,	,	,	_	4	punct
17	then	then	RB	_	20	advmod
18	2	2	CD	_	19	compound
19	mg	mg	NN	_	20	amod
20	drug2	drug2	NN	_	4	parataxis
21	/	/	:	_	23	punct
22	kg	kg	NN	_	23	compound
23	bwt	bwt	NN	_	25	nsubjpass
24	were	be	VBD	_	25	auxpass
25	given	give	VBN	_	20	acl:relcl
26	i.v.	i.v.	IN	_	25	dep

1	drug1	drug1	NN	_	2	compound
2	infusion	infusion	NN	_	4	nsubjpass
3	was	be	VBD	_	4	auxpass
4	continued	continue	VBN	_	0	ROOT
5	for	for	IN	_	8	case
6	a	a	DT	_	8	det
7	third	third	JJ	_	8	amod
8	hour	hour	NN	_	4	nmod
9	,	,	,	_	4	punct
10	and	and	CC	_	4	cc
11	then	then	RB	_	13	advmod
12	hoof	hoof	NN	_	13	compound
13	twitch	twitch	VB	_	16	nsubjpass
14	was	be	VBD	_	16	auxpass
15	again	again	RB	_	16	advmod
16	allowed	allow	VBN	_	4	conj
17	to	to	TO	_	18	mark
18	recover	recover	VB	_	16	xcomp
19	spontaneously	spontaneously	RB	_	18	advmod
20	to	to	TO	_	22	case
21	75	75	CD	_	22	nummod
22	%	%	NN	_	18	nmod
23	.	.	.	_	4	punct

1	drug1	drug1	NN	_	2	nsubj
2	reduced	reduce	VBD	_	0	ROOT
3	twitch	twitch	VB	_	2	xcomp
4	strength	strength	NN	_	3	dobj
5	from	from	IN	_	6	case
6	40	40	CD	_	3	nmod
7	+	+	CC	_	6	cc
8	/	/	:	_	6	punct
9	-	-	:	_	8	punct
10	1	1	CD	_	11	nummod
11	%	%	NN	_	9	root
12	-LRB-	-lrb-	-LRB-	_	13	punct
13	mean	mean	NN	_	11	dep
14	+	+	CC	_	13	cc
15	/	/	:	_	13	punct
16	-	-	:	_	13	punct
17	sem	sem	NN	_	13	dep
18	-RRB-	-rrb-	-RRB-	_	13	punct
19	to	to	TO	_	11	dep
20	29	29	CD	_	11	dep
21	+	+	CC	_	20	cc
22	/	/	:	_	20	punct
23	-	-	:	_	22	punct
24	4	4	CD	_	25	nummod
25	%	%	NN	_	23	root
26	within	within	IN	_	27	case
27	7.0	7.0	CD	_	25	nmod
28	+	+	CC	_	27	cc
29	/	/	:	_	32	punct
30	-	-	:	_	32	punct
31	1.5	1.5	CD	_	32	nummod
32	min	min	NN	_	27	conj
33	-LRB-	-lrb-	-LRB-	_	34	punct
34	P	p	NN	_	32	dep
35	=	=	JJ	_	34	amod
36	0.02	0.02	CD	_	35	dep
37	-RRB-	-rrb-	-RRB-	_	34	punct
38	.	.	.	_	25	punct

1	Twitch	twitch	VB	_	0	ROOT
2	gradually	gradually	RB	_	3	advmod
3	returned	return	VBN	_	1	dep
4	to	to	TO	_	5	case
5	pre	pre	JJ	_	3	nmod
6	-	-	:	_	1	punct
7	drug1	drug1	NN	_	8	compound
8	strength	strength	NN	_	1	dep
9	over	over	IN	_	11	case
10	the	the	DT	_	11	det
11	course	course	NN	_	8	nmod
12	of	of	IN	_	15	case
13	the	the	DT	_	15	det
14	next	next	JJ	_	15	amod
15	hour	hour	NN	_	11	nmod
16	.	.	.	_	1	punct

1	Recovery	recovery	NN	_	4	nsubj
2	of	of	IN	_	3	case
3	hoof	hoof	NN	_	1	nmod
4	twitch	twitch	VB	_	0	ROOT
5	from	from	IN	_	7	case
6	50	50	CD	_	7	nummod
7	%	%	NN	_	4	nmod
8	to	to	TO	_	10	case
9	75	75	CD	_	10	nummod
10	%	%	NN	_	7	nmod
11	took	take	VBD	_	4	dep
12	7.7	7.7	CD	_	11	dobj
13	+	+	CC	_	12	cc
14	/	/	:	_	17	punct
15	-	-	:	_	17	punct
16	0.7	0.7	CD	_	17	nummod
17	min	min	NN	_	12	conj
18	for	for	IN	_	19	case
19	drug1	drug1	NN	_	17	nmod
20	alone	alone	RB	_	19	advmod
21	and	and	CC	_	19	cc
22	11.5	11.5	CD	_	27	nummod
23	+	+	CC	_	22	cc
24	/	/	:	_	27	punct
25	-	-	:	_	27	punct
26	2.7	2.7	CD	_	27	nummod
27	min	min	NN	_	19	conj
28	for	for	IN	_	29	case
29	drug2	drug2	NN	_	27	nmod
30	plus	plus	CC	_	29	cc
31	drug3	drug3	NN	_	29	conj
32	-LRB-	-lrb-	-LRB-	_	33	punct
33	P	p	NN	_	17	dep
34	=	=	JJ	_	33	amod
35	0.03	0.03	CD	_	34	dep
36	-RRB-	-rrb-	-RRB-	_	33	punct
37	.	.	.	_	4	punct

1	Recovery	recovery	NN	_	5	nsubj
2	from	from	IN	_	4	case
3	50	50	CD	_	4	nummod
4	%	%	NN	_	1	nmod
5	twitch	twitch	VBP	_	0	ROOT
6	to	to	TO	_	10	case
7	75	75	CD	_	8	compound
8	%	%	NN	_	10	amod
9	fade	fade	VB	_	10	compound
10	recovery	recovery	NN	_	5	nmod
11	took	take	VBD	_	5	dep
12	13.8	13.8	CD	_	11	dobj
13	+	+	CC	_	12	cc
14	/	/	:	_	17	punct
15	-	-	:	_	17	punct
16	0.8	0.8	CD	_	17	nummod
17	min	min	NN	_	12	conj
18	for	for	IN	_	19	case
19	drug1	drug1	NN	_	17	nmod
20	alone	alone	RB	_	19	advmod
21	and	and	CC	_	19	cc
22	13.7	13.7	CD	_	27	nummod
23	+	+	CC	_	22	cc
24	/	/	:	_	27	punct
25	-	-	:	_	27	punct
26	1.2	1.2	CD	_	27	nummod
27	min	min	NN	_	19	conj
28	for	for	IN	_	29	case
29	drug2	drug2	NN	_	27	nmod
30	plus	plus	CC	_	29	cc
31	drug3	drug3	NN	_	29	conj
32	.	.	.	_	5	punct

1	At	at	IN	_	4	case
2	75	75	CD	_	3	compound
3	%	%	NN	_	4	amod
4	recovery	recovery	NN	_	0	ROOT
5	of	of	IN	_	6	case
6	fade	fade	VB	_	4	nmod
7	,	,	,	_	4	punct
8	hoof	hoof	JJ	_	9	amod
9	twitch	twitch	VB	_	7	root
10	was	be	VBD	_	9	dep
11	87	87	CD	_	10	nsubj
12	+	+	CC	_	11	cc
13	/	/	:	_	11	punct
14	-	-	:	_	13	punct
15	3	3	CD	_	16	nummod
16	%	%	NN	_	14	root
17	for	for	IN	_	18	case
18	drug1	drug1	NN	_	16	nmod
19	alone	alone	RB	_	18	advmod
20	and	and	CC	_	18	cc
21	82	82	CD	_	18	conj
22	+	+	CC	_	21	cc
23	/	/	:	_	21	punct
24	-	-	:	_	23	punct
25	4	4	CD	_	26	nummod
26	%	%	NN	_	24	root
27	for	for	IN	_	28	case
28	drug2	drug2	NN	_	26	nmod
29	plus	plus	CC	_	28	cc
30	drug3	drug3	NN	_	28	conj
31	.	.	.	_	26	punct

1	Reversal	reversal	NN	_	16	nsubj
2	of	of	IN	_	4	case
3	the	the	DT	_	4	det
4	block	block	NN	_	1	nmod
5	with	with	IN	_	6	case
6	drug1	drug1	NN	_	1	nmod
7	and	and	CC	_	6	cc
8	subsequent	subsequent	JJ	_	9	amod
9	recovery	recovery	NN	_	6	conj
10	of	of	IN	_	12	case
11	the	the	DT	_	12	det
12	horses	horse	NNS	_	6	nmod
13	from	from	IN	_	14	case
14	anaesthesia	anaesthesia	NN	_	12	nmod
15	were	be	VBD	_	16	cop
16	uneventful	uneventful	JJ	_	0	ROOT
17	.	.	.	_	16	punct

1	It	it	PRP	_	3	nsubjpass
2	was	be	VBD	_	3	auxpass
3	concluded	conclude	VBN	_	0	ROOT
4	that	that	IN	_	19	mark
5	,	,	,	_	19	punct
6	although	although	IN	_	9	mark
7	drug1	drug1	NN	_	9	nsubj
8	did	do	VBD	_	9	aux
9	augment	augment	VB	_	19	advcl
10	the	the	DT	_	12	det
11	neuromuscular	neuromuscular	JJ	_	12	amod
12	blockade	blockade	NN	_	9	dobj
13	of	of	IN	_	14	case
14	drug2	drug2	NN	_	12	nmod
15	,	,	,	_	19	punct
16	the	the	DT	_	17	det
17	effect	effect	NN	_	19	nsubj
18	was	be	VBD	_	19	cop
19	minimal	minimal	JJ	_	3	ccomp
20	.	.	.	_	3	punct

1	Diagnostic	diagnostic	JJ	_	0	ROOT
2	,	,	,	_	1	punct
3	treatment	treatment	NN	_	2	root
4	and	and	CC	_	3	cc
5	aftercare	aftercare	JJ	_	6	amod
6	approaches	approach	NNS	_	3	conj
7	to	to	TO	_	9	case
8	drug1	drug1	NN	_	9	compound
9	abuse	abuse	NN	_	6	nmod
10	.	.	.	_	3	punct

1	The	the	DT	_	3	det
2	general	general	JJ	_	3	amod
3	public	public	JJ	_	4	nsubj
4	feels	feel	VBZ	_	0	ROOT
5	that	that	IN	_	10	mark
6	drug1	drug1	NN	_	10	nsubj
7	is	be	VBZ	_	10	cop
8	not	not	RB	_	10	neg
9	particularly	particularly	RB	_	10	advmod
10	dangerous	dangerous	JJ	_	4	ccomp
11	because	because	IN	_	15	mark
12	it	it	PRP	_	15	nsubj
13	does	do	VBZ	_	15	aux
14	not	not	RB	_	15	neg
15	produce	produce	VB	_	10	advcl
16	a	a	DT	_	20	det
17	well	well	RB	_	18	advmod
18	defined	define	VBN	_	20	amod
19	physical	physical	JJ	_	20	amod
20	dependency	dependency	NN	_	15	dobj
21	and	and	CC	_	20	cc
22	abstinence	abstinence	NN	_	23	compound
23	syndrome	syndrome	NN	_	20	conj
24	.	.	.	_	4	punct

1	However	however	RB	_	27	advmod
2	,	,	,	_	27	punct
3	when	when	WRB	_	6	advmod
4	addiction	addiction	NN	_	6	nsubjpass
5	is	be	VBZ	_	6	auxpass
6	defined	define	VBN	_	27	advcl
7	as	as	IN	_	8	case
8	compulsion	compulsion	NN	_	6	nmod
9	,	,	,	_	27	punct
10	loss	loss	NN	_	27	dep
11	of	of	IN	_	12	case
12	control	control	NN	_	10	nmod
13	and	and	CC	_	10	cc
14	continued	continue	VBD	_	15	amod
15	use	use	NN	_	10	conj
16	in	in	IN	_	17	case
17	spite	spite	NN	_	15	nmod
18	of	of	IN	_	20	case
19	adverse	adverse	JJ	_	20	amod
20	consequences	consequence	NNS	_	17	nmod
21	,	,	,	_	27	punct
22	drug1	drug1	NN	_	24	compound
23	drug	drug	NN	_	24	compound
24	hunger	hunger	NN	_	27	nsubjpass
25	can	can	MD	_	27	aux
26	be	be	VB	_	27	auxpass
27	seen	see	VBN	_	0	ROOT
28	as	as	IN	_	30	case
29	an	a	DT	_	30	det
30	agent	agent	NN	_	27	nmod
31	of	of	IN	_	33	case
32	addictive	addictive	JJ	_	33	amod
33	disease	disease	NN	_	30	nmod
34	.	.	.	_	27	punct

1	Withdrawal	withdrawal	NN	_	6	nsubj
2	from	from	IN	_	4	case
3	drug1	drug1	NN	_	4	compound
4	dependence	dependence	NN	_	1	nmod
5	usually	usually	RB	_	6	advmod
6	involves	involve	VBZ	_	0	ROOT
7	depression	depression	NN	_	6	dobj
8	,	,	,	_	7	punct
9	anxiety	anxiety	NN	_	7	conj
10	and	and	CC	_	7	cc
11	lethargy	lethargy	NN	_	7	conj
12	.	.	.	_	6	punct

1	These	these	DT	_	3	nsubj
2	usually	usually	RB	_	3	advmod
3	clear	clear	JJ	_	0	ROOT
4	within	within	IN	_	6	case
5	a	a	DT	_	6	det
6	week	week	NN	_	3	nmod
7	,	,	,	_	3	punct
8	leaving	leave	VBG	_	3	xcomp
9	only	only	RB	_	13	advmod
10	the	the	DT	_	13	det
11	``	``	``	_	13	punct
12	drug	drug	NN	_	13	compound
13	hunger	hunger	NN	_	8	dobj
14	''	''	''	_	3	punct

1	to	to	TO	_	2	mark
2	contend	contend	VB	_	0	ROOT
3	with	with	IN	_	2	nmod
4	.	.	.	_	2	punct

1	Medication	medication	NN	_	4	nsubjpass
2	is	be	VBZ	_	4	auxpass
3	rarely	rarely	RB	_	4	advmod
4	needed	need	VBN	_	0	ROOT
5	.	.	.	_	4	punct

1	When	when	WRB	_	6	advmod
2	drug1	drug1	NN	_	6	nsubj
3	is	be	VBZ	_	6	cop
4	the	the	DT	_	6	det
5	primary	primary	JJ	_	6	amod
6	addiction	addiction	NN	_	16	advcl
7	,	,	,	_	16	punct
8	after	after	IN	_	9	case
9	withdrawal	withdrawal	NN	_	16	nmod
10	the	the	DT	_	13	det
11	most	most	RBS	_	12	advmod
12	effective	effective	JJ	_	13	amod
13	treatment	treatment	NN	_	16	nsubj
14	is	be	VBZ	_	16	cop
15	group	group	NN	_	16	compound
16	therapy	therapy	NN	_	0	ROOT
17	with	with	IN	_	21	case
18	other	other	JJ	_	21	amod
19	recovering	recover	VBG	_	21	amod
20	cocaine	cocaine	NN	_	21	compound
21	abusers	abuser	NNS	_	16	nmod
22	.	.	.	_	16	punct

1	We	we	PRP	_	2	nsubj
2	incorporate	incorporate	VBP	_	0	ROOT
3	the	the	DT	_	4	det
4	principles	principle	NNS	_	2	dobj
5	of	of	IN	_	6	case
6	recovery	recovery	NN	_	4	nmod
7	and	and	CC	_	2	cc
8	define	define	VB	_	2	conj
9	positive	positive	JJ	_	12	amod
10	and	and	CC	_	9	cc
11	constructive	constructive	JJ	_	9	conj
12	alternatives	alternative	NNS	_	8	dobj
13	in	in	IN	_	14	mark
14	dealing	deal	VBG	_	12	acl
15	with	with	IN	_	17	case
16	cocaine	cocaine	NN	_	17	compound
17	hunger	hunger	NN	_	14	nmod
18	.	.	.	_	2	punct

1	Recovery	recovery	NN	_	2	compound
2	programs	program	NNS	_	5	nsubj
3	should	should	MD	_	5	aux
4	be	be	VB	_	5	cop
5	flexible	flexible	JJ	_	0	ROOT
6	and	and	CC	_	5	cc
7	involve	involve	VB	_	5	conj
8	individual	individual	JJ	_	11	amod
9	and	and	CC	_	8	cc
10	family	family	NN	_	8	conj
11	education	education	NN	_	7	dobj
12	on	on	IN	_	13	case
13	recovery	recovery	NN	_	11	nmod
14	and	and	CC	_	11	cc
15	the	the	DT	_	16	det
16	nature	nature	NN	_	11	conj
17	of	of	IN	_	19	case
18	addictive	addictive	JJ	_	19	amod
19	disease	disease	NN	_	16	nmod
20	.	.	.	_	5	punct

1	Exercise	exercise	NN	_	9	nsubj
2	that	that	WDT	_	3	nsubj
3	produces	produce	VBZ	_	1	acl:relcl
4	cardiopulmonary	cardiopulmonary	JJ	_	5	amod
5	stimulation	stimulation	NN	_	3	dobj
6	is	be	VBZ	_	9	cop
7	a	a	DT	_	9	det
8	helpful	helpful	JJ	_	9	amod
9	means	means	NNS	_	0	ROOT
10	of	of	IN	_	11	mark
11	reducing	reduce	VBG	_	9	acl
12	drug	drug	NN	_	13	compound
13	hunger	hunger	NN	_	11	dobj
14	and	and	CC	_	13	cc
15	anxiety	anxiety	NN	_	13	conj
16	during	during	IN	_	18	case
17	recovery	recovery	NN	_	18	compound
18	therapy	therapy	NN	_	11	nmod
19	.	.	.	_	9	punct

1	Systemic	systemic	JJ	_	2	amod
2	drug1	drug1	NN	_	0	ROOT
3	.	.	.	_	2	punct

1	Understanding	understand	VBG	_	21	csubj
2	the	the	DT	_	3	det
3	breadth	breadth	NN	_	1	dobj
4	of	of	IN	_	6	case
5	systemic	systemic	JJ	_	6	amod
6	drug1	drug1	NN	_	3	nmod
7	available	available	JJ	_	6	amod
8	for	for	IN	_	9	case
9	use	use	NN	_	7	nmod
10	by	by	IN	_	12	case
11	the	the	DT	_	12	det
12	dermatologist	dermatologist	NN	_	9	nmod
13	and	and	CC	_	12	cc
14	their	they	PRP$	_	17	nmod:poss
15	associated	associate	VBN	_	17	amod
16	side-effect	side-effect	JJ	_	17	amod
17	profiles	profile	NNS	_	12	conj
18	and	and	CC	_	17	cc
19	drug	drug	NN	_	20	compound
20	interactions	interaction	NNS	_	17	conj
21	allows	allow	VBZ	_	0	ROOT
22	the	the	DT	_	23	det
23	clinician	clinician	NN	_	21	dobj
24	to	to	TO	_	25	mark
25	offer	offer	VB	_	21	xcomp
26	patients	patient	NNS	_	28	compound
27	optimal	optimal	JJ	_	28	amod
28	care	care	NN	_	25	dobj
29	in	in	IN	_	31	case
30	the	the	DT	_	31	det
31	management	management	NN	_	25	nmod
32	of	of	IN	_	35	case
33	cutaneous	cutaneous	JJ	_	35	amod
34	infectious	infectious	JJ	_	35	amod
35	disease	disease	NN	_	31	nmod
36	.	.	.	_	21	punct

1	Altered	altered	JJ	_	2	amod
2	responsiveness	responsiveness	NN	_	0	ROOT
3	to	to	TO	_	4	case
4	drug1	drug1	NN	_	2	nmod
5	after	after	IN	_	6	case
6	exposure	exposure	NN	_	2	nmod
7	to	to	TO	_	9	case
8	organic	organic	JJ	_	9	amod
9	lead	lead	NN	_	6	nmod
10	.	.	.	_	2	punct

1	drug1	drug1	NN	_	3	nsubjpass
2	is	be	VBZ	_	3	auxpass
3	known	know	VBN	_	0	ROOT
4	to	to	TO	_	5	mark
5	effect	effect	VB	_	3	xcomp
6	the	the	DT	_	8	det
7	functional	functional	JJ	_	8	amod
8	integrity	integrity	NN	_	5	dobj
9	of	of	IN	_	12	case
10	the	the	DT	_	12	det
11	limbic	limbic	JJ	_	12	amod
12	system	system	NN	_	8	nmod
13	,	,	,	_	5	punct
14	particularly	particularly	RB	_	16	advmod
15	the	the	DT	_	16	det
16	hippocampus	hippocampus	NN	_	5	dobj
17	,	,	,	_	16	punct
18	and	and	CC	_	16	cc
19	to	to	TO	_	20	mark
20	alter	alter	VB	_	16	conj
21	behaviors	behavior	NNS	_	20	dobj
22	which	which	WDT	_	24	nsubjpass
23	are	be	VBP	_	24	auxpass
24	thought	think	VBN	_	21	acl:relcl
25	to	to	TO	_	27	mark
26	be	be	VB	_	27	auxpass
27	mediated	mediate	VBN	_	24	xcomp
28	through	through	IN	_	30	case
29	limbic	limbic	JJ	_	30	amod
30	function	function	NN	_	27	nmod
31	.	.	.	_	3	punct

1	Organometals	organometal	NNS	_	3	nsubj
2	also	also	RB	_	3	advmod
3	compromise	compromise	VBP	_	0	ROOT
4	the	the	DT	_	6	det
5	limbic	limbic	JJ	_	6	amod
6	system	system	NN	_	3	dobj
7	and	and	CC	_	6	cc
8	result	result	NN	_	6	conj
9	in	in	IN	_	10	case
10	deficits	deficit	NNS	_	6	nmod
11	in	in	IN	_	12	case
12	learning	learning	NN	_	10	nmod
13	and	and	CC	_	12	cc
14	memory	memory	NN	_	12	conj
15	.	.	.	_	3	punct

1	Since	since	IN	_	7	mark
2	both	both	DT	_	3	cc:preconj
3	drug1	drug1	NN	_	7	nsubj
4	and	and	CC	_	3	cc
5	organoleads	organolead	NNS	_	3	conj
6	are	be	VBP	_	7	cop
7	present	present	JJ	_	25	advcl
8	in	in	IN	_	10	case
9	the	the	DT	_	10	det
10	environment	environment	NN	_	7	nmod
11	and	and	CC	_	7	cc
12	seem	seem	VBP	_	7	conj
13	to	to	TO	_	14	mark
14	influence	influence	VB	_	12	xcomp
15	limbic	limbic	JJ	_	16	amod
16	integration	integration	NN	_	14	dobj
17	,	,	,	_	25	punct
18	the	the	DT	_	19	det
19	interaction	interaction	NN	_	25	nsubjpass
20	of	of	IN	_	23	case
21	these	these	DT	_	23	det
22	two	two	CD	_	23	nummod
23	compounds	compound	NNS	_	19	nmod
24	was	be	VBD	_	25	auxpass
25	assessed	assess	VBN	_	0	ROOT
26	in	in	IN	_	29	case
27	the	the	DT	_	29	det
28	present	present	JJ	_	29	amod
29	experiment	experiment	NN	_	25	nmod
30	.	.	.	_	25	punct

1	Thirty	thirty	CD	_	3	nummod
2	male	male	JJ	_	3	amod
3	rats	rat	NNS	_	9	nsubjpass
4	of	of	IN	_	7	case
5	the	the	DT	_	7	det
6	Fischer-344	fischer-344	NN	_	7	compound
7	strain	strain	NN	_	3	nmod
8	were	be	VBD	_	9	auxpass
9	divided	divide	VBN	_	0	ROOT
10	into	into	IN	_	13	case
11	three	three	CD	_	13	nummod
12	equal	equal	JJ	_	13	amod
13	groups	group	NNS	_	9	nmod
14	and	and	CC	_	9	cc
15	were	be	VBD	_	16	auxpass
16	given	give	VBN	_	9	conj
17	injections	injection	NNS	_	16	dobj
18	of	of	IN	_	19	case
19	drug1	drug1	NN	_	17	nmod
20	-LRB-	-lrb-	-LRB-	_	21	punct
21	drug2	drug2	NN	_	19	appos
22	-RRB-	-rrb-	-RRB-	_	21	punct
23	-LRB-	-lrb-	-LRB-	_	28	punct
24	8.0	8.0	CD	_	28	nummod
25	or	or	CC	_	24	cc
26	17.0	17.0	CD	_	24	conj
27	mg/kg/ml	mg/kg/ml	NN	_	28	compound
28	SC	sc	NN	_	19	appos
29	-RRB-	-rrb-	-RRB-	_	28	punct
30	or	or	CC	_	19	cc
31	the	the	DT	_	33	det
32	saline	saline	NN	_	33	compound
33	vehicle	vehicle	NN	_	19	conj
34	.	.	.	_	9	punct

1	Fourteen	fourteen	CD	_	2	nummod
2	days	day	NNS	_	3	nmod:npmod
3	later	later	RB	_	8	advmod
4	,	,	,	_	8	punct
5	all	all	DT	_	6	det
6	animals	animal	NNS	_	8	nsubjpass
7	were	be	VBD	_	8	auxpass
8	challenged	challenge	VBN	_	0	ROOT
9	with	with	IN	_	13	case
10	a	a	DT	_	13	det
11	single	single	JJ	_	13	amod
12	hypnotic	hypnotic	JJ	_	13	amod
13	dose	dose	NN	_	8	nmod
14	of	of	IN	_	15	case
15	drug1	drug1	NN	_	13	nmod
16	-LRB-	-lrb-	-LRB-	_	19	punct
17	3.5	3.5	CD	_	19	nummod
18	g/kg	g/kg	NN	_	19	compound
19	IP	IP	NNP	_	13	appos
20	-RRB-	-rrb-	-RRB-	_	19	punct
21	.	.	.	_	8	punct

1	The	the	DT	_	5	det
2	20	20	CD	_	3	compound
3	%	%	NN	_	5	amod
4	v/v	v/v	NN	_	5	compound
5	solution	solution	NN	_	9	nsubjpass
6	of	of	IN	_	7	case
7	drug1	drug1	NN	_	5	nmod
8	was	be	VBD	_	9	auxpass
9	prepared	prepare	VBN	_	0	ROOT
10	in	in	IN	_	11	case
11	water	water	NN	_	9	nmod
12	from	from	IN	_	15	case
13	a	a	DT	_	15	det
14	stock	stock	NN	_	15	compound
15	solution	solution	NN	_	9	nmod
16	of	of	IN	_	19	case
17	95	95	CD	_	18	compound
18	%	%	NN	_	19	amod
19	drug2	drug2	NN	_	15	nmod
20	.	.	.	_	9	punct

1	The	the	DT	_	2	det
2	latency	latency	NN	_	15	nsubjpass
3	to	to	TO	_	4	case
4	loss	loss	NN	_	2	nmod
5	of	of	IN	_	8	case
6	the	the	DT	_	8	det
7	righting	right	VBG	_	8	amod
8	reflex	reflex	JJ	_	4	nmod
9	and	and	CC	_	4	cc
10	duration	duration	NN	_	4	conj
11	of	of	IN	_	13	case
12	sleep	sleep	NN	_	13	compound
13	time	time	NN	_	10	nmod
14	were	be	VBD	_	15	auxpass
15	recorded	record	VBN	_	0	ROOT
16	while	while	IN	_	20	mark
17	the	the	DT	_	18	det
18	rats	rat	NNS	_	20	nsubjpass
19	were	be	VBD	_	20	auxpass
20	kept	keep	VBN	_	15	advcl
21	in	in	IN	_	23	case
22	sound-attenuating	sound-attenuating	JJ	_	23	amod
23	chambers	chamber	NNS	_	20	nmod
24	.	.	.	_	15	punct

1	The	the	DT	_	2	det
2	rats	rat	NNS	_	10	nsubj
3	treated	treat	VBN	_	2	acl
4	with	with	IN	_	7	case
5	the	the	DT	_	7	det
6	highest	highest	JJS	_	7	amod
7	dose	dose	NN	_	3	nmod
8	of	of	IN	_	9	case
9	drug1	drug1	NN	_	7	nmod
10	manifested	manifest	VBN	_	0	ROOT
11	significantly	significantly	RB	_	12	advmod
12	longer	longer	RBR	_	13	amod
13	latencies	latency	NNS	_	10	dobj
14	to	to	TO	_	15	mark
15	lose	lose	VB	_	10	xcomp
16	the	the	DT	_	21	det
17	righting	right	VBG	_	21	amod
18	reflex	reflex	JJ	_	21	amod
19	and	and	CC	_	18	cc
20	shorter	shorter	JJR	_	18	conj
21	durations	duration	NNS	_	15	dobj
22	of	of	IN	_	23	case
23	sleep	sleep	NN	_	21	nmod
24	than	than	IN	_	25	dep
25	did	do	VBD	_	10	advcl
26	controls	control	NNS	_	25	nsubj
27	.	.	.	_	10	punct

1	These	these	DT	_	2	det
2	results	result	NNS	_	3	nsubj
3	suggest	suggest	VBP	_	0	ROOT
4	that	that	IN	_	10	mark
5	exposure	exposure	NN	_	10	nsubj
6	to	to	TO	_	8	case
7	environmental	environmental	JJ	_	8	amod
8	drug1	drug1	NN	_	5	nmod
9	may	may	MD	_	10	aux
10	alter	alter	VB	_	3	ccomp
11	the	the	DT	_	15	det
12	biological	biological	JJ	_	15	amod
13	and	and	CC	_	12	cc
14	behavioral	behavioral	JJ	_	12	conj
15	responsiveness	responsiveness	NN	_	10	dobj
16	of	of	IN	_	18	case
17	an	a	DT	_	18	det
18	animal	animal	NN	_	15	nmod
19	to	to	TO	_	20	case
20	drug2	drug2	NN	_	15	nmod
21	.	.	.	_	3	punct

1	Evidence	evidence	NN	_	0	ROOT
2	for	for	IN	_	3	case
3	reduction	reduction	NN	_	1	nmod
4	of	of	IN	_	7	case
5	drug1	drug1	NN	_	7	compound
6	uptake	uptake	NN	_	7	compound
7	sites	site	NNS	_	3	nmod
8	in	in	IN	_	12	case
9	the	the	DT	_	12	det
10	failing	fail	VBG	_	12	amod
11	human	human	JJ	_	12	amod
12	heart	heart	NN	_	3	nmod
13	.	.	.	_	1	punct

1	OBJECTIVES	objective	NNS	_	0	ROOT
2	.	.	.	_	1	punct

1	This	this	DT	_	2	det
2	study	study	NN	_	3	nsubj
3	investigated	investigate	VBD	_	0	ROOT
4	the	the	DT	_	5	det
5	role	role	NN	_	3	dobj
6	of	of	IN	_	8	case
7	neuronal	neuronal	JJ	_	8	amod
8	uptake	uptake	NN	_	5	nmod
9	of	of	IN	_	10	case
10	drug1	drug1	NN	_	8	nmod
11	-LRB-	-lrb-	-LRB-	_	12	punct
12	uptake-1	uptake-1	NN	_	10	appos
13	-RRB-	-rrb-	-RRB-	_	12	punct
14	in	in	IN	_	17	case
15	human	human	JJ	_	17	amod
16	heart	heart	NN	_	17	compound
17	failure	failure	NN	_	5	nmod
18	as	as	IN	_	21	case
19	a	a	DT	_	21	det
20	local	local	JJ	_	21	amod
21	factor	factor	NN	_	5	nmod
22	for	for	IN	_	24	case
23	altering	alter	VBG	_	24	amod
24	concentrations	concentration	NNS	_	21	nmod
25	of	of	IN	_	26	case
26	norepinephrine	norepinephrine	NN	_	24	nmod
27	at	at	IN	_	31	case
28	the	the	DT	_	31	det
29	cardiac	cardiac	JJ	_	31	amod
30	myocyte	myocyte	NN	_	31	compound
31	membranes	membrane	NNS	_	24	nmod
32	.	.	.	_	3	punct

1	BACKGROUND	background	NN	_	0	ROOT
2	.	.	.	_	1	punct

1	Several	several	JJ	_	4	amod
2	beta-adrenergic	beta-adrenergic	JJ	_	4	amod
3	neuroeffector	neuroeffector	NN	_	4	compound
4	defects	defect	NNS	_	5	nsubj
5	occur	occur	VBP	_	0	ROOT
6	in	in	IN	_	8	case
7	heart	heart	NN	_	8	compound
8	failure	failure	NN	_	5	nmod
9	.	.	.	_	5	punct

1	Whether	whether	IN	_	7	mark
2	an	a	DT	_	3	det
3	alteration	alteration	NN	_	7	nsubj
4	in	in	IN	_	6	case
5	drug1	drug1	NN	_	6	compound
6	uptake-1	uptake-1	NN	_	3	nmod
7	occurs	occur	VBZ	_	10	csubj
8	is	be	VBZ	_	10	cop
9	still	still	RB	_	10	advmod
10	unresolved	unresolved	JJ	_	0	ROOT
11	.	.	.	_	10	punct

1	METHODS	method	NNS	_	0	ROOT
2	.	.	.	_	1	punct

1	The	the	DT	_	2	det
2	role	role	NN	_	7	nsubjpass
3	of	of	IN	_	5	case
4	drug1	drug1	NN	_	5	compound
5	uptake-1	uptake-1	NN	_	2	nmod
6	was	be	VBD	_	7	auxpass
7	studied	study	VBN	_	0	ROOT
8	in	in	IN	_	22	case
9	electrically	electrically	RB	_	10	advmod
10	stimulated	stimulate	VBN	_	22	amod
11	-LRB-	-lrb-	-LRB-	_	13	punct
12	1	1	CD	_	13	nummod
13	Hz	hz	NN	_	10	dep
14	,	,	,	_	13	punct
15	37	37	CD	_	17	nummod
16	degrees	degree	NNS	_	17	compound
17	C	c	NN	_	13	appos
18	-RRB-	-rrb-	-RRB-	_	13	punct
19	human	human	JJ	_	22	amod
20	ventricular	ventricular	JJ	_	22	amod
21	cardiac	cardiac	JJ	_	22	amod
22	preparations	preparation	NNS	_	7	nmod
23	and	and	CC	_	22	cc
24	isolated	isolate	VBN	_	26	amod
25	myocardial	myocardial	JJ	_	26	amod
26	membranes	membrane	NNS	_	22	conj
27	.	.	.	_	7	punct

1	RESULTS	result	NNS	_	0	ROOT
2	.	.	.	_	1	punct

1	The	the	DT	_	2	det
2	effectiveness	effectiveness	NN	_	12	nsubjpass
3	of	of	IN	_	4	case
4	drug1	drug1	NN	_	2	nmod
5	in	in	IN	_	6	mark
6	increasing	increase	VBG	_	2	acl
7	the	the	DT	_	8	det
8	force	force	NN	_	6	dobj
9	of	of	IN	_	10	case
10	contraction	contraction	NN	_	8	nmod
11	was	be	VBD	_	12	auxpass
12	decreased	decrease	VBN	_	0	ROOT
13	in	in	IN	_	14	case
14	relation	relation	NN	_	12	nmod
15	to	to	TO	_	17	case
16	the	the	DT	_	17	det
17	degree	degree	NN	_	14	nmod
18	of	of	IN	_	20	case
19	heart	heart	NN	_	20	compound
20	failure	failure	NN	_	17	nmod
21	.	.	.	_	12	punct

1	In	in	IN	_	2	case
2	contrast	contrast	NN	_	9	nmod
3	,	,	,	_	9	punct
4	the	the	DT	_	5	det
5	potency	potency	NN	_	9	nsubjpass
6	of	of	IN	_	7	case
7	drug1	drug1	NN	_	5	nmod
8	was	be	VBD	_	9	auxpass
9	increased	increase	VBN	_	0	ROOT
10	in	in	IN	_	12	case
11	failing	fail	VBG	_	12	amod
12	hearts	heart	NNS	_	9	nmod
13	-LRB-	-lrb-	-LRB-	_	12	punct
14	New	New	NNP	_	17	compound
15	York	York	NNP	_	17	compound
16	Heart	Heart	NNP	_	17	compound
17	Association	Association	NNP	_	13	root
18	functional	functional	JJ	_	17	amod
19	class	class	NN	_	18	dep
20	IV	iv	CD	_	19	nummod
21	-RRB-	-rrb-	-RRB-	_	19	punct
22	in	in	IN	_	23	case
23	relation	relation	NN	_	17	nmod
24	to	to	TO	_	26	case
25	the	the	DT	_	26	det
26	concentrations	concentration	NNS	_	23	nmod
27	producing	produce	VBG	_	26	acl
28	50	50	CD	_	29	nummod
29	%	%	NN	_	27	dobj
30	of	of	IN	_	33	case
31	the	the	DT	_	33	det
32	maximal	maximal	JJ	_	33	amod
33	effect	effect	NN	_	29	nmod
34	-LRB-	-lrb-	-LRB-	_	35	punct
35	EC50	ec50	NN	_	33	appos
36	-RRB-	-rrb-	-RRB-	_	35	punct
37	.	.	.	_	17	punct

1	The	the	DT	_	3	det
2	EC50	ec50	NN	_	3	compound
3	values	value	NNS	_	17	nsubjpass
4	for	for	IN	_	5	case
5	drug1	drug1	NN	_	3	nmod
6	,	,	,	_	5	punct
7	which	which	WDT	_	11	nsubj
8	is	be	VBZ	_	11	cop
9	not	not	RB	_	11	neg
10	a	a	DT	_	11	det
11	substrate	substrate	NN	_	5	acl:relcl
12	for	for	IN	_	14	case
13	drug2	drug2	NN	_	14	compound
14	uptake-1	uptake-1	NN	_	11	nmod
15	,	,	,	_	5	punct
16	were	be	VBD	_	17	auxpass
17	reduced	reduce	VBN	_	0	ROOT
18	in	in	IN	_	19	case
19	myocardium	myocardium	NN	_	17	nmod
20	in	in	IN	_	22	case
21	functional	functional	JJ	_	22	amod
22	classes	class	NNS	_	17	nmod
23	II	ii	CD	_	22	nummod
24	to	to	TO	_	22	dep
25	III	iii	CD	_	22	nummod
26	and	and	CC	_	22	cc
27	IV	iv	CD	_	22	conj
28	compared	compare	VBN	_	30	case
29	with	with	IN	_	30	case
30	those	those	DT	_	17	advcl
31	in	in	IN	_	33	case
32	nonfailing	nonfailing	JJ	_	33	amod
33	myocardium	myocardium	NN	_	30	nmod
34	.	.	.	_	17	punct

1	The	the	DT	_	3	det
2	uptake	uptake	NN	_	3	compound
3	inhibitors	inhibitor	NNS	_	11	nsubj
4	drug1	drug1	NN	_	3	dep
5	and	and	CC	_	4	cc
6	drug2	drug2	NN	_	4	conj
7	-LRB-	-lrb-	-LRB-	_	9	punct
8	3	3	CD	_	9	nummod
9	mumol/liter	mumol/liter	NN	_	3	appos
10	-RRB-	-rrb-	-RRB-	_	9	punct
11	potentiated	potentiate	VBD	_	0	ROOT
12	the	the	DT	_	15	det
13	positive	positive	JJ	_	15	amod
14	inotropic	inotropic	JJ	_	15	amod
15	effects	effect	NNS	_	11	dobj
16	of	of	IN	_	17	case
17	drug3	drug3	NN	_	15	nmod
18	in	in	IN	_	20	case
19	nonfailing	nonfailing	JJ	_	20	amod
20	myocardium	myocardium	NN	_	15	nmod
21	-LRB-	-lrb-	-LRB-	_	23	punct
22	p	p	NN	_	23	dep
23	<	<	JJR	_	20	dep
24	0.05	0.05	CD	_	23	nummod
25	-RRB-	-rrb-	-RRB-	_	23	punct
26	but	but	CC	_	20	cc
27	not	not	RB	_	32	neg
28	in	in	IN	_	32	case
29	functional	functional	JJ	_	32	amod
30	class	class	NN	_	32	compound
31	IV	iv	CD	_	32	nummod
32	myocardium	myocardium	NN	_	20	conj
33	.	.	.	_	11	punct

1	Radioligand	radioligand	NN	_	3	compound
2	binding	binding	NN	_	3	compound
3	experiments	experiment	NNS	_	10	nsubj
4	using	use	VBG	_	3	acl
5	the	the	DT	_	9	det
6	uptake	uptake	NN	_	9	compound
7	inhibitor	inhibitor	NN	_	9	compound
8	hydrogen-3	hydrogen-3	NN	_	9	compound
9	drug1	drug1	NN	_	4	dobj
10	revealed	reveal	VBD	_	0	ROOT
11	a	a	DT	_	13	det
12	significant	significant	JJ	_	13	amod
13	decrease	decrease	NN	_	10	dobj
14	by	by	IN	_	17	case
15	approximately	approximately	RB	_	16	advmod
16	30	30	CD	_	17	nummod
17	%	%	NN	_	13	nmod
18	in	in	IN	_	22	case
19	drug2	drug2	NN	_	22	compound
20	uptake-1	uptake-1	NN	_	22	compound
21	carrier	carrier	NN	_	22	compound
22	density	density	NN	_	13	nmod
23	in	in	IN	_	25	case
24	functional	functional	JJ	_	25	amod
25	classes	class	NNS	_	13	nmod
26	II	ii	CD	_	25	nummod
27	to	to	TO	_	25	dep
28	III	iii	CD	_	25	nummod
29	and	and	CC	_	13	cc
30	IV	iv	CD	_	31	nummod
31	myocardium	myocardium	NN	_	13	conj
32	versus	versus	CC	_	31	cc
33	nonfailing	nonfailing	JJ	_	34	amod
34	myocardium	myocardium	NN	_	31	conj
35	-LRB-	-lrb-	-LRB-	_	37	punct
36	p	p	NN	_	37	dep
37	<	<	JJR	_	34	dep
38	0.05	0.05	CD	_	37	nummod
39	-RRB-	-rrb-	-RRB-	_	37	punct
40	.	.	.	_	10	punct

1	CONCLUSIONS	conclusion	NNS	_	0	ROOT
2	.	.	.	_	1	punct

1	In	in	IN	_	4	case
2	human	human	JJ	_	4	amod
3	heart	heart	NN	_	4	compound
4	failure	failure	NN	_	7	nmod
5	,	,	,	_	7	punct
6	there	there	EX	_	7	expl
7	is	be	VBZ	_	0	ROOT
8	a	a	DT	_	10	det
9	presynaptic	presynaptic	JJ	_	10	amod
10	defect	defect	NN	_	7	nsubj
11	in	in	IN	_	15	case
12	the	the	DT	_	15	det
13	sympathetic	sympathetic	JJ	_	15	amod
14	nervous	nervous	JJ	_	15	amod
15	system	system	NN	_	10	nmod
16	,	,	,	_	10	punct
17	leading	lead	VBG	_	10	acl
18	to	to	TO	_	21	case
19	reduced	reduce	VBN	_	21	amod
20	uptake-1	uptake-1	NN	_	21	compound
21	activity	activity	NN	_	17	nmod
22	.	.	.	_	7	punct

1	This	this	DT	_	2	det
2	defect	defect	NN	_	9	nsubjpass
3	in	in	IN	_	6	case
4	the	the	DT	_	6	det
5	failing	fail	VBG	_	6	amod
6	heart	heart	NN	_	2	nmod
7	can	can	MD	_	9	aux
8	be	be	VB	_	9	auxpass
9	mimicked	mimic	VBN	_	0	ROOT
10	by	by	IN	_	12	case
11	the	the	DT	_	12	det
12	effects	effect	NNS	_	9	nmod
13	of	of	IN	_	14	case
14	uptake	uptake	NN	_	12	nmod
15	blocking	block	VBG	_	16	compound
16	agents	agent	NNS	_	14	dep
17	,	,	,	_	14	punct
18	such	such	JJ	_	20	case
19	as	as	IN	_	18	mwe
20	drug1	drug1	NN	_	14	nmod
21	and	and	CC	_	20	cc
22	drug2	drug2	NN	_	20	conj
23	,	,	,	_	14	punct
24	in	in	IN	_	27	case
25	the	the	DT	_	27	det
26	nonfailing	nonfailing	JJ	_	27	amod
27	heart	heart	NN	_	14	nmod
28	only	only	RB	_	27	advmod
29	.	.	.	_	9	punct

1	Compromised	compromise	VBN	_	3	amod
2	drug1	drug1	NN	_	3	compound
3	uptake-1	uptake-1	NN	_	0	ROOT
4	in	in	IN	_	12	mark
5	functional	functional	JJ	_	12	dep
6	class	class	NN	_	12	nsubjpass
7	IV	iv	CD	_	6	nummod
8	can	can	MD	_	12	aux
9	not	not	RB	_	12	neg
10	be	be	VB	_	12	auxpass
11	further	further	RB	_	12	advmod
12	increased	increase	VBN	_	3	acl
13	by	by	IN	_	14	case
14	drug2	drug2	NN	_	12	nmod
15	and	and	CC	_	14	cc
16	drug3	drug3	NN	_	14	conj
17	.	.	.	_	3	punct

1	The	the	DT	_	3	det
2	pathophysiologic	pathophysiologic	JJ	_	3	amod
3	consequences	consequence	NNS	_	9	nsubj
4	could	could	MD	_	9	aux
5	be	be	VB	_	9	cop
6	an	a	DT	_	9	det
7	increased	increase	VBN	_	9	amod
8	synaptic	synaptic	JJ	_	9	amod
9	concentration	concentration	NN	_	0	ROOT
10	of	of	IN	_	11	case
11	drug1	drug1	NN	_	9	nmod
12	predisposing	predispose	VBG	_	11	acl
13	to	to	TO	_	16	case
14	adenylyl	adenylyl	JJ	_	16	amod
15	cyclase	cyclase	NN	_	16	compound
16	desensitization	desensitization	NN	_	12	nmod
17	.	.	.	_	9	punct

1	The	the	DT	_	2	det
2	mechanism	mechanism	NN	_	0	ROOT
3	of	of	IN	_	4	case
4	drug1	drug1	NN	_	2	nmod
5	-	-	:	_	2	punct
6	induced	induce	VBN	_	7	amod
7	vasorelaxation	vasorelaxation	NN	_	8	nsubj
8	differs	differ	VBZ	_	2	dep
9	in	in	IN	_	13	case
10	the	the	DT	_	13	det
11	mesenteric	mesenteric	JJ	_	13	amod
12	resistance	resistance	NN	_	13	compound
13	arteries	artery	NNS	_	8	nmod
14	of	of	IN	_	18	case
15	lean	lean	JJ	_	18	amod
16	and	and	CC	_	15	cc
17	obese	obese	JJ	_	15	conj
18	rats	rat	NNS	_	13	nmod
19	.	.	.	_	2	punct

1	drug1	drug1	NN	_	4	nsubjpass
2	has	have	VBZ	_	4	aux
3	been	be	VBN	_	4	auxpass
4	shown	show	VBN	_	0	ROOT
5	to	to	TO	_	6	mark
6	induce	induce	VB	_	4	xcomp
7	vasorelaxation	vasorelaxation	NN	_	6	dobj
8	.	.	.	_	4	punct

1	In	in	IN	_	3	case
2	this	this	DT	_	3	det
3	study	study	NN	_	6	nmod
4	,	,	,	_	6	punct
5	we	we	PRP	_	6	nsubj
6	investigated	investigate	VBD	_	0	ROOT
7	the	the	DT	_	10	det
8	mechanism	mechanism	NN	_	10	compound
9	-LRB-	-lrb-	-LRB-	_	10	punct
10	s	s	NNS	_	6	dobj
11	-RRB-	-rrb-	-RRB-	_	10	punct
12	of	of	IN	_	13	case
13	drug1	drug1	NN	_	10	nmod
14	-	-	:	_	10	punct
15	induced	induce	VBN	_	16	amod
16	vasorelaxation	vasorelaxation	NN	_	10	dep
17	in	in	IN	_	18	case
18	resistance	resistance	NN	_	16	nmod
19	mesenteric	mesenteric	JJ	_	20	amod
20	arteries	artery	NNS	_	18	dep
21	from	from	IN	_	23	case
22	male	male	JJ	_	23	amod
23	lean	lean	JJ	_	20	nmod
24	and	and	CC	_	23	cc
25	dietary-induced	dietary-induced	JJ	_	27	amod
26	obese	obese	JJ	_	27	amod
27	rats	rat	NNS	_	23	conj
28	.	.	.	_	6	punct

1	Compared	compare	VBN	_	4	case
2	with	with	IN	_	4	case
3	lean	lean	JJ	_	4	amod
4	rats	rat	NNS	_	10	advcl
5	,	,	,	_	10	punct
6	arteries	artery	NNS	_	10	nsubj
7	from	from	IN	_	9	case
8	dietary-obese	dietary-obese	JJ	_	9	amod
9	rats	rat	NNS	_	6	nmod
10	showed	show	VBD	_	0	ROOT
11	significant	significant	JJ	_	18	amod
12	-LRB-	-lrb-	-LRB-	_	18	punct
13	P	p	NN	_	18	compound
14	<	<	JJR	_	13	amod
15	0.001	0.001	CD	_	14	dep
16	-RRB-	-rrb-	-RRB-	_	18	punct
17	endothelial	endothelial	JJ	_	18	amod
18	dysfunction	dysfunction	NN	_	10	dobj
19	,	,	,	_	18	punct
20	as	as	IN	_	21	mark
21	indicated	indicate	VBN	_	18	dep
22	by	by	IN	_	24	case
23	a	a	DT	_	24	det
24	decrease	decrease	NN	_	21	nmod
25	-LRB-	-lrb-	-LRB-	_	28	punct
26	>	>	JJR	_	27	advmod
27	20	20	CD	_	28	nummod
28	%	%	NN	_	24	appos
29	-RRB-	-rrb-	-RRB-	_	28	punct
30	in	in	IN	_	33	case
31	maximal	maximal	JJ	_	33	amod
32	acetylcholine-induced	acetylcholine-induced	JJ	_	33	amod
33	vasorelaxation	vasorelaxation	NN	_	24	nmod
34	.	.	.	_	10	punct

1	drug1	drug1	NN	_	6	nsubj
2	-LRB-	-lrb-	-LRB-	_	4	punct
3	5-35	5-35	CD	_	4	nummod
4	micromol/l	micromol/l	NN	_	1	appos
5	-RRB-	-rrb-	-RRB-	_	4	punct
6	induced	induce	VBD	_	0	ROOT
7	concentration-dependent	concentration-dependent	JJ	_	8	amod
8	relaxation	relaxation	NN	_	6	dobj
9	of	of	IN	_	11	case
10	mesenteric	mesenteric	JJ	_	11	amod
11	arteries	artery	NNS	_	8	nmod
12	preconstricted	preconstrict	VBN	_	11	acl
13	with	with	IN	_	14	case
14	drug2	drug2	NN	_	12	nmod
15	-LRB-	-lrb-	-LRB-	_	17	punct
16	8	8	CD	_	17	nummod
17	micromol/l	micromol/l	NN	_	14	appos
18	-RRB-	-rrb-	-RRB-	_	17	punct
19	or	or	CC	_	14	cc
20	drug3	drug3	NN	_	14	conj
21	-LRB-	-lrb-	-LRB-	_	23	punct
22	125	125	CD	_	23	nummod
23	mmol/l	mmol/l	NN	_	20	appos
24	-RRB-	-rrb-	-RRB-	_	23	punct
25	from	from	IN	_	27	case
26	both	both	DT	_	27	cc:preconj
27	lean	lean	JJ	_	12	nmod
28	and	and	CC	_	27	cc
29	dietary-obese	dietary-obese	JJ	_	27	conj
30	rats	rat	NNS	_	27	dep
31	.	.	.	_	6	punct

1	There	there	EX	_	2	expl
2	were	be	VBD	_	0	ROOT
3	no	no	DT	_	5	neg
4	significant	significant	JJ	_	5	amod
5	differences	difference	NNS	_	2	nsubj
6	between	between	IN	_	9	case
7	the	the	DT	_	9	det
8	two	two	CD	_	9	nummod
9	groups	group	NNS	_	5	nmod
10	,	,	,	_	2	punct
11	achieving	achieve	VBG	_	2	advcl
12	a	a	DT	_	14	det
13	maximum	maximum	NN	_	14	compound
14	relaxation	relaxation	NN	_	11	dobj
15	of	of	IN	_	18	case
16	>	>	JJR	_	17	advmod
17	95	95	CD	_	18	nummod
18	%	%	NN	_	14	nmod
19	at	at	IN	_	21	case
20	a	a	DT	_	21	det
21	concentration	concentration	NN	_	11	nmod
22	of	of	IN	_	24	case
23	35	35	CD	_	24	nummod
24	micromol/l	micromol/l	NN	_	21	nmod
25	.	.	.	_	2	punct

1	However	however	RB	_	12	advmod
2	,	,	,	_	12	punct
3	drug1	drug1	NN	_	12	nsubj
4	-LRB-	-lrb-	-LRB-	_	8	punct
5	100	100	CD	_	8	nummod
6	and	and	CC	_	5	cc
7	300	300	CD	_	5	conj
8	micromol/l	micromol/l	NN	_	3	appos
9	-RRB-	-rrb-	-RRB-	_	8	punct
10	did	do	VBD	_	12	aux
11	not	not	RB	_	12	neg
12	alter	alter	VB	_	0	ROOT
13	the	the	DT	_	14	det
14	effects	effect	NNS	_	12	dobj
15	of	of	IN	_	16	case
16	drug2	drug2	NN	_	14	nmod
17	on	on	IN	_	18	case
18	arteries	artery	NNS	_	14	nmod
19	from	from	IN	_	21	case
20	dietary-obese	dietary-obese	JJ	_	21	amod
21	rats	rat	NNS	_	18	nmod
22	,	,	,	_	12	punct
23	giving	give	VBG	_	12	advcl
24	superimposed	superimpose	VBN	_	26	amod
25	concentration-responses	concentration-response	NNS	_	26	compound
26	curves	curve	NNS	_	23	dobj
27	.	.	.	_	12	punct

1	drug1	drug1	NN	_	4	nsubj
2	was	be	VBD	_	4	cop
3	also	also	RB	_	4	advmod
4	ineffective	ineffective	JJ	_	0	ROOT
5	in	in	IN	_	6	mark
6	altering	alter	VBG	_	4	advcl
7	drug2	drug2	NN	_	8	compound
8	activity	activity	NN	_	6	dobj
9	in	in	IN	_	10	case
10	arteries	artery	NNS	_	8	nmod
11	from	from	IN	_	13	case
12	both	both	DT	_	13	cc:preconj
13	lean	lean	JJ	_	10	nmod
14	and	and	CC	_	13	cc
15	dietary-obese	dietary-obese	JJ	_	13	conj
16	rats	rat	NNS	_	13	dep
17	.	.	.	_	4	punct

1	In	in	IN	_	2	case
2	drug1	drug1	NN	_	5	nmod
3	-	-	:	_	5	punct
4	precontracted	precontracted	JJ	_	5	amod
5	arteries	artery	NNS	_	0	ROOT
6	from	from	IN	_	8	case
7	dietary-obese	dietary-obese	JJ	_	8	amod
8	rats	rat	NNS	_	5	nmod
9	,	,	,	_	5	punct
10	responses	response	NNS	_	15	nsubjpass
11	to	to	TO	_	12	case
12	drug2	drug2	NN	_	10	nmod
13	were	be	VBD	_	15	auxpass
14	not	not	RB	_	15	neg
15	attenuated	attenuate	VBN	_	5	acl:relcl
16	by	by	IN	_	18	case
17	endothelial	endothelial	JJ	_	18	amod
18	denudation	denudation	NN	_	15	nmod
19	,	,	,	_	15	punct
20	indicating	indicate	VBG	_	15	xcomp
21	an	a	DT	_	22	det
22	action	action	NN	_	20	dobj
23	independent	independent	JJ	_	22	amod
24	of	of	IN	_	26	case
25	the	the	DT	_	26	det
26	endothelium	endothelium	NN	_	23	nmod
27	.	.	.	_	5	punct

1	This	this	DT	_	2	det
2	study	study	NN	_	3	nsubj
3	indicates	indicate	VBZ	_	0	ROOT
4	that	that	IN	_	11	mark
5	:	:	:	_	11	punct
6	-LRB-	-lrb-	-LRB-	_	7	punct
7	a	a	LS	_	11	dep
8	-RRB-	-rrb-	-RRB-	_	7	punct
9	the	the	DT	_	11	det
10	maximal	maximal	JJ	_	11	amod
11	effects	effect	NNS	_	24	nsubjpass
12	of	of	IN	_	13	case
13	drug1	drug1	NN	_	11	nmod
14	on	on	IN	_	16	case
15	resistance	resistance	NN	_	16	compound
16	arteries	artery	NNS	_	11	nmod
17	from	from	IN	_	21	case
18	lean	lean	JJ	_	21	amod
19	and	and	CC	_	18	cc
20	dietary-obese	dietary-obese	JJ	_	18	conj
21	rats	rat	NNS	_	16	nmod
22	are	be	VBP	_	24	auxpass
23	not	not	RB	_	24	neg
24	effected	effect	VBN	_	3	ccomp
25	by	by	IN	_	27	case
26	endothelial	endothelial	JJ	_	27	amod
27	dysfunction	dysfunction	NN	_	24	nmod
28	,	,	,	_	24	punct
29	and	and	CC	_	24	cc
30	-LRB-	-lrb-	-LRB-	_	31	punct
31	b	b	LS	_	56	dep
32	-RRB-	-rrb-	-RRB-	_	31	punct
33	the	the	DT	_	34	det
34	effects	effect	NNS	_	56	nsubjpass
35	of	of	IN	_	36	case
36	drug2	drug2	NN	_	34	nmod
37	in	in	IN	_	39	case
38	lean	lean	JJ	_	39	amod
39	animals	animal	NNS	_	34	nmod
40	-LRB-	-lrb-	-LRB-	_	46	punct
41	where	where	WRB	_	46	advmod
42	endothelial	endothelial	JJ	_	43	amod
43	function	function	NN	_	46	nsubj
44	is	be	VBZ	_	46	cop
45	not	not	RB	_	46	neg
46	impaired	impaired	JJ	_	39	dep
47	-RRB-	-rrb-	-RRB-	_	46	punct
48	,	,	,	_	39	punct
49	but	but	CC	_	39	cc
50	not	not	RB	_	53	neg
51	in	in	IN	_	53	case
52	dietary-obese	dietary-obese	JJ	_	53	amod
53	rats	rat	NNS	_	39	conj
54	,	,	,	_	34	punct
55	are	be	VBP	_	56	auxpass
56	mediated	mediate	VBN	_	24	conj
57	via	via	IN	_	58	case
58	NO	no	NN	_	56	nmod
59	.	.	.	_	3	punct

1	drug1	drug1	NN	_	0	ROOT
2	:	:	:	_	1	punct
3	an	a	DT	_	5	det
4	IgA-binding	iga-binding	JJ	_	5	amod
5	lectin	lectin	NN	_	1	dep
6	.	.	.	_	1	punct

1	We	we	PRP	_	3	nsubj
2	previously	previously	RB	_	3	advmod
3	reported	report	VBD	_	0	ROOT
4	that	that	IN	_	12	mark
5	seeds	seed	NNS	_	12	nsubj
6	of	of	IN	_	8	case
7	Artocarpus	Artocarpus	NNP	_	8	compound
8	integrifolia	integrifolia	NN	_	5	nmod
9	-LRB-	-lrb-	-LRB-	_	10	punct
10	jackfruit	jackfruit	NN	_	8	appos
11	-RRB-	-rrb-	-RRB-	_	10	punct
12	contain	contain	VBP	_	3	ccomp
13	a	a	DT	_	14	det
14	lectin	lectin	NN	_	12	dobj
15	,	,	,	_	14	punct
16	which	which	WDT	_	18	dobj
17	we	we	PRP	_	18	nsubj
18	call	call	VBP	_	14	acl:relcl
19	drug1	drug1	NN	_	18	xcomp
20	,	,	,	_	14	punct
21	that	that	WDT	_	28	nsubj
22	is	be	VBZ	_	28	cop
23	both	both	DT	_	28	cc:preconj
24	a	a	DT	_	28	det
25	potent	potent	JJ	_	28	amod
26	T	t	NN	_	28	compound
27	cell	cell	NN	_	28	compound
28	mitogen	mitogen	NN	_	14	acl:relcl
29	and	and	CC	_	28	cc
30	an	a	DT	_	34	det
31	apparently	apparently	RB	_	33	advmod
32	T	t	NN	_	33	nmod:npmod
33	cell-independent	cell-independent	JJ	_	34	amod
34	activator	activator	NN	_	28	conj
35	of	of	IN	_	38	case
36	human	human	JJ	_	38	amod
37	B	b	NN	_	38	compound
38	cells	cell	NNS	_	34	nmod
39	for	for	IN	_	41	case
40	the	the	DT	_	41	det
41	secretion	secretion	NN	_	34	nmod
42	of	of	IN	_	43	case
43	immunoglobulins	immunoglobulin	NNS	_	41	nmod
44	.	.	.	_	3	punct

1	During	during	IN	_	4	case
2	the	the	DT	_	4	det
3	above	above	JJ	_	4	amod
4	experiments	experiment	NNS	_	6	nmod
5	we	we	PRP	_	6	nsubj
6	noted	note	VBD	_	0	ROOT
7	a	a	DT	_	9	det
8	massive	massive	JJ	_	9	amod
9	precipitation	precipitation	NN	_	6	dobj
10	in	in	IN	_	12	case
11	cell	cell	NN	_	12	compound
12	cultures	culture	NNS	_	9	nmod
13	stimulated	stimulate	VBN	_	12	acl
14	with	with	IN	_	13	nmod
15	greater	greater	JJR	_	14	dep
16	than	than	IN	_	18	case
17	or	or	CC	_	18	cc
18	equal	equal	JJ	_	15	nmod
19	to	to	TO	_	21	case
20	100	100	CD	_	21	nummod
21	micrograms	microgram	NNS	_	18	nmod
22	of	of	IN	_	23	case
23	lectin	lectin	NN	_	21	nmod
24	.	.	.	_	6	punct

1	In	in	IN	_	3	case
2	this	this	DT	_	3	det
3	paper	paper	NN	_	6	nmod
4	,	,	,	_	6	punct
5	we	we	PRP	_	6	nsubj
6	show	show	VBP	_	0	ROOT
7	that	that	IN	_	11	mark
8	the	the	DT	_	9	det
9	precipitate	precipitate	NN	_	11	nsubjpass
10	is	be	VBZ	_	11	auxpass
11	formed	form	VBN	_	6	ccomp
12	after	after	IN	_	14	case
13	the	the	DT	_	14	det
14	interaction	interaction	NN	_	11	nmod
15	of	of	IN	_	16	case
16	drug1	drug1	NN	_	14	nmod
17	and	and	CC	_	16	cc
18	the	the	DT	_	20	det
19	serum	serum	NN	_	20	compound
20	protein	protein	NN	_	16	conj
21	added	add	VBD	_	14	acl
22	to	to	TO	_	25	case
23	the	the	DT	_	25	det
24	culture	culture	NN	_	25	compound
25	medium	medium	NN	_	21	nmod
26	.	.	.	_	6	punct

1	More	more	RBR	_	2	advmod
2	importantly	importantly	RB	_	5	advmod
3	,	,	,	_	5	punct
4	we	we	PRP	_	5	nsubj
5	demonstrate	demonstrate	VBP	_	0	ROOT
6	that	that	IN	_	13	mark
7	IgA	iga	NN	_	13	nsubj
8	is	be	VBZ	_	13	cop
9	probably	probably	RB	_	13	advmod
10	the	the	DT	_	13	det
11	major	major	JJ	_	13	amod
12	serum	serum	NN	_	13	compound
13	constituent	constituent	NN	_	5	ccomp
14	precipitated	precipitate	VBN	_	13	acl
15	by	by	IN	_	17	case
16	the	the	DT	_	17	det
17	lectin	lectin	NN	_	14	nmod
18	and	and	CC	_	13	cc
19	that	that	IN	_	26	mark
20	no	no	DT	_	21	neg
21	IgG	igg	NN	_	26	nsubjpass
22	or	or	CC	_	21	cc
23	IgM	igm	NN	_	21	conj
24	can	can	MD	_	26	aux
25	be	be	VB	_	26	auxpass
26	detected	detect	VBN	_	13	conj
27	in	in	IN	_	29	case
28	the	the	DT	_	29	det
29	precipitates	precipitate	NNS	_	26	nmod
30	.	.	.	_	5	punct

1	In	in	IN	_	2	case
2	secretions	secretion	NNS	_	11	nmod
3	such	such	JJ	_	5	case
4	as	as	IN	_	3	mwe
5	colostrum	colostrum	NN	_	2	nmod
6	,	,	,	_	11	punct
7	IgA	iga	NN	_	11	nsubj
8	is	be	VBZ	_	11	cop
9	the	the	DT	_	11	det
10	only	only	JJ	_	11	amod
11	protein	protein	NN	_	0	ROOT
12	precipitated	precipitate	VBN	_	11	acl
13	by	by	IN	_	14	case
14	drug1	drug1	NN	_	12	nmod
15	.	.	.	_	11	punct

1	On	on	IN	_	3	case
2	the	the	DT	_	3	det
3	basis	basis	NN	_	8	nmod
4	of	of	IN	_	6	case
5	this	this	DT	_	6	det
6	specificity	specificity	NN	_	3	nmod
7	we	we	PRP	_	8	nsubj
8	describe	describe	VBP	_	0	ROOT
9	a	a	DT	_	15	det
10	simple	simple	JJ	_	15	amod
11	and	and	CC	_	10	cc
12	reliable	reliable	JJ	_	10	conj
13	affinity	affinity	NN	_	15	compound
14	chromatography	chromatography	NN	_	15	compound
15	procedure	procedure	NN	_	8	dobj
16	for	for	IN	_	18	case
17	the	the	DT	_	18	det
18	purification	purification	NN	_	15	nmod
19	of	of	IN	_	22	case
20	both	both	CC	_	22	cc:preconj
21	human	human	JJ	_	22	amod
22	serum	serum	NN	_	18	nmod
23	and	and	CC	_	22	cc
24	colostrum	colostrum	NN	_	25	compound
25	IgA	iga	NN	_	22	conj
26	.	.	.	_	8	punct

1	drug1	drug1	NN	_	6	nsubj
2	is	be	VBZ	_	6	cop
3	a	a	DT	_	6	det
4	D-Gal	d-gal	JJ	_	6	amod
5	binding	binding	NN	_	6	compound
6	lectin	lectin	NN	_	0	ROOT
7	and	and	CC	_	6	cc
8	should	should	MD	_	12	aux
9	be	be	VB	_	12	cop
10	a	a	DT	_	12	det
11	useful	useful	JJ	_	12	amod
12	tool	tool	NN	_	6	conj
13	for	for	IN	_	14	mark
14	studying	study	VBG	_	12	acl
15	of	of	IN	_	16	case
16	serum	serum	NN	_	14	nmod
17	and	and	CC	_	16	cc
18	secretory	secretory	JJ	_	19	amod
19	IgA	iga	NN	_	16	conj
20	.	.	.	_	6	punct

1	-LSB-	-lsb-	-LRB-	_	3	punct
2	2	2	CD	_	3	nummod
3	epidemics	epidemic	NNS	_	30	nsubj
4	of	of	IN	_	6	case
5	arsenical	arsenical	JJ	_	6	amod
6	encephalopathy	encephalopathy	NN	_	3	nmod
7	in	in	IN	_	9	case
8	the	the	DT	_	9	det
9	treatment	treatment	NN	_	3	nmod
10	of	of	IN	_	11	case
11	trypanosomiasis	trypanosomiasis	NN	_	9	nmod
12	,	,	,	_	11	punct
13	Uganda	Uganda	NNP	_	11	appos
14	,	,	,	_	11	punct
15	1992-1993	1992-1993	CD	_	11	appos
16	-RSB-	-rsb-	-RRB-	_	3	punct
17	Since	since	IN	_	18	case
18	1988	1988	CD	_	3	nmod
19	,	,	,	_	3	punct
20	the	the	DT	_	25	det
21	french	french	JJ	_	25	amod
22	non-governmental	non-governmental	JJ	_	25	amod
23	organisation	organisation	NN	_	25	compound
24	M	m	NN	_	25	compound
25	decins	decin	NNS	_	26	nsubj
26	Sans	san	VBZ	_	3	acl:relcl
27	Fronti	Fronti	NNP	_	28	compound
28	res	re	NNS	_	26	dobj
29	is	be	VBZ	_	30	aux
30	running	run	VBG	_	0	ROOT
31	a	a	DT	_	33	det
32	control	control	NN	_	33	amod
33	program	program	NN	_	30	dobj
34	of	of	IN	_	37	case
35	human	human	JJ	_	37	amod
36	african	african	JJ	_	37	amod
37	trypanosomiasis	trypanosomiasis	NN	_	33	nmod
38	in	in	IN	_	40	case
39	the	the	DT	_	40	det
40	district	district	NN	_	33	nmod
41	of	of	IN	_	42	case
42	Moyo	Moyo	NNP	_	40	nmod
43	,	,	,	_	42	punct
44	North-Uganda	North-Uganda	NNP	_	42	appos
45	.	.	.	_	30	punct

1	Between	between	IN	_	2	case
2	1988	1988	CD	_	11	nmod
3	and	and	CC	_	2	cc
4	1993	1993	CD	_	2	conj
5	,	,	,	_	11	punct
6	more	more	JJR	_	8	advmod
7	than	than	IN	_	6	mwe
8	7,000	7,000	CD	_	9	nummod
9	patients	patient	NNS	_	11	nsubjpass
10	were	be	VBD	_	11	auxpass
11	diagnosed	diagnose	VBN	_	0	ROOT
12	and	and	CC	_	11	cc
13	treated	treat	VBN	_	11	conj
14	.	.	.	_	11	punct

1	Since	since	IN	_	2	case
2	1988	1988	CD	_	7	nmod
3	,	,	,	_	7	punct
4	it	it	PRP	_	7	nsubjpass
5	has	have	VBZ	_	7	aux
6	been	be	VBN	_	7	auxpass
7	noted	note	VBN	_	0	ROOT
8	that	that	IN	_	14	mark
9	incidence	incidence	NN	_	14	nsubj
10	of	of	IN	_	12	case
11	drug1	drug1	NN	_	12	compound
12	reaction	reaction	NN	_	9	nmod
13	had	have	VBD	_	14	aux
14	increased	increase	VBN	_	7	ccomp
15	systematically	systematically	RB	_	14	advmod
16	between	between	IN	_	17	case
17	June	June	NNP	_	14	nmod
18	and	and	CC	_	17	cc
19	October	October	NNP	_	17	conj
20	of	of	IN	_	22	case
21	each	each	DT	_	22	det
22	year	year	NN	_	17	nmod
23	,	,	,	_	14	punct
24	indicating	indicate	VBG	_	14	advcl
25	strong	strong	JJ	_	27	amod
26	seasonal	seasonal	JJ	_	27	amod
27	variation	variation	NN	_	24	dobj
28	.	.	.	_	7	punct

1	In	in	IN	_	2	case
2	1992	1992	CD	_	15	nmod
3	and	and	CC	_	2	cc
4	1993	1993	CD	_	2	conj
5	,	,	,	_	15	punct
6	two	two	CD	_	7	nummod
7	outbreaks	outbreak	NNS	_	15	nsubj
8	of	of	IN	_	11	case
9	arsenical	arsenical	JJ	_	11	amod
10	reactive	reactive	JJ	_	11	amod
11	encephalopathy	encephalopathy	NN	_	7	nmod
12	-LRB-	-lrb-	-LRB-	_	13	punct
13	ARE	be	VBP	_	11	appos
14	-RRB-	-rrb-	-RRB-	_	13	punct
15	occurred	occur	VBD	_	0	ROOT
16	in	in	IN	_	20	case
17	the	the	DT	_	20	det
18	sleeping	sleep	VBG	_	20	amod
19	sickness	sickness	NN	_	20	compound
20	center	center	NN	_	15	nmod
21	of	of	IN	_	22	case
22	Adjumani	Adjumani	NNP	_	20	nmod
23	.	.	.	_	15	punct

1	The	the	DT	_	2	det
2	incidence	incidence	NN	_	0	ROOT
3	of	of	IN	_	6	mark
4	ARE	be	VBP	_	6	auxpass
5	suddenly	suddenly	RB	_	6	advmod
6	exceeded	exceed	VBN	_	2	acl
7	10	10	CD	_	8	nummod
8	%	%	NN	_	6	dobj
9	of	of	IN	_	11	case
10	the	the	DT	_	11	det
11	patients	patient	NNS	_	8	nmod
12	treated	treat	VBN	_	11	acl
13	by	by	IN	_	14	case
14	drug1	drug1	NN	_	12	nmod
15	during	during	IN	_	16	case
16	August	August	NNP	_	12	nmod
17	1992	1992	CD	_	16	nummod
18	and	and	CC	_	16	cc
19	September	September	NNP	_	16	conj
20	1993	1993	CD	_	19	nummod
21	.	.	.	_	2	punct

1	The	the	DT	_	2	det
2	onset	onset	NN	_	0	ROOT
3	of	of	IN	_	5	case
4	80	80	CD	_	5	nummod
5	%	%	NN	_	2	nmod
6	of	of	IN	_	9	case
7	those	those	DT	_	9	det
8	``	``	``	_	9	punct
9	epidemic	epidemic	JJ	_	5	nmod
10	''	''	''	_	2	punct

1	cases	case	NNS	_	3	nsubj
2	,	,	,	_	3	punct
3	occurred	occur	VBD	_	0	ROOT
4	between	between	IN	_	6	case
5	the	the	DT	_	6	det
6	5th	5th	NN	_	3	nmod
7	and	and	CC	_	6	cc
8	the	the	DT	_	10	det
9	11th	11th	JJ	_	10	amod
10	day	day	NN	_	6	conj
11	of	of	IN	_	12	case
12	treatment	treatment	NN	_	10	nmod
13	.	.	.	_	3	punct

1	Two	two	CD	_	3	nummod
2	retrospective	retrospective	JJ	_	3	amod
3	studies	study	NNS	_	5	nsubjpass
4	were	be	VBD	_	5	auxpass
5	conducted	conduct	VBN	_	0	ROOT
6	in	in	IN	_	7	case
7	1992	1992	CD	_	5	nmod
8	-LRB-	-lrb-	-LRB-	_	10	punct
9	75	75	CD	_	10	nummod
10	cases	case	NNS	_	7	appos
11	-RRB-	-rrb-	-RRB-	_	10	punct
12	and	and	CC	_	7	cc
13	in	in	IN	_	14	case
14	1993	1993	CD	_	7	conj
15	-LRB-	-lrb-	-LRB-	_	17	punct
16	51	51	CD	_	17	nummod
17	cases	case	NNS	_	14	appos
18	-RRB-	-rrb-	-RRB-	_	17	punct
19	.	.	.	_	5	punct

1	Among	among	IN	_	4	case
2	the	the	DT	_	4	det
3	risk	risk	NN	_	4	compound
4	factors	factor	NNS	_	8	nmod
5	studied	study	VBN	_	4	acl
6	,	,	,	_	8	punct
7	two	two	CD	_	8	nsubj
8	appear	appear	VBP	_	0	ROOT
9	to	to	TO	_	10	mark
10	increase	increase	VB	_	8	xcomp
11	the	the	DT	_	12	det
12	risk	risk	NN	_	10	dobj
13	of	of	IN	_	14	case
14	ARE	be	VBP	_	12	nmod
15	:	:	:	_	8	punct
16	the	the	DT	_	17	det
17	prescription	prescription	NN	_	8	dep
18	of	of	IN	_	19	case
19	drug1	drug1	NN	_	17	nmod
20	to	to	TO	_	21	mark
21	treat	treat	VB	_	17	acl
22	strongyloidiasis	strongyloidiasis	NN	_	21	dobj
23	during	during	IN	_	26	case
24	the	the	DT	_	26	det
25	drug2	drug2	NN	_	26	compound
26	cure	cure	NN	_	21	nmod
27	and	and	CC	_	17	cc
28	the	the	DT	_	32	det
29	bad	bad	JJ	_	32	amod
30	general	general	JJ	_	32	amod
31	clinical	clinical	JJ	_	32	amod
32	conditions	condition	NNS	_	17	conj
33	of	of	IN	_	34	case
34	patients	patient	NNS	_	32	nmod
35	.	.	.	_	8	punct

1	These	these	DT	_	2	det
2	observations	observation	NNS	_	3	nsubj
3	suggest	suggest	VBP	_	0	ROOT
4	that	that	IN	_	9	mark
5	exogenous	exogenous	JJ	_	6	amod
6	co-factors	co-factor	NNS	_	9	nsubjpass
7	could	could	MD	_	9	aux
8	be	be	VB	_	9	auxpass
9	involved	involve	VBN	_	3	ccomp
10	in	in	IN	_	12	case
11	the	the	DT	_	12	det
12	occurrence	occurrence	NN	_	9	nmod
13	of	of	IN	_	14	case
14	ARE	be	VBP	_	12	nmod
15	.	.	.	_	3	punct

1	Recommendations	recommendation	NNS	_	2	nsubj
2	were	be	VBD	_	0	ROOT
3	to	to	TO	_	4	mark
4	avoid	avoid	VB	_	2	xcomp
5	administration	administration	NN	_	4	dobj
6	of	of	IN	_	9	case
7	diffusible	diffusible	JJ	_	9	amod
8	drug1	drug1	NN	_	9	compound
9	treatment	treatment	NN	_	5	nmod
10	during	during	IN	_	12	case
11	the	the	DT	_	12	det
12	cure	cure	NN	_	4	nmod
13	,	,	,	_	4	punct
14	and	and	CC	_	4	cc
15	to	to	TO	_	16	mark
16	improve	improve	VB	_	4	conj
17	the	the	DT	_	19	det
18	general	general	JJ	_	19	amod
19	conditions	condition	NNS	_	16	dobj
20	of	of	IN	_	21	case
21	patients	patient	NNS	_	19	nmod
22	before	before	IN	_	24	case
23	the	the	DT	_	24	det
24	cure	cure	NN	_	16	nmod
25	of	of	IN	_	26	case
26	drug2	drug2	NN	_	24	nmod
27	.	.	.	_	2	punct

1	Behavioral	behavioral	JJ	_	2	amod
2	responses	response	NNS	_	10	nsubj
3	to	to	TO	_	6	case
4	repeated	repeat	VBN	_	6	amod
5	drug1	drug1	NN	_	6	compound
6	exposure	exposure	NN	_	2	nmod
7	in	in	IN	_	8	case
8	mice	mouse	NNS	_	6	nmod
9	selectively	selectively	RB	_	10	advmod
10	bred	breed	VBD	_	0	ROOT
11	for	for	IN	_	13	case
12	differential	differential	JJ	_	13	amod
13	sensitivity	sensitivity	NN	_	10	nmod
14	to	to	TO	_	15	case
15	drug2	drug2	NN	_	13	nmod
16	.	.	.	_	10	punct

1	Mice	mouse	NNS	_	0	ROOT
2	from	from	IN	_	5	case
3	the	the	DT	_	5	det
4	20th	20th	JJ	_	5	amod
5	generation	generation	NN	_	1	nmod
6	of	of	IN	_	8	case
7	three	three	CD	_	8	nummod
8	lines	line	NNS	_	5	nmod
9	divergently	divergently	RB	_	10	advmod
10	selected	select	VBN	_	8	acl
11	for	for	IN	_	12	case
12	response	response	NN	_	10	nmod
13	to	to	TO	_	14	case
14	drug1	drug1	NN	_	12	nmod
15	-	-	:	_	1	punct
16	induced	induce	VBN	_	18	amod
17	sedation	sedation	NN	_	18	compound
18	times	time	NNS	_	42	nsubjpass
19	-LSB-	-lsb-	-LRB-	_	21	punct
20	long-sedation	long-sedation	JJ	_	21	amod
21	time	time	NN	_	18	dep
22	-LRB-	-lrb-	-LRB-	_	23	punct
23	LST	lst	NN	_	21	appos
24	-RRB-	-rrb-	-RRB-	_	23	punct
25	,	,	,	_	21	punct
26	short	short	JJ	_	28	amod
27	sedation	sedation	NN	_	28	compound
28	time	time	NN	_	21	conj
29	-LRB-	-lrb-	-LRB-	_	30	punct
30	SST	sst	NN	_	28	appos
31	-RRB-	-rrb-	-RRB-	_	30	punct
32	,	,	,	_	21	punct
33	and	and	CC	_	21	cc
34	randomly	randomly	RB	_	35	advmod
35	bred	breed	VBD	_	21	conj
36	control	control	NN	_	35	dobj
37	-LRB-	-lrb-	-LRB-	_	38	punct
38	RBC	rbc	NN	_	36	appos
39	-RRB-	-rrb-	-RRB-	_	38	punct
40	-RSB-	-rsb-	-RRB-	_	21	punct
41	were	be	VBD	_	42	auxpass
42	used	use	VBN	_	1	dep
43	to	to	TO	_	44	mark
44	study	study	VB	_	42	xcomp
45	drug2	drug2	NN	_	44	dobj
46	-	-	:	_	45	punct
47	induced	induce	VBN	_	49	amod
48	behavioral	behavioral	JJ	_	49	amod
49	sensitization	sensitization	NN	_	45	dep
50	.	.	.	_	1	punct

1	These	these	DT	_	2	det
2	lines	line	NNS	_	3	nsubj
3	showed	show	VBD	_	0	ROOT
4	variable	variable	JJ	_	5	amod
5	degrees	degree	NNS	_	3	dobj
6	of	of	IN	_	8	case
7	locomotor	locomotor	NN	_	8	compound
8	activities	activity	NNS	_	5	nmod
9	in	in	IN	_	12	case
10	response	response	NN	_	12	dep
11	to	to	TO	_	12	case
12	drug1	drug1	NN	_	3	nmod
13	.	.	.	_	3	punct

1	At	at	IN	_	5	case
2	a	a	DT	_	5	det
3	low	low	JJ	_	5	amod
4	drug1	drug1	NN	_	5	compound
5	dose	dose	NN	_	30	nmod
6	and	and	CC	_	5	cc
7	long	long	JJ	_	9	amod
8	withdrawal	withdrawal	NN	_	9	compound
9	period	period	NN	_	5	conj
10	-LRB-	-lrb-	-LRB-	_	12	punct
11	10	10	CD	_	12	nummod
12	mg/kg	mg/kg	NN	_	9	dep
13	,	,	,	_	12	punct
14	twice	twice	RB	_	16	advmod
15	a	a	DT	_	16	det
16	day	day	NN	_	12	appos
17	for	for	IN	_	19	case
18	5	5	CD	_	19	nummod
19	days	day	NNS	_	16	nmod
20	followed	follow	VBN	_	16	acl
21	by	by	IN	_	24	case
22	a	a	DT	_	24	det
23	14-day	14-day	JJ	_	24	amod
24	withdrawal	withdrawal	NN	_	20	nmod
25	-RRB-	-rrb-	-RRB-	_	12	punct
26	,	,	,	_	30	punct
27	the	the	DT	_	29	det
28	LST	LST	NNP	_	29	compound
29	mice	mouse	NNS	_	30	nsubj
30	showed	show	VBD	_	0	ROOT
31	tolerance	tolerance	NN	_	32	compound
32	development	development	NN	_	30	dobj
33	.	.	.	_	30	punct

1	In	in	IN	_	2	case
2	response	response	NN	_	15	nmod
3	to	to	TO	_	4	case
4	drug1	drug1	NN	_	2	nmod
5	,	,	,	_	15	punct
6	the	the	DT	_	8	det
7	locomotor	locomotor	NN	_	8	compound
8	activities	activity	NNS	_	15	nsubj
9	of	of	IN	_	11	case
10	the	the	DT	_	11	det
11	SST	SST	NNP	_	8	nmod
12	were	be	VBD	_	15	cop
13	not	not	RB	_	15	neg
14	significantly	significantly	RB	_	15	advmod
15	different	different	JJ	_	0	ROOT
16	from	from	IN	_	19	case
17	the	the	DT	_	19	det
18	RBC	rbc	NN	_	19	compound
19	group	group	NN	_	15	nmod
20	.	.	.	_	15	punct

1	At	at	IN	_	4	case
2	a	a	DT	_	4	det
3	higher	higher	JJR	_	4	amod
4	dose	dose	NN	_	28	nmod
5	and	and	CC	_	4	cc
6	a	a	DT	_	9	det
7	shorter	shorter	JJR	_	9	amod
8	withdrawal	withdrawal	NN	_	9	compound
9	period	period	NN	_	4	conj
10	-LRB-	-lrb-	-LRB-	_	12	punct
11	20	20	CD	_	12	nummod
12	mg/kg	mg/kg	NN	_	9	dep
13	,	,	,	_	12	punct
14	daily	daily	RB	_	17	advmod
15	for	for	IN	_	17	case
16	7	7	CD	_	17	nummod
17	days	day	NNS	_	12	nmod
18	followed	follow	VBN	_	17	acl
19	by	by	IN	_	22	case
20	a	a	DT	_	22	det
21	3-day	3-day	JJ	_	22	amod
22	withdrawal	withdrawal	NN	_	18	nmod
23	-RRB-	-rrb-	-RRB-	_	12	punct
24	,	,	,	_	28	punct
25	the	the	DT	_	27	det
26	SST	SST	NNP	_	27	compound
27	mice	mouse	NNS	_	28	nsubj
28	showed	show	VBD	_	0	ROOT
29	behavioral	behavioral	JJ	_	30	amod
30	sensitization	sensitization	NN	_	28	dobj
31	similar	similar	JJ	_	30	amod
32	to	to	TO	_	35	case
33	the	the	DT	_	35	det
34	RBC	rbc	NN	_	35	compound
35	mice	mouse	NNS	_	31	nmod
36	,	,	,	_	28	punct
37	but	but	CC	_	28	cc
38	the	the	DT	_	40	det
39	LST	lst	NN	_	40	compound
40	mice	mouse	NNS	_	43	nsubj
41	did	do	VBD	_	43	aux
42	not	not	RB	_	43	neg
43	develop	develop	VB	_	28	conj
44	sensitization	sensitization	NN	_	43	dobj
45	.	.	.	_	28	punct

1	The	the	DT	_	3	det
2	different	different	JJ	_	3	amod
3	responses	response	NNS	_	10	nsubj
4	in	in	IN	_	6	case
5	locomotor	locomotor	NN	_	6	compound
6	activity	activity	NN	_	3	nmod
7	induced	induce	VBN	_	6	acl
8	by	by	IN	_	9	case
9	drug1	drug1	NN	_	7	nmod
10	suggest	suggest	VBP	_	0	ROOT
11	that	that	IN	_	15	mark
12	genetic	genetic	JJ	_	13	amod
13	factors	factor	NNS	_	15	nsubj
14	may	may	MD	_	15	aux
15	play	play	VB	_	10	ccomp
16	a	a	DT	_	17	det
17	role	role	NN	_	15	dobj
18	in	in	IN	_	19	mark
19	determining	determine	VBG	_	15	advcl
20	the	the	DT	_	21	det
21	magnitude	magnitude	NN	_	19	dobj
22	of	of	IN	_	23	case
23	response	response	NN	_	21	nmod
24	to	to	TO	_	26	case
25	this	this	DT	_	26	det
26	drug	drug	NN	_	23	nmod
27	.	.	.	_	10	punct

1	Dopamine	dopamine	NN	_	5	compound
2	-LRB-	-lrb-	-LRB-	_	3	punct
3	DA	da	NN	_	1	appos
4	-RRB-	-rrb-	-RRB-	_	3	punct
5	levels	level	NNS	_	8	nsubj
6	did	do	VBD	_	8	aux
7	not	not	RB	_	8	neg
8	differ	differ	VB	_	0	ROOT
9	significantly	significantly	RB	_	8	advmod
10	in	in	IN	_	12	case
11	either	either	CC	_	12	cc:preconj
12	striatum	striatum	NN	_	8	nmod
13	-LRB-	-lrb-	-LRB-	_	14	punct
14	STR	str	NN	_	12	appos
15	-RRB-	-rrb-	-RRB-	_	14	punct
16	or	or	CC	_	12	cc
17	nucleus	nucleus	NN	_	18	compound
18	accumbens	accumben	NNS	_	12	conj
19	-LRB-	-lrb-	-LRB-	_	20	punct
20	NAC	nac	NN	_	18	appos
21	-RRB-	-rrb-	-RRB-	_	20	punct
22	for	for	IN	_	24	case
23	the	the	DT	_	24	det
24	drug1	drug1	NN	_	12	nmod
25	-	-	:	_	12	punct
26	treated	treat	VBN	_	27	amod
27	animals	animal	NNS	_	12	dep
28	to	to	TO	_	32	case
29	their	they	PRP$	_	32	nmod:poss
30	corresponding	corresponding	JJ	_	32	amod
31	saline-treated	saline-treated	JJ	_	32	amod
32	controls	control	NNS	_	27	nmod
33	.	.	.	_	8	punct

1	The	the	DT	_	2	det
2	affinity	affinity	NN	_	11	nsubj
3	-LRB-	-lrb-	-LRB-	_	4	punct
4	Kd	kd	NN	_	2	appos
5	-RRB-	-rrb-	-RRB-	_	4	punct
6	of	of	IN	_	7	case
7	D2	d2	NN	_	2	nmod
8	in	in	IN	_	10	case
9	the	the	DT	_	10	det
10	NAC	nac	NN	_	2	nmod
11	decreased	decrease	VBD	_	0	ROOT
12	significantly	significantly	RB	_	11	advmod
13	,	,	,	_	11	punct
14	without	without	IN	_	15	case
15	changes	change	NNS	_	11	nmod
16	in	in	IN	_	19	case
17	density	density	NN	_	19	compound
18	-LRB-	-lrb-	-LRB-	_	19	punct
19	Bmax	bmax	NN	_	15	nmod
20	-RRB-	-rrb-	-RRB-	_	11	punct
21	,	,	,	_	11	punct
22	in	in	IN	_	24	case
23	the	the	DT	_	24	det
24	drug1	drug1	NN	_	11	nmod
25	-	-	:	_	24	punct
26	treated	treat	VBN	_	30	amod
27	SST	SST	NNP	_	30	compound
28	and	and	CC	_	27	cc
29	RBC	RBC	NNP	_	27	conj
30	mice	mouse	NNS	_	24	dep
31	.	.	.	_	11	punct

1	On	on	IN	_	4	case
2	the	the	DT	_	4	det
3	other	other	JJ	_	4	amod
4	hand	hand	NN	_	24	nmod
5	,	,	,	_	24	punct
6	the	the	DT	_	7	det
7	density	density	NN	_	24	nsubjpass
8	of	of	IN	_	11	case
9	D2	d2	NN	_	11	compound
10	binding	binding	NN	_	11	compound
11	sites	site	NNS	_	7	nmod
12	in	in	IN	_	14	case
13	the	the	DT	_	14	det
14	SST	SST	NNP	_	11	nmod
15	and	and	CC	_	14	cc
16	the	the	DT	_	18	det
17	RBC	rbc	NN	_	18	compound
18	mice	mouse	NNS	_	14	conj
19	in	in	IN	_	21	case
20	the	the	DT	_	21	det
21	STR	str	NN	_	7	nmod
22	was	be	VBD	_	24	auxpass
23	significantly	significantly	RB	_	24	advmod
24	increased	increase	VBN	_	0	ROOT
25	in	in	IN	_	26	case
26	drug1	drug1	NN	_	24	nmod
27	-	-	:	_	26	punct
28	treated	treated	JJ	_	29	amod
29	groups	group	NNS	_	26	dep
30	without	without	IN	_	31	case
31	change	change	NN	_	29	nmod
32	in	in	IN	_	33	case
33	Kd	kd	NN	_	31	nmod
34	.	.	.	_	24	punct

1	The	the	DT	_	3	det
2	LST	lst	NN	_	3	compound
3	mice	mouse	NNS	_	6	nsubj
4	did	do	VBD	_	6	aux
5	not	not	RB	_	6	neg
6	show	show	VB	_	0	ROOT
7	any	any	DT	_	8	det
8	changes	change	NNS	_	6	dobj
9	in	in	IN	_	11	case
10	the	the	DT	_	11	det
11	Kd	kd	NN	_	8	nmod
12	and	and	CC	_	11	cc
13	Bmax	bmax	NN	_	11	conj
14	in	in	IN	_	17	case
15	either	either	CC	_	17	cc:preconj
16	the	the	DT	_	17	det
17	STR	str	NN	_	8	nmod
18	or	or	CC	_	17	cc
19	the	the	DT	_	20	det
20	NAC	nac	NN	_	17	conj
21	.	.	.	_	6	punct

1	Taken	take	VBN	_	6	advcl
2	together	together	RB	_	1	advmod
3	,	,	,	_	6	punct
4	these	these	DT	_	5	det
5	findings	finding	NNS	_	6	nsubj
6	suggest	suggest	VBP	_	0	ROOT
7	that	that	IN	_	27	mark
8	the	the	DT	_	9	det
9	changes	change	NNS	_	27	nsubj
10	in	in	IN	_	12	case
11	the	the	DT	_	12	det
12	Kd	kd	NN	_	9	nmod
13	of	of	IN	_	14	case
14	D2	d2	NN	_	12	nmod
15	in	in	IN	_	17	case
16	the	the	DT	_	17	det
17	NAC	nac	NN	_	12	nmod
18	and	and	CC	_	12	cc
19	the	the	DT	_	20	det
20	Bmax	bmax	NN	_	12	conj
21	of	of	IN	_	22	case
22	D2	d2	NN	_	20	nmod
23	in	in	IN	_	25	case
24	the	the	DT	_	25	det
25	STR	str	NN	_	20	nmod
26	may	may	MD	_	27	aux
27	contribute	contribute	VB	_	6	ccomp
28	to	to	TO	_	30	case
29	the	the	DT	_	30	det
30	differences	difference	NNS	_	27	nmod
31	in	in	IN	_	33	case
32	locomotor	locomotor	JJ	_	33	amod
33	responses	response	NNS	_	30	nmod
34	to	to	TO	_	35	mark
35	drug1	drug1	VB	_	30	acl
36	exposure	exposure	NN	_	35	dobj
37	in	in	IN	_	40	case
38	these	these	DT	_	40	det
39	mouse	mouse	NN	_	40	compound
40	lines	line	NNS	_	36	nmod
41	.	.	.	_	6	punct

1	drug1	drug1	NN	_	2	nsubj
2	inhibits	inhibit	VBZ	_	0	ROOT
3	the	the	DT	_	4	det
4	CYP2C9	cyp2c9	NN	_	2	dobj
5	catalyzed	catalyze	VBN	_	6	amod
6	biotransformation	biotransformation	NN	_	4	dep
7	of	of	IN	_	8	case
8	drug2	drug2	NN	_	6	nmod
9	.	.	.	_	2	punct

1	OBJECTIVE	objective	NN	_	0	ROOT
2	:	:	:	_	1	punct
3	Our	we	PRP$	_	4	nmod:poss
4	objective	objective	NN	_	5	nsubj
5	was	be	VBD	_	1	dep
6	to	to	TO	_	7	mark
7	examine	examine	VB	_	5	xcomp
8	the	the	DT	_	9	det
9	interaction	interaction	NN	_	7	dobj
10	between	between	IN	_	11	case
11	drug1	drug1	NN	_	9	nmod
12	and	and	CC	_	11	cc
13	drug2	drug2	NN	_	11	conj
14	to	to	TO	_	15	mark
15	confirm	confirm	VB	_	9	acl
16	that	that	IN	_	18	mark
17	drug3	drug3	NN	_	18	nsubj
18	inhibits	inhibit	VBZ	_	15	ccomp
19	CYP2C9	cyp2c9	NN	_	18	dobj
20	.	.	.	_	1	punct

1	METHODS	method	NNS	_	0	ROOT
2	:	:	:	_	1	punct
3	The	the	DT	_	4	det
4	study	study	NN	_	6	nsubjpass
5	was	be	VBD	_	6	auxpass
6	carried	carry	VBN	_	1	appos
7	out	out	RP	_	6	compound:prt
8	as	as	IN	_	15	case
9	an	a	DT	_	15	det
10	open	open	JJ	_	15	dep
11	,	,	,	_	10	punct
12	randomized	randomize	VBN	_	10	dep
13	,	,	,	_	10	punct
14	crossover	crossover	NN	_	15	compound
15	design	design	NN	_	6	nmod
16	with	with	IN	_	19	case
17	14	14	CD	_	19	nummod
18	healthy	healthy	JJ	_	19	amod
19	participants	participant	NNS	_	15	nmod
20	.	.	.	_	1	punct

1	In	in	IN	_	3	case
2	period	period	NN	_	3	compound
3	A	a	NN	_	7	nmod
4	,	,	,	_	7	punct
5	all	all	DT	_	6	det
6	volunteers	volunteer	NNS	_	7	nsubj
7	took	take	VBD	_	0	ROOT
8	500	500	CD	_	9	nummod
9	mg	mg	NN	_	7	dobj
10	of	of	IN	_	11	case
11	drug1	drug1	NN	_	9	nmod
12	orally	orally	RB	_	7	advmod
13	.	.	.	_	7	punct

1	In	in	IN	_	3	case
2	period	period	NN	_	3	compound
3	B	b	NN	_	9	nmod
4	,	,	,	_	9	punct
5	the	the	DT	_	6	det
6	volunteers	volunteer	NNS	_	9	nsubjpass
7	were	be	VBD	_	9	auxpass
8	randomly	randomly	RB	_	9	advmod
9	assigned	assign	VBN	_	0	ROOT
10	to	to	TO	_	11	case
11	one	one	CD	_	9	nmod
12	of	of	IN	_	14	case
13	two	two	CD	_	14	nummod
14	groups	group	NNS	_	11	nmod
15	.	.	.	_	9	punct

1	Each	each	DT	_	2	det
2	group	group	NN	_	3	nsubj
3	took	take	VBD	_	0	ROOT
4	either	either	CC	_	6	cc:preconj
5	150	150	CD	_	6	nummod
6	mg	mg	NN	_	3	dobj
7	or	or	CC	_	6	cc
8	75	75	CD	_	9	nummod
9	mg	mg	NN	_	6	conj
10	of	of	IN	_	11	case
11	drug1	drug1	NN	_	6	nmod
12	a	a	DT	_	13	det
13	day	day	NN	_	6	nmod:npmod
14	for	for	IN	_	16	case
15	5	5	CD	_	16	nummod
16	days	day	NNS	_	3	nmod
17	-LRB-	-lrb-	-LRB-	_	18	punct
18	day	day	NN	_	16	dep
19	-3	-3	CD	_	18	nummod
20	to	to	TO	_	18	dep
21	day	day	NN	_	18	dep
22	2	2	CD	_	21	nummod
23	-RRB-	-rrb-	-RRB-	_	18	punct
24	.	.	.	_	3	punct

1	The	the	DT	_	2	det
2	groups	group	NNS	_	4	nsubj
3	then	then	RB	_	4	advmod
4	took	take	VBD	_	0	ROOT
5	500	500	CD	_	6	nummod
6	mg	mg	NN	_	4	dobj
7	of	of	IN	_	8	case
8	drug1	drug1	NN	_	6	nmod
9	as	as	IN	_	12	case
10	a	a	DT	_	12	det
11	single	single	JJ	_	12	amod
12	dose	dose	NN	_	4	nmod
13	-LRB-	-lrb-	-LRB-	_	14	punct
14	day	day	NN	_	12	appos
15	0	0	CD	_	14	nummod
16	-RRB-	-rrb-	-RRB-	_	14	punct
17	.	.	.	_	4	punct

1	In	in	IN	_	3	case
2	both	both	DT	_	3	det
3	periods	period	NNS	_	9	nmod
4	,	,	,	_	9	punct
5	blood	blood	NN	_	9	nsubjpass
6	and	and	CC	_	5	cc
7	urine	urine	NN	_	5	conj
8	were	be	VBD	_	9	auxpass
9	sampled	sample	VBN	_	0	ROOT
10	at	at	IN	_	12	case
11	regular	regular	JJ	_	12	amod
12	intervals	interval	NNS	_	9	nmod
13	.	.	.	_	9	punct

1	Plasma	plasma	NN	_	3	nsubjpass
2	was	be	VBD	_	3	auxpass
3	analyzed	analyze	VBN	_	0	ROOT
4	for	for	IN	_	5	case
5	drug1	drug1	NN	_	3	nmod
6	,	,	,	_	3	punct
7	and	and	CC	_	3	cc
8	urine	urine	NN	_	10	nsubjpass
9	was	be	VBD	_	10	auxpass
10	analyzed	analyze	VBN	_	3	conj
11	for	for	IN	_	12	case
12	drug2	drug2	NN	_	10	nmod
13	and	and	CC	_	12	cc
14	its	its	PRP$	_	16	nmod:poss
15	two	two	CD	_	16	nummod
16	metabolites	metabolite	NNS	_	12	conj
17	,	,	,	_	16	punct
18	drug3	drug3	NN	_	16	appos
19	and	and	CC	_	18	cc
20	drug4	drug4	NN	_	18	conj
21	by	by	IN	_	22	case
22	means	means	NNS	_	10	nmod
23	of	of	IN	_	24	case
24	HPLC	hplc	NN	_	22	nmod
25	.	.	.	_	3	punct

1	RESULTS	result	NNS	_	0	ROOT
2	:	:	:	_	1	punct
3	During	during	IN	_	4	case
4	treatment	treatment	NN	_	9	nmod
5	with	with	IN	_	6	case
6	drug1	drug1	NN	_	4	nmod
7	,	,	,	_	9	punct
8	there	there	EX	_	9	expl
9	was	be	VBD	_	1	dep
10	a	a	DT	_	13	det
11	statistically	statistically	RB	_	12	advmod
12	significant	significant	JJ	_	13	amod
13	decrease	decrease	NN	_	9	nsubj
14	in	in	IN	_	16	case
15	the	the	DT	_	16	det
16	median	median	NN	_	13	nmod
17	of	of	IN	_	20	case
18	the	the	DT	_	20	det
19	total	total	JJ	_	20	amod
20	clearance	clearance	NN	_	16	nmod
21	of	of	IN	_	22	case
22	drug2	drug2	NN	_	20	nmod
23	,	,	,	_	13	punct
24	from	from	IN	_	26	case
25	845	845	CD	_	26	nummod
26	mL/h	ml/h	NN	_	13	nmod
27	to	to	TO	_	29	case
28	688	688	CD	_	29	nummod
29	mL/h	ml/h	NN	_	26	nmod
30	,	,	,	_	13	punct
31	among	among	IN	_	33	case
32	the	the	DT	_	33	det
33	volunteers	volunteer	NNS	_	13	nmod
34	who	who	WP	_	35	nsubj
35	received	receive	VBD	_	33	acl:relcl
36	75	75	CD	_	37	nummod
37	mg/d	mg/d	NN	_	35	dobj
38	.	.	.	_	1	punct

1	There	there	EX	_	2	expl
2	was	be	VBD	_	0	ROOT
3	a	a	DT	_	4	det
4	reduction	reduction	NN	_	2	nsubj
5	that	that	WDT	_	6	nsubj
6	reached	reach	VBD	_	4	acl:relcl
7	borderline	borderline	JJ	_	9	amod
8	statistical	statistical	JJ	_	9	amod
9	significance	significance	NN	_	6	dobj
10	in	in	IN	_	12	case
11	the	the	DT	_	12	det
12	group	group	NN	_	9	nmod
13	that	that	WDT	_	14	nsubj
14	received	receive	VBD	_	9	acl:relcl
15	150	150	CD	_	16	nummod
16	mg/d	mg/d	NN	_	14	dobj
17	of	of	IN	_	18	case
18	drug1	drug1	NN	_	16	nmod
19	.	.	.	_	2	punct

1	The	the	DT	_	2	det
2	clearance	clearance	NN	_	11	nsubjpass
3	by	by	IN	_	4	case
4	means	means	NNS	_	2	nmod
5	of	of	IN	_	6	case
6	drug1	drug1	NN	_	4	nmod
7	and	and	CC	_	6	cc
8	drug2	drug2	NN	_	6	conj
9	was	be	VBD	_	11	auxpass
10	significantly	significantly	RB	_	11	advmod
11	reduced	reduce	VBN	_	0	ROOT
12	in	in	IN	_	14	case
13	both	both	DT	_	14	det
14	groups	group	NNS	_	11	nmod
15	-LRB-	-lrb-	-LRB-	_	16	punct
16	ie	ie	FW	_	14	dep
17	,	,	,	_	16	punct
18	from	from	IN	_	20	case
19	901	901	CD	_	20	nummod
20	mL/h	ml/h	NN	_	16	nmod
21	to	to	TO	_	23	case
22	318	318	CD	_	23	nummod
23	mL/h	ml/h	NN	_	20	nmod
24	in	in	IN	_	26	case
25	the	the	DT	_	26	det
26	group	group	NN	_	23	nmod
27	that	that	WDT	_	28	nsubj
28	received	receive	VBD	_	20	acl:relcl
29	150	150	CD	_	30	nummod
30	mg	mg	NN	_	28	dobj
31	of	of	IN	_	32	case
32	drug3	drug3	NN	_	30	nmod
33	per	per	IN	_	34	case
34	day	day	NN	_	28	nmod
35	and	and	CC	_	28	cc
36	from	from	IN	_	38	case
37	723	723	CD	_	38	nummod
38	mL/h	ml/h	NN	_	28	conj
39	to	to	TO	_	41	case
40	457	457	CD	_	41	nummod
41	mL/h	ml/h	NN	_	38	nmod
42	in	in	IN	_	44	case
43	the	the	DT	_	44	det
44	group	group	NN	_	38	nmod
45	that	that	WDT	_	46	nsubj
46	received	receive	VBD	_	44	acl:relcl
47	75	75	CD	_	48	nummod
48	mg	mg	NN	_	46	dobj
49	of	of	IN	_	50	case
50	drug4	drug4	NN	_	48	nmod
51	per	per	IN	_	52	case
52	day	day	NN	_	46	nmod
53	-RRB-	-rrb-	-RRB-	_	16	punct
54	.	.	.	_	11	punct

1	Thus	thus	RB	_	3	advmod
2	there	there	EX	_	3	expl
3	was	be	VBD	_	0	ROOT
4	a	a	DT	_	5	det
5	tendency	tendency	NN	_	3	nsubj
6	toward	toward	IN	_	10	case
7	a	a	DT	_	10	det
8	more	more	RBR	_	9	advmod
9	pronounced	pronounced	JJ	_	10	amod
10	inhibition	inhibition	NN	_	5	nmod
11	of	of	IN	_	13	case
12	the	the	DT	_	13	det
13	4-hydroxylation	4-hydroxylation	NN	_	10	nmod
14	during	during	IN	_	15	case
15	treatment	treatment	NN	_	10	nmod
16	with	with	IN	_	18	case
17	150	150	CD	_	18	nummod
18	mg/d	mg/d	NN	_	15	nmod
19	of	of	IN	_	20	case
20	drug1	drug1	NN	_	18	nmod
21	compared	compare	VBN	_	24	case
22	with	with	IN	_	24	case
23	75	75	CD	_	24	nummod
24	mg/d	mg/d	NN	_	3	advcl
25	,	,	,	_	3	punct
26	but	but	CC	_	3	cc
27	the	the	DT	_	28	det
28	difference	difference	NN	_	32	nsubj
29	was	be	VBD	_	32	cop
30	not	not	RB	_	32	neg
31	statistically	statistically	RB	_	32	advmod
32	significant	significant	JJ	_	3	conj
33	.	.	.	_	3	punct

1	CONCLUSION	conclusion	NN	_	0	ROOT
2	:	:	:	_	1	punct
3	drug1	drug1	NN	_	7	nsubj
4	is	be	VBZ	_	7	cop
5	a	a	DT	_	7	det
6	moderate	moderate	JJ	_	7	amod
7	inhibitor	inhibitor	NN	_	1	dep
8	of	of	IN	_	9	case
9	CYP2C9	cyp2c9	NN	_	7	nmod
10	in	in	FW	_	11	compound
11	vivo	vivo	FW	_	7	advmod
12	.	.	.	_	1	punct

1	Influence	influence	NN	_	0	ROOT
2	of	of	IN	_	3	case
3	drug1	drug1	NN	_	1	nmod
4	on	on	IN	_	6	case
5	platelet	platelet	NN	_	6	compound
6	function	function	NN	_	1	nmod
7	and	and	CC	_	6	cc
8	arachidonic	arachidonic	JJ	_	10	amod
9	acid	acid	NN	_	10	compound
10	metabolism	metabolism	NN	_	6	conj
11	.	.	.	_	1	punct

1	Available	available	JJ	_	2	amod
2	data	datum	NNS	_	3	nsubj
3	indicate	indicate	VBP	_	0	ROOT
4	that	that	IN	_	13	mark
5	platelet	platelet	NN	_	6	compound
6	function	function	NN	_	13	nsubj
7	and	and	CC	_	6	cc
8	arachidonic	arachidonic	JJ	_	10	amod
9	acid	acid	NN	_	10	compound
10	metabolism	metabolism	NN	_	6	conj
11	are	be	VBP	_	13	cop
12	important	important	JJ	_	13	amod
13	factors	factor	NNS	_	3	ccomp
14	in	in	IN	_	15	case
15	hemostasis	hemostasis	NN	_	13	nmod
16	and	and	CC	_	15	cc
17	regulation	regulation	NN	_	15	conj
18	of	of	IN	_	20	case
19	vascular	vascular	JJ	_	20	amod
20	tone	tone	NN	_	15	nmod
21	.	.	.	_	3	punct

1	Plasma	plasma	NN	_	2	compound
2	membrane	membrane	NN	_	11	nsubj
3	and	and	CC	_	2	cc
4	intracellular	intracellular	JJ	_	5	amod
5	mobilization	mobilization	NN	_	2	conj
6	of	of	IN	_	8	case
7	calcium	calcium	NN	_	8	compound
8	ions	ion	NNS	_	2	nmod
9	are	be	VBP	_	11	cop
10	intimately	intimately	RB	_	11	advmod
11	related	relate	VBN	_	0	ROOT
12	to	to	TO	_	14	case
13	platelet	platelet	NN	_	14	compound
14	activation	activation	NN	_	11	nmod
15	and	and	CC	_	14	cc
16	release	release	NN	_	14	conj
17	of	of	IN	_	19	case
18	platelet	platelet	NN	_	19	compound
19	contents	contents	NNS	_	16	nmod
20	.	.	.	_	11	punct

1	Release	Release	NNP	_	21	nsubjpass
2	of	of	IN	_	4	case
3	arachidonic	arachidonic	JJ	_	4	amod
4	acid	acid	NN	_	1	nmod
5	from	from	IN	_	7	case
6	membrane	membrane	NN	_	7	compound
7	phospholipids	phospholipid	NNS	_	1	nmod
8	as	as	RB	_	1	cc
9	well	well	RB	_	8	mwe
10	as	as	IN	_	8	mwe
11	subsequent	subsequent	JJ	_	12	amod
12	synthesis	synthesis	NN	_	1	conj
13	and	and	CC	_	12	cc
14	release	release	NN	_	12	conj
15	of	of	IN	_	18	case
16	vasoconstrictor	vasoconstrictor	NN	_	18	compound
17	thromboxane	thromboxane	NN	_	18	compound
18	A2	a2	NN	_	12	nmod
19	are	be	VBP	_	21	auxpass
20	also	also	RB	_	21	advmod
21	regulated	regulate	VBN	_	0	ROOT
22	by	by	IN	_	23	case
23	movement	movement	NN	_	21	nmod
24	of	of	IN	_	26	case
25	calcium	calcium	NN	_	26	compound
26	ions	ion	NNS	_	23	nmod
27	.	.	.	_	21	punct

1	Adenosine	adenosine	NN	_	0	ROOT
2	3	3	CD	_	4	compound
3	'	'	''	_	4	punct
4	:5	:5	CD	_	1	nummod
5	'	'	''	_	1	punct
6	-	-	:	_	1	punct
7	cyclic	cyclic	JJ	_	8	amod
8	phosphate	phosphate	NN	_	1	dep
9	in	in	IN	_	12	case
10	turn	turn	NN	_	12	compound
11	controls	control	NNS	_	12	compound
12	levels	level	NNS	_	8	nmod
13	of	of	IN	_	16	case
14	free	free	JJ	_	16	amod
15	calcium	calcium	NN	_	16	compound
16	ions	ion	NNS	_	12	nmod
17	in	in	IN	_	18	case
18	platelets	platelet	NNS	_	16	nmod
19	and	and	CC	_	8	cc
20	regulates	regulate	VBZ	_	8	conj
21	calcium-dependent	calcium-dependent	JJ	_	22	amod
22	reactions	reaction	NNS	_	20	dobj
23	.	.	.	_	1	punct

1	drug1	drug1	NN	_	11	nsubj
2	,	,	,	_	1	punct
3	such	such	JJ	_	5	case
4	as	as	IN	_	3	mwe
5	drug2	drug2	NN	_	1	nmod
6	,	,	,	_	5	punct
7	drug3	drug3	NN	_	5	conj
8	and	and	CC	_	5	cc
9	drug4	drug4	NN	_	5	conj
10	,	,	,	_	1	punct
11	inhibit	inhibit	VBP	_	0	ROOT
12	platelet	platelet	NN	_	13	compound
13	activation	activation	NN	_	11	dobj
14	in	in	FW	_	15	compound
15	vitro	vitro	FW	_	11	advmod
16	,	,	,	_	11	punct
17	and	and	CC	_	11	cc
18	decrease	decrease	VB	_	11	conj
19	platelet	platelet	NN	_	20	compound
20	adhesion	adhesion	NN	_	18	dobj
21	intravascularly	intravascularly	RB	_	18	advmod
22	.	.	.	_	11	punct

1	These	these	DT	_	2	det
2	agents	agent	NNS	_	6	nsubjpass
3	have	have	VBP	_	6	aux
4	also	also	RB	_	6	advmod
5	been	be	VBN	_	6	auxpass
6	shown	show	VBN	_	0	ROOT
7	to	to	TO	_	8	mark
8	decrease	decrease	VB	_	6	xcomp
9	platelet	platelet	NN	_	11	compound
10	nucleotide	nucleotide	NN	_	11	compound
11	release	release	NN	_	8	dobj
12	and	and	CC	_	11	cc
13	thromboxane	thromboxane	NN	_	15	compound
14	A2	a2	NN	_	15	compound
15	generation	generation	NN	_	11	conj
16	.	.	.	_	6	punct

1	Some	some	DT	_	3	det
2	preliminary	preliminary	JJ	_	3	amod
3	data	datum	NNS	_	4	nsubj
4	suggest	suggest	VBP	_	0	ROOT
5	that	that	IN	_	8	mark
6	drug1	drug1	NN	_	8	nsubj
7	also	also	RB	_	8	advmod
8	increase	increase	VBP	_	4	ccomp
9	generation	generation	NN	_	8	dobj
10	of	of	IN	_	11	case
11	vasodilator	vasodilator	NN	_	9	nmod
12	and	and	CC	_	11	cc
13	platelet	platelet	NN	_	15	compound
14	antiaggregant	antiaggregant	JJ	_	15	amod
15	prostacyclin	prostacyclin	NN	_	11	conj
16	,	,	,	_	9	punct
17	which	which	WDT	_	19	nsubj
18	could	could	MD	_	19	aux
19	contribute	contribute	VB	_	9	acl:relcl
20	to	to	TO	_	21	mark
21	decrease	decrease	VB	_	19	xcomp
22	in	in	IN	_	24	case
23	platelet	platelet	NN	_	24	compound
24	function	function	NN	_	21	nmod
25	.	.	.	_	4	punct

1	These	these	DT	_	2	det
2	effects	effect	NNS	_	13	nsubj
3	of	of	IN	_	4	case
4	drug1	drug1	NN	_	2	nmod
5	on	on	IN	_	7	case
6	platelet	platelet	NN	_	7	compound
7	function	function	NN	_	2	nmod
8	and	and	CC	_	7	cc
9	arachidonic	arachidonic	JJ	_	11	amod
10	acid	acid	NN	_	11	compound
11	metabolism	metabolism	NN	_	7	conj
12	could	could	MD	_	13	aux
13	contribute	contribute	VB	_	0	ROOT
14	in	in	IN	_	15	case
15	part	part	NN	_	13	nmod
16	to	to	TO	_	18	case
17	their	they	PRP$	_	18	nmod:poss
18	efficacy	efficacy	NN	_	13	nmod
19	in	in	IN	_	20	case
20	patients	patient	NNS	_	18	nmod
21	with	with	IN	_	24	case
22	ischemic	ischemic	JJ	_	24	amod
23	heart	heart	NN	_	24	compound
24	disease	disease	NN	_	20	nmod
25	.	.	.	_	13	punct

1	Pharmacology	pharmacology	NN	_	0	ROOT
2	and	and	CC	_	1	cc
3	pharmacotherapy	pharmacotherapy	NN	_	1	conj
4	of	of	IN	_	6	case
5	cardiovascular	cardiovascular	JJ	_	6	amod
6	drugs	drug	NNS	_	1	nmod
7	in	in	IN	_	8	case
8	patients	patient	NNS	_	6	nmod
9	with	with	IN	_	12	case
10	chronic	chronic	JJ	_	12	amod
11	renal	renal	JJ	_	12	amod
12	disease	disease	NN	_	8	nmod
13	.	.	.	_	1	punct

1	Cardiovascular	Cardiovascular	NNP	_	2	compound
2	disease	disease	NN	_	6	nsubj
3	is	be	VBZ	_	6	cop
4	a	a	DT	_	6	det
5	common	common	JJ	_	6	amod
6	comorbidity	comorbidity	NN	_	0	ROOT
7	and	and	CC	_	6	cc
8	a	a	DT	_	10	det
9	major	major	JJ	_	10	amod
10	cause	cause	NN	_	6	conj
11	of	of	IN	_	12	case
12	mortality	mortality	NN	_	10	nmod
13	in	in	IN	_	14	case
14	patients	patient	NNS	_	12	nmod
15	with	with	IN	_	18	case
16	chronic	chronic	JJ	_	18	amod
17	renal	renal	JJ	_	18	amod
18	disease	disease	NN	_	14	nmod
19	.	.	.	_	6	punct

1	Drug	drug	NN	_	2	compound
2	regimens	regimen	NNS	_	10	nsubj
3	in	in	IN	_	4	case
4	patients	patient	NNS	_	2	nmod
5	with	with	IN	_	7	case
6	cardiovascular	cardiovascular	JJ	_	7	amod
7	disease	disease	NN	_	4	nmod
8	are	be	VBP	_	10	cop
9	frequently	frequently	RB	_	10	advmod
10	complex	complex	JJ	_	0	ROOT
11	and	and	CC	_	10	cc
12	can	can	MD	_	15	aux
13	be	be	VB	_	15	auxpass
14	significantly	significantly	RB	_	15	advmod
15	affected	affect	VBN	_	10	conj
16	by	by	IN	_	17	case
17	alterations	alteration	NNS	_	15	nmod
18	in	in	IN	_	20	case
19	renal	renal	JJ	_	20	amod
20	function	function	NN	_	17	nmod
21	.	.	.	_	10	punct

1	In	in	IN	_	2	case
2	addition	addition	NN	_	8	nmod
3	,	,	,	_	8	punct
4	several	several	JJ	_	6	amod
5	cardiovascular	cardiovascular	JJ	_	6	amod
6	drugs	drug	NNS	_	8	nsubj
7	directly	directly	RB	_	8	advmod
8	affect	affect	VBP	_	0	ROOT
9	renal	renal	JJ	_	10	amod
10	function	function	NN	_	8	dobj
11	and	and	CC	_	10	cc
12	the	the	DT	_	13	det
13	management	management	NN	_	10	conj
14	of	of	IN	_	15	case
15	patients	patient	NNS	_	13	nmod
16	with	with	IN	_	18	case
17	renal	renal	JJ	_	18	amod
18	disease	disease	NN	_	15	nmod
19	.	.	.	_	8	punct

1	This	this	DT	_	2	det
2	article	article	NN	_	3	nsubj
3	reviews	review	VBZ	_	0	ROOT
4	the	the	DT	_	5	det
5	impact	impact	NN	_	3	dobj
6	of	of	IN	_	8	case
7	renal	renal	JJ	_	8	amod
8	disease	disease	NN	_	5	nmod
9	on	on	IN	_	11	case
10	the	the	DT	_	11	det
11	pharmacokinetics	pharmacokinetic	NNS	_	5	nmod
12	of	of	IN	_	14	case
13	cardiovascular	cardiovascular	JJ	_	14	amod
14	drugs	drug	NNS	_	11	nmod
15	and	and	CC	_	3	cc
16	identifies	identify	VBZ	_	3	conj
17	clinically	clinically	RB	_	18	advmod
18	important	important	JJ	_	19	amod
19	interactions	interaction	NNS	_	16	dobj
20	between	between	IN	_	21	case
21	these	these	DT	_	19	nmod
22	and	and	CC	_	21	cc
23	other	other	JJ	_	24	amod
24	drugs	drug	NNS	_	21	conj
25	commonly	commonly	RB	_	26	advmod
26	used	use	VBN	_	21	acl
27	in	in	IN	_	29	case
28	the	the	DT	_	29	det
29	management	management	NN	_	26	nmod
30	of	of	IN	_	33	case
31	chronic	chronic	JJ	_	33	amod
32	renal	renal	JJ	_	33	amod
33	disease	disease	NN	_	29	nmod
34	.	.	.	_	3	punct

1	Several	several	JJ	_	2	amod
2	classes	class	NNS	_	8	nsubjpass
3	of	of	IN	_	5	case
4	cardiovascular	cardiovascular	JJ	_	5	amod
5	drugs	drug	NNS	_	2	nmod
6	are	be	VBP	_	8	auxpass
7	also	also	RB	_	8	advmod
8	discussed	discuss	VBN	_	0	ROOT
9	in	in	IN	_	10	case
10	relationship	relationship	NN	_	8	nmod
11	to	to	TO	_	14	case
12	their	they	PRP$	_	14	nmod:poss
13	differential	differential	JJ	_	14	amod
14	effects	effect	NNS	_	10	nmod
15	on	on	IN	_	17	case
16	the	the	DT	_	17	det
17	management	management	NN	_	14	nmod
18	and	and	CC	_	17	cc
19	progression	progression	NN	_	17	conj
20	of	of	IN	_	22	case
21	renal	renal	JJ	_	22	amod
22	disease	disease	NN	_	17	nmod
23	.	.	.	_	8	punct

1	Influence	influence	NN	_	0	ROOT
2	of	of	IN	_	3	case
3	drug1	drug1	NN	_	1	nmod
4	and	and	CC	_	3	cc
5	drug2	drug2	NN	_	3	conj
6	on	on	IN	_	8	case
7	the	the	DT	_	8	det
8	sensitivity	sensitivity	NN	_	1	nmod
9	of	of	IN	_	12	case
10	rat	rat	NN	_	12	compound
11	thoracic	thoracic	JJ	_	12	amod
12	aorta	aorta	NN	_	8	nmod
13	to	to	TO	_	14	case
14	drug3	drug3	NN	_	8	nmod
15	.	.	.	_	1	punct

1	The	the	DT	_	2	det
2	aim	aim	NN	_	6	nsubj
3	of	of	IN	_	5	case
4	this	this	DT	_	5	det
5	study	study	NN	_	2	nmod
6	was	be	VBD	_	0	ROOT
7	to	to	TO	_	8	mark
8	investigate	investigate	VB	_	6	xcomp
9	the	the	DT	_	10	det
10	effects	effect	NNS	_	8	dobj
11	of	of	IN	_	15	case
12	low	low	JJ	_	15	amod
13	and	and	CC	_	12	cc
14	high	high	JJ	_	12	conj
15	doses	dose	NNS	_	10	nmod
16	of	of	IN	_	17	case
17	drug1	drug1	NN	_	15	nmod
18	,	,	,	_	8	punct
19	and	and	CC	_	8	cc
20	of	of	IN	_	21	case
21	drug2	drug2	NN	_	8	conj
22	on	on	IN	_	24	case
23	the	the	DT	_	24	det
24	response	response	NN	_	21	nmod
25	to	to	TO	_	26	mark
26	drug3	drug3	VB	_	24	acl
27	in	in	IN	_	30	case
28	rat	rat	NN	_	30	compound
29	thoracic	thoracic	JJ	_	30	amod
30	aorta	aorta	NN	_	26	nmod
31	.	.	.	_	6	punct

1	Two	two	CD	_	2	nummod
2	weeks	week	NNS	_	9	nmod
3	after	after	IN	_	2	case
4	bilateral	bilateral	JJ	_	5	amod
5	ovariectomy	ovariectomy	NN	_	2	dep
6	,	,	,	_	9	punct
7	female	female	JJ	_	8	amod
8	rats	rat	NNS	_	9	nsubj
9	received	receive	VBD	_	0	ROOT
10	a	a	DT	_	11	det
11	s.c.	s.c.	NN	_	9	dobj

1	injection	injection	NN	_	0	ROOT
2	of	of	IN	_	3	case
3	vehicle	vehicle	NN	_	1	nmod
4	-LRB-	-lrb-	-LRB-	_	6	punct
5	corn	corn	NN	_	6	compound
6	oil	oil	NN	_	3	dep
7	,	,	,	_	6	punct
8	0.1	0.1	CD	_	9	nummod
9	mL/day	ml/day	NN	_	6	appos
10	-RRB-	-rrb-	-RRB-	_	6	punct
11	,	,	,	_	3	punct
12	drug1	drug1	NN	_	3	conj
13	-LRB-	-lrb-	-LRB-	_	15	punct
14	10	10	CD	_	15	nummod
15	microg/kg/day	microg/kg/day	NN	_	12	dep
16	or	or	CC	_	15	cc
17	4	4	CD	_	18	nummod
18	mg/kg/day	mg/kg/day	NN	_	15	conj
19	-RRB-	-rrb-	-RRB-	_	15	punct
20	and/or	and/or	CC	_	3	cc
21	drug2	drug2	NN	_	3	conj
22	-LRB-	-lrb-	-LRB-	_	24	punct
23	20	20	CD	_	24	nummod
24	mg/kg/day	mg/kg/day	NN	_	21	appos
25	-RRB-	-rrb-	-RRB-	_	24	punct
26	,	,	,	_	1	punct
27	for	for	IN	_	29	case
28	eight	eight	CD	_	29	nummod
29	days	day	NNS	_	1	nmod
30	.	.	.	_	1	punct

1	On	on	IN	_	4	case
2	the	the	DT	_	4	det
3	ninth	ninth	JJ	_	4	amod
4	day	day	NN	_	9	nmod
5	,	,	,	_	9	punct
6	the	the	DT	_	7	det
7	rats	rat	NNS	_	9	nsubjpass
8	were	be	VBD	_	9	auxpass
9	sacrificed	sacrifice	VBN	_	0	ROOT
10	and	and	CC	_	9	cc
11	aortic	aortic	JJ	_	12	amod
12	rings	ring	NNS	_	20	nsubjpass
13	,	,	,	_	12	punct
14	with	with	IN	_	17	nmod
15	or	or	CC	_	14	cc
16	without	without	IN	_	14	conj
17	endothelium	endothelium	NN	_	12	nmod
18	,	,	,	_	12	punct
19	were	be	VBD	_	20	auxpass
20	used	use	VBN	_	9	conj
21	to	to	TO	_	22	mark
22	generate	generate	VB	_	20	xcomp
23	concentration-response	concentration-response	JJ	_	24	amod
24	curves	curve	NNS	_	22	dobj
25	to	to	TO	_	26	case
26	drug1	drug1	NN	_	22	nmod
27	.	.	.	_	9	punct

1	Aortic	aortic	JJ	_	2	amod
2	rings	ring	NNS	_	16	nsubj
3	with	with	IN	_	5	case
4	intact	intact	JJ	_	5	amod
5	endothelium	endothelium	NN	_	2	nmod
6	from	from	IN	_	14	case
7	the	the	DT	_	14	det
8	high-dose	high-dose	JJ	_	14	amod
9	-LRB-	-lrb-	-LRB-	_	11	punct
10	4	4	CD	_	11	nummod
11	mg/kg/day	mg/kg/day	NN	_	8	dep
12	-RRB-	-rrb-	-RRB-	_	11	punct
13	drug1	drug1	NN	_	14	compound
14	group	group	NN	_	2	nmod
15	were	be	VBD	_	16	cop
16	supersensitive	supersensitive	JJ	_	0	ROOT
17	to	to	TO	_	18	case
18	drug2	drug2	NN	_	16	nmod
19	compared	compare	VBN	_	22	case
20	to	to	TO	_	22	case
21	the	the	DT	_	22	det
22	vehicle	vehicle	NN	_	16	advcl
23	or	or	CC	_	22	cc
24	low-dose	low-dose	JJ	_	22	conj
25	-LRB-	-lrb-	-LRB-	_	27	punct
26	10	10	CD	_	27	nummod
27	microg/kg/day	microg/kg/day	NN	_	24	dep
28	-RRB-	-rrb-	-RRB-	_	27	punct
29	estradiol	estradiol	NN	_	30	compound
30	groups	group	NNS	_	22	dep
31	-LRB-	-lrb-	-LRB-	_	33	punct
32	pD2	pd2	NN	_	33	compound
33	values	value	NNS	_	22	dep
34	=	=	JJ	_	33	amod
35	7.86	7.86	CD	_	34	dep
36	+	+	CC	_	35	cc
37	/	/	:	_	38	punct
38	-0.09	-0.09	CD	_	35	conj
39	,	,	,	_	35	punct
40	7.30	7.30	CD	_	35	conj
41	+	+	CC	_	35	cc
42	/	/	:	_	35	punct
43	-0.11	-0.11	CD	_	35	dep
44	and	and	CC	_	43	cc
45	7.35	7.35	CD	_	43	conj
46	+	+	CC	_	43	cc
47	/	/	:	_	48	punct
48	-0.04	-0.04	CD	_	43	conj
49	,	,	,	_	33	punct
50	respectively	respectively	RB	_	33	advmod
51	-RRB-	-rrb-	-RRB-	_	33	punct
52	.	.	.	_	16	punct

1	Endothelium-intact	endothelium-intact	JJ	_	3	amod
2	aortic	aortic	JJ	_	3	amod
3	rings	ring	NNS	_	10	nsubj
4	from	from	IN	_	8	case
5	high	high	JJ	_	8	amod
6	-	-	:	_	8	punct
7	drug1	drug1	NN	_	8	compound
8	rats	rat	NNS	_	3	nmod
9	were	be	VBD	_	10	cop
10	supersensitive	supersensitive	JJ	_	0	ROOT
11	to	to	TO	_	12	mark
12	drug2	drug2	VB	_	10	xcomp
13	when	when	WRB	_	14	advmod
14	compared	compare	VBN	_	12	advcl
15	to	to	TO	_	16	case
16	vehicle	vehicle	NN	_	14	nmod
17	-	-	:	_	10	punct
18	,	,	,	_	10	punct
19	drug3	drug3	NN	_	10	xcomp
20	-	-	:	_	22	punct
21	and	and	CC	_	22	cc
22	drug4	drug4	NN	_	19	dep
23	+	+	CC	_	22	cc
24	high	high	JJ	_	26	amod
25	-	-	:	_	26	punct
26	drug5	drug5	NN	_	22	conj
27	-	-	:	_	22	punct
28	treated	treat	VBN	_	29	amod
29	rats	rat	NNS	_	22	dep
30	-LRB-	-lrb-	-LRB-	_	32	punct
31	pD2	pd2	NN	_	32	compound
32	values	value	NNS	_	29	dep
33	=	=	JJ	_	32	amod
34	7.77	7.77	CD	_	33	dep
35	+	+	CC	_	34	cc
36	/	/	:	_	37	punct
37	-0.12	-0.12	CD	_	34	conj
38	,	,	,	_	34	punct
39	7.21	7.21	CD	_	34	conj
40	+	+	CC	_	34	cc
41	/	/	:	_	42	punct
42	-0.13	-0.13	CD	_	34	conj
43	,	,	,	_	34	punct
44	6.93	6.93	CD	_	34	conj
45	+	+	CC	_	34	cc
46	/	/	:	_	34	punct
47	-0.04	-0.04	CD	_	34	dep
48	and	and	CC	_	47	cc
49	7.22	7.22	CD	_	47	conj
50	+	+	CC	_	47	cc
51	/	/	:	_	52	punct
52	-0.18	-0.18	CD	_	47	conj
53	,	,	,	_	32	punct
54	respectively	respectively	RB	_	32	advmod
55	-RRB-	-rrb-	-RRB-	_	32	punct
56	.	.	.	_	10	punct

1	There	there	EX	_	2	expl
2	were	be	VBD	_	0	ROOT
3	no	no	DT	_	5	neg
4	significant	significant	JJ	_	5	amod
5	differences	difference	NNS	_	2	nsubj
6	among	among	IN	_	9	case
7	the	the	DT	_	9	det
8	pD2	pd2	NN	_	9	compound
9	values	value	NNS	_	5	nmod
10	for	for	IN	_	11	case
11	drug1	drug1	NN	_	5	nmod
12	in	in	IN	_	14	case
13	aortic	aortic	JJ	_	14	amod
14	rings	ring	NNS	_	11	nmod
15	without	without	IN	_	16	case
16	endothelium	endothelium	NN	_	11	nmod
17	.	.	.	_	2	punct

1	Both	both	DT	_	6	nsubj
2	of	of	IN	_	4	case
3	these	these	DT	_	4	det
4	effects	effect	NNS	_	1	nmod
5	were	be	VBD	_	6	cop
6	endothelium-dependent	endothelium-dependent	JJ	_	0	ROOT
7	.	.	.	_	6	punct

1	drug1	drug1	NN	_	0	ROOT
2	and	and	CC	_	1	cc
3	therapeutics	therapeutics	NNS	_	1	conj
4	.	.	.	_	1	punct

1	Two	two	CD	_	3	nummod
2	different	different	JJ	_	3	amod
3	types	type	NNS	_	9	nsubjpass
4	of	of	IN	_	5	case
5	therapy	therapy	NN	_	3	nmod
6	with	with	IN	_	7	case
7	drug1	drug1	NN	_	3	nmod
8	are	be	VBP	_	9	auxpass
9	used	use	VBN	_	0	ROOT
10	:	:	:	_	9	punct
11	physiological	physiological	JJ	_	14	amod
12	oral	oral	JJ	_	14	amod
13	drug2	drug2	NN	_	14	compound
14	supplementation	supplementation	NN	_	9	dep
15	which	which	WDT	_	18	nsubj
16	is	be	VBZ	_	18	cop
17	totally	totally	RB	_	18	advmod
18	atoxic	atoxic	JJ	_	14	acl:relcl
19	since	since	IN	_	21	mark
20	it	it	PRP	_	21	nsubj
21	palliates	palliate	VBZ	_	18	advcl
22	drug3	drug3	NN	_	23	compound
23	deficiencies	deficiency	NNS	_	21	dobj
24	by	by	IN	_	26	mark
25	simply	simply	RB	_	26	advmod
26	normalizing	normalize	VBG	_	21	advcl
27	the	the	DT	_	29	det
28	drug4	drug4	NN	_	29	compound
29	intake	intake	NN	_	26	dobj
30	and	and	CC	_	29	cc
31	pharmacological	pharmacological	JJ	_	33	amod
32	drug5	drug5	NN	_	33	compound
33	therapy	therapy	NN	_	29	conj
34	which	which	WDT	_	36	nsubj
35	may	may	MD	_	36	aux
36	induce	induce	VB	_	29	acl:relcl
37	toxicity	toxicity	NN	_	36	dobj
38	since	since	IN	_	40	mark
39	it	it	PRP	_	40	nsubj
40	creates	create	VBZ	_	36	advcl
41	iatrogenic	iatrogenic	JJ	_	43	amod
42	drug6	drug6	NN	_	43	compound
43	overload	overload	NN	_	40	dobj
44	.	.	.	_	9	punct

1	Primary	primary	JJ	_	5	amod
2	and	and	CC	_	1	cc
3	secondary	secondary	JJ	_	1	conj
4	drug1	drug1	NN	_	5	compound
5	deficiencies	deficiency	NNS	_	6	nsubj
6	constitute	constitute	VBP	_	0	ROOT
7	the	the	DT	_	9	det
8	sole	sole	JJ	_	9	amod
9	indication	indication	NN	_	6	dobj
10	of	of	IN	_	14	case
11	physiological	physiological	JJ	_	14	amod
12	oral	oral	JJ	_	14	amod
13	drug2	drug2	NN	_	14	compound
14	therapy	therapy	NN	_	9	nmod
15	.	.	.	_	6	punct

1	It	it	PRP	_	4	nsubj
2	is	be	VBZ	_	4	cop
3	therefore	therefore	RB	_	4	advmod
4	necessary	necessary	JJ	_	0	ROOT
5	to	to	TO	_	8	mark
6	be	be	VB	_	8	auxpass
7	well	well	RB	_	8	advmod
8	acquainted	acquaint	VBN	_	4	xcomp
9	with	with	IN	_	14	case
10	the	the	DT	_	14	det
11	clinical	clinical	JJ	_	14	amod
12	and	and	CC	_	11	cc
13	paraclinical	paraclinical	JJ	_	11	conj
14	pattern	pattern	NN	_	8	nmod
15	of	of	IN	_	17	case
16	drug1	drug1	NN	_	17	compound
17	deficit	deficit	NN	_	14	nmod
18	and	and	CC	_	14	cc
19	to	to	TO	_	20	mark
20	discriminate	discriminate	VB	_	14	conj
21	between	between	IN	_	23	case
22	drug2	drug2	NN	_	23	compound
23	deficiency	deficiency	NN	_	20	nmod
24	due	due	JJ	_	29	case
25	to	to	TO	_	24	mwe
26	an	a	DT	_	29	det
27	insufficient	insufficient	JJ	_	29	amod
28	drug3	drug3	NN	_	29	compound
29	intake	intake	NN	_	20	nmod
30	which	which	WDT	_	32	nsubj
31	only	only	RB	_	32	advmod
32	requires	require	VBZ	_	29	acl:relcl
33	oral	oral	JJ	_	35	amod
34	physiological	physiological	JJ	_	35	amod
35	supplementation	supplementation	NN	_	32	dobj
36	and	and	CC	_	35	cc
37	drug4	drug4	NN	_	38	compound
38	depletion	depletion	NN	_	35	conj
39	related	related	JJ	_	35	amod
40	to	to	TO	_	42	case
41	a	a	DT	_	42	det
42	dysregulation	dysregulation	NN	_	39	nmod
43	of	of	IN	_	46	case
44	the	the	DT	_	46	det
45	control	control	NN	_	46	compound
46	mechanisms	mechanism	NNS	_	42	nmod
47	of	of	IN	_	49	case
48	drug5	drug5	NN	_	49	compound
49	status	status	NN	_	46	nmod
50	which	which	WDT	_	51	nsubj
51	requires	require	VBZ	_	46	acl:relcl
52	more	more	RBR	_	56	advmod
53	or	or	CC	_	52	cc
54	less	less	RBR	_	52	conj
55	specific	specific	JJ	_	56	amod
56	regulation	regulation	NN	_	51	dobj
57	of	of	IN	_	60	case
58	its	its	PRP$	_	60	nmod:poss
59	causal	causal	JJ	_	60	amod
60	dysregulation	dysregulation	NN	_	56	nmod
61	.	.	.	_	4	punct

1	Physiological	physiological	JJ	_	4	amod
2	oral	oral	JJ	_	4	amod
3	drug1	drug1	NN	_	4	compound
4	load	load	NN	_	5	nsubj
5	constitutes	constitute	VBZ	_	0	ROOT
6	the	the	DT	_	8	det
7	best	best	JJS	_	8	amod
8	tool	tool	NN	_	5	dobj
9	for	for	IN	_	10	case
10	diagnosis	diagnosis	NN	_	8	nmod
11	of	of	IN	_	13	case
12	drug2	drug2	NN	_	13	compound
13	deficiency	deficiency	NN	_	10	nmod
14	and	and	CC	_	8	cc
15	the	the	DT	_	17	det
16	first	first	JJ	_	17	amod
17	step	step	NN	_	8	conj
18	of	of	IN	_	20	case
19	its	its	PRP$	_	20	nmod:poss
20	treatment	treatment	NN	_	17	nmod
21	.	.	.	_	5	punct

1	Physiological	physiological	JJ	_	4	amod
2	oral	oral	JJ	_	4	amod
3	drug1	drug1	NN	_	4	compound
4	supplementation	supplementation	NN	_	10	nsubj
5	-LRB-	-lrb-	-LRB-	_	7	punct
6	5	5	CD	_	7	nummod
7	mg/kg/day	mg/kg/day	NN	_	4	appos
8	-RRB-	-rrb-	-RRB-	_	7	punct
9	is	be	VBZ	_	10	cop
10	easy	easy	JJ	_	0	ROOT
11	and	and	CC	_	10	cc
12	can	can	MD	_	14	aux
13	be	be	VB	_	14	auxpass
14	carried	carry	VBN	_	10	conj
15	out	out	RP	_	14	compound:prt
16	in	in	IN	_	18	case
17	the	the	DT	_	18	det
18	diet	diet	NN	_	14	nmod
19	or	or	CC	_	18	cc
20	with	with	IN	_	22	case
21	drug2	drug2	NN	_	22	compound
22	s	s	NNS	_	18	conj
23	,	,	,	_	10	punct
24	with	with	IN	_	28	case
25	practically	practically	RB	_	27	advmod
26	only	only	RB	_	27	advmod
27	one	one	CD	_	28	nummod
28	contra-indication	contra-indication	NN	_	10	nmod
29	:	:	:	_	10	punct
30	overt	overt	JJ	_	32	amod
31	renal	renal	JJ	_	32	amod
32	failure	failure	NN	_	10	dep
33	.	.	.	_	10	punct

1	Specific	specific	JJ	_	4	amod
2	and	and	CC	_	1	cc
3	aspecific	aspecific	JJ	_	1	conj
4	treatments	treatment	NNS	_	9	nsubj
5	of	of	IN	_	7	case
6	drug1	drug1	NN	_	7	compound
7	depletion	depletion	NN	_	4	nmod
8	are	be	VBP	_	9	cop
9	tricky	tricky	JJ	_	0	ROOT
10	using	use	VBG	_	9	xcomp
11	for	for	IN	_	13	case
12	example	example	NN	_	13	compound
13	drug2	drug2	NN	_	10	nmod
14	,	,	,	_	13	punct
15	pharmacological	pharmacological	JJ	_	16	amod
16	doses	dose	NNS	_	13	conj
17	of	of	IN	_	18	case
18	drug3	drug3	NN	_	16	nmod
19	,	,	,	_	13	punct
20	physiological	physiological	JJ	_	21	amod
21	doses	dose	NNS	_	13	appos
22	of	of	IN	_	23	case
23	drug4	drug4	NN	_	21	nmod
24	and	and	CC	_	23	cc
25	of	of	IN	_	26	case
26	drug5	drug5	NN	_	23	conj
27	.	.	.	_	9	punct

1	In	in	IN	_	4	mark
2	order	order	NN	_	1	mwe
3	to	to	TO	_	4	mark
4	use	use	VB	_	24	advcl
5	the	the	DT	_	7	det
6	pharmacological	pharmacological	JJ	_	7	amod
7	properties	property	NNS	_	4	dobj
8	of	of	IN	_	11	case
9	induced	induce	VBN	_	11	amod
10	therapeutic	therapeutic	JJ	_	11	amod
11	hypermagnesaemia	hypermagnesaemia	NN	_	7	nmod
12	,	,	,	_	11	punct
13	high	high	JJ	_	15	amod
14	oral	oral	JJ	_	15	amod
15	doses	dose	NNS	_	11	conj
16	of	of	IN	_	17	case
17	drug1	drug1	NN	_	15	nmod
18	-LRB-	-lrb-	-LRB-	_	21	punct
19	>	>	JJR	_	20	advmod
20	10	10	CD	_	21	nummod
21	mg/kg/day	mg/kg/day	NN	_	15	appos
22	-RRB-	-rrb-	-RRB-	_	21	punct
23	are	be	VBP	_	24	cop
24	advisable	advisable	JJ	_	33	csubj
25	for	for	IN	_	27	case
26	chronic	chronic	JJ	_	27	amod
27	indications	indication	NNS	_	24	nmod
28	and	and	CC	_	27	cc
29	the	the	DT	_	31	det
30	parenteral	parenteral	JJ	_	31	amod
31	route	route	NN	_	27	conj
32	is	be	VBZ	_	33	cop
33	suitable	suitable	JJ	_	0	ROOT
34	for	for	IN	_	36	case
35	acute	acute	JJ	_	36	amod
36	indications	indication	NNS	_	33	nmod
37	.	.	.	_	33	punct

1	There	there	EX	_	2	expl
2	are	be	VBP	_	0	ROOT
3	3	3	CD	_	4	nummod
4	types	type	NNS	_	2	nsubj
5	of	of	IN	_	6	case
6	indications	indication	NNS	_	4	nmod
7	:	:	:	_	4	punct
8	specific	specific	JJ	_	4	dep
9	-LRB-	-lrb-	-LRB-	_	12	punct
10	for	for	IN	_	12	case
11	the	the	DT	_	12	det
12	treatment	treatment	NN	_	8	nmod
13	of	of	IN	_	15	case
14	some	some	DT	_	15	det
15	forms	form	NNS	_	12	nmod
16	of	of	IN	_	18	case
17	drug1	drug1	NN	_	18	compound
18	deficit	deficit	NN	_	15	nmod
19	i.e.	i.e.	FW	_	20	advmod
20	acute	acute	JJ	_	18	amod
21	-RRB-	-rrb-	-RRB-	_	12	punct
22	,	,	,	_	8	punct
23	pharmacological	pharmacological	JJ	_	27	amod
24	-LRB-	-lrb-	-LRB-	_	27	punct
25	i.e.	i.e.	FW	_	27	advmod
26	without	without	IN	_	27	case
27	alterations	alteration	NNS	_	8	conj
28	of	of	IN	_	30	case
29	drug2	drug2	NN	_	30	compound
30	status	status	NN	_	27	nmod
31	-RRB-	-rrb-	-RRB-	_	8	punct
32	and	and	CC	_	8	cc
33	mixed	mixed	JJ	_	8	conj
34	--	--	:	_	8	punct
35	pharmacological	pharmacological	JJ	_	8	dep
36	and	and	CC	_	35	cc
37	aetiopathogenic	aetiopathogenic	JJ	_	35	conj
38	--	--	:	_	8	punct
39	-LRB-	-lrb-	-LRB-	_	42	punct
40	for	for	IN	_	42	case
41	example	example	NN	_	42	compound
42	complications	complication	NNS	_	8	dep
43	of	of	IN	_	45	case
44	chronic	chronic	JJ	_	45	amod
45	alcoholism	alcoholism	NN	_	42	nmod
46	-RRB-	-rrb-	-RRB-	_	42	punct
47	.	.	.	_	2	punct

1	Today	today	NN	_	4	compound
2	pharmacological	pharmacological	JJ	_	4	amod
3	drug1	drug1	NN	_	4	compound
4	therapy	therapy	NN	_	6	nsubj
5	mainly	mainly	RB	_	6	advmod
6	concerns	concern	VBZ	_	0	ROOT
7	the	the	DT	_	13	det
8	obstetrical	obstetrical	JJ	_	13	amod
9	,	,	,	_	8	punct
10	cardiological	cardiological	JJ	_	8	conj
11	and	and	CC	_	8	cc
12	anaesthesiological	anaesthesiological	JJ	_	8	conj
13	fields	field	NNS	_	6	dobj
14	.	.	.	_	6	punct

1	The	the	DT	_	3	det
2	main	main	JJ	_	3	amod
3	indications	indication	NNS	_	5	nsubj
4	are	be	VBP	_	5	cop
5	eclampsia	eclampsia	NN	_	0	ROOT
6	,	,	,	_	5	punct
7	some	some	DT	_	8	det
8	dysrhythmias	dysrhythmia	NNS	_	5	conj
9	-LRB-	-lrb-	-LRB-	_	10	punct
10	torsades	torsade	NNS	_	8	appos
11	de	de	IN	_	12	compound
12	pointe	pointe	FW	_	10	dep
13	particularly	particularly	RB	_	12	advmod
14	-RRB-	-rrb-	-RRB-	_	10	punct
15	and	and	CC	_	5	cc
16	myocardial	myocardial	JJ	_	17	amod
17	ischaemias	ischaemia	NNS	_	5	conj
18	.	.	.	_	5	punct

1	But	but	CC	_	5	cc
2	it	it	PRP	_	5	nsubj
3	is	be	VBZ	_	5	cop
4	now	now	RB	_	5	advmod
5	difficult	difficult	JJ	_	0	ROOT
6	to	to	TO	_	7	mark
7	situate	situate	VB	_	5	xcomp
8	the	the	DT	_	10	det
9	exact	exact	JJ	_	10	amod
10	place	place	NN	_	7	dobj
11	of	of	IN	_	14	case
12	the	the	DT	_	14	det
13	pharmacological	pharmacological	JJ	_	14	amod
14	indications	indication	NNS	_	10	nmod
15	of	of	IN	_	16	case
16	drug1	drug1	NN	_	14	nmod
17	.	.	.	_	5	punct

1	drug1	drug1	NN	_	2	compound
2	infusions	infusion	NNS	_	6	nsubjpass
3	can	can	MD	_	6	aux
4	only	only	RB	_	6	advmod
5	be	be	VB	_	6	auxpass
6	envisaged	envisage	VBN	_	0	ROOT
7	in	in	IN	_	10	case
8	intensive	intensive	JJ	_	10	amod
9	care	care	NN	_	10	compound
10	units	unit	NNS	_	6	nmod
11	with	with	IN	_	13	case
12	careful	careful	JJ	_	13	amod
13	monitoring	monitoring	NN	_	10	nmod
14	of	of	IN	_	15	case
15	pulse	pulse	NN	_	13	nmod
16	,	,	,	_	6	punct
17	arterial	arterial	JJ	_	18	amod
18	pressure	pressure	NN	_	6	dobj
19	,	,	,	_	18	punct
20	deep	deep	JJ	_	22	amod
21	tendon	tendon	NN	_	22	compound
22	reflexes	reflex	NNS	_	18	conj
23	,	,	,	_	18	punct
24	hourly	hourly	JJ	_	25	amod
25	diuresis	diuresis	NN	_	18	conj
26	,	,	,	_	18	punct
27	electrocardiogram	electrocardiogram	NN	_	18	conj
28	and	and	CC	_	18	cc
29	respiratory	respiratory	JJ	_	30	amod
30	recordings	recording	NNS	_	18	conj
31	.	.	.	_	6	punct

1	High	high	JJ	_	4	amod
2	oral	oral	JJ	_	4	amod
3	drug1	drug1	NN	_	4	compound
4	doses	dose	NNS	_	10	nsubj
5	besides	besides	IN	_	8	case
6	their	they	PRP$	_	8	nmod:poss
7	laxative	laxative	NN	_	8	compound
8	action	action	NN	_	4	nmod
9	may	may	MD	_	10	aux
10	bring	bring	VB	_	0	ROOT
11	latent	latent	JJ	_	12	amod
12	complications	complication	NNS	_	10	dobj
13	which	which	WDT	_	15	nsubj
14	may	may	MD	_	15	aux
15	reduce	reduce	VB	_	12	acl:relcl
16	lifespan	lifespan	NN	_	15	dobj
17	.	.	.	_	10	punct

1	There	there	EX	_	3	expl
2	may	may	MD	_	3	aux
3	remain	remain	VB	_	0	ROOT
4	some	some	DT	_	5	det
5	indications	indication	NNS	_	3	xcomp
6	of	of	IN	_	11	case
7	the	the	DT	_	11	det
8	laxative	laxative	NN	_	11	compound
9	and	and	CC	_	8	cc
10	antacid	antacid	NN	_	8	conj
11	properties	property	NNS	_	5	nmod
12	of	of	IN	_	15	case
13	non	non	JJ	_	15	amod
14	soluble	soluble	JJ	_	15	amod
15	drug1	drug1	NN	_	11	nmod
16	,	,	,	_	15	punct
17	particularly	particularly	RB	_	20	advmod
18	during	during	IN	_	20	case
19	intermittent	intermittent	JJ	_	20	amod
20	haemodialysis	haemodialysis	NN	_	15	nmod
21	.	.	.	_	3	punct

1	Lastly	lastly	RB	_	2	advmod
2	local	local	JJ	_	3	amod
3	use	use	NN	_	14	nsubj
4	of	of	IN	_	9	case
5	the	the	DT	_	9	det
6	mucocutaneous	mucocutaneous	JJ	_	9	amod
7	and	and	CC	_	6	cc
8	cytoprotective	cytoprotective	JJ	_	6	conj
9	properties	property	NNS	_	3	nmod
10	of	of	IN	_	11	case
11	drug1	drug1	NN	_	9	nmod
12	is	be	VBZ	_	14	cop
13	still	still	RB	_	14	advmod
14	valid	valid	JJ	_	0	ROOT
15	,	,	,	_	14	punct
16	in	in	IN	_	17	case
17	drug2	drug2	NN	_	14	nmod
18	and	and	CC	_	17	cc
19	for	for	IN	_	20	case
20	preservation	preservation	NN	_	17	conj
21	of	of	IN	_	22	case
22	transplants	transplant	NNS	_	20	nmod
23	particularly	particularly	RB	_	14	advmod
24	.	.	.	_	14	punct

1	The	the	DT	_	2	det
2	effects	effect	NNS	_	0	ROOT
3	of	of	IN	_	4	case
4	drug1	drug1	NN	_	2	nmod
5	and	and	CC	_	4	cc
6	drug2	drug2	NN	_	4	conj
7	upon	upon	IN	_	8	case
8	drug3	drug3	NN	_	2	nmod
9	-LRB-	-lrb-	-LRB-	_	10	punct
10	drug4	drug4	NN	_	8	appos
11	-RRB-	-rrb-	-RRB-	_	10	punct
12	-	-	:	_	2	punct
13	induced	induce	VBN	_	14	amod
14	locomotion	locomotion	NN	_	2	dep
15	and	and	CC	_	14	cc
16	behavioral	behavioral	JJ	_	17	amod
17	changes	change	NNS	_	14	conj
18	in	in	IN	_	19	case
19	mice	mouse	NNS	_	14	nmod
20	.	.	.	_	2	punct

1	The	the	DT	_	3	det
2	behavioral	behavioral	JJ	_	3	amod
3	changes	change	NNS	_	0	ROOT
4	of	of	IN	_	5	case
5	mice	mouse	NNS	_	3	nmod
6	induced	induce	VBN	_	5	acl
7	by	by	IN	_	8	case
8	acute	acute	JJ	_	6	nmod
9	and	and	CC	_	8	cc
10	repeated	repeated	JJ	_	8	conj
11	i.p.	i.p.	RB	_	8	dep

1	injection	injection	NN	_	8	nsubjpass
2	of	of	IN	_	3	case
3	drug1	drug1	NN	_	1	nmod
4	-LRB-	-lrb-	-LRB-	_	5	punct
5	drug2	drug2	NN	_	3	appos
6	-RRB-	-rrb-	-RRB-	_	5	punct
7	were	be	VBD	_	8	auxpass
8	observed	observe	VBN	_	0	ROOT
9	by	by	IN	_	10	mark
10	measuring	measure	VBG	_	8	advcl
11	locomotor	locomotor	NN	_	12	compound
12	activity	activity	NN	_	10	dobj
13	and	and	CC	_	12	cc
14	stereotyped	stereotyped	JJ	_	15	amod
15	behavior	behavior	NN	_	12	conj
16	.	.	.	_	8	punct

1	Then	then	RB	_	27	advmod
2	,	,	,	_	27	punct
3	the	the	DT	_	4	det
4	effects	effect	NNS	_	27	nsubjpass
5	of	of	IN	_	8	case
6	metabotropic	metabotropic	JJ	_	8	amod
7	glutamate	glutamate	NN	_	8	compound
8	receptor	receptor	NN	_	4	nmod
9	-LRB-	-lrb-	-LRB-	_	10	punct
10	mGluR	mglur	NN	_	8	appos
11	-RRB-	-rrb-	-RRB-	_	10	punct
12	agonists	agonist	NNS	_	8	dep
13	,	,	,	_	8	punct
14	drug1	drug1	NN	_	8	conj
15	and	and	CC	_	8	cc
16	drug2	drug2	NN	_	8	conj
17	,	,	,	_	4	punct
18	on	on	IN	_	22	case
19	the	the	DT	_	22	det
20	above	above	JJ	_	22	amod
21	behavioral	behavioral	JJ	_	22	amod
22	changes	change	NNS	_	4	nmod
23	induced	induce	VBN	_	22	acl
24	by	by	IN	_	25	case
25	drug3	drug3	NN	_	23	nmod
26	were	be	VBD	_	27	auxpass
27	found	find	VBN	_	0	ROOT
28	.	.	.	_	27	punct

1	The	the	DT	_	2	det
2	effects	effect	NNS	_	7	nsubj
3	of	of	IN	_	4	case
4	drug1	drug1	NN	_	2	nmod
5	were	be	VBD	_	7	cop
6	very	very	RB	_	7	advmod
7	strong	strong	JJ	_	0	ROOT
8	and	and	CC	_	7	cc
9	completely	completely	RB	_	10	advmod
10	depressed	depress	VBD	_	7	conj
11	the	the	DT	_	12	det
12	drug2	drug2	NN	_	10	dobj
13	-	-	:	_	12	punct
14	induced	induce	VBN	_	15	amod
15	hyperlocomotion	hyperlocomotion	NN	_	12	dep
16	.	.	.	_	7	punct

1	The	the	DT	_	2	det
2	effects	effect	NNS	_	8	nsubj
3	of	of	IN	_	4	case
4	drug1	drug1	NN	_	2	nmod
5	were	be	VBD	_	8	cop
6	not	not	RB	_	8	neg
7	so	so	RB	_	8	advmod
8	strong	strong	JJ	_	0	ROOT
9	.	.	.	_	8	punct

1	Repeated	repeated	JJ	_	2	amod
2	injection	injection	NN	_	10	nsubj
3	of	of	IN	_	4	case
4	drug1	drug1	NN	_	2	nmod
5	for	for	IN	_	7	case
6	20	20	CD	_	7	nummod
7	days	day	NNS	_	2	nmod
8	into	into	IN	_	9	case
9	mice	mouse	NNS	_	7	nmod
10	induced	induce	VBD	_	0	ROOT
11	lower	lower	JJR	_	13	amod
12	locomotor	locomotor	NN	_	13	compound
13	activity	activity	NN	_	10	dobj
14	than	than	IN	_	15	case
15	that	that	DT	_	13	nmod
16	in	in	IN	_	19	case
17	acutely	acutely	RB	_	18	advmod
18	injected	inject	VBN	_	19	amod
19	mice	mouse	NNS	_	15	nmod
20	.	.	.	_	10	punct

1	These	these	DT	_	3	det
2	behavioral	behavioral	JJ	_	3	amod
3	changes	change	NNS	_	6	nsubjpass
4	may	may	MD	_	6	aux
5	be	be	VB	_	6	auxpass
6	related	relate	VBN	_	0	ROOT
7	with	with	IN	_	10	case
8	the	the	DT	_	10	det
9	negative	negative	JJ	_	10	amod
10	symptoms	symptom	NNS	_	6	nmod
11	of	of	IN	_	12	case
12	schizophrenia	schizophrenia	NN	_	10	nmod
13	.	.	.	_	6	punct

1	In	in	IN	_	4	mark
2	order	order	NN	_	1	mwe
3	to	to	TO	_	4	mark
4	examine	examine	VB	_	0	ROOT
5	some	some	DT	_	7	det
6	molecular	molecular	JJ	_	7	amod
7	mechanisms	mechanism	NNS	_	4	dobj
8	of	of	IN	_	9	case
9	drug1	drug1	NN	_	7	nmod
10	-	-	:	_	7	punct
11	induced	induce	VBN	_	13	amod
12	behavioral	behavioral	JJ	_	13	amod
13	changes	change	NNS	_	36	nsubjpass
14	,	,	,	_	13	punct
15	Northern	northern	NN	_	17	compound
16	blot	blot	NN	_	17	compound
17	analysis	analysis	NN	_	13	appos
18	of	of	IN	_	20	case
19	total	total	JJ	_	20	amod
20	RNA	rna	NN	_	17	nmod
21	from	from	IN	_	24	case
22	prefrontal	prefrontal	JJ	_	24	amod
23	cortical	cortical	JJ	_	24	amod
24	tissues	tissue	NNS	_	20	nmod
25	of	of	IN	_	26	case
26	mice	mouse	NNS	_	24	nmod
27	treated	treat	VBN	_	26	acl
28	with	with	IN	_	29	case
29	drug2	drug2	NN	_	27	nmod
30	,	,	,	_	29	punct
31	drug3	drug3	NN	_	29	conj
32	,	,	,	_	29	punct
33	and	and	CC	_	29	cc
34	drug4	drug4	NN	_	29	conj
35	was	be	VBD	_	36	auxpass
36	carried	carry	VBN	_	7	acl:relcl
37	out	out	RP	_	36	compound:prt
38	.	.	.	_	4	punct

1	Lack	lack	NN	_	0	ROOT
2	of	of	IN	_	4	case
3	an	a	DT	_	4	det
4	effect	effect	NN	_	1	nmod
5	of	of	IN	_	6	case
6	drug1	drug1	NN	_	4	nmod
7	on	on	IN	_	9	case
8	the	the	DT	_	9	det
9	disposition	disposition	NN	_	4	nmod
10	of	of	IN	_	11	case
11	drug2	drug2	NN	_	9	nmod
12	and	and	CC	_	11	cc
13	drug3	drug3	NN	_	11	conj
14	in	in	IN	_	16	case
15	HIV-infected	hiv-infected	JJ	_	16	amod
16	patients	patient	NNS	_	9	nmod
17	.	.	.	_	1	punct

1	Two	two	CD	_	2	nummod
2	studies	study	NNS	_	4	nsubjpass
3	were	be	VBD	_	4	auxpass
4	conducted	conduct	VBN	_	0	ROOT
5	in	in	IN	_	7	case
6	HIV-infected	hiv-infected	JJ	_	7	amod
7	subjects	subject	NNS	_	4	nmod
8	to	to	TO	_	9	mark
9	assess	assess	VB	_	7	acl
10	the	the	DT	_	11	det
11	potential	potential	NN	_	9	dobj
12	for	for	IN	_	13	case
13	drug1	drug1	NN	_	11	nmod
14	to	to	TO	_	15	mark
15	interact	interact	VB	_	11	acl
16	with	with	IN	_	17	case
17	drug2	drug2	NN	_	15	nmod
18	and	and	CC	_	17	cc
19	drug3	drug3	NN	_	17	conj
20	.	.	.	_	4	punct

1	Both	both	DT	_	2	det
2	studies	study	NNS	_	3	nsubj
3	used	use	VBD	_	0	ROOT
4	12	12	CD	_	5	nummod
5	subjects	subject	NNS	_	3	dobj
6	.	.	.	_	3	punct

1	The	the	DT	_	3	det
2	drug1	drug1	NN	_	3	compound
3	study	study	NN	_	4	nsubj
4	dosed	dose	VBD	_	0	ROOT
5	subjects	subject	NNS	_	4	dobj
6	with	with	IN	_	8	case
7	1200	1200	CD	_	8	nummod
8	mg/day	mg/day	NN	_	5	nmod
9	of	of	IN	_	10	case
10	drug2	drug2	NN	_	8	nmod
11	-LRB-	-lrb-	-LRB-	_	12	punct
12	n	n	NN	_	8	dep
13	=	=	JJ	_	12	amod
14	7	7	CD	_	13	dep
15	-RRB-	-rrb-	-RRB-	_	12	punct
16	-LRB-	-lrb-	-LRB-	_	18	punct
17	later	later	RB	_	18	advmod
18	changed	change	VBD	_	4	parataxis
19	to	to	TO	_	21	case
20	600	600	CD	_	21	nummod
21	mg/day	mg/day	NN	_	18	nmod
22	-LSB-	-lsb-	-LRB-	_	24	punct
23	n	n	NN	_	24	nsubj
24	=	=	JJ	_	18	parataxis
25	5	5	CD	_	24	dobj
26	-RSB-	-rsb-	-RRB-	_	24	punct
27	-RRB-	-rrb-	-RRB-	_	18	punct
28	for	for	IN	_	29	case
29	Days	day	NNS	_	4	nmod
30	8	8	CD	_	29	nummod
31	to	to	TO	_	29	dep
32	21	21	CD	_	29	nummod
33	of	of	IN	_	36	case
34	a	a	DT	_	36	det
35	21-day	21-day	JJ	_	36	amod
36	course	course	NN	_	29	nmod
37	of	of	IN	_	39	case
38	100	100	CD	_	39	nummod
39	mg	mg	NN	_	36	nmod
40	,	,	,	_	39	punct
41	five	five	CD	_	42	nummod
42	times/day	times/day	NN	_	39	appos
43	of	of	IN	_	44	case
44	drug3	drug3	NN	_	42	nmod
45	.	.	.	_	4	punct

1	Subjects	subject	NNS	_	13	nsubj
2	treated	treat	VBN	_	1	acl
3	with	with	IN	_	5	case
4	200	200	CD	_	5	nummod
5	mg	mg	NN	_	2	nmod
6	of	of	IN	_	7	case
7	drug1	drug1	NN	_	5	nmod
8	twice	twice	RB	_	9	advmod
9	daily	daily	RB	_	13	advmod
10	for	for	IN	_	12	case
11	21	21	CD	_	12	nummod
12	days	day	NNS	_	13	nmod
13	received	receive	VBD	_	0	ROOT
14	1200	1200	CD	_	15	nummod
15	mg	mg	NN	_	13	dobj
16	of	of	IN	_	17	case
17	drug2	drug2	NN	_	15	nmod
18	or	or	CC	_	15	cc
19	an	a	DT	_	21	det
20	equivalent	equivalent	JJ	_	21	amod
21	amount	amount	NN	_	15	conj
22	of	of	IN	_	23	case
23	placebo/day	placebo/day	NN	_	21	nmod
24	for	for	IN	_	25	case
25	Days	day	NNS	_	21	nmod
26	8	8	CD	_	25	nummod
27	to	to	TO	_	25	dep
28	21	21	CD	_	25	nummod
29	.	.	.	_	13	punct

1	drug1	drug1	NN	_	2	compound
2	plasma	plasma	NN	_	7	nsubjpass
3	and	and	CC	_	2	cc
4	urine	urine	NN	_	5	compound
5	sampling	sampling	NN	_	2	conj
6	were	be	VBD	_	7	auxpass
7	conducted	conduct	VBN	_	0	ROOT
8	on	on	IN	_	9	case
9	Days	day	NNS	_	7	nmod
10	1	1	CD	_	9	nummod
11	,	,	,	_	9	punct
12	7	7	CD	_	9	nummod
13	,	,	,	_	9	punct
14	and	and	CC	_	9	cc
15	21	21	CD	_	9	conj
16	for	for	IN	_	17	case
17	drug2	drug2	NN	_	15	nmod
18	and	and	CC	_	7	cc
19	on	on	IN	_	20	case
20	Days	day	NNS	_	7	conj
21	7	7	CD	_	20	nummod
22	and	and	CC	_	20	cc
23	21	21	CD	_	20	conj
24	for	for	IN	_	25	case
25	drug3	drug3	NN	_	20	nmod
26	.	.	.	_	7	punct

1	Peripheral	peripheral	JJ	_	3	amod
2	mononuclear	mononuclear	JJ	_	3	amod
3	cells	cell	NNS	_	6	nsubjpass
4	were	be	VBD	_	6	auxpass
5	also	also	RB	_	6	advmod
6	collected	collect	VBN	_	0	ROOT
7	for	for	IN	_	8	case
8	quantitation	quantitation	NN	_	6	nmod
9	of	of	IN	_	11	case
10	phosphorylated	phosphorylate	VBN	_	11	amod
11	drug1	drug1	NN	_	8	nmod
12	.	.	.	_	6	punct

1	drug1	drug1	NN	_	2	nsubj
2	had	have	VBD	_	0	ROOT
3	no	no	DT	_	5	neg
4	significant	significant	JJ	_	5	amod
5	impact	impact	NN	_	2	dobj
6	on	on	IN	_	8	case
7	the	the	DT	_	8	det
8	Cmax	cmax	NN	_	2	nmod
9	and	and	CC	_	8	cc
10	AUC	auc	NN	_	8	conj
11	of	of	IN	_	12	case
12	drug2	drug2	NN	_	8	nmod
13	,	,	,	_	2	punct
14	although	although	IN	_	17	mark
15	it	it	PRP	_	17	nsubj
16	significantly	significantly	RB	_	17	advmod
17	decreased	decrease	VBD	_	2	advcl
18	the	the	DT	_	20	det
19	drug3	drug3	NN	_	20	compound
20	tmax	tmax	NN	_	17	dobj
21	by	by	IN	_	23	case
22	44	44	CD	_	23	nummod
23	%	%	NN	_	17	nmod
24	and	and	CC	_	17	cc
25	increased	increase	VBD	_	17	conj
26	the	the	DT	_	28	det
27	intracellular	intracellular	JJ	_	28	amod
28	exposure	exposure	NN	_	25	dobj
29	to	to	TO	_	31	case
30	phosphorylated	phosphorylate	VBN	_	31	amod
31	drug4	drug4	NN	_	28	nmod
32	by	by	IN	_	34	case
33	110	110	CD	_	34	nummod
34	%	%	NN	_	25	nmod
35	.	.	.	_	2	punct

1	drug1	drug1	NN	_	2	nsubj
2	had	have	VBD	_	0	ROOT
3	no	no	DT	_	5	neg
4	significant	significant	JJ	_	5	amod
5	effect	effect	NN	_	2	dobj
6	on	on	IN	_	8	case
7	drug2	drug2	NN	_	8	compound
8	pharmacokinetics	pharmacokinetic	NNS	_	2	nmod
9	.	.	.	_	2	punct

1	Based	base	VBN	_	4	case
2	on	on	IN	_	4	case
3	the	the	DT	_	4	det
4	results	result	NNS	_	11	advcl
5	of	of	IN	_	7	case
6	these	these	DT	_	7	det
7	studies	study	NNS	_	4	nmod
8	,	,	,	_	11	punct
9	it	it	PRP	_	11	nsubjpass
10	is	be	VBZ	_	11	auxpass
11	concluded	conclude	VBN	_	0	ROOT
12	that	that	IN	_	17	mark
13	drug1	drug1	NN	_	17	nsubjpass
14	may	may	MD	_	17	aux
15	be	be	VB	_	17	auxpass
16	safely	safely	RB	_	17	advmod
17	coadministered	coadminister	VBN	_	11	ccomp
18	with	with	IN	_	20	case
19	both	both	CC	_	20	cc:preconj
20	drug2	drug2	NN	_	17	nmod
21	and	and	CC	_	20	cc
22	drug3	drug3	NN	_	20	conj
23	.	.	.	_	11	punct

1	Clinical	clinical	JJ	_	2	amod
2	implications	implication	NNS	_	0	ROOT
3	of	of	IN	_	5	case
4	drug1	drug1	NN	_	5	compound
5	interactions	interaction	NNS	_	2	nmod
6	with	with	IN	_	8	case
7	five	five	CD	_	8	nummod
8	drug2	drug2	NN	_	5	nmod
9	.	.	.	_	2	punct

1	The	the	DT	_	2	det
2	intensity	intensity	NN	_	23	nsubjpass
3	,	,	,	_	2	punct
4	uniformity	uniformity	NN	_	2	conj
5	and	and	CC	_	2	cc
6	time	time	NN	_	7	compound
7	course	course	NN	_	2	conj
8	of	of	IN	_	10	case
9	drug1	drug1	NN	_	10	compound
10	interference	interference	NN	_	2	nmod
11	by	by	IN	_	12	case
12	drug2	drug2	NN	_	10	nmod
13	,	,	,	_	12	punct
14	drug3	drug3	NN	_	12	conj
15	,	,	,	_	12	punct
16	drug4	drug4	NN	_	12	conj
17	,	,	,	_	12	punct
18	drug5	drug5	NN	_	12	conj
19	and	and	CC	_	12	cc
20	drug6	drug6	NN	_	12	conj
21	were	be	VBD	_	23	auxpass
22	systematically	systematically	RB	_	23	advmod
23	investigated	investigate	VBN	_	0	ROOT
24	in	in	IN	_	26	case
25	16	16	CD	_	26	nummod
26	patients	patient	NNS	_	23	nmod
27	receiving	receive	VBG	_	26	acl
28	drug7	drug7	NN	_	29	compound
29	therapy	therapy	NN	_	27	dobj
30	.	.	.	_	23	punct

1	Each	each	DT	_	2	det
2	subject	subject	JJ	_	3	nsubj
3	received	receive	VBD	_	0	ROOT
4	an	a	DT	_	8	det
5	individualized	individualized	JJ	_	8	amod
6	fixed	fixed	JJ	_	8	amod
7	daily	daily	JJ	_	8	amod
8	dose	dose	NN	_	3	dobj
9	of	of	IN	_	10	case
10	drug1	drug1	NN	_	8	nmod
11	and	and	CC	_	3	cc
12	served	serve	VBD	_	3	conj
13	as	as	IN	_	16	case
14	his	he	PRP$	_	16	nmod:poss
15	own	own	JJ	_	16	amod
16	pre	pre	JJ	_	12	nmod
17	-	-	:	_	3	punct
18	and	and	CC	_	3	cc
19	postsedative	postsedative	JJ	_	21	amod
20	treatment	treatment	NN	_	21	compound
21	control	control	NN	_	3	conj
22	.	.	.	_	3	punct

1	Prothrombin	Prothrombin	NNP	_	2	compound
2	times	time	NNS	_	4	nsubjpass
3	were	be	VBD	_	4	auxpass
4	measured	measure	VBN	_	0	ROOT
5	four	four	CD	_	6	compound
6	times	time	NNS	_	7	nummod
7	weekly	weekly	JJ	_	4	xcomp
8	during	during	IN	_	11	case
9	five	five	CD	_	11	nummod
10	long-term	long-term	JJ	_	11	amod
11	experiments	experiment	NNS	_	7	nmod
12	.	.	.	_	4	punct

1	Anticoagulant	anticoagulant	JJ	_	2	amod
2	inhibition	inhibition	NN	_	4	nsubjpass
3	was	be	VBD	_	4	auxpass
4	observed	observe	VBN	_	0	ROOT
5	during	during	IN	_	7	case
6	the	the	DT	_	7	det
7	administration	administration	NN	_	4	nmod
8	of	of	IN	_	9	case
9	drug1	drug1	NN	_	7	nmod
10	,	,	,	_	9	punct
11	drug2	drug2	NN	_	9	conj
12	and	and	CC	_	9	cc
13	drug3	drug3	NN	_	9	conj
14	;	;	:	_	4	punct

1	there	there	EX	_	2	expl
2	was	be	VBD	_	0	ROOT
3	no	no	DT	_	5	neg
4	significant	significant	JJ	_	5	amod
5	change	change	NN	_	2	nsubj
6	in	in	IN	_	8	case
7	prothrombin	prothrombin	NN	_	8	compound
8	test	test	NN	_	2	nmod
9	results	result	VBZ	_	2	nsubj
10	during	during	IN	_	12	case
11	the	the	DT	_	12	det
12	trials	trial	NNS	_	9	nmod
13	of	of	IN	_	14	case
14	drug1	drug1	NN	_	12	nmod
15	and	and	CC	_	14	cc
16	drug2	drug2	NN	_	14	conj
17	.	.	.	_	2	punct

1	drug1	drug1	NN	_	7	nsubjpass
2	and	and	CC	_	1	cc
3	drug2	drug2	NN	_	1	conj
4	should	should	MD	_	7	aux
5	not	not	RB	_	7	neg
6	be	be	VB	_	7	auxpass
7	administered	administer	VBN	_	0	ROOT
8	to	to	TO	_	9	case
9	patients	patient	NNS	_	7	nmod
10	receiving	receive	VBG	_	9	acl
11	drug3	drug3	NN	_	10	dobj
12	.	.	.	_	7	punct

1	The	the	DT	_	3	det
2	concurrent	concurrent	JJ	_	3	amod
3	use	use	NN	_	10	nsubj
4	of	of	IN	_	5	case
5	drugs	drug	NNS	_	3	nmod
6	from	from	IN	_	8	case
7	these	these	DT	_	8	det
8	groups	group	NNS	_	5	nmod
9	is	be	VBZ	_	10	aux
10	decreasing	decrease	VBG	_	0	ROOT
11	according	accord	VBG	_	14	case
12	to	to	TO	_	11	mwe
13	a	a	DT	_	14	det
14	survey	survey	NN	_	10	nmod
15	of	of	IN	_	19	case
16	200	200	CD	_	19	nummod
17	hospital	hospital	NN	_	19	compound
18	medical	medical	JJ	_	19	amod
19	records	record	NNS	_	14	nmod
20	.	.	.	_	10	punct

1	drug1	drug1	NN	_	4	nsubj
2	and	and	CC	_	1	cc
3	drug2	drug2	NN	_	1	conj
4	interact	interact	VBP	_	0	ROOT
5	pharmacologically	pharmacologically	RB	_	4	advmod
6	with	with	IN	_	9	case
7	orally	orally	RB	_	8	advmod
8	administered	administer	VBN	_	9	amod
9	drug3	drug3	NN	_	4	nmod
10	,	,	,	_	4	punct
11	but	but	CC	_	4	cc
12	the	the	DT	_	13	det
13	effect	effect	NN	_	17	nsubj
14	is	be	VBZ	_	17	cop
15	not	not	RB	_	17	neg
16	clinically	clinically	RB	_	17	advmod
17	significant	significant	JJ	_	4	conj
18	.	.	.	_	4	punct

1	It	it	PRP	_	3	nsubjpass
2	is	be	VBZ	_	3	auxpass
3	concluded	conclude	VBN	_	0	ROOT
4	that	that	IN	_	10	mark
5	drug1	drug1	NN	_	10	nsubjpass
6	and	and	CC	_	5	cc
7	drug2	drug2	NN	_	5	conj
8	may	may	MD	_	10	aux
9	be	be	VB	_	10	auxpass
10	administered	administer	VBN	_	3	ccomp
11	safely	safely	RB	_	10	advmod
12	without	without	IN	_	14	case
13	additional	additional	JJ	_	14	amod
14	caution	caution	NN	_	10	nmod
15	in	in	IN	_	18	case
16	prothrombin	prothrombin	NN	_	18	compound
17	test	test	NN	_	18	compound
18	monitoring	monitoring	NN	_	14	nmod
19	during	during	IN	_	22	case
20	oral	oral	JJ	_	22	amod
21	drug3	drug3	NN	_	22	compound
22	therapy	therapy	NN	_	10	nmod
23	.	.	.	_	3	punct

1	Interaction	interaction	NN	_	0	ROOT
2	of	of	IN	_	4	case
3	the	the	DT	_	4	det
4	constituents	constituent	NNS	_	1	nmod
5	of	of	IN	_	7	case
6	alcoholic	alcoholic	JJ	_	7	amod
7	beverages	beverage	NNS	_	4	nmod
8	in	in	IN	_	10	case
9	the	the	DT	_	10	det
10	promotion	promotion	NN	_	1	nmod
11	of	of	IN	_	13	case
12	liver	liver	NN	_	13	compound
13	damage	damage	NN	_	10	nmod
14	.	.	.	_	1	punct

1	Little	Little	NNP	_	4	nsubjpass
2	has	have	VBZ	_	4	aux
3	been	be	VBN	_	4	auxpass
4	studied	study	VBN	_	0	ROOT
5	of	of	IN	_	8	case
6	the	the	DT	_	8	det
7	adverse	adverse	JJ	_	8	amod
8	effects	effect	NNS	_	4	nmod
9	of	of	IN	_	11	case
10	the	the	DT	_	11	det
11	exposure	exposure	NN	_	8	nmod
12	of	of	IN	_	14	case
13	the	the	DT	_	14	det
14	liver	liver	NN	_	11	nmod
15	to	to	TO	_	17	case
16	the	the	DT	_	17	det
17	interaction	interaction	NN	_	8	nmod
18	of	of	IN	_	19	case
19	drug1	drug1	NN	_	17	nmod
20	with	with	IN	_	22	case
21	its	its	PRP$	_	22	nmod:poss
22	congeners	congener	NNS	_	17	nmod
23	and	and	CC	_	22	cc
24	drug2	drug2	NN	_	22	conj
25	,	,	,	_	4	punct
26	coexisting	coexist	VBG	_	4	advcl
27	in	in	IN	_	29	case
28	the	the	DT	_	29	det
29	contents	contents	NNS	_	26	nmod
30	of	of	IN	_	32	case
31	alcoholic	alcoholic	JJ	_	32	amod
32	beverages	beverage	NNS	_	29	nmod
33	.	.	.	_	4	punct

1	Twenty	twenty	CD	_	5	nummod
2	four	four	CD	_	5	nummod
3	male	male	JJ	_	5	amod
4	Wistar	Wistar	NNP	_	5	compound
5	rats	rat	NNS	_	7	nsubjpass
6	were	be	VBD	_	7	auxpass
7	divided	divide	VBN	_	0	ROOT
8	into	into	IN	_	10	case
9	four	four	CD	_	10	nummod
10	groups	group	NNS	_	7	nmod
11	.	.	.	_	7	punct

1	Two	two	CD	_	2	nummod
2	groups	group	NNS	_	9	nsubjpass
3	-LRB-	-lrb-	-LRB-	_	4	punct
4	SH/DA	sh/da	NN	_	2	appos
5	;	;	:	_	4	punct
6	SH/FA	sh/fa	NN	_	4	dep
7	-RRB-	-rrb-	-RRB-	_	4	punct
8	were	be	VBD	_	9	auxpass
9	submitted	submit	VBN	_	0	ROOT
10	to	to	TO	_	12	case
11	daily	daily	JJ	_	12	amod
12	treatment	treatment	NN	_	9	nmod
13	with	with	IN	_	16	case
14	synthetic	synthetic	JJ	_	16	amod
15	hydroalcoholic	hydroalcoholic	JJ	_	16	amod
16	solutions	solution	NNS	_	12	nmod
17	containing	contain	VBG	_	16	acl
18	drug1	drug1	NN	_	17	dobj
19	,	,	,	_	18	punct
20	drug2	drug2	NN	_	18	conj
21	,	,	,	_	18	punct
22	higher	higher	JJR	_	23	amod
23	drug3	drug3	NN	_	18	conj
24	and	and	CC	_	18	cc
25	drug4	drug4	NN	_	18	conj
26	in	in	IN	_	29	case
27	the	the	DT	_	29	det
28	same	same	JJ	_	29	amod
29	proportions	proportion	NNS	_	17	nmod
30	as	as	IN	_	31	case
31	those	those	DT	_	29	nmod
32	found	find	VBN	_	31	acl
33	in	in	IN	_	36	case
34	most	most	JJS	_	35	advmod
35	common	common	JJ	_	36	amod
36	distilled	distil	VBN	_	32	nmod
37	and	and	CC	_	36	cc
38	fermented	ferment	VBN	_	40	amod
39	alcoholic	alcoholic	JJ	_	40	amod
40	beverages	beverage	NNS	_	36	conj
41	;	;	:	_	9	punct

1	the	the	DT	_	3	det
2	third	third	JJ	_	3	amod
3	group	group	NN	_	8	nsubjpass
4	-LRB-	-lrb-	-LRB-	_	5	punct
5	SH/EA	sh/ea	NN	_	3	appos
6	-RRB-	-rrb-	-RRB-	_	5	punct
7	was	be	VBD	_	8	auxpass
8	treated	treat	VBN	_	0	ROOT
9	with	with	IN	_	12	case
10	a	a	DT	_	12	det
11	hydroalcoholic	hydroalcoholic	JJ	_	12	amod
12	solution	solution	NN	_	8	nmod
13	of	of	IN	_	14	case
14	drug1	drug1	NN	_	12	nmod
15	;	;	:	_	8	punct

1	the	the	DT	_	3	det
2	fourth	fourth	JJ	_	3	amod
3	group	group	NN	_	4	nsubj
4	served	serve	VBD	_	0	ROOT
5	as	as	IN	_	6	case
6	control	control	NN	_	4	nmod
7	and	and	CC	_	4	cc
8	received	receive	VBD	_	4	conj
9	an	a	DT	_	11	det
10	equivalent	equivalent	JJ	_	11	amod
11	volume	volume	NN	_	8	dobj
12	of	of	IN	_	15	case
13	an	a	DT	_	15	det
14	isocaloric	isocaloric	JJ	_	15	amod
15	solution	solution	NN	_	11	nmod
16	of	of	IN	_	17	case
17	drug1	drug1	NN	_	15	nmod
18	.	.	.	_	4	punct

1	All	all	PDT	_	3	det:predet
2	the	the	DT	_	3	det
3	animals	animal	NNS	_	5	nsubjpass
4	were	be	VBD	_	5	auxpass
5	killed	kill	VBN	_	0	ROOT
6	at	at	IN	_	8	case
7	the	the	DT	_	8	det
8	end	end	NN	_	5	nmod
9	of	of	IN	_	12	case
10	the	the	DT	_	12	det
11	9th	9th	JJ	_	12	amod
12	week	week	NN	_	8	nmod
13	of	of	IN	_	15	case
14	the	the	DT	_	15	det
15	experiment	experiment	NN	_	12	nmod
16	.	.	.	_	5	punct

1	The	the	DT	_	2	det
2	ratio	ratio	NN	_	11	nsubjpass
3	between	between	IN	_	6	case
4	the	the	DT	_	6	det
5	liver	liver	NN	_	6	compound
6	weight	weight	NN	_	2	nmod
7	and	and	CC	_	6	cc
8	body	body	NN	_	9	compound
9	weight	weight	NN	_	6	conj
10	was	be	VBD	_	11	auxpass
11	found	find	VBN	_	0	ROOT
12	to	to	TO	_	14	mark
13	be	be	VB	_	14	cop
14	lower	lower	JJR	_	11	xcomp
15	in	in	IN	_	18	case
16	the	the	DT	_	18	det
17	treated	treated	JJ	_	18	amod
18	animals	animal	NNS	_	14	nmod
19	than	than	IN	_	23	case
20	in	in	IN	_	23	case
21	the	the	DT	_	23	det
22	control	control	NN	_	23	compound
23	group	group	NN	_	14	nmod
24	.	.	.	_	11	punct

1	The	the	DT	_	2	det
2	histology	histology	NN	_	7	nsubjpass
3	of	of	IN	_	5	case
4	the	the	DT	_	5	det
5	liver	liver	NN	_	2	nmod
6	was	be	VBD	_	7	auxpass
7	altered	alter	VBN	_	0	ROOT
8	in	in	IN	_	11	case
9	the	the	DT	_	11	det
10	three	three	CD	_	11	nummod
11	groups	group	NNS	_	7	nmod
12	which	which	WDT	_	14	nsubjpass
13	were	be	VBD	_	14	auxpass
14	submitted	submit	VBN	_	11	acl:relcl
15	to	to	TO	_	16	case
16	treatment	treatment	NN	_	14	nmod
17	with	with	IN	_	20	case
18	the	the	DT	_	20	det
19	hydroalcoholic	hydroalcoholic	JJ	_	20	amod
20	solutions	solution	NNS	_	16	nmod
21	,	,	,	_	7	punct
22	with	with	IN	_	26	case
23	quantitative	quantitative	JJ	_	26	amod
24	and	and	CC	_	23	cc
25	qualitative	qualitative	JJ	_	23	conj
26	differences	difference	NNS	_	7	nmod
27	between	between	IN	_	29	case
28	the	the	DT	_	29	det
29	groups	group	NNS	_	26	nmod
30	.	.	.	_	7	punct

1	These	these	DT	_	2	det
2	results	result	NNS	_	3	nsubj
3	suggest	suggest	VBP	_	0	ROOT
4	that	that	IN	_	13	mark
5	the	the	DT	_	6	det
6	hepatoxicity	hepatoxicity	NN	_	13	nsubjpass
7	of	of	IN	_	8	case
8	drug1	drug1	NN	_	6	nmod
9	in	in	IN	_	11	case
10	alcoholic	alcoholic	JJ	_	11	amod
11	beverages	beverage	NNS	_	6	nmod
12	is	be	VBZ	_	13	auxpass
13	enhanced	enhance	VBN	_	3	ccomp
14	by	by	IN	_	15	case
15	interaction	interaction	NN	_	13	nmod
16	with	with	IN	_	18	case
17	its	its	PRP$	_	18	nmod:poss
18	congeners	congener	NNS	_	15	nmod
19	and	and	CC	_	18	cc
20	drug2	drug2	NN	_	18	conj
21	;	;	:	_	3	punct

1	they	they	PRP	_	3	nsubj
2	also	also	RB	_	3	advmod
3	suggest	suggest	VBP	_	0	ROOT
4	that	that	IN	_	9	mark
5	alcoholic	alcoholic	JJ	_	6	amod
6	beverages	beverage	NNS	_	9	nsubj
7	are	be	VBP	_	9	cop
8	not	not	RB	_	9	neg
9	equivalent	equivalent	JJ	_	3	ccomp
10	in	in	IN	_	12	case
11	their	they	PRP$	_	12	nmod:poss
12	potential	potential	JJ	_	9	nmod
13	to	to	TO	_	14	mark
14	cause	cause	VB	_	12	acl
15	liver	liver	NN	_	16	compound
16	damage	damage	NN	_	14	dobj
17	.	.	.	_	3	punct

1	Administration	administration	NN	_	0	ROOT
2	of	of	IN	_	4	case
3	drug1	drug1	NN	_	4	compound
4	prophylaxis	prophylaxis	NN	_	1	nmod
5	.	.	.	_	1	punct

1	Successful	successful	JJ	_	2	amod
2	prophylaxis	prophylaxis	NN	_	6	nsubj
3	of	of	IN	_	5	case
4	manic-depressive	manic-depressive	NN	_	5	compound
5	disorder	disorder	NN	_	2	nmod
6	requires	require	VBZ	_	0	ROOT
7	more	more	JJR	_	6	dobj
8	than	than	IN	_	10	case
9	the	the	DT	_	10	det
10	prescription	prescription	NN	_	7	nmod
11	of	of	IN	_	12	case
12	drug1	drug1	NN	_	10	nmod
13	.	.	.	_	6	punct

1	The	the	DT	_	3	det
2	administrative	administrative	JJ	_	3	amod
3	arrangements	arrangement	NNS	_	10	nsubjpass
4	in	in	IN	_	6	case
5	an	a	DT	_	6	det
6	area	area	NN	_	3	nmod
7	of	of	IN	_	8	case
8	Scotland	Scotland	NNP	_	6	nmod
9	were	be	VBD	_	10	auxpass
10	accompanied	accompany	VBN	_	0	ROOT
11	by	by	IN	_	15	case
12	a	a	DT	_	15	det
13	300	300	CD	_	14	compound
14	%	%	NN	_	15	amod
15	increase	increase	NN	_	10	nmod
16	in	in	IN	_	18	case
17	the	the	DT	_	18	det
18	frequency	frequency	NN	_	15	nmod
19	of	of	IN	_	20	case
20	admissions	admission	NNS	_	18	nmod
21	for	for	IN	_	22	case
22	mania	mania	NN	_	20	nmod
23	,	,	,	_	10	punct
24	whereas	whereas	IN	_	10	dep
25	in	in	IN	_	27	case
26	an	a	DT	_	27	det
27	area	area	NN	_	24	nmod
28	of	of	IN	_	31	case
29	the	the	DT	_	31	det
30	West	West	NNP	_	31	compound
31	Midlands	Midlands	NNPS	_	27	nmod
32	,	,	,	_	31	punct
33	a	a	DT	_	35	det
34	large	large	JJ	_	35	amod
35	decrease	decrease	NN	_	37	nsubjpass
36	was	be	VBD	_	37	auxpass
37	achieved	achieve	VBN	_	31	acl:relcl
38	.	.	.	_	10	punct

1	Effect	effect	NN	_	0	ROOT
2	of	of	IN	_	3	case
3	drug1	drug1	NN	_	1	nmod
4	on	on	IN	_	6	case
5	the	the	DT	_	6	det
6	pharmacokinetics	pharmacokinetic	NNS	_	1	nmod
7	of	of	IN	_	8	case
8	drug2	drug2	NN	_	6	nmod
9	in	in	IN	_	11	case
10	healthy	healthy	JJ	_	11	amod
11	volunteers	volunteer	NNS	_	6	nmod
12	.	.	.	_	1	punct

1	The	the	DT	_	2	det
2	authors	author	NNS	_	3	nsubj
3	examined	examine	VBD	_	0	ROOT
4	the	the	DT	_	5	det
5	effect	effect	NN	_	3	dobj
6	of	of	IN	_	12	case
7	the	the	DT	_	12	det
8	cyclooxygenase-2	cyclooxygenase-2	NN	_	12	compound
9	-LRB-	-lrb-	-LRB-	_	10	punct
10	COX-2	cox-2	NN	_	8	appos
11	-RRB-	-rrb-	-RRB-	_	10	punct
12	inhibitor	inhibitor	NN	_	5	nmod
13	,	,	,	_	12	punct
14	drug1	drug1	NN	_	12	appos
15	,	,	,	_	12	punct
16	at	at	IN	_	18	case
17	steady	steady	JJ	_	18	amod
18	state	state	NN	_	5	nmod
19	on	on	IN	_	21	case
20	the	the	DT	_	21	det
21	pharmacokinetics	pharmacokinetic	NNS	_	5	nmod
22	of	of	IN	_	23	case
23	drug2	drug2	NN	_	21	nmod
24	following	follow	VBG	_	27	case
25	a	a	DT	_	27	det
26	single	single	JJ	_	27	amod
27	dose	dose	NN	_	3	nmod
28	in	in	IN	_	30	case
29	healthy	healthy	JJ	_	30	amod
30	subjects	subject	NNS	_	27	nmod
31	.	.	.	_	3	punct

1	Each	each	DT	_	3	det
2	healthy	healthy	JJ	_	3	amod
3	subject	subject	NN	_	9	nsubj
4	-LRB-	-lrb-	-LRB-	_	6	punct
5	N	n	NN	_	6	nsubj
6	=	=	JJ	_	3	dep
7	10	10	CD	_	6	dobj
8	-RRB-	-rrb-	-RRB-	_	6	punct
9	received	receive	VBD	_	0	ROOT
10	drug1	drug1	NN	_	9	dobj
11	-LRB-	-lrb-	-LRB-	_	13	punct
12	75	75	CD	_	13	nummod
13	mg	mg	NN	_	10	dep
14	once	once	RB	_	15	advmod
15	daily	daily	JJ	_	13	amod
16	-RRB-	-rrb-	-RRB-	_	13	punct
17	or	or	CC	_	10	cc
18	placebo	placebo	NN	_	10	conj
19	for	for	IN	_	21	case
20	11	11	CD	_	21	nummod
21	days	day	NNS	_	9	nmod
22	in	in	IN	_	32	case
23	a	a	DT	_	32	det
24	double-blind	double-blind	JJ	_	32	amod
25	,	,	,	_	24	punct
26	randomized	randomize	VBN	_	24	dep
27	,	,	,	_	24	punct
28	balanced	balanced	JJ	_	24	dep
29	,	,	,	_	24	punct
30	two-period	two-period	JJ	_	24	dep
31	crossover	crossover	NN	_	32	compound
32	study	study	NN	_	9	nmod
33	.	.	.	_	9	punct

1	A	a	DT	_	4	det
2	single	single	JJ	_	4	amod
3	0.5	0.5	CD	_	4	nummod
4	mg	mg	NN	_	11	nsubjpass
5	oral	oral	JJ	_	6	amod
6	dose	dose	NN	_	4	dep
7	of	of	IN	_	9	case
8	drug1	drug1	NN	_	9	compound
9	elixir	elixir	NN	_	6	nmod
10	was	be	VBD	_	11	auxpass
11	administered	administer	VBN	_	0	ROOT
12	on	on	IN	_	15	case
13	the	the	DT	_	15	det
14	7th	7th	JJ	_	15	amod
15	day	day	NN	_	11	nmod
16	of	of	IN	_	19	case
17	each	each	DT	_	19	det
18	11-day	11-day	JJ	_	19	amod
19	period	period	NN	_	15	nmod
20	.	.	.	_	11	punct

1	Each	each	DT	_	3	det
2	treatment	treatment	NN	_	3	compound
3	period	period	NN	_	5	nsubjpass
4	was	be	VBD	_	5	auxpass
5	separated	separate	VBN	_	0	ROOT
6	by	by	IN	_	10	case
7	14	14	CD	_	9	compound
8	to	to	TO	_	9	dep
9	21	21	CD	_	10	nummod
10	days	day	NNS	_	5	nmod
11	.	.	.	_	5	punct

1	Samples	sample	NNS	_	10	nsubjpass
2	for	for	IN	_	3	case
3	plasma	plasma	NN	_	1	nmod
4	and	and	CC	_	3	cc
5	urine	urine	NN	_	3	conj
6	immunoreactive	immunoreactive	JJ	_	8	amod
7	drug1	drug1	NN	_	8	compound
8	concentrations	concentration	NNS	_	3	dep
9	were	be	VBD	_	10	auxpass
10	collected	collect	VBN	_	0	ROOT
11	through	through	IN	_	13	case
12	120	120	CD	_	13	nummod
13	hours	hour	NNS	_	10	nmod
14	following	follow	VBG	_	17	case
15	the	the	DT	_	17	det
16	drug2	drug2	NN	_	17	compound
17	dose	dose	NN	_	10	nmod
18	.	.	.	_	10	punct

1	No	no	DT	_	4	neg
2	statistically	statistically	RB	_	3	advmod
3	significant	significant	JJ	_	4	amod
4	differences	difference	NNS	_	9	nsubjpass
5	between	between	IN	_	7	case
6	treatment	treatment	NN	_	7	compound
7	groups	group	NNS	_	4	nmod
8	were	be	VBD	_	9	auxpass
9	observed	observe	VBN	_	0	ROOT
10	for	for	IN	_	11	case
11	any	any	DT	_	9	nmod
12	of	of	IN	_	17	case
13	the	the	DT	_	17	det
14	calculated	calculate	VBN	_	17	amod
15	drug1	drug1	NN	_	17	compound
16	pharmacokinetic	pharmacokinetic	JJ	_	17	amod
17	parameters	parameter	NNS	_	11	nmod
18	.	.	.	_	9	punct

1	For	for	IN	_	3	case
2	drug1	drug1	NN	_	3	compound
3	AUC	auc	NN	_	37	nmod
4	-LRB-	-lrb-	-LRB-	_	5	punct
5	0-infinity	0-infinity	NN	_	3	appos
6	-RRB-	-rrb-	-RRB-	_	5	punct
7	,	,	,	_	37	punct
8	AUC	auc	NN	_	37	nsubj
9	-LRB-	-lrb-	-LRB-	_	10	punct
10	0-24	0-24	CD	_	8	appos
11	-RRB-	-rrb-	-RRB-	_	10	punct
12	,	,	,	_	8	punct
13	and	and	CC	_	8	cc
14	Cmax	Cmax	NNP	_	8	conj
15	,	,	,	_	14	punct
16	the	the	DT	_	19	det
17	geometric	geometric	JJ	_	19	amod
18	mean	mean	JJ	_	19	amod
19	ratios	ratio	NNS	_	14	appos
20	-LRB-	-lrb-	-LRB-	_	24	punct
21	90	90	CD	_	22	compound
22	%	%	NN	_	24	amod
23	confidence	confidence	NN	_	24	compound
24	interval	interval	NN	_	19	appos
25	-RRB-	-rrb-	-RRB-	_	24	punct
26	for	for	IN	_	28	case
27	-LRB-	-lrb-	-LRB-	_	28	punct
28	drug2	drug2	NN	_	19	nmod
29	+	+	CC	_	28	cc
30	drug3	drug3	NN	_	28	conj
31	/	/	:	_	28	punct
32	placebo	placebo	NN	_	28	dep
33	+	+	CC	_	32	cc
34	drug4	drug4	NN	_	32	conj
35	-RRB-	-rrb-	-RRB-	_	28	punct
36	were	be	VBD	_	37	cop
37	1.04	1.04	CD	_	0	ROOT
38	-LRB-	-lrb-	-LRB-	_	39	punct
39	0.94	0.94	CD	_	37	dep
40	,	,	,	_	39	punct
41	1.14	1.14	CD	_	39	dep
42	-RRB-	-rrb-	-RRB-	_	39	punct
43	,	,	,	_	37	punct
44	1.02	1.02	CD	_	37	conj
45	-LRB-	-lrb-	-LRB-	_	46	punct
46	0.94	0.94	CD	_	44	dep
47	,	,	,	_	46	punct
48	1.09	1.09	CD	_	46	dep
49	-RRB-	-rrb-	-RRB-	_	46	punct
50	,	,	,	_	37	punct
51	and	and	CC	_	37	cc
52	1.00	1.00	CD	_	37	conj
53	-LRB-	-lrb-	-LRB-	_	54	punct
54	0.91	0.91	CD	_	52	dep
55	,	,	,	_	54	punct
56	1.10	1.10	CD	_	54	dep
57	-RRB-	-rrb-	-RRB-	_	54	punct
58	,	,	,	_	37	punct
59	respectively	respectively	RB	_	37	advmod
60	.	.	.	_	37	punct

1	The	the	DT	_	4	det
2	drug1	drug1	NN	_	4	compound
3	median	median	NN	_	4	compound
4	tmax	tmax	NN	_	7	nsubj
5	was	be	VBD	_	7	cop
6	0.5	0.5	CD	_	7	nummod
7	hours	hour	NNS	_	0	ROOT
8	for	for	IN	_	10	case
9	both	both	DT	_	10	det
10	treatments	treatment	NNS	_	7	nmod
11	.	.	.	_	7	punct

1	The	the	DT	_	5	det
2	harmonic	harmonic	JJ	_	5	amod
3	mean	mean	NN	_	5	compound
4	elimination	elimination	NN	_	5	compound
5	half-life	half-life	NN	_	7	nsubj
6	was	be	VBD	_	7	cop
7	45.7	45.7	CD	_	0	ROOT
8	and	and	CC	_	7	cc
9	43.4	43.4	CD	_	7	conj
10	hours	hour	NNS	_	7	dep
11	for	for	IN	_	12	case
12	drug1	drug1	NN	_	7	nmod
13	+	+	CC	_	12	cc
14	drug2	drug2	NN	_	12	conj
15	and	and	CC	_	12	cc
16	placebo	placebo	NN	_	19	compound
17	+	+	CC	_	16	cc
18	drug3	drug3	NN	_	16	conj
19	treatments	treatment	NNS	_	12	conj
20	,	,	,	_	7	punct
21	respectively	respectively	RB	_	7	advmod
22	.	.	.	_	7	punct

1	drug1	drug1	NN	_	3	nsubjpass
2	is	be	VBZ	_	3	auxpass
3	eliminated	eliminate	VBN	_	0	ROOT
4	renally	renally	RB	_	3	advmod
5	.	.	.	_	3	punct

1	The	the	DT	_	8	det
2	mean	mean	NN	_	8	compound
3	-LRB-	-lrb-	-LRB-	_	4	punct
4	SD	sd	NN	_	2	appos
5	-RRB-	-rrb-	-RRB-	_	4	punct
6	cumulative	cumulative	JJ	_	8	amod
7	urinary	urinary	JJ	_	8	amod
8	excretion	excretion	NN	_	20	nsubj
9	of	of	IN	_	11	case
10	immunoreactive	immunoreactive	JJ	_	11	amod
11	drug1	drug1	NN	_	8	nmod
12	after	after	IN	_	14	case
13	concurrent	concurrent	JJ	_	14	amod
14	treatment	treatment	NN	_	8	nmod
15	with	with	IN	_	16	case
16	drug2	drug2	NN	_	14	nmod
17	or	or	CC	_	16	cc
18	placebo	placebo	NN	_	16	conj
19	was	be	VBD	_	20	cop
20	228.2	228.2	CD	_	0	ROOT
21	-LRB-	-lrb-	-LRB-	_	22	punct
22	+	+	CC	_	20	dep
23	/	/	:	_	22	punct
24	-	-	:	_	22	punct
25	30.8	30.8	CD	_	22	dep
26	-RRB-	-rrb-	-RRB-	_	22	punct
27	and	and	CC	_	20	cc
28	235.1	235.1	CD	_	20	conj
29	-LRB-	-lrb-	-LRB-	_	30	punct
30	+	+	CC	_	20	dep
31	/	/	:	_	30	punct
32	-	-	:	_	30	punct
33	39.1	39.1	CD	_	30	dep
34	-RRB-	-rrb-	-RRB-	_	30	punct
35	micrograms/120	micrograms/120	NN	_	36	compound
36	hours	hour	NNS	_	20	conj
37	,	,	,	_	20	punct
38	respectively	respectively	RB	_	20	advmod
39	.	.	.	_	20	punct

1	Transient	transient	JJ	_	5	amod
2	and	and	CC	_	1	cc
3	minor	minor	JJ	_	1	conj
4	adverse	adverse	JJ	_	5	amod
5	events	event	NNS	_	6	nsubj
6	occurred	occur	VBD	_	0	ROOT
7	with	with	IN	_	9	case
8	similar	similar	JJ	_	9	amod
9	frequency	frequency	NN	_	6	nmod
10	on	on	IN	_	11	case
11	placebo	placebo	NN	_	9	nmod
12	and	and	CC	_	11	cc
13	drug1	drug1	NN	_	14	compound
14	treatments	treatment	NNS	_	11	conj
15	,	,	,	_	6	punct
16	and	and	CC	_	6	cc
17	no	no	DT	_	19	neg
18	treatment-related	treatment-related	JJ	_	19	amod
19	pattern	pattern	NN	_	21	nsubj
20	was	be	VBD	_	21	cop
21	apparent	apparent	JJ	_	6	conj
22	.	.	.	_	6	punct

1	drug1	drug1	NN	_	4	nsubj
2	did	do	VBD	_	4	aux
3	not	not	RB	_	4	neg
4	influence	influence	VB	_	0	ROOT
5	the	the	DT	_	7	det
6	plasma	plasma	NN	_	7	compound
7	pharmacokinetics	pharmacokinetic	NNS	_	4	dobj
8	or	or	CC	_	7	cc
9	renal	renal	JJ	_	10	amod
10	elimination	elimination	NN	_	7	conj
11	of	of	IN	_	15	case
12	a	a	DT	_	15	det
13	single	single	JJ	_	15	amod
14	oral	oral	JJ	_	15	amod
15	dose	dose	NN	_	7	nmod
16	of	of	IN	_	17	case
17	drug2	drug2	NN	_	15	nmod
18	.	.	.	_	4	punct

1	drug1	drug1	NN	_	0	ROOT
2	-LRB-	-lrb-	-LRB-	_	3	punct
3	drug2	drug2	NN	_	1	appos
4	-RRB-	-rrb-	-RRB-	_	3	punct
5	and	and	CC	_	1	cc
6	drug3	drug3	NN	_	1	conj
7	:	:	:	_	1	punct
8	comparison	comparison	NN	_	1	dep
9	of	of	IN	_	11	case
10	antiaddictive	antiaddictive	JJ	_	11	amod
11	efficacy	efficacy	NN	_	8	nmod
12	,	,	,	_	11	punct
13	toxicity	toxicity	NN	_	11	conj
14	,	,	,	_	11	punct
15	and	and	CC	_	11	cc
16	mechanisms	mechanism	NNS	_	11	conj
17	of	of	IN	_	18	case
18	action	action	NN	_	16	nmod
19	.	.	.	_	1	punct

1	drug1	drug1	NN	_	11	nsubjpass
2	,	,	,	_	1	punct
3	a	a	DT	_	7	det
4	novel	novel	JJ	_	7	amod
5	iboga	iboga	NN	_	7	compound
6	alkaloid	alkaloid	NN	_	7	compound
7	congener	congener	NN	_	1	appos
8	,	,	,	_	1	punct
9	is	be	VBZ	_	11	aux
10	being	be	VBG	_	11	auxpass
11	developed	develop	VBN	_	0	ROOT
12	as	as	IN	_	15	case
13	a	a	DT	_	15	det
14	potential	potential	JJ	_	15	amod
15	treatment	treatment	NN	_	11	nmod
16	for	for	IN	_	18	case
17	multiple	multiple	JJ	_	18	amod
18	forms	form	NNS	_	15	nmod
19	of	of	IN	_	21	case
20	drug	drug	NN	_	21	compound
21	abuse	abuse	NN	_	18	nmod
22	.	.	.	_	11	punct

1	Like	like	IN	_	2	case
2	drug1	drug1	NN	_	13	nmod
3	-LRB-	-lrb-	-LRB-	_	5	punct
4	40	40	CD	_	5	nummod
5	mg/kg	mg/kg	NN	_	2	appos
6	-RRB-	-rrb-	-RRB-	_	5	punct
7	,	,	,	_	13	punct
8	drug2	drug2	NN	_	13	nsubj
9	-LRB-	-lrb-	-LRB-	_	11	punct
10	40	40	CD	_	11	nummod
11	mg/kg	mg/kg	NN	_	8	appos
12	-RRB-	-rrb-	-RRB-	_	11	punct
13	decreases	decrease	VBZ	_	0	ROOT
14	the	the	DT	_	16	det
15	intravenous	intravenous	JJ	_	16	amod
16	self-administration	self-administration	NN	_	13	dobj
17	of	of	IN	_	18	case
18	drug3	drug3	NN	_	16	nmod
19	and	and	CC	_	18	cc
20	drug4	drug4	NN	_	18	conj
21	and	and	CC	_	16	cc
22	the	the	DT	_	24	det
23	oral	oral	JJ	_	24	amod
24	self-administration	self-administration	NN	_	16	conj
25	of	of	IN	_	26	case
26	drug5	drug5	NN	_	24	nmod
27	and	and	CC	_	26	cc
28	drug6	drug6	NN	_	26	conj
29	in	in	IN	_	30	case
30	rats	rat	NNS	_	13	nmod
31	;	;	:	_	13	punct

1	unlike	unlike	IN	_	2	case
2	drug1	drug1	NN	_	7	nmod
3	,	,	,	_	7	punct
4	drug2	drug2	NN	_	7	nsubj
5	does	do	VBZ	_	7	aux
6	not	not	RB	_	7	neg
7	affect	affect	VB	_	0	ROOT
8	responding	respond	VBG	_	7	xcomp
9	for	for	IN	_	12	case
10	a	a	DT	_	12	det
11	nondrug	nondrug	JJ	_	12	amod
12	reinforcer	reinforcer	NN	_	8	nmod
13	-LRB-	-lrb-	-LRB-	_	14	punct
14	water	water	NN	_	12	appos
15	-RRB-	-rrb-	-RRB-	_	14	punct
16	.	.	.	_	7	punct

1	Both	both	DT	_	2	cc:preconj
2	drug1	drug1	NN	_	5	nsubj
3	and	and	CC	_	2	cc
4	drug2	drug2	NN	_	2	conj
5	ameliorate	ameliorate	VBP	_	0	ROOT
6	drug3	drug3	NN	_	8	compound
7	withdrawal	withdrawal	NN	_	8	compound
8	signs	sign	NNS	_	5	dobj
9	.	.	.	_	5	punct

1	Both	both	DT	_	2	cc:preconj
2	drug1	drug1	NN	_	5	nsubj
3	and	and	CC	_	2	cc
4	drug2	drug2	NN	_	2	conj
5	decrease	decrease	NN	_	0	ROOT
6	extracellular	extracellular	JJ	_	7	amod
7	levels	level	NNS	_	5	dobj
8	of	of	IN	_	9	case
9	dopamine	dopamine	NN	_	7	nmod
10	in	in	IN	_	13	case
11	the	the	DT	_	13	det
12	nucleus	nucleus	NN	_	13	compound
13	accumbens	accumben	NNS	_	5	nmod
14	,	,	,	_	5	punct
15	but	but	CC	_	5	cc
16	only	only	RB	_	17	advmod
17	drug3	drug3	NN	_	18	nsubj
18	increases	increase	VBZ	_	5	conj
19	extracellular	extracellular	JJ	_	20	amod
20	levels	level	NNS	_	18	dobj
21	of	of	IN	_	22	case
22	serotonin	serotonin	NN	_	20	nmod
23	in	in	IN	_	26	case
24	the	the	DT	_	26	det
25	nucleus	nucleus	NN	_	26	compound
26	accumbens	accumben	NNS	_	18	nmod
27	.	.	.	_	5	punct

1	Both	both	DT	_	2	cc:preconj
2	drug1	drug1	NN	_	5	nsubj
3	and	and	CC	_	2	cc
4	drug2	drug2	NN	_	2	conj
5	block	block	NN	_	0	ROOT
6	drug3	drug3	NN	_	14	dep
7	-	-	:	_	6	punct
8	induced	induce	VBN	_	6	dep
9	and	and	CC	_	8	cc
10	drug4	drug4	NN	_	8	conj
11	-	-	:	_	6	punct
12	induced	induce	VBN	_	14	amod
13	dopamine	dopamine	NN	_	14	compound
14	release	release	NN	_	5	dobj
15	in	in	IN	_	18	case
16	the	the	DT	_	18	det
17	nucleus	nucleus	NN	_	18	compound
18	accumbens	accumben	NNS	_	14	nmod
19	;	;	:	_	5	punct

1	only	only	RB	_	2	advmod
2	drug1	drug1	NN	_	3	nsubj
3	enhances	enhance	VBZ	_	0	ROOT
4	drug2	drug2	NN	_	3	dobj
5	-	-	:	_	4	punct
6	induced	induce	VBN	_	7	amod
7	increases	increase	NNS	_	4	dep
8	in	in	IN	_	10	case
9	accumbal	accumbal	JJ	_	10	amod
10	dopamine	dopamine	NN	_	7	nmod
11	.	.	.	_	3	punct

1	Both	both	DT	_	2	cc:preconj
2	drug1	drug1	NN	_	5	nsubj
3	and	and	CC	_	2	cc
4	drug2	drug2	NN	_	2	conj
5	enhance	enhance	VBP	_	0	ROOT
6	the	the	DT	_	10	det
7	locomotor	locomotor	NN	_	10	amod
8	and/or	and/or	CC	_	7	cc
9	stereotypic	stereotypic	JJ	_	7	conj
10	effects	effect	NNS	_	5	dobj
11	of	of	IN	_	12	case
12	stimulants	stimulant	NNS	_	10	nmod
13	.	.	.	_	5	punct

1	drug1	drug1	NN	_	2	nsubj
2	attenuates	attenuate	VBZ	_	0	ROOT
3	,	,	,	_	2	punct
4	but	but	CC	_	2	cc
5	drug2	drug2	NN	_	6	nsubj
6	potentiates	potentiate	VBZ	_	2	conj
7	,	,	,	_	6	punct
8	the	the	DT	_	11	det
9	acute	acute	JJ	_	11	amod
10	locomotor	locomotor	JJ	_	11	amod
11	effects	effect	NNS	_	6	dobj
12	of	of	IN	_	13	case
13	drug3	drug3	NN	_	11	nmod
14	;	;	:	_	2	punct

1	both	both	DT	_	2	det
2	compounds	compound	NNS	_	3	nsubj
3	attenuate	attenuate	VBP	_	0	ROOT
4	drug1	drug1	NN	_	7	compound
5	-	-	:	_	7	punct
6	induced	induce	VBN	_	7	amod
7	locomotion	locomotion	NN	_	3	dobj
8	in	in	IN	_	9	case
9	drug2	drug2	NN	_	7	nmod
10	-	-	:	_	7	punct
11	experienced	experienced	JJ	_	12	amod
12	rats	rat	NNS	_	7	dep
13	.	.	.	_	3	punct

1	drug1	drug1	NN	_	2	nsubj
2	produces	produce	VBZ	_	0	ROOT
3	whole	whole	JJ	_	5	amod
4	body	body	NN	_	5	compound
5	tremors	tremor	NNS	_	2	dobj
6	and	and	CC	_	2	cc
7	,	,	,	_	2	punct
8	at	at	IN	_	10	case
9	high	high	JJ	_	10	amod
10	doses	dose	NNS	_	2	nmod
11	-LRB-	-lrb-	-LRB-	_	20	punct
12	>	>	JJR	_	20	dep
13	or	or	CC	_	12	cc
14	=	=	JJ	_	12	conj
15	100	100	CD	_	16	nummod
16	mg/kg	mg/kg	NN	_	14	dep
17	-RRB-	-rrb-	-RRB-	_	12	punct
18	,	,	,	_	20	punct
19	cerebellar	cerebellar	NN	_	20	compound
20	damage	damage	NN	_	10	dep
21	;	;	:	_	2	punct

1	drug1	drug1	NN	_	4	nsubj
2	does	do	VBZ	_	4	aux
3	not	not	RB	_	4	neg
4	produce	produce	VB	_	0	ROOT
5	these	these	DT	_	6	det
6	effects	effect	NNS	_	4	dobj
7	.	.	.	_	4	punct

1	drug1	drug1	NN	_	7	nsubj
2	,	,	,	_	1	punct
3	but	but	CC	_	4	cc
4	not	not	RB	_	1	cc
5	drug2	drug2	NN	_	1	conj
6	,	,	,	_	1	punct
7	decreases	decrease	VBZ	_	0	ROOT
8	heart	heart	NN	_	9	compound
9	rate	rate	NN	_	7	dobj
10	at	at	IN	_	12	case
11	high	high	JJ	_	12	amod
12	doses	dose	NNS	_	7	nmod
13	.	.	.	_	7	punct

1	While	while	IN	_	5	mark
2	drug1	drug1	NN	_	5	nsubj
3	and	and	CC	_	2	cc
4	drug2	drug2	NN	_	2	conj
5	have	have	VBP	_	17	advcl
6	similar	similar	JJ	_	7	amod
7	affinities	affinity	NNS	_	5	dobj
8	for	for	IN	_	10	case
9	kappa	kappa	NN	_	10	compound
10	opioid	opioid	NN	_	7	nmod
11	and	and	CC	_	5	cc
12	possibly	possibly	RB	_	13	advmod
13	nicotinic	nicotinic	JJ	_	14	amod
14	receptors	receptor	NNS	_	5	conj
15	,	,	,	_	17	punct
16	drug3	drug3	NN	_	17	nsubj
17	has	have	VBZ	_	0	ROOT
18	much	much	RB	_	19	advmod
19	lower	lower	JJR	_	20	amod
20	affinities	affinity	NNS	_	17	dobj
21	than	than	IN	_	22	case
22	drug4	drug4	NN	_	20	nmod
23	for	for	IN	_	24	case
24	NMDA	nmda	NN	_	20	nmod
25	and	and	CC	_	24	cc
26	sigma-2	sigma-2	NN	_	27	compound
27	receptors	receptor	NNS	_	24	conj
28	,	,	,	_	30	punct
29	sodium	sodium	NN	_	30	compound
30	channels	channel	NNS	_	17	dep
31	,	,	,	_	30	punct
32	and	and	CC	_	30	cc
33	the	the	DT	_	35	det
34	5-HT	5-ht	NN	_	35	compound
35	transporter	transporter	NN	_	30	conj
36	.	.	.	_	17	punct

1	Both	both	DT	_	2	cc:preconj
2	drug1	drug1	NN	_	6	nsubjpass
3	and	and	CC	_	2	cc
4	drug2	drug2	NN	_	2	conj
5	are	be	VBP	_	6	auxpass
6	sequestered	sequester	VBN	_	0	ROOT
7	in	in	IN	_	8	case
8	fat	fat	JJ	_	6	nmod
9	and	and	CC	_	8	cc
10	,	,	,	_	16	punct
11	like	like	IN	_	12	case
12	drug3	drug3	NN	_	16	nmod
13	,	,	,	_	16	punct
14	drug4	drug4	NN	_	16	nsubj
15	probably	probably	RB	_	16	advmod
16	has	have	VBZ	_	8	conj
17	an	a	DT	_	19	det
18	active	active	JJ	_	19	amod
19	metabolite	metabolite	NN	_	16	dobj
20	.	.	.	_	6	punct

1	The	the	DT	_	2	det
2	data	datum	NNS	_	3	nsubj
3	suggest	suggest	VBP	_	0	ROOT
4	that	that	IN	_	6	mark
5	drug1	drug1	NN	_	6	nsubj
6	has	have	VBZ	_	3	ccomp
7	a	a	DT	_	9	det
8	narrower	narrower	JJR	_	9	amod
9	spectrum	spectrum	NN	_	6	dobj
10	of	of	IN	_	11	case
11	actions	action	NNS	_	9	nmod
12	and	and	CC	_	6	cc
13	will	will	MD	_	14	aux
14	have	have	VB	_	6	conj
15	a	a	DT	_	19	det
16	substantially	substantially	RB	_	17	advmod
17	greater	greater	JJR	_	19	amod
18	therapeutic	therapeutic	JJ	_	19	amod
19	index	index	NN	_	14	dobj
20	than	than	IN	_	21	case
21	drug2	drug2	NN	_	19	nmod
22	.	.	.	_	3	punct

1	Effect	effect	NN	_	0	ROOT
2	of	of	IN	_	4	case
3	coadministered	coadministered	JJ	_	4	amod
4	drugs	drug	NNS	_	1	nmod
5	and	and	CC	_	4	cc
6	drug1	drug1	NN	_	4	conj
7	on	on	IN	_	9	case
8	the	the	DT	_	9	det
9	binding	binding	NN	_	1	nmod
10	of	of	IN	_	12	case
11	therapeutic	therapeutic	JJ	_	12	amod
12	drugs	drug	NNS	_	9	nmod
13	to	to	TO	_	15	case
14	human	human	JJ	_	15	amod
15	serum	serum	NN	_	9	nmod
16	in	in	FW	_	17	compound
17	vitro	vitro	FW	_	9	advmod
18	.	.	.	_	1	punct

1	The	the	DT	_	2	det
2	effects	effect	NNS	_	20	nsubjpass
3	of	of	IN	_	5	case
4	coadministered	coadministered	JJ	_	5	amod
5	drugs	drug	NNS	_	2	nmod
6	and	and	CC	_	5	cc
7	drug1	drug1	NN	_	5	conj
8	on	on	IN	_	10	case
9	the	the	DT	_	10	det
10	binding	binding	NN	_	2	nmod
11	of	of	IN	_	13	case
12	therapeutic	therapeutic	JJ	_	13	amod
13	drugs	drug	NNS	_	10	nmod
14	to	to	TO	_	16	case
15	human	human	JJ	_	16	amod
16	serum	serum	NN	_	10	nmod
17	in	in	FW	_	18	compound
18	vitro	vitro	FW	_	10	advmod
19	was	be	VBD	_	20	auxpass
20	investigated	investigate	VBN	_	0	ROOT
21	.	.	.	_	20	punct

1	drug1	drug1	NN	_	14	nsubjpass
2	,	,	,	_	1	punct
3	drug2	drug2	NN	_	1	conj
4	,	,	,	_	1	punct
5	drug3	drug3	NN	_	1	conj
6	,	,	,	_	1	punct
7	drug4	drug4	NN	_	1	conj
8	,	,	,	_	1	punct
9	drug5	drug5	NN	_	1	conj
10	,	,	,	_	1	punct
11	and	and	CC	_	1	cc
12	drug6	drug6	NN	_	1	conj
13	were	be	VBD	_	14	auxpass
14	added	add	VBN	_	0	ROOT
15	to	to	TO	_	18	case
16	pooled	pooled	JJ	_	18	amod
17	human	human	JJ	_	18	amod
18	serum	serum	NN	_	14	nmod
19	at	at	IN	_	21	case
20	therapeutic	therapeutic	JJ	_	21	amod
21	concentrations	concentration	NNS	_	14	nmod
22	.	.	.	_	14	punct

1	To	to	TO	_	3	case
2	each	each	DT	_	3	det
3	preparation	preparation	NN	_	5	nmod
4	was	be	VBD	_	5	auxpass
5	added	add	VBN	_	0	ROOT
6	one	one	CD	_	8	nummod
7	additional	additional	JJ	_	8	amod
8	drug	drug	NN	_	5	dobj
9	at	at	IN	_	11	case
10	three	three	CD	_	11	nummod
11	concentrations	concentration	NNS	_	5	nmod
12	ranging	range	VBG	_	11	acl
13	from	from	IN	_	14	case
14	therapeutic	therapeutic	JJ	_	12	nmod
15	to	to	TO	_	16	case
16	toxic	toxic	JJ	_	14	nmod
17	.	.	.	_	5	punct

1	The	the	DT	_	4	det
2	following	follow	VBG	_	4	amod
3	eight	eight	CD	_	4	nummod
4	target	target	NN	_	9	nsubjpass
5	drug/added	drug/added	VBN	_	7	amod
6	drug	drug	NN	_	7	compound
7	combinations	combination	NNS	_	4	dep
8	were	be	VBD	_	9	auxpass
9	studied	study	VBN	_	0	ROOT
10	:	:	:	_	9	punct
11	drug1	drug1	NN	_	13	compound
12	/	/	:	_	13	punct
13	drug2	drug2	NN	_	9	dep
14	.	.	.	_	9	punct

1	drug1	drug1	NN	_	3	compound
2	/	/	:	_	3	punct
3	drug2	drug2	NN	_	0	ROOT
4	,	,	,	_	3	punct
5	drug3	drug3	NN	_	7	compound
6	/	/	:	_	7	punct
7	drug4	drug4	NN	_	3	conj
8	,	,	,	_	3	punct
9	drug5	drug5	NN	_	11	compound
10	/	/	:	_	11	punct
11	drug6	drug6	NN	_	3	conj
12	,	,	,	_	3	punct
13	drug7	drug7	NN	_	15	compound
14	/	/	:	_	15	punct
15	drug8	drug8	NN	_	3	conj
16	,	,	,	_	3	punct
17	drug9	drug9	NN	_	19	compound
18	/	/	:	_	19	punct
19	drug10	drug10	NN	_	3	conj
20	,	,	,	_	3	punct
21	drug11	drug11	NN	_	23	compound
22	/	/	:	_	23	punct
23	drug12	drug12	NN	_	3	conj
24	,	,	,	_	3	punct
25	and	and	CC	_	3	cc
26	drug13	drug13	NN	_	28	compound
27	/	/	:	_	28	punct
28	drug14	drug14	NN	_	3	conj
29	.	.	.	_	3	punct

1	Each	each	DT	_	2	det
2	serum	serum	NN	_	23	nsubjpass
3	without	without	IN	_	7	case
4	the	the	DT	_	7	det
5	other	other	JJ	_	7	amod
6	added	add	VBN	_	7	amod
7	drug	drug	NN	_	2	nmod
8	as	as	RB	_	2	cc
9	well	well	RB	_	8	mwe
10	as	as	IN	_	8	mwe
11	the	the	DT	_	12	det
12	serum	serum	NN	_	2	conj
13	supplemented	supplement	VBN	_	12	acl
14	with	with	IN	_	17	case
15	the	the	DT	_	17	det
16	other	other	JJ	_	17	amod
17	drug	drug	NN	_	13	nmod
18	at	at	IN	_	21	case
19	the	the	DT	_	21	det
20	three	three	CD	_	21	nummod
21	concentrations	concentration	NNS	_	13	nmod
22	was	be	VBD	_	23	auxpass
23	dialyzed	dialyze	VBN	_	0	ROOT
24	against	against	IN	_	26	case
25	phosphate	phosphate	NN	_	26	compound
26	buffer	buffer	NN	_	23	nmod
27	.	.	.	_	23	punct

1	Similarly	similarly	RB	_	2	advmod
2	dialyzed	dialyze	VBN	_	0	ROOT
3	were	be	VBD	_	2	auxpass
4	drug1	drug1	NN	_	2	nsubjpass
5	,	,	,	_	4	punct
6	drug2	drug2	NN	_	4	conj
7	,	,	,	_	4	punct
8	and	and	CC	_	4	cc
9	drug3	drug3	NN	_	4	conj
10	,	,	,	_	2	punct
11	both	both	CC	_	15	dep
12	alone	alone	RB	_	11	advmod
13	at	at	IN	_	15	case
14	therapeutic	therapeutic	JJ	_	15	amod
15	concentrations	concentration	NNS	_	2	nmod
16	in	in	IN	_	17	case
17	serum	serum	NN	_	15	nmod
18	and	and	CC	_	15	cc
19	with	with	IN	_	20	case
20	drug4	drug4	NN	_	15	conj
21	at	at	IN	_	24	case
22	three	three	CD	_	24	nummod
23	different	different	JJ	_	24	amod
24	concentrations	concentration	NNS	_	20	nmod
25	in	in	IN	_	26	case
26	serum	serum	NN	_	24	nmod
27	.	.	.	_	2	punct

1	The	the	DT	_	2	det
2	percentage	percentage	NN	_	10	nsubjpass
3	of	of	IN	_	5	case
4	drug	drug	NN	_	5	compound
5	binding	binding	NN	_	2	nmod
6	in	in	IN	_	8	case
7	each	each	DT	_	8	det
8	preparation	preparation	NN	_	2	nmod
9	was	be	VBD	_	10	auxpass
10	calculated	calculate	VBN	_	0	ROOT
11	.	.	.	_	10	punct

1	drug1	drug1	NN	_	2	nsubj
2	diminished	diminish	VBD	_	0	ROOT
3	the	the	DT	_	4	det
4	binding	binding	NN	_	2	dobj
5	of	of	IN	_	6	case
6	drug2	drug2	NN	_	4	nmod
7	to	to	TO	_	9	case
8	human	human	JJ	_	9	amod
9	serum	serum	NN	_	4	nmod
10	by	by	IN	_	13	case
11	a	a	DT	_	13	det
12	net	net	JJ	_	13	amod
13	change	change	NN	_	4	nmod
14	of	of	IN	_	16	case
15	5.7	5.7	CD	_	16	nummod
16	%	%	NN	_	13	nmod
17	-LRB-	-lrb-	-LRB-	_	19	punct
18	percentage	percentage	NN	_	19	compound
19	increase	increase	NN	_	16	dep
20	in	in	IN	_	23	case
21	free	free	JJ	_	23	amod
22	drug	drug	NN	_	23	compound
23	fraction	fraction	NN	_	19	nmod
24	-LSB-	-lsb-	-LRB-	_	25	punct
25	FDF	fdf	NN	_	19	appos
26	-RSB-	-rsb-	-RRB-	_	25	punct
27	,	,	,	_	19	punct
28	11.0	11.0	CD	_	29	nummod
29	%	%	NN	_	19	appos
30	-RRB-	-rrb-	-RRB-	_	19	punct
31	at	at	IN	_	33	case
32	662	662	CD	_	33	nummod
33	micromol/L	micromol/l	NN	_	4	nmod
34	and	and	CC	_	2	cc
35	by	by	IN	_	38	case
36	a	a	DT	_	38	det
37	net	net	JJ	_	38	amod
38	change	change	NN	_	2	conj
39	of	of	IN	_	41	case
40	7.1	7.1	CD	_	41	nummod
41	%	%	NN	_	38	nmod
42	-LRB-	-lrb-	-LRB-	_	44	punct
43	percentage	percentage	NN	_	44	compound
44	increase	increase	NN	_	41	dep
45	in	in	IN	_	46	case
46	FDF	FDF	NNP	_	44	nmod
47	,	,	,	_	44	punct
48	13.7	13.7	CD	_	49	nummod
49	%	%	NN	_	44	dep
50	-RRB-	-rrb-	-RRB-	_	44	punct
51	at	at	IN	_	53	case
52	1324	1324	CD	_	53	nummod
53	micromol/L	micromol/l	NN	_	38	nmod
54	.	.	.	_	2	punct

1	drug1	drug1	NN	_	2	nsubj
2	decreased	decrease	VBD	_	0	ROOT
3	the	the	DT	_	4	det
4	binding	binding	NN	_	2	dobj
5	of	of	IN	_	6	case
6	drug2	drug2	NN	_	4	nmod
7	by	by	IN	_	10	case
8	a	a	DT	_	10	det
9	net	net	JJ	_	10	amod
10	change	change	NN	_	4	nmod
11	of	of	IN	_	13	case
12	6.8	6.8	CD	_	13	nummod
13	%	%	NN	_	10	nmod
14	-LRB-	-lrb-	-LRB-	_	16	punct
15	percentage	percentage	NN	_	16	compound
16	increase	increase	NN	_	13	dep
17	in	in	IN	_	18	case
18	FDF	FDF	NNP	_	16	nmod
19	,	,	,	_	16	punct
20	8.8	8.8	CD	_	21	nummod
21	%	%	NN	_	16	dep
22	-RRB-	-rrb-	-RRB-	_	16	punct
23	at	at	IN	_	25	case
24	277.5	277.5	CD	_	25	nummod
25	micromol/L	micromol/l	NN	_	2	nmod
26	;	;	:	_	2	punct

1	drug1	drug1	NN	_	2	nsubj
2	reduced	reduce	VBD	_	0	ROOT
3	it	it	PRP	_	2	dobj
4	by	by	IN	_	7	case
5	a	a	DT	_	7	det
6	net	net	JJ	_	7	amod
7	change	change	NN	_	2	nmod
8	of	of	IN	_	10	case
9	6.6	6.6	CD	_	10	nummod
10	%	%	NN	_	7	nmod
11	-LRB-	-lrb-	-LRB-	_	13	punct
12	percentage	percentage	NN	_	13	compound
13	increase	increase	NN	_	10	dep
14	in	in	IN	_	15	case
15	FDF	FDF	NNP	_	13	nmod
16	,	,	,	_	13	punct
17	8.5	8.5	CD	_	18	nummod
18	%	%	NN	_	13	dep
19	-RRB-	-rrb-	-RRB-	_	13	punct
20	at	at	IN	_	22	case
21	431	431	CD	_	22	nummod
22	micromol/L	micromol/l	NN	_	2	nmod
23	.	.	.	_	2	punct

1	drug1	drug1	NN	_	2	nsubj
2	diminished	diminish	VBD	_	0	ROOT
3	binding	binding	NN	_	2	dobj
4	of	of	IN	_	5	case
5	drug2	drug2	NN	_	3	nmod
6	by	by	IN	_	9	case
7	a	a	DT	_	9	det
8	net	net	JJ	_	9	amod
9	change	change	NN	_	3	nmod
10	of	of	IN	_	12	case
11	9.9	9.9	CD	_	12	nummod
12	%	%	NN	_	9	nmod
13	-LRB-	-lrb-	-LRB-	_	15	punct
14	percentage	percentage	NN	_	15	compound
15	increase	increase	NN	_	12	dep
16	in	in	IN	_	17	case
17	FDF	FDF	NNP	_	15	nmod
18	,	,	,	_	15	punct
19	21.2	21.2	CD	_	20	nummod
20	%	%	NN	_	15	dep
21	-RRB-	-rrb-	-RRB-	_	15	punct
22	at	at	IN	_	24	case
23	1732	1732	CD	_	24	nummod
24	micromol/L	micromol/l	NN	_	3	nmod
25	.	.	.	_	2	punct

1	No	no	DT	_	3	neg
2	significant	significant	JJ	_	3	amod
3	effects	effect	NNS	_	5	nsubjpass
4	were	be	VBD	_	5	auxpass
5	noted	note	VBN	_	0	ROOT
6	with	with	IN	_	9	case
7	other	other	JJ	_	9	amod
8	drug	drug	NN	_	9	compound
9	combinations	combination	NNS	_	5	nmod
10	or	or	CC	_	9	cc
11	with	with	IN	_	13	case
12	the	the	DT	_	13	det
13	addition	addition	NN	_	9	conj
14	of	of	IN	_	15	case
15	drug1	drug1	NN	_	13	nmod
16	.	.	.	_	5	punct

1	Coingestion	coingestion	NN	_	20	nsubj
2	of	of	IN	_	3	case
3	drug1	drug1	NN	_	1	nmod
4	with	with	IN	_	5	case
5	drug2	drug2	NN	_	1	nmod
6	,	,	,	_	1	punct
7	drug3	drug3	NN	_	1	conj
8	with	with	IN	_	9	case
9	drug4	drug4	NN	_	7	nmod
10	,	,	,	_	1	punct
11	and	and	CC	_	1	cc
12	drug5	drug5	NN	_	1	conj
13	with	with	IN	_	14	case
14	drug6	drug6	NN	_	12	nmod
15	at	at	IN	_	16	case
16	high	high	JJ	_	1	nmod
17	to	to	TO	_	19	case
18	toxic	toxic	JJ	_	19	amod
19	concentrations	concentration	NNS	_	16	nmod
20	decreases	decrease	VBZ	_	0	ROOT
21	the	the	DT	_	22	det
22	binding	binding	NN	_	20	dobj
23	of	of	IN	_	26	case
24	the	the	DT	_	26	det
25	target	target	NN	_	26	compound
26	drug	drug	NN	_	22	nmod
27	.	.	.	_	20	punct

1	The	the	DT	_	3	det
2	resulting	result	VBG	_	3	amod
3	increase	increase	NN	_	9	nsubj
4	in	in	IN	_	7	case
5	free	free	JJ	_	7	amod
6	drug	drug	NN	_	7	compound
7	concentration	concentration	NN	_	3	nmod
8	may	may	MD	_	9	aux
9	lead	lead	VB	_	0	ROOT
10	to	to	TO	_	13	case
11	enhanced	enhance	VBN	_	13	amod
12	drug	drug	NN	_	13	compound
13	effect	effect	NN	_	9	nmod
14	in	in	FW	_	15	compound
15	vivo	vivo	FW	_	13	advmod
16	.	.	.	_	9	punct

1	Effect	effect	NN	_	0	ROOT
2	of	of	IN	_	3	case
3	drug1	drug1	NN	_	1	nmod
4	on	on	IN	_	6	case
5	the	the	DT	_	6	det
6	pharmacokinetics	pharmacokinetic	NNS	_	1	nmod
7	of	of	IN	_	8	case
8	drug2	drug2	NN	_	6	nmod
9	.	.	.	_	1	punct

1	The	the	DT	_	2	det
2	effect	effect	NN	_	12	nsubjpass
3	of	of	IN	_	4	case
4	drug1	drug1	NN	_	2	nmod
5	on	on	IN	_	8	case
6	the	the	DT	_	8	det
7	steady-state	steady-state	JJ	_	8	amod
8	pharmacokinetics	pharmacokinetic	NNS	_	2	nmod
9	of	of	IN	_	10	case
10	drug2	drug2	NN	_	8	nmod
11	was	be	VBD	_	12	auxpass
12	evaluated	evaluate	VBN	_	0	ROOT
13	in	in	IN	_	18	case
14	a	a	DT	_	18	det
15	randomized	randomize	VBN	_	18	amod
16	,	,	,	_	18	punct
17	double-blind	double-blind	JJ	_	18	amod
18	study	study	NN	_	12	nmod
19	.	.	.	_	12	punct

1	Five	five	CD	_	2	nummod
2	days	day	NNS	_	9	nsubj
3	of	of	IN	_	5	case
4	drug1	drug1	NN	_	5	compound
5	treatment	treatment	NN	_	2	nmod
6	did	do	VBD	_	9	aux
7	not	not	RB	_	9	neg
8	significantly	significantly	RB	_	9	advmod
9	affect	affect	VB	_	0	ROOT
10	steady-state	steady-state	JJ	_	12	amod
11	pharmacokinetic	pharmacokinetic	JJ	_	12	amod
12	variables	variable	NNS	_	9	dobj
13	of	of	IN	_	14	case
14	drug2	drug2	NN	_	12	nmod
15	compared	compare	VBN	_	17	case
16	with	with	IN	_	17	case
17	placebo	placebo	NN	_	9	advcl
18	;	;	:	_	9	punct

1	therefore	therefore	RB	_	9	advmod
2	,	,	,	_	9	punct
3	the	the	DT	_	4	det
4	use	use	NN	_	9	nsubj
5	of	of	IN	_	6	case
6	drug1	drug1	NN	_	4	nmod
7	does	do	VBZ	_	9	aux
8	not	not	RB	_	9	neg
9	necessitate	necessitate	VB	_	0	ROOT
10	an	a	DT	_	11	det
11	adjustment	adjustment	NN	_	9	dobj
12	in	in	IN	_	14	case
13	drug2	drug2	NN	_	14	compound
14	dose	dose	NN	_	11	nmod
15	to	to	TO	_	16	mark
16	maintain	maintain	VB	_	11	acl
17	therapeutic	therapeutic	JJ	_	19	amod
18	digoxin	digoxin	NN	_	19	compound
19	levels	level	NNS	_	16	dobj
20	.	.	.	_	9	punct

1	Acid-catalyzed	acid-catalyzed	JJ	_	2	amod
2	ethanolysis	ethanolysis	NN	_	0	ROOT
3	of	of	IN	_	4	case
4	drug1	drug1	NN	_	2	nmod
5	in	in	IN	_	10	case
6	anhydrous	anhydrous	JJ	_	10	amod
7	and	and	CC	_	6	cc
8	aqueous	aqueous	JJ	_	6	conj
9	drug2	drug2	NN	_	10	compound
10	solutions	solution	NNS	_	2	nmod
11	.	.	.	_	2	punct

1	The	the	DT	_	2	det
2	drug1	drug1	NN	_	5	nsubj
3	are	be	VBP	_	5	cop
4	a	a	DT	_	5	det
5	family	family	NN	_	0	ROOT
6	of	of	IN	_	7	case
7	drug2	drug2	NN	_	5	nmod
8	and	and	CC	_	7	cc
9	drug3	drug3	NN	_	7	conj
10	.	.	.	_	5	punct

1	When	when	WRB	_	2	advmod
2	taken	take	VBN	_	11	advcl
3	concurrently	concurrently	RB	_	2	advmod
4	with	with	IN	_	5	case
5	drug1	drug1	NN	_	2	nmod
6	,	,	,	_	11	punct
7	a	a	DT	_	9	det
8	pharmacological	pharmacological	JJ	_	9	amod
9	interaction	interaction	NN	_	11	nsubj
10	may	may	MD	_	11	aux
11	occur	occur	VB	_	0	ROOT
12	,	,	,	_	11	punct
13	potentiating	potentiate	VBG	_	11	xcomp
14	the	the	DT	_	18	det
15	central	central	JJ	_	18	amod
16	nervous	nervous	JJ	_	18	amod
17	system	system	NN	_	18	compound
18	depression	depression	NN	_	13	dobj
19	produced	produce	VBN	_	18	acl
20	by	by	IN	_	22	case
21	either	either	CC	_	22	det
22	drug	drug	NN	_	19	nmod
23	.	.	.	_	11	punct

1	In	in	IN	_	2	case
2	addition	addition	NN	_	10	nmod
3	to	to	TO	_	6	case
4	this	this	DT	_	6	det
5	pharmacological	pharmacological	JJ	_	6	amod
6	interaction	interaction	NN	_	2	nmod
7	,	,	,	_	10	punct
8	this	this	DT	_	9	det
9	report	report	NN	_	10	nsubj
10	describes	describe	VBZ	_	0	ROOT
11	a	a	DT	_	14	det
12	novel	novel	JJ	_	14	amod
13	chemical	chemical	NN	_	14	compound
14	reaction	reaction	NN	_	10	dobj
15	between	between	IN	_	16	case
16	drug1	drug1	NN	_	14	nmod
17	-LRB-	-lrb-	-LRB-	_	19	punct
18	a	a	DT	_	19	det
19	drug2	drug2	NN	_	16	appos
20	-RRB-	-rrb-	-RRB-	_	19	punct
21	and	and	CC	_	16	cc
22	drug3	drug3	NN	_	16	conj
23	under	under	IN	_	25	case
24	acidic	acidic	JJ	_	25	amod
25	conditions	condition	NNS	_	14	nmod
26	similar	similar	JJ	_	25	amod
27	to	to	TO	_	28	case
28	those	those	DT	_	26	nmod
29	found	find	VBN	_	28	acl
30	in	in	FW	_	31	compound
31	vivo	vivo	FW	_	29	advmod
32	,	,	,	_	10	punct
33	resulting	result	VBG	_	10	advcl
34	in	in	IN	_	37	case
35	a	a	DT	_	37	det
36	3-ethoxylated	3-ethoxylated	JJ	_	37	amod
37	product	product	NN	_	33	nmod
38	.	.	.	_	10	punct

1	Optimal	optimal	JJ	_	2	amod
2	conditions	condition	NNS	_	16	nsubjpass
3	,	,	,	_	2	punct
4	kinetics	kinetics	NNS	_	2	conj
5	,	,	,	_	2	punct
6	equilibrium	equilibrium	NN	_	2	conj
7	,	,	,	_	2	punct
8	and	and	CC	_	2	cc
9	the	the	DT	_	10	det
10	mechanism	mechanism	NN	_	2	conj
11	of	of	IN	_	14	case
12	this	this	DT	_	14	det
13	acid-catalyzed	acid-catalyzed	JJ	_	14	amod
14	ethanolysis	ethanolysis	NN	_	10	nmod
15	are	be	VBP	_	16	auxpass
16	reported	report	VBN	_	0	ROOT
17	.	.	.	_	16	punct

1	The	the	DT	_	2	det
2	results	result	NNS	_	3	nsubj
3	raise	raise	VBP	_	0	ROOT
4	the	the	DT	_	5	det
5	possibility	possibility	NN	_	3	dobj
6	that	that	IN	_	11	mark
7	the	the	DT	_	9	det
8	ethanolysis	ethanolysis	NN	_	9	compound
9	reaction	reaction	NN	_	11	nsubj
10	may	may	MD	_	11	aux
11	occur	occur	VB	_	5	ccomp
12	in	in	IN	_	14	case
13	the	the	DT	_	14	det
14	stomach	stomach	NN	_	11	nmod
15	of	of	IN	_	16	case
16	people	people	NNS	_	14	nmod
17	who	who	WP	_	18	nsubj
18	consume	consume	VBP	_	16	acl:relcl
19	drug1	drug1	NN	_	18	dobj
20	and	and	CC	_	19	cc
21	drug2	drug2	NN	_	19	conj
22	on	on	IN	_	25	case
23	a	a	DT	_	25	det
24	regular	regular	JJ	_	25	amod
25	basis	basis	NN	_	18	nmod
26	.	.	.	_	3	punct

1	The	the	DT	_	6	det
2	acid-catalyzed	acid-catalyzed	JJ	_	6	amod
3	drug1	drug1	NN	_	6	compound
4	-	-	:	_	6	punct
5	drug	drug	NN	_	6	compound
6	reaction	reaction	NN	_	11	nsubj
7	is	be	VBZ	_	11	cop
8	a	a	DT	_	11	det
9	relatively	relatively	RB	_	10	advmod
10	unexplored	unexplored	JJ	_	11	amod
11	area	area	NN	_	0	ROOT
12	and	and	CC	_	11	cc
13	may	may	MD	_	14	aux
14	alter	alter	VB	_	11	conj
15	the	the	DT	_	17	det
16	pharmacological	pharmacological	JJ	_	17	amod
17	action	action	NN	_	14	dobj
18	of	of	IN	_	20	case
19	some	some	DT	_	20	det
20	drugs	drug	NNS	_	17	nmod
21	.	.	.	_	11	punct

1	Inhibitory	inhibitory	JJ	_	2	amod
2	effects	effect	NNS	_	0	ROOT
3	of	of	IN	_	4	case
4	drug1	drug1	NN	_	2	nmod
5	on	on	IN	_	6	case
6	inositol	inositol	NN	_	2	nmod
7	1,4	1,4	CD	_	6	nummod
8	,	,	,	_	6	punct
9	5-trisphosphate-induced	5-trisphosphate-induced	JJ	_	10	amod
10	responses	response	NNS	_	6	appos
11	in	in	IN	_	13	case
12	rat	rat	NN	_	13	compound
13	megakaryocytes	megakaryocyte	NNS	_	10	nmod
14	.	.	.	_	2	punct

1	The	the	DT	_	2	det
2	effects	effect	NNS	_	0	ROOT
3	of	of	IN	_	4	case
4	drug1	drug1	NN	_	2	nmod
5	-LRB-	-lrb-	-LRB-	_	6	punct
6	drug2	drug2	NN	_	4	appos
7	-RRB-	-rrb-	-RRB-	_	6	punct
8	on	on	IN	_	17	case
9	drug3	drug3	NN	_	17	dep
10	-LRB-	-lrb-	-LRB-	_	11	punct
11	drug4	drug4	NN	_	9	appos
12	-RRB-	-rrb-	-RRB-	_	11	punct
13	-	-	:	_	17	punct
14	induced	induce	VBN	_	15	amod
15	responses	response	NNS	_	17	nsubjpass
16	were	be	VBD	_	17	auxpass
17	studied	study	VBN	_	2	acl
18	in	in	IN	_	22	case
19	rat	rat	NN	_	22	compound
20	bone	bone	NN	_	22	compound
21	marrow	marrow	NN	_	22	compound
22	megakaryocytes	megakaryocyte	NNS	_	17	nmod
23	with	with	IN	_	28	case
24	the	the	DT	_	28	det
25	patch-clamp	patch-clamp	JJ	_	28	amod
26	whole-cell	whole-cell	JJ	_	28	amod
27	recording	recording	NN	_	28	compound
28	technique	technique	NN	_	17	nmod
29	in	in	IN	_	30	case
30	combination	combination	NN	_	28	nmod
31	with	with	IN	_	33	case
32	fura-2	fura-2	NN	_	33	compound
33	microfluorometry	microfluorometry	NN	_	30	nmod
34	.	.	.	_	2	punct

1	Internal	internal	JJ	_	2	amod
2	application	application	NN	_	9	nsubj
3	of	of	IN	_	4	case
4	drug1	drug1	NN	_	2	nmod
5	-LRB-	-lrb-	-LRB-	_	7	punct
6	100	100	CD	_	7	nummod
7	microM	microm	NN	_	4	appos
8	-RRB-	-rrb-	-RRB-	_	7	punct
9	increased	increase	VBN	_	0	ROOT
10	intracellular	intracellular	JJ	_	11	amod
11	Ca	ca	NN	_	9	dobj
12	-LRB-	-lrb-	-LRB-	_	16	punct
13	2	2	CD	_	16	nummod
14	+	+	CC	_	13	cc
15	-RRB-	-rrb-	-RRB-	_	16	punct
16	concentration	concentration	NN	_	11	dep
17	-LRB-	-lrb-	-LRB-	_	19	punct
18	-LSB-	-lsb-	-LRB-	_	19	punct
19	Ca	ca	NN	_	16	dep
20	-LRB-	-lrb-	-LRB-	_	19	punct
21	2	2	CD	_	19	nummod
22	+	+	CC	_	19	dep
23	-RRB-	-rrb-	-RRB-	_	19	punct
24	-RSB-	-rsb-	-RRB-	_	16	punct
25	-LRB-	-lrb-	-LRB-	_	26	punct
26	i	i	LS	_	11	dep
27	-RRB-	-rrb-	-RRB-	_	26	punct
28	-RRB-	-rrb-	-RRB-	_	9	punct
29	and	and	CC	_	9	cc
30	activated	activate	VBD	_	9	conj
31	the	the	DT	_	32	det
32	Ca	ca	NN	_	30	dobj
33	-LRB-	-lrb-	-LRB-	_	35	punct
34	2	2	CD	_	35	nummod
35	+	+	CC	_	32	dep
36	-RRB-	-rrb-	-RRB-	_	35	punct
37	-	-	:	_	32	punct
38	dependent	dependent	JJ	_	39	amod
39	K	k	NN	_	32	dep
40	-LRB-	-lrb-	-LRB-	_	41	punct
41	+	+	CC	_	39	appos
42	-RRB-	-rrb-	-RRB-	_	41	punct
43	current	current	JJ	_	39	amod
44	.	.	.	_	9	punct

1	Administering	administer	VBG	_	10	nsubj
2	drug1	drug1	NN	_	1	dobj
3	together	together	RB	_	1	advmod
4	with	with	IN	_	5	case
5	drug2	drug2	NN	_	1	nmod
6	-LRB-	-lrb-	-LRB-	_	8	punct
7	100-500	100-500	CD	_	8	nummod
8	microM	microm	NN	_	5	appos
9	-RRB-	-rrb-	-RRB-	_	8	punct
10	inhibited	inhibit	VBD	_	0	ROOT
11	InsP	insp	NN	_	10	dobj
12	-LRB-	-lrb-	-LRB-	_	13	punct
13	3	3	CD	_	11	appos
14	-RRB-	-rrb-	-RRB-	_	13	punct
15	-	-	:	_	11	punct
16	induced	induce	VBN	_	17	amod
17	responses	response	NNS	_	11	dep
18	-LRB-	-lrb-	-LRB-	_	20	punct
19	both	both	CC	_	20	cc:preconj
20	Ca	ca	NN	_	17	dep
21	-LRB-	-lrb-	-LRB-	_	23	punct
22	2	2	CD	_	23	nummod
23	+	+	CC	_	20	dep
24	-RRB-	-rrb-	-RRB-	_	23	punct
25	and	and	CC	_	20	cc
26	current	current	JJ	_	27	amod
27	responses	response	NNS	_	20	conj
28	-RRB-	-rrb-	-RRB-	_	20	punct
29	in	in	IN	_	32	case
30	a	a	DT	_	32	det
31	dose-dependent	dose-dependent	JJ	_	32	amod
32	fashion	fashion	NN	_	17	nmod
33	.	.	.	_	10	punct

1	Pretreatment	pretreatment	NN	_	12	nsubj
2	of	of	IN	_	3	case
3	megakaryocytes	megakaryocyte	NNS	_	1	nmod
4	with	with	IN	_	6	case
5	extracellular	extracellular	JJ	_	6	amod
6	drug1	drug1	NN	_	1	nmod
7	-LRB-	-lrb-	-LRB-	_	9	punct
8	50	50	CD	_	9	nummod
9	microM	microm	NN	_	6	appos
10	-RRB-	-rrb-	-RRB-	_	9	punct
11	also	also	RB	_	12	advmod
12	inhibited	inhibit	VBD	_	0	ROOT
13	drug2	drug2	NN	_	12	dobj
14	-	-	:	_	13	punct
15	induced	induce	VBN	_	16	amod
16	responses	response	NNS	_	13	dep
17	.	.	.	_	12	punct

1	Intracellular	intracellular	JJ	_	7	nsubj
2	and	and	CC	_	1	cc
3	extracellular	extracellular	JJ	_	1	conj
4	application	application	NN	_	1	dep
5	of	of	IN	_	6	case
6	drug1	drug1	NN	_	1	nmod
7	reduced	reduce	VBD	_	0	ROOT
8	ADP-induced	adp-induced	JJ	_	9	amod
9	increases	increase	NNS	_	7	dobj
10	in	in	IN	_	12	case
11	-LSB-	-lsb-	-LRB-	_	12	punct
12	Ca	ca	NN	_	9	nmod
13	-LRB-	-lrb-	-LRB-	_	15	punct
14	2	2	CD	_	15	nummod
15	+	+	CC	_	12	dep
16	-RRB-	-rrb-	-RRB-	_	15	punct
17	-RSB-	-rsb-	-RRB-	_	12	punct
18	-LRB-	-lrb-	-LRB-	_	19	punct
19	i	i	LS	_	12	dep
20	-RRB-	-rrb-	-RRB-	_	19	punct
21	.	.	.	_	7	punct

1	In	in	IN	_	2	case
2	contrast	contrast	NN	_	12	nmod
3	,	,	,	_	12	punct
4	in	in	IN	_	9	case
5	isolated	isolate	VBN	_	9	amod
6	single	single	JJ	_	9	amod
7	pancreatic	pancreatic	JJ	_	9	amod
8	acinar	acinar	JJ	_	9	amod
9	cells	cell	NNS	_	12	nmod
10	,	,	,	_	12	punct
11	drug1	drug1	NN	_	12	nsubj
12	had	have	VBD	_	0	ROOT
13	no	no	DT	_	14	neg
14	effect	effect	NN	_	12	dobj
15	on	on	IN	_	16	case
16	drug2	drug2	NN	_	12	nmod
17	-	-	:	_	16	punct
18	induced	induce	VBN	_	19	amod
19	responses	response	NNS	_	16	dep
20	.	.	.	_	12	punct

1	Taken	take	VBN	_	6	advcl
2	together	together	RB	_	1	advmod
3	,	,	,	_	6	punct
4	these	these	DT	_	5	det
5	results	result	NNS	_	6	nsubj
6	suggest	suggest	VBP	_	0	ROOT
7	that	that	IN	_	23	mark
8	the	the	DT	_	9	det
9	site	site	NN	_	23	nsubj
10	of	of	IN	_	13	case
11	the	the	DT	_	13	det
12	inhibitory	inhibitory	JJ	_	13	amod
13	action	action	NN	_	9	nmod
14	of	of	IN	_	15	case
15	drug1	drug1	NN	_	13	nmod
16	is	be	VBZ	_	23	cop
17	at	at	IN	_	23	case
18	the	the	DT	_	23	det
19	InsP	insp	NN	_	23	compound
20	-LRB-	-lrb-	-LRB-	_	23	punct
21	3	3	CD	_	23	nummod
22	-RRB-	-rrb-	-RRB-	_	23	punct
23	receptor	receptor	NN	_	6	ccomp
24	,	,	,	_	23	punct
25	or	or	CC	_	23	cc
26	its	its	PRP$	_	29	nmod:poss
27	closely	closely	RB	_	28	advmod
28	associated	associated	JJ	_	29	amod
29	proteins	protein	NNS	_	23	conj
30	.	.	.	_	6	punct

1	In	in	IN	_	2	case
2	addition	addition	NN	_	6	nmod
3	,	,	,	_	6	punct
4	we	we	PRP	_	6	nsubj
5	have	have	VBP	_	6	aux
6	shown	show	VBN	_	0	ROOT
7	that	that	IN	_	13	mark
8	drug1	drug1	NN	_	13	nsubj
9	is	be	VBZ	_	13	cop
10	a	a	DT	_	13	det
11	useful	useful	JJ	_	13	amod
12	pharmacological	pharmacological	JJ	_	13	amod
13	tool	tool	NN	_	6	ccomp
14	with	with	IN	_	15	case
15	which	which	WDT	_	17	nmod
16	to	to	TO	_	17	mark
17	examine	examine	VB	_	13	acl:relcl
18	the	the	DT	_	19	det
19	drug2	drug2	NN	_	17	dobj
20	-	-	:	_	19	punct
21	mediated	mediated	JJ	_	22	amod
22	responses	response	NNS	_	19	dep
23	of	of	IN	_	24	case
24	megakaryocytes	megakaryocyte	NNS	_	22	nmod
25	.	.	.	_	6	punct

1	Concomitant	concomitant	JJ	_	2	amod
2	drug1	drug1	NN	_	0	ROOT
3	,	,	,	_	2	punct
4	drug2	drug2	NN	_	2	conj
5	,	,	,	_	2	punct
6	drug3	drug3	NN	_	2	conj
7	,	,	,	_	2	punct
8	and	and	CC	_	2	cc
9	drug4	drug4	NN	_	10	compound
10	chemotherapy	chemotherapy	NN	_	2	conj
11	plus	plus	CC	_	10	cc
12	drug5	drug5	NN	_	13	compound
13	therapy	therapy	NN	_	10	conj
14	in	in	IN	_	15	case
15	patients	patient	NNS	_	2	nmod
16	with	with	IN	_	19	case
17	human	human	JJ	_	19	amod
18	immunodeficiency	immunodeficiency	NN	_	19	nmod:npmod
19	virus-related	virus-related	JJ	_	15	nmod
20	,	,	,	_	15	punct
21	non-Hodgkin	non-hodgkin	JJ	_	22	amod
22	lymphoma	lymphoma	NN	_	15	appos
23	.	.	.	_	2	punct

1	BACKGROUND	background	NN	_	0	ROOT
2	:	:	:	_	1	punct
3	The	the	DT	_	4	det
4	feasibility	feasibility	NN	_	18	nsubj
5	and	and	CC	_	4	cc
6	efficacy	efficacy	NN	_	4	conj
7	of	of	IN	_	9	case
8	concomitant	concomitant	JJ	_	9	amod
9	chemotherapy	chemotherapy	NN	_	4	nmod
10	and	and	CC	_	9	cc
11	drug1	drug1	NN	_	12	compound
12	therapy	therapy	NN	_	9	conj
13	-LRB-	-lrb-	-LRB-	_	14	punct
14	HAART	haart	NN	_	12	appos
15	-RRB-	-rrb-	-RRB-	_	14	punct
16	is	be	VBZ	_	18	cop
17	still	still	RB	_	18	advmod
18	unknown	unknown	JJ	_	1	dep
19	in	in	IN	_	20	case
20	patients	patient	NNS	_	18	nmod
21	with	with	IN	_	24	case
22	human	human	JJ	_	24	amod
23	immunodeficiency	immunodeficiency	NN	_	24	compound
24	virus	virus	NN	_	20	nmod
25	-LRB-	-lrb-	-LRB-	_	26	punct
26	HIV	hiv	NN	_	24	appos
27	-RRB-	-rrb-	-RRB-	_	26	punct
28	-	-	:	_	18	punct
29	related	related	JJ	_	30	amod
30	malignancies	malignancy	NNS	_	18	dep
31	.	.	.	_	1	punct

1	To	to	TO	_	2	mark
2	evaluate	evaluate	VB	_	0	ROOT
3	the	the	DT	_	4	det
4	impact	impact	NN	_	2	dobj
5	of	of	IN	_	6	case
6	chemotherapy	chemotherapy	NN	_	4	nmod
7	plus	plus	CC	_	6	cc
8	HAART	haart	NN	_	6	conj
9	on	on	IN	_	12	case
10	the	the	DT	_	12	det
11	clinical	clinical	JJ	_	12	amod
12	course	course	NN	_	4	nmod
13	of	of	IN	_	14	case
14	patients	patient	NNS	_	12	nmod
15	with	with	IN	_	16	case
16	HIV-related	hiv-related	JJ	_	14	nmod
17	,	,	,	_	16	punct
18	systemic	systemic	JJ	_	16	conj
19	,	,	,	_	16	punct
20	non-Hodgkin	non-hodgkin	JJ	_	21	amod
21	lymphoma	lymphoma	NN	_	16	conj
22	-LRB-	-lrb-	-LRB-	_	23	punct
23	HIV-NHL	hiv-nhl	NN	_	21	appos
24	-RRB-	-rrb-	-RRB-	_	23	punct
25	,	,	,	_	16	punct
26	the	the	DT	_	27	det
27	authors	author	NNS	_	16	appos
28	compared	compare	VBN	_	27	acl
29	retrospectively	retrospectively	RB	_	28	advmod
30	a	a	DT	_	31	det
31	group	group	NN	_	29	dep
32	of	of	IN	_	34	case
33	24	24	CD	_	34	nummod
34	patients	patient	NNS	_	31	nmod
35	with	with	IN	_	36	case
36	HIV-NHL	hiv-nhl	NN	_	34	nmod
37	who	who	WP	_	39	nsubjpass
38	were	be	VBD	_	39	auxpass
39	treated	treat	VBN	_	34	acl:relcl
40	with	with	IN	_	42	case
41	the	the	DT	_	42	det
42	drug1	drug1	NN	_	39	nmod
43	,	,	,	_	42	punct
44	drug2	drug2	NN	_	42	conj
45	,	,	,	_	42	punct
46	drug3	drug3	NN	_	42	conj
47	,	,	,	_	42	punct
48	and	and	CC	_	42	cc
49	drug4	drug4	NN	_	54	compound
50	-LRB-	-lrb-	-LRB-	_	51	punct
51	CHOP	chop	NN	_	49	appos
52	-RRB-	-rrb-	-RRB-	_	51	punct
53	chemotherapy	chemotherapy	NN	_	54	compound
54	regimen	regimen	NN	_	42	conj
55	plus	plus	CC	_	54	cc
56	HAART	haart	NN	_	54	conj
57	with	with	IN	_	59	case
58	a	a	DT	_	59	det
59	group	group	NN	_	54	nmod
60	of	of	IN	_	62	case
61	80	80	CD	_	62	nummod
62	patients	patient	NNS	_	59	nmod
63	who	who	WP	_	65	nsubjpass
64	were	be	VBD	_	65	auxpass
65	treated	treat	VBN	_	62	acl:relcl
66	with	with	IN	_	68	case
67	CHOP	chop	NN	_	68	compound
68	chemotherapy	chemotherapy	NN	_	65	nmod
69	or	or	CC	_	68	cc
70	a	a	DT	_	72	det
71	CHOP-like	chop-like	JJ	_	72	amod
72	regimen	regimen	NN	_	68	conj
73	-LRB-	-lrb-	-LRB-	_	76	punct
74	i.e.	i.e.	FW	_	76	dep
75	,	,	,	_	76	punct
76	drug5	drug5	NN	_	72	dep
77	,	,	,	_	76	punct
78	drug6	drug6	NN	_	76	conj
79	,	,	,	_	76	punct
80	drug7	drug7	NN	_	76	conj
81	,	,	,	_	76	punct
82	and	and	CC	_	76	cc
83	drug8	drug8	NN	_	76	conj
84	with	with	IN	_	85	case
85	drug9	drug9	NN	_	83	nmod
86	plus	plus	CC	_	85	cc
87	drug10	drug10	NN	_	85	conj
88	-RRB-	-rrb-	-RRB-	_	76	punct
89	without	without	IN	_	90	mark
90	receiving	receive	VBG	_	65	advcl
91	drug11	drug11	NN	_	92	compound
92	therapy	therapy	NN	_	90	dobj
93	.	.	.	_	2	punct

1	METHODS	method	NNS	_	0	ROOT
2	:	:	:	_	1	punct
3	All	all	DT	_	4	det
4	patients	patient	NNS	_	6	nsubjpass
5	were	be	VBD	_	6	auxpass
6	enrolled	enrol	VBN	_	1	appos
7	in	in	IN	_	10	case
8	two	two	CD	_	10	nummod
9	sequential	sequential	JJ	_	10	amod
10	trials	trial	NNS	_	6	nmod
11	performed	perform	VBN	_	10	acl
12	at	at	IN	_	16	case
13	the	the	DT	_	16	det
14	Aviano	Aviano	NNP	_	16	compound
15	Cancer	Cancer	NNP	_	16	compound
16	Center	Center	NNP	_	11	nmod
17	,	,	,	_	16	punct
18	Italy	Italy	NNP	_	16	appos
19	,	,	,	_	16	punct
20	from	from	IN	_	21	case
21	April	April	NNP	_	6	nmod
22	1988	1988	CD	_	21	nummod
23	to	to	TO	_	24	case
24	December	December	NNP	_	21	nmod
25	1998	1998	CD	_	24	nummod
26	.	.	.	_	1	punct

1	HAART	HAART	NNP	_	3	nsubjpass
2	was	be	VBD	_	3	auxpass
3	included	include	VBN	_	0	ROOT
4	with	with	IN	_	6	case
5	combination	combination	NN	_	6	compound
6	therapy	therapy	NN	_	3	nmod
7	from	from	IN	_	8	case
8	January	January	NNP	_	6	nmod
9	1997	1997	CD	_	8	nummod
10	.	.	.	_	3	punct

1	drug1	drug1	NN	_	2	compound
2	regimens	regimen	NNS	_	3	nsubj
3	consisted	consist	VBD	_	0	ROOT
4	of	of	IN	_	6	case
5	two	two	CD	_	6	nummod
6	drug2	drug2	NN	_	3	nmod
7	and	and	CC	_	6	cc
8	one	one	CD	_	9	nummod
9	drug3	drug3	NN	_	6	conj
10	.	.	.	_	3	punct

1	RESULTS	result	NNS	_	0	ROOT
2	:	:	:	_	1	punct
3	The	the	DT	_	6	det
4	two	two	CD	_	6	nummod
5	treatment	treatment	NN	_	6	compound
6	groups	group	NNS	_	9	nsubjpass
7	were	be	VBD	_	9	auxpass
8	well	well	RB	_	9	advmod
9	matched	match	VBN	_	1	appos
10	with	with	IN	_	11	case
11	regard	regard	NN	_	9	nmod
12	to	to	TO	_	14	case
13	patient	patient	NN	_	14	compound
14	demographics	demographic	NNS	_	11	nmod
15	,	,	,	_	14	punct
16	NHL	nhl	NN	_	17	compound
17	characteristics	characteristic	NNS	_	14	conj
18	,	,	,	_	14	punct
19	HIV	hiv	NN	_	20	compound
20	status	status	NN	_	14	conj
21	,	,	,	_	14	punct
22	and	and	CC	_	14	cc
23	treatment	treatment	NN	_	14	conj
24	,	,	,	_	23	punct
25	i.e.	i.e.	FW	_	23	dep
26	,	,	,	_	23	punct
27	the	the	DT	_	28	det
28	number	number	NN	_	23	appos
29	of	of	IN	_	30	case
30	cycles	cycle	NNS	_	28	nmod
31	and	and	CC	_	30	cc
32	chemotherapy	chemotherapy	NN	_	33	compound
33	dose	dose	NN	_	30	conj
34	.	.	.	_	1	punct

1	The	the	DT	_	3	det
2	response	response	NN	_	3	compound
3	rates	rate	NNS	_	5	nsubj
4	were	be	VBD	_	5	cop
5	similar	similar	JJ	_	0	ROOT
6	between	between	IN	_	9	case
7	the	the	DT	_	9	det
8	two	two	CD	_	9	nummod
9	groups	group	NNS	_	5	nmod
10	.	.	.	_	5	punct

1	Severe	severe	JJ	_	2	amod
2	anemia	anemia	NN	_	16	nsubj
3	-LRB-	-lrb-	-LRB-	_	4	punct
4	Grade	Grade	NNP	_	2	appos
5	3-4	3-4	CD	_	4	nummod
6	according	accord	VBG	_	12	case
7	to	to	TO	_	6	mwe
8	the	the	DT	_	12	det
9	World	World	NNP	_	12	compound
10	Health	Health	NNP	_	12	compound
11	Organization	Organization	NNP	_	12	compound
12	criteria	criterion	NNS	_	4	nmod
13	-RRB-	-rrb-	-RRB-	_	4	punct
14	was	be	VBD	_	16	cop
15	significantly	significantly	RB	_	16	advmod
16	greater	greater	JJR	_	0	ROOT
17	in	in	IN	_	19	case
18	the	the	DT	_	19	det
19	patients	patient	NNS	_	16	nmod
20	who	who	WP	_	21	nsubj
21	received	receive	VBD	_	19	acl:relcl
22	CHOP-HAART	CHOP-HAART	NNP	_	21	dobj
23	compared	compare	VBN	_	26	case
24	with	with	IN	_	26	case
25	the	the	DT	_	26	det
26	patients	patient	NNS	_	16	advcl
27	who	who	WP	_	28	nsubj
28	received	receive	VBD	_	26	acl:relcl
29	CHOP	chop	NN	_	28	dobj
30	alone	alone	RB	_	28	advmod
31	-LRB-	-lrb-	-LRB-	_	41	punct
32	33	33	CD	_	33	nummod
33	%	%	NN	_	41	dep
34	vs.	vs.	CC	_	33	cc
35	7	7	CD	_	36	nummod
36	%	%	NN	_	33	conj
37	,	,	,	_	33	punct
38	respectively	respectively	RB	_	33	advmod
39	;	;	:	_	41	punct
40	P	p	NN	_	41	nsubj
41	=	=	JJ	_	26	dep
42	0.001	0.001	CD	_	41	dobj
43	-RRB-	-rrb-	-RRB-	_	41	punct
44	.	.	.	_	16	punct

1	Leukopenia	leukopenia	NN	_	3	nsubj
2	was	be	VBD	_	3	cop
3	similar	similar	JJ	_	0	ROOT
4	between	between	IN	_	7	case
5	the	the	DT	_	7	det
6	two	two	CD	_	7	nummod
7	groups	group	NNS	_	3	nmod
8	,	,	,	_	3	punct
9	but	but	CC	_	3	cc
10	colony	colony	NN	_	13	compound
11	stimulating	stimulating	NN	_	13	compound
12	factor	factor	NN	_	13	compound
13	support	support	NN	_	16	nsubj
14	was	be	VBD	_	16	cop
15	significantly	significantly	RB	_	16	advmod
16	greater	greater	JJR	_	3	conj
17	in	in	IN	_	20	case
18	the	the	DT	_	20	det
19	CHOP-HAART	CHOP-HAART	NNP	_	20	compound
20	group	group	NN	_	16	nmod
21	than	than	IN	_	25	case
22	in	in	IN	_	25	case
23	the	the	DT	_	25	det
24	control	control	NN	_	25	compound
25	group	group	NN	_	16	nmod
26	-LRB-	-lrb-	-LRB-	_	36	punct
27	92	92	CD	_	28	nummod
28	%	%	NN	_	36	dep
29	vs.	vs.	CC	_	28	cc
30	66	66	CD	_	31	nummod
31	%	%	NN	_	28	conj
32	,	,	,	_	28	punct
33	respectively	respectively	RB	_	28	advmod
34	;	;	:	_	36	punct
35	P	p	NN	_	36	nsubj
36	=	=	JJ	_	16	parataxis
37	0.03	0.03	CD	_	36	dobj
38	-RRB-	-rrb-	-RRB-	_	36	punct
39	.	.	.	_	3	punct

1	Seventeen	seventeen	CD	_	2	nummod
2	percent	percent	NN	_	6	nsubj
3	of	of	IN	_	5	case
4	CHOP-HAART	chop-haart	NN	_	5	compound
5	patients	patient	NNS	_	2	nmod
6	developed	develop	VBD	_	0	ROOT
7	severe	severe	JJ	_	9	amod
8	autonomic	autonomic	JJ	_	9	amod
9	neurotoxicity	neurotoxicity	NN	_	6	dobj
10	,	,	,	_	6	punct
11	whereas	whereas	IN	_	6	dep
12	none	none	NN	_	17	nsubj
13	of	of	IN	_	16	case
14	the	the	DT	_	16	det
15	CHOP	chop	NN	_	16	compound
16	patients	patient	NNS	_	12	nmod
17	developed	develop	VBD	_	6	parataxis
18	neurotoxicity	neurotoxicity	NN	_	17	dobj
19	-LRB-	-lrb-	-LRB-	_	21	punct
20	P	p	NN	_	21	nsubj
21	=	=	JJ	_	18	dep
22	0.002	0.002	CD	_	21	dobj
23	-RRB-	-rrb-	-RRB-	_	21	punct
24	.	.	.	_	6	punct

1	At	at	IN	_	4	case
2	similar	similar	JJ	_	4	amod
3	median	median	JJ	_	4	amod
4	follow-up	follow-up	NN	_	16	nmod
5	,	,	,	_	16	punct
6	opportunistic	opportunistic	JJ	_	7	amod
7	infection	infection	NN	_	11	compound
8	-LRB-	-lrb-	-LRB-	_	9	punct
9	OI	oi	NN	_	7	appos
10	-RRB-	-rrb-	-RRB-	_	9	punct
11	rates	rate	NNS	_	16	nsubj
12	and	and	CC	_	11	cc
13	mortality	mortality	NN	_	11	conj
14	were	be	VBD	_	16	cop
15	significantly	significantly	RB	_	16	advmod
16	lower	lower	JJR	_	0	ROOT
17	in	in	IN	_	20	case
18	the	the	DT	_	20	det
19	CHOP-HAART	chop-haart	NN	_	20	compound
20	patients	patient	NNS	_	16	nmod
21	than	than	IN	_	25	case
22	in	in	IN	_	25	case
23	the	the	DT	_	25	det
24	CHOP	chop	NN	_	25	compound
25	patients	patient	NNS	_	16	advcl
26	-LRB-	-lrb-	-LRB-	_	36	punct
27	18	18	CD	_	28	nummod
28	%	%	NN	_	36	dep
29	vs.	vs.	CC	_	28	cc
30	52	52	CD	_	31	nummod
31	%	%	NN	_	28	conj
32	,	,	,	_	28	punct
33	respectively	respectively	RB	_	28	advmod
34	;	;	:	_	36	punct
35	P	p	NN	_	36	nsubj
36	=	=	JJ	_	25	dep
37	0.05	0.05	CD	_	36	dobj
38	;	;	:	_	36	punct
39	and	and	CC	_	36	cc
40	38	38	CD	_	41	nummod
41	%	%	NN	_	36	conj
42	vs.	vs.	CC	_	41	cc
43	85	85	CD	_	44	nummod
44	%	%	NN	_	41	conj
45	,	,	,	_	36	punct
46	respectively	respectively	RB	_	36	advmod
47	;	;	:	_	36	punct
48	P	p	NN	_	49	nsubj
49	=	=	JJ	_	36	parataxis
50	0.001	0.001	CD	_	49	dobj
51	-RRB-	-rrb-	-RRB-	_	36	punct
52	.	.	.	_	16	punct

1	The	the	DT	_	3	det
2	median	median	JJ	_	3	amod
3	survival	survival	NN	_	9	nsubjpass
4	for	for	IN	_	6	case
5	CHOP-HAART	chop-haart	NN	_	6	compound
6	patients	patient	NNS	_	3	nmod
7	was	be	VBD	_	9	auxpass
8	not	not	RB	_	9	neg
9	reached	reach	VBN	_	0	ROOT
10	,	,	,	_	9	punct
11	whereas	whereas	IN	_	9	dep
12	the	the	DT	_	14	det
13	medial	medial	JJ	_	14	amod
14	survival	survival	NN	_	20	nsubj
15	of	of	IN	_	17	case
16	CHOP	chop	NN	_	17	compound
17	patients	patient	NNS	_	14	nmod
18	was	be	VBD	_	20	cop
19	7	7	CD	_	20	nummod
20	months	month	NNS	_	9	parataxis
21	-LRB-	-lrb-	-LRB-	_	23	punct
22	P	p	NN	_	23	nsubj
23	=	=	JJ	_	20	parataxis
24	0.03	0.03	CD	_	23	dobj
25	-RRB-	-rrb-	-RRB-	_	23	punct
26	.	.	.	_	9	punct

1	CONCLUSIONS	conclusion	NNS	_	0	ROOT
2	:	:	:	_	1	punct
3	The	the	DT	_	4	det
4	combination	combination	NN	_	10	nsubj
5	of	of	IN	_	6	case
6	CHOP	chop	NN	_	4	nmod
7	plus	plus	CC	_	6	cc
8	HAART	haart	NN	_	6	conj
9	is	be	VBZ	_	10	cop
10	feasible	feasible	JJ	_	1	dep
11	and	and	CC	_	10	cc
12	may	may	MD	_	13	aux
13	reduce	reduce	VB	_	10	conj
14	the	the	DT	_	15	det
15	morbidity	morbidity	NN	_	13	dobj
16	from	from	IN	_	17	case
17	OIs	oi	NNS	_	15	nmod
18	in	in	IN	_	20	case
19	HIV-NHL	hiv-nhl	NN	_	20	compound
20	patients	patient	NNS	_	17	nmod
21	.	.	.	_	1	punct

1	However	however	RB	_	7	advmod
2	,	,	,	_	7	punct
3	careful	careful	JJ	_	4	amod
4	attention	attention	NN	_	7	nsubjpass
5	must	must	MD	_	7	aux
6	be	be	VB	_	7	auxpass
7	directed	direct	VBN	_	0	ROOT
8	to	to	TO	_	9	mark
9	cross	cross	VB	_	7	xcomp
10	toxicity	toxicity	NN	_	9	dobj
11	and	and	CC	_	10	cc
12	possible	possible	JJ	_	14	amod
13	pharmacokinetic	pharmacokinetic	JJ	_	14	amod
14	interactions	interaction	NNS	_	10	conj
15	between	between	IN	_	16	case
16	drug1	drug1	NN	_	9	nmod
17	and	and	CC	_	16	cc
18	drug2	drug2	NN	_	16	conj
19	.	.	.	_	7	punct

1	The	the	DT	_	2	det
2	impact	impact	NN	_	13	nsubj
3	of	of	IN	_	6	case
4	the	the	DT	_	6	det
5	combined	combined	JJ	_	6	amod
6	chemotherapy	chemotherapy	NN	_	2	nmod
7	plus	plus	CC	_	6	cc
8	HAART	haart	NN	_	9	compound
9	treatment	treatment	NN	_	6	conj
10	on	on	IN	_	12	case
11	patient	patient	NN	_	12	compound
12	survival	survival	NN	_	2	nmod
13	needs	need	VBZ	_	0	ROOT
14	urgently	urgently	RB	_	13	advmod
15	to	to	TO	_	17	mark
16	be	be	VB	_	17	auxpass
17	evaluated	evaluate	VBN	_	13	xcomp
18	in	in	IN	_	20	case
19	prospective	prospective	JJ	_	20	amod
20	studies	study	NNS	_	17	nmod
21	.	.	.	_	13	punct

1	drug1	drug1	NN	_	0	ROOT
2	and	and	CC	_	1	cc
3	drug2	drug2	NN	_	1	conj
4	:	:	:	_	1	punct
5	a	a	DT	_	7	det
6	drug	drug	NN	_	7	compound
7	interaction	interaction	NN	_	1	dep
8	.	.	.	_	1	punct

1	The	the	DT	_	3	det
2	drug	drug	NN	_	3	compound
3	interaction	interaction	NN	_	11	nsubjpass
4	between	between	IN	_	5	case
5	drug1	drug1	NN	_	3	nmod
6	and	and	CC	_	5	cc
7	drug2	drug2	NN	_	5	conj
8	is	be	VBZ	_	11	auxpass
9	not	not	RB	_	11	neg
10	well	well	RB	_	11	advmod
11	known	know	VBN	_	0	ROOT
12	.	.	.	_	11	punct

1	drug1	drug1	NN	_	4	nsubjpass
2	has	have	VBZ	_	4	aux
3	been	be	VBN	_	4	auxpass
4	reported	report	VBN	_	0	ROOT
5	to	to	TO	_	6	mark
6	increase	increase	VB	_	4	xcomp
7	the	the	DT	_	9	det
8	drug2	drug2	NN	_	9	compound
9	requirements	requirement	NNS	_	6	dobj
10	in	in	IN	_	12	case
11	human	human	JJ	_	12	amod
12	subjects	subject	NNS	_	9	nmod
13	ingesting	ingest	VBG	_	12	acl
14	these	these	DT	_	15	det
15	agents	agent	NNS	_	13	dobj
16	simultaneously	simultaneously	RB	_	13	advmod
17	.	.	.	_	4	punct

1	The	the	DT	_	3	det
2	concomitant	concomitant	JJ	_	3	amod
3	administration	administration	NN	_	8	nsubj
4	of	of	IN	_	5	case
5	drug1	drug1	NN	_	3	nmod
6	and	and	CC	_	5	cc
7	drug2	drug2	NN	_	5	conj
8	resulted	result	VBD	_	0	ROOT
9	in	in	IN	_	11	case
10	the	the	DT	_	11	det
11	need	need	NN	_	8	nmod
12	for	for	IN	_	17	case
13	an	a	DT	_	17	det
14	unusually	unusually	RB	_	15	advmod
15	high	high	JJ	_	17	amod
16	maintenance	maintenance	NN	_	17	compound
17	dose	dose	NN	_	11	nmod
18	of	of	IN	_	19	case
19	drug3	drug3	NN	_	17	nmod
20	-LRB-	-lrb-	-LRB-	_	22	punct
21	20	20	CD	_	22	nummod
22	mg	mg	NN	_	17	dep
23	per	per	IN	_	24	case
24	day	day	NN	_	22	nmod
25	-RRB-	-rrb-	-RRB-	_	22	punct
26	in	in	IN	_	29	mark
27	order	order	NN	_	26	mwe
28	to	to	TO	_	29	mark
29	produce	produce	VB	_	11	acl
30	a	a	DT	_	32	det
31	therapeutic	therapeutic	JJ	_	32	amod
32	effect	effect	NN	_	29	dobj
33	.	.	.	_	8	punct

1	Withdrawal	withdrawal	NN	_	4	nsubj
2	of	of	IN	_	3	case
3	drug1	drug1	NN	_	1	nmod
4	decreased	decrease	VBD	_	0	ROOT
5	the	the	DT	_	7	det
6	drug2	drug2	NN	_	7	compound
7	requirement	requirement	NN	_	4	dobj
8	by	by	IN	_	10	case
9	50	50	CD	_	10	nummod
10	%	%	NN	_	4	nmod
11	.	.	.	_	4	punct

1	This	this	DT	_	2	det
2	effect	effect	NN	_	5	nsubjpass
3	may	may	MD	_	5	aux
4	be	be	VB	_	5	auxpass
5	mediated	mediate	VBN	_	0	ROOT
6	by	by	IN	_	8	case
7	the	the	DT	_	8	det
8	ability	ability	NN	_	5	nmod
9	of	of	IN	_	10	case
10	drug1	drug1	NN	_	8	nmod
11	to	to	TO	_	12	mark
12	induce	induce	VB	_	8	acl
13	microsomal	microsomal	JJ	_	14	amod
14	enzymes	enzyme	NNS	_	12	dobj
15	and	and	CC	_	5	cc
16	,	,	,	_	5	punct
17	thus	thus	RB	_	5	advmod
18	,	,	,	_	5	punct
19	the	the	DT	_	20	det
20	catabolism	catabolism	NN	_	5	dobj
21	of	of	IN	_	22	case
22	drug2	drug2	NN	_	20	nmod
23	.	.	.	_	5	punct

1	The	the	DT	_	2	det
2	effect	effect	NN	_	12	nsubj
3	of	of	IN	_	4	case
4	drug1	drug1	NN	_	2	nmod
5	on	on	IN	_	8	case
6	the	the	DT	_	8	det
7	drug2	drug2	NN	_	8	compound
8	requirement	requirement	NN	_	2	nmod
9	of	of	IN	_	11	case
10	our	we	PRP$	_	11	nmod:poss
11	patient	patient	NN	_	8	nmod
12	appeared	appear	VBD	_	0	ROOT
13	to	to	TO	_	19	mark
14	be	be	VB	_	19	cop
15	maximal	maximal	JJ	_	19	amod
16	5	5	CD	_	18	compound
17	to	to	TO	_	18	dep
18	7	7	CD	_	19	nummod
19	days	day	NNS	_	12	xcomp
20	after	after	IN	_	22	case
21	the	the	DT	_	22	det
22	initiation	initiation	NN	_	19	nmod
23	of	of	IN	_	24	case
24	drug3	drug3	NN	_	22	nmod
25	and	and	CC	_	12	cc
26	extended	extend	VBD	_	12	conj
27	a	a	DT	_	29	det
28	similar	similar	JJ	_	29	amod
29	length	length	NN	_	26	dobj
30	of	of	IN	_	31	case
31	time	time	NN	_	29	nmod
32	after	after	IN	_	34	case
33	drug4	drug4	NN	_	34	compound
34	withdrawal	withdrawal	NN	_	26	nmod
35	.	.	.	_	12	punct

1	This	this	DT	_	2	det
2	interaction	interaction	NN	_	3	nsubj
3	appears	appear	VBZ	_	0	ROOT
4	to	to	TO	_	7	mark
5	be	be	VB	_	7	cop
6	clinically	clinically	RB	_	7	advmod
7	significant	significant	JJ	_	3	xcomp
8	.	.	.	_	3	punct

1	Increased	increase	VBN	_	2	amod
2	stability	stability	NN	_	0	ROOT
3	of	of	IN	_	4	case
4	nucleophosmin/B23	nucleophosmin/b23	NN	_	2	nmod
5	in	in	IN	_	7	case
6	anti-apoptotic	anti-apoptotic	JJ	_	7	amod
7	effect	effect	NN	_	2	nmod
8	of	of	IN	_	9	case
9	ras	ras	NN	_	7	nmod
10	during	during	IN	_	12	case
11	serum	serum	NN	_	12	compound
12	deprivation	deprivation	NN	_	7	nmod
13	.	.	.	_	2	punct

1	We	we	PRP	_	2	nsubj
2	obtained	obtain	VBD	_	0	ROOT
3	evidence	evidence	NN	_	2	dobj
4	that	that	IN	_	10	mark
5	increased	increase	VBN	_	6	amod
6	stability	stability	NN	_	10	nsubjpass
7	of	of	IN	_	8	case
8	nucleophosmin/B23	nucleophosmin/b23	NN	_	6	nmod
9	is	be	VBZ	_	10	auxpass
10	involved	involve	VBN	_	3	ccomp
11	in	in	IN	_	13	case
12	antiapoptotic	antiapoptotic	JJ	_	13	amod
13	effect	effect	NN	_	10	nmod
14	of	of	IN	_	15	case
15	ras	ras	NN	_	13	nmod
16	during	during	IN	_	18	case
17	serum	serum	NN	_	18	compound
18	deprivation	deprivation	NN	_	13	nmod
19	.	.	.	_	2	punct

1	Nucleophosmin/B23	nucleophosmin/b23	NN	_	12	nsubjpass
2	in	in	IN	_	3	case
3	serum-deprived	serum-deprived	JJ	_	1	nmod
4	-LRB-	-lrb-	-LRB-	_	7	punct
5	0	0	CD	_	6	compound
6	%	%	NN	_	7	amod
7	serum	serum	NN	_	3	appos
8	-RRB-	-rrb-	-RRB-	_	7	punct
9	NIH-3T3	nih-3t3	NN	_	10	compound
10	cells	cell	NNS	_	3	dep
11	was	be	VBD	_	12	auxpass
12	found	find	VBN	_	0	ROOT
13	to	to	TO	_	16	mark
14	be	be	VB	_	16	cop
15	highly	highly	RB	_	16	advmod
16	unstable	unstable	JJ	_	12	xcomp
17	with	with	IN	_	19	case
18	a	a	DT	_	19	det
19	half-life	half-life	NN	_	16	nmod
20	less	less	RBR	_	22	advmod
21	than	than	IN	_	20	mwe
22	4	4	CD	_	23	nummod
23	h	h	NN	_	16	nmod:tmod
24	.	.	.	_	12	punct

1	In	in	IN	_	2	case
2	contrast	contrast	NN	_	14	nmod
3	,	,	,	_	14	punct
4	nucleophosmin/B23	nucleophosmin/b23	NN	_	14	nsubj
5	in	in	IN	_	11	case
6	serum-deprived	serum-deprived	JJ	_	11	amod
7	ras-transformed	ras-transformed	JJ	_	11	amod
8	-LRB-	-lrb-	-LRB-	_	11	punct
9	RAS-3T3	ras-3t3	NN	_	11	compound
10	-RRB-	-rrb-	-RRB-	_	11	punct
11	cells	cell	NNS	_	4	nmod
12	was	be	VBD	_	14	cop
13	as	as	IN	_	14	advmod
14	stable	stable	JJ	_	0	ROOT
15	as	as	IN	_	16	case
16	that	that	DT	_	14	nmod
17	in	in	IN	_	19	case
18	serum-supplemented	serum-supplemented	JJ	_	19	amod
19	NIH-3T3	nih-3t3	NN	_	16	nmod
20	or	or	CC	_	19	cc
21	RAS-3T3	ras-3t3	NN	_	22	compound
22	cells	cell	NNS	_	19	conj
23	.	.	.	_	14	punct

1	Treatment	treatment	NN	_	10	nsubj
2	of	of	IN	_	4	case
3	RAS-3T3	ras-3t3	NN	_	4	compound
4	cells	cell	NNS	_	1	nmod
5	with	with	IN	_	8	case
6	nucleophosmin/B23	nucleophosmin/b23	NN	_	8	compound
7	antisense	antisense	JJ	_	8	amod
8	oligomer	oligomer	NN	_	1	nmod
9	significantly	significantly	RB	_	10	advmod
10	potentiated	potentiate	VBD	_	0	ROOT
11	the	the	DT	_	12	det
12	apoptosis	apoptosis	NN	_	10	dobj
13	induced	induce	VBN	_	12	acl
14	by	by	IN	_	16	case
15	serum	serum	NN	_	16	compound
16	deprivation	deprivation	NN	_	13	nmod
17	.	.	.	_	10	punct

1	Much	much	RB	_	2	advmod
2	less	less	JJR	_	4	amod
3	caspase-3	caspase-3	NN	_	4	compound
4	activity	activity	NN	_	6	nsubjpass
5	was	be	VBD	_	6	auxpass
6	noted	note	VBN	_	0	ROOT
7	in	in	IN	_	9	case
8	the	the	DT	_	9	det
9	lysate	lysate	NN	_	6	nmod
10	derived	derive	VBN	_	9	acl
11	from	from	IN	_	14	case
12	serum-deprived	serum-deprived	JJ	_	14	amod
13	RAS-3T3	ras-3t3	NN	_	14	compound
14	cells	cell	NNS	_	10	nmod
15	compared	compare	VBN	_	17	case
16	with	with	IN	_	17	case
17	that	that	DT	_	6	advcl
18	in	in	IN	_	20	case
19	the	the	DT	_	20	det
20	lysate	lysate	NN	_	17	nmod
21	of	of	IN	_	24	case
22	serum-deprived	serum-deprived	JJ	_	24	amod
23	NIH-3T3	nih-3t3	NN	_	24	compound
24	cells	cell	NNS	_	20	nmod
25	.	.	.	_	6	punct

1	Cell	cell	NN	_	4	compound
2	permeable	permeable	JJ	_	4	amod
3	caspase-3	caspase-3	NN	_	4	compound
4	inhibitor	inhibitor	NN	_	5	nsubj
5	added	add	VBD	_	0	ROOT
6	in	in	IN	_	8	case
7	the	the	DT	_	8	det
8	medium	medium	NN	_	5	nmod
9	blocked	block	VBD	_	5	dep
10	the	the	DT	_	11	det
11	decrease	decrease	NN	_	9	dobj
12	of	of	IN	_	13	case
13	nucleophosmin/B23	nucleophosmin/b23	NN	_	11	nmod
14	and	and	CC	_	13	cc
15	apoptosis	apoptosis	NN	_	13	conj
16	induced	induce	VBN	_	13	acl
17	by	by	IN	_	19	case
18	serum	serum	NN	_	19	compound
19	deprivation	deprivation	NN	_	16	nmod
20	in	in	IN	_	22	case
21	NIH-3T3	nih-3t3	NN	_	22	compound
22	cells	cell	NNS	_	16	nmod
23	.	.	.	_	5	punct

1	The	the	DT	_	2	det
2	inhibitor	inhibitor	NN	_	9	nsubj
3	,	,	,	_	9	punct
4	on	on	IN	_	7	case
5	the	the	DT	_	7	det
6	other	other	JJ	_	7	amod
7	hand	hand	NN	_	9	nmod
8	,	,	,	_	9	punct
9	promoted	promote	VBD	_	0	ROOT
10	significant	significant	JJ	_	11	amod
11	decrease	decrease	NN	_	9	dobj
12	of	of	IN	_	13	case
13	nucleolin/C23	nucleolin/c23	NN	_	11	nmod
14	in	in	IN	_	16	case
15	NIH-3T3	nih-3t3	NN	_	16	compound
16	cells	cell	NNS	_	11	nmod
17	during	during	IN	_	19	case
18	serum	serum	NN	_	19	compound
19	deprivation	deprivation	NN	_	9	nmod
20	.	.	.	_	9	punct

1	Unlike	unlike	IN	_	2	case
2	nucleolin/C23	nucleolin/c23	NN	_	10	nmod
3	,	,	,	_	10	punct
4	down-regulation	down-regulation	NN	_	10	nsubj
5	of	of	IN	_	6	case
6	nucleophosmin/B23	nucleophosmin/b23	NN	_	4	nmod
7	was	be	VBD	_	10	cop
8	thus	thus	RB	_	10	advmod
9	not	not	RB	_	10	neg
10	proliferation-dependent	proliferation-dependent	JJ	_	0	ROOT
11	but	but	CC	_	10	cc
12	caspase-3	caspase-3	NN	_	10	conj
13	-	-	:	_	10	punct
14	and	and	CC	_	10	cc
15	apoptosis-dependent	apoptosis-dependent	JJ	_	10	conj
16	.	.	.	_	10	punct

1	Our	we	PRP$	_	2	nmod:poss
2	results	result	NNS	_	3	nsubj
3	indicate	indicate	VBP	_	0	ROOT
4	important	important	JJ	_	5	amod
5	relationships	relationship	NNS	_	3	dobj
6	among	among	IN	_	7	case
7	ras	ras	NN	_	5	nmod
8	,	,	,	_	7	punct
9	nucleophosmin/B23	nucleophosmin/b23	NN	_	7	conj
10	,	,	,	_	7	punct
11	activation	activation	NN	_	7	conj
12	of	of	IN	_	13	case
13	caspase-3	caspase-3	NN	_	11	nmod
14	,	,	,	_	7	punct
15	and	and	CC	_	7	cc
16	induction	induction	NN	_	7	conj
17	of	of	IN	_	18	case
18	apoptosis	apoptosis	NN	_	16	nmod
19	.	.	.	_	3	punct

1	drug1	drug1	NN	_	0	ROOT
2	:	:	:	_	1	punct
3	mammalian	mammalian	JJ	_	4	amod
4	target	target	NN	_	1	dep
5	of	of	IN	_	7	case
6	drug2	drug2	NN	_	7	compound
7	inhibitor	inhibitor	NN	_	4	nmod
8	to	to	TO	_	9	mark
9	prevent	prevent	VB	_	4	acl
10	kidney	kidney	NN	_	11	compound
11	rejection	rejection	NN	_	9	dobj
12	.	.	.	_	1	punct

1	Current	current	JJ	_	3	amod
2	immunosuppressive	immunosuppressive	JJ	_	3	amod
3	therapies	therapy	NNS	_	5	nsubj
4	are	be	VBP	_	5	cop
5	effective	effective	JJ	_	0	ROOT
6	but	but	CC	_	5	cc
7	can	can	MD	_	9	aux
8	be	be	VB	_	9	auxpass
9	associated	associate	VBN	_	5	conj
10	with	with	IN	_	13	case
11	significant	significant	JJ	_	13	amod
12	adverse	adverse	JJ	_	13	amod
13	reactions	reaction	NNS	_	9	nmod
14	.	.	.	_	5	punct

1	drug1	drug1	NN	_	2	nsubj
2	works	work	VBZ	_	0	ROOT
3	differently	differently	RB	_	2	advmod
4	from	from	IN	_	6	case
5	the	the	DT	_	6	det
6	drug2	drug2	NN	_	2	nmod
7	currently	currently	RB	_	8	advmod
8	available	available	JJ	_	6	amod
9	,	,	,	_	2	punct
10	and	and	CC	_	2	cc
11	except	except	IN	_	15	case
12	for	for	IN	_	15	case
13	increased	increase	VBN	_	15	amod
14	lipid	lipid	NN	_	15	compound
15	levels	level	NNS	_	2	conj
16	,	,	,	_	15	punct
17	the	the	DT	_	20	det
18	adverse	adverse	JJ	_	20	amod
19	reaction	reaction	NN	_	20	compound
20	profile	profile	NN	_	25	nsubj
21	of	of	IN	_	22	case
22	drug3	drug3	NN	_	20	nmod
23	does	do	VBZ	_	25	aux
24	not	not	RB	_	25	neg
25	appear	appear	VB	_	15	acl:relcl
26	to	to	TO	_	27	mark
27	overlap	overlap	VB	_	25	xcomp
28	to	to	TO	_	31	case
29	any	any	DT	_	31	det
30	great	great	JJ	_	31	amod
31	extent	extent	NN	_	27	nmod
32	with	with	IN	_	33	case
33	that	that	DT	_	31	nmod
34	associated	associate	VBN	_	33	acl
35	with	with	IN	_	36	case
36	drug4	drug4	NN	_	34	nmod
37	or	or	CC	_	36	cc
38	drug5	drug5	NN	_	36	conj
39	.	.	.	_	2	punct

1	While	while	IN	_	5	mark
2	additional	additional	JJ	_	3	amod
3	research	research	NN	_	5	nsubjpass
4	is	be	VBZ	_	5	auxpass
5	needed	need	VBN	_	14	advcl
6	,	,	,	_	14	punct
7	the	the	DT	_	10	det
8	initial	initial	JJ	_	10	amod
9	clinical	clinical	JJ	_	10	amod
10	data	datum	NNS	_	14	nsubj
11	in	in	IN	_	13	case
12	kidney	kidney	NN	_	13	compound
13	recipients	recipient	NNS	_	10	nmod
14	suggest	suggest	VBP	_	0	ROOT
15	that	that	IN	_	26	mark
16	drug1	drug1	NN	_	26	nsubj
17	,	,	,	_	26	punct
18	in	in	IN	_	19	case
19	combination	combination	NN	_	26	nmod
20	with	with	IN	_	21	case
21	drug2	drug2	NN	_	19	nmod
22	or	or	CC	_	21	cc
23	drug3	drug3	NN	_	21	conj
24	,	,	,	_	26	punct
25	might	might	MD	_	26	aux
26	have	have	VB	_	14	ccomp
27	the	the	DT	_	28	det
28	potential	potential	JJ	_	26	dobj
29	to	to	TO	_	30	mark
30	reduce	reduce	VB	_	28	acl
31	the	the	DT	_	32	det
32	frequency	frequency	NN	_	30	dobj
33	of	of	IN	_	35	case
34	rejection	rejection	NN	_	35	compound
35	episodes	episode	NNS	_	32	nmod
36	,	,	,	_	14	punct
37	permit	permit	VBP	_	14	conj
38	reductions	reduction	NNS	_	37	dobj
39	in	in	IN	_	40	case
40	drug4	drug4	NN	_	38	nmod
41	or	or	CC	_	40	cc
42	drug5	drug5	NN	_	43	compound
43	dosage	dosage	NN	_	40	conj
44	,	,	,	_	14	punct
45	and	and	CC	_	14	cc
46	permit	permit	VB	_	14	conj
47	steroid	steroid	NN	_	48	compound
48	withdrawal	withdrawal	NN	_	46	dobj
49	-LRB-	-lrb-	-LRB-	_	50	punct
50	Kelly	Kelly	NNP	_	48	dep
51	,	,	,	_	50	punct
52	1999	1999	CD	_	50	amod
53	-RRB-	-rrb-	-RRB-	_	50	punct
54	.	.	.	_	14	punct

1	Development	Development	NNP	_	0	ROOT
2	and	and	CC	_	1	cc
3	pharmacology	pharmacology	NN	_	1	conj
4	of	of	IN	_	5	case
5	drug1	drug1	NN	_	1	nmod
6	.	.	.	_	1	punct

1	drug1	drug1	NN	_	5	nsubj
2	is	be	VBZ	_	5	cop
3	the	the	DT	_	5	det
4	first	first	JJ	_	5	amod
5	drug2	drug2	NN	_	0	ROOT
6	to	to	TO	_	8	mark
7	be	be	VB	_	8	auxpass
8	approved	approve	VBN	_	5	acl
9	for	for	IN	_	11	case
10	clinical	clinical	JJ	_	11	amod
11	use	use	NN	_	8	nmod
12	,	,	,	_	5	punct
13	and	and	CC	_	5	cc
14	has	have	VBZ	_	16	aux
15	been	be	VBN	_	16	auxpass
16	studied	study	VBN	_	5	conj
17	extensively	extensively	RB	_	16	advmod
18	in	in	IN	_	19	case
19	humans	human	NNS	_	16	nmod
20	since	since	IN	_	21	case
21	1986	1986	CD	_	16	nmod
22	.	.	.	_	5	punct

1	It	it	PRP	_	4	nsubj
2	is	be	VBZ	_	4	cop
3	structurally	structurally	RB	_	4	advmod
4	distinct	distinct	JJ	_	0	ROOT
5	from	from	IN	_	10	case
6	the	the	DT	_	10	det
7	other	other	JJ	_	10	amod
8	currently	currently	RB	_	9	advmod
9	available	available	JJ	_	10	amod
10	drug1	drug1	NN	_	4	nmod
11	-LRB-	-lrb-	-LRB-	_	12	punct
12	drug2	drug2	NN	_	10	dep
13	,	,	,	_	12	punct
14	drug3	drug3	NN	_	12	conj
15	,	,	,	_	12	punct
16	and	and	CC	_	12	cc
17	drug4	drug4	NN	_	12	conj
18	-RRB-	-rrb-	-RRB-	_	12	punct
19	,	,	,	_	4	punct
20	leading	lead	VBG	_	4	xcomp
21	to	to	TO	_	24	case
22	unique	unique	JJ	_	24	amod
23	biopharmaceutical	biopharmaceutical	JJ	_	24	amod
24	properties	property	NNS	_	20	nmod
25	relative	relative	JJ	_	24	amod
26	to	to	TO	_	29	case
27	the	the	DT	_	29	det
28	other	other	JJ	_	29	amod
29	agents	agent	NNS	_	25	nmod
30	of	of	IN	_	32	case
31	this	this	DT	_	32	det
32	class	class	NN	_	29	nmod
33	.	.	.	_	4	punct

1	Absorption	absorption	NN	_	6	nsubj
2	of	of	IN	_	3	case
3	drug1	drug1	NN	_	1	nmod
4	is	be	VBZ	_	6	cop
5	virtually	virtually	RB	_	6	advmod
6	complete	complete	JJ	_	0	ROOT
7	across	across	IN	_	9	case
8	all	all	DT	_	9	det
9	species	species	NNS	_	6	nmod
10	,	,	,	_	9	punct
11	including	include	VBG	_	12	case
12	man	man	NN	_	9	nmod
13	,	,	,	_	9	punct
14	and	and	CC	_	9	cc
15	is	be	VBZ	_	17	auxpass
16	not	not	RB	_	17	neg
17	affected	affect	VBN	_	9	conj
18	by	by	IN	_	20	case
19	the	the	DT	_	20	det
20	presence	presence	NN	_	17	nmod
21	of	of	IN	_	22	case
22	food	food	NN	_	20	nmod
23	.	.	.	_	6	punct

1	Systemic	systemic	JJ	_	2	amod
2	exposure	exposure	NN	_	4	nsubjpass
3	is	be	VBZ	_	4	auxpass
4	limited	limit	VBN	_	0	ROOT
5	,	,	,	_	4	punct
6	as	as	IN	_	9	mark
7	drug1	drug1	NN	_	9	nsubj
8	is	be	VBZ	_	9	cop
9	subject	subject	JJ	_	4	advcl
10	to	to	TO	_	12	case
11	first-pass	first-pass	JJ	_	12	amod
12	metabolism	metabolism	NN	_	9	nmod
13	,	,	,	_	4	punct
14	and	and	CC	_	4	cc
15	the	the	DT	_	17	det
16	plasma	plasma	NN	_	17	compound
17	half-life	half-life	NN	_	24	nsubj
18	of	of	IN	_	20	case
19	the	the	DT	_	20	det
20	drug	drug	NN	_	17	nmod
21	is	be	VBZ	_	24	cop
22	approximately	approximately	RB	_	23	advmod
23	30	30	CD	_	24	nummod
24	minutes	minute	NNS	_	4	conj
25	.	.	.	_	4	punct

1	Some	some	DT	_	2	advmod
2	95	95	CD	_	3	nummod
3	%	%	NN	_	11	nsubjpass
4	of	of	IN	_	7	case
5	a	a	DT	_	7	det
6	single	single	JJ	_	7	amod
7	dosage	dosage	NN	_	3	nmod
8	of	of	IN	_	9	case
9	drug1	drug1	NN	_	7	nmod
10	is	be	VBZ	_	11	auxpass
11	excreted	excrete	VBN	_	0	ROOT
12	via	via	IN	_	15	case
13	the	the	DT	_	15	det
14	biliary	biliary	JJ	_	15	amod
15	route	route	NN	_	11	nmod
16	,	,	,	_	11	punct
17	with	with	IN	_	21	case
18	less	less	JJR	_	20	advmod
19	than	than	IN	_	18	mwe
20	2	2	CD	_	21	nummod
21	%	%	NN	_	11	nmod
22	of	of	IN	_	23	case
23	this	this	DT	_	21	nmod
24	being	be	VBG	_	27	cop
25	the	the	DT	_	27	det
26	parent	parent	NN	_	27	compound
27	compound	compound	NN	_	21	dep
28	.	.	.	_	11	punct

1	Additionally	additionally	RB	_	4	advmod
2	,	,	,	_	4	punct
3	there	there	EX	_	4	expl
4	is	be	VBZ	_	0	ROOT
5	no	no	DT	_	6	neg
6	evidence	evidence	NN	_	4	nsubj
7	of	of	IN	_	10	case
8	circulating	circulate	VBG	_	10	amod
9	active	active	JJ	_	10	amod
10	metabolites	metabolite	NNS	_	6	nmod
11	or	or	CC	_	10	cc
12	accumulation	accumulation	NN	_	10	conj
13	during	during	IN	_	15	case
14	chronic	chronic	JJ	_	15	amod
15	dosing	dosing	NN	_	10	nmod
16	.	.	.	_	4	punct

1	Studies	study	NNS	_	13	nsubj
2	of	of	IN	_	4	case
3	the	the	DT	_	4	det
4	effect	effect	NN	_	1	nmod
5	of	of	IN	_	6	case
6	food	food	NN	_	4	nmod
7	on	on	IN	_	9	case
8	the	the	DT	_	9	det
9	pharmacokinetics	pharmacokinetic	NNS	_	4	nmod
10	of	of	IN	_	11	case
11	drug1	drug1	NN	_	9	nmod
12	have	have	VBP	_	13	aux
13	demonstrated	demonstrate	VBN	_	0	ROOT
14	marked	marked	JJ	_	15	amod
15	reductions	reduction	NNS	_	13	dobj
16	in	in	IN	_	18	case
17	the	the	DT	_	18	det
18	rate	rate	NN	_	15	nmod
19	of	of	IN	_	20	case
20	bioavailability	bioavailability	NN	_	18	nmod
21	--	--	:	_	15	punct
22	from	from	IN	_	24	case
23	40	40	CD	_	24	nummod
24	%	%	NN	_	15	nmod
25	to	to	TO	_	27	case
26	60	60	CD	_	27	nummod
27	%	%	NN	_	24	nmod
28	;	;	:	_	13	punct

1	however	however	RB	_	16	advmod
2	,	,	,	_	16	punct
3	a	a	DT	_	4	det
4	comparison	comparison	NN	_	16	nsubj
5	of	of	IN	_	7	case
6	drug1	drug1	NN	_	7	compound
7	administration	administration	NN	_	4	nmod
8	with	with	IN	_	11	case
9	the	the	DT	_	11	det
10	evening	evening	NN	_	11	compound
11	meal	meal	NN	_	4	nmod
12	or	or	CC	_	11	cc
13	at	at	IN	_	14	case
14	bedtime	bedtime	NN	_	11	conj
15	has	have	VBZ	_	16	aux
16	revealed	reveal	VBN	_	0	ROOT
17	no	no	DT	_	19	neg
18	significant	significant	JJ	_	19	amod
19	differences	difference	NNS	_	16	dobj
20	in	in	IN	_	22	case
21	the	the	DT	_	22	det
22	extent	extent	NN	_	19	nmod
23	of	of	IN	_	24	case
24	bioavailability	bioavailability	NN	_	22	nmod
25	-LRB-	-lrb-	-LRB-	_	26	punct
26	area	area	NN	_	24	dep
27	under	under	IN	_	29	case
28	the	the	DT	_	29	det
29	curve	curve	NN	_	26	nmod
30	-RRB-	-rrb-	-RRB-	_	26	punct
31	of	of	IN	_	34	case
32	these	these	DT	_	34	det
33	two	two	CD	_	34	nummod
34	regimens	regimen	NNS	_	24	nmod
35	.	.	.	_	16	punct

1	Furthermore	furthermore	RB	_	19	advmod
2	,	,	,	_	19	punct
3	no	no	DT	_	5	neg
4	significant	significant	JJ	_	5	amod
5	difference	difference	NN	_	19	nsubjpass
6	in	in	IN	_	8	case
7	pharmacodynamic	pharmacodynamic	JJ	_	8	amod
8	effect	effect	NN	_	5	nmod
9	-LRB-	-lrb-	-LRB-	_	10	punct
10	reduction	reduction	NN	_	5	dep
11	in	in	IN	_	15	case
12	low-density	low-density	JJ	_	15	amod
13	lipoprotein	lipoprotein	NN	_	15	compound
14	cholesterol	cholesterol	NN	_	15	compound
15	levels	level	NNS	_	10	nmod
16	-RRB-	-rrb-	-RRB-	_	10	punct
17	could	could	MD	_	19	aux
18	be	be	VB	_	19	auxpass
19	ascertained	ascertain	VBN	_	0	ROOT
20	between	between	IN	_	22	case
21	mealtime	mealtime	NN	_	22	compound
22	dosing	dosing	NN	_	19	nmod
23	and	and	CC	_	22	cc
24	bedtime	bedtime	NN	_	25	compound
25	dosing	dosing	NN	_	22	conj
26	.	.	.	_	19	punct

1	The	the	DT	_	2	det
2	pharmacokinetics	pharmacokinetic	NNS	_	8	nsubjpass
3	of	of	IN	_	4	case
4	drug1	drug1	NN	_	2	nmod
5	have	have	VBP	_	8	aux
6	also	also	RB	_	8	advmod
7	been	be	VBN	_	8	auxpass
8	assessed	assess	VBN	_	0	ROOT
9	in	in	IN	_	12	case
10	various	various	JJ	_	12	amod
11	demographic	demographic	JJ	_	12	amod
12	groups	group	NNS	_	8	nmod
13	.	.	.	_	8	punct

1	Relative	relative	JJ	_	13	ccomp
2	to	to	TO	_	5	case
3	the	the	DT	_	5	det
4	general	general	JJ	_	5	amod
5	population	population	NN	_	1	nmod
6	,	,	,	_	13	punct
7	plasma	plasma	NN	_	8	compound
8	concentrations	concentration	NNS	_	13	nsubj
9	of	of	IN	_	10	case
10	drug1	drug1	NN	_	8	nmod
11	do	do	VBP	_	13	aux
12	not	not	RB	_	13	neg
13	vary	vary	VB	_	0	ROOT
14	as	as	IN	_	16	case
15	a	a	DT	_	16	det
16	function	function	NN	_	13	nmod
17	of	of	IN	_	19	case
18	either	either	CC	_	19	cc:preconj
19	age	age	NN	_	16	nmod
20	or	or	CC	_	19	cc
21	gender	gender	NN	_	19	conj
22	.	.	.	_	13	punct

1	In	in	IN	_	2	case
2	addition	addition	NN	_	12	nmod
3	,	,	,	_	12	punct
4	administration	administration	NN	_	12	nsubj
5	to	to	TO	_	8	case
6	a	a	DT	_	8	det
7	patient	patient	NN	_	8	compound
8	population	population	NN	_	4	nmod
9	with	with	IN	_	11	case
10	hepatic	hepatic	JJ	_	11	amod
11	insufficiency	insufficiency	NN	_	8	nmod
12	resulted	result	VBD	_	0	ROOT
13	in	in	IN	_	16	case
14	a	a	DT	_	16	det
15	2.5-fold	2.5-fold	JJ	_	16	amod
16	increase	increase	NN	_	12	nmod
17	in	in	IN	_	20	case
18	both	both	CC	_	20	cc:preconj
19	the	the	DT	_	20	det
20	rate	rate	NN	_	16	nmod
21	and	and	CC	_	20	cc
22	extent	extent	NN	_	20	conj
23	of	of	IN	_	24	case
24	bioavailability	bioavailability	NN	_	20	nmod
25	relative	relative	JJ	_	24	amod
26	to	to	TO	_	27	case
27	controls	control	NNS	_	25	nmod
28	.	.	.	_	12	punct

1	Also	also	RB	_	34	advmod
2	,	,	,	_	34	punct
3	although	although	IN	_	15	mark
4	minimal	minimal	JJ	_	5	amod
5	alterations	alteration	NNS	_	15	nsubjpass
6	of	of	IN	_	8	case
7	drug1	drug1	NN	_	8	compound
8	clearance	clearance	NN	_	5	nmod
9	in	in	IN	_	10	case
10	patients	patient	NNS	_	8	nmod
11	with	with	IN	_	13	case
12	renal	renal	JJ	_	13	amod
13	insufficiency	insufficiency	NN	_	10	nmod
14	are	be	VBP	_	15	auxpass
15	anticipated	anticipate	VBN	_	34	advcl
16	due	due	JJ	_	20	case
17	to	to	TO	_	16	mwe
18	limited	limited	JJ	_	20	amod
19	renal	renal	JJ	_	20	amod
20	excretion	excretion	NN	_	15	nmod
21	-LRB-	-lrb-	-LRB-	_	23	punct
22	5	5	CD	_	23	nummod
23	%	%	NN	_	20	appos
24	-RRB-	-rrb-	-RRB-	_	23	punct
25	,	,	,	_	34	punct
26	a	a	DT	_	27	det
27	study	study	NN	_	34	nsubj
28	in	in	IN	_	31	case
29	this	this	DT	_	31	det
30	patient	patient	NN	_	31	compound
31	group	group	NN	_	27	nmod
32	is	be	VBZ	_	34	cop
33	currently	currently	RB	_	34	advmod
34	underway	underway	NN	_	0	ROOT
35	to	to	TO	_	36	mark
36	examine	examine	VB	_	34	xcomp
37	this	this	DT	_	36	dobj
38	further	further	RBR	_	37	advmod
39	.	.	.	_	34	punct

1	Interaction	interaction	NN	_	2	compound
2	studies	study	NNS	_	5	nsubjpass
3	have	have	VBP	_	5	aux
4	been	be	VBN	_	5	auxpass
5	performed	perform	VBN	_	0	ROOT
6	with	with	IN	_	7	case
7	drug1	drug1	NN	_	5	nmod
8	and	and	CC	_	7	cc
9	several	several	JJ	_	10	amod
10	drugs	drug	NNS	_	7	conj
11	with	with	IN	_	12	case
12	which	which	WDT	_	16	nmod
13	it	it	PRP	_	16	nsubjpass
14	might	might	MD	_	16	aux
15	be	be	VB	_	16	auxpass
16	coadministered	coadminister	VBN	_	7	acl:relcl
17	.	.	.	_	5	punct

1	drug1	drug1	NN	_	7	nsubj
2	,	,	,	_	1	punct
3	an	a	DT	_	5	det
4	anionic-binding	anionic-binding	JJ	_	5	amod
5	resin	resin	NN	_	1	appos
6	,	,	,	_	1	punct
7	has	have	VBZ	_	0	ROOT
8	a	a	DT	_	10	det
9	considerable	considerable	JJ	_	10	amod
10	effect	effect	NN	_	7	dobj
11	in	in	IN	_	12	mark
12	lowering	lower	VBG	_	7	advcl
13	the	the	DT	_	14	det
14	rate	rate	NN	_	12	dobj
15	and	and	CC	_	14	cc
16	extent	extent	NN	_	14	conj
17	of	of	IN	_	19	case
18	drug2	drug2	NN	_	19	compound
19	bioavailability	bioavailability	NN	_	14	nmod
20	.	.	.	_	7	punct

1	Although	although	IN	_	5	mark
2	this	this	DT	_	3	det
3	effect	effect	NN	_	5	nsubjpass
4	was	be	VBD	_	5	auxpass
5	noted	note	VBN	_	21	advcl
6	even	even	RB	_	7	advmod
7	when	when	WRB	_	10	advmod
8	drug1	drug1	NN	_	10	nsubjpass
9	was	be	VBD	_	10	auxpass
10	given	give	VBN	_	5	advcl
11	4	4	CD	_	12	nummod
12	hours	hour	NNS	_	10	dobj
13	prior	prior	RB	_	12	advmod
14	to	to	TO	_	15	case
15	drug2	drug2	NN	_	13	nmod
16	,	,	,	_	21	punct
17	this	this	DT	_	18	det
18	regimen	regimen	NN	_	21	nsubj
19	did	do	VBD	_	21	aux
20	not	not	RB	_	21	neg
21	result	result	VB	_	0	ROOT
22	in	in	IN	_	24	case
23	diminished	diminish	VBN	_	24	amod
24	efficacy	efficacy	NN	_	21	nmod
25	.	.	.	_	21	punct

1	Further	further	RB	_	13	advmod
2	,	,	,	_	13	punct
3	no	no	DT	_	4	neg
4	effects	effect	NNS	_	13	nsubjpass
5	on	on	IN	_	8	case
6	either	either	CC	_	8	cc:preconj
7	drug1	drug1	NN	_	8	compound
8	levels	level	NNS	_	4	nmod
9	or	or	CC	_	8	cc
10	prothrombin	prothrombin	NN	_	11	compound
11	times	time	NNS	_	8	conj
12	were	be	VBD	_	13	auxpass
13	observed	observe	VBN	_	0	ROOT
14	in	in	IN	_	16	case
15	a	a	DT	_	16	det
16	study	study	NN	_	13	nmod
17	involving	involve	VBG	_	16	acl
18	concomitant	concomitant	JJ	_	19	amod
19	administration	administration	NN	_	17	dobj
20	of	of	IN	_	21	case
21	drug2	drug2	NN	_	19	nmod
22	and	and	CC	_	21	cc
23	drug3	drug3	NN	_	21	conj
24	.	.	.	_	13	punct

1	Moreover	moreover	RB	_	12	advmod
2	,	,	,	_	12	punct
3	additional	additional	JJ	_	5	amod
4	interaction	interaction	NN	_	5	compound
5	studies	study	NNS	_	12	nsubj
6	with	with	IN	_	7	case
7	drug1	drug1	NN	_	5	nmod
8	and	and	CC	_	7	cc
9	drug2	drug2	NN	_	7	conj
10	have	have	VBP	_	12	aux
11	not	not	RB	_	12	neg
12	demonstrated	demonstrate	VBN	_	0	ROOT
13	any	any	DT	_	14	det
14	effect	effect	NN	_	12	dobj
15	on	on	IN	_	18	case
16	drug3	drug3	NN	_	18	compound
17	plasma	plasma	NN	_	18	compound
18	levels	level	NNS	_	14	nmod
19	,	,	,	_	12	punct
20	and	and	CC	_	12	cc
21	administration	administration	NN	_	29	nsubj
22	to	to	TO	_	25	case
23	a	a	DT	_	25	det
24	patient	patient	NN	_	25	compound
25	population	population	NN	_	21	nmod
26	chronically	chronically	RB	_	27	advmod
27	receiving	receive	VBG	_	25	acl
28	drug4	drug4	NN	_	27	dobj
29	resulted	result	VBD	_	12	conj
30	in	in	IN	_	32	case
31	no	no	DT	_	32	neg
32	difference	difference	NN	_	29	nmod
33	in	in	IN	_	35	case
34	the	the	DT	_	35	det
35	extent	extent	NN	_	32	nmod
36	of	of	IN	_	37	case
37	bioavailability	bioavailability	NN	_	35	nmod
38	of	of	IN	_	39	case
39	drug5	drug5	NN	_	37	nmod
40	relative	relative	JJ	_	32	amod
41	to	to	TO	_	42	mark
42	control	control	VB	_	40	xcomp
43	data	datum	NNS	_	42	dobj
44	.	.	.	_	12	punct

1	The	the	DT	_	2	det
2	results	result	NNS	_	3	nsubj
3	generated	generate	VBD	_	0	ROOT
4	to	to	TO	_	5	case
5	date	date	NN	_	3	nmod
6	in	in	IN	_	9	case
7	clinical	clinical	JJ	_	9	amod
8	pharmacokinetic	pharmacokinetic	JJ	_	9	amod
9	studies	study	NNS	_	3	nmod
10	with	with	IN	_	11	case
11	drug1	drug1	NN	_	9	nmod
12	thus	thus	RB	_	13	advmod
13	support	support	VBP	_	3	dep
14	its	its	PRP$	_	15	nmod:poss
15	use	use	NN	_	13	dobj
16	in	in	IN	_	19	case
17	a	a	DT	_	19	det
18	broad	broad	JJ	_	19	amod
19	population	population	NN	_	13	nmod
20	of	of	IN	_	22	case
21	hypercholesterolaemic	hypercholesterolaemic	JJ	_	22	amod
22	patients	patient	NNS	_	19	nmod
23	.	.	.	_	3	punct

1	Molecular	molecular	JJ	_	2	amod
2	basis	basis	NN	_	0	ROOT
3	for	for	IN	_	6	case
4	the	the	DT	_	6	det
5	selective	selective	JJ	_	6	amod
6	toxicity	toxicity	NN	_	2	nmod
7	of	of	IN	_	8	case
8	drug1	drug1	NN	_	6	nmod
9	for	for	IN	_	10	case
10	yeast	yeast	NN	_	6	nmod
11	and	and	CC	_	10	cc
12	drug2	drug2	NN	_	10	conj
13	for	for	IN	_	15	case
14	animal	animal	NN	_	15	compound
15	cells	cell	NNS	_	6	nmod
16	.	.	.	_	2	punct

1	Among	among	IN	_	3	case
2	the	the	DT	_	3	det
3	drug1	drug1	NN	_	13	nmod
4	,	,	,	_	13	punct
5	many	many	JJ	_	13	nsubjpass
6	,	,	,	_	13	punct
7	like	like	IN	_	8	case
8	drug2	drug2	NN	_	13	nmod
9	,	,	,	_	13	punct
10	can	can	MD	_	13	aux
11	not	not	RB	_	13	neg
12	be	be	VB	_	13	auxpass
13	used	use	VBN	_	0	ROOT
14	clinically	clinically	RB	_	13	advmod
15	because	because	IN	_	18	mark
16	they	they	PRP	_	18	nsubj
17	are	be	VBP	_	18	cop
18	toxic	toxic	JJ	_	13	advcl
19	;	;	:	_	13	punct

1	drug1	drug1	NN	_	6	nsubj
2	,	,	,	_	6	punct
3	however	however	RB	_	6	advmod
4	,	,	,	_	6	punct
5	is	be	VBZ	_	6	cop
6	useful	useful	JJ	_	0	ROOT
7	in	in	IN	_	8	case
8	therapy	therapy	NN	_	6	nmod
9	of	of	IN	_	12	case
10	human	human	JJ	_	12	amod
11	fungal	fungal	JJ	_	12	amod
12	infections	infection	NNS	_	8	nmod
13	because	because	IN	_	17	mark
14	it	it	PRP	_	17	nsubj
15	is	be	VBZ	_	17	cop
16	less	less	RBR	_	17	advmod
17	toxic	toxic	JJ	_	6	advcl
18	.	.	.	_	6	punct

1	Both	both	CC	_	3	cc:preconj
2	the	the	DT	_	3	det
3	toxicity	toxicity	NN	_	14	nsubjpass
4	of	of	IN	_	5	case
5	drug1	drug1	NN	_	3	nmod
6	and	and	CC	_	3	cc
7	the	the	DT	_	9	det
8	therapeutic	therapeutic	JJ	_	9	amod
9	value	value	NN	_	3	conj
10	of	of	IN	_	11	case
11	drug2	drug2	NN	_	9	nmod
12	can	can	MD	_	14	aux
13	be	be	VB	_	14	auxpass
14	rationalized	rationalize	VBN	_	0	ROOT
15	at	at	IN	_	20	case
16	the	the	DT	_	20	det
17	cellular	cellular	JJ	_	20	amod
18	and	and	CC	_	17	cc
19	molecular	molecular	JJ	_	17	conj
20	level	level	NN	_	14	nmod
21	by	by	IN	_	24	case
22	the	the	DT	_	24	det
23	following	follow	VBG	_	24	amod
24	observations	observation	NNS	_	14	nmod
25	:	:	:	_	14	punct
26	-LRB-	-lrb-	-LRB-	_	27	punct
27	i	i	LS	_	31	dep
28	-RRB-	-rrb-	-RRB-	_	27	punct
29	these	these	DT	_	30	det
30	drug3	drug3	NN	_	31	nsubj
31	showed	show	VBD	_	14	parataxis
32	differential	differential	JJ	_	33	amod
33	effects	effect	NNS	_	31	dobj
34	on	on	IN	_	35	case
35	cells	cell	NNS	_	33	nmod
36	;	;	:	_	14	punct

1	drug1	drug1	NN	_	4	nsubj
2	was	be	VBD	_	4	cop
3	more	more	RBR	_	4	advmod
4	potent	potent	JJ	_	0	ROOT
5	in	in	IN	_	6	mark
6	lysing	lyse	VBG	_	4	advcl
7	human	human	JJ	_	10	amod
8	red	red	JJ	_	10	amod
9	blood	blood	NN	_	10	compound
10	cells	cell	NNS	_	6	dobj
11	,	,	,	_	4	punct
12	whereas	whereas	IN	_	4	dep
13	drug2	drug2	NN	_	16	nsubj
14	was	be	VBD	_	16	cop
15	more	more	RBR	_	16	advmod
16	potent	potent	JJ	_	4	parataxis
17	in	in	IN	_	18	mark
18	inhibiting	inhibit	VBG	_	16	advcl
19	yeast	yeast	NN	_	21	compound
20	cell	cell	NN	_	21	compound
21	growth	growth	NN	_	18	dobj
22	;	;	:	_	4	punct

1	and	and	CC	_	12	cc
2	-LRB-	-lrb-	-LRB-	_	3	punct
3	ii	ii	LS	_	12	dep
4	-RRB-	-rrb-	-RRB-	_	3	punct
5	the	the	DT	_	6	det
6	effects	effect	NNS	_	12	nsubjpass
7	of	of	IN	_	8	case
8	drug1	drug1	NN	_	6	nmod
9	were	be	VBD	_	12	auxpass
10	more	more	RBR	_	11	advmod
11	efficiently	efficiently	RB	_	12	advmod
12	inhibited	inhibit	VBN	_	0	ROOT
13	by	by	IN	_	15	case
14	added	add	VBN	_	15	amod
15	cholesterol	cholesterol	NN	_	12	nmod
16	,	,	,	_	15	punct
17	the	the	DT	_	20	det
18	major	major	JJ	_	20	amod
19	membrane	membrane	NN	_	20	compound
20	sterol	sterol	NN	_	15	appos
21	in	in	IN	_	23	case
22	human	human	JJ	_	23	amod
23	cells	cell	NNS	_	20	nmod
24	,	,	,	_	12	punct
25	whereas	whereas	IN	_	12	dep
26	the	the	DT	_	27	det
27	effects	effect	NNS	_	33	nsubjpass
28	of	of	IN	_	29	case
29	drug2	drug2	NN	_	27	nmod
30	were	be	VBD	_	33	auxpass
31	more	more	RBR	_	32	advmod
32	efficiently	efficiently	RB	_	33	advmod
33	inhibited	inhibit	VBN	_	12	parataxis
34	by	by	IN	_	35	case
35	ergosterol	ergosterol	NN	_	33	nmod
36	,	,	,	_	35	punct
37	the	the	DT	_	40	det
38	major	major	JJ	_	40	amod
39	membrane	membrane	NN	_	40	compound
40	sterol	sterol	NN	_	35	appos
41	in	in	IN	_	42	case
42	yeast	yeast	NN	_	40	nmod
43	.	.	.	_	12	punct

1	The	the	DT	_	3	det
2	simplest	simplest	JJS	_	3	amod
3	inference	inference	NN	_	4	nsubj
4	is	be	VBZ	_	0	ROOT
5	that	that	IN	_	13	mark
6	the	the	DT	_	7	det
7	toxicity	toxicity	NN	_	13	nsubjpass
8	and	and	CC	_	7	cc
9	effectiveness	effectiveness	NN	_	7	conj
10	of	of	IN	_	11	case
11	polyenes	polyene	NNS	_	7	nmod
12	are	be	VBP	_	13	auxpass
13	determined	determine	VBN	_	4	ccomp
14	by	by	IN	_	17	case
15	their	they	PRP$	_	17	nmod:poss
16	relative	relative	JJ	_	17	amod
17	avidities	avidity	NNS	_	13	nmod
18	for	for	IN	_	21	case
19	the	the	DT	_	21	det
20	predominant	predominant	JJ	_	21	amod
21	sterol	sterol	NN	_	17	nmod
22	in	in	IN	_	24	case
23	cell	cell	NN	_	24	compound
24	membranes	membrane	NNS	_	21	nmod
25	.	.	.	_	4	punct

1	-LSB-	-lsb-	-LRB-	_	2	punct
2	Hippocampus	hippocampus	NN	_	16	dep
3	as	as	IN	_	5	case
4	interaction	interaction	NN	_	5	compound
5	sites	site	NNS	_	2	nmod
6	between	between	IN	_	9	case
7	cerebral	cerebral	JJ	_	9	amod
8	memory	memory	NN	_	9	compound
9	systems	system	NNS	_	5	nmod
10	-RSB-	-rsb-	-RRB-	_	2	punct
11	Most	most	JJS	_	16	nsubj
12	of	of	IN	_	15	case
13	the	the	DT	_	15	det
14	current	current	JJ	_	15	amod
15	theories	theory	NNS	_	11	nmod
16	assume	assume	VBP	_	0	ROOT
17	that	that	IN	_	19	mark
18	there	there	EX	_	19	expl
19	are	be	VBP	_	16	ccomp
20	multiple	multiple	JJ	_	21	amod
21	forms	form	NNS	_	19	nsubj
22	of	of	IN	_	23	case
23	memory	memory	NN	_	21	nmod
24	that	that	WDT	_	26	nsubjpass
25	are	be	VBP	_	26	auxpass
26	supported	support	VBN	_	21	acl:relcl
27	by	by	IN	_	30	case
28	separate	separate	JJ	_	30	amod
29	brain	brain	NN	_	30	compound
30	systems	system	NNS	_	26	nmod
31	and	and	CC	_	16	cc
32	have	have	VBP	_	16	conj
33	different	different	JJ	_	34	amod
34	characteristics	characteristic	NNS	_	32	dobj
35	.	.	.	_	16	punct

1	Animals	animal	NNS	_	2	compound
2	studies	study	NNS	_	10	nsubjpass
3	on	on	IN	_	7	case
4	the	the	DT	_	7	det
5	various	various	JJ	_	7	amod
6	dual-memory	dual-memory	JJ	_	7	amod
7	theories	theory	NNS	_	2	nmod
8	have	have	VBP	_	10	aux
9	been	be	VBN	_	10	auxpass
10	carried	carry	VBN	_	0	ROOT
11	out	out	RP	_	10	compound:prt
12	mainly	mainly	RB	_	10	advmod
13	on	on	IN	_	15	case
14	the	the	DT	_	15	det
15	basis	basis	NN	_	10	nmod
16	of	of	IN	_	19	case
17	hippocampal	hippocampal	JJ	_	19	amod
18	system	system	NN	_	19	compound
19	function	function	NN	_	15	nmod
20	.	.	.	_	10	punct

1	Specifically	specifically	RB	_	5	advmod
2	,	,	,	_	5	punct
3	they	they	PRP	_	5	nsubj
4	have	have	VBP	_	5	aux
5	focused	focus	VBN	_	0	ROOT
6	on	on	IN	_	7	case
7	aspects	aspect	NNS	_	5	nmod
8	of	of	IN	_	9	case
9	learning	learning	NN	_	7	nmod
10	and	and	CC	_	9	cc
11	memory	memory	NN	_	9	conj
12	that	that	WDT	_	14	nsubj
13	are	be	VBP	_	14	aux
14	impaired	impaired	JJ	_	7	acl:relcl
15	-LRB-	-lrb-	-LRB-	_	17	punct
16	vs.	vs.	FW	_	17	dep
17	spared	spare	VBN	_	14	dep
18	-RRB-	-rrb-	-RRB-	_	17	punct
19	by	by	IN	_	20	case
20	lesions	lesion	NNS	_	14	nmod
21	of	of	IN	_	24	case
22	the	the	DT	_	24	det
23	hippocampal	hippocampal	JJ	_	24	amod
24	formation	formation	NN	_	20	nmod
25	.	.	.	_	5	punct

1	However	however	RB	_	4	advmod
2	,	,	,	_	4	punct
3	there	there	EX	_	4	expl
4	are	be	VBP	_	0	ROOT
5	several	several	JJ	_	6	amod
6	instances	instance	NNS	_	4	nsubj
7	in	in	IN	_	10	case
8	the	the	DT	_	10	det
9	animal	animal	NN	_	10	compound
10	literature	literature	NN	_	6	nmod
11	showing	show	VBG	_	6	acl
12	that	that	IN	_	16	mark
13	hippocampal	hippocampal	JJ	_	14	amod
14	lesions	lesion	NNS	_	16	nsubj
15	actually	actually	RB	_	16	advmod
16	produced	produce	VBD	_	11	ccomp
17	enhanced	enhance	VBN	_	18	amod
18	learning	learning	NN	_	16	dobj
19	and	and	CC	_	18	cc
20	memory	memory	NN	_	21	compound
21	function	function	NN	_	18	conj
22	.	.	.	_	4	punct

1	Moreover	moreover	RB	_	19	advmod
2	,	,	,	_	19	punct
3	the	the	DT	_	4	det
4	acquisition	acquisition	NN	_	19	nsubjpass
5	of	of	IN	_	6	case
6	tasks	task	NNS	_	4	nmod
7	that	that	WDT	_	9	nsubjpass
8	are	be	VBP	_	9	auxpass
9	facilitated	facilitate	VBN	_	6	acl:relcl
10	by	by	IN	_	12	case
11	hippocampal	hippocampal	JJ	_	12	amod
12	lesions	lesion	NNS	_	9	nmod
13	-LRB-	-lrb-	-LRB-	_	15	punct
14	or	or	CC	_	15	cc
15	dysfunction	dysfunction	NN	_	12	appos
16	-RRB-	-rrb-	-RRB-	_	15	punct
17	is	be	VBZ	_	19	auxpass
18	nevertheless	nevertheless	RB	_	19	advmod
19	associated	associate	VBN	_	0	ROOT
20	,	,	,	_	19	punct
21	in	in	IN	_	23	case
22	intact	intact	JJ	_	23	amod
23	subjects	subject	NNS	_	19	nmod
24	,	,	,	_	19	punct
25	with	with	IN	_	28	case
26	specific	specific	JJ	_	28	amod
27	neurobiological	neurobiological	JJ	_	28	amod
28	alterations	alteration	NNS	_	19	nmod
29	in	in	IN	_	31	case
30	the	the	DT	_	31	det
31	hippocampus	hippocampus	NN	_	28	nmod
32	.	.	.	_	19	punct

1	This	this	DT	_	2	det
2	problem	problem	NN	_	5	nsubjpass
3	has	have	VBZ	_	5	aux
4	been	be	VBN	_	5	auxpass
5	analysed	analyse	VBN	_	0	ROOT
6	using	use	VBG	_	5	xcomp
7	two	two	CD	_	9	nummod
8	different	different	JJ	_	9	amod
9	tasks	task	NNS	_	6	dobj
10	in	in	IN	_	11	case
11	mice	mouse	NNS	_	9	nmod
12	:	:	:	_	5	punct
13	a	a	DT	_	15	det
14	bar-press	bar-press	JJ	_	15	amod
15	conditioning	conditioning	NN	_	5	dep
16	and	and	CC	_	15	cc
17	a	a	DT	_	20	det
18	spatial	spatial	JJ	_	20	amod
19	discrimination	discrimination	NN	_	20	compound
20	task	task	NN	_	15	conj
21	.	.	.	_	5	punct

1	Results	result	NNS	_	2	nsubj
2	showed	show	VBD	_	0	ROOT
3	that	that	IN	_	15	mark
4	,	,	,	_	15	punct
5	depending	depend	VBG	_	8	case
6	on	on	IN	_	8	case
7	the	the	DT	_	8	det
8	task	task	NN	_	15	advcl
9	considered	consider	VBN	_	8	acl
10	,	,	,	_	15	punct
11	the	the	DT	_	14	det
12	same	same	JJ	_	14	amod
13	pharmacological	pharmacological	JJ	_	14	amod
14	treatment	treatment	NN	_	15	nsubj
15	produced	produce	VBD	_	2	ccomp
16	either	either	CC	_	18	cc:preconj
17	a	a	DT	_	18	det
18	facilitation	facilitation	NN	_	15	dobj
19	or	or	CC	_	18	cc
20	an	a	DT	_	21	det
21	impairment	impairment	NN	_	18	conj
22	of	of	IN	_	23	case
23	acquisition	acquisition	NN	_	21	nmod
24	.	.	.	_	2	punct

1	Moreover	moreover	RB	_	5	advmod
2	,	,	,	_	5	punct
3	each	each	DT	_	4	det
4	task	task	NN	_	5	nsubj
5	induced	induce	VBD	_	0	ROOT
6	significant	significant	JJ	_	7	amod
7	alterations	alteration	NNS	_	5	dobj
8	in	in	IN	_	12	case
9	hippocampal	hippocampal	JJ	_	12	amod
10	adenylate	adenylate	NN	_	12	compound
11	cyclase	cyclase	NN	_	12	compound
12	activity	activity	NN	_	7	nmod
13	but	but	CC	_	12	cc
14	in	in	IN	_	16	case
15	opposite	opposite	JJ	_	16	amod
16	directions	direction	NNS	_	12	conj
17	.	.	.	_	5	punct

1	Together	together	RB	_	8	advmod
2	with	with	IN	_	4	case
3	previous	previous	JJ	_	4	amod
4	findings	finding	NNS	_	1	nmod
5	,	,	,	_	8	punct
6	these	these	DT	_	7	det
7	results	result	NNS	_	8	nsubj
8	suggest	suggest	VBP	_	0	ROOT
9	that	that	IN	_	13	mark
10	the	the	DT	_	11	det
11	hippocampus	hippocampus	NN	_	13	nsubjpass
12	is	be	VBZ	_	13	auxpass
13	involved	involve	VBN	_	8	ccomp
14	in	in	IN	_	19	case
15	both	both	CC	_	19	cc:preconj
16	the	the	DT	_	19	det
17	so-called	so-called	JJ	_	19	amod
18	``	``	``	_	19	punct
19	hippocampal-dependent	hippocampal-dependent	JJ	_	13	nmod
20	''	''	''	_	19	punct

1	``	``	``	_	0	ROOT
2	hippocampal-independent	hippocampal-independent	JJ	_	1	root
3	''	''	''	_	2	punct

1	forms	form	NNS	_	0	ROOT
2	of	of	IN	_	3	case
3	memory	memory	NN	_	1	nmod
4	.	.	.	_	1	punct

1	It	it	PRP	_	3	nsubjpass
2	is	be	VBZ	_	3	auxpass
3	postulated	postulate	VBN	_	0	ROOT
4	that	that	IN	_	13	mark
5	some	some	DT	_	13	nsubj
6	of	of	IN	_	11	case
7	the	the	DT	_	11	det
8	observed	observe	VBN	_	11	amod
9	training-induced	training-induced	JJ	_	11	amod
10	neurobiological	neurobiological	JJ	_	11	amod
11	alterations	alteration	NNS	_	5	nmod
12	might	might	MD	_	13	aux
13	reflect	reflect	VB	_	3	ccomp
14	the	the	DT	_	15	det
15	interaction	interaction	NN	_	13	dobj
16	between	between	IN	_	17	case
17	two	two	CD	_	15	nmod
18	-LRB-	-lrb-	-LRB-	_	20	punct
19	or	or	CC	_	20	cc
20	more	more	JJR	_	17	dep
21	-RRB-	-rrb-	-RRB-	_	20	punct
22	competing	compete	VBG	_	24	amod
23	memory	memory	NN	_	24	compound
24	systems	system	NNS	_	17	dep
25	at	at	IN	_	28	case
26	the	the	DT	_	28	det
27	hippocampal	hippocampal	JJ	_	28	amod
28	level	level	NN	_	24	nmod
29	.	.	.	_	3	punct

1	Thus	thus	RB	_	21	advmod
2	,	,	,	_	21	punct
3	in	in	IN	_	4	case
4	addition	addition	NN	_	21	nmod
5	to	to	TO	_	11	case
6	its	its	PRP$	_	11	nmod:poss
7	proposed	propose	VBN	_	11	amod
8	specific	specific	JJ	_	11	amod
9	information	information	NN	_	11	compound
10	processing	processing	NN	_	11	compound
11	functions	function	NNS	_	4	nmod
12	-LRB-	-lrb-	-LRB-	_	15	punct
13	i.e.	i.e.	FW	_	15	advmod
14	,	,	,	_	15	punct
15	relational	relational	JJ	_	11	dep
16	-RRB-	-rrb-	-RRB-	_	15	punct
17	,	,	,	_	21	punct
18	the	the	DT	_	19	det
19	hippocampus	hippocampus	NN	_	21	nsubj
20	would	would	MD	_	21	aux
21	play	play	VB	_	0	ROOT
22	a	a	DT	_	23	det
23	role	role	NN	_	21	dobj
24	in	in	IN	_	25	mark
25	addressing	address	VBG	_	21	advcl
26	information	information	NN	_	25	dobj
27	to	to	TO	_	31	case
28	the	the	DT	_	31	det
29	brain	brain	NN	_	31	compound
30	memory	memory	NN	_	31	compound
31	system	system	NN	_	25	nmod
32	that	that	WDT	_	39	nsubj
33	,	,	,	_	39	punct
34	in	in	IN	_	37	case
35	a	a	DT	_	37	det
36	given	give	VBN	_	37	amod
37	situation	situation	NN	_	39	nmod
38	,	,	,	_	39	punct
39	has	have	VBZ	_	31	acl:relcl
40	the	the	DT	_	43	det
41	best	best	JJS	_	43	amod
42	adaptive	adaptive	JJ	_	43	amod
43	value	value	NN	_	39	dobj
44	.	.	.	_	21	punct
45	-LRB-	-lrb-	-LRB-	_	46	punct
46	ABSTRACT	abstract	NN	_	21	parataxis
47	TRUNCATED	truncate	VBN	_	46	acl
48	AT	at	IN	_	50	case
49	250	250	CD	_	50	nummod
50	WORDS	word	NNS	_	47	nmod
51	-RRB-	-rrb-	-RRB-	_	46	punct

1	Behavioral	behavioral	JJ	_	2	amod
2	mechanisms	mechanism	NNS	_	0	ROOT
3	underlying	underlie	VBG	_	2	acl
4	the	the	DT	_	5	det
5	link	link	NN	_	3	dobj
6	between	between	IN	_	7	case
7	smoking	smoking	NN	_	5	nmod
8	and	and	CC	_	7	cc
9	drinking	drinking	NN	_	7	conj
10	.	.	.	_	2	punct

1	Many	many	JJ	_	2	amod
2	people	people	NNS	_	3	nsubj
3	use	use	VBP	_	0	ROOT
4	both	both	DT	_	5	cc:preconj
5	drug1	drug1	NN	_	3	dobj
6	and	and	CC	_	5	cc
7	drug2	drug2	NN	_	5	conj
8	-LRB-	-lrb-	-LRB-	_	11	punct
9	i.e.	i.e.	FW	_	11	dep
10	,	,	,	_	11	punct
11	cigarettes	cigarette	NNS	_	5	dep
12	and	and	CC	_	11	cc
13	other	other	JJ	_	15	amod
14	tobacco	tobacco	NN	_	15	compound
15	products	product	NNS	_	11	conj
16	-RRB-	-rrb-	-RRB-	_	11	punct
17	.	.	.	_	3	punct

1	The	the	DT	_	3	det
2	behavioral	behavioral	JJ	_	3	amod
3	effects	effect	NNS	_	8	nsubj
4	of	of	IN	_	7	case
5	these	these	DT	_	7	det
6	two	two	CD	_	7	nummod
7	drugs	drug	NNS	_	3	nmod
8	differ	differ	VBP	_	0	ROOT
9	,	,	,	_	8	punct
10	and	and	CC	_	8	cc
11	they	they	PRP	_	14	nsubj
12	do	do	VBP	_	14	aux
13	not	not	RB	_	14	neg
14	act	act	VB	_	8	conj
15	on	on	IN	_	19	case
16	the	the	DT	_	19	det
17	same	same	JJ	_	19	amod
18	target	target	NN	_	19	compound
19	sites	site	NNS	_	14	nmod
20	in	in	IN	_	22	case
21	the	the	DT	_	22	det
22	brain	brain	NN	_	19	nmod
23	,	,	,	_	8	punct
24	although	although	IN	_	27	mark
25	they	they	PRP	_	27	nsubj
26	may	may	MD	_	27	aux
27	share	share	VB	_	8	advcl
28	,	,	,	_	27	punct
29	or	or	CC	_	27	cc
30	partly	partly	RB	_	31	advmod
31	share	share	NN	_	27	conj
32	,	,	,	_	27	punct
33	certain	certain	JJ	_	34	amod
34	properties	property	NNS	_	27	dobj
35	.	.	.	_	8	punct

1	The	the	DT	_	2	det
2	initiation	initiation	NN	_	10	nsubjpass
3	of	of	IN	_	4	case
4	drug1	drug1	NN	_	2	nmod
5	or	or	CC	_	4	cc
6	drug2	drug2	NN	_	7	compound
7	use	use	NN	_	4	conj
8	may	may	MD	_	10	aux
9	be	be	VB	_	10	auxpass
10	precipitated	precipitate	VBN	_	0	ROOT
11	by	by	IN	_	14	case
12	similar	similar	JJ	_	14	amod
13	personality	personality	NN	_	14	compound
14	characteristics	characteristic	NNS	_	10	nmod
15	in	in	IN	_	17	case
16	the	the	DT	_	17	det
17	user	user	NN	_	14	nmod
18	,	,	,	_	14	punct
19	such	such	JJ	_	21	case
20	as	as	IN	_	19	mwe
21	impulsivity	impulsivity	NN	_	14	nmod
22	and	and	CC	_	21	cc
23	sensation	sensation	NN	_	21	conj
24	seeking	seek	VBG	_	21	acl
25	.	.	.	_	10	punct

1	Moreover	moreover	RB	_	12	advmod
2	,	,	,	_	12	punct
3	the	the	DT	_	4	det
4	mechanisms	mechanism	NNS	_	12	nsubj
5	underlying	underlie	VBG	_	4	acl
6	the	the	DT	_	7	det
7	development	development	NN	_	5	dobj
8	of	of	IN	_	9	case
9	dependence	dependence	NN	_	7	nmod
10	may	may	MD	_	12	aux
11	be	be	VB	_	12	cop
12	similar	similar	JJ	_	0	ROOT
13	for	for	IN	_	14	case
14	drug1	drug1	NN	_	12	nmod
15	and	and	CC	_	14	cc
16	drug2	drug2	NN	_	14	conj
17	.	.	.	_	12	punct

1	Thus	thus	RB	_	22	advmod
2	,	,	,	_	22	punct
3	certain	certain	JJ	_	4	amod
4	factors	factor	NNS	_	22	nsubj
5	,	,	,	_	4	punct
6	such	such	JJ	_	8	mark
7	as	as	IN	_	6	mwe
8	reinforcing	reinforce	VBG	_	4	acl
9	drug	drug	NN	_	10	compound
10	effects	effect	NNS	_	8	dobj
11	,	,	,	_	4	punct
12	conditioning	conditioning	NN	_	13	compound
13	processes	process	NNS	_	4	conj
14	,	,	,	_	4	punct
15	automatic	automatic	JJ	_	16	amod
16	behavior	behavior	NN	_	4	conj
17	,	,	,	_	4	punct
18	and	and	CC	_	4	cc
19	stress	stress	NN	_	4	conj
20	,	,	,	_	22	punct
21	may	may	MD	_	22	aux
22	influence	influence	VB	_	0	ROOT
23	the	the	DT	_	24	det
24	development	development	NN	_	22	dobj
25	of	of	IN	_	26	case
26	dependence	dependence	NN	_	24	nmod
27	on	on	IN	_	29	case
28	both	both	DT	_	29	det
29	drugs	drug	NNS	_	24	nmod
30	.	.	.	_	22	punct

1	Other	other	JJ	_	2	amod
2	factors	factor	NNS	_	23	nsubj
3	,	,	,	_	2	punct
4	such	such	JJ	_	6	case
5	as	as	IN	_	4	mwe
6	tolerance	tolerance	NN	_	2	nmod
7	and	and	CC	_	6	cc
8	sensitization	sensitization	NN	_	6	conj
9	to	to	TO	_	13	case
10	the	the	DT	_	11	det
11	drugs	drug	NNS	_	13	nmod:poss
12	'	'	POS	_	11	case
13	actions	action	NNS	_	8	nmod
14	and	and	CC	_	6	cc
15	the	the	DT	_	16	det
16	development	development	NN	_	6	conj
17	of	of	IN	_	19	case
18	withdrawal	withdrawal	NN	_	19	compound
19	symptoms	symptom	NNS	_	16	nmod
20	,	,	,	_	2	punct
21	may	may	MD	_	23	aux
22	also	also	RB	_	23	advmod
23	contribute	contribute	VB	_	0	ROOT
24	to	to	TO	_	25	case
25	dependence	dependence	NN	_	23	nmod
26	.	.	.	_	23	punct

1	This	this	DT	_	2	det
2	review	review	NN	_	3	nsubj
3	discusses	discuss	VBZ	_	0	ROOT
4	the	the	DT	_	5	det
5	actions	action	NNS	_	3	dobj
6	of	of	IN	_	9	case
7	the	the	DT	_	9	det
8	two	two	CD	_	9	nummod
9	drugs	drug	NNS	_	5	nmod
10	on	on	IN	_	13	case
11	certain	certain	JJ	_	13	amod
12	brain	brain	NN	_	13	compound
13	chemical	chemical	NN	_	5	nmod
14	-LRB-	-lrb-	-LRB-	_	17	punct
15	i.e.	i.e.	FW	_	17	dep
16	,	,	,	_	17	punct
17	neurotransmitter	neurotransmitter	NN	_	19	dep
18	-RRB-	-rrb-	-RRB-	_	17	punct
19	systems	system	NNS	_	13	dep
20	and	and	CC	_	13	cc
21	the	the	DT	_	22	det
22	extent	extent	NN	_	13	conj
23	to	to	TO	_	24	case
24	which	which	WDT	_	32	nmod
25	the	the	DT	_	26	det
26	effects	effect	NNS	_	32	nsubj
27	of	of	IN	_	30	case
28	the	the	DT	_	30	det
29	two	two	CD	_	30	nummod
30	drugs	drug	NNS	_	26	nmod
31	may	may	MD	_	32	aux
32	interact	interact	VB	_	22	acl:relcl
33	.	.	.	_	3	punct

1	Vancomycin	Vancomycin	NNP	_	3	compound
2	resistance	resistance	NN	_	3	compound
3	reversal	reversal	NN	_	0	ROOT
4	in	in	IN	_	5	case
5	enterococci	enterococci	NN	_	3	nmod
6	by	by	IN	_	7	case
7	flavonoids	flavonoid	NNS	_	5	nmod
8	.	.	.	_	3	punct

1	The	the	DT	_	2	det
2	development	development	NN	_	15	nsubj
3	of	of	IN	_	6	case
4	clinical	clinical	JJ	_	6	amod
5	vancomycin-resistant	vancomycin-resistant	JJ	_	6	amod
6	strains	strain	NNS	_	2	nmod
7	of	of	IN	_	8	case
8	enterococci	enterococci	NN	_	6	nmod
9	-LRB-	-lrb-	-LRB-	_	10	punct
10	VRE	vre	NN	_	8	appos
11	-RRB-	-rrb-	-RRB-	_	10	punct
12	is	be	VBZ	_	15	cop
13	a	a	DT	_	15	det
14	major	major	JJ	_	15	amod
15	cause	cause	NN	_	0	ROOT
16	for	for	IN	_	17	case
17	concern	concern	NN	_	15	nmod
18	.	.	.	_	15	punct

1	Here	here	RB	_	3	advmod
2	we	we	PRP	_	3	nsubj
3	show	show	VBP	_	0	ROOT
4	that	that	IN	_	15	mark
5	a	a	DT	_	6	det
6	combination	combination	NN	_	15	nsubjpass
7	of	of	IN	_	8	case
8	drug1	drug1	NN	_	6	nmod
9	or	or	CC	_	8	cc
10	3,7-dihydroxyflavone	3,7-dihydroxyflavone	NN	_	8	conj
11	with	with	IN	_	12	case
12	drug2	drug2	NN	_	6	nmod
13	may	may	MD	_	15	aux
14	be	be	VB	_	15	auxpass
15	used	use	VBN	_	3	ccomp
16	to	to	TO	_	17	mark
17	sensitize	sensitize	VB	_	15	xcomp
18	resistant	resistant	JJ	_	19	amod
19	strains	strain	NNS	_	17	dobj
20	of	of	IN	_	22	case
21	Enterococcus	enterococcus	NN	_	22	compound
22	faecalis	faecalis	NN	_	19	nmod
23	and	and	CC	_	22	cc
24	Enterococcus	enterococcus	NN	_	25	compound
25	faecium	faecium	NN	_	22	conj
26	to	to	TO	_	28	case
27	the	the	DT	_	28	det
28	level	level	NN	_	17	nmod
29	of	of	IN	_	31	case
30	vancomycin-sensitive	vancomycin-sensitive	JJ	_	31	amod
31	strains	strain	NNS	_	28	nmod
32	.	.	.	_	3	punct

1	Minimum	Minimum	NNP	_	3	compound
2	inhibitory	inhibitory	JJ	_	3	amod
3	concentrations	concentration	NNS	_	11	nsubjpass
4	-LRB-	-lrb-	-LRB-	_	5	punct
5	MICs	mic	NNS	_	3	appos
6	-RRB-	-rrb-	-RRB-	_	5	punct
7	and	and	CC	_	3	cc
8	viable	viable	JJ	_	9	amod
9	counts	count	NNS	_	3	conj
10	were	be	VBD	_	11	auxpass
11	determined	determine	VBN	_	0	ROOT
12	in	in	IN	_	14	case
13	Iso-sensitest	iso-sensitest	JJ	_	14	amod
14	broth	broth	NN	_	11	nmod
15	using	use	VBG	_	11	xcomp
16	a	a	DT	_	18	det
17	microtitre	microtitre	NN	_	18	compound
18	method	method	NN	_	15	dobj
19	.	.	.	_	11	punct

1	MICs	mic	NNS	_	18	nsubjpass
2	of	of	IN	_	3	case
3	drug1	drug1	NN	_	1	nmod
4	against	against	IN	_	6	case
5	67	67	CD	_	6	nummod
6	%	%	NN	_	1	nmod
7	of	of	IN	_	10	case
8	resistant	resistant	JJ	_	10	amod
9	clinical	clinical	JJ	_	10	amod
10	isolates	isolate	NNS	_	6	nmod
11	and	and	CC	_	6	cc
12	a	a	DT	_	14	det
13	type	type	NN	_	14	compound
14	strain	strain	NN	_	6	conj
15	of	of	IN	_	16	case
16	enterococci	enterococcus	NNS	_	14	nmod
17	were	be	VBD	_	18	auxpass
18	lowered	lower	VBN	_	0	ROOT
19	from	from	IN	_	23	case
20	>	>	JJR	_	21	advmod
21	250	250	CD	_	23	nummod
22	microg	microg	NN	_	23	compound
23	mL	ml	NN	_	18	nmod
24	-LRB-	-lrb-	-LRB-	_	25	punct
25	-1	-1	CD	_	23	appos
26	-RRB-	-rrb-	-RRB-	_	25	punct
27	to	to	TO	_	28	case
28	1	1	CD	_	23	nmod

1	4	4	CD	_	3	nummod
2	microg	microg	NN	_	3	compound
3	mL	ml	NN	_	0	ROOT
4	-LRB-	-lrb-	-LRB-	_	5	punct
5	-1	-1	CD	_	3	appos
6	-RRB-	-rrb-	-RRB-	_	5	punct
7	in	in	IN	_	11	case
8	the	the	DT	_	11	dep
9	presence	presence	NN	_	11	dep
10	of	of	IN	_	11	case
11	drug1	drug1	NN	_	3	nmod
12	-LRB-	-lrb-	-LRB-	_	15	punct
13	12.5	12.5	CD	_	15	nummod
14	microg	microg	NN	_	15	compound
15	mL	ml	NN	_	11	dep
16	-LRB-	-lrb-	-LRB-	_	17	punct
17	-1	-1	CD	_	15	appos
18	-RRB-	-rrb-	-RRB-	_	17	punct
19	-RRB-	-rrb-	-RRB-	_	15	punct
20	or	or	CC	_	11	cc
21	3,7-dihydroxyflavone	3,7-dihydroxyflavone	NN	_	25	compound
22	-LRB-	-lrb-	-LRB-	_	25	punct
23	6.25	6.25	CD	_	25	nummod
24	microg	microg	NN	_	25	compound
25	mL	ml	NN	_	11	conj
26	-LRB-	-lrb-	-LRB-	_	27	punct
27	-1	-1	CD	_	25	appos
28	-RRB-	-rrb-	-RRB-	_	27	punct
29	-RRB-	-rrb-	-RRB-	_	3	punct
30	.	.	.	_	3	punct

1	Viable	viable	JJ	_	2	amod
2	counts	count	NNS	_	0	ROOT
3	for	for	IN	_	6	case
4	type	type	NN	_	6	compound
5	culture	culture	NN	_	6	compound
6	E.	E.	NNP	_	2	nmod

1	faecalis	faecalis	NN	_	2	compound
2	ATCC	atcc	NN	_	4	nsubj
3	51299	51299	CD	_	2	nummod
4	showed	show	VBD	_	0	ROOT
5	the	the	DT	_	6	det
6	flavonoids	flavonoid	NNS	_	9	nsubj
7	alone	alone	RB	_	6	advmod
8	significantly	significantly	RB	_	9	advmod
9	lowered	lower	VBD	_	4	ccomp
10	numbers	number	NNS	_	9	dobj
11	of	of	IN	_	14	case
12	colony	colony	NN	_	14	compound
13	forming	form	VBG	_	14	amod
14	units	unit	NNS	_	10	nmod
15	-LRB-	-lrb-	-LRB-	_	16	punct
16	CFUs	cfus	NNS	_	14	appos
17	-RRB-	-rrb-	-RRB-	_	16	punct
18	.	.	.	_	4	punct

1	CFUs	cfus	NNS	_	3	nsubjpass
2	were	be	VBD	_	3	auxpass
3	maintained	maintain	VBN	_	0	ROOT
4	at	at	IN	_	6	case
5	low	low	JJ	_	6	amod
6	levels	level	NNS	_	3	nmod
7	-LRB-	-lrb-	-LRB-	_	13	punct
8	10	10	CD	_	13	nummod
9	-LRB-	-lrb-	-LRB-	_	13	punct
10	3	3	CD	_	13	nummod
11	-RRB-	-rrb-	-RRB-	_	13	punct
12	CFU	CFU	NNP	_	13	compound
13	mL	ml	NN	_	6	dep
14	-LRB-	-lrb-	-LRB-	_	15	punct
15	-1	-1	CD	_	13	appos
16	-RRB-	-rrb-	-RRB-	_	15	punct
17	-RRB-	-rrb-	-RRB-	_	13	punct
18	for	for	IN	_	20	case
19	24	24	CD	_	20	nummod
20	h	h	NN	_	3	nmod
21	by	by	IN	_	22	case
22	drug1	drug1	NN	_	3	nmod
23	/	/	:	_	22	punct
24	flavone	flavone	NN	_	25	compound
25	combinations	combination	NNS	_	22	dep
26	.	.	.	_	3	punct

1	This	this	DT	_	3	det
2	combinational	combinational	JJ	_	3	amod
3	action	action	NN	_	10	nsubj
4	in	in	IN	_	5	mark
5	reversing	reverse	VBG	_	3	acl
6	vancomycin	vancomycin	NN	_	7	compound
7	resistance	resistance	NN	_	5	dobj
8	of	of	IN	_	9	case
9	enterococci	enterococci	NN	_	7	nmod
10	highlights	highlight	VBZ	_	0	ROOT
11	novel	novel	JJ	_	13	amod
12	drug	drug	NN	_	13	compound
13	targets	target	NNS	_	10	dobj
14	and	and	CC	_	10	cc
15	has	have	VBZ	_	10	conj
16	importance	importance	NN	_	15	dobj
17	in	in	IN	_	19	case
18	the	the	DT	_	19	det
19	design	design	NN	_	16	nmod
20	of	of	IN	_	23	case
21	new	new	JJ	_	23	amod
22	therapeutic	therapeutic	JJ	_	23	amod
23	regimes	regime	NNS	_	19	nmod
24	against	against	IN	_	26	case
25	resistant	resistant	JJ	_	26	amod
26	pathogens	pathogen	NNS	_	23	nmod
27	.	.	.	_	10	punct

1	Lack	lack	NN	_	0	ROOT
2	of	of	IN	_	3	case
3	interaction	interaction	NN	_	1	nmod
4	between	between	IN	_	5	case
5	drug1	drug1	NN	_	3	nmod
6	and	and	CC	_	5	cc
7	drug2	drug2	NN	_	5	conj
8	:	:	:	_	1	punct
9	pharmacokinetics	pharmacokinetic	NNS	_	1	dep
10	and	and	CC	_	9	cc
11	drug	drug	NN	_	12	compound
12	disposition	disposition	NN	_	9	conj
13	.	.	.	_	1	punct

1	Previous	previous	JJ	_	2	amod
2	studies	study	NNS	_	4	nsubj
3	have	have	VBP	_	4	aux
4	demonstrated	demonstrate	VBN	_	0	ROOT
5	a	a	DT	_	7	det
6	significant	significant	JJ	_	7	amod
7	reduction	reduction	NN	_	4	dobj
8	in	in	IN	_	11	case
9	the	the	DT	_	11	det
10	oral	oral	JJ	_	11	amod
11	bioavailability	bioavailability	NN	_	7	nmod
12	of	of	IN	_	13	case
13	drug1	drug1	NN	_	11	nmod
14	and	and	CC	_	13	cc
15	drug2	drug2	NN	_	13	conj
16	when	when	WRB	_	17	advmod
17	administered	administer	VBN	_	4	advcl
18	concomitantly	concomitantly	RB	_	17	advmod
19	with	with	IN	_	22	case
20	an	a	DT	_	22	det
21	intravenous	intravenous	JJ	_	22	amod
22	drug3	drug3	NN	_	17	nmod
23	such	such	JJ	_	25	case
24	as	as	IN	_	23	mwe
25	drug4	drug4	NN	_	22	nmod
26	.	.	.	_	4	punct

1	This	this	DT	_	2	det
2	decrease	decrease	NN	_	5	nsubj
3	in	in	IN	_	4	case
4	absorption	absorption	NN	_	2	nmod
5	results	result	VBZ	_	0	ROOT
6	in	in	IN	_	9	case
7	a	a	DT	_	9	det
8	36	36	CD	_	9	nummod
9	%	%	NN	_	5	nmod
10	and	and	CC	_	9	cc
11	50	50	CD	_	12	nummod
12	%	%	NN	_	9	conj
13	lower	lower	JJR	_	14	amod
14	AUC	auc	NN	_	9	dep
15	for	for	IN	_	16	case
16	drug1	drug1	NN	_	14	nmod
17	and	and	CC	_	16	cc
18	drug2	drug2	NN	_	16	conj
19	,	,	,	_	9	punct
20	respectively	respectively	RB	_	9	advmod
21	,	,	,	_	9	punct
22	which	which	WDT	_	24	nsubj
23	could	could	MD	_	24	aux
24	cause	cause	VB	_	9	acl:relcl
25	clinical	clinical	JJ	_	26	amod
26	failures	failure	NNS	_	24	dobj
27	.	.	.	_	5	punct

1	The	the	DT	_	2	det
2	authors	author	NNS	_	3	nsubj
3	investigated	investigate	VBD	_	0	ROOT
4	the	the	DT	_	5	det
5	possibility	possibility	NN	_	3	dobj
6	of	of	IN	_	9	case
7	a	a	DT	_	9	det
8	similar	similar	JJ	_	9	amod
9	interaction	interaction	NN	_	5	nmod
10	between	between	IN	_	11	case
11	drug1	drug1	NN	_	9	nmod
12	and	and	CC	_	11	cc
13	drug2	drug2	NN	_	11	conj
14	.	.	.	_	3	punct

1	Eight	eight	CD	_	3	nummod
2	healthy	healthy	JJ	_	3	amod
3	volunteers	volunteer	NNS	_	5	nsubjpass
4	were	be	VBD	_	5	auxpass
5	randomized	randomize	VBN	_	0	ROOT
6	in	in	IN	_	12	case
7	an	a	DT	_	12	det
8	open-label	open-label	JJ	_	12	amod
9	,	,	,	_	12	punct
10	two-way	two-way	JJ	_	12	amod
11	crossover	crossover	NN	_	12	compound
12	study	study	NN	_	5	nmod
13	to	to	TO	_	14	mark
14	receive	receive	VB	_	12	acl
15	drug1	drug1	NN	_	14	dobj
16	,	,	,	_	15	punct
17	5	5	CD	_	18	compound
18	mg	mg	NN	_	19	amod
19	p.o.	p.o.	NN	_	15	appos

1	Q4H	q4h	NN	_	0	ROOT
2	,	,	,	_	1	punct
3	and	and	CC	_	1	cc
4	drug1	drug1	NN	_	1	conj
5	,	,	,	_	4	punct
6	500	500	CD	_	7	compound
7	mg	mg	NN	_	8	amod
8	p.o.	p.o.	NN	_	4	appos

1	1	1	CD	_	2	nummod
2	hour	hour	NN	_	0	ROOT
3	after	after	IN	_	2	mark
4	starting	start	VBG	_	2	dep
5	the	the	DT	_	6	det
6	drug1	drug1	NN	_	4	dobj
7	or	or	CC	_	6	cc
8	drug2	drug2	NN	_	10	compound
9	500	500	CD	_	10	compound
10	mg	mg	NN	_	6	conj
11	p.o.	p.o.	NN	_	6	dep

1	alone	alone	RB	_	0	ROOT
2	.	.	.	_	1	punct

1	Blood	blood	NN	_	2	compound
2	samples	sample	NNS	_	4	nsubjpass
3	were	be	VBD	_	4	auxpass
4	drawn	draw	VBN	_	0	ROOT
5	at	at	IN	_	6	case
6	0	0	CD	_	4	nmod
7	,	,	,	_	6	punct
8	0.5	0.5	CD	_	6	conj
9	,	,	,	_	6	punct
10	1	1	CD	_	6	conj
11	,	,	,	_	6	punct
12	1.5	1.5	CD	_	6	conj
13	,	,	,	_	6	punct
14	2	2	CD	_	6	conj
15	,	,	,	_	6	punct
16	3	3	CD	_	6	conj
17	,	,	,	_	6	punct
18	4	4	CD	_	6	conj
19	,	,	,	_	6	punct
20	6	6	CD	_	6	conj
21	,	,	,	_	6	punct
22	8	8	CD	_	6	conj
23	,	,	,	_	6	punct
24	12	12	CD	_	6	conj
25	,	,	,	_	6	punct
26	18	18	CD	_	6	conj
27	,	,	,	_	6	punct
28	and	and	CC	_	6	cc
29	24	24	CD	_	6	conj
30	hours	hour	NNS	_	6	dep
31	for	for	IN	_	32	case
32	Cmax	Cmax	NNP	_	4	nmod
33	,	,	,	_	32	punct
34	tmax	tmax	NN	_	32	conj
35	,	,	,	_	32	punct
36	and	and	CC	_	32	cc
37	AUC	auc	NN	_	38	compound
38	determinations	determination	NNS	_	32	conj
39	.	.	.	_	4	punct

1	There	there	EX	_	2	expl
2	was	be	VBD	_	0	ROOT
3	not	not	RB	_	2	neg
4	a	a	DT	_	6	det
5	significant	significant	JJ	_	6	amod
6	difference	difference	NN	_	2	nsubj
7	-LRB-	-lrb-	-LRB-	_	9	punct
8	p	p	NN	_	9	dep
9	>	>	JJR	_	6	dep
10	0.05	0.05	CD	_	9	nummod
11	-RRB-	-rrb-	-RRB-	_	9	punct
12	in	in	IN	_	13	case
13	AUC	auc	NN	_	6	nmod
14	-LRB-	-lrb-	-LRB-	_	13	punct
15	48.59	48.59	CD	_	14	root
16	+	+	CC	_	15	cc
17	/	/	:	_	15	conj
18	-	-	:	_	17	punct
19	8.52	8.52	CD	_	18	root
20	vs.	vs.	CC	_	19	cc
21	49.9	49.9	CD	_	19	conj
22	+	+	CC	_	19	cc
23	/	/	:	_	25	punct
24	-	-	:	_	25	punct
25	9.93	9.93	CD	_	19	conj
26	-RRB-	-rrb-	-RRB-	_	25	punct
27	,	,	,	_	19	punct
28	Cmax	cmax	NN	_	27	root
29	-LRB-	-lrb-	-LRB-	_	28	punct
30	7.73	7.73	CD	_	29	root
31	+	+	CC	_	30	cc
32	/	/	:	_	30	conj
33	-	-	:	_	32	punct
34	2.6	2.6	CD	_	33	root
35	vs.	vs.	CC	_	34	cc
36	6.6	6.6	CD	_	34	conj
37	+	+	CC	_	34	cc
38	/	/	:	_	40	punct
39	-	-	:	_	40	punct
40	2.0	2.0	CD	_	34	conj
41	-RRB-	-rrb-	-RRB-	_	40	punct
42	,	,	,	_	34	punct
43	and	and	CC	_	34	cc
44	tmax	tmax	NN	_	64	dep
45	-LRB-	-lrb-	-LRB-	_	64	punct
46	1.1	1.1	CD	_	64	dep
47	+	+	CC	_	46	cc
48	/	/	:	_	64	punct
49	-	-	:	_	64	punct
50	0.6	0.6	CD	_	64	nummod
51	vs.	vs.	CC	_	50	cc
52	1.6	1.6	CD	_	50	conj
53	+	+	CC	_	50	cc
54	/	/	:	_	56	punct
55	-	-	:	_	56	punct
56	1.1	1.1	CD	_	50	conj
57	-RRB-	-rrb-	-RRB-	_	56	punct
58	for	for	IN	_	59	case
59	drug1	drug1	NN	_	56	nmod
60	versus	versus	CC	_	59	cc
61	drug2	drug2	NN	_	59	conj
62	/	/	:	_	64	punct
63	drug3	drug3	NN	_	64	compound
64	regimens	regimen	NNS	_	34	conj
65	.	.	.	_	34	punct

1	It	it	PRP	_	3	nsubjpass
2	was	be	VBD	_	3	auxpass
3	concluded	conclude	VBN	_	0	ROOT
4	that	that	IN	_	11	mark
5	oral	oral	JJ	_	6	amod
6	drug1	drug1	NN	_	11	nsubjpass
7	and	and	CC	_	6	cc
8	drug2	drug2	NN	_	6	conj
9	can	can	MD	_	11	aux
10	be	be	VB	_	11	auxpass
11	administered	administer	VBN	_	3	ccomp
12	concomitantly	concomitantly	RB	_	11	advmod
13	without	without	IN	_	16	case
14	a	a	DT	_	16	det
15	significant	significant	JJ	_	16	amod
16	decrease	decrease	NN	_	11	nmod
17	in	in	IN	_	18	case
18	AUC	auc	NN	_	16	nmod
19	,	,	,	_	18	punct
20	Cmax	cmax	NN	_	18	conj
21	,	,	,	_	18	punct
22	or	or	CC	_	18	cc
23	tmax	tmax	NN	_	18	conj
24	.	.	.	_	3	punct

1	The	the	DT	_	2	det
2	mode	mode	NN	_	0	ROOT
3	of	of	IN	_	5	case
4	toxic	toxic	JJ	_	5	amod
5	action	action	NN	_	2	nmod
6	of	of	IN	_	9	case
7	the	the	DT	_	9	det
8	pesticide	pesticide	NN	_	9	compound
9	drug1	drug1	NN	_	5	nmod
10	:	:	:	_	2	punct
11	the	the	DT	_	12	det
12	metabolism	metabolism	NN	_	2	dep
13	of	of	IN	_	14	case
14	drug2	drug2	NN	_	12	nmod
15	to	to	TO	_	16	case
16	drug3	drug3	NN	_	12	nmod
17	.	.	.	_	2	punct

1	The	the	DT	_	3	det
2	biochemical	biochemical	JJ	_	3	amod
3	toxicology	toxicology	NN	_	23	nsubjpass
4	of	of	IN	_	5	case
5	drug1	drug1	NN	_	3	nmod
6	,	,	,	_	5	punct
7	a	a	DT	_	9	det
8	known	known	JJ	_	9	amod
9	metabolite	metabolite	NN	_	5	appos
10	of	of	IN	_	13	case
11	the	the	DT	_	13	det
12	major	major	JJ	_	13	amod
13	ingredient	ingredient	NN	_	9	nmod
14	of	of	IN	_	17	case
15	the	the	DT	_	17	det
16	pesticide	pesticide	NN	_	17	compound
17	drug2	drug2	NN	_	13	nmod
18	-LRB-	-lrb-	-LRB-	_	19	punct
19	drug3	drug3	NN	_	17	appos
20	-RRB-	-rrb-	-RRB-	_	19	punct
21	,	,	,	_	5	punct
22	was	be	VBD	_	23	auxpass
23	investigated	investigate	VBN	_	0	ROOT
24	in	in	FW	_	25	compound
25	vivo	vivo	FW	_	26	advmod
26	and	and	CC	_	23	advmod
27	in	in	FW	_	28	compound
28	vitro	vitro	FW	_	26	advmod
29	.	.	.	_	23	punct

1	Rat	rat	NN	_	3	compound
2	kidney	kidney	NN	_	3	compound
3	homogenates	homogenate	NNS	_	0	ROOT
4	supplemented	supplement	VBN	_	3	acl
5	with	with	IN	_	7	case
6	coenzyme	coenzyme	NN	_	7	compound
7	A	a	NN	_	4	nmod
8	,	,	,	_	7	punct
9	ATP	atp	NN	_	7	conj
10	,	,	,	_	7	punct
11	oxaloacetate	oxaloacetate	NN	_	7	conj
12	,	,	,	_	7	punct
13	and	and	CC	_	7	cc
14	Mg2	mg2	NN	_	7	conj
15	+	+	CC	_	3	cc
16	converted	convert	VBD	_	3	conj
17	drug1	drug1	NN	_	16	dobj
18	to	to	TO	_	19	case
19	drug2	drug2	NN	_	16	nmod
20	in	in	FW	_	21	compound
21	vitro	vitro	FW	_	16	advmod
22	.	.	.	_	3	punct

1	Administration	administration	NN	_	0	ROOT
2	of	of	IN	_	3	case
3	drug1	drug1	NN	_	1	nmod
4	-LRB-	-lrb-	-LRB-	_	7	punct
5	100	100	CD	_	7	nummod
6	mg	mg	NN	_	7	compound
7	kg	kg	NN	_	18	nsubj
8	-LRB-	-lrb-	-LRB-	_	12	punct
9	-1	-1	CD	_	12	nummod
10	-RRB-	-rrb-	-RRB-	_	12	punct
11	body	body	NN	_	12	compound
12	weight	weight	NN	_	7	appos
13	-RRB-	-rrb-	-RRB-	_	12	punct
14	to	to	TO	_	15	case
15	rats	rat	NNS	_	7	nmod
16	in	in	FW	_	17	compound
17	vivo	vivo	FW	_	7	advmod
18	resulted	result	VBD	_	3	acl:relcl
19	in	in	IN	_	21	case
20	drug2	drug2	NN	_	21	compound
21	synthesis	synthesis	NN	_	18	nmod
22	in	in	IN	_	24	case
23	the	the	DT	_	24	det
24	kidney	kidney	NN	_	21	nmod
25	,	,	,	_	24	punct
26	which	which	WDT	_	28	nsubjpass
27	was	be	VBD	_	28	auxpass
28	preceded	precede	VBN	_	24	acl:relcl
29	by	by	IN	_	31	case
30	an	a	DT	_	31	det
31	elevation	elevation	NN	_	28	nmod
32	in	in	IN	_	34	case
33	fluoride	fluoride	NN	_	34	compound
34	levels	level	NNS	_	31	nmod
35	and	and	CC	_	28	cc
36	followed	follow	VBN	_	28	conj
37	by	by	IN	_	39	case
38	citrate	citrate	NN	_	39	compound
39	accumulation	accumulation	NN	_	36	nmod
40	.	.	.	_	1	punct

1	Animals	animal	NNS	_	7	nsubj
2	dosed	dose	VBN	_	1	acl
3	with	with	IN	_	4	case
4	drug1	drug1	NN	_	2	nmod
5	did	do	VBD	_	7	aux
6	not	not	RB	_	7	neg
7	display	display	VB	_	0	ROOT
8	the	the	DT	_	12	det
9	2-3	2-3	CD	_	12	nummod
10	hour	hour	NN	_	12	compound
11	lag	lag	NN	_	12	compound
12	phase	phase	NN	_	7	dobj
13	in	in	IN	_	16	case
14	either	either	CC	_	16	cc:preconj
15	drug2	drug2	NN	_	16	compound
16	synthesis	synthesis	NN	_	7	nmod
17	or	or	CC	_	16	cc
18	in	in	IN	_	19	case
19	citrate	citrate	NN	_	16	conj
20	and	and	CC	_	19	cc
21	fluoride	fluoride	NN	_	23	compound
22	accumulation	accumulation	NN	_	23	compound
23	characteristic	characteristic	NN	_	19	conj
24	of	of	IN	_	25	case
25	animals	animal	NNS	_	19	nmod
26	dosed	dose	VBN	_	25	acl
27	with	with	IN	_	28	case
28	drug3	drug3	NN	_	26	nmod
29	.	.	.	_	7	punct

1	We	we	PRP	_	2	nsubj
2	demonstrate	demonstrate	VBP	_	0	ROOT
3	that	that	IN	_	20	mark
4	the	the	DT	_	5	det
5	conversion	conversion	NN	_	20	nsubj
6	of	of	IN	_	7	case
7	drug1	drug1	NN	_	5	nmod
8	to	to	TO	_	9	case
9	drug2	drug2	NN	_	5	nmod
10	by	by	IN	_	12	case
11	an	a	DT	_	12	det
12	NAD	NAD	NNP	_	5	nmod
13	+	+	CC	_	12	cc
14	-	-	:	_	12	punct
15	dependent	dependent	JJ	_	16	amod
16	oxidation	oxidation	NN	_	12	dep
17	is	be	VBZ	_	20	cop
18	the	the	DT	_	20	det
19	rate-limiting	rate-limiting	JJ	_	20	amod
20	step	step	NN	_	2	ccomp
21	in	in	IN	_	23	case
22	the	the	DT	_	23	det
23	synthesis	synthesis	NN	_	20	nmod
24	of	of	IN	_	27	case
25	the	the	DT	_	27	det
26	toxic	toxic	JJ	_	27	amod
27	product	product	NN	_	23	nmod
28	,	,	,	_	23	punct
29	drug3	drug3	NN	_	23	appos
30	from	from	IN	_	31	case
31	drug4	drug4	NN	_	29	nmod
32	.	.	.	_	2	punct

1	Prior	prior	RB	_	0	ROOT
2	administration	administration	NN	_	1	dep
3	of	of	IN	_	4	case
4	drug1	drug1	NN	_	2	nmod
5	-LRB-	-lrb-	-LRB-	_	8	punct
6	90	90	CD	_	7	compound
7	mg	mg	NN	_	8	amod
8	kg	kg	NN	_	16	nsubjpass
9	-LRB-	-lrb-	-LRB-	_	13	punct
10	-1	-1	CD	_	13	nummod
11	-RRB-	-rrb-	-RRB-	_	13	punct
12	body	body	NN	_	13	compound
13	weight	weight	NN	_	8	appos
14	-RRB-	-rrb-	-RRB-	_	13	punct
15	was	be	VBD	_	16	auxpass
16	shown	show	VBN	_	4	acl:relcl
17	to	to	TO	_	18	mark
18	prevent	prevent	VB	_	16	xcomp
19	the	the	DT	_	20	det
20	conversion	conversion	NN	_	18	dobj
21	of	of	IN	_	22	case
22	drug2	drug2	NN	_	20	nmod
23	-LRB-	-lrb-	-LRB-	_	26	punct
24	100	100	CD	_	26	nummod
25	mg	mg	NN	_	26	compound
26	kg	kg	NN	_	22	dep
27	-LRB-	-lrb-	-LRB-	_	31	punct
28	-1	-1	CD	_	31	nummod
29	-RRB-	-rrb-	-RRB-	_	31	punct
30	body	body	NN	_	31	compound
31	weight	weight	NN	_	26	appos
32	-RRB-	-rrb-	-RRB-	_	31	punct
33	to	to	TO	_	34	mark
34	drug3	drug3	VB	_	26	acl
35	in	in	FW	_	36	compound
36	vivo	vivo	FW	_	34	advmod
37	and	and	CC	_	34	cc
38	to	to	TO	_	39	mark
39	eliminate	eliminate	VB	_	34	conj
40	the	the	DT	_	44	det
41	fluoride	fluoride	NN	_	44	compound
42	and	and	CC	_	41	cc
43	citrate	citrate	NN	_	41	conj
44	elevations	elevation	NNS	_	39	dobj
45	seen	see	VBN	_	44	acl
46	in	in	IN	_	47	case
47	drug4	drug4	NN	_	45	nmod
48	-	-	:	_	26	punct
49	intoxicated	intoxicated	JJ	_	50	amod
50	animals	animal	NNS	_	26	dep
51	.	.	.	_	1	punct

1	However	however	RB	_	0	ROOT
2	,	,	,	_	1	punct
3	administration	administration	NN	_	2	root
4	of	of	IN	_	5	case
5	drug1	drug1	NN	_	3	nmod
6	-LRB-	-lrb-	-LRB-	_	9	punct
7	90	90	CD	_	8	compound
8	mg	mg	NN	_	9	amod
9	kg	kg	NN	_	5	dep
10	-LRB-	-lrb-	-LRB-	_	14	punct
11	-1	-1	CD	_	14	nummod
12	-RRB-	-rrb-	-RRB-	_	14	punct
13	body	body	NN	_	14	compound
14	weight	weight	NN	_	9	appos
15	-RRB-	-rrb-	-RRB-	_	14	punct
16	to	to	TO	_	17	case
17	rats	rat	NNS	_	9	nmod
18	2	2	CD	_	19	nummod
19	hours	hour	NNS	_	17	dobj
20	prior	prior	RB	_	34	advmod
21	to	to	TO	_	22	case
22	drug2	drug2	NN	_	34	nmod
23	-LRB-	-lrb-	-LRB-	_	26	punct
24	100	100	CD	_	26	nummod
25	mg	mg	NN	_	26	compound
26	kg	kg	NN	_	34	nsubj
27	-LRB-	-lrb-	-LRB-	_	31	punct
28	-1	-1	CD	_	31	nummod
29	-RRB-	-rrb-	-RRB-	_	31	punct
30	body	body	NN	_	31	compound
31	weight	weight	NN	_	26	appos
32	-RRB-	-rrb-	-RRB-	_	31	punct
33	was	be	VBD	_	34	cop
34	ineffective	ineffective	JJ	_	19	amod
35	in	in	IN	_	36	mark
36	preventing	prevent	VBG	_	34	advcl
37	drug3	drug3	NN	_	38	compound
38	synthesis	synthesis	NN	_	36	dobj
39	and	and	CC	_	9	cc
40	did	do	VBD	_	42	aux
41	not	not	RB	_	42	neg
42	diminish	diminish	VB	_	9	conj
43	fluoride	fluoride	NN	_	46	compound
44	or	or	CC	_	43	cc
45	citrate	citrate	NN	_	43	conj
46	accumulation	accumulation	NN	_	42	dobj
47	in	in	FW	_	48	compound
48	vivo	vivo	FW	_	42	advmod
49	.	.	.	_	3	punct

1	We	we	PRP	_	2	nsubj
2	conclude	conclude	VBP	_	0	ROOT
3	that	that	IN	_	17	mark
4	the	the	DT	_	8	det
5	prophylactic	prophylactic	NN	_	8	amod
6	and	and	CC	_	5	cc
7	antidotal	antidotal	JJ	_	5	conj
8	properties	property	NNS	_	17	nsubj
9	of	of	IN	_	10	case
10	drug1	drug1	NN	_	8	nmod
11	seen	see	VBN	_	8	acl
12	in	in	IN	_	13	case
13	animals	animal	NNS	_	11	nmod
14	treated	treat	VBN	_	13	acl
15	with	with	IN	_	16	case
16	drug2	drug2	NN	_	14	nmod
17	derive	derive	VBP	_	2	ccomp
18	from	from	IN	_	20	case
19	its	its	PRP$	_	20	nmod:poss
20	capacity	capacity	NN	_	17	nmod
21	to	to	TO	_	22	mark
22	inhibit	inhibit	VB	_	20	acl
23	the	the	DT	_	24	det
24	NAD	NAD	NNP	_	22	dobj
25	+	+	CC	_	24	cc
26	-	-	:	_	24	punct
27	dependent	dependent	JJ	_	28	amod
28	oxidation	oxidation	NN	_	24	dep
29	responsible	responsible	JJ	_	28	amod
30	for	for	IN	_	31	mark
31	converting	convert	VBG	_	29	advcl
32	drug3	drug3	NN	_	31	dobj
33	to	to	TO	_	34	case
34	drug4	drug4	NN	_	31	nmod
35	in	in	IN	_	38	case
36	the	the	DT	_	38	det
37	committed	committed	JJ	_	38	amod
38	step	step	NN	_	31	nmod
39	of	of	IN	_	42	case
40	the	the	DT	_	42	det
41	toxic	toxic	JJ	_	42	amod
42	pathway	pathway	NN	_	38	nmod
43	.	.	.	_	2	punct

1	drug1	drug1	NN	_	12	dep
2	-	-	:	_	1	punct
3	induced	induce	VBN	_	5	amod
4	oxidative	oxidative	JJ	_	5	amod
5	stress	stress	NN	_	12	nsubjpass
6	in	in	IN	_	8	case
7	rat	rat	NN	_	8	compound
8	brain	brain	NN	_	5	nmod
9	and	and	CC	_	8	cc
10	liver	liver	NN	_	8	conj
11	is	be	VBZ	_	12	auxpass
12	prevented	prevent	VBN	_	0	ROOT
13	by	by	IN	_	14	case
14	drug2	drug2	NN	_	12	nmod
15	or	or	CC	_	14	cc
16	drug3	drug3	NN	_	14	conj
17	.	.	.	_	12	punct

1	Considering	consider	VBG	_	25	advcl
2	that	that	IN	_	14	mark
3	the	the	DT	_	4	det
4	involvement	involvement	NN	_	14	nsubjpass
5	of	of	IN	_	8	case
6	reactive	reactive	JJ	_	8	amod
7	oxygen	oxygen	NN	_	8	compound
8	species	species	NNS	_	4	nmod
9	-LRB-	-lrb-	-LRB-	_	10	punct
10	ROS	ros	NN	_	8	appos
11	-RRB-	-rrb-	-RRB-	_	10	punct
12	has	have	VBZ	_	14	aux
13	been	be	VBN	_	14	auxpass
14	implicated	implicate	VBN	_	1	ccomp
15	in	in	IN	_	17	case
16	the	the	DT	_	17	det
17	toxicity	toxicity	NN	_	14	nmod
18	of	of	IN	_	20	case
19	various	various	JJ	_	20	amod
20	pesticides	pesticide	NNS	_	17	nmod
21	,	,	,	_	25	punct
22	this	this	DT	_	23	det
23	study	study	NN	_	25	nsubjpass
24	was	be	VBD	_	25	auxpass
25	designed	design	VBN	_	0	ROOT
26	to	to	TO	_	27	mark
27	investigate	investigate	VB	_	25	xcomp
28	the	the	DT	_	29	det
29	possibility	possibility	NN	_	27	dobj
30	of	of	IN	_	33	case
31	oxidative	oxidative	JJ	_	33	amod
32	stress	stress	NN	_	33	compound
33	induction	induction	NN	_	29	nmod
34	by	by	IN	_	35	case
35	drug1	drug1	NN	_	33	nmod
36	,	,	,	_	35	punct
37	a	a	DT	_	38	det
38	drug2	drug2	NN	_	35	appos
39	.	.	.	_	25	punct

1	Either	either	CC	_	23	cc
2	single	single	JJ	_	19	amod
3	-LRB-	-lrb-	-LRB-	_	5	punct
4	170	170	CD	_	5	nummod
5	mg/kg	mg/kg	NN	_	2	dep
6	-RRB-	-rrb-	-RRB-	_	5	punct
7	or	or	CC	_	2	cc
8	repeated	repeat	VBN	_	2	conj
9	-LRB-	-lrb-	-LRB-	_	11	punct
10	75	75	CD	_	11	nummod
11	mg/kg	mg/kg	NN	_	8	dep
12	per	per	IN	_	13	case
13	day	day	NN	_	11	nmod
14	for	for	IN	_	16	case
15	5	5	CD	_	16	nummod
16	days	day	NNS	_	11	nmod
17	-RRB-	-rrb-	-RRB-	_	11	punct
18	oral	oral	JJ	_	19	amod
19	administration	administration	NN	_	23	nsubjpass
20	of	of	IN	_	21	case
21	drug1	drug1	NN	_	19	nmod
22	was	be	VBD	_	23	auxpass
23	found	find	VBN	_	0	ROOT
24	to	to	TO	_	25	mark
25	produce	produce	VB	_	23	xcomp
26	significant	significant	JJ	_	28	amod
27	oxidative	oxidative	JJ	_	28	amod
28	stress	stress	NN	_	25	dobj
29	in	in	IN	_	33	case
30	cerebral	cerebral	JJ	_	33	amod
31	and	and	CC	_	30	cc
32	hepatic	hepatic	JJ	_	30	conj
33	tissues	tissue	NNS	_	25	nmod
34	of	of	IN	_	35	case
35	rats	rat	NNS	_	33	nmod
36	,	,	,	_	25	punct
37	as	as	RB	_	39	advmod
38	was	be	VBD	_	39	cop
39	evident	evident	JJ	_	25	advcl
40	by	by	IN	_	42	case
41	the	the	DT	_	42	det
42	elevation	elevation	NN	_	39	nmod
43	of	of	IN	_	45	case
44	the	the	DT	_	45	det
45	level	level	NN	_	42	nmod
46	of	of	IN	_	50	case
47	thiobarbituric	thiobarbituric	JJ	_	50	amod
48	acid	acid	NN	_	50	compound
49	reactive	reactive	JJ	_	50	amod
50	substances	substance	NNS	_	45	nmod
51	-LRB-	-lrb-	-LRB-	_	52	punct
52	TBARS	tbar	NNS	_	50	appos
53	-RRB-	-rrb-	-RRB-	_	52	punct
54	in	in	IN	_	56	case
55	both	both	CC	_	56	det
56	tissues	tissue	NNS	_	50	nmod
57	,	,	,	_	39	punct
58	either	either	CC	_	62	cc:preconj
59	4	4	CD	_	62	nummod
60	or	or	CC	_	59	cc
61	24	24	CD	_	59	conj
62	h	h	NN	_	39	dep
63	after	after	IN	_	64	case
64	treatment	treatment	NN	_	62	nmod
65	.	.	.	_	23	punct

1	Much	much	RB	_	2	advmod
2	higher	higher	JJR	_	3	amod
3	changes	change	NNS	_	5	nsubjpass
4	were	be	VBD	_	5	auxpass
5	observed	observe	VBN	_	0	ROOT
6	in	in	IN	_	7	case
7	liver	liver	NN	_	5	nmod
8	,	,	,	_	5	punct
9	increasing	increase	VBG	_	5	xcomp
10	from	from	IN	_	12	case
11	a	a	DT	_	12	det
12	level	level	NN	_	9	nmod
13	of	of	IN	_	15	case
14	60	60	CD	_	15	nummod
15	%	%	NN	_	12	nmod
16	at	at	IN	_	18	case
17	4	4	CD	_	18	nummod
18	h	h	NN	_	9	nmod
19	up	up	IN	_	23	advmod
20	to	to	TO	_	23	dep
21	nearly	nearly	RB	_	23	advmod
22	4	4	CD	_	23	compound
23	times	time	NNS	_	25	nummod
24	the	the	DT	_	25	det
25	control	control	NN	_	9	dobj
26	at	at	IN	_	28	case
27	24	24	CD	_	28	nummod
28	h	h	NN	_	25	nmod
29	for	for	IN	_	31	case
30	single	single	JJ	_	31	amod
31	dose	dose	NN	_	25	nmod
32	.	.	.	_	5	punct

1	Reduced	reduce	VBN	_	2	amod
2	levels	level	NNS	_	36	nsubj
3	-LRB-	-lrb-	-LRB-	_	7	punct
4	up	up	RB	_	6	advmod
5	to	to	TO	_	6	dep
6	20	20	CD	_	7	nummod
7	%	%	NN	_	2	appos
8	-RRB-	-rrb-	-RRB-	_	7	punct
9	of	of	IN	_	11	case
10	total	total	JJ	_	11	amod
11	glutathione	glutathione	NN	_	2	nmod
12	-LRB-	-lrb-	-LRB-	_	14	punct
13	total	total	JJ	_	14	amod
14	GSH	gsh	NN	_	11	appos
15	-RRB-	-rrb-	-RRB-	_	14	punct
16	,	,	,	_	2	punct
17	and	and	CC	_	2	cc
18	elevation	elevation	NN	_	2	conj
19	of	of	IN	_	21	case
20	conjugated	conjugate	VBN	_	21	amod
21	dienes	diene	NNS	_	18	nmod
22	-LRB-	-lrb-	-LRB-	_	25	punct
23	approximately	approximately	RB	_	24	advmod
24	60	60	CD	_	25	nummod
25	%	%	NN	_	21	dep
26	in	in	IN	_	27	case
27	liver	liver	NN	_	25	nmod
28	by	by	IN	_	30	case
29	single	single	JJ	_	30	amod
30	dose	dose	NN	_	25	nmod
31	at	at	IN	_	33	case
32	4	4	CD	_	33	nummod
33	h	h	NN	_	25	nmod
34	-RRB-	-rrb-	-RRB-	_	25	punct
35	also	also	RB	_	36	advmod
36	indicated	indicate	VBD	_	0	ROOT
37	the	the	DT	_	38	det
38	presence	presence	NN	_	36	dobj
39	of	of	IN	_	42	case
40	an	a	DT	_	42	det
41	oxidative	oxidative	JJ	_	42	amod
42	insult	insult	NN	_	38	nmod
43	.	.	.	_	36	punct

1	Glutathione-S-transferase	glutathione-s-transferase	NN	_	5	compound
2	-LRB-	-lrb-	-LRB-	_	3	punct
3	GST	gst	NN	_	1	appos
4	-RRB-	-rrb-	-RRB-	_	3	punct
5	activity	activity	NN	_	11	nsubj
6	,	,	,	_	11	punct
7	however	however	RB	_	11	advmod
8	,	,	,	_	11	punct
9	did	do	VBD	_	11	aux
10	not	not	RB	_	11	neg
11	differ	differ	VB	_	0	ROOT
12	from	from	IN	_	14	case
13	control	control	NN	_	14	compound
14	values	value	NNS	_	11	nmod
15	for	for	IN	_	17	case
16	any	any	DT	_	17	det
17	dose	dose	NN	_	14	nmod
18	or	or	CC	_	17	cc
19	at	at	IN	_	22	case
20	any	any	DT	_	22	det
21	time	time	NN	_	22	compound
22	point	point	NN	_	17	conj
23	in	in	IN	_	27	case
24	cerebral	cerebral	JJ	_	27	amod
25	and	and	CC	_	24	cc
26	hepatic	hepatic	JJ	_	24	conj
27	tissues	tissue	NNS	_	22	nmod
28	.	.	.	_	11	punct

1	Pretreatment	pretreatment	NN	_	36	nsubj
2	of	of	IN	_	3	case
3	rats	rat	NNS	_	1	nmod
4	with	with	IN	_	5	case
5	drug1	drug1	NN	_	1	nmod
6	-LRB-	-lrb-	-LRB-	_	8	punct
7	100	100	CD	_	8	nummod
8	mg/kg	mg/kg	NN	_	5	dep
9	,	,	,	_	8	punct
10	ip	ip	NN	_	8	appos
11	-RRB-	-rrb-	-RRB-	_	8	punct
12	or	or	CC	_	5	cc
13	drug2	drug2	NN	_	5	conj
14	-LRB-	-lrb-	-LRB-	_	16	punct
15	100	100	CD	_	16	nummod
16	mg/kg	mg/kg	NN	_	13	dep
17	per	per	IN	_	18	case
18	day	day	NN	_	16	nmod
19	,	,	,	_	16	punct
20	ig	ig	NN	_	16	appos
21	,	,	,	_	16	punct
22	for	for	IN	_	24	case
23	3	3	CD	_	24	nummod
24	days	day	NNS	_	16	nmod
25	and	and	CC	_	24	cc
26	a	a	DT	_	27	det
27	dose	dose	NN	_	24	conj
28	of	of	IN	_	30	case
29	40	40	CD	_	30	nummod
30	mg/kg	mg/kg	NN	_	27	nmod
31	on	on	IN	_	34	case
32	the	the	DT	_	34	det
33	4th	4th	JJ	_	34	amod
34	day	day	NN	_	16	nmod
35	-RRB-	-rrb-	-RRB-	_	16	punct
36	provided	provide	VBD	_	0	ROOT
37	significant	significant	JJ	_	38	amod
38	protection	protection	NN	_	36	dobj
39	against	against	IN	_	41	case
40	the	the	DT	_	41	det
41	elevation	elevation	NN	_	38	nmod
42	of	of	IN	_	44	case
43	TBARS	tbar	NNS	_	44	compound
44	levels	level	NNS	_	41	nmod
45	in	in	IN	_	49	case
46	cerebral	cerebral	JJ	_	49	amod
47	and	and	CC	_	46	cc
48	hepatic	hepatic	JJ	_	46	conj
49	tissues	tissue	NNS	_	38	nmod
50	,	,	,	_	36	punct
51	induced	induce	VBN	_	36	dep
52	by	by	IN	_	55	case
53	single	single	JJ	_	55	amod
54	high	high	JJ	_	55	amod
55	dose	dose	NN	_	51	nmod
56	of	of	IN	_	59	case
57	oral	oral	JJ	_	59	amod
58	drug3	drug3	NN	_	59	compound
59	administration	administration	NN	_	55	nmod
60	within	within	IN	_	62	case
61	4	4	CD	_	62	nummod
62	h.	h.	NN	_	51	nmod

1	Thus	thus	RB	_	5	advmod
2	,	,	,	_	5	punct
3	the	the	DT	_	4	det
4	results	result	NNS	_	5	nsubj
5	suggest	suggest	VBP	_	0	ROOT
6	that	that	IN	_	11	mark
7	drug1	drug1	NN	_	8	compound
8	exposure	exposure	NN	_	11	nsubj
9	of	of	IN	_	10	case
10	rats	rat	NNS	_	8	nmod
11	results	result	VBZ	_	5	ccomp
12	in	in	IN	_	16	case
13	free	free	JJ	_	16	amod
14	radical-mediated	radical-mediated	JJ	_	16	amod
15	tissue	tissue	NN	_	16	compound
16	damage	damage	NN	_	11	nmod
17	,	,	,	_	11	punct
18	as	as	IN	_	19	mark
19	indicated	indicate	VBN	_	11	advcl
20	by	by	IN	_	22	case
21	elevated	elevated	JJ	_	22	amod
22	cerebral	cerebral	JJ	_	19	nmod
23	and	and	CC	_	22	cc
24	hepatic	hepatic	JJ	_	26	amod
25	lipid	lipid	NN	_	26	compound
26	peroxidation	peroxidation	NN	_	22	conj
27	,	,	,	_	22	punct
28	which	which	WDT	_	30	nsubjpass
29	was	be	VBD	_	30	auxpass
30	prevented	prevent	VBN	_	22	acl:relcl
31	by	by	IN	_	32	case
32	drug2	drug2	NN	_	30	nmod
33	and	and	CC	_	32	cc
34	drug3	drug3	NN	_	32	conj
35	.	.	.	_	5	punct

1	Serum	serum	NN	_	3	compound
2	drug1	drug1	NN	_	3	compound
3	levels	level	NNS	_	0	ROOT
4	using	use	VBG	_	3	acl
5	an	a	DT	_	7	det
6	125I-labelled	125i-labelled	JJ	_	7	amod
7	antigen	antigen	NN	_	4	dobj
8	:	:	:	_	7	punct
9	Validation	validation	NN	_	7	dep
10	of	of	IN	_	11	case
11	method	method	NN	_	9	nmod
12	and	and	CC	_	11	cc
13	observations	observation	NNS	_	11	conj
14	on	on	IN	_	16	case
15	cardiac	cardiac	JJ	_	16	amod
16	patients	patient	NNS	_	9	nmod
17	.	.	.	_	3	punct

1	1	1	LS	_	0	ROOT
2	.	.	.	_	1	punct

1	Determinations	determination	NNS	_	15	nsubj
2	of	of	IN	_	5	case
3	serum	serum	NN	_	5	compound
4	drug1	drug1	NN	_	5	compound
5	levels	level	NNS	_	1	nmod
6	utilizing	utilize	VBG	_	1	acl
7	commercially	commercially	RB	_	8	advmod
8	available	available	JJ	_	9	amod
9	kits	kit	NNS	_	6	dobj
10	with	with	IN	_	13	case
11	an	a	DT	_	13	det
12	125I-labelled	125i-labelled	JJ	_	13	amod
13	antigen	antigen	NN	_	9	nmod
14	were	be	VBD	_	15	cop
15	precise	precise	JJ	_	0	ROOT
16	and	and	CC	_	15	cc
17	not	not	RB	_	19	neg
18	materially	materially	RB	_	19	advmod
19	different	different	JJ	_	15	conj
20	from	from	IN	_	21	case
21	results	result	NNS	_	15	nmod
22	obtained	obtain	VBN	_	21	acl
23	with	with	IN	_	26	case
24	a	a	DT	_	26	det
25	3H-labelled	3h-labelled	JJ	_	26	amod
26	antigen	antigen	NN	_	22	nmod
27	.	.	.	_	15	punct

1	2	2	LS	_	0	ROOT
2	.	.	.	_	1	punct

1	In	in	IN	_	4	mark
2	order	order	NN	_	1	mwe
3	to	to	TO	_	4	dep
4	approximate	approximate	JJ	_	15	advcl
5	the	the	DT	_	8	det
6	steady	steady	JJ	_	8	amod
7	state	state	NN	_	8	compound
8	level	level	NN	_	4	dobj
9	,	,	,	_	15	punct
10	serum	serum	NN	_	12	compound
11	drug1	drug1	NN	_	12	compound
12	levels	level	NNS	_	15	nsubjpass
13	should	should	MD	_	15	aux
14	be	be	VB	_	15	auxpass
15	drawn	draw	VBN	_	0	ROOT
16	either	either	CC	_	22	cc:preconj
17	before	before	IN	_	22	case
18	or	or	CC	_	22	cc
19	at	at	IN	_	20	case
20	least	least	JJS	_	21	nmod:npmod
21	six	six	CD	_	22	nummod
22	hours	hour	NNS	_	15	nmod
23	following	follow	VBG	_	25	case
24	the	the	DT	_	25	det
25	administration	administration	NN	_	22	nmod
26	of	of	IN	_	29	case
27	an	a	DT	_	29	det
28	oral	oral	JJ	_	29	amod
29	tablet	tablet	NN	_	25	nmod
30	.	.	.	_	15	punct

1	3	3	LS	_	0	ROOT
2	.	.	.	_	1	punct

1	Concomitantly	concomitantly	RB	_	3	advmod
2	given	give	VBN	_	3	amod
3	drug1	drug1	NN	_	6	nsubj
4	did	do	VBD	_	6	aux
5	not	not	RB	_	6	neg
6	interfere	interfere	VB	_	0	ROOT
7	with	with	IN	_	9	case
8	the	the	DT	_	9	det
9	absorption	absorption	NN	_	6	nmod
10	of	of	IN	_	12	case
11	a	a	DT	_	12	det
12	tablet	tablet	NN	_	9	nmod
13	of	of	IN	_	14	case
14	drug2	drug2	NN	_	12	nmod
15	.	.	.	_	6	punct

1	4	4	LS	_	0	ROOT
2	.	.	.	_	1	punct

1	In	in	IN	_	4	case
2	the	the	DT	_	4	det
3	digitalized	digitalized	JJ	_	4	amod
4	patient	patient	NN	_	0	ROOT
5	,	,	,	_	4	punct
6	slow	slow	JJ	_	7	amod
7	alterations	alteration	NNS	_	5	root
8	in	in	IN	_	10	case
9	serum	serum	NN	_	10	compound
10	levels	level	NNS	_	7	nmod
11	after	after	IN	_	14	mark
12	oral	oral	JJ	_	13	amod
13	administration	administration	NN	_	14	nsubj
14	appeared	appear	VBD	_	7	acl
15	well	well	RB	_	16	advmod
16	correlated	correlate	VBN	_	14	xcomp
17	with	with	IN	_	16	nmod
18	,	,	,	_	16	punct
19	at	at	IN	_	16	advmod
20	least	least	JJS	_	19	mwe
21	,	,	,	_	16	punct
22	the	the	DT	_	25	det
23	negative	negative	JJ	_	25	amod
24	chronotropic	chronotropic	JJ	_	25	amod
25	effects	effect	NNS	_	16	dobj
26	of	of	IN	_	28	case
27	the	the	DT	_	28	det
28	drug	drug	NN	_	25	nmod
29	.	.	.	_	7	punct

1	5	5	CD	_	0	ROOT
2	.	.	.	_	1	punct

1	Maximal	maximal	JJ	_	3	amod
2	exercise	exercise	NN	_	3	compound
3	testing	testing	NN	_	16	nsubj
4	,	,	,	_	3	punct
5	a	a	DT	_	6	det
6	maneuver	maneuver	NN	_	8	nsubj
7	often	often	RB	_	8	advmod
8	applied	apply	VBD	_	3	acl:relcl
9	to	to	TO	_	11	case
10	cardiac	cardiac	JJ	_	11	amod
11	patients	patient	NNS	_	8	nmod
12	,	,	,	_	3	punct
13	does	do	VBZ	_	16	aux
14	not	not	RB	_	16	neg
15	significantly	significantly	RB	_	16	advmod
16	alter	alter	VB	_	0	ROOT
17	the	the	DT	_	20	det
18	serum	serum	NN	_	20	compound
19	drug1	drug1	NN	_	20	compound
20	level	level	NN	_	16	dobj
21	.	.	.	_	16	punct

1	Analysis	analysis	NN	_	0	ROOT
2	of	of	IN	_	3	case
3	drug1	drug1	NN	_	1	nmod
4	-	-	:	_	1	punct
5	induced	induce	VBN	_	6	amod
6	diarrhea	diarrhea	NN	_	1	dep
7	in	in	IN	_	9	case
8	cecectomized	cecectomized	JJ	_	9	amod
9	rats	rat	NNS	_	6	nmod
10	.	.	.	_	1	punct

1	The	the	DT	_	10	dep
2	drug1	drug1	NN	_	10	dep
3	-LRB-	-lrb-	-LRB-	_	4	punct
4	drug2	drug2	NN	_	2	appos
5	-RRB-	-rrb-	-RRB-	_	4	punct
6	-	-	:	_	10	punct
7	induced	induce	VBN	_	8	amod
8	diarrhea	diarrhea	NN	_	10	nsubjpass
9	was	be	VBD	_	10	auxpass
10	analyzed	analyze	VBN	_	0	ROOT
11	in	in	IN	_	13	case
12	cecectomized	cecectomized	JJ	_	13	amod
13	rats	rat	NNS	_	10	nmod
14	prepared	prepare	VBN	_	13	acl
15	by	by	IN	_	16	mark
16	resecting	resect	VBG	_	14	advcl
17	the	the	DT	_	18	det
18	cecum	cecum	NN	_	16	dobj
19	and	and	CC	_	18	cc
20	its	its	PRP$	_	21	nmod:poss
21	vasculature	vasculature	NN	_	18	conj
22	without	without	IN	_	23	mark
23	disturbing	disturb	VBG	_	16	advcl
24	the	the	DT	_	26	det
25	ileocecal	ileocecal	JJ	_	26	amod
26	junction	junction	NN	_	23	dobj
27	.	.	.	_	10	punct

1	drug1	drug1	NN	_	0	ROOT
2	-LRB-	-lrb-	-LRB-	_	5	punct
3	0.1-1	0.1-1	CD	_	4	compound
4	.0	.0	CD	_	5	nummod
5	mg/kg	mg/kg	NN	_	1	dep
6	,	,	,	_	5	punct
7	p.o.	p.o.	NN	_	5	appos
8	-RRB-	-rrb-	-RRB-	_	5	punct

1	dose-dependently	dose-dependently	RB	_	2	advmod
2	increased	increase	VBN	_	4	amod
3	the	the	DT	_	4	det
4	number	number	NN	_	0	ROOT
5	of	of	IN	_	7	case
6	defecation	defecation	NN	_	7	compound
7	episodes	episode	NNS	_	4	nmod
8	and	and	CC	_	4	cc
9	induced	induce	VBD	_	4	conj
10	a	a	DT	_	14	det
11	soft	soft	JJ	_	14	amod
12	and	and	CC	_	11	cc
13	watery	watery	JJ	_	11	conj
14	stool	stool	NN	_	9	dobj
15	in	in	IN	_	17	case
16	cecectomized	cecectomized	JJ	_	17	amod
17	rats	rat	NNS	_	14	nmod
18	.	.	.	_	4	punct

1	At	at	IN	_	3	case
2	0.3	0.3	CD	_	3	nummod
3	mg/kg	mg/kg	NN	_	12	nmod
4	,	,	,	_	12	punct
5	the	the	DT	_	7	det
6	diarrhea-inducing	diarrhea-inducing	JJ	_	7	amod
7	effects	effect	NNS	_	12	nsubj
8	of	of	IN	_	9	case
9	drug1	drug1	NN	_	7	nmod
10	were	be	VBD	_	12	cop
11	more	more	RBR	_	12	advmod
12	pronounced	pronounced	JJ	_	0	ROOT
13	in	in	IN	_	14	case
14	cecectomized	cecectomize	VBN	_	12	nmod
15	than	than	IN	_	18	case
16	in	in	IN	_	18	case
17	control	control	NN	_	18	compound
18	rats	rat	NNS	_	12	nmod
19	.	.	.	_	12	punct

1	When	when	WRB	_	2	advmod
2	given	give	VBN	_	10	advcl
3	i.p.	i.p.	RB	_	2	advmod
4	,	,	,	_	10	punct
5	drug1	drug1	NN	_	10	nsubj
6	-LRB-	-lrb-	-LRB-	_	8	punct
7	0.3	0.3	CD	_	8	nummod
8	mg/kg	mg/kg	NN	_	5	appos
9	-RRB-	-rrb-	-RRB-	_	8	punct
10	induced	induce	VBD	_	0	ROOT
11	a	a	DT	_	13	det
12	watery	watery	JJ	_	13	amod
13	stool	stool	NN	_	10	dobj
14	in	in	IN	_	18	case
15	cecectomized	cecectomize	VBN	_	18	amod
16	and	and	CC	_	15	cc
17	control	control	JJ	_	15	conj
18	rats	rat	NNS	_	10	nmod
19	with	with	IN	_	22	case
20	the	the	DT	_	22	det
21	same	same	JJ	_	22	amod
22	efficacy	efficacy	NN	_	10	nmod
23	,	,	,	_	10	punct
24	although	although	IN	_	28	mark
25	these	these	DT	_	26	det
26	effects	effect	NNS	_	28	nsubj
27	were	be	VBD	_	28	cop
28	short-lasting	short-lasting	JJ	_	10	advcl
29	as	as	IN	_	30	mark
30	compared	compare	VBN	_	28	advcl
31	to	to	TO	_	33	case
32	oral	oral	JJ	_	33	amod
33	administration	administration	NN	_	30	nmod
34	.	.	.	_	10	punct

1	drug1	drug1	NN	_	0	ROOT
2	-LRB-	-lrb-	-LRB-	_	4	punct
3	4	4	CD	_	4	nummod
4	ml/kg	ml/kg	NN	_	1	dep
5	,	,	,	_	4	punct
6	p.o.	p.o.	NN	_	4	appos
7	-RRB-	-rrb-	-RRB-	_	4	punct

1	also	also	RB	_	2	advmod
2	induced	induce	VBN	_	0	ROOT
3	diarrhea	diarrhea	NN	_	2	dobj
4	,	,	,	_	2	punct
5	but	but	CC	_	2	cc
6	did	do	VBD	_	8	aux
7	not	not	RB	_	8	neg
8	produce	produce	VB	_	2	conj
9	a	a	DT	_	11	det
10	watery	watery	JJ	_	11	amod
11	stool	stool	NN	_	8	dobj
12	in	in	IN	_	14	case
13	cecectomized	cecectomized	JJ	_	14	amod
14	rats	rat	NNS	_	11	nmod
15	.	.	.	_	2	punct

1	There	there	EX	_	2	expl
2	were	be	VBD	_	0	ROOT
3	no	no	DT	_	4	neg
4	differences	difference	NNS	_	2	nsubj
5	between	between	IN	_	9	case
6	cecectomized	cecectomized	JJ	_	9	amod
7	and	and	CC	_	6	cc
8	control	control	JJ	_	6	conj
9	rats	rat	NNS	_	4	nmod
10	in	in	IN	_	14	case
11	basal	basal	JJ	_	14	amod
12	small	small	JJ	_	14	amod
13	intestinal	intestinal	JJ	_	14	amod
14	transits	transit	NNS	_	9	nmod
15	or	or	CC	_	14	cc
16	in	in	IN	_	17	case
17	drug1	drug1	NN	_	14	conj
18	-LRB-	-lrb-	-LRB-	_	20	punct
19	0.3	0.3	CD	_	20	nummod
20	mg/kg	mg/kg	NN	_	17	dep
21	,	,	,	_	20	punct
22	p.o.	p.o.	NN	_	20	appos
23	-RRB-	-rrb-	-RRB-	_	20	punct
24	-	-	:	_	4	punct
25	induced	induce	VBN	_	26	amod
26	enhancements	enhancement	NNS	_	4	dep
27	.	.	.	_	2	punct

1	Moreover	moreover	RB	_	15	advmod
2	,	,	,	_	15	punct
3	the	the	DT	_	12	det
4	basal	basal	JJ	_	12	amod
5	and	and	CC	_	4	cc
6	drug1	drug1	NN	_	4	conj
7	-	-	:	_	4	punct
8	induced	induce	VBN	_	12	amod
9	jejunal	jejunal	JJ	_	12	amod
10	net	net	JJ	_	12	amod
11	fluid	fluid	NN	_	12	compound
12	transfers	transfer	NNS	_	15	nsubj
13	were	be	VBD	_	15	cop
14	the	the	DT	_	15	det
15	same	same	JJ	_	0	ROOT
16	in	in	IN	_	21	case
17	cecectomized	cecectomize	VBN	_	21	amod
18	and	and	CC	_	17	cc
19	in	in	IN	_	17	conj
20	control	control	NN	_	21	compound
21	rats	rat	NNS	_	15	nmod
22	.	.	.	_	15	punct

1	On	on	IN	_	4	case
2	the	the	DT	_	4	det
3	other	other	JJ	_	4	amod
4	hand	hand	NN	_	20	nmod
5	,	,	,	_	20	punct
6	the	the	DT	_	8	det
7	enhanced	enhance	VBN	_	8	amod
8	secretion	secretion	NN	_	20	nsubj
9	of	of	IN	_	11	case
10	colonic	colonic	JJ	_	11	amod
11	fluid	fluid	NN	_	8	nmod
12	by	by	IN	_	13	case
13	drug1	drug1	NN	_	8	nmod
14	,	,	,	_	8	punct
15	given	give	VBN	_	8	acl
16	intraluminally	intraluminally	RB	_	15	advmod
17	,	,	,	_	8	punct
18	was	be	VBD	_	20	cop
19	only	only	RB	_	20	advmod
20	half	half	NN	_	0	ROOT
21	of	of	IN	_	22	case
22	that	that	DT	_	20	nmod
23	in	in	IN	_	25	case
24	control	control	NN	_	25	compound
25	rats	rat	NNS	_	22	nmod
26	,	,	,	_	20	punct
27	whereas	whereas	IN	_	20	dep
28	the	the	DT	_	31	det
29	colonic	colonic	JJ	_	31	amod
30	transit-enhancing	transit-enhancing	NN	_	31	compound
31	effect	effect	NN	_	39	nsubj
32	of	of	IN	_	33	case
33	drug2	drug2	NN	_	31	nmod
34	in	in	IN	_	36	case
35	cecectomized	cecectomized	JJ	_	36	amod
36	rats	rat	NNS	_	31	nmod
37	was	be	VBD	_	39	cop
38	more	more	RBR	_	39	advmod
39	pronounced	pronounced	JJ	_	20	parataxis
40	than	than	IN	_	43	case
41	in	in	IN	_	43	case
42	control	control	NN	_	43	compound
43	rats	rat	NNS	_	39	nmod
44	at	at	IN	_	45	case
45	15	15	CD	_	39	nmod
46	but	but	CC	_	45	cc
47	not	not	RB	_	50	neg
48	at	at	IN	_	50	case
49	30	30	CD	_	50	nummod
50	min	min	NN	_	45	conj
51	after	after	IN	_	53	case
52	its	its	PRP$	_	53	nmod:poss
53	administration	administration	NN	_	50	nmod
54	.	.	.	_	20	punct

1	The	the	DT	_	5	det
2	basal	basal	JJ	_	5	amod
3	colonic	colonic	JJ	_	5	amod
4	fluid	fluid	NN	_	5	compound
5	contents	contents	NNS	_	10	nsubj
6	and	and	CC	_	5	cc
7	transits	transit	NNS	_	5	conj
8	were	be	VBD	_	10	cop
9	the	the	DT	_	10	det
10	same	same	JJ	_	0	ROOT
11	in	in	IN	_	16	case
12	cecectomized	cecectomize	VBN	_	16	amod
13	and	and	CC	_	12	cc
14	in	in	IN	_	12	conj
15	control	control	NN	_	16	compound
16	rats	rat	NNS	_	10	nmod
17	.	.	.	_	10	punct

1	drug1	drug1	NN	_	0	ROOT
2	and	and	CC	_	1	cc
3	drug2	drug2	NN	_	1	conj
4	-LRB-	-lrb-	-LRB-	_	8	punct
5	0.1	0.1	CD	_	8	nummod
6	and	and	CC	_	5	cc
7	1.0	1.0	CD	_	5	conj
8	mg/kg	mg/kg	NN	_	1	dep
9	,	,	,	_	8	punct
10	s.c.	s.c.	NN	_	8	appos
11	-RRB-	-rrb-	-RRB-	_	8	punct

1	drug1	drug1	NN	_	12	nsubj
2	and	and	CC	_	1	cc
3	drug2	drug2	NN	_	1	conj
4	-LRB-	-lrb-	-LRB-	_	8	punct
5	0.1	0.1	CD	_	8	nummod
6	and	and	CC	_	5	cc
7	1.0	1.0	CD	_	5	conj
8	mg/kg	mg/kg	NN	_	1	dep
9	,	,	,	_	8	punct
10	s.c.	s.c.	NN	_	8	appos
11	-RRB-	-rrb-	-RRB-	_	8	punct
12	inhibited	inhibit	VBD	_	0	ROOT
13	the	the	DT	_	14	det
14	drug3	drug3	NN	_	12	dobj
15	-LRB-	-lrb-	-LRB-	_	17	punct
16	0.3	0.3	CD	_	17	nummod
17	mg/kg	mg/kg	NN	_	14	dep
18	,	,	,	_	17	punct
19	p.o.	p.o.	NN	_	17	appos
20	-RRB-	-rrb-	-RRB-	_	17	punct
21	-	-	:	_	14	punct
22	induced	induce	VBN	_	23	amod
23	diarrhea	diarrhea	NN	_	14	dep
24	in	in	IN	_	26	case
25	cecectomized	cecectomized	JJ	_	26	amod
26	rats	rat	NNS	_	23	nmod
27	.	.	.	_	12	punct

1	drug1	drug1	NN	_	0	ROOT
2	-LRB-	-lrb-	-LRB-	_	4	punct
3	5	5	CD	_	4	nummod
4	mg/kg	mg/kg	NN	_	1	dep
5	,	,	,	_	4	punct
6	s.c.	s.c.	NN	_	4	appos
7	-RRB-	-rrb-	-RRB-	_	4	punct

1	drug1	drug1	NN	_	9	nsubj
2	-LRB-	-lrb-	-LRB-	_	4	punct
3	5	5	CD	_	4	nummod
4	mg/kg	mg/kg	NN	_	1	dep
5	,	,	,	_	4	punct
6	s.c.	s.c.	NN	_	4	appos
7	-RRB-	-rrb-	-RRB-	_	4	punct
8	completely	completely	RB	_	9	advmod
9	antagonized	antagonize	VBD	_	0	ROOT
10	the	the	DT	_	12	det
11	inhibitory	inhibitory	JJ	_	12	amod
12	effect	effect	NN	_	9	dobj
13	of	of	IN	_	14	case
14	drug2	drug2	NN	_	12	nmod
15	and	and	CC	_	9	cc
16	partly	partly	RB	_	17	advmod
17	antagonized	antagonize	VBD	_	9	conj
18	the	the	DT	_	19	det
19	effect	effect	NN	_	17	dobj
20	of	of	IN	_	21	case
21	drug3	drug3	NN	_	19	nmod
22	.	.	.	_	9	punct

1	These	these	DT	_	2	det
2	results	result	NNS	_	3	nsubj
3	suggest	suggest	VBP	_	0	ROOT
4	that	that	IN	_	9	mark
5	oral	oral	JJ	_	6	amod
6	administration	administration	NN	_	9	nsubj
7	of	of	IN	_	8	case
8	drug1	drug1	NN	_	6	nmod
9	induces	induce	VBZ	_	3	ccomp
10	a	a	DT	_	14	det
11	more	more	RBR	_	12	advmod
12	pronounced	pronounced	JJ	_	14	amod
13	secretory	secretory	JJ	_	14	amod
14	diarrhea	diarrhea	NN	_	9	dobj
15	in	in	IN	_	16	case
16	cecectomized	cecectomize	VBN	_	9	nmod
17	than	than	IN	_	20	case
18	in	in	IN	_	20	case
19	control	control	NN	_	20	compound
20	rats	rat	NNS	_	16	nmod
21	,	,	,	_	16	punct
22	probably	probably	RB	_	26	advmod
23	due	due	JJ	_	26	case
24	to	to	TO	_	23	mwe
25	the	the	DT	_	26	det
26	lack	lack	NN	_	16	nmod
27	of	of	IN	_	30	case
28	the	the	DT	_	30	det
29	reservoir	reservoir	NN	_	30	compound
30	function	function	NN	_	26	nmod
31	of	of	IN	_	33	case
32	the	the	DT	_	33	det
33	cecum	cecum	NN	_	30	nmod
34	in	in	IN	_	37	case
35	the	the	DT	_	37	det
36	operated	operate	VBN	_	37	amod
37	animals	animal	NNS	_	30	nmod
38	.	.	.	_	3	punct

1	This	this	DT	_	4	det
2	secretory	secretory	JJ	_	4	amod
3	diarrhea	diarrhea	NN	_	4	compound
4	model	model	NN	_	6	nsubj
5	is	be	VBZ	_	6	cop
6	suitable	suitable	JJ	_	0	ROOT
7	for	for	IN	_	8	mark
8	evaluating	evaluate	VBG	_	6	advcl
9	the	the	DT	_	11	det
10	antidiarrheal	antidiarrheal	JJ	_	11	amod
11	activity	activity	NN	_	8	dobj
12	of	of	IN	_	13	case
13	drugs	drug	NNS	_	11	nmod
14	.	.	.	_	6	punct

1	drug1	drug1	NN	_	0	ROOT
2	as	as	IN	_	4	case
3	potent	potent	JJ	_	4	amod
4	drug2	drug2	NN	_	1	nmod
5	of	of	IN	_	12	case
6	glucocorticoid-induced	glucocorticoid-induced	JJ	_	12	amod
7	mouse	mouse	NN	_	12	compound
8	mammary	mammary	JJ	_	12	amod
9	tumor	tumor	NN	_	12	compound
10	virus	virus	NN	_	12	compound
11	gene	gene	NN	_	12	compound
12	expression	expression	NN	_	4	nmod
13	.	.	.	_	1	punct

1	The	the	DT	_	2	det
2	effect	effect	NN	_	14	nsubjpass
3	of	of	IN	_	8	case
4	natural	natural	JJ	_	8	amod
5	and	and	CC	_	4	cc
6	synthetic	synthetic	JJ	_	4	conj
7	galloyl	galloyl	NN	_	8	compound
8	esters	ester	NNS	_	2	nmod
9	on	on	IN	_	12	case
10	glucocorticoid-induced	glucocorticoid-induced	JJ	_	12	amod
11	gene	gene	NN	_	12	compound
12	expression	expression	NN	_	2	nmod
13	was	be	VBD	_	14	auxpass
14	evaluated	evaluate	VBN	_	0	ROOT
15	by	by	IN	_	16	mark
16	using	use	VBG	_	14	advcl
17	rat	rat	NN	_	20	compound
18	fibroblast	fibroblast	NN	_	20	compound
19	3Y1	3y1	NN	_	20	compound
20	cells	cell	NNS	_	16	dobj
21	stably	stably	RB	_	22	advmod
22	transfected	transfect	VBN	_	20	acl
23	with	with	IN	_	27	case
24	a	a	DT	_	27	det
25	luciferase	luciferase	NN	_	27	compound
26	reporter	reporter	NN	_	27	compound
27	gene	gene	NN	_	22	nmod
28	under	under	IN	_	31	case
29	the	the	DT	_	31	det
30	transcriptional	transcriptional	JJ	_	31	amod
31	regulation	regulation	NN	_	22	nmod
32	of	of	IN	_	38	case
33	the	the	DT	_	38	det
34	mouse	mouse	NN	_	38	compound
35	mammary	mammary	JJ	_	38	amod
36	tumor	tumor	NN	_	38	compound
37	virus	virus	NN	_	38	compound
38	drug1	drug1	NN	_	31	nmod
39	.	.	.	_	14	punct

1	The	the	DT	_	4	det
2	glucocorticoid-induced	glucocorticoid-induced	JJ	_	4	amod
3	gene	gene	NN	_	4	compound
4	transcription	transcription	NN	_	7	nsubjpass
5	was	be	VBD	_	7	auxpass
6	strongly	strongly	RB	_	7	advmod
7	suppressed	suppress	VBN	_	0	ROOT
8	by	by	IN	_	11	case
9	synthetic	synthetic	JJ	_	11	amod
10	alkyl	alkyl	NN	_	11	compound
11	esters	ester	NNS	_	7	nmod
12	;	;	:	_	7	punct

1	drug1	drug1	NN	_	2	nsubj
2	showed	show	VBD	_	0	ROOT
3	the	the	DT	_	6	det
4	most	most	RBS	_	5	advmod
5	potent	potent	JJ	_	6	amod
6	inhibition	inhibition	NN	_	2	dobj
7	-LRB-	-lrb-	-LRB-	_	10	punct
8	66	66	CD	_	9	compound
9	%	%	NN	_	10	amod
10	inhibition	inhibition	NN	_	6	dep
11	at	at	IN	_	13	case
12	10	10	CD	_	13	nummod
13	microM	microm	NN	_	10	nmod
14	-RRB-	-rrb-	-RRB-	_	10	punct
15	,	,	,	_	6	punct
16	which	which	WDT	_	20	nsubj
17	was	be	VBD	_	20	cop
18	far	far	RB	_	20	advmod
19	more	more	RBR	_	20	advmod
20	potent	potent	JJ	_	6	acl:relcl
21	than	than	IN	_	22	case
22	that	that	DT	_	20	nmod
23	of	of	IN	_	25	case
24	crude	crude	JJ	_	25	amod
25	drug2	drug2	NN	_	22	nmod
26	.	.	.	_	2	punct

1	n-Octyl	n-octyl	NN	_	4	compound
2	and	and	CC	_	1	cc
3	n-cetyl	n-cetyl	NN	_	1	conj
4	gallate	gallate	NN	_	6	nsubj
5	also	also	RB	_	6	advmod
6	showed	show	VBD	_	0	ROOT
7	good	good	JJ	_	8	amod
8	inhibition	inhibition	NN	_	6	dobj
9	,	,	,	_	6	punct
10	while	while	IN	_	17	mark
11	gallic	gallic	JJ	_	12	amod
12	acid	acid	NN	_	17	nsubj
13	itself	itself	PRP	_	12	nmod:npmod
14	was	be	VBD	_	17	cop
15	not	not	RB	_	17	neg
16	so	so	RB	_	17	advmod
17	active	active	JJ	_	6	advcl
18	,	,	,	_	6	punct
19	suggesting	suggest	VBG	_	6	advcl
20	that	that	IN	_	28	mark
21	the	the	DT	_	22	det
22	presence	presence	NN	_	28	nsubj
23	of	of	IN	_	26	case
24	hydrophobic	hydrophobic	JJ	_	26	amod
25	side	side	NN	_	26	compound
26	chain	chain	NN	_	22	nmod
27	is	be	VBZ	_	28	cop
28	important	important	JJ	_	19	ccomp
29	for	for	IN	_	32	case
30	the	the	DT	_	32	det
31	suppressive	suppressive	JJ	_	32	amod
32	effect	effect	NN	_	28	nmod
33	.	.	.	_	6	punct

1	On	on	IN	_	4	case
2	the	the	DT	_	4	det
3	other	other	JJ	_	4	amod
4	hand	hand	NN	_	14	nmod
5	,	,	,	_	14	punct
6	surprisingly	surprisingly	RB	_	14	advmod
7	,	,	,	_	14	punct
8	drug1	drug1	NN	_	14	dep
9	,	,	,	_	14	punct
10	-LRB-	-lrb-	-LRB-	_	14	punct
11	-	-	:	_	14	punct
12	-RRB-	-rrb-	-RRB-	_	14	punct
13	-	-	:	_	14	punct
14	epigallocatechin-3-O-gallate	epigallocatechin-3-o-gallate	NN	_	0	ROOT
15	and	and	CC	_	14	cc
16	theasinensin	theasinensin	NN	_	17	compound
17	A	a	NN	_	14	conj
18	,	,	,	_	14	punct
19	potently	potently	RB	_	20	advmod
20	enhanced	enhance	VBD	_	14	acl
21	the	the	DT	_	23	det
22	promoter	promoter	NN	_	23	compound
23	activity	activity	NN	_	20	dobj
24	-LRB-	-lrb-	-LRB-	_	29	punct
25	182	182	CD	_	28	compound
26	and	and	CC	_	25	cc
27	247	247	CD	_	25	conj
28	%	%	NN	_	29	amod
29	activity	activity	NN	_	23	dep
30	at	at	IN	_	32	case
31	1	1	CD	_	32	nummod
32	microM	microm	NN	_	29	nmod
33	,	,	,	_	29	punct
34	respectively	respectively	RB	_	29	advmod
35	-RRB-	-rrb-	-RRB-	_	29	punct
36	.	.	.	_	14	punct

1	The	the	DT	_	2	det
2	regulation	regulation	NN	_	18	nsubj
3	of	of	IN	_	5	case
4	the	the	DT	_	5	det
5	level	level	NN	_	2	nmod
6	of	of	IN	_	10	case
7	the	the	DT	_	10	det
8	glucocorticoid-induced	glucocorticoid-induced	JJ	_	10	amod
9	gene	gene	NN	_	10	compound
10	expression	expression	NN	_	5	nmod
11	by	by	IN	_	14	case
12	the	the	DT	_	14	det
13	antioxidative	antioxidative	JJ	_	14	amod
14	gallates	gallate	NNS	_	2	nmod
15	is	be	VBZ	_	18	cop
16	of	of	IN	_	18	case
17	great	great	JJ	_	18	amod
18	interest	interest	NN	_	0	ROOT
19	from	from	IN	_	22	case
20	a	a	DT	_	22	det
21	therapeutic	therapeutic	JJ	_	22	amod
22	point	point	NN	_	18	nmod
23	of	of	IN	_	24	case
24	view	view	NN	_	22	nmod
25	.	.	.	_	18	punct

1	High-dose	high-dose	JJ	_	2	amod
2	drug1	drug1	NN	_	0	ROOT
3	with	with	IN	_	5	case
4	drug2	drug2	NN	_	5	compound
5	protection	protection	NN	_	2	nmod
6	.	.	.	_	2	punct

1	Nephrotoxicity	nephrotoxicity	NN	_	3	nsubj
2	frequently	frequently	RB	_	3	advmod
3	limits	limit	VBZ	_	0	ROOT
4	the	the	DT	_	5	det
5	dose	dose	NN	_	3	dobj
6	of	of	IN	_	7	case
7	drug1	drug1	NN	_	5	nmod
8	to	to	TO	_	12	case
9	less	less	JJR	_	11	advmod
10	than	than	IN	_	9	mwe
11	120	120	CD	_	12	nummod
12	mg/m2	mg/m2	NN	_	3	nmod
13	per	per	IN	_	14	case
14	injection	injection	NN	_	12	nmod
15	.	.	.	_	3	punct

1	drug1	drug1	NN	_	5	nsubj
2	is	be	VBZ	_	5	cop
3	a	a	DT	_	5	det
4	neutralizing	neutralize	VBG	_	5	amod
5	agent	agent	NN	_	0	ROOT
6	for	for	IN	_	7	case
7	drug2	drug2	NN	_	5	nmod
8	that	that	WDT	_	9	nsubj
9	protects	protect	VBZ	_	5	acl:relcl
10	against	against	IN	_	12	case
11	renal	renal	JJ	_	12	amod
12	damage	damage	NN	_	9	nmod
13	.	.	.	_	5	punct

1	To	to	TO	_	2	mark
2	determine	determine	VB	_	26	advcl
3	whether	whether	IN	_	8	mark
4	injection	injection	NN	_	8	nsubj
5	of	of	IN	_	6	case
6	drug1	drug1	NN	_	4	nmod
7	would	would	MD	_	8	aux
8	permit	permit	VB	_	2	ccomp
9	larger	larger	JJR	_	10	amod
10	doses	dose	NNS	_	8	dobj
11	of	of	IN	_	12	case
12	drug2	drug2	NN	_	10	nmod
13	to	to	TO	_	15	mark
14	be	be	VB	_	15	auxpass
15	administered	administer	VBN	_	8	xcomp
16	,	,	,	_	26	punct
17	a	a	DT	_	19	det
18	fixed	fix	VBN	_	19	amod
19	9.9-g	9.9-g	NN	_	26	nsubjpass
20	/	/	:	_	19	punct
21	m2	m2	NN	_	22	compound
22	dose	dose	NN	_	19	dep
23	of	of	IN	_	24	case
24	drug3	drug3	NN	_	22	nmod
25	was	be	VBD	_	26	auxpass
26	given	give	VBN	_	0	ROOT
27	intravenously	intravenously	RB	_	26	advmod
28	over	over	IN	_	30	case
29	three	three	CD	_	30	nummod
30	hours	hour	NNS	_	26	nmod
31	concurrently	concurrently	RB	_	30	advmod
32	with	with	IN	_	34	case
33	escalating	escalate	VBG	_	34	amod
34	doses	dose	NNS	_	26	nmod
35	of	of	IN	_	36	case
36	drug4	drug4	NN	_	34	nmod
37	.	.	.	_	26	punct

1	drug1	drug1	NN	_	3	nsubjpass
2	was	be	VBD	_	3	auxpass
3	administered	administer	VBN	_	0	ROOT
4	over	over	IN	_	8	case
5	the	the	DT	_	8	det
6	last	last	JJ	_	8	amod
7	two	two	CD	_	8	nummod
8	hours	hour	NNS	_	3	nmod
9	of	of	IN	_	12	case
10	the	the	DT	_	12	det
11	drug2	drug2	NN	_	12	compound
12	infusion	infusion	NN	_	8	nmod
13	.	.	.	_	3	punct

1	Using	use	VBG	_	7	advcl
2	this	this	DT	_	3	det
3	technique	technique	NN	_	1	dobj
4	,	,	,	_	7	punct
5	it	it	PRP	_	7	nsubj
6	was	be	VBD	_	7	cop
7	possible	possible	JJ	_	0	ROOT
8	to	to	TO	_	9	mark
9	escalate	escalate	VB	_	7	xcomp
10	the	the	DT	_	12	det
11	drug1	drug1	NN	_	12	compound
12	dose	dose	NN	_	9	dobj
13	to	to	TO	_	15	case
14	225	225	CD	_	15	nummod
15	mg/m2	mg/m2	NN	_	9	nmod
16	before	before	IN	_	20	mark
17	dose-limiting	dose-limiting	JJ	_	18	amod
18	toxicities	toxicity	NNS	_	20	nsubjpass
19	were	be	VBD	_	20	auxpass
20	encountered	encounter	VBN	_	9	advcl
21	.	.	.	_	7	punct

1	Comparison	comparison	NN	_	23	nsubj
2	of	of	IN	_	4	case
3	drug1	drug1	NN	_	4	compound
4	pharmacokinetics	pharmacokinetic	NNS	_	1	nmod
5	in	in	IN	_	6	case
6	patients	patient	NNS	_	4	nmod
7	treated	treat	VBN	_	6	acl
8	with	with	IN	_	10	case
9	202.5	202.5	CD	_	10	nummod
10	mg/m2	mg/m2	NN	_	7	nmod
11	plus	plus	CC	_	10	cc
12	drug2	drug2	NN	_	10	conj
13	to	to	TO	_	14	case
14	those	those	DT	_	6	nmod
15	in	in	IN	_	16	case
16	patients	patient	NNS	_	14	nmod
17	treated	treat	VBN	_	16	acl
18	with	with	IN	_	20	case
19	100	100	CD	_	20	nummod
20	mg/m2	mg/m2	NN	_	17	nmod
21	without	without	IN	_	22	case
22	drug3	drug3	NN	_	17	nmod
23	indicated	indicate	VBD	_	0	ROOT
24	that	that	IN	_	26	mark
25	there	there	EX	_	26	expl
26	were	be	VBD	_	23	ccomp
27	no	no	DT	_	28	neg
28	changes	change	NNS	_	26	nsubj
29	in	in	IN	_	35	case
30	the	the	DT	_	35	det
31	elimination	elimination	NN	_	33	nmod:npmod
32	rate	rate	NN	_	33	nmod:npmod
33	constant	constant	JJ	_	35	amod
34	,	,	,	_	33	punct
35	volume	volume	NN	_	28	nmod
36	of	of	IN	_	37	case
37	distribution	distribution	NN	_	35	nmod
38	,	,	,	_	35	punct
39	or	or	CC	_	35	cc
40	total	total	JJ	_	42	amod
41	body	body	NN	_	42	compound
42	clearance	clearance	NN	_	35	conj
43	of	of	IN	_	44	case
44	drug4	drug4	NN	_	42	nmod
45	.	.	.	_	23	punct

1	The	the	DT	_	4	det
2	total	total	JJ	_	4	amod
3	drug	drug	NN	_	4	compound
4	exposure	exposure	NN	_	15	nsubj
5	for	for	IN	_	7	case
6	the	the	DT	_	7	det
7	plasma	plasma	NN	_	4	nmod
8	was	be	VBD	_	15	cop
9	approximately	approximately	RB	_	10	advmod
10	twofold	twofold	RB	_	15	advmod
11	at	at	IN	_	15	case
12	the	the	DT	_	15	det
13	higher	higher	JJR	_	15	amod
14	drug1	drug1	NN	_	15	compound
15	dose	dose	NN	_	0	ROOT
16	.	.	.	_	15	punct

1	This	this	DT	_	2	det
2	study	study	NN	_	3	nsubj
3	demonstrates	demonstrate	VBZ	_	0	ROOT
4	that	that	IN	_	9	mark
5	concurrent	concurrent	JJ	_	6	amod
6	administration	administration	NN	_	9	nsubj
7	of	of	IN	_	8	case
8	drug1	drug1	NN	_	6	nmod
9	permits	permit	VBZ	_	3	ccomp
10	at	at	IN	_	11	case
11	least	least	JJS	_	14	advmod
12	a	a	DT	_	14	det
13	twofold	twofold	JJ	_	14	amod
14	increase	increase	NN	_	9	dobj
15	in	in	IN	_	16	case
16	dose	dose	NN	_	14	nmod
17	and	and	CC	_	14	cc
18	total	total	JJ	_	19	amod
19	exposure	exposure	NN	_	14	conj
20	to	to	TO	_	21	case
21	drug2	drug2	NN	_	19	nmod
22	.	.	.	_	3	punct

1	Interaction	interaction	NN	_	0	ROOT
2	on	on	IN	_	5	case
3	the	the	DT	_	5	det
4	antinociceptive	antinociceptive	JJ	_	5	amod
5	effect	effect	NN	_	1	nmod
6	between	between	IN	_	7	case
7	drug1	drug1	NN	_	5	nmod
8	and	and	CC	_	7	cc
9	drug2	drug2	NN	_	7	conj
10	or	or	CC	_	9	cc
11	drug3	drug3	NN	_	9	conj
12	.	.	.	_	1	punct

1	The	the	DT	_	2	det
2	aim	aim	NN	_	6	nsubj
3	of	of	IN	_	5	case
4	this	this	DT	_	5	det
5	paper	paper	NN	_	2	nmod
6	was	be	VBD	_	0	ROOT
7	to	to	TO	_	8	mark
8	study	study	VB	_	6	xcomp
9	the	the	DT	_	10	det
10	interaction	interaction	NN	_	8	dobj
11	between	between	IN	_	12	case
12	drug1	drug1	NN	_	10	nmod
13	and	and	CC	_	12	cc
14	both	both	DT	_	15	cc:preconj
15	drug2	drug2	NN	_	12	conj
16	or	or	CC	_	15	cc
17	its	its	PRP$	_	20	nmod:poss
18	synthetic	synthetic	JJ	_	20	amod
19	analogue	analogue	NN	_	20	compound
20	drug3	drug3	NN	_	15	conj
21	,	,	,	_	12	punct
22	or	or	CC	_	12	cc
23	drug4	drug4	NN	_	12	conj
24	,	,	,	_	10	punct
25	on	on	IN	_	28	case
26	the	the	DT	_	28	det
27	antinonciceptive	antinonciceptive	JJ	_	28	amod
28	effect	effect	NN	_	10	nmod
29	of	of	IN	_	31	case
30	these	these	DT	_	31	det
31	peptides	peptide	NNS	_	28	nmod
32	in	in	IN	_	33	case
33	mice	mouse	NNS	_	28	nmod
34	after	after	IN	_	36	case
35	intracisternal	intracisternal	JJ	_	36	amod
36	injection	injection	NN	_	28	nmod
37	.	.	.	_	6	punct

1	Antinociception	antinociception	NN	_	3	nsubjpass
2	was	be	VBD	_	3	auxpass
3	measured	measure	VBN	_	0	ROOT
4	by	by	IN	_	7	case
5	the	the	DT	_	7	det
6	hot-plate	hot-plate	JJ	_	7	amod
7	method	method	NN	_	3	nmod
8	.	.	.	_	3	punct

1	It	it	PRP	_	3	nsubjpass
2	was	be	VBD	_	3	auxpass
3	shown	show	VBN	_	0	ROOT
4	that	that	IN	_	6	mark
5	drug1	drug1	NN	_	6	nsubj
6	antagonized	antagonize	VBD	_	3	ccomp
7	evidently	evidently	RB	_	6	advmod
8	the	the	DT	_	10	det
9	antinociceptive	antinociceptive	JJ	_	10	amod
10	effect	effect	NN	_	6	dobj
11	of	of	IN	_	12	case
12	drug2	drug2	NN	_	10	nmod
13	and	and	CC	_	12	cc
14	their	they	PRP$	_	15	nmod:poss
15	analogue	analogue	NN	_	12	conj
16	.	.	.	_	3	punct

1	On	on	IN	_	3	case
2	the	the	DT	_	3	det
3	contrary	contrary	NN	_	9	nmod
4	,	,	,	_	9	punct
5	drug1	drug1	NN	_	9	nsubj
6	and	and	CC	_	5	cc
7	drug2	drug2	NN	_	5	conj
8	were	be	VBD	_	9	cop
9	agonists	agonist	NNS	_	0	ROOT
10	in	in	IN	_	11	case
11	induction	induction	NN	_	9	nmod
12	of	of	IN	_	13	case
13	analgesia	analgesia	NN	_	11	nmod
14	.	.	.	_	9	punct

1	It	it	PRP	_	3	nsubjpass
2	is	be	VBZ	_	3	auxpass
3	concluded	conclude	VBN	_	0	ROOT
4	that	that	IN	_	6	mark
5	drug1	drug1	NN	_	6	nsubj
6	modulates	modulate	VBZ	_	3	ccomp
7	in	in	IN	_	10	case
8	an	a	DT	_	10	det
9	opposite	opposite	JJ	_	10	amod
10	way	way	NN	_	6	nmod
11	the	the	DT	_	12	det
12	function	function	NN	_	10	dep
13	of	of	IN	_	16	case
14	the	the	DT	_	16	det
15	enkephalinergic	enkephalinergic	JJ	_	16	amod
16	neurons	neuron	NNS	_	12	nmod
17	and	and	CC	_	12	cc
18	the	the	DT	_	20	det
19	central	central	JJ	_	20	amod
20	action	action	NN	_	12	conj
21	of	of	IN	_	22	case
22	drug2	drug2	NN	_	20	nmod
23	.	.	.	_	3	punct

1	The	the	DT	_	3	det
2	emerging	emerge	VBG	_	3	amod
3	roles	role	NNS	_	0	ROOT
4	of	of	IN	_	5	case
5	drug1	drug1	NN	_	3	nmod
6	in	in	IN	_	8	case
7	drug2	drug2	NN	_	8	compound
8	therapy	therapy	NN	_	3	nmod
9	.	.	.	_	3	punct

1	The	the	DT	_	2	det
2	availability	availability	NN	_	0	ROOT
3	of	of	IN	_	5	case
4	potent	potent	JJ	_	5	amod
5	drug1	drug1	NN	_	2	nmod
6	-LRB-	-lrb-	-LRB-	_	7	punct
7	drug2	drug2	NN	_	5	appos
8	-RRB-	-rrb-	-RRB-	_	7	punct
9	-	-	:	_	5	punct
10	based	base	VBN	_	11	amod
11	regimens	regimen	NNS	_	5	dep
12	for	for	IN	_	14	case
13	drug3	drug3	NN	_	14	compound
14	therapy	therapy	NN	_	11	nmod
15	and	and	CC	_	11	cc
16	concerns	concern	NNS	_	11	conj
17	regarding	regard	VBG	_	16	acl
18	drug4	drug4	NN	_	17	dobj
19	-LRB-	-lrb-	-LRB-	_	20	punct
20	drug5	drug5	NN	_	18	appos
21	-RRB-	-rrb-	-RRB-	_	20	punct
22	-	-	:	_	18	punct
23	related	related	JJ	_	25	amod
24	metabolic	metabolic	JJ	_	25	amod
25	disturbances	disturbance	NNS	_	27	nsubj
26	have	have	VBP	_	27	aux
27	led	lead	VBN	_	18	dep
28	to	to	TO	_	30	case
29	significant	significant	JJ	_	30	amod
30	shifts	shift	NNS	_	27	nmod
31	in	in	IN	_	33	case
32	treatment	treatment	NN	_	33	compound
33	practices	practice	NNS	_	30	nmod
34	in	in	IN	_	36	case
35	HIV	hiv	NN	_	36	compound
36	infection	infection	NN	_	33	nmod
37	.	.	.	_	2	punct

1	drug1	drug1	NN	_	4	compound
2	-	-	:	_	4	punct
3	based	base	VBN	_	4	amod
4	regimens	regimen	NNS	_	6	nsubj
5	may	may	MD	_	6	aux
6	have	have	VB	_	0	ROOT
7	several	several	JJ	_	8	amod
8	advantages	advantage	NNS	_	6	dobj
9	over	over	IN	_	10	case
10	drug2	drug2	NN	_	8	nmod
11	-	-	:	_	8	punct
12	based	base	VBN	_	13	amod
13	therapy	therapy	NN	_	8	dep
14	for	for	IN	_	18	case
15	initial	initial	JJ	_	18	amod
16	or	or	CC	_	15	cc
17	prolonged	prolonged	JJ	_	15	conj
18	therapy	therapy	NN	_	13	nmod
19	,	,	,	_	13	punct
20	including	include	VBG	_	24	case
21	more	more	RBR	_	22	advmod
22	convenient	convenient	JJ	_	24	amod
23	administration	administration	NN	_	24	compound
24	regimens	regimen	NNS	_	13	nmod
25	,	,	,	_	24	punct
26	lower	lower	JJR	_	28	amod
27	tablet	tablet	NN	_	28	compound
28	volume	volume	NN	_	24	conj
29	,	,	,	_	24	punct
30	fewer	fewer	JJR	_	32	amod
31	drug	drug	NN	_	32	compound
32	interactions	interaction	NNS	_	24	conj
33	,	,	,	_	24	punct
34	and	and	CC	_	24	cc
35	central	central	JJ	_	38	amod
36	nervous	nervous	JJ	_	38	amod
37	system	system	NN	_	38	compound
38	penetration	penetration	NN	_	24	conj
39	.	.	.	_	6	punct

1	No	no	DT	_	2	neg
2	data	datum	NNS	_	8	nsubj
3	from	from	IN	_	6	case
4	prospective	prospective	JJ	_	6	amod
5	clinical	clinical	JJ	_	6	amod
6	trials	trial	NNS	_	2	nmod
7	currently	currently	RB	_	8	advmod
8	exist	exist	VBP	_	0	ROOT
9	comparing	compare	VBG	_	8	xcomp
10	the	the	DT	_	13	det
11	3	3	CD	_	13	nummod
12	approved	approve	VBN	_	13	amod
13	agents	agent	NNS	_	9	dobj
14	-LRB-	-lrb-	-LRB-	_	15	punct
15	drug1	drug1	NN	_	13	dep
16	,	,	,	_	15	punct
17	drug2	drug2	NN	_	15	conj
18	or	or	CC	_	15	cc
19	drug3	drug3	NN	_	15	conj
20	-RRB-	-rrb-	-RRB-	_	15	punct
21	.	.	.	_	8	punct

1	Both	both	DT	_	2	cc:preconj
2	drug1	drug1	NN	_	7	nsubjpass
3	and	and	CC	_	2	cc
4	drug2	drug2	NN	_	2	conj
5	have	have	VBP	_	7	aux
6	been	be	VBN	_	7	auxpass
7	compared	compare	VBN	_	0	ROOT
8	to	to	TO	_	10	case
9	triple	triple	JJ	_	10	amod
10	therapy	therapy	NN	_	7	nmod
11	with	with	IN	_	14	case
12	the	the	DT	_	14	det
13	drug3	drug3	NN	_	14	compound
14	drug4	drug4	NN	_	10	nmod
15	over	over	IN	_	17	case
16	48	48	CD	_	17	nummod
17	weeks	week	NNS	_	10	nmod
18	as	as	IN	_	20	case
19	initial	initial	JJ	_	20	amod
20	therapy	therapy	NN	_	7	nmod
21	,	,	,	_	20	punct
22	with	with	IN	_	24	case
23	similar	similar	JJ	_	24	amod
24	responses	response	NNS	_	20	nmod
25	being	be	VBG	_	26	auxpass
26	observed	observe	VBN	_	24	acl
27	with	with	IN	_	29	case
28	drug5	drug5	NN	_	29	compound
29	regimens	regimen	NNS	_	26	nmod
30	and	and	CC	_	29	cc
31	superiority	superiority	NN	_	29	conj
32	observed	observe	VBN	_	29	acl
33	with	with	IN	_	34	case
34	drug6	drug6	NN	_	32	nmod
35	.	.	.	_	7	punct

1	A	a	DT	_	4	det
2	smaller	smaller	JJR	_	4	amod
3	24-week	24-week	JJ	_	4	amod
4	study	study	NN	_	6	nsubj
5	has	have	VBZ	_	6	aux
6	suggested	suggest	VBN	_	0	ROOT
7	drug1	drug1	NN	_	10	nsubj
8	may	may	MD	_	10	aux
9	be	be	VB	_	10	cop
10	superior	superior	JJ	_	6	ccomp
11	to	to	TO	_	14	case
12	the	the	DT	_	14	det
13	drug2	drug2	NN	_	14	compound
14	drug3	drug3	NN	_	10	nmod
15	.	.	.	_	6	punct

1	Limited	limited	JJ	_	3	amod
2	comparative	comparative	JJ	_	3	amod
3	data	datum	NNS	_	0	ROOT
4	in	in	IN	_	5	case
5	patients	patient	NNS	_	3	nmod
6	with	with	IN	_	9	case
7	high	high	JJ	_	9	amod
8	viral	viral	JJ	_	9	amod
9	loads	load	NNS	_	5	nmod
10	treated	treat	VBN	_	9	acl
11	with	with	IN	_	12	case
12	drug1	drug1	NN	_	10	nmod
13	-	-	:	_	12	punct
14	or	or	CC	_	12	cc
15	drug2	drug2	NN	_	12	conj
16	-	-	:	_	3	punct
17	based	base	VBN	_	18	amod
18	regimens	regimen	NNS	_	20	nsubj
19	currently	currently	RB	_	20	advmod
20	exist	exist	VBP	_	3	dep
21	.	.	.	_	3	punct

1	However	however	RB	_	12	advmod
2	,	,	,	_	12	punct
3	cohort	cohort	NN	_	4	compound
4	data	datum	NNS	_	12	nsubj
5	and	and	CC	_	4	cc
6	selected	select	VBN	_	8	amod
7	patient	patient	NN	_	8	compound
8	data	datum	NNS	_	4	conj
9	from	from	IN	_	11	case
10	clinical	clinical	JJ	_	11	amod
11	trials	trial	NNS	_	8	nmod
12	suggest	suggest	VBP	_	0	ROOT
13	comparable	comparable	JJ	_	14	amod
14	activity	activity	NN	_	12	dobj
15	to	to	TO	_	16	case
16	drug1	drug1	NN	_	14	nmod
17	-	-	:	_	14	punct
18	based	base	VBN	_	19	amod
19	regimens	regimen	NNS	_	14	dep
20	in	in	IN	_	22	case
21	these	these	DT	_	22	det
22	patients	patient	NNS	_	19	nmod
23	.	.	.	_	12	punct

1	The	the	DT	_	2	det
2	superiority	superiority	NN	_	0	ROOT
3	of	of	IN	_	4	case
4	drug1	drug1	NN	_	2	nmod
5	over	over	IN	_	6	case
6	drug2	drug2	NN	_	2	nmod
7	-	-	:	_	2	punct
8	based	base	VBN	_	9	amod
9	regimens	regimen	NNS	_	12	nsubjpass
10	has	have	VBZ	_	12	aux
11	been	be	VBN	_	12	auxpass
12	observed	observe	VBN	_	2	dep
13	in	in	IN	_	15	case
14	comparative	comparative	JJ	_	15	amod
15	data	datum	NNS	_	12	nmod
16	in	in	IN	_	18	case
17	a	a	DT	_	18	det
18	subset	subset	NN	_	15	nmod
19	of	of	IN	_	20	case
20	patients	patient	NNS	_	18	nmod
21	with	with	IN	_	24	case
22	high	high	JJ	_	24	amod
23	viral	viral	JJ	_	24	amod
24	loads	load	NNS	_	20	nmod
25	.	.	.	_	2	punct

1	In	in	IN	_	3	case
2	treatment-experienced	treatment-experienced	JJ	_	3	amod
3	patients	patient	NNS	_	8	nmod
4	,	,	,	_	8	punct
5	available	available	JJ	_	7	amod
6	uncontrolled	uncontrolled	JJ	_	7	amod
7	data	datum	NNS	_	8	nsubj
8	suggest	suggest	VBP	_	0	ROOT
9	these	these	DT	_	10	det
10	agents	agent	NNS	_	11	nsubj
11	contribute	contribute	VBP	_	8	ccomp
12	to	to	TO	_	14	case
13	regimen	regimen	NNS	_	14	compound
14	efficacy	efficacy	NN	_	11	nmod
15	in	in	IN	_	16	case
16	drug1	drug1	NN	_	14	nmod
17	-	-	:	_	11	punct
18	na	na	TO	_	19	mark
19	ve	have	VB	_	11	advcl
20	,	,	,	_	19	punct
21	treatment-experienced	treatment-experienced	JJ	_	22	amod
22	patients	patient	NNS	_	19	dobj
23	.	.	.	_	8	punct

1	drug1	drug1	NN	_	3	nsubj
2	has	have	VBZ	_	3	aux
3	demonstrated	demonstrate	VBN	_	0	ROOT
4	superiority	superiority	NN	_	3	dobj
5	over	over	IN	_	6	case
6	drug2	drug2	NN	_	4	nmod
7	in	in	IN	_	9	case
8	nucleoside-experienced	nucleoside-experienced	JJ	_	9	amod
9	patients	patient	NNS	_	4	nmod
10	,	,	,	_	3	punct
11	although	although	IN	_	12	mark
12	combining	combine	VBG	_	17	csubj
13	these	these	DT	_	15	det
14	2	2	CD	_	15	nummod
15	agents	agent	NNS	_	12	dobj
16	may	may	MD	_	17	aux
17	represent	represent	VB	_	3	parataxis
18	the	the	DT	_	20	det
19	best	best	JJS	_	20	amod
20	approach	approach	NN	_	17	dobj
21	in	in	IN	_	23	case
22	these	these	DT	_	23	det
23	circumstances	circumstance	NNS	_	20	nmod
24	.	.	.	_	3	punct

1	The	the	DT	_	2	det
2	tolerability	tolerability	NN	_	5	nsubj
3	of	of	IN	_	4	case
4	drug1	drug1	NN	_	2	nmod
5	appears	appear	VBZ	_	0	ROOT
6	generally	generally	RB	_	7	advmod
7	good	good	JJ	_	5	xcomp
8	with	with	IN	_	11	mark
9	few	few	JJ	_	10	amod
10	individuals	individual	NNS	_	11	nsubj
11	discontinuing	discontinue	VBG	_	7	advcl
12	in	in	IN	_	14	case
13	clinical	clinical	JJ	_	14	amod
14	studies	study	NNS	_	11	nmod
15	as	as	IN	_	17	case
16	a	a	DT	_	17	det
17	result	result	NN	_	11	nmod
18	of	of	IN	_	21	case
19	adverse	adverse	JJ	_	21	amod
20	drug	drug	NN	_	21	compound
21	events	event	NNS	_	17	nmod
22	.	.	.	_	5	punct

1	The	the	DT	_	2	det
2	majority	majority	NN	_	8	nsubj
3	of	of	IN	_	5	case
4	adverse	adverse	JJ	_	5	amod
5	events	event	NNS	_	2	nmod
6	with	with	IN	_	7	case
7	drug1	drug1	NN	_	5	nmod
8	occur	occur	VBP	_	0	ROOT
9	within	within	IN	_	12	case
10	the	the	DT	_	12	det
11	first	first	JJ	_	12	amod
12	month	month	NN	_	8	nmod
13	,	,	,	_	8	punct
14	and	and	CC	_	8	cc
15	are	be	VBP	_	16	cop
16	predictable	predictable	JJ	_	8	conj
17	and	and	CC	_	16	cc
18	manageable	manageable	JJ	_	16	conj
19	without	without	IN	_	21	case
20	therapy	therapy	NN	_	21	compound
21	interruption	interruption	NN	_	16	nmod
22	.	.	.	_	8	punct

1	Suppression	suppression	NN	_	0	ROOT
2	by	by	IN	_	3	case
3	drug1	drug1	NN	_	1	nmod
4	of	of	IN	_	5	case
5	drug2	drug2	NN	_	3	nmod
6	-	-	:	_	1	punct
7	enhanced	enhance	VBN	_	9	amod
8	peritoneal	peritoneal	JJ	_	9	amod
9	metastasis	metastasis	NN	_	1	dep
10	of	of	IN	_	12	case
11	intestinal	intestinal	JJ	_	12	amod
12	adenocarcinomas	adenocarcinoma	NNS	_	9	nmod
13	induced	induce	VBN	_	12	acl
14	by	by	IN	_	15	case
15	drug3	drug3	NN	_	13	nmod
16	in	in	IN	_	18	case
17	wistar	wistar	JJ	_	18	amod
18	rats	rat	NNS	_	13	nmod
19	.	.	.	_	1	punct

1	BACKGROUND	background	NN	_	0	ROOT
2	:	:	:	_	1	punct
3	The	the	DT	_	4	det
4	effects	effect	NNS	_	42	nsubjpass
5	of	of	IN	_	7	case
6	combined	combined	JJ	_	7	amod
7	administration	administration	NN	_	4	nmod
8	of	of	IN	_	9	case
9	drug1	drug1	NN	_	7	nmod
10	and	and	CC	_	9	cc
11	drug2	drug2	NN	_	9	conj
12	-LRB-	-lrb-	-LRB-	_	13	punct
13	drug3	drug3	NN	_	11	appos
14	-RRB-	-rrb-	-RRB-	_	13	punct
15	,	,	,	_	4	punct
16	a	a	DT	_	17	det
17	drug4	drug4	NN	_	4	appos
18	,	,	,	_	4	punct
19	on	on	IN	_	21	case
20	the	the	DT	_	21	det
21	incidence	incidence	NN	_	4	nmod
22	of	of	IN	_	24	case
23	peritoneal	peritoneal	JJ	_	24	amod
24	metastasis	metastasis	NN	_	21	nmod
25	of	of	IN	_	27	case
26	intestinal	intestinal	JJ	_	27	amod
27	adenocarcinomas	adenocarcinoma	NNS	_	24	nmod
28	induced	induce	VBN	_	27	acl
29	by	by	IN	_	30	case
30	drug5	drug5	NN	_	28	nmod
31	-LRB-	-lrb-	-LRB-	_	32	punct
32	drug6	drug6	NN	_	30	appos
33	-RRB-	-rrb-	-RRB-	_	32	punct
34	and	and	CC	_	30	cc
35	the	the	DT	_	37	det
36	labeling	labeling	NN	_	37	compound
37	index	index	NN	_	30	conj
38	of	of	IN	_	40	case
39	intestinal	intestinal	JJ	_	40	amod
40	cancers	cancer	NNS	_	37	nmod
41	were	be	VBD	_	42	auxpass
42	investigated	investigate	VBN	_	1	appos
43	in	in	IN	_	46	case
44	male	male	JJ	_	46	amod
45	Wistar	Wistar	NNP	_	46	compound
46	rats	rat	NNS	_	42	nmod
47	.	.	.	_	1	punct

1	METHODS	method	NNS	_	0	ROOT
2	:	:	:	_	1	punct
3	From	from	IN	_	5	case
4	the	the	DT	_	5	det
5	beginning	beginning	NN	_	12	nmod
6	of	of	IN	_	8	case
7	the	the	DT	_	8	det
8	experiment	experiment	NN	_	5	nmod
9	,	,	,	_	12	punct
10	rats	rat	NNS	_	12	nsubjpass
11	were	be	VBD	_	12	auxpass
12	given	give	VBN	_	1	dep
13	10	10	CD	_	16	nummod
14	weekly	weekly	JJ	_	16	amod
15	subcutaneous	subcutaneous	JJ	_	16	amod
16	injections	injection	NNS	_	12	iobj
17	of	of	IN	_	18	case
18	drug1	drug1	NN	_	16	nmod
19	-LRB-	-lrb-	-LRB-	_	23	punct
20	7.4	7.4	CD	_	23	nummod
21	mg/kg	mg/kg	NN	_	23	compound
22	body	body	NN	_	23	compound
23	weight	weight	NN	_	16	appos
24	-RRB-	-rrb-	-RRB-	_	23	punct
25	and	and	CC	_	16	cc
26	subcutaneous	subcutaneous	JJ	_	27	amod
27	injections	injection	NNS	_	16	conj
28	of	of	IN	_	29	case
29	drug2	drug2	NN	_	27	nmod
30	-LRB-	-lrb-	-LRB-	_	34	punct
31	40	40	CD	_	34	nummod
32	microg/kg	microg/kg	NN	_	34	compound
33	body	body	NN	_	34	compound
34	weight	weight	NN	_	29	appos
35	-RRB-	-rrb-	-RRB-	_	34	punct
36	every	every	DT	_	38	det
37	other	other	JJ	_	38	amod
38	day	day	NN	_	12	nmod:tmod
39	,	,	,	_	12	punct
40	and	and	CC	_	12	cc
41	from	from	IN	_	42	case
42	week	week	NN	_	12	conj
43	16	16	CD	_	42	nummod
44	,	,	,	_	42	punct
45	intraperitoneal	intraperitoneal	JJ	_	46	amod
46	injections	injection	NNS	_	42	appos
47	of	of	IN	_	48	case
48	drug3	drug3	NN	_	46	nmod
49	-LRB-	-lrb-	-LRB-	_	55	punct
50	10	10	CD	_	55	nummod
51	or	or	CC	_	50	cc
52	20	20	CD	_	50	conj
53	mg/kg	mg/kg	NN	_	55	compound
54	body	body	NN	_	55	compound
55	weight	weight	NN	_	48	appos
56	-RRB-	-rrb-	-RRB-	_	55	punct
57	every	every	DT	_	59	det
58	other	other	JJ	_	59	amod
59	day	day	NN	_	46	nmod:tmod
60	until	until	IN	_	62	case
61	the	the	DT	_	62	det
62	end	end	NN	_	46	nmod
63	fo	fo	NN	_	65	compound
64	the	the	DT	_	65	det
65	experiment	experiment	NN	_	62	dep
66	in	in	IN	_	67	case
67	week	week	NN	_	65	nmod
68	45	45	CD	_	67	nummod
69	.	.	.	_	1	punct

1	RESULTS	result	NNS	_	0	ROOT
2	:	:	:	_	1	punct
3	drug1	drug1	NN	_	5	nsubj
4	significantly	significantly	RB	_	5	advmod
5	increased	increase	VBD	_	1	dep
6	the	the	DT	_	7	det
7	incidence	incidence	NN	_	5	dobj
8	of	of	IN	_	10	case
9	intestinal	intestinal	JJ	_	10	amod
10	tumors	tumor	NNS	_	7	nmod
11	and	and	CC	_	10	cc
12	cancer	cancer	NN	_	13	compound
13	metastasis	metastasis	NN	_	10	conj
14	to	to	TO	_	16	case
15	the	the	DT	_	16	det
16	peritoneum	peritoneum	NN	_	5	nmod
17	.	.	.	_	1	punct

1	Although	although	IN	_	3	mark
2	drug1	drug1	NN	_	3	nsubj
3	administered	administer	VBN	_	0	ROOT
4	at	at	IN	_	6	case
5	either	either	CC	_	6	det
6	dose	dose	NN	_	3	nmod
7	had	have	VBD	_	3	dep
8	little	little	JJ	_	7	dobj
9	or	or	CC	_	8	cc
10	no	no	DT	_	8	conj
11	effect	effect	NN	_	8	dep
12	on	on	IN	_	14	case
13	the	the	DT	_	14	det
14	enhancement	enhancement	NN	_	7	nmod
15	of	of	IN	_	17	case
16	intestinal	intestinal	JJ	_	17	amod
17	carcinogenesis	carcinogenesis	NN	_	14	nmod
18	by	by	IN	_	19	case
19	drug2	drug2	NN	_	14	nmod
20	or	or	CC	_	19	cc
21	on	on	IN	_	23	case
22	the	the	DT	_	23	det
23	location	location	NN	_	19	conj
24	,	,	,	_	14	punct
25	histologic	histologic	JJ	_	26	amod
26	type	type	NN	_	14	conj
27	,	,	,	_	26	punct
28	depth	depth	NN	_	26	appos
29	of	of	IN	_	30	case
30	involvement	involvement	NN	_	28	nmod
31	,	,	,	_	26	punct
32	labeling	label	VBG	_	33	compound
33	index	index	NN	_	26	appos
34	,	,	,	_	26	punct
35	apoptotic	apoptotic	JJ	_	36	amod
36	index	index	NN	_	26	conj
37	or	or	CC	_	26	cc
38	tumor	tumor	NN	_	39	compound
39	vascularity	vascularity	NN	_	26	conj
40	of	of	IN	_	42	case
41	intestinal	intestinal	JJ	_	42	amod
42	cancers	cancer	NNS	_	26	nmod
43	,	,	,	_	14	punct
44	it	it	PRP	_	46	nsubj
45	significantly	significantly	RB	_	46	advmod
46	decreased	decrease	VBD	_	14	acl:relcl
47	the	the	DT	_	48	det
48	incidence	incidence	NN	_	46	dobj
49	of	of	IN	_	51	case
50	cancer	cancer	NN	_	51	compound
51	metastasis	metastasis	NN	_	48	nmod
52	.	.	.	_	3	punct

1	drug1	drug1	NN	_	4	nsubj
2	also	also	RB	_	4	advmod
3	significantly	significantly	RB	_	4	advmod
4	decreased	decrease	VBD	_	0	ROOT
5	the	the	DT	_	6	det
6	incidence	incidence	NN	_	4	dobj
7	of	of	IN	_	9	case
8	lymphatic	lymphatic	JJ	_	9	amod
9	invasion	invasion	NN	_	6	nmod
10	of	of	IN	_	11	case
11	adenocarcinomas	adenocarcinoma	NNS	_	9	nmod
12	,	,	,	_	9	punct
13	which	which	WDT	_	15	nsubjpass
14	was	be	VBD	_	15	auxpass
15	enhanced	enhance	VBN	_	9	acl:relcl
16	by	by	IN	_	17	case
17	drug2	drug2	NN	_	15	nmod
18	.	.	.	_	4	punct

1	CONCLUSION	conclusion	NN	_	0	ROOT
2	:	:	:	_	1	punct
3	These	these	DT	_	4	det
4	findings	finding	NNS	_	5	nsubj
5	indicate	indicate	VBP	_	1	appos
6	that	that	IN	_	8	mark
7	drug1	drug1	NN	_	8	nsubj
8	inhibits	inhibit	VBZ	_	5	ccomp
9	cancer	cancer	NN	_	10	compound
10	metastasis	metastasis	NN	_	8	dobj
11	through	through	IN	_	12	case
12	actions	action	NNS	_	8	nmod
13	that	that	WDT	_	16	nsubj
14	do	do	VBP	_	16	aux
15	not	not	RB	_	16	neg
16	affect	affect	VB	_	12	acl:relcl
17	the	the	DT	_	18	det
18	growth	growth	NN	_	16	dobj
19	of	of	IN	_	21	case
20	intestinal	intestinal	JJ	_	21	amod
21	cancers	cancer	NNS	_	18	nmod
22	.	.	.	_	1	punct

1	-LSB-	-lsb-	-LRB-	_	3	punct
2	Dose-time	dose-time	JJ	_	3	amod
3	effects	effect	NNS	_	47	dep
4	of	of	IN	_	6	case
5	competitive	competitive	JJ	_	6	amod
6	displacement	displacement	NN	_	3	nmod
7	of	of	IN	_	8	case
8	drug1	drug1	NN	_	6	nmod
9	by	by	IN	_	10	case
10	drug2	drug2	NN	_	3	nmod
11	following	follow	VBG	_	15	case
12	oral	oral	JJ	_	15	amod
13	and	and	CC	_	12	cc
14	intravenous	intravenous	JJ	_	12	conj
15	administration	administration	NN	_	3	nmod
16	-RSB-	-rsb-	-RRB-	_	3	punct
17	The	the	DT	_	18	det
18	effect	effect	NN	_	47	nsubjpass
19	of	of	IN	_	21	case
20	various	various	JJ	_	21	amod
21	doses	dose	NNS	_	18	nmod
22	of	of	IN	_	23	case
23	drug3	drug3	NN	_	21	nmod
24	in	in	IN	_	27	case
25	several	several	JJ	_	27	amod
26	dose	dose	NN	_	27	compound
27	fractions	fraction	NNS	_	18	nmod
28	on	on	IN	_	30	case
29	the	the	DT	_	30	det
30	extent	extent	NN	_	18	nmod
31	and	and	CC	_	18	cc
32	the	the	DT	_	34	det
33	time	time	NN	_	34	compound
34	scale	scale	NN	_	18	conj
35	of	of	IN	_	36	case
36	displacement	displacement	NN	_	34	nmod
37	of	of	IN	_	38	case
38	drug4	drug4	NN	_	36	nmod
39	,	,	,	_	18	punct
40	in	in	IN	_	41	case
41	dependence	dependence	NN	_	18	nmod
42	on	on	IN	_	44	case
43	application	application	NN	_	44	compound
44	mode	mode	NN	_	41	nmod
45	,	,	,	_	18	punct
46	was	be	VBD	_	47	auxpass
47	studied	study	VBN	_	0	ROOT
48	.	.	.	_	47	punct

1	An	a	DT	_	3	det
2	intravenous	intravenous	JJ	_	3	amod
3	dose	dose	NN	_	10	nsubj
4	of	of	IN	_	7	case
5	50	50	CD	_	7	nummod
6	mg	mg	NN	_	7	compound
7	drug1	drug1	NN	_	3	nmod
8	was	be	VBD	_	10	cop
9	in	in	IN	_	10	case
10	respect	respect	NN	_	0	ROOT
11	of	of	IN	_	13	case
12	competitive	competitive	JJ	_	13	amod
13	suppression	suppression	NN	_	10	nmod
14	of	of	IN	_	15	case
15	organs	organ	NNS	_	13	nmod
16	actively	actively	RB	_	17	advmod
17	concentrating	concentrate	VBG	_	10	acl
18	drug2	drug2	NN	_	17	dobj
19	as	as	IN	_	20	advmod
20	effective	effective	JJ	_	17	advcl
21	as	as	IN	_	25	case
22	intravenous	intravenous	JJ	_	25	amod
23	1000	1000	CD	_	25	nummod
24	mg	mg	NN	_	25	compound
25	ClO-4	clo-4	NN	_	20	nmod
26	-	-	:	_	20	punct
27	simultaneously	simultaneously	RB	_	30	advmod
28	or	or	CC	_	27	cc
29	1000	1000	CD	_	27	conj
30	mg	mg	NN	_	33	compound
31	orally	orally	RB	_	32	advmod
32	30	30	CD	_	33	nummod
33	min	min	NN	_	20	dep
34	before	before	IN	_	36	case
35	the	the	DT	_	36	det
36	injection	injection	NN	_	33	nmod
37	of	of	IN	_	38	case
38	drug3	drug3	NN	_	36	nmod
39	.	.	.	_	10	punct

1	An	a	DT	_	3	det
2	intravenous	intravenous	JJ	_	3	amod
3	injection	injection	NN	_	9	nsubj
4	of	of	IN	_	5	case
5	drug1	drug1	NN	_	3	nmod
6	given	give	VBN	_	9	mark
7	later	later	RB	_	9	advmod
8	also	also	RB	_	9	advmod
9	produces	produce	VBZ	_	0	ROOT
10	a	a	DT	_	15	det
11	complete	complete	JJ	_	15	amod
12	and	and	CC	_	11	cc
13	immediately	immediately	RB	_	14	advmod
14	beginning	begin	VBG	_	11	conj
15	depletion	depletion	NN	_	9	dobj
16	of	of	IN	_	17	case
17	drug2	drug2	NN	_	15	nmod
18	already	already	RB	_	19	advmod
19	accumulated	accumulate	VBN	_	15	acl
20	in	in	IN	_	22	case
21	the	the	DT	_	22	det
22	thyroid	thyroid	NN	_	19	nmod
23	,	,	,	_	9	punct
24	within	within	IN	_	26	case
25	a	a	DT	_	26	det
26	period	period	NN	_	9	nmod
27	of	of	IN	_	29	case
28	195	195	CD	_	29	nummod
29	min	min	NN	_	26	nmod
30	after	after	IN	_	31	case
31	99m-TcO-4-injection	99m-tco-4-injection	NN	_	26	nmod
32	with	with	IN	_	35	case
33	a	a	DT	_	35	det
34	corresponding	corresponding	JJ	_	35	amod
35	increase	increase	NN	_	31	nmod
36	in	in	IN	_	38	case
37	blood	blood	NN	_	38	compound
38	levels	level	NNS	_	35	nmod
39	.	.	.	_	9	punct

1	20	20	CD	_	2	compound
2	mg	mg	NN	_	3	amod
3	result	result	NN	_	0	ROOT
4	in	in	IN	_	6	case
5	incomplete	incomplete	JJ	_	6	amod
6	depletion	depletion	NN	_	3	nmod
7	which	which	WDT	_	8	nsubj
8	becomes	become	VBZ	_	6	acl:relcl
9	complete	complete	JJ	_	8	xcomp
10	after	after	IN	_	14	case
11	a	a	DT	_	14	det
12	second	second	JJ	_	14	amod
13	additional	additional	JJ	_	14	amod
14	dose	dose	NN	_	8	nmod
15	.	.	.	_	3	punct

1	The	the	DT	_	3	det
2	intravenous	intravenous	JJ	_	3	amod
3	application	application	NN	_	6	nsubj
4	of	of	IN	_	5	case
5	drug1	drug1	NN	_	3	nmod
6	offers	offer	VBZ	_	0	ROOT
7	advantages	advantage	NNS	_	6	dobj
8	in	in	IN	_	10	case
9	clinical	clinical	JJ	_	10	amod
10	use	use	NN	_	6	nmod
11	.	.	.	_	6	punct

1	Combinations	combination	NNS	_	0	ROOT
2	of	of	IN	_	3	case
3	drug1	drug1	NN	_	1	nmod
4	and	and	CC	_	3	cc
5	drug2	drug2	NN	_	3	conj
6	:	:	:	_	1	punct
7	effects	effect	NNS	_	1	dep
8	on	on	IN	_	10	case
9	drug	drug	NN	_	10	compound
10	discrimination	discrimination	NN	_	7	nmod
11	and	and	CC	_	10	cc
12	behavioral	behavioral	JJ	_	13	amod
13	inhibition	inhibition	NN	_	10	conj
14	in	in	IN	_	15	case
15	rats	rat	NNS	_	10	nmod
16	.	.	.	_	1	punct

1	drug1	drug1	NN	_	5	nsubj
2	-LRB-	-lrb-	-LRB-	_	3	punct
3	drug2	drug2	NN	_	1	appos
4	-RRB-	-rrb-	-RRB-	_	3	punct
5	produces	produce	VBZ	_	0	ROOT
6	psychotomimetic	psychotomimetic	JJ	_	7	amod
7	effects	effect	NNS	_	5	dobj
8	in	in	IN	_	9	case
9	humans	human	NNS	_	5	nmod
10	that	that	WDT	_	11	nsubj
11	resemble	resemble	VBP	_	9	acl:relcl
12	schizophrenia	schizophrenia	NN	_	13	compound
13	symptoms	symptom	NNS	_	11	dobj
14	.	.	.	_	5	punct

1	In	in	IN	_	3	case
2	an	a	DT	_	3	det
3	effort	effort	NN	_	14	nmod
4	to	to	TO	_	5	mark
5	screen	screen	NN	_	3	acl
6	compounds	compound	NNS	_	5	dobj
7	for	for	IN	_	9	case
8	antipsychotic	antipsychotic	JJ	_	9	amod
9	activity	activity	NN	_	5	nmod
10	,	,	,	_	14	punct
11	preclinical	preclinical	JJ	_	12	amod
12	researchers	researcher	NNS	_	14	nsubj
13	have	have	VBP	_	14	aux
14	investigated	investigate	VBN	_	0	ROOT
15	whether	whether	IN	_	18	mark
16	these	these	DT	_	17	det
17	compounds	compound	NNS	_	18	nsubj
18	block	block	VBP	_	14	ccomp
19	drug1	drug1	NN	_	22	compound
20	-	-	:	_	22	punct
21	induced	induce	VBN	_	22	amod
22	behaviors	behavior	NNS	_	18	dobj
23	in	in	IN	_	24	case
24	animals	animal	NNS	_	22	nmod
25	.	.	.	_	14	punct

1	In	in	IN	_	4	case
2	the	the	DT	_	4	det
3	present	present	JJ	_	4	amod
4	study	study	NN	_	10	nmod
5	,	,	,	_	10	punct
6	the	the	DT	_	8	det
7	drug1	drug1	NN	_	8	compound
8	drug2	drug2	NN	_	10	nsubjpass
9	was	be	VBD	_	10	auxpass
10	tested	test	VBN	_	0	ROOT
11	in	in	IN	_	12	case
12	combination	combination	NN	_	10	nmod
13	with	with	IN	_	16	case
14	an	a	DT	_	16	det
15	active	active	JJ	_	16	amod
16	dose	dose	NN	_	12	nmod
17	of	of	IN	_	18	case
18	drug3	drug3	NN	_	16	nmod
19	in	in	IN	_	22	case
20	two-lever	two-lever	JJ	_	22	amod
21	drug	drug	NN	_	22	compound
22	discrimination	discrimination	NN	_	16	nmod
23	and	and	CC	_	22	cc
24	mixed	mixed	JJ	_	26	amod
25	signalled-unsignalled	signalled-unsignalled	JJ	_	26	amod
26	differential-reinforcement-of-low-rates	differential-reinforcement-of-low-rate	NNS	_	22	conj
27	-LRB-	-lrb-	-LRB-	_	28	punct
28	DRL	drl	NN	_	26	appos
29	-RRB-	-rrb-	-RRB-	_	28	punct
30	procedures	procedure	NNS	_	22	dep
31	.	.	.	_	10	punct

1	drug1	drug1	NN	_	2	nsubj
2	produced	produce	VBD	_	0	ROOT
3	distinctive	distinctive	JJ	_	4	amod
4	effects	effect	NNS	_	2	dobj
5	in	in	IN	_	7	case
6	each	each	DT	_	7	det
7	task	task	NN	_	2	nmod
8	:	:	:	_	2	punct
9	it	it	PRP	_	10	nsubj
10	substituted	substitute	VBD	_	2	parataxis
11	for	for	IN	_	14	case
12	the	the	DT	_	14	det
13	training	training	NN	_	14	compound
14	dose	dose	NN	_	10	nmod
15	in	in	IN	_	17	case
16	drug2	drug2	NN	_	17	compound
17	discrimination	discrimination	NN	_	10	nmod
18	and	and	CC	_	10	cc
19	it	it	PRP	_	20	nsubj
20	increased	increase	VBD	_	10	conj
21	the	the	DT	_	22	det
22	number	number	NN	_	20	dobj
23	of	of	IN	_	24	case
24	responses	response	NNS	_	22	nmod
25	with	with	IN	_	26	case
26	short	short	JJ	_	24	nmod
27	-LRB-	-lrb-	-LRB-	_	30	punct
28	<	<	JJR	_	29	advmod
29	3	3	CD	_	30	nummod
30	s	s	NNS	_	26	dep
31	-RRB-	-rrb-	-RRB-	_	30	punct
32	interresponse	interresponse	JJ	_	33	amod
33	times	time	NNS	_	26	dep
34	as	as	RB	_	33	cc
35	well	well	RB	_	34	mwe
36	as	as	IN	_	34	mwe
37	increasing	increase	VBG	_	40	amod
38	overall	overall	JJ	_	40	amod
39	response	response	NN	_	40	compound
40	rates	rate	NNS	_	33	conj
41	in	in	IN	_	44	case
42	the	the	DT	_	44	det
43	DRL	DRL	NNP	_	44	compound
44	schedule	schedule	NN	_	40	nmod
45	.	.	.	_	2	punct

1	Acute	acute	JJ	_	2	amod
2	dosing	dosing	NN	_	5	nsubj
3	with	with	IN	_	4	case
4	drug1	drug1	NN	_	2	nmod
5	failed	fail	VBD	_	0	ROOT
6	to	to	TO	_	7	mark
7	alter	alter	VB	_	5	xcomp
8	the	the	DT	_	10	det
9	behavioral	behavioral	JJ	_	10	amod
10	effects	effect	NNS	_	7	dobj
11	of	of	IN	_	12	case
12	drug2	drug2	NN	_	10	nmod
13	in	in	IN	_	15	case
14	either	either	CC	_	15	det
15	procedure	procedure	NN	_	10	nmod
16	even	even	RB	_	17	advmod
17	when	when	WRB	_	18	advmod
18	tested	test	VBN	_	7	advcl
19	up	up	IN	_	21	case
20	to	to	TO	_	21	case
21	doses	dose	NNS	_	18	nmod
22	that	that	WDT	_	23	nsubj
23	produced	produce	VBD	_	21	acl:relcl
24	pharmacological	pharmacological	JJ	_	25	amod
25	effects	effect	NNS	_	23	dobj
26	alone	alone	RB	_	23	advmod
27	.	.	.	_	5	punct

1	These	these	DT	_	2	det
2	results	result	NNS	_	3	nsubj
3	suggest	suggest	VBP	_	0	ROOT
4	that	that	IN	_	11	mark
5	acute	acute	JJ	_	6	amod
6	dosing	dosing	NN	_	11	nsubj
7	with	with	IN	_	8	case
8	drug1	drug1	NN	_	6	nmod
9	would	would	MD	_	11	aux
10	not	not	RB	_	11	neg
11	affect	affect	VB	_	3	ccomp
12	behaviors	behavior	NNS	_	11	dobj
13	most	most	RBS	_	14	advmod
14	closely	closely	RB	_	15	advmod
15	associated	associate	VBN	_	11	dep
16	with	with	IN	_	18	case
17	drug2	drug2	NN	_	18	compound
18	intoxication	intoxication	NN	_	15	nmod
19	.	.	.	_	3	punct

1	Further	further	RB	_	4	advmod
2	,	,	,	_	4	punct
3	they	they	PRP	_	4	nsubj
4	bring	bring	VBP	_	0	ROOT
5	into	into	IN	_	6	case
6	question	question	NN	_	4	nmod
7	the	the	DT	_	8	det
8	utility	utility	NN	_	4	dobj
9	of	of	IN	_	10	mark
10	using	use	VBG	_	8	acl
11	drug1	drug1	NN	_	13	compound
12	combination	combination	NN	_	13	compound
13	procedures	procedure	NNS	_	10	dobj
14	in	in	IN	_	15	case
15	animals	animal	NNS	_	10	nmod
16	to	to	TO	_	17	mark
17	screen	screen	VB	_	10	advcl
18	for	for	IN	_	20	case
19	antipsychotic	antipsychotic	JJ	_	20	amod
20	potential	potential	NN	_	17	nmod
21	.	.	.	_	4	punct

1	Since	since	IN	_	5	mark
2	chronic	chronic	JJ	_	3	amod
3	dosing	dosing	NN	_	5	nsubjpass
4	is	be	VBZ	_	5	auxpass
5	required	require	VBN	_	15	csubj
6	for	for	IN	_	8	case
7	therapeutic	therapeutic	JJ	_	8	amod
8	efficacy	efficacy	NN	_	5	nmod
9	of	of	IN	_	10	case
10	drug1	drug1	NN	_	8	nmod
11	,	,	,	_	10	punct
12	future	future	JJ	_	13	amod
13	studies	study	NNS	_	10	appos
14	should	should	MD	_	15	aux
15	focus	focus	VB	_	0	ROOT
16	on	on	IN	_	17	case
17	investigation	investigation	NN	_	15	nmod
18	of	of	IN	_	21	case
19	chronic	chronic	JJ	_	21	amod
20	dosing	dosing	NN	_	21	compound
21	effects	effect	NNS	_	17	nmod
22	of	of	IN	_	24	case
23	these	these	DT	_	24	det
24	drugs	drug	NNS	_	21	nmod
25	in	in	IN	_	26	case
26	combination	combination	NN	_	21	nmod
27	with	with	IN	_	28	case
28	drug2	drug2	NN	_	26	nmod
29	.	.	.	_	15	punct

1	-LSB-	-lsb-	-LRB-	_	4	punct
2	Multiple	multiple	JJ	_	4	amod
3	occupational	occupational	JJ	_	4	amod
4	exposure	exposure	NN	_	0	ROOT
5	to	to	TO	_	6	case
6	solvents	solvent	NNS	_	4	nmod
7	-RSB-	-rsb-	-RRB-	_	4	punct
8	This	this	DT	_	11	det
9	article	article	NN	_	11	compound
10	review	review	NN	_	11	compound
11	papers	papers	NNS	_	4	dep
12	published	publish	VBN	_	11	acl
13	over	over	IN	_	17	case
14	the	the	DT	_	17	det
15	last	last	JJ	_	17	amod
16	20	20	CD	_	17	nummod
17	years	year	NNS	_	12	nmod
18	on	on	IN	_	21	case
19	multiple	multiple	JJ	_	21	amod
20	occupational	occupational	JJ	_	21	amod
21	exposure	exposure	NN	_	12	nmod
22	to	to	TO	_	23	case
23	solvents	solvent	NNS	_	21	nmod
24	.	.	.	_	4	punct

1	At	at	IN	_	2	case
2	low-levels	low-level	NNS	_	14	nmod
3	of	of	IN	_	4	case
4	exposure	exposure	NN	_	2	nmod
5	the	the	DT	_	7	det
6	toxicokinetic	toxicokinetic	JJ	_	7	amod
7	interferences	interference	NNS	_	14	nsubjpass
8	between	between	IN	_	9	case
9	solvents	solvent	NNS	_	7	nmod
10	have	have	VBP	_	14	aux
11	generally	generally	RB	_	14	advmod
12	not	not	RB	_	14	neg
13	been	be	VBN	_	14	auxpass
14	observed	observe	VBN	_	0	ROOT
15	in	in	IN	_	16	case
16	man	man	NN	_	14	nmod
17	and	and	CC	_	16	cc
18	presumably	presumably	RB	_	21	advmod
19	a	a	DT	_	21	det
20	threshold	threshold	NN	_	21	compound
21	limit	limit	NN	_	16	conj
22	exists	exist	VBZ	_	14	dep
23	.	.	.	_	14	punct

1	Conversely	conversely	RB	_	0	ROOT
2	,	,	,	_	1	punct
3	at	at	IN	_	5	case
4	exposure	exposure	NN	_	5	compound
5	levels	level	NNS	_	2	root
6	close	close	RB	_	5	advmod
7	to	to	TO	_	11	case
8	the	the	DT	_	11	det
9	``	``	``	_	11	punct
10	limit	limit	NN	_	11	compound
11	values	value	NNS	_	6	nmod
12	''	''	''	_	5	punct

1	metabolic	metabolic	JJ	_	2	amod
2	interference	interference	NN	_	6	nsubjpass
3	has	have	VBZ	_	6	aux
4	sometimes	sometimes	RB	_	6	advmod
5	been	be	VBN	_	6	auxpass
6	observed	observe	VBN	_	0	ROOT
7	and	and	CC	_	6	cc
8	the	the	DT	_	9	det
9	behaviour	behaviour	NN	_	14	nsubj
10	of	of	IN	_	13	case
11	the	the	DT	_	13	det
12	biological	biological	JJ	_	13	amod
13	indicators	indicator	NNS	_	9	nmod
14	differs	differ	VBZ	_	6	conj
15	from	from	IN	_	19	mark
16	what	what	WP	_	19	nsubjpass
17	would	would	MD	_	19	aux
18	be	be	VB	_	19	auxpass
19	expected	expect	VBN	_	14	advcl
20	.	.	.	_	6	punct

1	Toxicodynamic	toxicodynamic	JJ	_	2	amod
2	interference	interference	NN	_	6	nsubj
3	between	between	IN	_	4	case
4	solvents	solvent	NNS	_	2	nmod
5	can	can	MD	_	6	aux
6	give	give	VB	_	0	ROOT
7	rise	rise	VB	_	6	dobj
8	to	to	TO	_	9	case
9	additive	additive	JJ	_	7	nmod
10	,	,	,	_	9	punct
11	potentiation	potentiation	NN	_	9	conj
12	,	,	,	_	9	punct
13	synergistic	synergistic	JJ	_	9	conj
14	,	,	,	_	9	punct
15	antagonistic	antagonistic	JJ	_	16	amod
16	effects	effect	NNS	_	9	conj
17	.	.	.	_	6	punct

1	For	for	IN	_	3	case
2	the	the	DT	_	3	det
3	identification	identification	NN	_	14	nmod
4	of	of	IN	_	7	case
5	``	``	``	_	7	punct
6	limit	limit	NN	_	7	compound
7	values	value	NNS	_	3	nmod
8	''	''	''	_	7	punct
9	,	,	,	_	14	punct
10	it	it	PRP	_	14	nsubjpass
11	has	have	VBZ	_	14	aux
12	generally	generally	RB	_	14	advmod
13	been	be	VBN	_	14	auxpass
14	suggested	suggest	VBN	_	0	ROOT
15	in	in	IN	_	17	case
16	the	the	DT	_	17	det
17	literature	literature	NN	_	14	nmod
18	that	that	IN	_	27	mark
19	the	the	DT	_	21	det
20	possible	possible	JJ	_	21	amod
21	effects	effect	NNS	_	27	nsubjpass
22	deriving	derive	VBG	_	21	acl
23	from	from	IN	_	25	case
24	multiple	multiple	JJ	_	25	amod
25	exposure	exposure	NN	_	22	nmod
26	be	be	VB	_	27	auxpass
27	considered	consider	VBN	_	14	ccomp
28	as	as	IN	_	29	case
29	additive	additive	JJ	_	27	advcl
30	.	.	.	_	14	punct

1	However	however	RB	_	9	advmod
2	,	,	,	_	9	punct
3	numerous	numerous	JJ	_	5	amod
4	potentiation	potentiation	NN	_	5	compound
5	effects	effect	NNS	_	9	nsubjpass
6	have	have	VBP	_	9	aux
7	frequently	frequently	RB	_	9	advmod
8	been	be	VBN	_	9	auxpass
9	reported	report	VBN	_	0	ROOT
10	for	for	IN	_	12	case
11	combined	combined	JJ	_	12	amod
12	exposure	exposure	NN	_	9	nmod
13	to	to	TO	_	14	case
14	substances	substance	NNS	_	12	nmod
15	of	of	IN	_	17	case
16	widespread	widespread	JJ	_	17	amod
17	use	use	NN	_	14	nmod
18	.	.	.	_	9	punct

1	In	in	IN	_	4	case
2	this	this	DT	_	4	det
3	paper	paper	NN	_	4	compound
4	lists	list	NNS	_	0	ROOT
5	of	of	IN	_	7	case
6	multiple	multiple	JJ	_	7	amod
7	exposure	exposure	NN	_	4	nmod
8	in	in	IN	_	9	case
9	which	which	WDT	_	29	nmod
10	the	the	DT	_	11	det
11	doses	dose	NNS	_	29	nsubjpass
12	of	of	IN	_	14	case
13	the	the	DT	_	14	det
14	substances	substance	NNS	_	11	nmod
15	,	,	,	_	11	punct
16	the	the	DT	_	17	det
17	types	type	NNS	_	11	conj
18	of	of	IN	_	19	case
19	interferences	interference	NNS	_	17	nmod
20	and	and	CC	_	11	cc
21	the	the	DT	_	22	det
22	behaviour	behaviour	NN	_	11	conj
23	of	of	IN	_	26	case
24	the	the	DT	_	26	det
25	biological	biological	JJ	_	26	amod
26	levels	level	NNS	_	22	nmod
27	have	have	VBP	_	29	aux
28	been	be	VBN	_	29	auxpass
29	drawn	draw	VBN	_	7	acl:relcl
30	up	up	RP	_	29	compound:prt
31	and	and	CC	_	29	cc
32	proposed	propose	VBN	_	29	conj
33	as	as	IN	_	35	case
34	a	a	DT	_	35	det
35	tool	tool	NN	_	32	nmod
36	for	for	IN	_	38	case
37	easy	easy	JJ	_	38	amod
38	consultation	consultation	NN	_	35	nmod
39	.	.	.	_	4	punct

1	drug1	drug1	NN	_	4	nsubj
2	and	and	CC	_	1	cc
3	drug2	drug2	NN	_	1	conj
4	exert	exert	VBP	_	0	ROOT
5	additive	additive	JJ	_	10	amod
6	ocular	ocular	JJ	_	10	amod
7	and	and	CC	_	6	cc
8	renal	renal	JJ	_	6	conj
9	vasodilator	vasodilator	NN	_	10	compound
10	effects	effect	NNS	_	4	dobj
11	on	on	IN	_	13	case
12	healthy	healthy	JJ	_	13	amod
13	humans	human	NNS	_	4	nmod
14	.	.	.	_	4	punct

1	AIMS/HYPOTHESIS	AIMS/HYPOTHESIS	NNP	_	0	ROOT
2	:	:	:	_	1	punct
3	There	there	EX	_	4	expl
4	is	be	VBZ	_	1	parataxis
5	evidence	evidence	NN	_	4	nsubj
6	that	that	IN	_	10	mark
7	drug1	drug1	NN	_	10	nsubj
8	and	and	CC	_	7	cc
9	drug2	drug2	NN	_	7	conj
10	cause	cause	VBP	_	5	ccomp
11	renal	renal	JJ	_	14	amod
12	and	and	CC	_	11	cc
13	ocular	ocular	JJ	_	11	conj
14	vasodilation	vasodilation	NN	_	10	dobj
15	.	.	.	_	1	punct

1	There	there	EX	_	2	expl
2	is	be	VBZ	_	0	ROOT
3	,	,	,	_	2	punct
4	however	however	RB	_	2	advmod
5	,	,	,	_	2	punct
6	currently	currently	RB	_	2	advmod
7	no	no	DT	_	8	neg
8	data	datum	NNS	_	2	nsubj
9	on	on	IN	_	11	case
10	the	the	DT	_	11	det
11	effect	effect	NN	_	8	nmod
12	of	of	IN	_	14	case
13	combined	combined	JJ	_	14	amod
14	hyperglycaemia	hyperglycaemia	NN	_	11	nmod
15	and	and	CC	_	14	cc
16	hyper	hyper	JJ	_	18	amod
17	drug1	drug1	NN	_	18	compound
18	aemia	aemia	NN	_	14	conj
19	on	on	IN	_	25	case
20	the	the	DT	_	25	det
21	renal	renal	JJ	_	25	amod
22	and	and	CC	_	21	cc
23	ocular	ocular	JJ	_	21	conj
24	blood	blood	NN	_	25	compound
25	flow	flow	NN	_	11	nmod
26	seen	see	VBN	_	25	acl
27	in	in	IN	_	29	case
28	diabetic	diabetic	JJ	_	29	amod
29	patients	patient	NNS	_	26	nmod
30	on	on	IN	_	32	case
31	insulin	insulin	NN	_	32	compound
32	therapy	therapy	NN	_	29	nmod
33	.	.	.	_	2	punct

1	METHODS	method	NNS	_	4	nsubj
2	:	:	:	_	4	punct
3	We	we	PRP	_	4	nsubj
4	carried	carry	VBD	_	0	ROOT
5	out	out	RP	_	4	compound:prt
6	two	two	CD	_	10	nummod
7	different	different	JJ	_	10	amod
8	3-way	3-way	JJ	_	10	amod
9	crossover	crossover	NN	_	10	compound
10	studies	study	NNS	_	4	dobj
11	in	in	IN	_	13	case
12	healthy	healthy	JJ	_	13	amod
13	subjects	subject	NNS	_	10	nmod
14	-LRB-	-lrb-	-LRB-	_	18	punct
15	each	each	DT	_	18	dep
16	,	,	,	_	18	punct
17	n	n	NN	_	18	nsubj
18	=	=	JJ	_	10	dep
19	9	9	CD	_	18	dobj
20	-RRB-	-rrb-	-RRB-	_	18	punct
21	.	.	.	_	4	punct

1	In	in	IN	_	2	case
2	study	study	NN	_	20	nmod
3	one	one	CD	_	2	nummod
4	,	,	,	_	20	punct
5	hyperglycaemic	hyperglycaemic	JJ	_	6	amod
6	clamps	clamp	NNS	_	20	nsubjpass
7	-LRB-	-lrb-	-LRB-	_	9	punct
8	5.6	5.6	CD	_	9	nummod
9	mmol/l	mmol/l	NN	_	6	appos
10	,	,	,	_	9	punct
11	11.1	11.1	CD	_	12	nummod
12	mmol	mmol	NN	_	9	appos
13	/	/	:	_	9	punct
14	1	1	CD	_	9	dep
15	,	,	,	_	14	punct
16	16.7	16.7	CD	_	17	nummod
17	mmol/l	mmol/l	NN	_	14	appos
18	-RRB-	-rrb-	-RRB-	_	9	punct
19	were	be	VBD	_	20	auxpass
20	carried	carry	VBN	_	0	ROOT
21	out	out	RP	_	20	compound:prt
22	during	during	IN	_	23	case
23	placebo	placebo	NN	_	20	nmod
24	or	or	CC	_	23	cc
25	drug1	drug1	NN	_	39	compound
26	-LRB-	-lrb-	-LRB-	_	27	punct
27	dose	dose	NN	_	25	dep
28	1	1	CD	_	27	nummod
29	:	:	:	_	27	punct
30	1	1	CD	_	31	nummod
31	mU/kg/min	mu/kg/min	NN	_	27	dep
32	;	;	:	_	27	punct
33	dose	dose	NN	_	27	dep
34	2	2	CD	_	33	nummod
35	:	:	:	_	33	punct
36	2	2	CD	_	37	nummod
37	mU/kg/min	mu/kg/min	NN	_	33	dep
38	-RRB-	-rrb-	-RRB-	_	27	punct
39	infusion	infusion	NN	_	23	conj
40	.	.	.	_	20	punct

1	The	the	DT	_	3	det
2	second	second	JJ	_	3	amod
3	study	study	NN	_	5	nsubj
4	was	be	VBD	_	5	cop
5	identical	identical	JJ	_	0	ROOT
6	but	but	CC	_	5	cc
7	endogenous	endogenous	JJ	_	9	amod
8	insulin	insulin	NN	_	9	compound
9	secretion	secretion	NN	_	11	nsubjpass
10	was	be	VBD	_	11	auxpass
11	blocked	block	VBN	_	5	conj
12	with	with	IN	_	13	case
13	drug1	drug1	NN	_	11	nmod
14	.	.	.	_	5	punct

1	The	the	DT	_	4	det
2	renal	renal	JJ	_	4	amod
3	plasma	plasma	NN	_	4	compound
4	flow	flow	NN	_	15	nsubjpass
5	,	,	,	_	4	punct
6	glomerular	glomerular	JJ	_	8	amod
7	filtration	filtration	NN	_	8	compound
8	rate	rate	NN	_	4	conj
9	and	and	CC	_	4	cc
10	pulsatile	pulsatile	JJ	_	13	amod
11	choroidal	choroidal	JJ	_	13	amod
12	blood	blood	NN	_	13	compound
13	flow	flow	NN	_	4	conj
14	were	be	VBD	_	15	auxpass
15	measured	measure	VBN	_	0	ROOT
16	using	use	VBG	_	15	xcomp
17	the	the	DT	_	19	det
18	paraaminohippurate	paraaminohippurate	NN	_	19	compound
19	method	method	NN	_	16	dobj
20	,	,	,	_	15	punct
21	the	the	DT	_	23	det
22	inulin	inulin	NN	_	23	compound
23	method	method	NN	_	20	root
24	and	and	CC	_	23	cc
25	a	a	DT	_	28	det
26	laser	laser	NN	_	28	compound
27	interferometric	interferometric	JJ	_	28	amod
28	measurement	measurement	NN	_	23	conj
29	of	of	IN	_	32	case
30	fundus	fundus	NN	_	32	compound
31	pulsation	pulsation	NN	_	32	compound
32	amplitude	amplitude	NN	_	28	nmod
33	,	,	,	_	23	punct
34	respectively	respectively	RB	_	23	advmod
35	.	.	.	_	23	punct

1	RESULTS	result	NNS	_	0	ROOT
2	:	:	:	_	1	punct
3	drug1	drug1	NN	_	4	nsubj
4	increased	increase	VBD	_	1	appos
5	renal	renal	JJ	_	7	amod
6	plasma	plasma	NN	_	7	compound
7	flow	flow	NN	_	4	dobj
8	and	and	CC	_	7	cc
9	fundus	fundus	NN	_	11	compound
10	pulsation	pulsation	NN	_	11	compound
11	amplitude	amplitude	NN	_	7	conj
12	but	but	CC	_	13	cc
13	not	not	RB	_	7	cc
14	the	the	DT	_	17	det
15	glomerular	glomerular	JJ	_	17	amod
16	filtration	filtration	NN	_	17	compound
17	rate	rate	NN	_	7	conj
18	.	.	.	_	1	punct

1	Hyperglycaemia	hyperglycaemia	NN	_	2	nsubj
2	increased	increase	VBD	_	0	ROOT
3	all	all	PDT	_	8	det:predet
4	the	the	DT	_	8	det
5	renal	renal	JJ	_	8	amod
6	and	and	CC	_	5	cc
7	ocular	ocular	JJ	_	5	conj
8	parameters	parameter	NNS	_	2	dobj
9	studied	study	VBN	_	8	acl
10	.	.	.	_	2	punct

1	Haemodynamic	haemodynamic	JJ	_	2	amod
2	effects	effect	NNS	_	8	nsubj
3	of	of	IN	_	4	case
4	drug1	drug1	NN	_	2	nmod
5	and	and	CC	_	4	cc
6	drug2	drug2	NN	_	4	conj
7	were	be	VBD	_	8	cop
8	additive	additive	JJ	_	0	ROOT
9	when	when	WRB	_	12	advmod
10	drug3	drug3	NN	_	12	nsubj
11	was	be	VBD	_	12	cop
12	co-administered	co-administered	JJ	_	8	advcl
13	but	but	CC	_	12	cc
14	not	not	RB	_	17	neg
15	under	under	IN	_	17	case
16	basal	basal	JJ	_	17	amod
17	conditions	condition	NNS	_	12	conj
18	.	.	.	_	8	punct

1	CONCLUSIONS/INTERPRETATION	CONCLUSIONS/INTERPRETATION	NNP	_	0	ROOT
2	:	:	:	_	1	punct
3	drug1	drug1	NN	_	7	nsubj
4	and	and	CC	_	3	cc
5	drug2	drug2	NN	_	3	conj
6	can	can	MD	_	7	aux
7	exert	exert	VB	_	1	dep
8	additive	additive	JJ	_	10	amod
9	vasodilator	vasodilator	NN	_	10	compound
10	properties	property	NNS	_	7	dobj
11	on	on	IN	_	15	case
12	renal	renal	JJ	_	15	amod
13	and	and	CC	_	12	cc
14	ocular	ocular	JJ	_	12	conj
15	circulation	circulation	NN	_	7	nmod
16	.	.	.	_	1	punct

1	To	to	TO	_	2	mark
2	find	find	VB	_	29	csubjpass
3	out	out	RP	_	2	compound:prt
4	whether	whether	IN	_	8	mark
5	this	this	DT	_	6	det
6	observation	observation	NN	_	8	nsubjpass
7	is	be	VBZ	_	8	auxpass
8	related	relate	VBN	_	2	ccomp
9	to	to	TO	_	13	case
10	the	the	DT	_	13	det
11	increased	increase	VBN	_	13	amod
12	regional	regional	JJ	_	13	amod
13	perfusion	perfusion	NN	_	8	nmod
14	in	in	IN	_	17	case
15	diabetes	diabetes	NN	_	17	compound
16	longitudinal	longitudinal	JJ	_	17	amod
17	studies	study	NNS	_	13	nmod
18	on	on	IN	_	19	case
19	patients	patient	NNS	_	17	nmod
20	with	with	IN	_	21	case
21	Type	type	NN	_	19	nmod
22	I	i	CD	_	21	nummod
23	-LRB-	-lrb-	-LRB-	_	24	punct
24	insulin-dependent	insulin-dependent	JJ	_	21	appos
25	-RRB-	-rrb-	-RRB-	_	24	punct
26	diabetes	diabetes	NN	_	27	compound
27	mellitus	mellitus	NN	_	21	dep
28	are	be	VBP	_	29	auxpass
29	needed	need	VBN	_	0	ROOT
30	.	.	.	_	29	punct

1	Interaction	interaction	NN	_	0	ROOT
2	between	between	IN	_	3	case
3	drug1	drug1	NN	_	1	nmod
4	and	and	CC	_	3	cc
5	antidiuretic	antidiuretic	JJ	_	6	amod
6	hormone	hormone	NN	_	3	conj
7	and	and	CC	_	3	cc
8	its	its	PRP$	_	9	nmod:poss
9	effect	effect	NN	_	3	conj
10	on	on	IN	_	13	case
11	the	the	DT	_	13	det
12	milk	milk	NN	_	13	compound
13	secretion	secretion	NN	_	9	nmod
14	by	by	IN	_	15	case
15	alveoli	alveolus	NNS	_	1	nmod
16	of	of	IN	_	19	case
17	the	the	DT	_	19	det
18	mammary	mammary	JJ	_	19	amod
19	gland	gland	NN	_	15	nmod
20	of	of	IN	_	22	case
21	lactating	lactating	JJ	_	22	amod
22	rats	rat	NNS	_	19	nmod
23	.	.	.	_	1	punct

1	Interaction	interaction	NN	_	10	nsubjpass
2	between	between	IN	_	6	case
3	exogenous	exogenous	JJ	_	6	amod
4	and	and	CC	_	3	cc
5	endogenous	endogenous	JJ	_	3	conj
6	drug1	drug1	NN	_	1	nmod
7	and	and	CC	_	6	cc
8	vasopressin	vasopressin	NN	_	6	conj
9	was	be	VBD	_	10	auxpass
10	found	find	VBN	_	0	ROOT
11	to	to	TO	_	12	mark
12	affect	affect	VB	_	10	xcomp
13	the	the	DT	_	14	det
14	mechanism	mechanism	NN	_	12	dobj
15	of	of	IN	_	17	case
16	milk	milk	NN	_	17	compound
17	ejection	ejection	NN	_	14	nmod
18	by	by	IN	_	20	case
19	the	the	DT	_	20	det
20	alveoli	alveolus	NNS	_	14	nmod
21	of	of	IN	_	24	case
22	the	the	DT	_	24	det
23	mammary	mammary	JJ	_	24	amod
24	gland	gland	NN	_	20	nmod
25	in	in	IN	_	27	case
26	lactating	lactating	JJ	_	27	amod
27	rats	rat	NNS	_	24	nmod
28	.	.	.	_	10	punct

1	Inhibition	inhibition	NN	_	15	nsubjpass
2	and	and	CC	_	1	cc
3	stimulation	stimulation	NN	_	1	conj
4	of	of	IN	_	6	case
5	the	the	DT	_	6	det
6	effect	effect	NN	_	1	nmod
7	of	of	IN	_	8	case
8	drug1	drug1	NN	_	6	nmod
9	on	on	IN	_	11	case
10	milk	milk	NN	_	11	compound
11	ejection	ejection	NN	_	6	nmod
12	by	by	IN	_	13	case
13	vasopressin	vasopressin	NN	_	1	nmod
14	was	be	VBD	_	15	auxpass
15	demonstrated	demonstrate	VBN	_	0	ROOT
16	.	.	.	_	15	punct

1	On	on	IN	_	3	case
2	the	the	DT	_	3	det
3	basis	basis	NN	_	7	nmod
4	of	of	IN	_	6	case
5	the	the	DT	_	6	det
6	principles	principle	NNS	_	3	nmod
7	observed	observe	VBD	_	0	ROOT
8	the	the	DT	_	9	det
9	concentrations	concentration	NNS	_	10	nsubj
10	fo	fo	VBP	_	7	ccomp
11	these	these	DT	_	12	det
12	hormones	hormone	NNS	_	14	nsubjpass
13	were	be	VBD	_	14	auxpass
14	investigated	investigate	VBN	_	10	ccomp
15	in	in	IN	_	17	case
16	the	the	DT	_	17	det
17	plasma	plasma	NN	_	14	nmod
18	of	of	IN	_	19	case
19	dogs	dog	NNS	_	17	nmod
20	deprived	deprive	VBN	_	19	acl
21	of	of	IN	_	22	case
22	water	water	NN	_	20	nmod
23	for	for	IN	_	25	case
24	3	3	CD	_	25	nummod
25	days	day	NNS	_	20	nmod
26	and	and	CC	_	14	cc
27	then	then	RB	_	28	advmod
28	allowed	allow	VBD	_	14	conj
29	to	to	TO	_	30	mark
30	drink	drink	VB	_	28	xcomp
31	.	.	.	_	7	punct

1	-LSB-	-lsb-	-LRB-	_	3	punct
2	Quantitative	quantitative	JJ	_	3	amod
3	approach	approach	NN	_	0	ROOT
4	to	to	TO	_	5	case
5	treatment	treatment	NN	_	3	nmod
6	with	with	IN	_	8	case
7	incisive	incisive	JJ	_	8	amod
8	drug1	drug1	NN	_	5	nmod
9	by	by	IN	_	11	case
10	therapeutic	therapeutic	JJ	_	11	amod
11	monitoring	monitoring	NN	_	3	nmod
12	-RSB-	-rsb-	-RRB-	_	3	punct
13	;	;	:	_	3	punct
14	The	the	DT	_	15	det
15	problems	problem	NNS	_	27	nsubjpass
16	encountered	encounter	VBN	_	15	acl
17	during	during	IN	_	20	case
18	the	the	DT	_	20	det
19	longterm	longterm	JJ	_	20	amod
20	treatment	treatment	NN	_	16	nmod
21	of	of	IN	_	23	case
22	psychotic	psychotic	JJ	_	23	amod
23	patients	patient	NNS	_	20	nmod
24	with	with	IN	_	25	case
25	drug2	drug2	NN	_	23	nmod
26	are	be	VBP	_	27	auxpass
27	illustrated	illustrate	VBN	_	3	parataxis
28	by	by	IN	_	32	case
29	six	six	CD	_	32	nummod
30	typical	typical	JJ	_	32	amod
31	case	case	NN	_	32	compound
32	reports	report	NNS	_	27	nmod
33	.	.	.	_	3	punct

1	A	a	DT	_	2	det
2	group	group	NN	_	17	nsubjpass
3	of	of	IN	_	4	case
4	patients	patient	NNS	_	2	nmod
5	who	who	WP	_	7	nsubj
6	had	have	VBD	_	7	aux
7	had	have	VBN	_	4	acl:relcl
8	a	a	DT	_	11	det
9	new	new	JJ	_	11	amod
10	acute	acute	JJ	_	11	amod
11	episode	episode	NN	_	7	dobj
12	despite	despite	IN	_	15	case
13	seemingly	seemingly	RB	_	14	advmod
14	adequate	adequate	JJ	_	15	amod
15	treatment	treatment	NN	_	7	nmod
16	were	be	VBD	_	17	auxpass
17	selected	select	VBN	_	0	ROOT
18	.	.	.	_	17	punct

1	In	in	IN	_	4	case
2	these	these	DT	_	4	det
3	six	six	CD	_	4	nummod
4	cases	case	NNS	_	7	nmod
5	it	it	PRP	_	7	nsubjpass
6	was	be	VBD	_	7	auxpass
7	demonstrated	demonstrate	VBN	_	0	ROOT
8	that	that	IN	_	13	mark
9	the	the	DT	_	11	det
10	drug1	drug1	NN	_	11	compound
11	dosage	dosage	NN	_	13	nsubj
12	was	be	VBD	_	13	cop
13	inappropriate	inappropriate	JJ	_	7	ccomp
14	,	,	,	_	13	punct
15	being	be	VBG	_	18	cop
16	either	either	CC	_	18	cc:preconj
17	too	too	RB	_	18	advmod
18	high	high	JJ	_	13	xcomp
19	or	or	CC	_	18	cc
20	too	too	RB	_	21	advmod
21	low	low	JJ	_	18	conj
22	as	as	IN	_	23	mark
23	judged	judge	VBN	_	18	dep
24	from	from	IN	_	27	case
25	the	the	DT	_	27	det
26	plasma	plasma	NN	_	27	compound
27	concentrations	concentration	NNS	_	23	nmod
28	.	.	.	_	7	punct

1	Ways	Ways	NNP	_	15	nsubjpass
2	of	of	IN	_	3	mark
3	improving	improve	VBG	_	1	acl
4	the	the	DT	_	5	det
5	adequacy	adequacy	NN	_	3	dobj
6	of	of	IN	_	8	case
7	the	the	DT	_	8	det
8	treatment	treatment	NN	_	5	nmod
9	of	of	IN	_	11	case
10	psychotic	psychotic	JJ	_	11	amod
11	patients	patient	NNS	_	8	nmod
12	with	with	IN	_	13	case
13	drug1	drug1	NN	_	11	nmod
14	are	be	VBP	_	15	auxpass
15	discussed	discuss	VBN	_	0	ROOT
16	.	.	.	_	15	punct

1	Longitudinal	longitudinal	JJ	_	2	amod
2	assessment	assessment	NN	_	0	ROOT
3	of	of	IN	_	4	case
4	drug1	drug1	NN	_	2	nmod
5	in	in	IN	_	10	case
6	de	de	FW	_	10	amod
7	novo	novo	FW	_	6	dep
8	renal	renal	JJ	_	10	amod
9	transplant	transplant	NN	_	10	compound
10	recipients	recipient	NNS	_	2	nmod
11	over	over	IN	_	15	case
12	the	the	DT	_	15	det
13	first	first	JJ	_	15	amod
14	post-transplant	post-transplant	JJ	_	15	amod
15	year	year	NN	_	2	nmod
16	:	:	:	_	2	punct
17	pharmacokinetics	pharmacokinetic	NNS	_	2	dep
18	,	,	,	_	17	punct
19	exposure-response	exposure-response	JJ	_	20	amod
20	relationships	relationship	NNS	_	17	conj
21	,	,	,	_	17	punct
22	and	and	CC	_	17	cc
23	influence	influence	NN	_	17	conj
24	on	on	IN	_	25	case
25	drug2	drug2	NN	_	23	nmod
26	.	.	.	_	2	punct

1	OBJECTIVE	objective	NN	_	0	ROOT
2	:	:	:	_	1	punct
3	Our	we	PRP$	_	4	nmod:poss
4	objective	objective	NN	_	5	nsubj
5	was	be	VBD	_	1	dep
6	to	to	TO	_	7	mark
7	characterize	characterize	VB	_	5	xcomp
8	the	the	DT	_	10	det
9	steady-state	steady-state	JJ	_	10	amod
10	pharmacokinetics	pharmacokinetic	NNS	_	7	dobj
11	of	of	IN	_	12	case
12	drug1	drug1	NN	_	10	nmod
13	and	and	CC	_	12	cc
14	drug2	drug2	NN	_	12	conj
15	-LRB-	-lrb-	-LRB-	_	16	punct
16	INN	inn	NN	_	10	dep
17	,	,	,	_	16	punct
18	drug3	drug3	NN	_	16	appos
19	-RRB-	-rrb-	-RRB-	_	16	punct
20	when	when	WRB	_	21	advmod
21	coadministered	coadminister	VBN	_	7	advcl
22	in	in	IN	_	27	case
23	de	de	FW	_	27	amod
24	novo	novo	FW	_	23	dep
25	kidney	kidney	NN	_	27	compound
26	allograft	allograft	NN	_	27	compound
27	recipients	recipient	NNS	_	21	nmod
28	during	during	IN	_	31	case
29	the	the	DT	_	31	det
30	first	first	JJ	_	31	amod
31	year	year	NN	_	21	nmod
32	after	after	IN	_	33	case
33	transplantation	transplantation	NN	_	31	nmod
34	.	.	.	_	1	punct

1	METHOD	method	NN	_	0	ROOT
2	:	:	:	_	1	punct
3	This	this	DT	_	4	det
4	study	study	NN	_	10	nsubj
5	was	be	VBD	_	10	cop
6	a	a	DT	_	10	det
7	multicenter	multicenter	JJ	_	10	amod
8	randomized	randomize	VBN	_	10	amod
9	double-blind	double-blind	JJ	_	10	amod
10	study	study	NN	_	1	dep
11	of	of	IN	_	13	case
12	101	101	CD	_	13	nummod
13	patients	patient	NNS	_	10	nmod
14	who	who	WP	_	17	nsubjpass
15	were	be	VBD	_	17	auxpass
16	randomly	randomly	RB	_	17	advmod
17	assigned	assign	VBN	_	13	acl:relcl
18	1:1:1	1:1:1	CD	_	17	dobj
19	to	to	TO	_	20	mark
20	receive	receive	VB	_	17	advcl
21	drug1	drug1	NN	_	22	compound
22	tablets	tablet	NNS	_	20	dobj
23	at	at	IN	_	24	case
24	doses	dose	NNS	_	20	nmod
25	of	of	IN	_	27	case
26	0.5	0.5	CD	_	27	nummod
27	mg	mg	NN	_	24	nmod
28	,	,	,	_	27	punct
29	1	1	CD	_	30	nummod
30	mg	mg	NN	_	27	conj
31	,	,	,	_	27	punct
32	or	or	CC	_	27	cc
33	2	2	CD	_	34	nummod
34	mg	mg	NN	_	27	conj
35	twice	twice	RB	_	36	advmod
36	daily	daily	RB	_	34	advmod
37	with	with	IN	_	38	case
38	drug2	drug2	NN	_	34	nmod
39	and	and	CC	_	38	cc
40	drug3	drug3	NN	_	38	conj
41	.	.	.	_	1	punct

1	Blood	blood	NN	_	2	compound
2	sampling	sampling	NN	_	11	nsubjpass
3	for	for	IN	_	5	case
4	the	the	DT	_	5	det
5	pharmacokinetics	pharmacokinetic	NNS	_	2	nmod
6	of	of	IN	_	7	case
7	drug1	drug1	NN	_	5	nmod
8	and	and	CC	_	7	cc
9	drug2	drug2	NN	_	7	conj
10	was	be	VBD	_	11	auxpass
11	performed	perform	VBN	_	0	ROOT
12	on	on	IN	_	13	case
13	day	day	NN	_	11	nmod
14	1	1	CD	_	13	nummod
15	,	,	,	_	11	punct
16	on	on	IN	_	17	case
17	weeks	week	NNS	_	11	nmod
18	1	1	CD	_	17	nummod
19	,	,	,	_	17	punct
20	2	2	CD	_	17	nummod
21	,	,	,	_	17	punct
22	3	3	CD	_	17	nummod
23	,	,	,	_	17	punct
24	and	and	CC	_	17	cc
25	4	4	CD	_	17	conj
26	,	,	,	_	11	punct
27	and	and	CC	_	11	cc
28	on	on	IN	_	29	case
29	months	month	NNS	_	11	conj
30	2	2	CD	_	29	nummod
31	,	,	,	_	29	punct
32	3	3	CD	_	29	nummod
33	,	,	,	_	29	punct
34	6	6	CD	_	29	nummod
35	,	,	,	_	29	punct
36	9	9	CD	_	29	nummod
37	,	,	,	_	29	punct
38	and	and	CC	_	29	cc
39	12	12	CD	_	29	conj
40	.	.	.	_	11	punct

1	drug1	drug1	NN	_	2	compound
2	dose-proportionality	dose-proportionality	NN	_	8	nsubjpass
3	and	and	CC	_	2	cc
4	stability	stability	NN	_	2	conj
5	over	over	IN	_	6	case
6	time	time	NN	_	2	nmod
7	were	be	VBD	_	8	auxpass
8	assessed	assess	VBN	_	0	ROOT
9	in	in	IN	_	11	case
10	the	the	DT	_	11	det
11	context	context	NN	_	8	nmod
12	of	of	IN	_	14	case
13	linear	linear	JJ	_	14	amod
14	regression	regression	NN	_	11	nmod
15	and	and	CC	_	14	cc
16	ANOVA	ANOVA	NNP	_	17	compound
17	models	model	NNS	_	14	conj
18	.	.	.	_	8	punct

1	drug1	drug1	NN	_	3	compound
2	exposure-response	exposure-response	NN	_	3	compound
3	relationships	relationship	NNS	_	24	nsubjpass
4	between	between	IN	_	5	case
5	area	area	NN	_	3	nmod
6	under	under	IN	_	10	case
7	the	the	DT	_	10	det
8	blood	blood	NN	_	10	compound
9	concentration-time	concentration-time	NN	_	10	compound
10	curve	curve	NN	_	3	nmod
11	-LRB-	-lrb-	-LRB-	_	12	punct
12	AUC	auc	NN	_	10	appos
13	-RRB-	-rrb-	-RRB-	_	12	punct
14	and	and	CC	_	10	cc
15	changes	change	NNS	_	10	conj
16	in	in	IN	_	17	case
17	platelets	platelet	NNS	_	15	nmod
18	,	,	,	_	17	punct
19	leukocytes	leukocyte	NNS	_	17	conj
20	,	,	,	_	17	punct
21	and	and	CC	_	17	cc
22	lipids	lipid	NNS	_	17	conj
23	were	be	VBD	_	24	auxpass
24	explored	explore	VBN	_	0	ROOT
25	with	with	IN	_	28	case
26	the	the	DT	_	28	det
27	median-effect	median-effect	JJ	_	28	amod
28	model	model	NN	_	24	nmod
29	.	.	.	_	24	punct

1	Potential	potential	JJ	_	2	amod
2	differences	difference	NNS	_	15	nsubjpass
3	in	in	IN	_	5	case
4	drug1	drug1	NN	_	5	compound
5	dosing	dosing	NN	_	2	nmod
6	and	and	CC	_	5	cc
7	pharmacokinetics	pharmacokinetic	NNS	_	5	conj
8	at	at	IN	_	10	case
9	different	different	JJ	_	10	amod
10	levels	level	NNS	_	2	nmod
11	of	of	IN	_	13	case
12	drug2	drug2	NN	_	13	compound
13	exposure	exposure	NN	_	10	nmod
14	were	be	VBD	_	15	auxpass
15	assessed	assess	VBN	_	0	ROOT
16	in	in	IN	_	18	case
17	the	the	DT	_	18	det
18	context	context	NN	_	15	nmod
19	of	of	IN	_	20	case
20	ANOVA	ANOVA	NNP	_	18	nmod
21	.	.	.	_	15	punct

1	RESULTS	result	NNS	_	0	ROOT
2	:	:	:	_	1	punct
3	drug1	drug1	NN	_	5	compound
4	steady	steady	JJ	_	5	amod
5	state	state	NN	_	7	nsubjpass
6	was	be	VBD	_	7	auxpass
7	reached	reach	VBN	_	1	dep
8	on	on	IN	_	11	case
9	or	or	CC	_	8	cc
10	before	before	IN	_	8	conj
11	day	day	NN	_	7	nmod
12	7	7	CD	_	11	nummod
13	,	,	,	_	7	punct
14	with	with	IN	_	18	case
15	a	a	DT	_	18	det
16	median	median	JJ	_	18	amod
17	3-fold	3-fold	JJ	_	18	amod
18	accumulation	accumulation	NN	_	7	nmod
19	of	of	IN	_	21	case
20	drug	drug	NN	_	21	compound
21	exposure	exposure	NN	_	18	nmod
22	compared	compare	VBN	_	24	case
23	with	with	IN	_	24	case
24	that	that	DT	_	18	nmod
25	after	after	IN	_	29	case
26	the	the	DT	_	29	det
27	first	first	JJ	_	29	amod
28	postoperative	postoperative	JJ	_	29	amod
29	dose	dose	NN	_	24	nmod
30	.	.	.	_	1	punct

1	Both	both	DT	_	4	cc:preconj
2	steady-state	steady-state	JJ	_	4	amod
3	maximum	maximum	NN	_	4	compound
4	concentration	concentration	NN	_	9	nsubj
5	and	and	CC	_	4	cc
6	AUC	auc	NN	_	4	conj
7	were	be	VBD	_	9	cop
8	dose	dose	NN	_	9	nmod:npmod
9	proportional	proportional	JJ	_	0	ROOT
10	over	over	IN	_	14	case
11	the	the	DT	_	14	det
12	full	full	JJ	_	14	amod
13	dose	dose	NN	_	14	compound
14	range	range	NN	_	9	nmod
15	when	when	WRB	_	16	advmod
16	assessed	assess	VBN	_	9	advcl
17	on	on	IN	_	18	case
18	day	day	NN	_	16	nmod
19	1	1	CD	_	18	nummod
20	,	,	,	_	9	punct
21	as	as	RB	_	9	cc
22	well	well	RB	_	21	mwe
23	as	as	IN	_	21	mwe
24	for	for	IN	_	27	case
25	the	the	DT	_	27	det
26	full	full	JJ	_	27	amod
27	duration	duration	NN	_	9	conj
28	of	of	IN	_	30	case
29	the	the	DT	_	30	det
30	study	study	NN	_	27	nmod
31	at	at	IN	_	33	case
32	steady	steady	JJ	_	33	amod
33	state	state	NN	_	30	nmod
34	.	.	.	_	9	punct

1	There	there	EX	_	2	expl
2	was	be	VBD	_	0	ROOT
3	evidence	evidence	NN	_	2	nsubj
4	for	for	IN	_	6	case
5	longitudinal	longitudinal	JJ	_	6	amod
6	stability	stability	NN	_	3	nmod
7	in	in	IN	_	8	case
8	AUC	auc	NN	_	6	nmod
9	of	of	IN	_	10	case
10	drug1	drug1	NN	_	8	nmod
11	during	during	IN	_	13	case
12	the	the	DT	_	13	det
13	course	course	NN	_	6	nmod
14	of	of	IN	_	16	case
15	the	the	DT	_	16	det
16	study	study	NN	_	13	nmod
17	.	.	.	_	2	punct

1	The	the	DT	_	4	det
2	interindividual	interindividual	JJ	_	4	amod
3	pharmacokinetic	pharmacokinetic	JJ	_	4	amod
4	variability	variability	NN	_	9	nsubj
5	for	for	IN	_	6	case
6	AUC	auc	NN	_	4	nmod
7	was	be	VBD	_	9	cop
8	85.4	85.4	CD	_	9	nummod
9	%	%	NN	_	0	ROOT
10	and	and	CC	_	9	cc
11	intraindividual	intraindividual	JJ	_	9	conj
12	,	,	,	_	9	punct
13	interoccasion	interoccasion	NN	_	14	compound
14	variability	variability	NN	_	17	nsubj
15	was	be	VBD	_	17	cop
16	40.8	40.8	CD	_	17	nummod
17	%	%	NN	_	9	parataxis
18	.	.	.	_	9	punct

1	Age	age	NN	_	3	compound
2	-LRB-	-lrb-	-LRB-	_	3	punct
3	range	range	NN	_	29	nsubj
4	,	,	,	_	3	punct
5	17-69	17-69	CD	_	6	nummod
6	years	year	NNS	_	3	appos
7	-RRB-	-rrb-	-RRB-	_	3	punct
8	,	,	,	_	3	punct
9	weight	weight	NN	_	11	compound
10	-LRB-	-lrb-	-LRB-	_	11	punct
11	range	range	NN	_	3	conj
12	,	,	,	_	11	punct
13	49-106	49-106	CD	_	14	nummod
14	kg	kg	NN	_	11	appos
15	-RRB-	-rrb-	-RRB-	_	11	punct
16	,	,	,	_	3	punct
17	and	and	CC	_	3	cc
18	sex	sex	NN	_	3	conj
19	-LRB-	-lrb-	-LRB-	_	21	punct
20	65	65	CD	_	21	nummod
21	men	man	NNS	_	18	dep
22	and	and	CC	_	21	cc
23	36	36	CD	_	24	nummod
24	women	woman	NNS	_	21	conj
25	-RRB-	-rrb-	-RRB-	_	21	punct
26	were	be	VBD	_	29	cop
27	not	not	RB	_	29	neg
28	significant	significant	JJ	_	29	amod
29	contributors	contributor	NNS	_	0	ROOT
30	to	to	TO	_	31	case
31	variability	variability	NN	_	29	nmod
32	.	.	.	_	29	punct

1	There	there	EX	_	2	expl
2	was	be	VBD	_	0	ROOT
3	an	a	DT	_	5	det
4	increasing	increase	VBG	_	5	amod
5	incidence	incidence	NN	_	2	nsubj
6	of	of	IN	_	8	case
7	transient	transient	JJ	_	8	amod
8	thrombocytopenia	thrombocytopenia	NN	_	5	nmod
9	-LRB-	-lrb-	-LRB-	_	11	punct
10	or	or	CC	_	11	cc
11	=	=	JJ	_	8	dep
12	100	100	CD	_	16	nummod
13	x	x	CC	_	12	cc
14	10	10	CD	_	12	conj
15	-LRB-	-lrb-	-LRB-	_	16	punct
16	9	9	CD	_	11	dep
17	-RRB-	-rrb-	-RRB-	_	11	punct
18	/	/	:	_	19	punct
19	L	l	NN	_	8	dep
20	-RRB-	-rrb-	-RRB-	_	19	punct
21	with	with	IN	_	24	case
22	increasing	increase	VBG	_	24	amod
23	drug1	drug1	NN	_	24	compound
24	AUC	auc	NN	_	2	nmod
25	-LRB-	-lrb-	-LRB-	_	26	punct
26	P	p	NN	_	24	dep
27	=	=	JJ	_	26	amod
28	.03	.03	CD	_	27	dep
29	-RRB-	-rrb-	-RRB-	_	26	punct
30	.	.	.	_	2	punct

1	drug1	drug1	NN	_	2	compound
2	doses	dose	NNS	_	9	nsubj
3	,	,	,	_	2	punct
4	trough	trough	NN	_	5	compound
5	concentrations	concentration	NNS	_	2	conj
6	,	,	,	_	2	punct
7	and	and	CC	_	2	cc
8	AUC	auc	NN	_	2	conj
9	exhibited	exhibit	VBD	_	0	ROOT
10	similar	similar	JJ	_	12	amod
11	temporal	temporal	JJ	_	12	amod
12	patterns	pattern	NNS	_	9	dobj
13	during	during	IN	_	15	case
14	the	the	DT	_	15	det
15	course	course	NN	_	9	nmod
16	of	of	IN	_	18	case
17	the	the	DT	_	18	det
18	study	study	NN	_	15	nmod
19	regardless	regardless	RB	_	9	advmod
20	of	of	IN	_	25	case
21	the	the	DT	_	25	det
22	co-administered	co-administered	JJ	_	25	amod
23	drug2	drug2	NN	_	25	compound
24	dose	dose	NN	_	25	compound
25	level	level	NN	_	19	nmod
26	-LRB-	-lrb-	-LRB-	_	28	punct
27	P	p	NN	_	28	nsubj
28	=	=	JJ	_	25	dep
29	.13	.13	CD	_	28	dobj
30	,	,	,	_	28	punct
31	.82	.82	CD	_	28	conj
32	,	,	,	_	28	punct
33	and	and	CC	_	28	cc
34	.76	.76	CD	_	28	conj
35	,	,	,	_	28	punct
36	respectively	respectively	RB	_	28	advmod
37	-RRB-	-rrb-	-RRB-	_	28	punct
38	.	.	.	_	9	punct

1	CONCLUSIONS	conclusion	NNS	_	0	ROOT
2	:	:	:	_	1	punct
3	drug1	drug1	NN	_	4	nsubj
4	exhibited	exhibit	VBD	_	1	appos
5	dose-proportional	dose-proportional	JJ	_	8	amod
6	,	,	,	_	5	punct
7	stable	stable	JJ	_	5	dep
8	exposure	exposure	NN	_	4	dobj
9	during	during	IN	_	13	case
10	the	the	DT	_	13	det
11	first	first	JJ	_	13	amod
12	post-transplant	post-transplant	JJ	_	13	amod
13	year	year	NN	_	4	nmod
14	.	.	.	_	1	punct

1	For	for	IN	_	4	case
2	a	a	DT	_	4	det
3	4-fold	4-fold	JJ	_	4	amod
4	range	range	NN	_	9	nmod
5	of	of	IN	_	7	case
6	drug1	drug1	NN	_	7	compound
7	doses	dose	NNS	_	4	nmod
8	there	there	EX	_	9	expl
9	were	be	VBD	_	0	ROOT
10	no	no	DT	_	12	neg
11	differential	differential	JJ	_	12	amod
12	effects	effect	NNS	_	9	nsubj
13	on	on	IN	_	15	case
14	drug2	drug2	NN	_	15	compound
15	dosing	dosing	NN	_	12	nmod
16	or	or	CC	_	15	cc
17	pharmacokinetics	pharmacokinetic	NNS	_	15	conj
18	.	.	.	_	9	punct

1	Toxicity	toxicity	NN	_	0	ROOT
2	of	of	IN	_	3	case
3	cadmium	cadmium	NN	_	1	nmod
4	and	and	CC	_	3	cc
5	drug1	drug1	NN	_	3	conj
6	to	to	TO	_	7	case
7	encystment	encystment	NN	_	1	nmod
8	and	and	CC	_	7	cc
9	in	in	FW	_	11	amod
10	vitro	vitro	FW	_	9	dep
11	excystment	excystment	NN	_	7	conj
12	of	of	IN	_	14	case
13	Parorchis	Parorchis	NNP	_	14	compound
14	acanthus	acanthus	NN	_	7	nmod
15	-LRB-	-lrb-	-LRB-	_	16	punct
16	Digenea	digenea	NN	_	14	appos
17	:	:	:	_	16	punct
18	Philophthalmidae	Philophthalmidae	NNP	_	16	dep
19	-RRB-	-rrb-	-RRB-	_	16	punct
20	.	.	.	_	1	punct

1	The	the	DT	_	2	det
2	toxicity	toxicity	NN	_	0	ROOT
3	of	of	IN	_	4	case
4	cadmium	cadmium	NN	_	2	nmod
5	,	,	,	_	4	punct
6	drug1	drug1	NN	_	4	conj
7	and	and	CC	_	4	cc
8	cadmium/zinc	cadmium/zinc	NN	_	9	compound
9	mixtures	mixture	NNS	_	4	conj
10	at	at	IN	_	11	case
11	concentrations	concentration	NNS	_	2	nmod
12	ranging	range	VBG	_	11	acl
13	from	from	IN	_	14	case
14	1000	1000	CD	_	19	nmod
15	to	to	TO	_	16	dep
16	50000	50000	CD	_	17	nummod
17	microg/l	microg/l	NN	_	19	nsubjpass
18	were	be	VBD	_	19	auxpass
19	investigated	investigate	VBN	_	12	ccomp
20	against	against	IN	_	21	case
21	cercariae	cercaria	NNS	_	19	nmod
22	and	and	CC	_	21	cc
23	metacercariae	metacercaria	NNS	_	21	conj
24	of	of	IN	_	26	case
25	Parorchis	Parorchis	NNP	_	26	compound
26	acanthus	acanthus	NN	_	21	nmod
27	obtained	obtain	VBN	_	26	acl
28	from	from	IN	_	33	case
29	the	the	DT	_	33	det
30	dog	dog	NN	_	33	compound
31	whelk	whelk	NN	_	33	compound
32	Nucella	nucella	NN	_	33	compound
33	lapillus	lapillus	NN	_	27	nmod
34	.	.	.	_	2	punct

1	Cercarial	cercarial	JJ	_	2	amod
2	encystment	encystment	NN	_	12	nsubj
3	at	at	IN	_	4	case
4	concentrations	concentration	NNS	_	2	nmod
5	of	of	IN	_	7	case
6	25000	25000	CD	_	7	nummod
7	microg/l	microg/l	NN	_	4	nmod
8	or	or	CC	_	7	cc
9	higher	higher	JJR	_	7	conj
10	was	be	VBD	_	12	aux
11	significantly	significantly	RB	_	12	advmod
12	impaired	impaired	JJ	_	0	ROOT
13	by	by	IN	_	16	case
14	all	all	DT	_	16	det
15	test	test	NN	_	16	compound
16	metals	metal	NNS	_	12	nmod
17	;	;	:	_	12	punct

1	however	however	RB	_	8	advmod
2	,	,	,	_	8	punct
3	at	at	IN	_	5	case
4	lower	lower	JJR	_	5	amod
5	concentrations	concentration	NNS	_	8	nmod
6	only	only	RB	_	7	advmod
7	drug1	drug1	NN	_	8	nsubj
8	demonstrated	demonstrate	VBD	_	0	ROOT
9	toxicity	toxicity	NN	_	8	dobj
10	.	.	.	_	8	punct

1	Mixtures	mixture	NNS	_	6	nsubj
2	of	of	IN	_	3	case
3	cadmium	cadmium	NN	_	1	nmod
4	and	and	CC	_	3	cc
5	drug1	drug1	NN	_	3	conj
6	had	have	VBD	_	0	ROOT
7	a	a	DT	_	9	det
8	synergistic	synergistic	JJ	_	9	amod
9	effect	effect	NN	_	6	dobj
10	compared	compare	VBN	_	14	case
11	with	with	IN	_	14	case
12	single	single	JJ	_	14	amod
13	metal	metal	NN	_	14	compound
14	toxicity	toxicity	NN	_	9	nmod
15	but	but	CC	_	14	cc
16	only	only	RB	_	19	advmod
17	at	at	IN	_	19	case
18	50000	50000	CD	_	19	nummod
19	microg/l	microg/l	NN	_	14	conj
20	.	.	.	_	6	punct

1	Excystment	Excystment	NNP	_	7	nsubjpass
2	in	in	FW	_	3	compound
3	vitro	vitro	FW	_	1	advmod
4	was	be	VBD	_	7	auxpass
5	only	only	RB	_	6	advmod
6	significantly	significantly	RB	_	7	advmod
7	affected	affect	VBN	_	0	ROOT
8	by	by	IN	_	9	case
9	cercariae	cercariae	NN	_	7	nmod
10	exposed	expose	VBN	_	9	acl
11	to	to	TO	_	13	case
12	cadmium/zinc	cadmium/zinc	NN	_	13	compound
13	mixtures	mixture	NNS	_	10	nmod
14	whilst	whilst	IN	_	15	case
15	encysting	encysting	NN	_	13	nmod
16	.	.	.	_	7	punct

1	Twenty-four	twenty-four	CD	_	3	nummod
2	h	h	NN	_	3	compound
3	exposures	exposure	NNS	_	8	nsubj
4	of	of	IN	_	7	case
5	fully	fully	RB	_	6	advmod
6	formed	form	VBN	_	7	amod
7	cysts	cyst	NNS	_	3	nmod
8	had	have	VBD	_	0	ROOT
9	no	no	DT	_	10	neg
10	effect	effect	NN	_	8	dobj
11	on	on	IN	_	12	case
12	excystment	excystment	NN	_	8	nmod
13	in	in	FW	_	14	compound
14	vitro	vitro	FW	_	8	advmod
15	.	.	.	_	8	punct

1	Effects	effect	NNS	_	12	nsubj
2	on	on	IN	_	6	case
3	in	in	FW	_	6	amod
4	vitro	vitro	FW	_	3	dep
5	excystment	excystment	NN	_	6	compound
6	rates	rate	NNS	_	1	nmod
7	over	over	IN	_	11	case
8	a	a	DT	_	11	det
9	2	2	CD	_	11	nummod
10	h	h	NN	_	11	compound
11	period	period	NN	_	1	nmod
12	demonstrated	demonstrate	VBD	_	0	ROOT
13	widespread	widespread	JJ	_	14	amod
14	effects	effect	NNS	_	12	dobj
15	for	for	IN	_	17	case
16	cercariae-exposed	cercariae-exposed	JJ	_	17	amod
17	P.	P.	NNP	_	14	nmod

1	acanthus	acanthus	NN	_	0	ROOT
2	.	.	.	_	1	punct

1	No	no	DT	_	2	neg
2	effects	effect	NNS	_	4	nsubj
3	were	be	VBD	_	4	cop
4	evident	evident	JJ	_	0	ROOT
5	on	on	IN	_	7	case
6	excystment	excystment	NN	_	7	compound
7	rates	rate	NNS	_	4	nmod
8	of	of	IN	_	10	case
9	cyst-exposed	cyst-exposed	JJ	_	10	amod
10	parasites	parasite	NNS	_	7	nmod
11	.	.	.	_	4	punct

